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Associations Between Individual, Social and Service Factors, Recovery Expectations and 
Recovery Strategies for Individuals with Mental Illness 
Gary W. Walby 
ABSTRACT 
 Clinical and consumer recovery efforts continue to advance more successful 
recovery agendas. Limited research into the effect of the expectation to recover and what 
strategies are most effective in enhancing recovery impedes coherent recovery 
programming.  What factors are significantly associated with recovery expectancy and 
recovery strategies is still largely unknown.  Thus, this study addresses three key gaps in 
the field.  First, which factors associate with the expectation of recovery and is 
expectation related to strategy choice?  Second, what are common strategies for recovery 
from mental illness and what factors are associated with each strategy?  Third, does 
recovery expectancy or severity of mental illness mediate or moderate the relationship 
between clinical, social and service factors and recovery strategies?   
 This study surveyed a sample of 350 randomly chosen participants from a 
community mental health organization with varying degrees of mental illness in a cross-
sectional study utilizing instruments that measured clinical/historical, social, and service 
factors and recovery.  The results were examined in multivariate analysis targeted to 
address the gaps noted above.  The six recovery strategies included:  (1) effective illness 
management, (2) positive future orientation, (3) meaningfulness, personal control, and 
hope, (4) recognizing support, (5) help seeking, and (6) symptom eradication.   
 xvi
 Recovery expectancy was not significantly predicted by any of the clinical, social, 
or service factors.  Although 25% of the variance was explained by the full model, factors 
associated with expectancy differ from recovery strategies and require further 
investigation.  Except for symptom eradication, recovery expectancy was significantly 
negatively associated with each recovery strategy. 
Main effects models were significant for all six recovery strategies.  The social 
factor constructs (social support, empowerment, stigma) were most consistently and 
robustly associated with all recovery strategies.  Variance explained in full models ranged 
from 71% for positive future orientation to 19% for symptom eradication.  However, no 
mediating or moderating effects were detected for recovery expectancy or illness 
severity.  The results of this study further the understanding of recovery and provide 
information for development of recovery programs.   
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Chapter One 
Introduction 
Mental illness is a leading cause of disability and morbidity in the United States 
and internationally (Murray & Lopez, 1996).  With regard to years lived with a disability, 
depression is the leading cause worldwide (Ustun, Ayuso-Mateos, Chatterji, Mathers, & 
Murray, 2004).  Mental illness contributes to a reduced life span, especially for 
individuals diagnosed with schizophrenia, but is not itself usually a cause of mortality, 
with the obvious exception of increased risk for suicidal behavior.  Nonetheless, in terms 
of disability, mental illness surpasses all forms of cancer and HIV/AIDS and is nearly as 
disabling as cardiovascular and respiratory diseases (Ustun, 1999).  
The financial impact of mental illness is noteworthy.  In 1988, the financial 
burden of mental illness, considering direct and indirect costs, was $129.3 billion for the 
United States, with the largest expenditure for schizophrenia (Wacylenki, 1994).  Direct 
and indirect costs increased to approximately $328.4 billion in 2002 (Levy, 2005).  
Annual costs combined with the prevalence of mental illness makes mental illness more 
costly to society than other health problems.  For example, a comparison of expenditures 
for individuals with HIV/AIDS and serious mental illness finds that those with 
HIV/AIDS (a disease with relatively low prevalence) spend on average $7,400 annually 
on illness-related care, whereas those with a severe mental illness (a high prevalence 
category) spend approximately $5,800 per year.  Individuals with neither category of 
illness spend approximately $1,800 annually (Rothbard, Metraux, & Blank, 2003).   
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Addressing prevalence more specifically, the Centers for Disease Control and 
Prevention (CDC) estimates the occurrence of HIV infected individuals in the U.S. as 
approximately 850,000-950,000 with an additional estimated 180,000-280,000 
undiagnosed (CDC, 2005).  Contrast this with individuals with severe and persistent 
mental illness (4.8 million or 2.6% of the population), those with serious mental illness 
(10 million or 5.4% of the population) or those with any mental disorder (44.2 million or 
23.9% of the population) (Kessler & Zhao, 1999), and the burden becomes obvious.  
With the prevalence of severe mental illnesses alone at twelve times that of HIV/AIDS, it 
can be easily seen that the cost of mental illness is extraordinary.  Additionally, the 
untreated cost of mental illness may add an addition $70 billion or more of uncounted 
expenditures annually (Kramer, 2000).   
The cost estimates of mental illness pertain to all individuals with mental illness, 
from mild to severely symptomatic.  Costs, symptoms and diagnoses all point to mental 
illness existing on a continuum from transient symptoms related to stressful situations 
(e.g., divorce) to severe and persistent mental illness (Kessler, Walters, & Forthofer, 
1998; Kessler & Zhao, 1999).   However, a psychiatric diagnosis alone does not by itself 
constitute mental illness.  A disruption in social, occupational or academic function is 
required for an individual to be considered mentally ill.  For those with the label “severe 
mental illness” (SMI), psychiatric disorders will cluster with one or more primary and 
severe mental disorders and one or more less severe disorders (Kessler, Davis, & 
Kendler, 1997; Kessler & Zhao, 1999).  The diagnoses with the highest probability of 
leading to the SMI label are schizophrenia, schizoaffective disorder, bipolar disorder, and 
major depression.  A potential problem with diagnosis when comparing across studies is 
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the consistency of the diagnostic system.  For this research, the Diagnostic and Statistical 
Manual for Mental Disorders, Fourth Edition criteria were used to identify mental 
disorders by the partnering mental health center.  Further, all diagnoses were performed 
by a licensed psychiatrist or by a licensed nurse practitioner and then validated by a 
psychiatrist. 
Extreme cases of normally less severe diagnoses can qualify an individual for the 
SMI label as well, (e.g., complex post-traumatic stress disorder or severe obsessive-
compulsive disorder).   In most cases, individuals with mild to moderate mental illness 
are typically diagnosed with one or more disorders of less severity and experience less 
compromise in functioning (e.g., simple phobia or dysthymic disorder).  Nevertheless, 
mild disorders should not be ignored as there is evidence that mild disorders place a 
person at considerable risk for a major mental disorder (Kessler, Merikangas, Berglund, 
Eaton, Koretz, & Walters, 2003). 
Schizophrenia, bipolar disorder and other severe diagnoses often have an earlier 
onset than less severe disorders and have a period of deteriorating functioning (known as 
the prodromal phase) before meeting criteria for a major mental illness (Lencz, Smith, 
Auther, Correll, & Cornblatt, 2004; Miller et al., 2002; Yung, et al., 2003).  Those with 
mild to moderate illnesses will experience a shorter or no apparent prodromal phase and 
their illness is more likely to be (but not exclusively) a response to environmental 
occurrences (Eaton, Badawi, & Melton, 1995).  Individuals with limited and contextually 
stimulated and maintained disorder may remit spontaneously or with limited assistance, 
while those with severe disorders typically require more intensive clinical assistance and 
take longer to remit, if remission ever occurs (Dell’Osso, Pini, Casano, Mastrocinque, 
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Seckinger, Saettoni, et al., 2002; Gitlin, Nuechterlein, Subotnik, Ventura, Mintz, 
Fogelson, et al., 2001). 
For individuals with severe mental illness, recovery has been defined as living a 
satisfying life within the constraints of the mental illness (Anthony, 1993; Deegan, 2001).  
This is a common definition in first person accounts of recovery.  Processes of recovery 
that have been examined include hope, independence, stigma resistance, treatment, help 
seeking, self-management and empowerment (Borowitz-Ensfield, 1998; Corrigan, 
Giffort, Rashid, Leary, & Okeke, 1999; Corrigan, Salzer, Ralph, & Okeke, 2005).  For 
individuals with less severe mental illness, recovery has rarely been addressed as a 
relevant concept even though there can be periods of intense symptoms and compromised 
functioning (Hayden & Klein, 2001; Sheppard & Teasdale, 2004).  Whether recovery 
requires treatment, can occur spontaneously, or is a combination of both is still a matter 
of debate.  However, part of the appeal of the increasing focus on recovery is that it has 
reintroduced the idea of hope and meaningfulness, considered essential components of 
the recovery construct (Corrigan & Ralph, 2005).   
Among mental health professionals and mental health services researchers, 
conceptualizations of recovery have been focused primarily on individual and clinical 
factors such as symptom control and psychiatric self-management skills (Repper & 
Perkins, 2003; Smith, Bellack, & Liberman, 1996; Smith et al., 1996).  Previous research 
has paid limited attention to the role of social context and social interactions as factors 
that may explain recovery, reintegration experiences and clinical outcomes (Chadwick, 
1997).  Consequently, recovery has generally been equated with treatment factors such as 
medication compliance.  Even with state of the art medication, most consumers with 
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severe mental illnesses feel unaccepted and lack a basic trust in their ability to care for 
themselves or to be cared for by others (Walby, 2003a).  Furthermore, many individuals 
with a mental illness have become isolated from the greater society and maintain a 
supportive network comprised only of mental health providers, caretakers, and other 
mentally ill persons (Cresswell, Kuipers, & Power, 1992; Dickinson, Green Hayes, 
Gilheany, & Whittaker, 2002).  Limiting the concept of recovery to reduction in clinical 
symptoms ignores potentially powerful contextual factors that may be a barrier to, or an 
asset for, an enhanced state of recovery (Nelson, Lord, & Ochocka, 2001; Repper & 
Perkins, 2003). 
Purpose of Study and Significance 
The purpose of this study was to investigate factors that influence the process of recovery 
for individuals on a continuum of mental illness.  In this study recovery was defined as 
the individual’s belief that they will reach life goals and contentment either through 
elimination of mental illness or within the restrictions of mental illness.  Different 
processes or strategies for recovery have been identified, but what factors support these 
conduits has had little systematic investigation (Borowitz-Ensfield, 1998; Corrigan, 
Giffort et al., 1999; Corrigan, et al., 2005).  For instance, hope, personal challenge, 
professional assistance, and control of symptoms are all potential individual strategies 
important for recovery. For this research, the term strategies is used for the different 
processes of recovery.  To describe aspects of recovery as strategies is deliberate to help 
differentiate between the process of recovery and recovery as an outcome.  Further, 
strategies imply choice and action, supporting the consumer generated recovery literature 
that suggests such concepts are crucial for recovery (Chadwick, 1997).   Whether these 
strategies operate independently, and whether some or all are necessary for the outcome 
of recovery has not been established.    Figure 1 illustrates the recovery model tested in 
this study.   Specifically, the domains of individual (referencing clinical and historical 
factors), social, and service factors were tested for direct associations with expectation of 
recovery and recovery strategies.  Further, recovery expectancy could either mediate or 
moderate the relationship between the individual, social, or service domains and recovery 
strategies.  Both of these potential relationships were tested.  Finally, severity of mental 
illness was also examined for potential moderating affects on the relationship between  
 
 
Figure 1 
 
Recovery Model 
 
 
 
6 
 
 
 
 
 
 
 
 
 
 
Individual 
Factors 
Domain 
Social 
Factors 
Domain 
Service 
Factors 
Domain 
Recovery 
Strategies 
Recovery 
Expectancy 
Severity of 
Mental Illness 
 
 
7 
individual, social, and service domains and recovery strategies. 
Recovery has been defined in the context of life satisfaction within the constraints 
of some level of psychological impairment (Anthony, 1993; Deegan, 2001).  This is 
based on the assumption that recovery is only relevant to individuals with severe mental 
illness.  Another assumption is that individuals with mental illness believe that they will 
always be mentally ill and that all individuals pursuing recovery accepts some level of 
impairment as inevitable.  These beliefs and expectations have not been tested 
empirically.  However, pilot studies for this project have demonstrated that allowing for 
both elimination and restriction of mental illness as recovery outcomes is important 
because some individuals with differing symptom severity and illness trajectories have 
endorsed the ability to eradicate mental illness from their lives while others believe that 
mental illness is something they will cope with forever (Walby, 2003a, 2003b).  This 
pattern of findings runs counter to the prevailing yet largely untested assumption that all 
individuals with severe mental illness believe they will always have mental illness and 
that less severe cases always believe that they will eventually eliminate or be cured of 
mental illness.       
One unique contribution of this study was to investigate expectations of recovery 
from mental illness.  Whether a person has an inherent belief in recovery may impact the 
degree an individual chooses to endorse different recovery strategies.  This objective was 
important objective because other studies have assumed that recovery is a process 
embraced by all and one that each individual will define and accomplish in his or her own 
way (Chadwick, 1997; Deegan, 1998, 2001).  Belief that a goal is attainable or that a 
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process is within the individual’s behavioral capacity will alter the degree of effort and 
perseverance committed to accomplishing the tasks necessary to complete the goal. 
Another contribution of this study was to broaden understanding of the recovery 
concept by applying recovery to individuals with different severities of mental illness.  
Recovery may or may not be relevant to individuals who are clinically compromised but 
not severely mentally ill.  If recovery is relevant to non-SMI individuals, do they expect 
to recover completely and what strategies do they endorse?  How is this different from 
those with a severe mental illness?  Engaging individual’s with less severe symptoms and 
diagnoses into the process of recovery may normalize the prevalence of mental illness 
decreasing stigma or, at least, lower the burden of isolation carried by the majority of 
those with severe illnesses. 
Following investigation into recovery expectancy and the potential relevance of 
recovery to the less severely impaired, the next task was to begin to understand what 
factors affect choice of recovery path and expectation of recovery outcome.  These 
choices can be sorted into individual/clinical-historical, social, and service domains.   
Previous recovery research had been focused on individual and clinical factors such as 
symptom control and psychiatric self-management skills (Smith et al., 1996).  Similar 
factors (e.g., age of onset, treatment compliance, diagnosis and other variables) were 
tested for association with recovery strategies or pathways identified by other researchers.  
Thus, considerable previous research has targeted clinical aspects of recovery and, while 
not completely at odds with the consumer vision of recovery, the research has not 
included social and service factors to any great degree. 
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The roles of social factors in recovery strategies and outcomes are poorly 
understood.  Levels of support, satisfaction with relationships, experiences of belonging 
to ones community and internalization of stigma are potential factors that could affect 
recovery beliefs and choices.  A thorough examination of these factors is presented in 
Chapter 2. 
Finally, the degree that services affect recovery strategies and the recovery 
expectancy was investigated.  This serves an important purpose because service intensity 
and satisfaction have not been investigated for an association with different recovery 
strategies.  In fact, there is controversy about whether being involved in services supports 
or inhibits the individual path to recovery (Chadwick, 1997).   
The results of this research will inform the development of linkages between 
mental health agencies and community-based initiatives to facilitate recovery and 
reintegration of persons with severe mental illness into communities.  Understanding 
recovery strategies and what influences them will assist in the development of targeted 
recovery programs that will lessen the burden of mental illness on individuals and 
society.  Additionally, understanding recovery will assist in both primary and secondary 
prevention programs targeted to mental illness.  Finally, the construct of recovery can be 
expanded by exploring the generalizability of the concept of recovery to different 
severities of mental illness. 
Study Rationale  
The recovery paradigm first introduced in the mid-1980’s continues to gain 
momentum.  The paradigm, generated by consumers of mental health services, is based 
on hope, empowerment and choice in a clinical atmosphere often believed by consumers 
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to be targeted exclusively to symptom relief and not personal growth (Fisher, 2003; 
Mueser et al., 2002; Resnick, Rosenheck, & Lehman, 2004).  Recovery from mental 
illness, however, has been difficult to define and in most cases has simply incorporated 
recovery concepts from physical disability and addictions research without considering 
the unique aspects of mental illness.  To begin to close this gap, this study addressed 
various aspects of mental illness recovery that, up to now, have limited exposure in the 
literature. 
One aspect of recovery conspicuously absent from the literature is the degree that 
individuals believe they are going to recover from mental illness.  Expectancy beliefs 
may inhibit or promote whether recovery strategies are utilized or the strategy for 
recovery chosen.  In turn, various factors may influence expectation beliefs.  The 
exploration of recovery expectancy in this study took the following form:   first, recovery 
expectations of the sample surveyed was quantified, next factors significantly associated 
with expectancy were identified, and lastly, recovery expectancies relationship with 
recovery strategies was explored. 
The research targeting recovery strategies is limited as well.  Further, factors that 
may be associated with such preferences (e.g., level of psychiatric impairment) have not 
been studied.  Thus, this study identifies preferred strategies for recovery for the 
combined sample.  These strategies reflect aspects of personal empowerment, support, 
professional assistance, and other relevant pathways identified in the literature (Borowitz-
Ensfield, 1998; Corrigan, Giffort et al., 1999; Corrigan et al., 2005). 
To more fully understand recovery, it is not enough to understand if individuals 
believe they will recover and what their current practices to operationalize their recovery 
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journey entail.  It is necessary to understand what factors are associated with each 
strategy chosen and how much of the variance of strategies they explain. The factors 
influencing recovery can be grouped into three domains.  These domains are not 
arbitrary, but they are also not consistent with other studies in the literature.  An 
exhaustive examination of the current recovery literature informed the choice to utilize 
three domains.  To investigate what influences recovery, these three domains are 
hypothesized to interact to influence opportunities and preferences for recovery 
trajectories (Figure 2).  The first domain is the individual factors, historical and clinical 
factors domain that includes psychiatric symptoms, age of onset, hospitalization history, 
familial history of mental illness, and employment factors. These factors are both clinical 
and historical because they assess current symptom levels and diagnosis as well as 
recollection of key aspects of mental health history associated with disorder, e.g., 
hospitalization history and family members with a diagnosed mental illness.  The second 
domain consists of the social context/individual social factors that each individual 
interacts with and is influenced by.  The constructs in question include social support, 
stigma, and perceived cohesiveness between self and society.  The social context domain 
had received the least attention in previous recovery research but may be vital for 
generation of successful interventions.  The third domain (clinical and support services 
domain) encompasses the services in place to provide clinical intervention (therapy, 
medication), and assistance to promote community living and to prevent relapse and re-
hospitalization (i.e., case management, supported living, supported employment, and 
residential treatment).  However, this study did not examine the individual impact of 
different clinical and service support choices in this analysis but instead examined the 
Figure 2 
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amount of contact and satisfaction with services for potential association with recovery 
expectancies and strategies.  An innovation of this study was the simultaneous attention 
to all three domains and how they contribute to recovery along the separate courses.   
Several surveys, each with multiple sub-scales relevant to the domains outlined above 
were utilized to operationalize and quantify the constructs. 
Limitations of Existing Knowledge Base 
 A lack of consensus on what constitutes recovery for individuals with mental 
illness continues to hinder research and program development.  There are four main 
directions that recovery research has taken thus far.  Together, these have evolved into 
what is called the ‘recovery movement’ in this study.  The recovery movement can be 
theorized as a fifth direction and is described below.  The first direction is a focus on 
individual narratives of recovery, fostering a belief that recovery is a private and singular 
process that is very personal and individual with limited commentary on factors that may 
be common across those recovering (Chadwick, 1997; Davidson, 2003; Deegan, 2001).  
The second direction begins the search for commonalities via qualitative research that has 
sought to identify themes within samples identified as recovering from mental illness 
(Davidson, Sells, Sangster, & O’Connell, 2005; Sells, Stayner, & Davidson, 2004; Young 
& Ensing, 1999).  The next direction equates recovery with treatment compliance and 
symptom reduction, reducing the concept of recovery to measurable clinical concepts 
while ignoring aspects of rehabilitation, services, employment, education, and other 
social factors (Holzinger, Loffler, Muller, Priebe, & Angermeyer, 2002; Svedberg, 
Backenroth-Ohsako, & Lutzen, 2003; Ziguras, Klimidis, Lambert, & Jackson, 2001).  In 
other words, recovery is tantamount to clinical success.  Finally, recovery is viewed as 
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synonymous with employment.  A recovered person, noting the language that views 
recovery as outcome versus process, is a person able to obtain and maintain employment 
(Marwaha & Johnson, 2004; Provencher, Gregg, Mead, & Mueser, 2002). 
 The recovery movement represents the current philosophy, service provision, and 
policy of recovery. The recovery movement is an ongoing reconceptualization of mental 
health services that has become a guiding vision for mental health in the United States 
(President’s New Freedom Commission on Mental Health, 2003).  Initially begun in 
protest of and opposition to the perceived reductionistic practices of the clinical treatment 
establishment there has been recent efforts at rapprochement between clinical services 
and the consumer empowerment movement in recovery (Corrigan & Garman, 1997; 
Nelson, Lord, & Ochocka, 2001).  The shared goal of recovery is reflected in the 
emphasis on empowerment and choice as key aspects of the President’s New Freedom 
Initiative’s vision, the primary policy document driving the recovery movement.  
Recovery in the New Freedom Initiative promotes the expectation that consumers make 
informed choices from available clinical services that are, hopefully, evidence-based as 
well as supportive (e.g., supported housing) with the overarching goals of defeating 
stigma, reducing unfair treatment limitations, and making the fragmented service delivery 
system more cohesive.  Though consistent with some of the key aspects of the recovery 
movement there are still obstacles in operationalizing the vision of the recovery 
movement.  Lack of access to recovery based services and continued mistrust of the 
consumer’s capacity for making informed judgments remain key obstacles (Corrigan & 
Ralph, 2005). 
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The lack of consensus for a defined construct of recovery that satisfies the clinical 
professionals, social service advocates, consumer run organizations, national, state, and 
local mental health lobbying organizations, and policy makers further restrict 
understanding of what promotes or limits recovery.  Various factors culled from first 
person reports, qualitative studies, empirical studies targeting treatment compliance and 
the growing body of recovery based literature demonstrates a wide array of potential 
covariates in the recovery process.  There has been little effort as yet to systematically 
investigate these factors for direct, mediating, or moderating effects.  A further 
contributor to the uncertainty stems from whether recovery is a process or an outcome 
(Andresen, Oades, & Caputi, 2003; Corrigan, Calabrese et al., 2002).  What would 
comprise a recovered individual?  Is a person with mental illness continually on the path 
of recovery with some individuals further along or further behind (i.e. the addictions 
recovery model)?  First person accounts and qualitative research are more likely to 
promote the process of recovery and agree with the concept of ‘a process with no end’ 
than quantitative/empirical researchers who would prefer a measurable endpoint.  This 
study addresses the issue of recovery as a process, reflecting the ongoing use of strategies 
with the assumption that as an individual becomes non-symptomatic the option exists to 
discontinue active implementation of recovery strategies until once again needed.  
Various strategies and covariates of recovery were measured as indicators of an active 
recovery process and captured in five research questions that were targeted in this effort. 
Research Questions 
RQ1:  To what degree does illness severity influence beliefs in recovery for the 
individual? 
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RQ2:  Are individual, social or service factors associated with recovery expectancy?  
RQ2.1:  Are individual factors associated with recovery expectancy? 
RQ2.2:  Are social factors associated with recovery expectancy? 
RQ2.3:  Are service factors associated with recovery expectancy? 
RQ3:  Are individual, social or service factors associated with recovery strategies? 
RQ3.1:  Are individual factors associated with recovery strategies? 
RQ3.2:  Are social factors associated with recovery expectancy? 
RQ3.3:  Are service factors associated with recovery expectancy? 
RQ4a:   Does the expectation of recovery mediate the relationship between individual, 
social and service factors and recovery strategies? 
RQ4b:   Does the expectation of recovery moderate the relationship between individual, 
social and service factors and recovery strategies? 
RQ5:   Does severity of mental illness moderate the relationship between individual, 
social, and service factors and recovery strategies? 
Overview of Design 
This study is a cross-sectional/ecological, nonexperimental study with 
retrospective elements that utilizes primary data.  Individual factors (e.g., symptoms) and 
contextual factors (e.g., social support), representing micro- and meso-level factors were 
investigated simultaneously.  The population investigated for this research was 
individuals with mental illness.  Further, this research addressed two clinical subgroups 
of this population, individuals with severe mental illness and individuals with mild to 
moderate mental illness.  Random sampling of both samples was completed with 
assistance from the partnering agency.  The sample with severe mental illness is referred 
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to throughout this document as the SMI sample.  The mild to moderate sample engaged 
in outpatient treatment is referred to as the OP sample.  A full description of the 
population, sampling, inclusion and exclusion criteria are provided in Chapter 3. 
This study utilized a three-part design.  First, the respondents were assessed for 
their recovery beliefs and endorsement of different recovery strategies.  This included 
comparing the SMI and OP samples on whether recovery is expected and if there is a 
significant relationship.  Second, the study investigated recovery strategies (dependent 
variables) and various factors believed to be associated with recovery (independent 
variables) in bivariate and multivariate analyses.  Third, the mediating effect of recovery 
expectancy and the moderating effect of expectancy and severity of illness were 
explored.  
Implications for Public Health 
Implications for this study include both research and practical benefits.  In 
general, this project challenges the Public Health core concepts of equity and social 
justice through focusing on understanding the needs of a highly disenfranchised group of 
citizens.  There exists an inherent bias towards and stigmatization of this population.  
Indeed, structural stigma in legislative bodies that control policy and funding for mental 
health services has been investigated (Corrigan, et al., 2005).  Further, increased 
understanding of the mentally ill will help professionals in public health to better 
understand the morbidity attached to mental illness in severe forms as well as less severe, 
and far more common, forms.  This is essential as public health continues to move away 
from its traditional roots embedded in the study of mortality to encompass quality of life, 
functioning and wellness issues. 
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The concept of recovery from mental illness has, before this study, been 
exclusively applied to severe forms of mental illness, psychological responses to physical 
disabilities or injuries, and addictions.  By expanding the concept of recovery and testing 
its applicability to less severe forms of mental illness, this study tested the flexibility and 
applicability of the recovery concept and broadened the concept of population at risk. 
Delimitations 
The following are delimitations of this study enforced by the researcher. 
1. The sample of individuals in the severely mentally ill sample was diagnostically 
limited to schizophrenia (any type), schizophrenia spectrum disorders (e.g. 
paranoid disorder, delusional disorder, schizoaffective disorder), bipolar disorder 
(Bipolar I or Bipolar II), and major depression.  Though other individuals with 
psychiatric diagnoses, (e.g., severe obsessive-compulsive disorder, severe post-
traumatic stress disorder) can meet the general criteria for SMI, there is less 
consensus for their inclusion and they constitute only a small proportion of the 
SMI population (Kessler, 2000; Kessler et al., 1996; Kessler & Zhao, 1999).  
However, for individuals identified as SMI and not diagnosed with schizophrenia, 
schizoaffective disorder, bipolar, or major depression, a conference with their 
primary clinician was completed before deciding whether to include or exclude 
the individual. 
2. The outpatient sample contained any outpatient therapy consumer who did not 
meet the criteria for SMI used in this study and also excluded consumers who 
were receiving only substance abuse treatment. 
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3. Individuals randomly selected who are incarcerated or hospitalized for psychiatric 
or medical reasons were ineligible due to access and stability considerations.  
Similarly, consumers randomly selected who were living in the community but 
judged too unstable to complete data collection were not eligible for the study. 
Limitations 
1. Because of the study delimitations noted above and the fact that all participants 
will be selected from one mental health agency (albeit a large agency with 33 sites 
spanning three counties), this study does not generalize to all mentally ill 
individuals. 
2. As this study focuses on individuals with a SMI or less severe type of mental 
illness who are in treatment, the results do not generalize to individuals who are 
not involved in mental health services. 
3. This study is restricted to the instruments chosen or created for the purpose of the 
study and did not investigate in-depth the contextual milieu of the participants. 
4. The instruments chosen to measure the criterion variable (recovery) have only had 
limited use in studies and, though psychometrically sound, lack a track record that 
further establishes their validity.  However, they were designed with the full 
ongoing participation of individuals with mental illness and the factors identified 
were congruent with the current recovery literature. 
5. Because the design is ecological and not longitudinal there are risks of ecologic 
fallacies and the limitation of articulating associations versus causal pathways. 
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Select Definitions 
Bipolar Disorder:  Bipolar disorder is a cyclical disorder constituting both major 
depressive disorder and the excessive energy and poor judgment of manic disorder.  
Potential symptoms when depressed include sadness, helplessness and hopelessness, loss 
of energy and interest, negative thought processes and disturbed sleep and appetite.  
When manic, possible symptoms include excessive energy, reduced need for sleep, 
grandiose assessment of abilities that can become delusional, racing thoughts and flights 
of ideas, poor judgment and impulsive behavior.  For this study Bipolar I and Bipolar II 
disorders were eligible for inclusion.  Bipolar I diagnostic codes included 296.0 (single 
episode), 296.40 (most recent episode hypomanic), 296.4x (most recent episode manic), 
296.6x (most recent episode mixed), 296.5x (most recent episode depressed), and 296.7 
(most recent episode unspecified).  The ‘x’ provides additional information as follows: if 
x = 1 the disorder is mild, 2 = moderate, 3 = severe without psychotic features, 4 = severe 
with psychotic features, 5 = in partial remission, 6 = full remission, and 0 = unspecified 
(American Psychological Association, 1994).  Bipolar I include manic and mixed 
episodes that are more severe then the hypomanic episodes associated with Bipolar II.  
Bipolar disorder was previously called manic-depression.   
Ecologic Fallacy:  The fallacy sometimes present when drawing inferences at the 
individual level (that is, regarding relations between individual level variables) based on 
group level data. In other words, assuming that the differences noted at the aggregated or 
group level is representative of a specific individual.  The ecological fallacy arises 
because associations between two variables at the group level (or ecological level) may 
differ from associations between analogous variables measured at the individual level. 
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Empowerment:  Empowerment is a multi-level construct that includes an individual’s 
feeling of personal power and control, an organizations ability to help its workers and 
customers or consumers feel that they have choices and a voice, and a belief within a 
community that its citizens can accomplish their goals and promote their own health.  
Thus, empowerment is the experience and benefits of choice, independence, voice and 
control ecologically embedded at multiple levels of experience by and within society. 
Major Depression:  A major depressive episode is a period of time of at least two weeks 
where the individual experiences extreme sadness, loss of hope, and a feeling of 
helplessness as well as other somatic and psychological symptoms.  Though the major 
symptom picture of the disorder is only required to be present for two weeks for a 
diagnosis to be made, the majority of episodes last considerably longer and can be quite 
debilitating.  Major depression disorder is when more than one episode of intense 
depression is reported.  Multiple episodes over time indicate a chronic course with higher 
likelihood of being resistant to treatment.  Individuals with a diagnostic code of 296.2x 
(single episode) or 296.3x (recurrent) were included in the study.  The use of the ‘x’ 
parallels bipolar disorder. 
Recovery:  Recovery is an elusive concept still poorly defined.  Consumers in one study 
succinctly defined recovery as psychological recovery from the consequences of illness 
(Andresen et al., 2003).  Other definitions have touched on recovery as a process of 1) 
overcoming "stuckness," 2) discovering and fostering self-empowerment, 3) learning and 
self-redefinition, 4) returning to basic functioning, and 5) improving quality of life 
(Young & Ensing, 1999).  
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Schizoaffective Disorder:  This disorder combines schizophrenia with major depression 
or bipolar disorder.  Diagnostic code is 295.7 for all cases. 
Schizophrenia:  This disorder has, in general, two different symptom clusters.  The first is 
the ‘negative cluster’ where the individual does not experience what would be normally 
expected in a situation, (i.e., lack of emotion, lack of interest, disruption in experiencing 
pleasure from that which used to be pleasurable).  The second cluster is the ‘positive 
cluster’ in which the individual has experiences they are not supposed to have, (i.e., 
delusions, hallucinations, loose associations, disruption in thought process).  The disorder 
has also been called a psychotic or thought disorder.  The major disruption is in cognitive 
processes though depression and other mood related symptoms are common.  Diagnostic 
codes identified in this study included: 295.30 (schizophrenia, paranoid type), 295.90 
(undifferentiated), 295.60 (residual type), and 297.1 (delusional disorder). 
Severe Mental Illness:  The combination of a major mental disorder, one or more relapses 
and disturbance in occupational, academic, or educational functioning defines SMI. 
Social Support:  The level of assistance from others that an individual can count on in 
various domains, (i.e., emotional support, instrumental or practical support, knowledge 
support). 
Stigma:  Stigma is defined as the co-occurrence of its components: labeling, stereotyping, 
separation, status loss, and discrimination.  Stigma is both an occurrence outside and a 
process within an individual (Link & Phelan, 2001). 
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Chapter 2 
Comprehensive Literature Review 
Introduction/Overview 
 According to the Department of Health and Human Services (DHHS), individuals 
with severe mental illness (SMI) constitute one of the largest disenfranchised and 
stigmatized populations in the United States (DHHS, 1999).  Indeed, mental illness is a 
factor in marginalization regardless of level of severity.  Though ubiquitous with twenty-
five percent of the population meeting criteria for a psychiatric diagnosis at any given 
time (Kessler & Walters, 2002; Kessler & Zhao, 1999), mental illness remains for many a 
mystifying and troubling event.  There is no single cause of mental illness and multiple 
risk factors appear to be related to onset of most disorders.  It also holds true that many 
risk factors are causally relevant for the onset of more then one disorder.  Etiological 
uncertainty combined with attributions of dangerousness, disruption of identity cohesion, 
and manifestation of unpredictable behavior and emotions, limits responses to the 
mentally ill to primarily anger, pity or, fear (Corrigan, 2000; Corrigan, Markowitz, 
Watson, Rowan, & Kubiak, 2003).   
Despite causal uncertainty, there are effective treatments for many mental 
disorders. These evidence-based practices vary in the degree that they incorporate 
recovery principles of choice and empowerment (Azrin & Goldman, 2005; Resnick, 
Fontana, Lehman, Rosenheck, 2005).  Efforts to increase understanding, access, and 
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evaluation of evidence-based practices continue though the majority of mental health 
services remain traditional, meaning not developed as evidence-based practices but are 
endorsed via longevity (Shem & Evans, 2005).  However, evidence-based practices are 
more often developed for mild to moderate levels of symptoms and impairment and 
symptom resolution and the omnipresent threat of relapse are the best that conventional 
treatment can offer for severe mental illness.  Further, the availability of efficacious 
treatment is limited and parity in coverage via insurance is unrealized (Abrahamson, 
Steel, & Abrahamson, 2003).   
Consumers have responded to limited and rigid services by leading the 
development of the concept of recovery (Chadwick, 1997; Corrigan & Ralph, 2005; 
Deegan, 2001).  Recovery, initially viewed with skepticism by the professional 
psychiatric community, is becoming more accepted and mainstream.  The President’ New 
Freedom Commission on Mental Health, (2003) was directly responsible for launching 
the concept of recovery into mainstream psychiatry.  Detractors of this effort have argued 
that this policy document’s main purpose was to disown clinical responsibility onto the 
afflicted and to consumer organizations that are often poorly funded and lacking skills in 
program development and evaluation.  There are further accusations that instead of 
organizing and streamlining service provision  while bringing evidence-baaed services to 
more individuals in need, the result is less funding and responsibility for the government 
while privatizing to the lowest bidder with limited accountability.  There is limited 
evidence for or against these allegations and there are many others that believe that the 
President’s Initiative is an accurate and straightforward analysis with reasonable policy 
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suggestions.  Regardless, the Commission’s report has served to raise recognition of the 
recovery concept. 
 Research in recovery is attempting to define the construct in relation to similar 
concepts (e.g., reintegration and social inclusion), formalize the relationship between 
recovery and clinical intervention, and to understand the factors that promote and inhibit 
recovery.  At the same time, the concept of recovery is being defined by multiple 
stakeholders based on philosophical differences that are at times conflicted and others 
cooperative.  The suspicion noted above colors some of the attempts in making recovery 
a beneficial empirically based concept but has, for the most part, been limited to rhetoric.  
Of more concern is a reactive integration of recovery based services into mainstream 
clinical services without proper consideration of contextual factors, impact on already 
established clinical, but non-recovery based, services and without incorporating proper 
evaluation design to measure service effects. 
To better understand recovery in its complexity, this chapter is organized into 
several sub-sections that provide an overview and synthesis of relevant literature as well 
as providing the structure for this research effort.  There is some variability in the degree 
of coverage for each section as the breadth and depth of reporting depends on the 
availability of empirical information.  First, those with severe mental illness are described 
and then contrasted with individuals who have less severe forms of mental illness.  Next, 
recovery strategies and their many dimensions will be elaborated.  This will be followed 
by descriptions of three domains of associated factors that appear to impact recovery 
from mental illness.  The first domain is comprised of individual factors, events, and 
familial influences that may be related to onset, maintenance, and recovery from mental 
26 
illness.  The second domain is consists of social factors that may affect recovery, (e.g., 
stigma, social support, and empowerment).  The third domain is comprised of service 
factors that may increase or decrease the process and outcome of recovery. 
The risk of covering broad areas of information deemed relevant to recovery is a 
fragmented discourse, reflecting, unfortunately, the current state of the field.  Every effort 
has been made to integrate the information in relation to this research effort.  The 
literature reviewed for each section will focus on the relevant points of the subject and its 
relation to recovery.  Thus, the common or focusing theme that ties each of the following 
sections together is recovery. 
Mental Illness 
Mental illness exists along a continuum from severe to mildly symptomatic (van 
Os et al., 1999; Verdoux & van Os, 2002).  Many individuals successfully function in 
their daily lives with mild to moderate symptoms (Kennedy, Abbot, & Paykel, 2004; 
Solomon, Haaga, & Arnow, 2001).  Others experience symptoms that cause varying 
levels of disturbance in their ability to function in social, occupational, and educational 
settings (Klein, Schwartz, Rose, & Leader, 2000; Ormel, Oldehinkel, & Brilman, 2001).  
The more severe, frequent and robust the symptom pattern, the more likely that 
disturbance in functioning will result.  Those labeled as severely mentally ill (SMI) are 
individuals who manifest repeated episodes of depression, psychosis, mania or other 
symptom clusters.  Multiple episodes over a lifetime can result in substantially impaired 
functioning in key settings and in completing daily tasks of living.  Disorders that carry 
the label of severe mental illness are considered chronic because of their tendency to 
cycle from no discernible symptoms to highly symptomatic over the life course. 
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Typical diagnoses of the SMI include major depression, schizophrenia, bipolar 
disorder and schizoaffective disorder.  Approximately five to seven percent of the U.S. 
population is believed to suffer from a severe mental illness (Kessler & Walters, 2002).  
According to the American Psychiatric Association (APA), and others, individuals are 
qualified for this label via diagnosis with a major psychiatric diagnosis, a chronic course, 
and impairment in social, occupational and educational functioning (APA, 1994; Kessler, 
& Walters, 2002).  Typically, these consumers demonstrate a pattern of short 
hospitalization and discharge followed by repeated admissions.  The most important 
characteristic of these patients is that they have rarely been treated successfully (Morin & 
Seidman, 1986), although the picture is confused further by several long term studies that 
indicates that partial or total remission has been observed for individuals with severe 
mental illness as they age (Calabrese & Corrigan, 2005).  Investigation into the ‘burning 
out’ of mental disorders over time appears to support that the effect does exist when 
considering the population as a whole, but with little knowledge of how the phenomenon 
occurs.  Treatment for individuals labeled SMI is usually a combination of medication to 
reduce primary symptoms and psychosocial interventions to increase quality of life and 
successful adaptation to community living (Barton, 1999; Zygmunt, Olfson, Boyer, & 
Mechanic, 2002).   
Individuals with mild to moderate mental illness tend to present with a much 
wider array of potential symptoms across the population while the SMI population is 
more individually seriously symptomatic.  Different manifestations of anxiety, 
depression, dissociation, or somatic symptoms are common in mild to moderate cases.  
At times, behavioral manifestations such as eating disorders, impulse control problems, 
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and addictions are the presenting problem. What separates this group from individuals 
with a SMI is the level of symptom severity, less consistent and pervasive functional 
impairment, and greater potential for successful treatment. 
Categories of mental illness diagnoses are detailed in the Diagnostic and 
Statistical Manual of Mental Disorders, 4th edition (APA, 1994).  The vast majority of 
diagnoses relevant to the SMI are contained in the ‘mood’ and ‘schizophrenia and other 
psychotic disorder’ categories.  While there is crossover in categories of diagnoses for 
SMI and non-SMI labeled individuals, this is in most cases differences in primary 
diagnosis and severity of the disorder.  Individuals with less severe impairment often 
receive a primary diagnosis from many other diagnostic categories, e.g., anxiety, sleep, 
adjustment, and sexual disorders.  Individuals with a SMI often meet the criteria for 
multiple diagnoses with one or more major diagnosis (e.g., schizophrenia or bipolar 
disorder) and often one or more less severe diagnosis like the ones listed above. 
Important to the understanding of mental illness, especially severe mental illness, 
is that diagnoses are manifested in different ways by different individual’s and that a 
diagnosis alone does not a label of SMI make.  Yet, a diagnostic label is a powerful 
carrier of perceived etiologies, behavioral expectations and stigma (Link, Phelan, 
Bresnahan, Stueve, & Pescosolido, 1999).  Thus, to describe a mental illness will require 
at the least an understanding of the diagnosis, symptom expression, social, occupational 
or educational impairment, attributions of blame, stigma, and support factors. 
Recovery 
 Recovery has been defined as living a satisfying life within the constraints of 
mental illness (Anthony, 1993; Deegan, 2001).  Deegan (1998), a health professional 
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successfully adapting to severe mental illness, stated “recovery refers to the lived or real 
life experience of people as they accept and overcome the challenge of disability… they 
experience themselves as recovering a new sense of self and of purpose within and 
beyond the limits of the disability (p 12).”  Recovery challenges traditional notions of 
psychiatry.  Kraepelin (1913) originally postulated that severe mental illness (especially 
schizophrenia) had an inevitable course leading to permanent impairment and 
dysfunction.  However, longitudinal studies indicate that from one-half to two-thirds of 
individuals with schizophrenia, or other mental disorders severe enough to require 
ongoing hospitalization over the course of years, no longer needed to be hospitalized 
starting in their mid- to late-40’s, were relatively symptom free, many were able to work 
in some capacity, and most were living with family or friends (Calabrese & Corrigan, 
2005).  Personal accounts and empirical evidence have led to different beliefs regarding 
recovery from the psychiatric and consumer perspectives, increasing tension between 
these groups (Fisher, 2003; McGruder, 2001).  However, recovery has succeeded in 
catching the attention of the Federal government that, despite the problems still facing 
acceptance and understanding of recovery, have made it the cornerstone of the report 
from the President’s New Freedom Commission (Hogan, 2003).   
Recoveries conflict with clinical science is arguably based more on the limitations 
of the science differing with the desires of the consumers.  Historically there is evidence 
that some treatments may exacerbate symptoms. Further, diagnoses may be biased 
toward the view that certain mental illnesses, especially schizophrenia, are 
insurmountable.  For instance, treatments with conventional neuroleptics cause some of 
the negative symptoms (e.g., anhedonia, apathy) and slowed cognitive processes that can 
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be misinterpreted as symptoms of disorder.  This has been referred to as the neuroleptic-
induced deficit syndrome (NIDS) (Gerlach & Larsen, 1999; Velligan & Miller, 1999).  
Diagnostically, schizophrenia spectrum disorders (e.g. delusional disorder, 
schizoaffective, schizophreniform), vary in the degree of expected recovery.  For 
instance, schizophreniform disorder is diagnosed in place of schizophrenia when the 
episode (prodromal, active, and residual) lasts between one- and 6-months, absence of 
blunted or flat affect, and requires good premorbid functioning (APA, 1994).  This 
disorder is less severe and has a higher expectation of recovery than schizophrenia itself 
(Kruger, 2000b; McGorry, 1992).  Thus, clinically and diagnostically, schizophrenia, and 
to a lesser extent major depression and bipolar disorder, is biased away from recovery 
and toward the expectation of permanent impairment. 
Before continuing on with a discussion of recovery, it is important to briefly 
mention other terms that have been used in the same context as recovery, specifically 
reintegration and social inclusion.  Reintegration appears to be a term that signifies the 
outcome of recovery.  Individuals who are reintegrated live successfully and 
independently in the community (Hartman, 1996).  Reintegration has also been closely 
aligned with research in stigma management and a reintegrated person is one who is 
either stigma resistant or is no longer stigmatized because they are fully reintegrated and 
accepted in the community (Herman, 1993).  Reintegration is also a term used with 
treatment compliance, especially medication compliance, and acquiring of appropriate 
life skills for independent living (Littrell & Littrell, 1998; Smith, et al., 1996).  Thus, 
more narrowly, reintegration can also be viewed as the successful clinical intervention of 
individuals with mental illness who are back in the community. 
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Social inclusion has a broader focus, akin to recovery, that takes into account the 
subjective experience of belonging to the community and the various processes that bring 
one from marginalization to inclusion (Repper & Perkins, 2003).  Social inclusion is a 
term used mostly in the literature from the United Kingdom and means that an individual 
with mental illness is accepted to the same extent as a person without mental illness while 
fully realizing potential functional limitations and influence of active symptoms.  Social 
inclusion is bi-directional in that the individual feels accepted by the community and in 
turn accepts the community.  Social inclusion also implies that stigma and discrimination 
have limited impact on an individual.  Further, the holistic and comprehensive 
characteristics of social inclusion places emphasis on rehabilitation as a broadly 
encompassing construct that includes employment and independent living skills as well 
as social, relationship, health maintaining and other skill sets necessary for seamless 
immersion in the community.  Though reflective of positive values, realistic efforts to 
maintain SMI individuals in the community have focused on psychosocial intervention 
and clinical treatment with limited resources placed into rehabilitation.  Inclusion back 
into the community, and maintenance of an integrated community-based status, has been 
consistently secondary to control of psychiatric symptoms and the skills to support 
medication treatment.  Much like recovery, there is limited understanding of the 
mechanisms that either promote or support social inclusion (Repper & Brooker, 1998; 
Repper & Perkins, 2003). 
 Recovery has been investigated from clinical and social perspectives.  Clinically, 
psychiatry would likely define recovery as the cessation of symptoms and the restoration 
of functioning sufficient for self-care.  This is consistently referred to as illness 
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management (Mueser et al., 2002).  There is generally one common route to clinical 
recovery.  This includes compliance with medication and treatment regimens, limiting 
chronic and acute stress, engagement in supportive services as needed, and skill building 
(interpersonal and employment) through psychiatric rehabilitation.  Thus, the focus is on 
objective measures of symptoms and functioning.  This is an improvement over the 
traditional psychiatric view of severe mental illness where it is considered a chronic and 
permanent condition in which cure is impossible so a life of adaptation to illness, or 
succumbing to the illness, is guaranteed (Kraepelin, 1919).  Conspicuously absent from 
the older clinical views are concepts such as personal growth, empowerment, goal 
attainment or choice. 
 Recovery as a social phenomenon parallels growth of the consumer movement.  
Consumers have banded together to fill perceived gaps in services and have also sought 
more compassion and hope for their lives within and without the traditional treatment 
establishment (Bassman, 2001; Dickerson, 1998).  There are various pathways to 
recovery and individuals have choices in what they define as recovery and the process to 
achieve it.  Indeed, recovery is considered a very personal process with no clearly defined 
outcome.  For some consumers, the concept of recovery equates to clinical recovery 
defined above, for others there is acceptance of the clinical pathway as part of the process 
but regard it as insufficient on its own, while for others clinical recovery is a false door 
that leads to dependence and addiction to prescribed medications that at first take the 
place of quality of life, and then commandeers it.  Regardless, the clinical pathway is 
considered one of many possible avenues to recovery that an individual consumer may or 
may not endorse. 
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 On the other hand, the language of the consumer and related recovery literature 
suggests that recovery is inevitable or at least a normative process that all individuals 
with SMI are in some way part of (Bledsoe, 2001; Chadwick, 1997; Deegan, 1998, 
2001).  However, there is little evidence that recovery is either embraced by or relevant to 
all individuals with a SMI.  Further, there is little to support recovery as an important 
concept for individuals with less severe forms of mental illness.  The concept of ‘cure’ 
might be more relevant to individuals who assume that reduction in symptoms is 
equivalent to elimination of disorder, though whether this is accurate is unknown.  In 
other words, cure might be relevant for those with mild to moderate disorders that are 
limited in duration and intensity and do not follow a typical chronic course.  However, 
there is evidence that many disorders, for example obsessive-compulsive disorder, post-
traumatic stress disorder, dysthymic disorder, etc., are also recurrent disorders with 
periodic impact on functioning that, though less than SMI, is still appreciable (Bystrirsky, 
Liberman, Hwang, & Wallace, 2001; Frank et al., 1991; Mintz, Mintz, Arruda, & Hwang, 
1992).  Therefore, recovery may have broader applications than currently demonstrated. 
Within the population of individuals with an SMI, recovery from schizophrenia 
has received the most attention from recovery researchers (Andresen et al., 2003; Bender, 
1995; Frese, 1998, Sells et al., 2004).  Assessing differences in recovery processes for 
different diagnoses associated with SMI has only just begun.  Some researchers stress 
that diagnosis is less important than other factors such as self-efficacy and empowerment 
(Bender, 1995; Yanos, Rosenfield, & Horwitz, 2001).  However, there are substantial 
differences in how different disorders manifest (i.e., schizophrenia versus bipolar 
disorder), the expected course of the disorder, efficacy of treatment, stigma and 
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acceptance, and impact on functioning.  What may be a recovery related preference for 
individuals with schizophrenia (thought disorder) might be different than individuals with 
bipolar disorder or major depression (mood disorders).  The focus on schizophrenia has 
fostered growth in the development of recovery stage models for schizophrenia that are, 
at times and perhaps inappropriately, generalized to all individuals with a severe mental 
illness (Andresen et al., 2003). 
Both qualitative and quantitative methods have been used to explore stages of 
recovery in schizophrenia.  Andresen et al. (2003) developed a conceptual model of 
schizophrenia via review of the literature that addressed schizophrenia and other mental 
disorders, consumer contributions and qualitative research.  Stage one in their model is 
moratorium in which the individual is overwhelmed by their symptoms, the weight of the 
diagnosis, and the changes that have come over their lives.  The second stage is 
awareness, where recovery begins and the process of delineating affected from non-
affected parts of the self is begun.  Hope is kindled in this stage.  The third stage, 
preparation, is a more deliberate resolution to recover followed by taking stock of 
abilities and finding resources that help in recovery.  Rebuilding (stage four) is where the 
majority of recovery work takes place and involves goal setting and assessment of values.  
Risks and setbacks are common in this stage.  The final stage is growth, where the 
individual is either symptom free or knows how to handle symptoms as they arise and has 
hope and faith in their future and is generally positive.  A similar approach was used to 
summarize both qualitative and quantitative studies on recovery to identify common 
dimensions or factors relevant to recovery (Ralph, 2000).  Internal factors (impact of 
illness, insight), self-managed care (idiosyncratic methods of self-care), external factors 
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(support, treatment), and empowerment (internal strength and caring) were identified as 
common across studies.  These factors are likely to be most relevant for the stages of 
preparation, rebuilding and growth noted above (Andresen, et al., 2003).  Thus, for 
schizophrenia at least, there is some understanding of the stages relevant to recovery and 
the factors within the stages that help promote recovery.   
Though there are several other models of recovery for schizophrenia, the results 
are markedly similar to the two models detailed (Baxter & Diehl, 1998; Pettie & Triolo, 
1999; Resnick et al., 2004; Spaniol, Wewiorski, Gagne, & Anthony, 2002; Young & 
Ensing, 1999).  The two examples detailed suffice to point out that different research 
efforts have resulted in different stages of recovery for schizophrenia that are 
thematically similar.  Differences can be attributed in part to diverse values that 
researchers bring to their work, choice of research methodologies employed, and 
dissimilar methods of operationalizing recovery.  Recovery as an outcome requires a set 
definition that continues to elude consensus in the recovery literature.  Liberman & 
Kopelowicz (2005) have proposed criteria to operationalize recovery from schizophrenia.  
These include  
“Remission of both positive and negative psychotic symptoms and signs, working 
or studying in normative employment or educational settings, independent living 
without supervision of money, self-care skills, and medication, social activities 
with peers, cordial family relations and contacts, recreational activity in normative 
settings (i.e., not in psychosocial clubhouses or day treatment programs), 
resilience and capacity for problem solving when faced with new stressors or 
challenges in everyday life, subjective satisfaction with life, self-esteem and 
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stable self-identity, participation as a citizen in voting, and self-advocacy, 
neighborliness, and other civic arenas (p. 108).”   
This is a lofty list of standards that when applied might suggest no residual effects of 
mental illness at all.  In fact, one might imagine that meeting these requirements would 
be a difficult task for anyone with no appreciable challenge to his or her mental health 
status.  However, it is a list developed from both empirical research and consumer 
narratives and does provide a place to begin when designing recovery research.   
Projected as a set of potentially measurable endpoints, the operationalization of 
recovery noted above also points toward processes important to recovery.   Consequently, 
it should be apparent that recovery could be viewed as both process and outcome.  
Whether recovery as an outcome (e.g., an endpoint identifiable as a recovered individual) 
is attainable is still much debated.  Recovery for this research effort did not directly use 
the concepts ‘outcome’ and ‘process.’  Instead, the concepts of recovery expectancies and 
recovery strategies helped guide and operationalize the research.  The more general 
concepts of outcome and process are not abandoned, however, as recovery expectancies 
are related to recovery outcomes though not directly measuring an outcome attained but 
measuring an outcome projected.   In turn, recovery strategies are related to the process 
of recovery.   
Referring back to Figure 1, introduced in Chapter 1 (page 8), expectations for 
recovery include elimination of mental disorder or ongoing restriction of functioning 
from mental disorder that nevertheless allows fulfillment, quality of life, and happiness.  
The expectation of recovery serves as a subjective measure of recovery as an outcome, 
for instance, if a respondent states, “I have recovered” or “I am halfway to the point of 
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being recovered” or “I will never recover,” he or she is stating their expectation of 
recovery as a present or future outcome.   
Utilization of recovery strategies was defined as the degree that each respondent 
endorsed various strategies for recovery as important to their personal recovery.  Chapter 
3 discusses how research strategies were detected and operationalized for this research.  
Historically, these strategies have included how much help-seeking, reliance and support 
from others is necessary for recovery as well has the need to find and maintain hope 
(Lysaker, Buck, Hammoud, Taylor, & Roe, 2006; Resnick, Fontana, Lehman, & 
Rosenheck, 2005).  In addition, symptom control and viewing recovery as a personal 
challenge are identified strategies (Ochocka, Nelson, & Janzen, 2005).   
Domains of Factors Associated with Recovery 
The number of factors that might be involved in the recovery process is 
substantial.  This section will review key factors that have either empirical or theoretical 
support for their influence on recovery.  These factors are grouped into three domains.  
Figure 2 provided a graphical representation of the conceptualized domains that influence 
recovery (Chapter 1, p 12).  The first domain encompasses individual, historical and 
clinical factors that include the proximal clinical, genetic, abuse/assault, and substance 
use factors that directly influence the individual either currently or in the past.  The 
second domain addresses factors that influence recovery in the social context.  Interaction 
with others is the thread that draws these factors together.  For example, stigma, 
discrimination, empowerment, and social support are factors that may influence recovery 
through direct interaction between the individual and the environment.  The final domain 
is the clinical and support services domain that includes the access to services and types 
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of services that may be associated with expectancies for recovery and choice of recovery 
strategy.  Described in Chapter 3, this domain focuses less on which specific services are 
provided and focuses instead on the number of services and satisfaction with services. 
Each domain contains multiple constructs.  These represent different levels of the 
social and personal environment.  An individual construct may represent micro 
(individual/familial), meso (bridging), or macro (community/societal) levels.  A complete 
description of each construct will include an indication of which level, or levels, that a 
construct represents. 
Domain One:  Individual, Historical and Clinical Factors 
 Individual and historical factors that may influence recovery expectancy and 
choice or utilization of recovery strategies include diagnosis, current symptoms, age of 
onset, familial history of mental illness, history of trauma or abuse, treatment compliance, 
hospitalization history, and current use of substances as well as substance use history. 
Diagnosis 
 Diagnosis is a micro-level construct that represents both specific symptoms and 
varying degrees of impairment in social, occupational, or educational functioning.  
Clinical manifestation, expected and objective impact on functioning, degree of 
anticipated recovery, and social sequelae are dissimilar for disorders typically associated 
with the SMI label.  Less severe disorders have even greater variance in these areas.  This 
section will briefly discuss these issues in relation to schizophrenia, major depression and 
bipolar disorder.   
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Schizophrenia. 
Previously noted, schizophrenia has been the only diagnosis consistently 
evaluated for its association with recovery when recovery is conceptualized beyond 
clinical improvement.  Symptoms of schizophrenia broadly include positive and negative 
clusters.  Positive symptoms are experiences that are not supposed to be present, e.g. 
hallucinations and delusions.  Negative symptoms are defined as the inability to have 
experiences normally expected, for example when symptoms include flat or inappropriate 
affect, anhedonia (inability to derive pleasure from what used to be or should be 
pleasurable) or apathy.   
Subtypes of schizophrenia include disorganized, paranoid, undifferentiated, 
catatonic, and residual.  Disorganized schizophrenia (also known as hebephrenia) is the 
most serious subtype and is likely to cause life long impairment and the need for 
custodial care.  The negative symptoms and disorganized thought, speech, affect and 
attention process is quite severe and there is a relative little involvement of positive 
symptoms.  This type of schizophrenia is rarely treated in outpatient settings and there 
were no individuals in this study diagnosed with this subtype.  Individuals with Paranoid 
schizophrenia usually has less cognitive impairment involved but is more likely to be 
associated with pervasive delusional belief systems and hallucinations.  Paranoid 
schizophrenia is amenable to treatment with psychotropic medication and cognitive-
behavioral intervention after remittance of the delusional state.  Marked psychomotor 
disturbance involving voluntary movement, posturing, and speech abnormalities (e.g., 
mutism or echoalia) is the primary characteristic of catatonic schizophrenia.  The rigid 
posturing may be replaced by a frenzied excitement.  Catatonia has decreased in 
40 
prevalence over the last several decades and is rarely seen in outpatient settings.  
Psychotropic medications are effective in reducing the symptoms noted above.  
Undifferentiated schizophrenia meets criteria for the primary characteristics of 
schizophrenia are present but the individual does not meet criteria for disorganized, 
paranoid, or catatonic subtypes.  Residual schizophrenia is absent complete positive 
symptoms though attenuated symptoms may be present, e.g. eccentric behavior.  
Negative symptoms are still present. 
Describing the different subtypes of schizophrenia hopefully served as an 
indication of the complexity of schizophrenia.  There is considerable debate still on the 
usefulness of subtyping.  Inability to find a ‘cause’ of schizophrenia may hinge, in part, 
on the low specificity of the subtypes and the study of unintentionally mixed groups in 
research that result in a systematic bias in the data.  Other typologies have been offered as 
options to increase the accuracy of subtypes including dividing schizophrenia into 
cortical, subcortical, and composite subtypes (Turetsky, et al., 2002).  The cortical 
subtype has pervasive attentional and cognitive deficits and few positive symptoms, 
similar to the disorganized type.  The subcortical type has pervasive positive symptoms, 
multiple negative symptoms and dementia and appears similar to Huntington’s chorea.  
The composite type presents with features similar to both cortical and subcortical, but 
with less intensity.  Memory deficits may also be useful in distinguishing between more 
accurate subtypes of schizophrenia (Barclay, 2002).  Using the same subtyping as 
Turetsky, et al, (2002) above, Barclay (2002) found that fully 51% of study sample did 
not meet criteria for cortical or subcortical types, raising the question of the inclusiveness 
of other typologies. 
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Studying schizophrenia has turned in the last decade to a focus on predicting first 
onset and intervention for first onset cases.  For first onset cases, adequate treatment will 
result in positive symptom remission for nearly 50% of cases and result in adequate 
social functioning for approximately 25% of cases.  However, only approximately 14% 
of cases treated clinically have both symptom remission and adequate social functioning 
(Robinson, Woerner, McMeniman, Mendelowitz, & Bilder, 2004). 
Thought disorder associated with schizophrenia is fairly specific to the disorder.  
Neurocognitive dysfunction is present in schizophrenia from the prodromal period to full 
remission in varying degrees.  Typical for schizophrenia are decision making deficits 
including longer time to make decisions, impaired risk adjustment, and impaired optimal 
decision making (choosing the right course of action) (Bell, 2001; Green, 2001).  
Individuals with schizophrenia may have difficulty utilizing available contextual 
information when processing social stimuli (Aghevli, Blanchard, & Horan, 2003).  This 
could have direct consequences when studying the impact of domain 2 social factors such 
as social support and community connectedness as outlined in brief in Chapter 1.  
Maintaining internal representations across time may also be impaired, inhibiting the 
ability to use information from the past in order to estimate future events (Kapur, 2003).  
Over- or under-inhibition of behavior, motion perception impairment, inappropriate 
social distancing and stereotypic movements are additional cognitive-behavioral features 
of schizophrenia.   
Schizophrenia will impact on functioning level during active psychosis with 
residual effects in most cases (Falloon, Heid, Roncone, Coverdale, & Laidlaw, 1998).  
Cognitive dysfunction certainly contributes to problems in overall functioning, but with a 
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fair amount of variation across individuals.  The majority of impairment is in the 
beginning and middle of the life course of schizophrenia with less impairment noted later 
in life as the disease ‘burns out.’  Longitudinal studies have demonstrated a natural 
remission for up to two-thirds of schizophrenia cases (Calabrese & Corrigan, 2005).  
Natural remission is not the same as active recovery, however, and active recovery is 
viewed as a way to accelerate remission and to increase and maintain gains in functioning 
(Ralph & Corrigan, 2005).  Cognitive dysfunction and the resultant oddities in behavior 
are reasons that individuals with schizophrenia appear to pay the highest social costs.  
Qualitative studies have especially captured the pain, isolation, and fear of individuals 
with schizophrenia, their relatives, and an uncomprehending public that is terrified at 
what is often interpreted as an assault on the very identify of a person (Holzinger, Kilian, 
Lindenbach, Petscheleit, & Angermeyer, 2003; Humberstone, 2002; Milliken & 
Northcott, 2003; Rungreangkulkij & Chesla, 2001; Williams & Collins, 2002). 
Major depression. 
Major depression (MD) is often measured in relation to multiple recurrences or 
relapses.  A single occurrence is termed a major depressive episode with any subsequent 
episodes indicating major depressive disorder (APA, 1994).  A single MD episode has a 
high risk of being followed by a second at some point during the life course.  The overall 
risk of recurrence is 16% with each successive episode (Solomon et al., 2000).  
Helplessness, hopelessness, loss of energy, poor self-esteem, lack of self-efficacy, and 
disturbances in sleep and appetite are typical for MD.  Episodes of depression that are 
extreme may also include hallucinations, thought disorder and pseudo-dementia (APA, 
1994).  Though MD is considered primarily a mood disorder, it is important to note that 
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there are cognitive-behavioral features of the disorder as well.  Arbitrary inferences 
(drawing conclusions in the absence of evidence), selective abstraction (focusing on the 
negative detail in a situation), overgeneralization (tendency to draw a general rule on the 
basis of an isolated incident and apply it indiscriminately), and personalization (to relate 
external events to oneself without evidence) are characteristic for MD (Sacco & Beck, 
1995).  However, there is less residual cognitive impairment compared to schizophrenia 
as the depression remits.  For instance, access to dysfunctional schema (i.e. arbitrary 
inferences, personalization) is high when actively depressed while metacognition (the 
ability to think about how you are thinking) is low.  For individuals in partial remission 
access to dysfunctional schema remains high but metacognition is also high, allowing the 
individual to recognize the negative thought process.  When fully remitted, access to 
dysfunctional schema shifts to low (healthy) and metacognition remains high (Sheppard 
& Teasdale, 2004). 
The social sequelae alter slowly in depression compared to schizophrenia or other 
psychotic disorders.  An individual may go through several episodes of depression with 
reduced functioning before the ‘SMI’ label is attached, whereas the label may be attached 
more or less automatically for a psychotic disorder like schizophrenia.  Similarly, in 
psychosis residual compromise of functioning is expected while remission of symptoms 
was automatically assumed to include full restoration of functioning for depression.  This 
assumption has recently changed with a growing emphasis on multiple recurrences of 
major depression and residual affects on global functioning (Zegal, Person, & THase, 
2003; Solomon et al., 2000).   
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Research in recovery from major depression has isolated important similarities to 
the recovery from schizophrenia.  Chronicity of illness episodes effects overall functional 
recovery with higher levels of functional impairment during and between episodes for 
chronic depression (Klein, Shankman, & Rose, 2006).  Likewise, the course of 
schizophrenia is partly measured in terms of the number of psychotic episodes with 
greater number of episodes equating with lower functioning and decreased probability of 
recovery.  Further, one qualitative study attempting to isolate areas of importance for 
recovery from major depression found that the areas of self-healing, managing the illness, 
receiving social support, and finding meaning were of primary importance (Sjarsater, 
Dencker, Bergbom, Haggstrom, & Fridlund, 2003).  Qualitative research targeting 
recovery and schizophrenia emphasize hope, recovering the self, managing illness, 
maintaining relationships, and finding meaning in life (Davidson, 2003). 
Bipolar disorder. 
Bipolar disorder (BD) is a combination of manic disorder and major depression.  
Mania is a period of elevated mood that passes rationality and effects cognition, 
decisions, judgment and reasonable self-care (APA, 1994).  Recurrence in bipolar 
disorder is much higher than other disorders with 95% of individuals with a first 
occurrence of mania cycling into recurrent bipolar disorder (Carlson, Bromet, & Sievers, 
2000).  Bipolar I disorder is more severe with one or more major depressive episodes 
and/or manic episodes.  Bipolar II also has one or more MD episodes with one or more 
hypomanic episodes.  Hypomania is a less severe form of mania.  There is some 
disagreement whether BD and MD are actually different disorders since there is some 
evidence that individuals with MD experience clusters of manic equivalent symptoms 
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over the course of their illness but do not cross the diagnostic threshold to mania, 
suggesting a mood spectrum approach in place of mood categories (Cassano et al., 2004).   
Recovery from BD has focused a great deal on symptom management.  Acquiring 
and maintaining skills for self-care are crucial for BD because of the tendency to cycle 
through two distinct symptom clusters (Cutler, 2001).  Deficits in social support are 
especially problematic for BD, with full remission partially dependent on adequate 
support (Johnson, Lundstrom, Aberg-Wistedt, & Mathe, 2003).   Bipolar disorder 
contributes significantly to disability, poverty, suicidal behavior and disrupted 
relationships (Judd & Akiskal, 2003).  Combined, active problems in these areas could 
interfere with recovery efforts. 
Compared to schizophrenia and even major depression, bipolar disorder has had 
relatively little research attention targeted to recovery.  Symptom recovery and effects of 
medication has predominated in the literature.  Empowerment, hope and other recovery 
topics central to the consumer movement have not been investigated for bipolar disorder 
to any degree. 
Current Symptom Levels 
 Current symptoms reflect more precisely the clinical picture of an individual 
compared to diagnosis.  Like diagnosis, this is a micro level construct that describes 
psychiatric stability and is temporally more immediate than diagnosis, since the 
diagnostic label may have been first presented from the recent to the distant past.  
Diagnosis reveals what clinical manifestations could be present while an accurate 
description of symptoms describes what is present.  Depending to what degree an 
individual has remitted, current symptoms could be more relevant than diagnosis.  
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Various investigators have included measures that address symptoms while investigating 
recovery.  For instance, Corrigan & Phelan (2004) utilized the Brief Psychiatric Rating 
Scale and Pevalin & Goldberg, (2003) administered the General Health Questionnaire to 
gain a general idea of psychiatric symptoms.  Other researchers choose to investigate 
more thoroughly the symptoms within specific diagnoses.  For example, Gureje, Harvey, 
& Herrman (2004) explored the influence of self-esteem on psychosis and utilized the 
Diagnostic Interview for Psychosis to better understand psychotic symptoms within the 
sample.  Similarly, Tait, Birchwood, & Trower (2003) used the Structured Clinical 
interview for the Positive and Negative Syndrome Scale to assess psychotic symptoms.  
Either approach would be valid, depending on the goal of the research and the 
heterogeneity of the respondents.   
 There is some evidence that specific symptoms that do not meet criteria for a 
mental disorder (sub-clinical or sub-syndromal symptoms) influence recovery.  Lower 
levels of depressive symptoms are related to a positive recovery orientation regardless of 
the psychiatric diagnosis (Resnick et al., 2004).  Identifying these symptom patterns is 
important for validating comorbid diagnoses and detecting unrecognized co-occurrences 
and their effects on recovery.  For example, post-traumatic stress disorder (PTSD) is 
often diagnosed in general psychiatric samples yet may also be undetected as a co-
occurring disorder in individuals in many psychiatric classifications (McFarlane, 
Bookless, & Air, 2001), and yet could still have a profound impact on recovery.  Overall, 
individuals with higher levels of current symptoms tend to endorse lower scores on 
measures of recovery strategies (Corrigan, Giffort et al., 1999). 
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 What is not known about different types of symptoms is to what degree they are 
associated with either the belief in the ability to recover or the choice of recovery 
strategy.   To this point, no studies have been found that address a broad selection of 
symptom patterns and recovery beliefs or choice in routes to recovery.  This research will 
begin to close this gap.  
Age of Onset 
Age of onset is negatively correlated with recovery and is also a micro level 
factor.  Early onset usually indicates a shorter period of normal development and less 
historical stability to inform compensation when symptoms remit.  Onset before the age 
of 21 is correlated with greater barriers to recovery (Stephens, Richard, & McHugh, 
1997).  Early age of onset increases risk for developmental deviance and is associated 
with poor premorbid adjustment in childhood, and delays in speech, reading, and spelling 
(Vourdas, Pipe, Corrigall, & Frangou, 2003).  Increased childhood psychopathology is 
related to reduced functional outcome and level of remission that in turn affects the level 
of recovery (Carlson, Bromet, Driessens, Mojtabai, & Schwartz, 2002).   
Information on age of onset age 21 or later is not as conclusive for impact on 
course of illness or recovery.  Schizophrenia, however, has an age of onset later for 
females, perhaps due to the protective factor of the female hormone oestradiol (Riecher-
Rossler & Hafner, 2000).  There is also a second spike for onset at approximately age 45 
for females, presumably when there is a decline in oestradiol (APA, 1994).  Available 
information on age of onset is not conclusive.  This is partly due to inconsistent 
definitions of age of onset.  Age of onset can be defined as the first age recalled or 
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observed that burgeoning symptoms impact level of functioning.  Onset may also be 
defined as the age of first diagnosis by a mental health professional. 
Trauma and Abuse 
Early experiences with child abuse impact on the onset and course of illness, with 
abuse associated with earlier onset of disorder, severity of course, suicide attempts and 
addictions for individuals with schizophrenia (Darves-Bornoz, Lemperiere, Degiovanni, 
& Gaillard, 1995).  Trauma and abuse can be viewed both as a micro-level variable 
(individual affects of trauma experiences) and meso-level (necessity of interaction with 
someone in the immediate environment, often someone known to the victim).  Repetition 
of sexual traumas has been observed in higher numbers for individuals with 
schizophrenia than bipolar disorder, though both are elevated above prevalence levels in 
the general public (Darves-Bornoz et al., 1995).   One estimate for lifetime physical or 
sexual assault for individuals with severe mental illness was nearly identical for females 
(86.8%) and males (86.7%) (Goodman et al., 2001).  Lifetime sexual assault in the 
general population was estimated at 3.8% for males and 22.0% for women (Elliott, Mok, 
& Briere, 2004).  For individuals with severe mental illness, one-year incidence of sexual 
assault was estimated at 7.6% males and 20.3% female.  This climbed sharply to 36.7% 
male and 33.4% female when approximating both physical and sexual assault incidence 
rates.  Experiences of childhood sexual or physical assault are nearly identical in 
prevalence for males and females with severe mental illness with approximately two-
thirds of the population reporting one or more events (Goodman et al., 2001).   
Specifically for major depression, 37% of those with major depression report 
sexual abuse compared to 23% without major depression (Cheasty, Clare, & Collins, 
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1998).  For individuals with any major mental disorder, early trauma frequently leads to 
undiagnosed stress reactions (e.g. post-traumatic stress disorder or PTSD) in a large 
proportion of individuals.  For instance, undiagnosed PTSD was found in 43% of a 
sample that identified as experiencing at least one traumatic life event while only 2% had 
this diagnosis in their charts (Mueser et al., 1998).  Why such large segments of the SMI 
population are unidentified as trauma survivors is unknown.  One possible explanation is 
a lack of training for entry-level providers in recognizing and being comfortable with 
inquiry into abuse issues.  In a report from a recent evaluation, providers (n=83) either 
recognized that abuse experiences were pervasive with the consumers they were assigned 
to or recognized no abuse at all (Walby, 2005).  It is unlikely that individuals with abuse 
experiences were accidentally selected into these groups and more likely reflects provider 
ability and willingness to probe these sensitive areas. 
Prevalence of sexual and physical assault is not only elevated for individuals with 
severe psychopathology.  Information is consistent that individuals with less severe forms 
of mental disorder (e.g., panic disorder, other anxiety disorders, dysthymic disorder) have 
experienced more acts of abuse than non-mentally ill individuals (Friedman et al., 2002; 
Hayden & Klein, 2001).  In fact, one common theme across the abuse/mental illness 
literature is just how common these experiences are. 
Clearly, physical or sexual abuse is related to mental illness but what is less clear 
is why it has not been investigated as a factor relevant to recovery.  While information on 
recovery from childhood abuse or adult assault is available, the interaction between 
abuse, mental illness, and recovery self-efficacy and recovery activities is scarce 
(Alexander, Muenzenmaier, Dumont, & Auslander, 2005).  However, there are beginning 
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to be treatment methods designed to intervene with individuals with a SMI who have 
been traumatized (Fallot & Harris, 2002).  Recovery requires a degree of behavioral 
control, insight, and self-efficacy that may be disrupted by abuse experiences.  An abuse 
history significantly increases the risk of suicide attempts, higher impulsivity, and 
aggression for individuals with mental illness (Brodsky et al., 2001).  Noted earlier, 
comorbid disorders hamper the recovery process and it has been demonstrated that early 
abuse, especially sexual abuse, is linked to comorbid depression and anxiety more 
powerfully than either disorder category alone (Levitan, Rector, Sheldon, & Goering, 
2003).  The affects of abuse/assault potentially raise serious impediments to recovery that 
may affect both belief in recovery and how an individual structures his or her own 
recovery. 
Hospitalization History 
 There is no evidence that hospitalization history has any direct affect on 
expectation to recover or endorsement of recovery strategies when considered beyond the 
clinical benefits of hospitalization.  However, hospitalization is an indicator that clinical 
stability is compromised, which in turn might affect efforts toward recovery.  
Hospitalization does not preclude recovery and may in fact be a reasonable compromise 
to accelerate needed clinical stability and could indeed be part of a recovery plan 
(Copeland, 2001).  Conversely, hospitalization is described as a personal failure and an 
impediment to being accepted, appreciated and a barrier to meeting life goals by some 
individuals with mental illness (Walby, 2003b).  Individuals with consistent patterns of 
hospitalization may also reflect more serious clinical and functional impairment.  
Referring to the recovery section above, systematically coping with mental illness while 
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fulfilling life goals is a common component of recovery definitions.  An extensive history 
of hospitalizations could negatively impact meeting life goals and thus be an identifiable 
barrier to recovery efforts.  However, the lack of empirical evidence and the forced 
reliance on anecdotal evidence suggests that the impact of hospitalization on endorsement 
of recovery has not been adequately investigated.  The assumption of a negative 
association between recovery and hospitalization investigated in this study addresses this 
gap. 
Employment History and Current Employment 
 Employment is another variable or construct that is micro-level in providing self-
esteem, security and other factors and meso-level because of the interactional nature of 
most employment.  Competitive employment, volunteering and other forms of 
employment is rare for individuals with a SMI, with only 14% reporting steady 
employment (Becker & Drake, 2003).  Employment is helpful in reducing symptoms, 
raising self-esteem and increasing a sense of attachment to the community (Evans & 
Repper, 2000; Gates, Akabas, & Zwelling, 2001). 
 Stigma, fear, and insufficient skills are barriers to employment endorsed by many 
individuals with mental illness (Laudet, Magura, Vogel, & Knight, 2002).  Once these 
barriers are overcome, however, there is general agreement from clinicians and 
consumers that employment is beneficial to recovery (Marwaha & Johnson, 2004; 
Warner & Mandiberg, 2004).  Employment is normalizing for individuals with mental 
illness and helps to offset stigma (Laudet et al., 2002).  The literature does not illuminate 
the relationship between recovery and extensiveness of work history or the relationship 
between work, recovery and individuals with less severe forms of mental illness.  
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 Employment is, however, a goal that is consistently promulgated as a sign that 
stability has been achieved.  Indeed, a primary outcome measure for Florida that is used 
to evaluate programs working with severely mentally ill consumers is numbers of days 
worked.  A minimum of 40 days per year per consumer is required to meet the 
employment criteria, justifying the block funds provided for an agency.  Some providers 
feel this is artificial and does not particularly enhance either recovery or quality of life for 
the consumers, especially when employment quotas are not paired with sufficient 
rehabilitative and employment training (Monte, 2006). 
Current Use of Substances/Substance Use History 
  Substance use for individuals with mental illness can range from casual use to co-
occurring disorder.  Substance use progresses differently for individuals with and without 
SMI including age of onset of serious substance use (usually younger for SMI), order of 
drug preference, length of use before addiction and other key areas (Gandhi, Bogrov, 
Osher, & Myers, 2003).  Prevalence of substance use is higher in individuals with mental 
illness than non-mentally ill comparisons, which may be a function of or related to 
coping/self-soothing of disturbing symptoms and a much higher rate of abuse and assault 
experiences for individuals with mental illness (Gearon, Bellack, Rachbeisel, & Dixon, 
2001).  Treatment ranges from adjunct supportive counseling for individuals engaged in 
casual use to multiple component therapy including harm reduction, treatment in stages, 
motivational interviewing, cognitive-behavioral interventions, and modified 12-step self-
help groups for individuals with substance addiction and a SMI (Rachbeisel, Scott, & 
Dixon, 1999).   
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Substance use may dilute or negate the effects of psychotropic medications 
prescribed for various purposes.  Drugs and alcohol reduce motivation to succeed and 
may interfere with the personal growth and self-direction inherent in the recovery 
paradigm.  Self-help groups and 12-step programs tailored to SMI (i.e. the Double 
Trouble in Recovery Program) embraces many of the key components of the recovery 
process (Magura et al., 2003).  Recovery is still possible for individuals with SMI and 
that abuse substances, but there is little information whether the addition of substance 
problems changes expectancies for recovery or the individual strategies for recovery.  
 Recovery from mental illness was preceded by recovery from substance abuse 
and was motivated, in part, by the substance abuse recovery models.  However, there has 
been no systematic comparison of recovery from substance abuse and recovery from 
mental illness.  Evidence-based practices targeted to mental illness that, at least on the 
surface, advocate for recovery principles, often focus on substance use recovery for those 
clients dual diagnosed (e.g., assertive community treatment) with claims of better 
outcomes (McHugo, Drake, Teague, & Xie, 1999).  However, there is also evidence 
supporting standard case management’s positive impact on substance use that is equal to 
the more expensive, intensive, and perhaps disempowering, models like assertive 
community treatment (Essock, Mueser, Drake, Covell, McHugo, Frisman, et al., 2006). 
Familial History of Mental Illness 
 Having a family member with a mental disorder increases risk of onset of illness 
for individuals through vertical transmission (parent to child or more generally older 
generation to younger generation) via genetic predisposition or through learning 
opportunities.  Horizontal transmission (within the same generation, for instance sibling 
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to sibling in some but not all pairs) through learning can also occur.  For example, 
probands of individuals with schizophrenia were shown to be at higher risk for onset of 
schizophrenia than probands with relatives diagnosed with acute and transient psychotic 
disorders (ATPs) (Das, Malhotra, & Basu, 1999).  Early onset of a major mental disorder 
is associated with higher risk for having a parent with a similar, though not necessarily 
identical, disorder.  The risk of having a parent with schizophrenia is approximately 25% 
for a child with early onset schizophrenia compared to 1.5% for comparison subjects 
(Fogelson, Neuchterlein, Asarnow, Payne, & Subotnik, 2004; Nicolson et al., 2003), with 
an adjusted summary odds ratio of 4.59 (95%CI = 2.41-8.74) (van Os & Sham, 2003). 
 Transmission within families of mental illness has been investigated to a 
significant degree for depression.  Living with a depressed person and coping on a daily 
basis with the manifestations of depression are associated with family strain and 
disruption (Coyne, 1990).  This burden manifests as a lack of interest in social life, 
hopelessness, worrying and fatigue (Keitner, Miller, Epstein, et al., 1990).  Various 
factors influence the child’s internalization/learning of depression including the child’s 
temperament, the intensity of maternal affect, how depression interferes with attachment 
behavior, and the social learning of coercive processes in interactions with a depressed 
parent (Schwoeri & Sholevar, 1994).   
Besides onset, familial history can also influence outcome of mental illness.  For 
example, individuals with major depression were significantly more likely to have a poor 
outcome if they had a familial history of schizophrenia, depression or suicide (Duggan, 
Sham, Minne, Lee, & Murray, 1998).  Family relationships also have an affect on the 
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level of social functioning, asserting an indirect effect on clinical outcomes and possibly 
affecting recovery (Giron & Gomez-Beneyto, 2004). 
The relationship exists between family history of mental illness and recovery has 
not been investigated.  Familial history of mental illness can be hypothesized to influence 
recovery by exposing the individual to genetic and interactional experiences that 
influence the individual’s belief in personal recovery and what acceptable ways to 
recover are chosen.  Witnessing family members coping techniques, recovery attempts, 
successes and failures for compensating for mental illness may in turn affect views on 
recovery.  Again, however, this is all conjecture.  The first step will be to establish if an 
association exists between having a close relative with a mental illness and the 
expectations of recovery.  This admittedly crude estimate will begin to answer this 
question and, if valid, can be followed up with more sophisticated investigation. 
Synthesis and conceptualization of the importance of domain 1 factors. 
A sizable percentage of the research into clinical recovery has targeted domain 1 
factors, though consumer defined recovery has had limited inclusion of these factors 
outside of symptoms and diagnosis.  Clinical services targeting recovery from the 
symptomatic and functional aspects of mental illness views these factors as critical to the 
treatment process.  These are biological and psychological aspects of the individual’s that 
are treatment goals or objectives for clinical intervention.  The recovery movement views 
factors in this domain as obstacles to recovery that are accepted for having occurred as 
part of the life story and not specifically empirically validated factors requiring 
intervention unless they are proven obstacles to the recovery process.  Recovery 
intervention can be clinical in nature provided by treatment professionals but has an equal 
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chance of being consumer run services, informal intervention by comrades, alternative 
therapies, or any combination of the above. 
Symptoms drive the diagnostic process and specific diagnoses are related to 
severe mental illness.  These, in turn, have been the focus of recovery research.  The 
association between symptoms and diagnosis is not especially precise.  Symptoms are not 
specific to disorders, with the exception of psychotic symptoms, which are far more 
likely to be associated with schizophrenia spectrum disorders.  The degree that each 
individual is challenged by active symptoms will, in all likelihood, affect their belief in 
recovery (Mancini, Hardiman, & Lawson, 2005). 
The etiology of symptoms is a concern when considering the effects on the belief 
in recovery and the choice of strategies.  Symptoms may represent a purely biological 
origin, an environmental origin, or some combination.  This is not a paraphrase of the 
nature versus nurture discussion.  For instance, individuals that are sexually abused as 
children will often develop trauma related symptoms.  These symptoms increase the risk 
for similar symptoms if a severe mental illness develops, as well as increasing the risk of 
the illness itself.  Lack of employment due to cognitive impairments or poor social skills 
can lead to depressive symptoms that increase the risk of mood and cognitive disorders 
over time.  A major concern is the number of vulnerabilities generated through 
interaction of these various clinical factors that influence the course of illness and affect 
recovery. 
Earlier age of onset and familial mental illness are part of the accumulation of 
genetic/biological and pathology modeling that leads to diagnosable illness (Sourander, 
Pihlakoski, Aromaa, Rautava, Helenius, & Silanpea, 2006).  Quality of familial support 
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and the internalization of the label of mental illness affects assimilation of the new 
challenges of mental illness and thus recovery as well (O’Brien, Gordon, Bearden, Lopez, 
Kopelowicz, & Cannon, 2006).  Further, the burden of additional family responsibilities, 
not understanding the symptoms and course of illness for close family member mental 
illness, and concern about their own and their families future increases the risk of illness 
for children/adolescents and may reduce belief in their own recovery potential 
(Valiakalayil, Paulson, & Tibbo, 2004).   
Expressed emotion has been investigated as a possible causal factor for mental 
illness and a risk for relapse and impediment to recovery (Hooley & Gotlib, 2000).  
Expressed emotion is a pattern of negative communication between individuals in close 
relationships, focused most often on the study of the family unit in regards to 
schizophrenia onset and relapse (Cutting & Docherty, 2000).  The concept has elements 
of familial mental illness, abuse related experiences, symptoms (biologically and 
environmentally induced), and employment.  Indeed, employment relationships can be 
stressful and negative sources of expressed emotion, increasing risk for exacerbation 
(Scheid, & Anderson, 1995). 
Experiences of child physical or sexual abuse contribute to the degree of clinical 
recovery attained and are important to consider within the additional context of 
hospitalizations, age of onset and familial mental illness.  Vulnerability to abuse 
experiences is higher for individuals with mentally ill parents, affecting monitoring of a 
child’s health and safety and modeling of appropriate self-protective behaviors are often 
impaired.  Individuals with mental illness who also experienced childhood abuse have, on 
average, earlier onset of illness, elevated symptoms, and more lifetime hospitalizations 
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(Schenkel, Spaulding, DiLillo, & Silverstein, 2005).  Indeed, individuals with an abuse 
history have greater levels of impaired functioning and elevated levels of hostility and 
suspiciousness (Shahar, Chinman, Sells, & Davidson, 2003).  Acceptance of recovery, 
and by extension the combined consumer/clinical perspective on recovery, requires a 
degree of illness management along with empowerment, trust, and connection to the 
community.  These assets are challenged for abuse survivors who are also coping with 
some level of mental illness and may be a substantial barrier to identifying with recovery 
and deployment of recovery strategies. 
Finally, employment can be logically, and to a lesser extent, empirically linked 
with other domain 1 factors when considering recovery.  Employment can be stressful 
and stress is known to exacerbate symptoms of mental illness.  However, as Marrone and 
Golowka (2005) argue, so does unemployment, poverty and social isolation.  
Employment is a buffer to the negative effects of early onset, increased symptoms, a 
diagnostic label, and hospitalization (Warner & Mandberg, 2004).  Conversely, earlier 
onset interferes with the establishment of a work history and lowers the potential benefits 
of a positive work environment.  Work history has is negatively correlated with symptom 
levels and social functioning (Marwaha & Johnson, 2004).  It is apparent that these 
clinical factors can increase or decrease the negative impact of mental illness depending 
on timing, what experiences the individual has (e.g., abuse, poor employment), and what 
protective factors and potential resilience are present. 
Domain 2:  Social Factors that Influence Recovery 
The second domain considers multiple aspects of the social context that may be 
associated with recovery.  Social support, social connectedness or integration, 
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empowerment, stigma and discrimination will each be reviewed for their potential impact 
on recovery.  Sufficient information to guide this research is provided in the following 
discussion.   
Social support 
Social support has been identified as an important social component in physical 
and mental health as well as influential in the recovery process.  Social support is a meso-
level to micro-level concept that influences self-esteem and other important social and 
cognitive constructs via interaction with other individuals in the social environment.  The 
following discussion expands on this statement by first looking briefly at social support 
in relation to social networks.  Next, multiple definitions of social support are considered 
and followed by an argument that social support should be viewed as contextually based.  
Social support affects on general health is touched on and then followed by social support 
for mental health and severe mental illness.  Lastly, social support in the context of 
recovery is addressed in greater detail. 
Social support and social networks are closely linked in research for individuals 
with mental illness.  The social networks of SMI individuals before their first admission 
are smaller and more conflicted than those of healthy individuals, and the continued loss 
of network members after multiple hospital admissions reduces even further the resources 
available to aid the patient returning to the community (Nolan & Clancy, 1995).  These 
same networks are deficient in maintaining the person in the community and preventing 
recurrent hospitalizations.  Network members are frequently replaced with providers who 
offer support without reciprocity, further hindering the recovery of SMI individuals 
(Brunt & Hansson, 2002; Cresswell et al., 1992).  This information is consistent across 
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the literature and recent research indicates that network size and satisfaction are not 
significantly associated with psychiatric symptoms or desire to recover (Corrigan & 
Phelan, 2004). 
Social support as a concept has had many definitions and a lack of consensus on 
even the ingredients for a single definition (Williams, Barclay, & Schmied, 2004).  This 
has hampered comparability of studies and the interpretability of findings.  Some 
definitions have stood the test of time.  For instance, one of the most cited definitions is 
by Cobb (1976) who states “Social support is defined as information leading the subject 
to believe that he is cared for and loved, esteemed, and a member of a network of mutual 
obligation (p. 300).”  This definition is interpretive (leading the subject to believe), 
emotionally supportive (cared for and loved, esteemed), interactive or communal 
(‘member of a network’) and reciprocal (mutual obligation).  Another popular definition 
is by House, (1998) which states “…social support is an interpersonal transaction 
involving one or more of the following:  (1) emotional concern (liking, love, empathy), 
(2) instrumental aid (goods or services), (3) information (about the environment), or (4) 
appraisal (information relevant to self evaluation) (p 24).”  This definition is likely 
closest to the understanding of social support in the social sciences as a more general 
form of help giving that can take discrete forms, depending what one person needs and 
another is willing to give.  
Another definition that is frequently cited is by Cohen & Syme, (1985), that 
states: “Social support is defined as the resources provided by other persons.  By viewing 
social support in terms of resources – potentially useful information or things – we allow 
for the possibility that support may have negative as well as positive effects on health and 
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well-being… (p 33)” This definition is more pragmatic and likens support to instrumental 
assistance (‘resources provided by other person’), as well as knowledge (‘potentially 
useful information’), and that support may not always be desired or welcome (‘negative 
as well as positive effects’).  This is one of the few definitions of social support that 
resonates with the Malone (1988) article directly investigating the social support and 
dissupport continuum. 
These representative definitions cover the emotional, instrumental, knowledge, 
appraisal, desirability of and response to social support (e.g., increased good will, access 
to goods).  The individuals that provide these are not part of the definitions noted above 
and require an understanding of the intersection between social support and social 
networks (Dickinson et al., 2002).  Social network theory recognizes that relationships 
exist in multiple contexts and that these may be positive or negative.  Typical social 
network clusters include family, friends, co-workers, and neighbors (Walsh, 1994; Watts, 
1999).  Other support networks that might be of special importance to individuals with 
mental illness include intimate partners or best friends and mental health providers 
(Macdonald, Hayes, & Baglioni, 2000; Meeks & Murrell, 1994). 
One consistent criticism of social support that is important to recognize in general 
and specifically to this research is that social support can also be viewed as contextually 
based, that is that social support will depend on the participants involved, resources 
available, support needed, willingness to provide support, potential for reciprocity, 
extenuating circumstances and other factors (Williams et al., 2004).  Individuals with 
mental illness are more likely to need then be in a position to provide instrumental 
support, though needing instrumental support does not necessarily predict mental distress 
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(Olstad, Sexton, & Sogaard, 1999).  Another contextually based aspect of social support, 
considering the limited social networks typical for individuals with mental illness noted 
above, are the clusters most likely to provide support.  For individuals with mental 
illness, their family, friendships (often with other consumers of mental health services) 
and providers make up the majority of their social network and are the most likely to 
supply social support functions.  This potentially is vital to understanding the influence of 
social support on recovery through assessing a more realistic depiction of social support. 
Social support and its effects on mental health have been widely investigated.  It 
is generally accepted that social support provides a buffer to stress and enhances feelings 
of well being that are useful for protecting against depression, anxiety and even more 
serious and complicated mental disorders such as schizophrenia and major depression 
(Kawachi, & Berkman, 2001; Olstad, Sexton, & Sogaard, 200l; Sjarsater et al., 2002; 
Thoits, 1995).  Conversely, lack of social support is a risk factor for onset and 
maintenance of common mental illnesses (Prevalin & Goldberg, 2003).  Further, social 
support is of increased importance in areas with limited or difficult to access services 
(e.g., rural areas) (Letvak, 2002). 
When limiting consideration to individuals with severe mental illness, social 
support takes on additional meaning.  Social support is important for severe mental 
illness because it is assumed to facilitate competence and coping (Buchanan, 1995).  This 
is especially important for individuals with frequent hospitalizations because such 
individuals have smaller non-family networks and fewer intimate relationships (Lipton, 
Cohen, Fisher, & Katz, 1981).  However, social support has additional value for SMI 
individuals because of its ability to ward off pervasive loneliness.  Stigma and exclusion 
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puts these individuals at risk for accepting almost any support as better than no support at 
all.  Stigmatizing interactions are especially powerful in predicting low quality of life 
while social support is related to higher quality of life (Yanos, Primavera, & Knight, 
2001).  Fragile self-esteem and willingness to accept one-down roles puts them at risk for 
exploitation.  It is no wonder that common and close social relationships are frequently 
viewed as both harmful and protective/supportive (Green, Hayes, Dickinson, Whittaker, 
& Gilheany, 2002).  For women with low income, limited resources, and mental illness, 
social support may increase role strain by placing too high a demand on the individual 
and interfering with coping (Kawachi & Berkman, 2001).  The interaction between active 
psychotic or depressive symptoms with perception of social support shows less 
satisfaction with social supports that have objectively not changed, furthering isolation 
(Skarsater, Agren, & Dencker, 2001).  Thus, there is both peril and safety in social 
supports relationship with symptoms of mental illness, which leads next into a brief 
discussion on the role of social support with recovery. 
 The role of social support in recovery has only recently been investigated and is 
probably one of the least understood areas for mental health improvement.  Recovery has 
been shown to be positively associated with self-esteem, social support, empowerment 
and quality of life and is inversely related to age and symptoms (Corrigan, Giffort et al., 
1999).  The relationship appears reciprocal between recovery and support and 
empowerment with a key role for self-esteem as a mediator between life satisfaction and 
symptoms (Markowitz, 2001).  Low social support increases the risk for relapse and the 
interruption of the recovery process may also inhibit recovery self-efficacy (Pevalin & 
Goldberg, 2003).  Small to moderate correlations were found in a study that used a 
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measure of social support and a measure of recovery and demonstrated that social support 
is related to a process orientation for recovery (Corrigan & Phelan, 2004).  However, this 
study did not investigate whether social support had different predictive capacity for 
diverse recovery pathways. 
 In summary, social support is important for protection from stress and in limiting 
the impact of mental disease.  Social support is important for all levels of mental illness, 
though the weight of evidence lies towards studies of the SMI.  How social support 
affects recovery is poorly understood and this study begins to fill this gap.  While social 
support appears to be necessary for health and possibly for recovery, the degree of 
perceived integration could be related as well, the subject of the next section. 
Social Integration or Community Connectedness 
Social integration became a part of the mental health concept system when 
Durkheim found that a lack of perception of community connection significantly 
increased the risk of suicide (Alaszewski & Manthorpe, 1995).  Community 
connectedness/social integration is experienced individually at the micro-level but is 
often investigated as a macro-level phenomenon.  This bond to the community is based 
on attachment (the degree an individual feels he or she belongs to a community as 
evidenced by the desire to maintain ties to society) and regulation (the degree that an 
individual believes in and is governed by the norms, values and beliefs of society) 
(Berkman & Glass, 2000).  Regulatory functions of social integration provide for social 
control, an area of considerable concern for individuals with severe mental illness who 
may feel the affect of involuntary hospitalization or incarceration.  Thus, social 
integration is a process that is in part feeling a sense of belonging to society; with society 
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doing its part by providing a structure that an individual feels is worth belonging to.  
Durkheim’s work is important for an additional reason, when he introduced the concept 
of alienation.  Alienation results when an individual does not feel either governed by or 
part of society with potential far-reaching ramifications for mental health and behavioral 
self-regulation (Berkman & Glass, 2000).  
The focus on social integration does not detract from the importance of social 
support.  Social cohesion is a macro-structural condition (at the level of culture) that is 
the glue that binds individuals to society (Berkman & Glass, 2000).  Because of its 
distance from the individual, social integration will not have as direct an influence on 
behavior as social support, but it does influence the provision of social support.  For 
instance, an individual with mental illness that is living on the periphery of society may 
invoke support through a genuine need while living within the boundaries of social 
regulation.  If this same individual violates social conventions, in effect disrupting 
attachment and regulatory boundaries via bizarre or unpredictable behavior, the provision 
of support may reduce or eliminate, or be substituted with powerful regulatory forces 
such as involuntary hospitalization.  This in turn may increase alienation and reduce 
reasonable attachment to the community.  While this cycle is neither inevitable nor 
unstoppable, it does help to explain the lack of trust and connection some individuals 
with mental illness feel to their community and society in general (Kawachi & Berkman, 
2000). 
The relationship between trust and social connection is important to this work.  
Trust is often viewed as a component of social capital, along with reciprocity and mutual 
aid (Kawachi & Berkman, 2000).  Interpersonal trust is a broader concept in the literature 
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and is synonymous with a general trust in society and other citizens and is not a measure 
of level of trust in friends, providers, family members or intimate partners.  Positive 
social support implies trust in these relationships.  Trust in others in the community is 
another way of saying that an individual is connected to their community.  Thus, the 
expectation of general community support is a macro level form of social support (Stroul, 
1989) and is important for community adaptation (Clinton, Lunney, Edwards, Weir, & 
Barr, 1998) and social bonding (Grusky, Tierney, Manderscheid, & Grusky, 1985).   
Trust and social connectedness may work together to increase attachment to 
society and internalization of societal norms and beliefs, in other words trust and social 
connectedness are aspects of social integration.  In this research social connectedness is 
viewed more as community connectedness, an attachment to the immediate structural, 
organizational, and interactional aspects of the local community in which the individuals 
with mental illness (whether severe, moderate or mild in degree) live.  This is a more 
personal and direct level of connection that falls short of considering the effects of social 
(macro) integration.  This level is of greater importance to individuals with mental illness 
as they are tied to their communities more directly via support services and mental health 
providers than they are tied to greater society (Nelson et al., 2001b).  This is not to imply 
that individuals with mental illness lack concern for or connection to greater society.  
However, the pressing needs of managing the illness do force a self-preservative focus on 
the immediate community (Nelson, Lord, & Ochocka, 2001a).  
A focus on community connectedness has a pragmatic aspect as well.  
Community connectedness is potentially an important aspect of recovery, though there is 
little direct crossover between the literature on social integration/cohesion/connectedness 
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and recovery.  There is a reciprocal nature between feeling connected and being accepted 
within the community.  Feeling connected increases concern for hygiene, appearance and 
others aspects of self-care that in turn increases acceptance in the community.  Connected 
individuals are more likely to be successful in employment (Nagle, Ccook, & Polatajko, 
2002) and in social relations (Sorgaard et al., 2001).  The interaction between social 
connectedness, trust, and social support is also relevant to employment, with individuals 
with a SMI who have high levels of connectedness, trust and strong social support from 
family and friends more likely to be employed half- or full-time (Evert, Harvey, Trauer, 
& Herrman, 2003).  Work, social connectedness, and trust are all considered important 
aspects of recovery Ralph & Corrigan, 2005). 
In summary, social connectedness and perceived trust are potentially important 
aspects of recovery that may affect recovery self-efficacy and preferred route of recovery.  
However, feeling connected and attached also provides a certain degree of control, 
autonomy and choice.  These are important aspects of empowerment, the subject of the 
next section. 
Empowerment 
 Empowerment emerged, much like recovery, in response to a mental health 
system viewed as inflexible and demeaning.  Empowerment predated recovery and 
received a great deal of attention as an alternative model of psychiatric intervention 
(Byrne et al., 1999; Lucksted, 1997; Segal, Silverman, & Temkin, 1995).  Empowerment 
is based on the principle that consumers can take control of their lives, make their own 
decisions, decide which treatment alternatives are in their best interest, and reduce their 
dependency on providers (Dickerson, 1998).   
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 Empowerment is a multi-level construct that has been investigated at the micro-
level, meso-level, and macro-level (Kruger, 2000a; Linhorst, Hamilton, Young, & Eckert, 
2002; Nelson et al., 2001a; Rappaport, 1995; Zimmerman, 2000).  A key reason for 
empowerment development is, not surprisingly, powerlessness experienced by 
individuals with disabilities (Fitzsimons, 2002).  Thus, when describing and measuring 
empowerment, the concept of power gained and powerlessness avoided is common 
(Rogers, Chamberlin, Ellison, & Crean, 1997).  Power is considered to exist with 
individuals, organizations and policy making/resource distribution bodies.  Thus, 
empowerment is an ecological construct that can be measured at individual, 
organizational, and community levels (Rappaport, 1987).   
 At the individual level, empowerment theory investigates the degree in which 
individuals reach a state of psychological empowerment (Zimmerman & Warschausky, 
1998).  However, the systemic nature of the empowerment construct has no levels 
operating in isolation.  Individual empowerment is thus affected by empowerment at 
organizational and community levels.  This is of primary importance in mental health as 
personal empowerment could be restricted or at best difficult in the face of a 
disempowering system of treatment provision or a community that refuses to allocate 
resources for mental health recovery.  Conceptually, this is important to avoid blaming 
the consumer for avoiding employment or other socially accepted choices.  Success is 
increased if multi-level systems are mutually empowering and working in unison, and not 
in conflict.   
 Psychological empowerment as a construct is intrapersonal, interactional, and 
behavioral (Zimmerman, 2000; Zimmerman, Israel, & Schulz, 1992).  The intrapersonal 
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component most relevant to this research is perceived control and self-efficacy.  
Perceived control considers degree of control in all levels of interaction (e.g., control in 
relationships, work or education environments, community groups, or political 
advocacy).  Self-efficacy is a related concept that measures the degree a person believes 
he or she is able to reach desired outcomes.  Together, these influence self-esteem, the 
degree that an individual holds self-love and self-respect, which then influences the 
confidence to become involved in social relationships, employment, and other social 
exchanges. 
 The interaction component involves how individuals relate to and think about 
their environment (Zimmerman & Warschausky, 1998).  Critical thinking, problem 
solving and decision-making are important aspects of this component.  Several mental 
disorders, especially disorders typical to the SMI, often compromise the very skills 
needed to successfully empower oneself in relation to others.  Rehabilitation based on 
empowerment can help offset these potential deficits.  The behavioral component is 
comprised of the specific actions taken by an individual to participate in community 
activities, join organizations, and address issues of power, resources, and politics.  
Participating in organized activities increases self-esteem, confidence and efficacy.  
Participation also reduces boredom, provides goals and instills direction in lives that, if 
unemployed and impoverished, are often challenged in finding a purpose.   
 Empowerment encompasses both processes and outcomes.  At the individual 
level, helping others and receiving help are examples of empowerment processes that 
foster a sense of control with critical awareness as a potentially critical outcome.  
Providing opportunities for organization members to develop skills and excel in their 
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careers is an organizational level empowerment process.  Actual provision of resources to 
facilitate employee growth is an organizational outcome.  At the community level, 
providing equal access to resources and freedom to share ideas are processes that could 
culminate with citizens well trained in empowerment policy development and influence 
(Zimmerman & Warschausky, 1998). 
 Providers of mental health services should ideally personify the organizational 
level of empowerment.  When evaluating providers, it is important to query whether 
providers are interested in empowerment, what their opinion of empowerment as a form 
of service delivery is, and what competencies are required in order to provide 
empowerment-based services.  However, this type of inquiry is still quite rare for the 
field of mental health.  Providers validate empowerment abstractly but are generally 
unsure what the concept means.  Individual empowerment is the best understood and 
most comfortable for providers (Ackerson & Harrison, 2000).  Organizational and 
political empowerment is, in turn, uncomfortable concepts for providers.  Organizational 
empowerment is viewed within the typical organizational hierarchy as something 
supplied from the top down, which runs counter to the principles of empowerment, while 
political empowerment is not considered part of what a provider should be involved in 
(Fawcett et al., 1996).  Indeed, empowerment seeks to diminish hierarchy and increase 
voice for all participants.  Such a concept is often confusing to providers that become lost 
in how to implement empowerment based services in an often rigid hierarchy based on 
measuring production of individual employees in order to solidify remuneration for the 
financial health of the agency. 
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 Empowering services ensure choices, consumer final word, flexibility and the 
ability for service changes while simultaneously being aware of dealing with forces 
impacting at the macro level.  However, what constitutes an empowering service is often 
different between consumers and providers.  Staff tends to focus on medication 
compliance, skills of daily living, and access to help.  Consumers do not negate these 
areas as unimportant but also focus more on improved access to material goods and 
improvement in general health (Meddings & Perkins, 2002).  Consumer perception is 
important because quality of life and reduced symptoms are related to perceptions of met 
needs for consumers (Roth & Crane-Ross, 2002).   
 Interventions that develop skills or abilities are considered of prime importance to 
consumers (Corrigan, 1997).  Preventing loss of control and subsequent reliance on 
inpatient facilities is of higher importance to consumers than staff (Yurkovich, Smyer, & 
Dean, 1999).  Outpatient services that are potentially coercive, (i.e. Assertive Community 
Treatment), are viewed as disempowering by some, but not all, consumers (Spindel & 
Nugent, 2000).  Indeed, strengths-based counseling approaches used to collaboratively 
develop client goals have the capacity to increase personal empowerment (White, 2002).  
 Becoming involved in empowerment services requires that providers work 
through loss of boundaries, join with the lives of mentally ill people, and explore new 
definitions of professional identity (Byrne, 1999).  This is probably the single greatest 
barrier to developing and successfully implementing empowerment based services.  The 
same argument is often made for recovery based services as well.  This redefinition of the 
working relationship between consumer and provider to one of equal voice runs counter 
to the training of the majority of mental health professionals.  Though not empirically 
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substantiated, it makes sense to assume that the current training of some mental health 
professionals is an additional barrier to establishing empowerment and recovery based 
services.  Some researchers/providers have argued that empowerment be a standard 
outcome when planning with consumers who are disabled and that additional or new 
training programs should be developed to foster both the therapeutic recovery based skills 
but also to help redefine the internalized identity of the helping professional to include 
facilitator and team member (Dempsey & Foreman, 1997). 
 Competencies for empowerment-based services are among many of the skills 
required for providing treatment or other services for individuals with mental illness.  A 
list of clinical competencies that support empowerment and rehabilitation was developed 
by Young and colleagues (Young, Forquer, Tran, Starzynski, & Shatkin, 2000).  
Categories of competencies include clinician-client relationship, initial and ongoing 
assessment, treatment, family and support system, social and cultural factors and 
resources and coordination of care.  One other category, rehabilitation and empowerment, 
is pertinent to this discussion.  This category contains seven competencies that in are in 
many ways beliefs and values.  
“(1) optimism:  believe in the potential for growth and improvement.  Have the 
skills to help the client restore or sustain hope and a sense of the future. (2) 
holistic approach:  Be able to view the client as a whole person and to see beyond 
the illness.  Have the skills to elicit the individual’s personal experiences and 
worldview. (3) Goals:  Be able to help the client identify and organize personal 
goals in the areas of learning, work, leisure, and living.  Know how to support the 
client’s unique pace toward goal achievement.  (4) Education:  Be able to educate 
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the client about mental illness, medications, and rehabilitation.  Be able to 
communicate the value of rehabilitation and medication treatment to clients.  (5) 
Rehabilitation:  Be skilled in using current psychosocial/psychiatric rehabilitation 
approaches.  Be able to teach goal-setting and problem-solving skills and living, 
social, and illness self-management skills.  Be able to help the client gain 
employment, education, and/or meaningful activity (when desired). (6) Client 
self-advocacy: Know how to create opportunities for the client to take optimal 
responsibility for his or her own life.  Be able to foster and support self-advocacy.  
(7) Natural supports:  Be able to provide flexible types and intensities of services.  
Know how to help the client meet changing needs and goals and transition from 
clinical to natural supports. (Young et al., 2000, p. 327).” 
These competencies can move the field forward in promoting empowerment through the 
redefinition of what a helping professional does and who a helping professional is.  The 
emphasis, however, is still on providers providing and consumers accepting.  Balancing 
the power differential is conspicuously absent from this list and almost unconsciously 
reinforces the professional identity still formalized in traditional therapy training 
programs.  These are a good place to start, however, in assisting individuals with mental 
illness to become more empowered. 
 Empowerment and recovery. 
 The relationship between empowerment and recovery is complex.  Many 
consumers who advocate for recovery strongly promote empowerment-oriented services 
as part of the process (Deegan, 2001).  Noted above, empowerment oriented services is 
more then an addition of new treatment type but requires a fundamental reassessment of 
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organizational culture in service settings.  The traditional and powerful roles of provider 
and consumer (or, more in line with the medical model, therapist and patient) are 
challenged to change.  What frightens providers is the thought of abandoning the years of 
training invested in becoming the helping professional that they envision themselves to 
be (Walby, 2005).  There is also concern that the consumers are fundamentally incapable 
of making good choices and managing their illnesses and their lives (Walby, 2003b).  
This is often a projection of what a consumer’s life should be from the perspective of the 
trained professional and not an empowering/recovery based perspective that assists the 
individual to formulate goals based on current strengths and capacities that promotes 
agency and growth toward new goals. 
 Empowerment is often viewed as a goal in itself (Bassman, 2001) and there is still 
a lack of a clear picture on the relationship between the constructs of recovery and 
empowerment other than that they are correlated (Corrigan, Giffort et al., 1999; Resnick 
et al., 2004).  Correlations are sufficiently weak to indicate that different constructs are in 
fact being measured.  It is likely that empowerment is one aspect or component of 
recovery and is not synonymous with recovery.  Empowerment is necessary but not 
sufficient for recovery, hence the inclusion of other social, clinical and services factors in 
this research effort. 
 It was noted in Chapter 1 that employment is considered a goal for and even a 
definition of recovery and empowerment has been linked to employment as well.  This 
area of overlap between the constructs together view employment as a source of personal 
control, self-esteem, challenge and socialization (Provencher et al., 2002).  An additional 
area of overlap between empowerment and recovery is the increase in personal power 
75 
(Corrigan, 2002).  Behaviorally, personal power is enacted as the capacity make choices, 
live with consequences, assertively lobby to have needs met without becoming aggressive 
or imposing power on others, and recognizing one’s limits.  A sense of powerlessness is 
often described in the literature via first person accounts and qualitative studies of 
recovery (Davidson, 2003; Deegan, 1998: Sayce, 1998).  Often viewed as a deliberate 
attempt to marginalize the individual and make them disappear, the interactions that 
foster powerlessness are consistently dehumanizing.  Empowerment and recovery 
actively work against such interactions to promote personal power. 
 Empowerment and recovery often interact qualitatively in the life experience of 
the consumer.  A consistent argument of individuals in recovery is that their life 
experience is often dismissed or mined for the purpose of establishing the course of the 
illness without being viewed as a potential source of resources and strength (McGruder, 
2001; Walby, 2003a).  Recovery is strength based and focusing on past successes by 
concentrating on ‘what went well then’ can transfer action steps to current problems, 
increasing a sense of control and empowerment. 
 Empowerment can improve recovery in other ways as well.  Environments that 
provide a variety of nonmedical interventions as well as meaningful work produce greater 
levels of empowerment and longevity of treatment gains (Nikelly, 2001).  Recovery is 
enhanced by treatment choices and employment.  Leadership training for mentally ill 
individuals has recovering and empowering effects (Bentley, 2000).  Leadership provides 
the opportunity to ‘work outside the self’ and to give when one usually is receiving, 
increasing self-esteem, considered a sub-construct of empowerment (Rogers, 
Chamberlin, Ellison, & Crean, 1997; Segal, Silverman, & Temkin, 1995).   
76 
 Different research methodologies, specifically participatory action research, 
empower individuals with a SMI through building partnerships between researchers and 
respondents (Rempfer & Knott, 2001).  Sufficient training allows consumers to become 
consumer-providers, further increasing empowerment and improving recovery (Bledsoe, 
2001).  In fact, consumers working with a consumer case manager have at least equal 
success in clinical outcomes (Chinman, Rosenheck, Lam, & Davidson, 2000) while the 
consumer case manager assumes a working culture of ‘being there’ with the consumer 
compared to professional case managers who were more task oriented, which is preferred 
by the consumer in treatment (Paulson et al., 1999).  
 Empowerment is a related facet of recovery and is multilevel, important for 
consumers in its own right, hope producing and can be part of service provision.  
Empowerment is also related to stigma, what the Surgeon General of the United States 
views as the greatest impediment to psychiatric rehabilitation and provision of services 
(DHHS, 1999).  Empowering individuals to meet life goals despite stigma is a benefit to 
recovery as well (Gingerich, 1998).  Thus, stigma and discrimination is the subject of the 
next section. 
Stigma and Discrimination 
 Individuals with mental illness are likely to confront stigma, prejudice, 
stereotypes and discrimination multiple times throughout their life course (Wahl, 1999).  
Stigma is based on a perceived difference between self and other that is discrediting 
(Goffman, 1963), operates at multiple levels (community, familial, individual) (Hinshaw 
& Cicchetti, 2002), and has negative affects on identity, self-esteem, socialization, and 
experiences of acceptance and belonging (Angermeyer & Maatschinger, 2003; 
77 
Blascovich, Mendes, Hunter, & Lickel, 2000; Camp, Finlay, & Lyons, 2002; Crocker, 
1999; Crocker & Quinn, 2000; Thompson, Noel, & Campbell, 2004).  Link & Phelan, 
(2001) define stigma, “…as the co-occurrence of its components-labeling, stereotyping, 
separation, status loss, and discrimination-and further indicate[s] that for stigmatization to 
occur, power must be exercised (p. 365).”  Stigma is, in effect, the interaction of multiple 
concepts that are rooted in power inequities.  The most relevant of these concepts for this 
work is discrimination.  Discrimination is the behavioral manifestation of stigma 
(Dovidio, Major, & Crocker, 2000).  For example, the action of refusing employment for 
an individual due to their mental health status is an act of discrimination.  Discrimination 
is a common experience for many individuals, with disadvantaged individuals more 
likely to experience it, and is strongly associated with mental health (Kessler, Mickelson, 
& Williams, 1999). 
 There is no single theory of stigma.   Various theories have been developed to 
explain stigma while other theories have been applied to the general concept of stigma.  
For the former, attribution theory (Corrigan, 2000; Corrigan et al., 2000; Corrigan, 
Rowan et al., 2002) and modified labeling theory (Camp et al., 2002; Link, 2001; Link, 
Cullen, Struening, Shrout, & Dohrenwend, 1989) were developed directly to explain 
stigma and its effects.  Social comparison theory (Finlay, Dinos, & Lyons, 2001) and 
social constructionism (Stangor & Crandall, 2000) have further developed the concept of 
stigma.  For this work, modified labeling theory, attribution theory, and social 
comparison theory are all potential lenses for interpreting the affect of stigma on 
recovery. 
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 Partly due to the effect of stigma, labeling an individual with mental illness leads 
to negative consequences that may reinforce or even cause mental illness.  This is the 
initial conceptualization of labeling and its relationship to stigma (Scheff, 1974).  Early 
critics of labeling theory felt that the label lead to treatment and other helpful outcomes 
and that stigma was overstated or even inconsequential (Rosenfield, 1997).  Modified 
labeling theory moved away from the direct effects of the label and states that labeling 
may not lead directly to mental disorder but does cause negative consequences through 
the perception of the label in the public mind and in the mind of the person with mental 
illness.  Thus, individuals may suffer consequences unrelated to their actual behavior but 
based on their expected behavior (Link, 1987).  Modified labeling theory helped to move 
stigma out of the label and into a broader social context.  Within this context are 
individuals that make judgments about other individuals perceived to be different.  These 
judgments are cognitively based and require a theory that addresses the vital component 
of the cognitive process in understanding stigma. 
Attribution theory addresses stigma from a primarily cognitive perspective and 
traces signaling events related to stigma, mediating cognitions, and the emotional 
responses that guide the choice of engaging in discriminatory behavior (Corrigan, 2000).  
Signals that promote cognition can result from direct interaction between two individuals 
that prompts attendance toward something that might be unusual or alarming, for instance 
an individual’s appearance or behavior may signal that something is out of the ordinary.  
If behavior is inappropriate to a setting or indicates symptoms commonly believed to be 
mental illness, then cognitive appraisal may commence.  Other signals may be less 
obvious, for instance some type of skill deficit.  If an individual is observed to have poor 
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social skills or lack abilities deemed necessary for a particular work or academic 
environment and this is attributed to mental illness, then this could result in 
discriminatory behavior.  Even more distal, if an individual is behaving and appears 
normal, yet they are suffering from a mental illness and this ‘label’ becomes known, the 
cognitive-emotion-behavior path to discrimination may be triggered as well.  This path is 
essential to attribution theory.  Cognitively, stereotypes may be triggered that lead to the 
common emotional responses of pity, fear, or anger towards an individual with mental 
illness.  Inappropriate stereotypes are misconceptions about the mentally ill that lead to 
beliefs such as all mentally ill are dangerous, childlike, or rebels (Farina, 1998).  
Behaviorally, as noted, discrimination may be the ultimate response to this chain. 
Another key factor that influences this attribution chain is the relationship of 
causality to discriminatory behavior.  Causal attributions affect how stigma is generated, 
experienced, and acted upon (Corrigan, 2000).  A stable causal attribution has 
traditionally been placed on severe mental illness, fostering the belief that mental illness 
is implacable, degenerative, and has ultimate negative results of lifetime hospitalization, 
suicide or premature death (Kraepelin, 1919).  Controllability of causal attribution is a 
related cognitive process that distributes responsibility for mental illness based on the 
reason for onset.  If mental illness is believed to be the result of moral failure or lack of 
self-control through engagement in risk behaviors (e.g., substance abuse), then the 
individual is responsible for their own plight and will be viewed with contempt and 
discriminated against.  Similarly, if the individual is not engaging in what is believed to 
be appropriate responses to cope with and limit the affect of the illness, this too will 
increase the likelihood of discriminatory responses.   
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Social distance has been investigated within and outside of attribution theory.  
Social distance is a proxy measure of stigma that examines how close a relationship an 
individual is willing to have with a mentally ill individual (Angermeyer, Matschinger, & 
Corrigan, 2004).  This relationship is often mediated by perceived dangerous which, in 
turn, is mediated by the amount of personal contact that an individual has had with 
mentally ill persons (Alexander & Link, 2003).  Indeed, personal contact has been found 
to be an effective means of reducing stigmatizing beliefs toward individuals with mental 
illness, an area investigated exclusively between those with and without mental illness 
(Corrigan, Rowan, et al., 2002).  However, an area that labeling theory, attribution 
theory, and social distance do not address is how stigma may be perpetuated within the 
mentally ill population. 
Self-knowledge and self-esteem are partially based on our perceptions and 
comparisons with others in our environment.  Self-esteem is considered a necessary 
component for recovery and empowerment.  However, individuals with a SMI are likely 
to have more challenges to their self-esteem through the combined insults of symptoms, 
labels and stigma.  The literature indicates that self-esteem and, to a lesser degree, self-
knowledge has been investigated for individuals with a severe mental illness (Blankertz, 
2001).  Social comparison, a potential key aspect pertaining to current levels of self-
esteem and the maintenance of self-esteem, has been relatively ignored when considering 
mental illness.  There has been limited investigation into the relationship between mental 
illness and social comparison, with the greatest investment looking at depression (Ahrens 
& Alloy, 1997).  Additionally, only one study has addressed social comparisons and 
schizophrenia (Finlay et al., 2001).   
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Mettee & Smith, (1977) provide a useful definition of social comparison, 
suggesting that it is a theory about “…our quest to know ourselves, about the search for 
self-relevant information and how people gain self-knowledge and discover reality about 
themselves (p. 72).”  In other words, people will compare themselves to others to 
understand the self and to compare the self in order to make judgments about the self.  
Thus, individuals make social comparisons for three primary reasons – self-evaluation, 
self-improvement, and self-enhancement.  Self-evaluation was the focus of the original 
formulation of social comparison theory (Festinger, 1954).  The motivation for self-
evaluation stemmed from the need for accuracy in our self-knowledge.  Additionally, the 
‘unidirectional drive upward’ was a component of the original theory and hypothesized 
that a person would seek to compare themselves with those that they consider better in a 
task or trait for self-improvement.   
Social comparison theory has grown regarding self-improvement but has 
remained targeted on evaluation of tasks, traits and improvements generally unrelated to 
issues of mental illness.  The third motivation, self-enhancement, more directly relates to 
self-esteem and, through the mediating effect of self-esteem, to recovery.  Downward 
comparisons, the process of comparing ourselves to those worse off in order to enhance 
self-esteem and feelings of well-being, are part of the self-enhancement comparison 
process.  It is unknown whether those with a serious mental illness utilize downward 
social comparisons to the same degree as those without a mental illness or whether their 
comparison target are others with a mental illness or not.  However, the investigation by 
(Finlay et al., 2001), does suggest that individuals with schizophrenia compare within the 
population of mentally ill individuals and also, actually to a greater degree, outside the 
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population.  The majority of social comparisons were downward, intended to increase 
self-esteem, and involved dimensions related to mental illness (for within group 
comparisons) and not related to mental illness (between group comparisons).   
The complexity of theory surrounding stigma helps to highlight its potential 
influence on recovery.  The consequences of stigma can be categorized as clinical 
symptom affects, internalized (e.g., self-esteem affects) and external, or discriminatory, 
affects.  Stigma has been found to have a lasting effect on individuals, even when 
symptoms and functioning improve (Link, Struening, Rahav, Phelan, & Nuttbrock, 
1997).  For individuals with schizophrenia, both positive and negative symptoms have the 
affect of increasing stigma, with negative symptoms having a more consistent impact 
(Penn, Kolmaier, & Corrigan, 2000).  However, positive symptoms correlate more 
strongly with beliefs in dangerousness and desire for avoidance (Schumacher, Corrigan, 
& DeJong, 2003).  Concern over stigma can lead to avoidance of social interactions and 
isolation, increasing symptoms of depression and lowering self-esteem (Perlick et al., 
2001).  It has also been documented that individuals with fewer concerns about stigma 
are associated with having less depressive symptoms (and the concomitant affect on 
negative cognitive schema), younger age and greater satisfaction with mental health 
(Pyne, Bean, & Sullivan, 2001).   
Research into the internalization of stigma has demonstrated the loss in self-
esteem and self-efficacy that results from stigma, particularly in narrative accounts of 
those afflicted with mental illness (Chernomas, Clarke, & Chisholm, 2000; Knight, 
Wykes & Hayward, 2003).  Other studies, however, have challenged the inevitability of 
low self-esteem (Camp et al., 2002; Finlay et al., 2001).  Individuals will, at times, have 
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the capacity to reject the negative societal messages and protect their self-esteem, and this 
ability may be contextually based (Crocker, 1999).  The extent of this protective ability 
may rest, in part, on their beliefs and opinions regarding the mentally ill before their own 
onset of mental illness.  Long before individuals become consumers, they have been 
socialized into what it means to have a mental illness, with many competing messages of 
attribution, fear, dangerousness, and the ability to recover (Link, 1987).  This information 
becomes a filter for the self once the individual begins his or her own journey into mental 
illness and, hopefully, recovery.  Strong messages of derision, fear, and contempt will 
interfere with self-esteem and self-efficacy.  More temperate internal messages may 
result in less of an assault on the self. 
External affects, manifested as discrimination, impact socially (e.g. relationships), 
and in employment, education, and medical care.  The two areas most pertinent for this 
review are social and employment effects of discrimination.  Relationships for 
individuals with mental illness are heavily weighted towards others with mental 
disorders, with over 80% revealing that they lost all or the majority of their friends when 
they found out that the respondent had been diagnosed with a mental illness (Walby, 
2003a).  Investigations into social distance have found that approximately 20% of the 
non-mentally ill feel that they would be unable to maintain a friendship with an 
individual diagnosed with schizophrenia (likely an underreport due to social desirability), 
50% feel they would be unable to room with, and over 75% said they would not marry an 
individual with schizophrenia (Stuart & Arboleda-Florez, 2001). 
Refusal of employment is one of the most common and potentially harmful forms 
of discrimination.  In one study, over 30% of individuals surveyed revealed that they had 
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been turned away for a job they were qualified for due to revelation of mental illness 
sometimes to very often (Wahl, 1999).  Individuals with mental illness are the least 
preferred disability type for hiring when compared to physical or sensory disabilities 
(Gouvier, Sytsma-Jordan, & Mayville, 2003).  Mental illness is often invisible and this 
affects the decision to disclose when making an application.  The decision to disclose is 
complex and often is the choice of risking shaming oneself through disclosure and 
rejection, or increasing stress and anxiety through actively telling a non-truth on an 
application (Dalgin & Gilbride, 2002).  Consumers and providers often view 
employment, accurately, as an aid to recovery, or as a sign of stability in recovery, yet 
86% of individuals with a severe mental illness remain unemployed (Laudet et al., 2002; 
Warner & Maindiberg, 2004). 
   There appears, then, to be a relationship between stigma and recovery.  
However, the relationship is ill-defined and under researched and often uses proxies for 
recovery, (e.g., employment, in place of direct investigation of stigma affects on recovery 
efficacy or recovery strategies).  Stigma resistance may be a factor in recovery and is 
often conceptualized as responsive to an individual level intervention.  However, 
countering stigma often requires a combination of individual and community level 
interventions.  Advertising of well-known individuals who successfully cope with mental 
illness and local community education are common in community interventions 
(Vaughan & Hansen, 2004).  Interventions that increase self-esteem, self-efficacy and 
personal empowerment are crucial for countering self-stigma on the individual level 
(Corrigan & Calabrese, 2005).  Maintaining control, accepting one’s personal value and 
becoming more active in the community are action steps individuals can take to counter 
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the affects of self-stigma (Corrigan, Calabrese, et al., 2002).  What is interesting about 
these anti-stigma suggestions is that they are very close to the suggestions made for 
enhancing recovery.  This may indicate that decreasing stigma is vital to recovery. 
Synthesis and conceptualization of the importance of Domain 2 factors. 
 Having reviewed social support, community connectedness, empowerment and 
stigma, or more accurately stigma resistance, it is reasonable to state that they share 
common ground.  Together, these constructs counteract isolation, enhance assertiveness, 
increase trust, assist in reciprocity between individual and community, increase self-
esteem and may even enhance the ability for competitive employment.  The recovery 
literature touches on many of these same attributes, yet there is little empirical evidence 
of a crossover.  Though some recovery research has touched independently on some of 
these factors collectively or in isolation, to this writer’s knowledge, no study has included 
all of them when investigating recovery expectancies or choice of recovery strategies.  
For instance, social support and its impact on recovery was investigated in isolation and 
found that social support was associated with quality of life, which in turn was associated 
with recovery (Corrigan & Phelan, 2004).  The potential effects of stigma and 
empowerment were not included in the Corrigan & Phelan study, which could potentially 
alter the studies conclusions. 
 Empowerment has the most empirical research in relation to recovery.  
Empowerment requires choice and choice is a key aspect of recovery (Paulson, Post, 
Herinckx, & Risser, 2002).  Empowerment was a logical choice for inclusion in this 
study with a methodological improvement of measuring social support and stigma at the 
same time.  This relationship has been advanced theoretically, but has limited empirical 
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support.  The one study found that includes empowerment, social support and recovery 
investigated concurrent validity between these constructs and found modest associations 
(Corrigan, Giffort et al., 1999).  Finally, stigma and recovery, noted in the previous 
section, have common ground in stigma resistance strategies.  Stigma resistance will be 
one aspect of stigma investigated in this work with the ability to see its contribution to 
recovery along with social support, empowerment, other social factors and the factors 
from the two other domains described in this chapter.  This turns our attention to the final 
domain, the services domain.  In the following section, the literature on different types of 
psychiatric and support services are reviewed in relation to recovery. 
Domain 3:  Service Factors that Influence Recovery 
 Services that promote mental health can be argued to be strategies for recovery 
and not factors that influence strategies for recovery.  There is no doubt that services are 
important for recovery to some consumers and will even be considered a primary 
influence for recovery.  However, not all consumers agree that services are sufficient or 
even necessary for recovery and may instead be viewed more as illness management 
(Mueser et al., 2002; Tait et al., 2003).  Services are more often targeted to clinical 
symptoms and restoration of functioning than to the less tangible aspects of the consumer 
model of recovery (e.g., choice, satisfaction, quality of life).  Thus, for this research, the 
domain of clinical and support services are viewed as possible associates to recovery 
strategies and may influence some strategies more than others.  Also for this research, 
specific services are of less importance than service availability, frequency of contact and 
consumer satisfaction with services.  However, before measuring service and its impact 
on recovery (see Chapter 3), which services are actually provided will be briefly 
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described.  What follows is a discussion of the services often provided to individuals with 
mental illness with accompanying discussion on their impact on recovery.   
Many consumers have identified positive, flexible, non-coercive, and relevant 
services as key to moving them along the path of recovery (Walby, 2003b).   There is 
evidence that services support recovery, though which services are more likely to 
influence different strategies for recovery is poorly understood.  Case management, 
medication and residential treatment are examples of more traditional services.  
Supportive services (e.g.. supported employment and supported living) have a closer 
philosophical agreement with the recovery philosophy.   A key aspect of services is the 
consumer belief that appropriate services are available and accessible.  Satisfaction with 
services may also be related to recovery.   The partnering agency for this research project 
has a wide variety of potential services potentially pertinent to recovery and is in fact 
moving toward a recovery team approach (Ellis-Lang, 2005).   
 Services that could impact recovery can be broken into traditional and supportive 
services, with an additional type being consumer run services.  Traditional services 
include case management, outpatient therapy, medication services, substance abuse 
treatment, inpatient hospitalization, day treatment or partial hospitalization programs, and 
residential treatment.  Together, these services support the notion of the individual as a 
patient.  There tends to be less choice and flexibility in these services, with the exception 
of some types of case management, which may have an inverse relationship to recovery.  
Individuals with a SMI are likely to be involved in medication services and case 
management.  Some of these individuals are involved in more traditional outpatient 
therapy and/or substance abuse treatment for a co-occurring addiction.  Consumers that 
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are more clinically or functionally compromised may participate in day treatment or 
partial hospitalization programs (Macchi, Peretti, & Barabino, 2996; Pittman, Parsons, & 
Peterson, 1990).  Individuals who have not been successful in traditional outpatient 
settings or who have difficulty with psychotropic medication will at times be accepted in 
residential treatment programs (Bola & Mosher, 2003; Fassino et al., 2004).  Medication 
and case management are the only traditional services that are addressed in the recovery 
literature, albeit minimally. 
 Atypical antipsychotics are more and more the treatment of choice for 
schizophrenia and are often viewed as a way to enhance recovery (Glick, Murray, 
Vasudevan, Marden, & Hu, 2001; Littrell & Littrell, 1998).  Recovery in this sense is 
clinical recovery and often falls short of the consumer vision of recovery (Fisher, 2003).  
Medication is viewed by some individuals with a SMI as imperative for recovery, but 
there is a strong preference for integrated care that includes assistance in daily living, 
financial assistance, skills training, shared decision making and empowerment along with 
the medication component (Malm, Ivarsson, Allebeck, & Falloon, 2003).  It should be 
remembered that medication is targeted to symptom control and consumers and other 
stakeholders consistently value functional outcomes, (e.g., improvement in social or 
occupational functioning, over symptom control).  For medication, consumers are more 
concerned about side effects than other stakeholders, (e.g., family members, and policy 
makers) (Shumway et al., 2003).  Antidepressants are best prescribed in conjunction with 
psychotherapy or some other appropriate treatment.  Though medications for depression 
are generally efficacious, they are only worthwhile if taken appropriately and do little to 
reduce the risk of further episodes if discontinued (Hollon, Thase, & Markowitz, 2003).  
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Recovery from depression appears to be partially linked to recurrence, with each 
recurrence increasing risk for another one, while the risk declines with the duration of 
recovery (defined as time episode free) (Solomon et al., 2000).    
 Case management has traditionally served to promote continuity of services and 
adherence to treatment plans (Crawford, de Jonge, Freeman, & Weaver, 2004).  There are 
different types of case management that may influence recovery differentially.  An 
exhaustive review of schools of case management is unnecessary for this review.  
However, there are some that emphasize autonomy and empowerment (strengths based) 
and others that are more control oriented (assertive community treatment), and 
understanding the differences will help to illuminate the diversity of case management.  
Strengths based case management has a low emphasis on service integration and a high 
level of consumer input, with as much control wielded by the consumer as possible.  This 
empowering approach is parallel to consumer-defined recovery.  When compared to 
traditional case management, strengths based service receivers have a greater reduction in 
need for care, less time spent in hospitals, and are more satisfied with care.  However, 
there is also no difference in clinical or social outcomes (Bjorkman, Hansson, & 
Sandlund, 2002).   
 Assertive community treatment (ACT) is a team approach to case management 
that occurs in the community and has a strong emphasis on maintaining residence in the 
community, taking of medication as prescribed and keeping all treatment or rehabilitation 
oriented appointments (Nieves, 2002).  Assertive Community Treatment teams typically 
consistent of, at a minimum, a psychiatrist, nurse, social worker and case manager.  
Assessment of ACT demonstrates that it does increase treatment compliance (Jorgensen 
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et al., 2000), but not necessarily reduce hospitalization or homelessness (Clarke et al., 
2000), though this is not consistent in the literature (Salkever et al., 1999).   Additionally, 
there is a great deal of concern that ACT and similar programs are overly coercive and 
disempowering (Spindel & Nugent, 2000).  Finally, housing is consistently an issue with 
mentally ill individuals and another primary task of case management, from all 
approaches, is to help individuals retain or obtain housing (Newman, 2001).  There is 
little doubt that stable housing is a necessity for recovery, with housing assistance of 
primary importance to individuals with mental illness and their families. 
 Supported programs include supported housing, supported employment, and 
supported education.  In general, supported programs are more likely to be viewed as 
consumer oriented and helpful to recovery.  Supported programs often offer more choices 
and are empowering.  Housing and employment are two key concrete components of 
recovery from consumer perspectives (Honey, 2004; Srebnik, Liningston, Gordon, & 
King, 1995).  Supported housing includes settings with 24-hour on-site staff, apartments 
where staff visit, and homes or apartments with no on-site services or visitations but with 
financial rent assistance.  Consumers in high supervision sites are more likely to be older, 
completed less education, unemployed, and diagnosed with schizophrenia (Friedrich, 
Hollingsworth, Hradek, Friedrich, & Culp, 1999).  However, this is contradicted by other 
research that found high-intensity settings tended toward younger, hospital referred, and 
comorbid addicted individuals (Lipton, Siegel, Hannigan, Samuels, & Baker, 2000).  
Consumers tend to desire less supervision, a natural preference for independence, while 
family members favor greater levels of supervision. 
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 Supported housing was developed with community integration in mind (Carling, 
1990).  The reader will recall that integration/reintegration are concepts similar to 
recovery.  However, there is evidence that individuals with SMI do not add to their 
support systems by living in supported housing but may in fact replace family and friends 
with staff and other residents (Goering et al., 1992).  Increased community contact and 
support systems are cited as examples of successful recovery and services that interfere 
with this could be counterproductive.  Additionally, peaceful surroundings are also 
conducive to recovery.  Research indicates that residents with comorbid substance abuse 
problems or who was medication noncompliant were more likely to be disruptive and 
ultimately unsuccessful in supported housing (Grunebaum, Aquila, Portera, Leon, & 
Weiden, 1999).   
 Supported employment is another service that fits the spirit of consumer-defined 
recovery and is viewed as empowering (Bellamy & Mowbray, 1998).  There are several 
models of supported employment, with the Individual Placement and Support (IPS) 
model and the Menu Approach (MA) the two most common.  The IPS model focus is to 
return consumers to community-based, competitive, integrated employment with 
unlimited follow-up provided to ensure success.  The MA approach is centered on 
providing work experiences to as many of the consumers at an agency as possible with a 
menu of options and with less emphasis on returning to competitive employment 
(Auerbach, 2001).  Whichever approach taken, consumers have a strong desire to work, 
provided that it is equitable, does not threaten other benefits until they are comfortable 
and confident that the employment is safe and beneficial, and that it is supplemented by 
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health and social services since many of the jobs for the mentally ill are entry level at best 
(Boardman, Grove, Perkins, & Shepherd, 2003). 
 Challenges to supported employment include implementation, job attendance and 
neurocognitive deficits.  Implementation has been difficult from the perspective of taking 
programs that are academically derived and translating them into multiple real world 
settings.  Success is predicated on foresight and careful planning while also having 
sufficient support personnel available, especially during the beginning of a job 
opportunity (Handler, Doel, Henry, & Lucca, 2003).   Job attendance can be improved 
with careful selection of employees for particular settings, adequate support services, and 
through innovative use of consumer employees.  For example, entrance into a job site 
may be enhanced with the promise of no days absent.  This could be accomplished by 
assigning more than one consumer to work at the setting, with a primary and one or more 
secondary employees that will provide the employer service if the primary worker is 
unable to attend.  Attendance is also enhanced through matching the consumer with a job 
that is interesting to him or her and through recognition that fear of relapse and 
socioeconomic realities are important factors for seeking and maintaining employment 
(Mueser, Becker, & Wolfe, 2001; Nagle er al., 2002).   
 Individuals with more severe positive and negative symptoms as well deficits in 
cognitive functioning (attention, psychomotor speed, verbal learning and memory, and 
executive functions) are more likely to be challenged in employment, supported or 
otherwise, but can excel with proper support (McGurk & Mueser, 2004).  Factors that 
interact with cognitive deficits to enhance or impede employment success include 
previous work history, amount of government financial assistance, and involvement in 
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sheltered work activity before competitive employment (McGurk, Mueser, Harvey, 
LaPuglia, & Marder, 2003).   
 The final support service is supported education.  Supported education programs 
provide financial and academic support to individuals with mental illness who want 
training, usually in Community College or University settings.  Services are 
individualized and based on client preferences while also incorporating mental health 
treatment as needed (Becker & Drake, 2003).  Supported education, like supported 
employment, requires organization of community stakeholders that are interested in 
assisting individuals with mental illness.  However, unlike other forms of supported 
assistance, supported education takes place in the context of a large bureaucracy that is 
simultaneously providing services to possibly thousands of other individuals.  Many of 
the individuals in supported employment may require assistance per the Americans with 
Disabilities Act, further increasing the burden on the educational setting.   
 Because of these constraints, it is necessary to plan carefully for all contingencies 
and not to overextend resources (Mowbray, Gutierrez, Bellamy, Sziilvagyi, & Strauss, 
2003).  The unique needs of the setting and the consumer make supported education a 
challenge, but also of great value to recovery.  To enhance recovery, individuals should 
be encouraged to stay engaged in productive activity outside of the school setting, to 
maintain contact with their support system, and to seek encouragement for their academic 
goals from their supports as well (Collins, Mowbray, & Bybee, 2000). 
 Consumer run services are rare in conjunction with mental health settings and 
comprise the third area of service, with traditional and supported services, that may 
influence recovery.  The notable exception to its rare status is drop-in centers and 
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clubhouses.  Drop-in centers are generally owned by a mental health center but are 
completely staffed by consumers.  Individuals that work in drop-in centers will benefit 
from empowerment and leadership training. This training often includes skills training for 
communication, problem solving, deescalation, and management skills, all of which 
could be potentially beneficial to recovery efforts (Bentley, 2000).  The clubhouse model, 
a combination of psychosocial rehabilitation and supported employment, has been found 
to enhance empowerment, a potentially key aspect of recovery (Dickerson, 1998).  
Autonomy, responsibility, leadership and, in many cases, participation in professional 
training are self-enhancing and important for recovery.  For individuals not employed by 
these settings, attending consumer run centers can lower isolation, increase socialization, 
and allow the consumer to practice social skills among compassionate and understanding 
individuals.   
A link between accessibility and satisfaction of services with recovery seems 
logical.  The reality is that there are limited resources available for traditional and 
supported services and drop-in centers or clubhouses are often very crowded.  Access is 
facilitated with appropriate triage that links the consumer most in need with an 
appropriate service.  For measurement purposes, it is easier to measure what services a 
consumer did receive compared to what services they should have received.  For this 
work, measurement of number of services received will be part of the data collection with 
full acknowledgment that each consumer may not receive all the services they require 
due to tremendous budgetary pressures. 
Satisfaction with services is correlated with availability and flexibility of services 
and with quality of life (Dixon, Goldberg, Lehman, & McNary, 2001; Perese, 1997).  
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Understanding differing perceptions of health between providers and consumers 
increases satisfaction (Berghofer, Schmidl, Rudas, Steinger, & Schmitz, 2002).  This is 
conceptually linked to the finding that services that understand consumer expectations are 
linked to higher levels of satisfaction (Noble, Douglas, & Newman, 2001).  Finally, 
services that assist with instrumental needs such as benefits and occupation are 
considered more satisfying (Secker et al., 2002).  The language used in these studies, 
such as flexibility, understanding perceptions and expectations, and assistance with 
instrumental needs, is identical to language used recovery, bridging, theoretically, the two 
literature bases. 
To summarize, services that are recovery oriented will focus on the social roles 
and needs of consumers and not just their symptoms.  These services will be strength 
oriented and will include the support systems important to the individual consumer, (e.g. 
friends or family members).  Services that are recovery oriented will also provide hope 
and empowerment through allowing real choices by the consumer and the services will 
be flexible enough to honor individual goals and aspirations (Repper & Perkins, 2003).   
 Synthesis and conceptualization of the importance of Domain 3 factors. 
 The services outlined in this section are typical of the services offered in many 
full service mental health centers.  Optimal services provision will provide access to all 
three areas of services (traditional, supported, consumer run).  Taken alone, this domain 
may have an impact on recovery efficacy and pathway choice.  However, for the majority 
of the services, their impact on recovery is hypothetical since there is little to no 
empirical research that intersects with the recovery literature.  A strength of this study 
will be its ability to determine if the number of services a respondent is currently engaged 
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in, the amount of contact time with providers or perceived satisfaction with services is 
associated with recovery expectations. 
Services may have their greatest impact on recovery when considered in 
conjunction with social and individual factors.  Services have been shown to increase 
empowerment and social support, two key components of the social domain (Hess & 
Mercer, 2001; Roth & Crane-Ross, 2002).  Services are also targeted to elimination of 
symptoms, and symptoms are demonstrated to be a barrier to recovery.  These brief 
examples again help to illuminate the clear advantage of this study for the investigation 
of recovery:  the investigation of multiple factors indicated in the theoretical or empirical 
literature to be associated with recovery.  The process of this investigation is the focus of 
Chapter 3. 
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Chapter 3 
Methodology 
 This chapter begins with an expansion of the research design outlined briefly in 
Chapter 1.    This is followed by discussion of the target population, inclusion and 
exclusion criteria and the sample.  Next, the research questions are re-stated with the 
addition of the research hypotheses linked to each question. After that, the setting in 
which the research was completed and the data collection instruments and tools that 
access the constructs investigated in this study are detailed.  Finally, the methods and a 
priori analysis plan are described. 
Study Design 
This study is an ecologic, nonexperimental design with retrospective features.  
Multiple questionnaires/surveys were used to collect data from two samples of clinical 
populations.  A number of factors that may influence the recovery process were culled 
from the literature and a multi-domain model of recovery influences was generated (see 
Figure 1 introduced in Chapter 2, page 8).  This, in turn, led to the development of a 
model of hypothesized linkages between the variables that constitute the three domains 
(see Figure 2, page 14). 
Dependent variables were generated through analysis of responses to three 
instruments completed by the participants.  Single question indicators targeting 
expectation of recovery were measured via the Recovery Expectancy Checklist.  The 
Recovery Assessment Scale (RAS) and the Personal Vision of Recovery Questionnaire 
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(PVRQ) were designed by their respective authors (Corrigan, Salzer, Ralph, Sangster, & 
Keck, 2005; Borowitz-Ensfield, 1998) to access recovery strategies utilized by mentally 
ill individuals. The RAS and PVRQ are recently developed and, though there is 
information on external validity, neither instrument has been utilized with multiple 
samples, nor have both instruments been administered to the same sample.  These 
considerations and the newness of the recovery construct, in general, informed the 
decision not to utilize, by default, the measurement models proposed by Corrigan, et al., 
(2005) and Borowitz-Ensfield, (1998).  Instead, the data from the RAS and PVRQ were 
subjected to a factor analysis to identify a measurement model for recovery strategies 
from the pooled questions.  The analysis section later in this chapter provides greater 
detail on this procedure.   
All criterion variables are nominal or quasi-interval (Hatcher & Stepanski, 1994).  
Quasi-interval is utilized to acknowledge that social science related research often treats 
scales as if there are equal distances between intervals when this is assumed and not 
proven true (e.g., the Personal Vision of Recovery Questionnaire).  However, although 
this controversy continues to exist, this study follows the lead of the field and treats 
survey scales as interval (e.g., a difference between 30 and 40 is assumed to have the 
same value as the difference between 60 and 70). 
Potential correlates are generated through one self-report/demographic 
instrument, six survey/questionnaires, and one chart abstraction tool.  Variables are 
nominal, interval and ratio in scale.  There are a total of 51 correlates (independent 
variables) that represent the largest main effect model examined.   
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Population/Sample 
 This study investigated two samples of clinical populations.  These were 
representative of populations with severe mental illness (designated the SMI sample) and 
mild to borderline severe mental illness being treated in an outpatient setting (designated 
the OP sample).  Specific inclusion/exclusion criteria were used to determine if an 
individual was eligible to participate in the study.  Following the statement of 
inclusion/exclusion criteria, the sampling frame, sampling method, and description of the 
samples follow.  Finally, a brief description of the power analysis used to ensure 
sufficient sample size is offered. 
Inclusion/Exclusion Criteria 
Inclusion criteria. 
• Age 18-65 (SMI and OP samples); 
• All clients of the partnering mental health center who were diagnosed with 
schizophrenia, other schizophrenia spectrum disorders (e.g., paranoid disorder or 
schizoaffective disorder), bipolar disorder, major depression or diagnosed with a 
severe example of another disorder (e.g., post-traumatic stress disorder) and who 
met the criteria for severe mental illness (SMI sample); and 
• All clients who did not meet the criteria for the SMI sample were eligible for the 
OP sample.  It is important to note that diagnosis alone does not distinguish SMI 
status.  There may have been crossover in diagnoses between the two samples,  
but the prevalence of more severe diagnoses  was expected to be higher in the 
SMI sample than in the OP sample. 
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Exclusion criteria. 
• Any individual <18 years of age or ≥ 65 (SMI and OP sample); 
• Any client who was hospitalized or incarcerated (SMI and OP sample) at the time 
of participant recruitment; 
• Any client who was experiencing sufficient instability that they were unable to 
participate in the study.  The representative of the partnering agency who was 
most involved with the individual case made this determination (SMI or OP 
sample); and 
• Any client diagnosed exclusively with a substance abuse or addiction disorder 
(OP sample). 
 
Sample Description and Procedures 
Sample 1:  Individuals with Severe Mental Illness   
The target population for the first sample was consumers of mental health services 
with a severe mental illness (e.g., schizophrenia spectrum disorders, bipolar disorder, 
major depression and schizoaffective disorder), and with impairment in social, academic, 
and/or occupational functioning.  The sampling frame was all individuals labeled as SMI 
who were receiving services at the partnering mental health center that are not currently 
inpatient or symptomatically impaired to where participation is unrealistic, and who are 
willing to participate.  Thus, to maximize the variance available, all individuals with a 
severe mental illness who meet inclusion/exclusion criteria were eligible for 
participation.  The sample population was estimated to be between 2,200 and 2,400 
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individuals served at the partnering mental health center.  Table 1 summarizes 
distributions for this sampling frame by gender and race/ethnicity. 
Systematic sampling was used to select participants.  This involved assigning a 
number to each eligible participant, and then randomly selecting a single digit number 
and using that number to contact every ‘nth’ person.  The number randomly chosen was 
four and every fourth person was added to a list until 300 potential participants were 
selected.  In order to preserve confidentiality, the names of the reserve participants were 
not known to the researcher until needed for contact.   
Table 1   
 
Gender/Race/Ethnicity of Individuals with a Severe Mental Illness Served at Partnering 
Community Mental Health Center 
 
 Category 
 
% 
Sex Male 37 
 Female 63 
   
Race American Indian / Alaskan Native   1 
 Asian <1 
 African-American   3 
 Hawaiian / Pacific Islander <1 
 Multi-Racial   1 
 Other   6 
 White 89 
   
Ethnicity Cuban <1 
 Haitian   1 
 Mexican <1 
 Non-Hispanic 95 
 Puerto Rican   1 
 Other Hispanic   2 
 
Note:  Total N = 2,354 
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Sample 2:  Individuals with Mild to Borderline Severe Mental Illness Attending 
Outpatient Services 
The second target population was comprised of individuals who were currently 
engaged in outpatient therapy for psychiatric distress who are less severe and do not meet 
the criteria for SMI.  There are approximately 1,000-1,200 outpatient clients who meet 
inclusion/exclusion criteria at the mental health center.  As exclusion criteria, participants 
with strictly substance related issues (i.e., alcohol or drug abuse or dependence) were not 
eligible to participate.  Data constraints at the partnering agency did not allow them to 
generate a gender/race/ethnicity breakdown of this sampling frame. 
To contact individuals, two lists of eligible clients were generated by the mental 
health center (SMI and OP samples).  The 175 names for each potential sample were 
given to the lead researcher.  Each client was paired with their primary provider on the 
list.  Each provider was contacted to ensure that the client met inclusion and exclusion 
criteria.  The agency had asked that contact be carried out primarily through the 
researcher due to agency personnel limitations and task requirements.  Each potential 
client received an invitation letter to the study (see Appendix C).  This letter briefly 
outlined the study purpose, client and researcher obligations, and the incentive for 
participation.  Additional names and number matches were made available as clients 
either refused or were ineligible.  Each letter was followed up with a phone call to 
arrange an appointment time. 
The process of contacting and beginning data collection was considerably slowed 
when it became evident that the contact information for the clients was not up-to-date.  
This required contacting providers and leaving letters for contacts at appointments.  This 
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slowed the process but did not interfere with the sample selection or randomization.  The 
initial list for the SMI sample included a number of individuals who had moved out the 
area, discontinued treatment, and two who were deceased.  The agency was asked to 
restrict their list to active clients and an appropriate list was generated.  The providers 
recommended no contact for ten individuals, and ten more did not meet inclusion and 
exclusion criteria.  A total of sixteen clients refused to participate.  Eleven of these 
refused during the scheduling phone contact.  None of the eleven clients opted to fill out 
the demographic short-form over the phone and only four clients did so in person.  The 
low level of refusal and even lower level of participation for filling out the short history 
form did not allow a comparison between participants and non-participants.  A summary 
of sample refusals and ineligibility is provided in Table 2.  The final sample size met the 
power requirements (see next section) of 175 SMI and 175 OP individuals. 
Table 2 
 
Summary of Contact Refusals and Ineligibility by Sample 
 
 Total 
Contacted 
Refused Provider 
Designated 
Ineligible 
 
Inclusion / 
Exclusion 
Ineligible 
SMI sample 195 6 10 4 
OP sample 186 10 0 6 
     
 
Power and Sample Size Estimation 
As stated, each sample was comprised of 175 participants, for a total of 350.  This 
number was selected following a sample size/power analysis for multivariate statistics, 
specifically for multiple linear regression (Milton’s procedure) and for logistic regression 
or its variants (e.g., probit analysis) (Brent, Mirelli, & Thompson, 1993; Cohen, 1988).  
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(see analysis section below for details on a priori statistical models).  For the Milton 
procedure, the following was considered in computation, with a final sample minimum of 
175 participants per sample: 
• Probability of a Type I error = .05; 
• A main effects model with 65 total terms; 
• Two-tailed analysis; 
• Estimated partial correlation for the least significant variable to be detected = 
.003; and 
• Estimated r-square (proportion of variance explained by the main effects models) 
= .15.  
The planned multivariate analyses included logistic regression, multiple linear 
regression, and probit analysis.  For a sample size of 175 per sample and 65 terms, 
logistic regression and probit analysis are sufficiently powered with a Type I error = 0.05 
and a Type II error = 0.2, to detect an odds ratio of 1.9 or larger.  With 55 total terms, this 
improves to detecting an odds ratio of 1.6 or larger. 
Research Questions and Hypotheses 
 Research questions (RQ) and hypotheses (Hyp) are logical extensions of the 
current state of the literature.  Hypotheses listed are a priori. 
RQ1:  To what degree does illness severity influence beliefs in recovery for the 
individual? 
Hyp1.1:  The OP sample will endorse that they will recover from mental illness to 
a greater extent than the SMI sample. 
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Hyp1.2:  The OP sample will endorse complete recovery as possible more than 
the SMI sample. 
Hyp1.3:  The SMI sample will endorse no expectation of recovery more than the 
OP sample. 
RQ2:  Are individual, social or service factors associated with recovery expectancy?    
RQ2.1:  Are individual factors associated with recovery expectancy? 
Hyp2.1a:  Less severe diagnoses will be associated with higher recovery 
expectancy. 
Hyp2.1b:  Lower somatization symptoms reported by participants will be 
associated with higher recovery expectancy. 
Hyp2.1c:  Lower obsessive-compulsive symptoms reported by participants 
will be associated with higher recovery expectancy. 
Hyp2.1d:  Lower interpersonal sensitivity reported by participants will be 
associated with higher recovery expectancy. 
Hyp2.1e:  Lower symptoms of depression reported by participants will be 
associated with higher recovery expectancy. 
Hyp2.1f:  Lower symptoms of anxiety reported by participants will be 
associated with higher recovery expectancy. 
Hyp2.1g:  Lower hostility reported by participants will be associated with 
higher recovery expectancy. 
Hyp.1h:  Lower phobic anxiety reported by participants will be associated 
with higher recovery expectancy. 
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Hyp2.1i:  Lower paranoid ideation reported by participants will be 
associated with higher recovery expectancy. 
Hyp2.1j:  Lower psychoticism reported by participants will be associated 
with higher recovery expectancy. 
Hyp2.1k:  Lower total number of symptoms reported by participants will 
be associated with higher recovery expectancy. 
Hyp2.1l:  Absence of a comorbid substance use disorder will be associated 
with higher recovery expectancy for participants. 
Hyp2.1m:  No psychiatric hospitalization in the last year will be associated 
with higher recovery expectancy for participants. 
Hyp2.1n:  Lower numbers of lifetime psychiatric hospitalizations will be 
associated with higher recovery expectancy for participants. 
Hyp2.1o:  Older age at onset of disorder will be associated with higher 
recovery expectancy for participants. 
Hyp2.1p:  Absence of familial mental illness in first-degree relatives will 
be associated with higher recovery expectancy for participants. 
Hyp2.1q:  Absence of familial mental illness in extended family members 
will be associated with higher recovery expectancy for participants. 
Hyp2.1r:  Being currently employed will be associated with higher 
recovery expectancy for participants. 
Hyp2.1s:  Greater number of years worked will be associated with higher 
recovery expectancy for participants. 
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Hyp2.1t:  Absence of prescribed anti-psychotic medication will be 
associated with higher recovery expectancy for participants.  
Hyp2.1u:  Absence of prescribed anti-depressant medication will be 
associated with higher recovery expectancy for participants. 
Hyp2.1v:  Absence of prescribed anti-mania medication will be associated 
with higher recovery expectancy for participants. 
Hyp2.1w:  Absence of prescribed anti-anxiety medication will be 
associated with higher recovery expectancy for participants. 
Hyp2.1x:  Absence of any other prescribed psychotropic medication will 
be associated with higher recovery expectancy for participants. 
Hyp2.1y:  Absence of child sexual abuse will be associated with higher 
recovery expectancy for participants. 
Hyp2.1z:  Absence of child physical abuse will be associated with higher 
recovery expectancy for participants. 
Hyp2.1aa:  Absence of adult sexual assault will be associated with higher 
recovery expectancy for participants. 
Hyp2.1ab:  Absence of adult physical assault will be associated with 
higher recovery expectancy for participants. 
RQ2.2:  Are social factors associated with recovery expectancy? 
Hyp2.2a:  Lower feelings of alienation will be associated with higher 
recovery expectancy for participants. 
Hyp2.2b:  Lower participant endorsement of mental illness stereotypes 
will be associated with higher recovery expectancy for participants. 
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Hyp2.2c:  Lower number of discrimination experiences will be associated 
with higher recovery expectancy for participants. 
Hyp2.2d:  Lower endorsement of social withdrawal will be associated 
with higher recovery expectancy for participants. 
Hyp2.2e:  Greater endorsement of stigma resistance will be associated 
with higher recovery expectancy for participants. 
Hyp2.2f:  Greater support through intimate partner or a best friend will be 
associated with higher recovery expectancy for participants. 
Hyp2.2g:  Greater support through family members will be associated 
with higher recovery expectancy for participants. 
Hyp2.2h:  Greater support via mental health providers will be associated 
with higher recovery expectancy for participants. 
Hyp2.2i:  Greater support through friendship will be associated with 
higher recovery expectancy for participants. 
Hyp2.2j:  Greater feelings of being connected to the community will be 
associated with higher recovery expectancy for participants. 
Hyp2.2k:  Greater trust in the motivation of others will be associated with 
higher recovery expectancy for participants. 
Hyp2.2l:  Higher ratings of self-esteem and self-efficacy will be associated 
with higher recovery expectancy for participants. 
Hyp2.2m:  Higher ratings of personal power will be associated with higher 
recovery expectancy for participants. 
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Hyp2.2n:  Greater involvement in the community will be associated with 
higher recovery expectancy for participants. 
Hyp2.2o:  Greater confidence in personal control over the future will be 
associated with higher recovery expectancy for participants. 
Hyp2.2q:  Higher ratings of righteous anger will be associated with higher 
recovery expectancy for participants. 
RQ2.3:  Are service factors associated with recovery expectancy? 
Hyp2.3a:  Total number of services will be positively associated with 
higher recovery expectancies for participants. 
Hyp2.3b:  The average number of contact hours per month will be 
positively associated with higher recovery expectancies for participants. 
Hyp2.3c:  Satisfaction level with services will be positively associated 
with higher recovery expectancies for participants. 
RQ3:  Are individual, social or service factors associated with recovery strategies?    
RQ3.1:  Are individual factors associated with recovery strategies? 
Hyp3.1a:  Less clinically severe diagnoses for participants will be 
associated with greater endorsement for a recovery strategy. 
Hyp3.1b:  Lower somatization symptoms reported by participants will be 
associated with greater endorsement for a recovery strategy. 
Hyp3.1c:  Lower obsessive-compulsive symptoms reported by participants 
will be associated with greater endorsement for a recovery strategy. 
Hyp3.1d:  Lower interpersonal sensitivity reported by participants will be 
associated with greater endorsement for a recovery strategy. 
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Hyp3.1e:  Lower symptoms of depression reported by participants will be 
associated with greater endorsement for a recovery strategy. 
Hyp3.1f:  Lower symptoms of anxiety reported by participants will be 
associated with greater endorsement for a recovery strategy. 
Hyp3.1g:  Lower hostility reported by participants will be associated with 
greater endorsement for a recovery strategy. 
Hyp3.1h:  Lower phobic anxiety reported by participants will be 
associated with greater endorsement for a recovery strategy. 
Hyp3.1i:  Lower paranoid ideation reported by participants will be 
associated with greater endorsement for a recovery strategy. 
Hyp3.1j:  Lower psychoticism reported by participants will be associated 
with greater endorsement for a recovery strategy. 
Hyp3.1k:  Lower total number of symptoms reported by participants will 
be associated with greater endorsement for a recovery strategy. 
Hyp3.1l:  Absence of a comorbid substance use disorder will be associated 
with greater endorsement for a recovery strategy for participants. 
Hyp3.1m:  No psychiatric hospitalization in the last year will be associated 
with greater endorsement for a recovery strategy for participants. 
Hyp3.1n:  Lower numbers of lifetime psychiatric hospitalizations will be 
associated with greater endorsement for a recovery strategy for 
participants. 
Hyp3.1o:  Older age at onset of disorder will be associated with greater 
endorsement for a recovery strategy for participants. 
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Hyp3.1p:  Absence of familial mental illness in first-degree relatives will 
be associated with greater endorsement for a recovery strategy for 
participants. 
Hyp3.1q:  Absence of familial mental illness in extended family members 
will be associated with greater endorsement for a recovery strategy for 
participants. 
Hyp3.1r:  Being currently employed will be associated with greater 
endorsement for a recovery strategy for participants. 
Hyp3.1s:  Greater number of years worked will be associated with greater 
endorsement for a recovery strategy for participants. 
Hyp3.1t:  Absence of prescribed anti-psychotic medication will be 
associated with greater endorsement for a recovery strategy for 
participants.  
Hyp3.1u:  Absence of prescribed anti-depressant medication will be 
associated with greater endorsement for a recovery strategy for 
participants. 
Hyp3.1v:  Absence of prescribed anti-manic medication will be associated 
with greater endorsement for a recovery strategy for participants. 
Hyp3.1w:  Absence of prescribed anti-anxiety medication will be 
associated with greater endorsement for a recovery strategy for 
participants. 
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Hyp3.1x:  Absence of any other prescribed psychotropic medication will 
be associated with greater endorsement for a recovery strategy for 
participants. 
Hyp3.1y:  Absence of child sexual abuse will be associated with greater 
endorsement for a recovery strategy for participants. 
Hyp3.1z:  Absence of child physical abuse will be associated with greater 
endorsement for a recovery strategy for participants. 
Hyp3.1aa:  Absence of adult sexual assault will be associated with greater 
endorsement for a recovery strategy for participants. 
Hyp3.1ab:  Absence of adult physical assault will be associated with 
greater endorsement for a recovery strategy for participants. 
RQ3.2:  Are social factors associated with recovery expectancy? 
Hyp3.2a:  Lower feelings of alienation will be associated with higher 
recovery expectancy for participants. 
Hyp3.2b:  Lower participant endorsement of mental illness stereotypes 
will be associated with higher recovery expectancy for participants. 
Hyp3.2c:  Lower number of discrimination experiences will be associated 
with higher recovery expectancy for participants. 
Hyp3.2d:  Lower endorsement of social withdrawal will be associated 
with higher recovery expectancy for participants. 
Hyp3.2e:  Greater endorsement of stigma resistance will be associated 
with higher recovery expectancy for participants. 
 113
Hyp3.2f:  Greater support through intimate partner or a best friend will be 
associated with higher recovery expectancy for participants. 
Hyp3.g:  Greater support through family members will be associated with 
higher recovery expectancy for participants. 
Hyp3.2h:  Greater support via mental health providers will be associated 
with higher recovery expectancy for participants. 
Hyp3.2i:  Greater support through friendship will be associated with 
higher recovery expectancy for participants. 
Hyp3.2j:  Greater feelings of being connected to the community will be 
associated with higher recovery expectancy for participants. 
Hyp3.2k:  Greater trust in the motivation of others will be associated with 
higher recovery expectancy for participants. 
Hyp3.2l:  Higher ratings of self-esteem and self-efficacy will be associated 
with higher recovery expectancy for participants. 
Hyp3.2m:  Higher ratings of personal power will be associated with higher 
recovery expectancy for participants. 
Hyp3.2n:  Greater involvement in the community will be associated with 
higher recovery expectancy for participants. 
Hyp3.2o:  Greater confidence in personal control over the future will be 
associated with higher recovery expectancy for participants. 
Hyp3.2q:  Higher ratings of righteous anger will be associated with higher 
recovery expectancy for participants. 
RQ3.3:  Are service factors associated with recovery expectancy? 
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Hyp3.3a:  Total number of services will be associated with higher 
recovery expectancies for participants. 
Hyp3.3b:  The average number of contact hours per month (averaged over 
one year of service) will be associated with higher recovery expectancies 
for participants 
Hyp3.3c:  Satisfaction level with services will be associated with higher 
recovery expectancies for participants. 
RQ4a:  Does the expectation of recovery mediate the relationship between individual, 
social and service factors and recovery strategies? 
Hyp4a.1:  Participants’ expectation of recovery will mediate the relationship 
between individual factors and recovery strategies. 
Hyp4a.2:  Participants’ expectation of recovery will mediate the relationship 
between social factors and recovery strategies. 
Hyp4a.3:  Participants’ expectation of recovery will mediate the relationship 
between service factors and recovery strategies. 
RQ4b:  Does the expectation of recovery moderate the relationship between individual, 
social and service factors and recovery strategies? 
Hyp4b.1:  Participants’ expectation of recovery will moderate the relationship 
between individual factors and recovery strategies. 
Post Hoc:  Post hoc analyses will target specific variables that are found to 
be statistically and clinically relevant to recovery 
Hyp4b.2:  Participants’ expectation of recovery will moderate the relationship 
between social factors and recovery strategies. 
 115
Post Hoc:  Post hoc analyses will target specific variables that are found to 
be statistically and clinically relevant to recovery 
Hyp4b.3:  Participants’ expectation of recovery will moderate the relationship 
between service factors and recovery strategies. 
Post Hoc:  Post hoc analyses will target specific variables that are found to 
be statistically and clinically relevant to recovery 
RQ5:  Does severity of mental illness moderate the relationship between individual, 
social and service factors and recovery strategies? 
Hyp5.1:  Severity of mental illness will moderate the relationship between 
individual factors and recovery strategies for participants. 
Post Hoc:  Post hoc analyses will target specific variables that are found to 
be statistically and clinically relevant to recovery 
Hyp5.2:  Severity of mental illness will moderate the relationship between social 
factors and recovery strategies for participants. 
Post Hoc:  Post hoc analyses will target specific variables that are found to 
be statistically and clinically relevant to recovery 
Hyp5.3:  Severity of mental illness will moderate the relationship between service 
factors and recovery strategies for participants. 
Post Hoc:  Post hoc analyses will target specific variables that are found to 
be statistically and clinically relevant to recovery 
Study Setting 
 The partnering agency (The Harbor Behavioral Health Care Institute), a large 
community mental health center serving over 20,000 individuals annually in 34 locations 
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across three counties, generously provided access to clients for this research.  Data 
collection occurred primarily in three clinic locations.  For the majority of study 
participants (89%), the researcher traveled to the agency location closest to the 
participant.  Home or apartment visits accommodated the remaining participants.  Data 
collection was completed on an individual basis with either the principal investigator or 
research assistant present and assisting each participant.  A private office or meeting 
room was provided for data collection in the agency and home visits were all completed 
free of interruption by family members.   
Data Collection Procedures 
   This section provides details of the study methods and procedures in temporal 
order.  Four sub-sections describe pre-data collection procedures, data collection 
procedures, theoretical constructs (in brief) and the instruments relevant to each 
construct, and post-data collection (data analysis) procedures. 
Pre-data collection procedures 
Institutional Review Board (IRB) authorization.  The community mental health 
center partner and the researcher negotiated full access for the study requirements.  The 
study was reviewed and sanctioned by both the University of South Florida IRB and from 
the IRB that permits research at the Harbor (Morton Plant Mease Bay Care IRB).  
Training of research assistants.  Four research assistants were trained for this 
project.  Training procedures and materials are detailed in Appendix D, but are briefly 
described here.  Three research assistants were undergraduate students at the University 
of South Florida, and one was a student at Pasco Hernando Community College.  The one 
student from the Community College was unable to complete the project.  Each student 
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volunteered and gave 6-12 hours a week toward data collection.  Before the start of data 
collection, each student completed the NIH training for human subject protection.  Study 
procedures were offered in five training sessions, each lasting three hours.  The topics 
covered in the training included:  ethics and human subject protection, confidentiality, 
emergency procedures if the consumer began to show signs of active symptoms (e.g., 
crying or anger), consent procedures and use of the informed consent checklist, use of the 
incentive receipt form, familiarity with each data collection instrument, procedures for 
when the consumer was willing and capable of filling out the forms for him or herself, 
procedures for when the interviewer read each question to the consumer, monitoring each 
instrument as it is completed to intercept missing data, use of the oversized print 
laminated response cue cards that correspond with each collection tool, provision of the 
incentive, and when/where to drop off completed forms to the lead researcher.   
Data collection procedures 
 Participant contact.  Contact occurred both formally and informally.   Contact 
formally via a letter sent to the participant’s residence or hand delivered by the 
participant’s primary provider occurred in 75% of cases.  Informally, providers were 
aware of which of their clients had been randomly selected.  Some providers informed 
their clients before letters of invitation could be personalized and delivered to the 
provider.  Similarly, some providers phoned their clients before letters were available and 
the client would in turn contact the researcher via phone to schedule an appointment.  In 
most cases, follow-up phone contacts to schedule were completed within four days of 
when the letter was received by the participant.    
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Confidentiality and data storage.  Data collection requires assurance of 
confidentiality and appropriate data storage.  Data are stored in the office of the 
researcher in a locked cabinet.  Computer files are password protected.  Consent forms 
are filed separately to ensure confidentiality and to verify that the full consent process 
was used.  Data collection forms only have the participant number, no names, and are 
stored sequentially by participant number.  Multiple backups of all computer data and 
analysis files have been maintained and encrypted. 
Informed consent and verification of inclusion/exclusion criteria.  Participants had 
the option of reading the consent form and authorization themselves or having it read to 
them.  Ninety-three percent (93%) chose to read the surveys on their own.  Informed 
consent for individuals with a mental disorder is somewhat controversial.  The SMI 
population especially is at risk for cognitive deficits that could impair their ability to 
understand and fully consent to the process, though similar deficits may be present in the 
OP sample.  Because of this, each subject from both samples was provided an 
independent capacity assessment through the following procedure:  The subjects had the 
consent form explained to them one point at a time.  Additionally, a brief set of questions 
concerning the most salient points (e.g., right of refusal, right to quit at any time) was 
developed (see Informed Consent Checklist in Appendix C), and consent was not 
considered complete until the subject answered each question correctly and sequentially 
(Carpenter et al., 2000; Wirshing, Wirshing, Marder, Liberman, & Mintz, 1998).  Results 
of the independent capacity assessment are provided in Table 3.  The majority (97%) of 
individuals in the SMI sample understood the consent process and passed the independent 
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capacity assessment on the first attempt.  All the OP sample participants passed on the 
first attempt.   
Table 3 
 
Summary of Independent Capacity Assessment Results 
 
 
Attempts to Pass Consent 
 
SMI Sample 
 
 
OP Sample 
First Attempt 97% 100% 
Second Attempt   2%  
Third Attempt 
 
  1%  
 
Incentives.  During the informed consent procedure, the incentive was explained 
again.  Each participant was given an incentive of $10.00 for participating after 
completion of the data collection process.  In order to track the monetary outlay, each 
participant signed a form that they have received the $10.00 incentive. 
Data collection.  Once informed consent was completed data collection began.  
Ordering of instruments is important, with longer instruments being used first followed 
by shorter instruments and instruments that require personal information being used last 
after rapport is established.  Complete descriptions of the instruments listed below are 
provided in the next section.  The following sequence was used with each individual: 
1. Symptom Checklist 90-Revised (SCL-90-R).  This is the longest instrument and 
also asks questions that consumers of clinical services are accustomed to, 
increasing comfort. 
2. Support and Community Connectedness Scale (SCCS) 
3. Recovery Expectation Checklist (REC) 
4. Recovery Assessment Scale (RAS) 
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5. Personal Vision of Recovery Questionnaire (PVRQ) 
6. Empowerment Scale (ES) 
7. Internalized Stigma of Mental Illness Scale (ISMI) 
8. Service Satisfaction Questionnaire (SSQ) 
9. Background and History form. 
The researcher provided all supplies.  Noted above, the participants had the option 
of having the researcher read the instrument questions aloud.  If this option was taken, a 
laminated ‘cue card’ with responses for each instrument was used to help the client select 
responses on the appropriate scale.   
The amount of time for data collection (from introduction to paying of incentive) 
was noted for each individual.  Data collection took, on average, 68 minutes to complete.  
The range of time was 27 minutes to 340 minutes.  Only three individuals took over three 
hours to complete their participation.  Four individuals needed between two and three 
hours.  Subjects were encouraged to take a brief break if they became fatigued and were 
allowed to stop and resume at a different time.  Of the 350 participants, less than one 
percent (n=2) chose to stop and resume on a different day.  There may be some concern 
that this was an inordinate amount of time for an individual with mental illness to 
participate.  However, qualitative studies using in-depth interviews with mentally ill 
participants have averaged 60-90 minutes per interview without any negative effect on 
the participant (Auquier, et al., 2003; Walby, 2003a, 2003b).  No individual complained 
of fatigue and there were no adverse events during data collection. 
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The total span of time for the data collection was eighteen weeks.  The researcher 
offered to collect data on weekends and evenings for clients who might indicate that this 
is the most convenient time, but no participants requested this option.  
Dependent Variables:  Recovery Expectancies and Strategies 
 Recovery is defined as both the belief that an individual will overcome mental 
illness, through suppression or compensation, and the strategies or processes an 
individual uses to enhance recovery.  The construct of recovery is operationalized using 
both expectancies and strategies in this research.  The expectation of recovery can be 
measured directly.  However, the measurement of recovery strategies requires consensus 
on what strategies for recovery are.  Identifying and describing recovery strategies is only 
beginning (Borowitz-Ensfield, 1998; Corrigan & Ralph, 2005; Corrigan et al., 2005). 
This research effort identifies recovery strategies by combining items from two recovery 
surveys and using factor analysis to identify strategies.  Recovery was assessed using 
three instruments.   
1. Recovery Expectation Checklist (REC). This instrument is unique in that it 
provides data as a dependent variable for some analyses and as a mediating or 
moderating variable for other analyses.  The REC data as mediator or 
moderator will be explained in the appropriate section below. 
2. Recovery Assessment Scale (RAS) 
3. Personal Vision of Recovery Questionnaire (PVRQ) 
Recovery Expectation Checklist
The recovery efficacy checklist is an original instrument that measures recovery 
expectancy by the participant indicating if they believe they will be able to recover from 
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mental illness and to what degree.  This is a four question instrument that, in addition to 
the direct inquiry of recovery belief, also inquires into the what recovery means to the 
participant and what resources or supports they feel are important to their recovery (see 
Appendix A for a formatted version of this and all other instruments described in this 
Chapter).   
The first two questions measure whether recovery is subjectively experienced as 
possible for each individual and to what degree they expect to recovery.  The responses 
are used to assess belief level in recovery for the total sample and to measure differences 
between the SMI and OP samples.  Question 3 of the REC provides the option of 
endorsing seven options that match key aspects of recovery (e.g., “I will be able to work 
full time”).  The fourth question is a simple checklist derived from a literature review that 
lists specific relationships, habits, or activities that were considered recovery enhancing.  
The list is not viewed as comprehensive and there are several spaces for additional 
responses.  Questions three and four are additional information for a more complete 
understanding of the recovery construct. 
Recovery Assessment Scale (RAS). 
 The RAS is a 41-item survey that measures strategies important to recovery from 
mental illness (Corrigan, et al., 1999).  The instrument was created in cooperation with 
consumers of mental health service and was designed to identify factors/pathways 
important to recovery.  A recent paper investigating the structure of the RAS identified 
five principal components generated from 24 of the 41-item inventory (Corrigan, Salzer, 
Ralph, Sangster, & Keck, 2004).    
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 One area of concern is that the author’s deviated from what might be considered 
best practice when confirming the factor structure of a new instrument.  They first used 
principal components analysis (PCA), in place of exploratory factor analysis (EFA), and 
followed the PCA with a confirmatory factor analysis (CFA).  Essentially, “only factor 
analysis may be used to identify the factor structure underlying a set of variables 
(Hatcher, 1994, p. 69).”  In PCA, the components extracted are linear combinations of the 
observed variables, whereas in factor analysis, the “…observed variables are linear 
combinations of the underlying factors (Hatcher, 1994, p. 70).”  Further, total variance 
(combined from common and unique variance) detected in PCA is different then factor 
analysis, which detects common variance alone (Isaac & Michael, 1995).  Thus, it is 
inappropriate to follow a PCA with a CFA since they are measuring different aspects of 
variance.  If items are generated that perfectly measure constructs, common variance and 
total variance are identical and the choice between PCA and EFA as an analytic approach 
would be irrelevant.  Since perfect items were not generated, the difference between 
common and total variance is salient for this and other research.  However, the errors in 
measurement addressed here do not affect the outcome of this research since the factor 
structure described by the author is not used in this analysis. 
Psychometric properties of the RAS include an overall test-retest reliability factor 
of r = 0.88 and internal consistency α = 0.93.  The results of the PCA and CFA are 
presented in Table 4.  Concurrent validity was measured through correlations with 
various psychosocial variables with significant concurrence identified for self-esteem, 
empowerment self-orientation, size of support network and quality of life.  Concurrence 
was not demonstrated with empowerment, community-orientation, satisfaction with  
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Table 4 
 
Factor Structure for Recovery Assessment Scale 
 
 Factor 
Loading 
PCA* 
Factor 
Loading 
CFA* 
Component 1:  Personal Confidence and Hope   
Fear doesn’t stop me from living the way I want to 0.46 0.54 
I can handle what happens in my life 0.49 0.67 
I like myself 0.68 0.72 
If people really knew me, they would like me 0.61 0.59 
I have an idea of who I would like to become 0.34 0.64 
Something good will eventually happen 0.49 0.65 
I am hopeful about my future 0.52 0.74 
I continue to have new interests 0.41 0.70 
I can handle stress 0.40 0.59 
 
Component 2:  Willingness to Ask for Help   
I know when to ask for help 0.74 0.76 
I am willing to ask for help 0.81 0.76 
I ask for help when I need it 0.81 0.82 
 
Component 3:  Goal and Success Orientation   
I have a desire to succeed 0.70 0.53 
I have my own plan for how to stay or become well 0.49 0.68 
I have goals in life that I want to reach 0.76 0.70 
I believe I can meet my current personal goals 0.52 0.79 
I have a purpose in life 0.50 0.75 
 
Component 4:  Reliance on Others   
Even when I don’t care about myself, other people do 0.68 0.58 
I have people I can count on 0.67 0.72 
Even when I don’t believe in myself, other people do 0.76 0.76 
It is important to have a variety of friends 0.34 0.54 
 
Component 5:  No Domination by Symptoms   
Coping with mental illness is no longer the main focus 
of my life 
0.74 0.59 
My symptoms interfere less and less with my life 0.75 0.87 
My symptoms seem to be a problem for shorter 
periods of time each time they occur 
0.68 0.65 
 
Note: *PCA = Principal Components Analysis; *CFA = Confirmatory Factor Analysis 
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support network, vocabulary or education.  These findings were in the predicted direction 
and supported the author’s claim of a valid and reliable instrument. 
Individual scale alpha-scores were in the middle to high range.  The items for this 
scale were developed to reflect the four domains of recovery postulated by Ralph (2000) 
that include (1) internal factors, (2) self-managed care, (3) external factors, and (4) 
empowerment.  A brief description and Cronbach’s alpha (internal consistency proxy for 
test-retest reliability) are provided for each of the factors of the RAS: 
(1) Personal confidence and hope:  α = 0.87.  This factor is composed of nine 
items.  The items reveal a future orientation that is hopeful and also reflects 
liking the self and being comfortable that others would like the person as 
well.  The questions also describe the ability to cope with stress and fear. 
(2) Willingness to ask for help:  α = 0.84.  The author’s voice concern about this 
factor since the wording of the three questions that comprise the factor are 
obvious variants on a theme.  The three questions address whether an 
individual knows when to ask for help, is willing to do so, and has a history 
of doing so if needed. 
(3) Goal and success orientation:  α = 0.82.  The five items comprising this 
factor describe success, purpose, meaning and goal accomplishment. 
(4) Reliance on others:  α = 0.74.   This factor encompasses four items.  The 
name of the factor evokes a willingness or history of relying on others for 
assistance.  However, the wording of the items targets believing that others 
care about or believe in the respondent and that the individual recognizes that 
they have people they can count on. 
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(5) No domination by symptoms:  α = 0.74.  The three items in this factor 
describe the individual’s perception of symptoms and if symptoms are a 
major point of consideration or contention in the respondents life. 
Personal Vision of Recovery Questionnaire (PVRQ).   
The PVRQ is a 24-item survey that measures recovery strategies for mental illness 
(Borowitz-Ensfield, 1998).  The survey was created through discussion and assistance 
from consumers and revealed five factors related to recovery.  Exploratory factor 
analysis, Cronbach’s alpha and construct validation through correlation with associated 
measures were used to develop and confirm the instrument.  The final array of factors is 
consistent with first- person accounts, qualitative research, and other documentation of 
the recovery process and is presented in Table 5.   
 Models testing a single versus multiple factors indicate that there is not one factor 
that sufficiently accounts for the variance, demonstrating that the recovery construct was 
multidimensional.  The five-factor model, the final model, accounted for the most 
variance.  The author used multiple indices of goodness of fit to evaluate the instrument.  
These included the scaled comparative fit index (CFI), which should exceed 0.9; the root 
mean square approximation (RMSEA), which should be ≤ 0.05; the Satorra-Bentler chi-
square, which should be approximately equal to the degrees of freedom; and, the 
standardized root mean squared residual (RMSR), which should also be ≤ 0.05 
(Borowitz-Ensfield, 1998, pg 23-25).    For the five-factor (final) model, the CFI = 0.94, 
the RMSEA = 0.02, the Satorra-Bentler chi-square = 249.77 (degrees of freedom = 234), 
and the RMSR = 0.08. 
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Table 5 
 
Factor Structure for Personal Vision of Recovery Questionnaire 
 
  
Factor 
Loading 
Factor 1:  Recovery through Support 
Self-help groups are important to my recovery .68 
Family support is important for my recovery .63 
Helping others is part of my recovery .56 
Recovery means becoming satisfied with my life .49 
I am responsible for my own recovery .46 
Support from mental health professionals is important for my recovery 
 
.42 
Factor 2:  Recovery through Personal Challenges 
Recovery involves finding new meaning in my life .68 
People who expect very little of me interfere with my recovery .64 
Side effects from my medication make it harder for me to recover .54 
Recovery means I will be free of symptoms .47 
Recovery means getting more control of my life 
 
.41 
Factor 3:  Recovery through Professional Assistance 
At times, treatment against my wishes is necessary for my recovery.  
For example, involuntary hospitalization, forced medication, or 
community probate 
.70 
The cause of mental illness is not important for my recovery .64 
Recovery means I will not be mentally ill anymore .54 
Being diagnosed correctly is necessary for my recovery 
 
.43 
Factor 4:  Recovery through Action and Help-Seeking 
Sticking up for clients’ rights is a part of my recovery .72 
Asking for help is a part of my recovery .53 
I know people who are recovering from problems similar to mine .49 
Having something meaningful to do is important for my recovery .46 
Support from a special person, such as a spouse or partner, is important 
for my recovery 
 
.32 
Factor 5:  Recovery through Affirmation 
Hope is important for my recovery .78 
Spirituality is a part of my recovery .50 
I am convinced that medication can help me to recover .49 
Recovery means my symptoms will be easier to control 
 
.39 
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It should be noted that the PVRQ scales have a lower degree of internal 
consistency then is usually noted in validated instruments.  The author hypothesizes that 
the low internal consistency likely reflected the fluid nature of the recovery construct.  
The definition and components of recovery are not used consistently in the literature and 
there is preliminary evidence that the concept of recovery alters over time (Andresen, 
Oades, & Caputti, 2003).  The participants in the study that developed the PVRQ were 
likely in different stages of recovery and responded to the question content differently 
due, in part, to where they lie on a continuum of recovery.   
Measurement of Potential Correlates (Independent Variables) Across Multiple Domains 
 Many factors that may enhance or impede recovery were introduced in 
Chapter 2.  It was not feasible to measure every one of these potentially valuable factors 
in this single study.  However, it was possible to measure the factors with the strongest 
theoretical links to recovery.  Individual measurement tools are discussed as they pertain 
to a domain. 
Domain 1:  Individual, Historical and Clinical Factors 
There is considerable information about diagnosis and, to a lesser degree, 
symptoms, and their effects on recovery.  Anecdotal and clinical literature suggests that 
familial mental illness, abuse history, age of onset and other factors may also be related 
to recovery expectancy and recovery strategies.  The following three instruments were 
used to tap key components of this domain. 
1. Background Characteristics, Related Aspects of History and Demographics 
a. Background Short Form 
2. Symptom Checklist 90-Revised (SCL-90R) 
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3. Chart Abstraction Tool 
Background Characteristics, Related Aspects of History and Demographics.   
Individuals were asked to complete a background form with items targeting age, 
gender, education, income, employment, current living situation, history of familial 
mental illness, substance use history, abuse/trauma history, age of onset, employment and 
other factors.  Due to the sensitive nature of some of the questions, several areas are 
investigated via the chart abstraction tool (see below), both as a validity check and to 
respect the wishes of individual participants who may find it uncomfortable to discuss 
some areas.  Only four individuals refused to answer questions, all of which were abuse 
history related.  Information from the clinical charts and recorded in the abstraction tool 
verified that all four individuals were severely abused as children and were reluctant to 
address this issue in therapy. 
Background Short Form.   
This form is an abridged version of the background form described above.  This 
form has a few key demographic questions that individuals who refuse to participate were 
asked to complete.  This information was intended to be compared against full study 
participants to check for systematic differences between participants and non-
participants.   However, noted in Table 2 above, only 16 individuals refused to 
participate.  Of these 16 individuals, only four completed the background short form, 
which did not provide sufficient information for a comparison. 
The Symptom Checklist 90-Revised (SCL-90-R).   
The SCL-90-R is a 90-item self-report symptom inventory designed to reflect the 
psychological symptom patterns of community, medical, and psychiatric participants 
 130
(Derogatis, 1994).  The SCL-90-R is a measure of current symptom status.  Measurement 
of present symptom levels is important as the effect of symptom severity and types of 
symptoms have not been sufficiently correlated with recovery.  Further, other studies of 
recovery have not correlated symptoms with diagnosis.  The nine subscales and three 
composite scales examine for a breadth of potential symptomatology.  Each item is scaled 
on a five-point scale with the range of answers from ‘not at all (0)’ to ‘extremely (4)’.  
Participants were asked to indicate “how much discomfort that problem has caused you” 
during the past seven days including the day of administration (Derogatis, 1994).  The 
symptom dimensions that comprise 83 of the 90 questions in the SCL-90-R include 
somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, 
hostility, phobic anxiety, paranoid ideation, and psychoticism.  A tenth dimension 
investigates points of relevant clinical interest that do not fit into the symptom categories.   
This instrument has been used in numerous research and clinical settings with a 
considerable amount of information relating to both validity and reliability accrued.  
There have been numerous applications of this survey to various types of psychiatric 
populations with analysis of reliability through test-retest and coefficient alpha.  Table 6 
reproduces the results from a selection of these studies.  The instrument is reliable across 
different types of psychiatric populations and for varying lengths of time between 
administrations.  One potential limitation is that several studies with different populations 
and utilizing factor analysis have found more or less factors than the nine factors detailed 
by the originator.  However, there was not uniformity in principal component analysis vs. 
factor analysis, procedures used for sample selection, or other methodological and 
analytic choices.  These inconsistencies may, in part, account for this discrepancy. 
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 Derogatis, (1994) provided evidence for the external validity of the SCL-90-R 
using three approaches.  The internal structure of the instrument was tested through a 
factor analytic procedure.  Factorial invariance – the constancy in the composition of a 
dimension as one changes significant subject parameters such as age, gender or social 
class – was examined through correlations across symptom dimensions by gender 
(Derogatis, 1994).  Finally, convergent and discriminant validity – the measure of interest 
correlates highly with other instruments known to measure the same construct or 
correlates poorly with instruments that measure dissimilar constructs – was confirmed by 
comparing the SCL-90-R with the Minnesota Multiphasic Personality Inventory (MMPI) 
and the Middlesex Hospital Questionnaire (Derogatis, 1994). 
The MMPI clinical scales were supplemented with the Wiggins content scales 
(Graham, 2005) (e.g., psychoticism, manifest hostility) and Tryon’s cluster scales 
(Derogatis, 1994) (e.g., anxiety, autism).  The convergent validity ranges from 0.42 
between the paranoia scales of the MMPI and the SCL-90-R to 0.75 between the Wiggins 
depression scale and SCL-90-R depression dimension.  Divergent validity also had a 
considerable range and in only one case was the divergent correlation for another factor 
higher than the convergent (SCL-R-90 paranoia and MMPI paranoia = 0.42; SCL-R-90 
psychoticism and MMPI paranoia = 0.48).  Several other studies have added to the 
validity literature on the SCL-90 (Carpenter & Hittner, 1995; Evenson, Holland, Mehta, 
& Yasin, 1980; Hafkenscheid, 1993; Rauter, Leonard, & Swett, 1996; Vassend & 
Skrondal, 1999).  These studies support the validity of the instrument and are especially 
consistent for the total pathology scale. 
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Table 6 
 
Reliability Estimates for the SCL-90-R – Original Reliability and Subsequent Estimates  
 
 Original Reliability Estimates 
 
Subsequent Reliability Estimates
Dimension a Coef α 
 
Test-Retest (r11) Coef α e Coef α f Coef α g Coef α h Coef α i
 Study 1 b 
 
Study 2 c Study 2 c Study 3 d    Pap-Pen h Computer h Ref h P/S i PC i Ref i
SOMA .86 .88 .68 .86 .92 .87 .79 .90 .79 .70 .86 .83 .70 
O-C .86 .87 .70 .85 .75 .81 .78 .84 .85 .75 .86 .85 .75 
I-S .86 .84 .81 .83 .79 .84 .79 .87 .84 .76 .87 .84 .76 
DEP .90 .90 .75 .82 .96 .89 .82 .92 .86 .83 .90 .90 .83 
ANX .85 .88 .80 .80 .56 .88 .82 .88 .88 .75 .87 .87 .75 
HOS .84 .85 .73 .78 .86 .76 .75 .73 .59 .62 .78 .78 .62 
PHOB .82 .89 .77 .90 .82 .89 .72 .92 .86 .51 .86 .80 .51 
PAR .80 .79 .83 .86 .89 .80 .67 .65 .76 .63 .78 .80 .63 
PSY .77 .80 .77 .84 .78 .76 .62 .77 .76 .65 .78 .79 .65 
GSI       .96    .97 .98 .94 
              
a SOMA = somatization; O-C = obsessive-compulsive; I-S = interpersonal sensitivity; DEP = depression; ANX = anxiety; HOS = hostility; PHOB = phobic anxiety; 
PAR = paranoia; PSY = psychoticism; GSI = global severity index 
bN = 209 “symptomatic volunteers” (Derogatis, Rickels, & Rock, 1976) (original estimate) 
cN = 103 psychiatric outpatients (Horowitz et al., 1988); elapsed time between tests = 10 weeks (original estimate) 
dN = 94 heterogeneous psychiatric outpatients (Derogatis, Rickels, & Rock, 1976); elapsed time between tests = 1 week (original estimate) 
eN = 451 acute psychiatric inpatients (Holcomb, Adams & Ponder, 1983) 
fN = 437 short-stay psychiatric inpatients (Hafkenscheid, 1993) 
gN = 484 general population sample (Argentina) (Bonicatto, et al., 1997) 
hN = 32 for paper-pencil (Pap-Pen) and computer (matched psychosomatic outpatients),and 1000 for reference (Ref) (Schmitz, et al., 1999) 
iN = 2425 Psychosomatic outpatients (P/S), 447 primary care sample (PC), 1006 reference (Ref) (Germany); (Schmitz, et al., 2000) 
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Chart Abstraction Tool. 
The chart abstraction was used to validate information provided through the 
demographic/history taking form and as a check for missing data.  Data the abstraction 
tool collected included:  age, education, current employment, past employment, current 
services, past services, medications, trauma (child and adult), primary psychiatric 
diagnosis, secondary psychiatric diagnosis, substance use/abuse diagnosis, age of onset, 
hospitalizations in last year, hospitalizations lifetime, and familial history of mental 
illness. 
 
Domain 2:  Social Factors that Influence Recovery 
 Domain 2 addresses several social constructs with potential relevance to recovery. 
The constructs include social support, community connectedness, trust, empowerment, 
stigma and discrimination.  These constructs are theoretically based and were introduced 
in Chapter 2.  There are three instruments that operationalize these constructs.  These 
include: 
1. Support and Community Connectedness Survey (SCCS), which provides data 
on social support, community connectedness and trust 
2. Empowerment Survey (ES) 
3. Internalized Stigma of Mental Illness Scale (ISMI) 
Support and Community Connectedness Survey (SCCS).   
The SCCS was designed specifically for this study.  Full details of item selection 
and development are included in Appendix B.  Two rounds of data collection were 
completed.  The first round comprised 125 individuals who took the original survey.  
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Each question was accompanied with a blank area to comment on the question, make 
suggestions for wording, or anything else the participant felt was needed.  After updating 
the survey, 350 different individuals completed the survey and a factor analysis was 
completed.  The survey was designed to assess six different areas of support and 
community connection:  support from an intimate partner, support from family, support 
from friends, support from providers, community connection and level of general trust.  
Thus, a six factor model was forced and the items were assessed for theoretical 
continuity.  The factor analysis of the original 80-item inventory reduced the items to a 
six-factor 34 total item survey that measure clusters of social support (e.g., family, 
friends), connection to the community and a related scale for general trust in others, 
consistent with item design and sub-scale prediction.  Approximately 38% of the variance 
was explained via the six-factor, 34 item survey.  The six-factors of the final instrument 
and their factor loadings are provided in Table 7. 
 In addition, one-factor, five-factor and seven-factor models were generated to 
evaluate changes in factor loadings.  A one-factor model was forced to assess whether the 
instrument was measuring a single, universal, construct.  The one-factor solution 
explained 11% of the variance with 16 items loading on the single factor.  This single 
factor encompassed questions from family, significant other, and friend support 
questions, capturing a general support construct.  Five and seven factor models were 
generated after the six-factor model to explore changes in the factor structure and to see 
whether any of the theorized six-factors combined or separated.  Items remained 
consistent in the five- and seven-factor models with the exception of the three questions 
addressing trust in government, which broke out as its own factor in the seven-factor  
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Table 7 
 
Factor Structure for Social Support and Community Connectedness Survey 
 
 Factor 
Loading 
Factor 1:  Support Via Intimate Partner or Best Friend  
My partner (or best friend) and I support each other equally .65 
My intimate partner (or best friend) helps me in many ways .77 
I can always turn to my partner (or best friend) for advice if I am confused .79 
My partner (or best friend) praises me and cheers for me when I accomplish something .83 
I wish my partner (or best friend) would try harder not to hurt my feelings .49 
Helping me feel good is what my partner or best friend does best .76 
When I do something wrong, my partner (or best friend) points it out to me .77 
When my back is in a corner, I can count on my partner (or best friend) to support me .83 
My friends spend time with my intimate partner (or best friend) and I .64 
My partner (or best friend) gives me things or helps me do things to make my life easier 
 
.77 
Factor 2:  Support Via Family  
I have a close relationship with my family .62 
My family meets many of my needs .66 
When I am sad or feeling blue, I can always turn to my family .80 
If I need money or help with a bill, my family almost always gives it to me .66 
If I need help fixing or making something, my family helps me .83 
If I need to know something my family usually has the answer 
 
.75 
Factor 3:  Support Via Provider  
My provider helps me with my emotional stability .60 
If I am making a mistake, my provider will always point it out .75 
Sometimes I feel that my provider does not take the time to hear me .49 
My friends know who my provider is .46 
If I need to know something, I ask my provider 
 
.71 
Factor 4:  Support Via Friends  
My friends help me feel good about myself .62 
If I make a mistake, my friends point it out so I will correct it .60 
Most of my friends help me in whatever way I need .59 
My closest relationships usually last for two years or more 
 
.39 
Factor 5:  Community Involvement or Connectedness  
I volunteer my time to organizations when I can .57 
The more I give to the community, the more I want to .56 
I keep myself informed on community issues .64 
I am one of the first to contribute to community projects or concerns .73 
I feel I give back to the community for what I take 
 
.64 
Factor 6:  Trust in Motivation of Others  
There are only a few people I completely trust .47 
People are trustworthy, but society is not .40 
Most people will do the wrong thing if they know they will not be caught .74 
Most of the time people are looking out for themselves, not trying to be helpful to others 
 
.58 
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model.  The government questions were not of sufficient strength in the six-factor model 
to be included.  Further, the wording and content of the questions were repetitive, calling 
into question whether they represented an underlying concept of importance or reflected 
bias in question development. 
 Reliability was assessed using both test-retest correlations with a 6-8 week 
interval between administrations and Cronbach alpha for internal consistency.  The first 
150 participants to complete the test were invited to retest, and 100 participants 
completed the second administration.  The test-retest reliability using the Pearson Product 
Moment coefficient for the total test was 0.72 (p ≤ .01).  Chronbach alpha for the test was 
0.84.  Further, total score on the total score and the sub-scales were compared for age, 
gender, and diagnosis with no difference detected, suggesting that the instrument does not 
favor any specific clinical group that provided data. 
The six scales with their eigenvalues (E), test-retest (T) and Alpha coefficients (α) 
are: 
(1) Support via intimate partner or best friend:  This scale measures support from the 
most intimate non-blood related relationship of the individual and has items that 
address emotional, informational and instrumental support, expectation of support 
and dissupport (Malone, 1988).  Individuals with mental illness are less likely to 
have an intimate partner but often endorse one or more best friends (E = 7.86; T = 
0.60 (p ≤ .01); α = 0.74). 
(2) Support via family:  Like the previous scale, this scale measures emotional, 
instrumental and informational support.  Individuals with mental illness tend 
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toward limited social networks with family members playing a larger role at more 
points in their lives (Walsh, 1994) (E = 3.78; T = 0.80 (p ≤ .01); α = 0.89).   
(3) Support via provider:  This scale investigates the support from the providers that 
the participant has relationships with.  This is unique to this instrument and 
directly measures emotional, informational and dissupport from the provider to 
the consumer.  Provider support is a substitute for lack of support from other 
areas for some individuals with mental illness and has been conspicuously absent 
from the empirical literature but relatively consistent in qualitative and narrative 
research (E = 2.25; T = 0.57; (p ≤ .01); α = 0.72). 
(4) Support via friends:  The final support scale measures support from friends other 
than the best friend/intimate partner.  Emotional and instrumental support is 
represented in specific questions (e.g., money when needed or having someone to 
talk to when needed) and one question that targets longevity of relationships (e.g., 
do most relationships last two or more years).  Many consumers become limited 
in friendships as they are forced to deal with frightening changes, disturbing 
symptoms and stigmatization (Rizzo, 2002). For many of them, their friendships 
are often with other consumers.  However, this remains a consistent area of 
support for mentally ill individuals (E = 1.95; T = 0.58 (p ≤ .01); α = 0.73). 
(5) Community involvement or connectedness:  This scale measures the degree that 
an individual feels they contribute to their community and are informed about 
their community.  Support is given as well as received and this scale is a measure 
of how much the person feels they give back in a more generalized fashion (E = 
2.58; T = 0.41 (p ≤ .05); α ≤ .58).  Test-retest and coefficient alpha may be 
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depressed compared to the support scales because of social desirability 
preferences. 
(6) Trust in motivation of others:  This scale investigates the degree that the 
participant feels others are motivated from altruism versus selfishness.  
Individuals with mental illness often have to hide their illness from others, 
especially others who can levy consequences, e.g. employers.  Secrecy can be 
projected outward as a sense of pervasive distrust (E = 1.57; T = 0.45 (p ≤ .01); α 
≤ .60).  Lack of trust has been identified as a barrier to recovery (Fisher, 2003). 
Empowerment Scale (ES). 
 The ES is a scale designed with the assistance of consumers of mental health 
services to measure the construct of empowerment (Rogers et al., 1997).  The survey 
consists of 28 items that comprise the total empowerment score and five sub-scales.  
Factor loadings and item listing for each sub-scale is provided in Table 8.  A principal 
components analysis and oblique rotation extracted the five factors, accounting for 54% 
of the variance (Rogers, Chamberlain, Ellison, & Crean, 1997).  Internal consistency of 
the empowerment scale was .86.  A replication study using principal components 
analysis, though with an orthogonal (varimax) rotation, confirmed the factor structure 
detected by Rogers, et al (1997) as well as a similar level of internal consistency (α = .85) 
(Wowra & McCarter, 1999).   For each item, a four-point scale (strongly agree, agree, 
disagree, strongly disagree) is used to endorse what the participant feels is the most 
relevant level of response for each item.  The test has a high degree of internal 
consistency (α = 0.86).  Construct validity was established by comparing empowerment 
scores to demographic variables, number of community activities that the participant 
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Table 8 
 
Empowerment Scale Factor Loadings 
 
 Factor 
Loading 
Factor 1:  Self-esteem and Self-Efficacy 
I generally accomplish what I set out to do .79 
I have a positive attitude about myself .74 
When I make plans, I am almost certain to make them work .72 
I am usually confident about the decisions I make .70 
I am often able to overcome barriers .56 
I feel I am a person of worth, at least on an equal basis with others .47 
I see myself as a capable person .46 
I am able to do things as well as most other people .41 
I feel I have a number of good qualities 
 
.41 
Factor 2:  Power-Powerlessness 
I feel powerless most of the time .69 
Making waves never gets you anywhere .66 
You can’t fight city hall .66 
When I am unsure about something, I usually go along with the group .66 
Experts are in the best position to decide what people should do or learn .63 
Most of the misfortunes in my life were due to bad luck .62 
Usually, I feel alone .60 
People have no right to get angry just because they don’t like something 
 
.43 
Factor 3:  Community Activism and Autonomy 
People have a right to make their own decisions, even if the are bad ones .68 
People should try to live their lives the way they want to .64 
People working together can have an effect on the community .62 
People have more power if they join together as a group .53 
Working with others in my community can help to change things for the better .52 
Very often a problem can be solved by taking action 
 
.41 
Factor 4:  Optimism and Control Over the Future 
People are limited only by what they think possible .78 
I can pretty much determine what will happen in my life .62 
I am generally optimistic about the future .58 
Very often a problem can be solved by taking action 
 
.42 
Factor 5:  Righteous Anger 
Getting angry about something is often the first step toward changing it .73 
People have no right to get angry just because they don’t like something .52 
Getting angry about something never helps .48 
Making waves never gets you anywhere 
 
.40 
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engages in, level of involvement with traditional mental health services, level of 
employment (number of hours and pay status), quality of life, social support, and self-
esteem.  Addressing these one at a time, demographic variables were not significantly 
related to empowerment, suggesting that there is no specific gender, race/ethnicity or age 
bias inherent in the instrument.  The number of community activities had a small but 
significant relationship to empowerment.  This was hypothesized a priori to be correlated 
with empowerment and was validated.  An inverse relationship was found between 
traditional psychiatric services and empowerment.  Empowerment was slightly elevated 
for individuals who were employed compared to individuals who were not, but this did 
not reach significance between any employment groups.  Quality of life, social support, 
and self-esteem were all significantly related to empowerment. 
 A separate analysis was completed to see if the ES could be reduced to the two 
factors of self- and community-orientations to empowerment.  The scale did successfully 
yield two consistent factors that could be interpreted as self- and community oriented.  
However, the authors of the study did not provide any indication if all 28 items were 
retained in this analysis or which items fit the categories (Corrigan, Faber, Rashid, & 
Leary, 1999). 
 The sub-scales of the ES and their corresponding Eigenvalue (E) include: 
(1) Self-esteem and self-efficacy:  This scale has items that measure feelings of 
worth, capabilities to accomplish goals, perceived ability to overcome obstacles 
and perseverance (E=6.85). 
(2) Power and powerlessness:  Items assessing locus of control, assertiveness, 
feelings of being controlled or small in comparison to organizations and society, 
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and willingness to voice opinions counter to the group comprise this scale 
(E=3.48). 
(3) Community activism and autonomy:  This scale measures level of belief in group 
activities and compares the ability to effect change in group versus individual 
action.  This scale also measures the degree an individual believes that a person 
should have the right of self-determination regardless of negative consequences 
(E=2.13). 
(4) Optimism and control over the future:  This scales items directly measure the 
degree an individual feels he or she controls his or her own destiny and the 
degree that this destiny is expected to be positive (E=1.50). 
(5) Righteous anger:  Empowering actions are sometimes stimulated by feelings of 
intense and justifiable anger.  This scale measures this aspect of empowerment 
targeting motivational energy (E=1.12). 
Internalized Stigma of Mental Illness Scale (ISMI).   
The ISMI is a recently developed 29-item instrument that assesses psychological 
and subjective affects of stigma (Ritsher, Otlingam, & Grajales, 2003).  Internalized 
stigma is the shame, devaluation, withdrawal and secrecy that result from internalizing 
negative stereotypes (Corrigan, 1998).  This scale was developed and its psychometric 
properties validated on participants similar to the SMI and OP samples proposed in this 
study.  Items were grouped a priori into the five theoretical areas, generating five sub-
scales and forcing a five-factor model.  Fifty-five items were reduced to 29-items through 
factor analysis (Table 9).  Items with low item-total correlations (< 0.40) were dropped 
from consideration.  The authors of the instrument report good reliability and validity  
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Table 9 
 
Internalized Stigma of Mental Illness Factor Loadings 
 
 Factor 
Loading 
Factor 1:  Alienation 
I feel out of place in the world because I have a mental illness .54 
Having a mental illness has spoiled my life .67 
People without mental illness could not possibly understand me .39 
I am embarrassed or ashamed that I have a mental illness .56 
I am disappointed in myself for having a mental illness .85 
I feel inferior to others who don’t have a mental illness 
 
.67 
Factor 2:  Stereotype Endorsement 
Stereotypes about the mentally ill apply to me .36 
People can tell that I have a mental illness by the way I look .36 
Mentally ill people tend to be violent .68 
Because I have a mental illness, I need others to make most decisions for me .55 
People with mental illness cannot live a good, rewarding life .54 
Mentally ill people shouldn’t get married .30 
I can’t contribute anything to society because I have a mental illness 
 
.42 
Factor 3:  Discrimination Experience 
People discriminate against me because I have a mental illness .52 
Others think that I can’t achieve much in life because I have a mental illness .66 
People ignore me or take me less seriously just because I have a mental illness .51 
People often patronize me, or treat me like a child, just because I have a 
mental illness 
.65 
Nobody would be interested in getting close to me because I have a mental 
illness 
 
.41 
Factor 4:  Social Withdrawal 
I don’t talk about myself much because I don’t want to burden others with my 
mental illness 
.37 
I don’t socialize as much as I used to because my mental illness might make 
me look or behave ‘weird’ 
.62 
Negative stereotypes about mental illness keep me isolated from the ‘normal’ 
world 
.39 
I stay away from social situations in order to protect my family or friends 
from embarrassment 
.40 
Being around people who don’t have a mental illness makes me feel out of 
place or inadequate 
.51 
I avoid getting close to people who don’t have a mental illness to avoid 
rejection  
.55 
 143
from their preliminary testing.  Reliability evidence, measured via test-retest and 
Cronbach’s alpha are provided with each sub-scale listed below. 
Construct validity was established by predicting whether items of the ISMI 
would, in general, positively or negatively correlate with items from other instruments 
(convergent and discriminant validity).  Additionally, items from the ISMI were factor 
analyzed with items from each other scale.  If the relationship was expected to be 
positive, then the items from each instrument were expected to load on two separate 
factors but have a positive correlation, indicating the measurement of distinct but related 
concepts.  If the relationship was predicted to be negative, the items from the two surveys 
would be expected to have a clear division and to have a negative correlation.  
Convergent validity was assessed via the Center for Epidemiological Studies-Depression 
scale (CES-D) and the Personal Devaluation and Discrimination Scale (PDDS).  
Discriminant validity was examined using the Rosenberg Self-Esteem Scale (RSES), the 
Empowerment Scale (ES), the Personal Empowerment Scale (PES), and the Recovery 
Expectancy Scale (RAS).   As predicted the ISMI was positively associated with the 
CED-D (r = 0.35, p ≤ 0.01) and the PDDS (r = 0.53, p ≤ .01).  The ISMI was negatively 
associated with the RSES (r = -0.52, p ≤ 0.01), the ES (r = -0.52, p ≤ 0.01), the PES (r = -
0.34, p ≤ 0.01), and the RAS (r = -0.49, p ≤ 0.01).  The scale provides a total 
internalization score as well as scores on the subscales of alienation, stereotype 
endorsement, discrimination experience, social withdrawal and stigma resistance.  
Measure of internal consistency (α) and test-retest reliability (T) is provided for each 
subscale.   
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(1) Alienation:  Measures level of disenfranchisement, i.e. having a ‘spoiled 
identity’ (Goffman, 1963) (α =0.79, T=0.68). 
(2) Stereotype endorsement:  Measures how much the sample agrees with or has 
internalized stereotypes about mentally ill people (α =0.72; T=0.94).   
(3) Discrimination experience: Captures how the participants feel that others 
currently treat them (α =0.75; T=0.89).   
(4) Social withdrawal: This subscale gives an estimate of the degree that 
stigmatization causes a withdrawal from social interaction (α =0.80; T=0.89).   
(5) Stigma resistance: This subscale measures the ability to resist or be unaffected 
by internalized stigma (α =0.58; T=0.80).  These five items are reverse coded 
for sake of data entry and subsequent analysis and thus provide a validity 
check. 
Domain 3:  Service Factors that Influence Recovery 
This domain requires the least involvement from the participant.  The participant 
provided information relevant to this domain via one instrument and additional 
information was gathered in the chart abstraction form introduced in Domain 1 above. 
Service Satisfaction Questionnaire 
 This brief questionnaire was developed for this research effort.  Services that the 
participant could be receiving at the partnering agency are listed.  The participant 
indicated which services they are currently involved in, how many hours of contact per 
month for each service, length of time in each service, satisfaction level, and whether 
they feel that particular service contributes to their recovery.  Together, these variables 
assess the service domain, Domain 3, described in Chapter 2.  These questions are not 
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related to form an underlying construct, thus they were not subjected to factor analysis or 
other psychometric examination.  Service types (e.g., case management or assertive 
community treatment) versus service frequency are considerably more researched for 
their influence on recovery (Cunningham, Wolbert, Graziano, Slocum, 2005; Mueser, 
Torrey, Lynde, Singer, Drake, 2003).  Services in general are not consistent with the 
consumer recovery movement and have, at times, drawn criticism for being 
disempowering or controlling (Spindel & Nugent, 2000).  For these reasons, service 
satisfaction, number of services, and service contact hours were investigated in place of 
service type. 
 The first indicator is the number of services they currently receive (total number 
of services scale). The second indicator totals the number of hours per month of service 
(service contact scale).  The third indicator is level of satisfaction with services, 
calculated by adding the satisfaction scores (satisfaction scale) and dividing by the total 
number of services.  This is a 6-point scale from very satisfied to very dissatisfied.  The 
final indicator is the ‘recovery relevancy score’ that totals the number of services that the 
participant feels is relevant to their recovery.  As this had not been piloted, it was 
impossible to tell whether the total number of services would actually differ from the 
recovery relevant services.  If identical, then the recovery relevancy indicator would be 
discarded.  This, in fact, occurred, with the services satisfaction and recovery relevance 
scales highly correlated (r = .98, p≤ .0001).  Thus, the relevancy score was dropped from 
any further analysis. 
Supported housing offers a special measurement challenge.  Supported housing 
can include assistance via governmentally subsidized housing where the consumer is 
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financially assisted in their independent living.  The partnering agency also has housing 
owned by the agency that consumers are entitled to live in for various lengths of time, 
with varying levels of supervision.  Supported housing was coded as follows:  0=no 
supported housing, 1=government assisted housing but not agency housing, 2=agency 
housing with no to minimal supervision, and 3=agency housing with moderate to 
constant supervision.  This information comprises the ‘housing scale.’  Individuals living 
in high levels of supervision from agency staff could claim 8-24 hours of contact per day 
with staff, artificially inflating the service contact scale.  The housing scale corrects for 
this. Initial analysis of this variable indicates that there is little actual variance.  Nearly 
all individuals in the SMI and all of the individuals in the OP samples are living 
independently.  Due to the lack of variance, this variable was also dropped from further 
analysis. 
Moderating and Mediating Variables. 
 First introduced in Chapter 2, Figure 1 (page 8) describes the model used in this 
research effort.  The model demonstrates that recovery expectancy acts as a dependent 
measure when considering the affects of the individual, social and service domains (see 
recovery section above, specifically the Recovery Expectancy Checklist (REC)).  
However, recovery expectancy was also investigated as a mediating factor between the 
individual, social and services domains and recovery strategies.  Finally, the moderating 
effect of recovery expectancy on the relationship between the three domains and recovery 
strategies was investigated.  Data from the REC was used to investigate mediating and 
moderating affects.  Question 1 from the REC (reproduced below) was used as a 
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mediating and moderating variable for evaluating research questions 4a and 4b (see 
analysis procedures below for details): 
(1) Do you think that recovery from mental illness will ever be possible for you? 
 Figure 1 also presents severity of mental illness as a potential moderating factor.  
Severity was measured as a dichotomous variable with (1) representing the SMI sample 
and (2) representing the OP sample.  Membership in either group indicates some level of 
clinical symptoms and potential deficits in functioning.  For many of the individuals, 
especially in the SMI sample, this label may mean a long-term struggle with mental 
illness.  This struggle is accompanied by numerous experiences that remind the 
individual that they are mentally ill.  These experiences could accrue over time and affect 
the relationship between individual, social and service factors and recovery strategy. 
Data Analysis Procedures 
Table 10 lists each variable by name, whether dependent, independent or control, 
instrument from which the variable is derived, and level of measurement (e.g., nominal, 
continuous).   
Data Entry, Cleaning and Verification.  A database was constructed with 
appropriate delimiters to help avoid out of range data entry errors.  Each form entered 
was followed by a quick visual check to assure that the numbers are entered correctly.  In 
addition, a randomly selected group of participants (10%) were re-entered to check for 
discrepancies and to estimate total data entry error.  Thus, 35 records were reentered into 
a separate database.  Each record was then compared to the original record via SAS.  
Data entry mistakes were found in two records, each on one question.  Thus, 
approximately 0.24% of data was wrongfully entered for 10% of randomly selected 
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Table 10 
 
Variable Descriptions 
 
 
Variable Name 
 
Instrument 
 
Measurement Level 
 
Control Variables 
 
  
Age Background and History/Chart Abstraction Continuous 
Gender Background and History/Chart Abstraction Dichotomous 
Income Background and History/Chart Abstraction Categorical 
Education 
 
Background and History/Chart Abstraction Categorical 
Dependent Variables 
 
Recovery Expectation 
 
  
Will you recover? Recovery Expectancy Checklist Dichotomous 
To what degree will you recover? Recovery Expectancy Checklist Continuous 
Will you completely recovery? Recovery Expectancy Checklist Dichotomous 
Will you never recover? Recovery Expectancy Checklist Dichotomous 
 
Recovery Strategy 
 
  
Effective illness management RAS and PVRQ* Continuous 
Positive Future Orientation RAS and PVRQ* Continuous 
Meaningfulness, Personal Control and Hope RAS and PVRQ* Continuous 
Recognizing Support RAS and PVRQ* Continuous 
Help Seeking RAS and PVRQ* Continuous 
Symptom Eradication RAS and PVRQ* Continuous 
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Table10 (cont.) 
 
 
Independent Variables 
 
  
Domain 1:  Personal, Historical, Clinical Factors 
 
  
Clinical   
 
Somatization symptoms 
 
Symptom Checklist 90-Revised 
 
Continuous 
Obsessive-compulsive symptoms Symptom Checklist 90-Revised Continuous 
Interpersonal sensitivity symptoms Symptom Checklist 90-Revised Continuous 
Depression symptoms Symptom Checklist 90-Revised Continuous 
Anxiety symptoms Symptom Checklist 90-Revised Continuous 
Hostility symptoms Symptom Checklist 90-Revised Continuous 
Phobic anxiety symptoms Symptom Checklist 90-Revised Continuous 
Paranoid ideation symptoms Symptom Checklist 90-Revised Continuous 
Psychoticism symptoms Symptom Checklist 90-Revised Continuous 
Severity of mental illness (SMI or OP sample) Background and History/Chart Abstraction Dichotomous 
Diagnosis Background and History/Chart Abstraction Categorical 
Substance Diagnosis Background and History/Chart Abstraction Dichotomous 
Hospitalized in the last 12-months Background and History/Chart Abstraction Dichotomous 
Hospitalizations in  lifetime Background and History/Chart Abstraction Continuous 
Age of onset Background and History/Chart Abstraction Continuous 
Medication:  Anti-psychotic Background and History/Chart Abstraction Dichotomous 
Medication:  Anti-depressant Background and History/Chart Abstraction Dichotomous 
Medication:  Anti-manic Background and History/Chart Abstraction Dichotomous 
Medication:  Anti-anxiety Background and History/Chart Abstraction Dichotomous 
Medication:  Other psychotropic Background and History/Chart Abstraction Dichotomous 
   
Employment    
   
Currently employed Background and History/Chart Abstraction Dichotomous 
Total years employed 
 
Background and History/Chart Abstraction Continuous 
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Table 10 (cont.) 
 
   
Trauma/Abuse   
   
Child sexual abuse Background and History/Chart Abstraction Dichotomous 
Child physical abuse Background and History/Chart Abstraction Dichotomous 
Adult sexual assault Background and History/Chart Abstraction Dichotomous 
Adult physical assault Background and History/Chart Abstraction Dichotomous 
   
Familial 
 
  
Familial mental illness: Nuclear Background and History/Chart Abstraction Continuous 
Familial mental illness:  Extended Background and History/Chart Abstraction Continuous 
   
Domain 2:  Social Factors that Influence Recovery 
 
Stigma 
 
  
Alienation Internalized Stigma of Mental Illness Continuous 
Stereotype endorsement Internalized Stigma of Mental Illness Continuous 
Discrimination occurrence Internalized Stigma of Mental Illness Continuous 
Social withdrawal Internalized Stigma of Mental Illness Continuous 
Stigma resistance Internalized Stigma of Mental Illness Continuous 
 
Social Support/Community Connectedness/Trust 
 
 
Support via intimate partner or best friend Support and Community Connectedness Survey Continuous 
Support via family Support and Community Connectedness Survey Continuous 
Support via provider Support and Community Connectedness Survey Continuous 
Support via friends Support and Community Connectedness Survey Continuous 
Trust in motivation of others Support and Community Connectedness Survey Continuous 
Community involvement or connectedness 
 
 
Support and Community Connectedness Survey Continuous 
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Table 10 (cont.) 
 
 
Empowerment 
 
Self-esteem and self-efficacy 
 
 
 
Empowerment Scale 
 
 
 
Continuous 
Power and powerlessness Empowerment Scale Continuous 
Community activism and autonomy Empowerment Scale Continuous 
Optimism and control over the future Empowerment Scale Continuous 
Righteous anger 
 
Empowerment Scale Continuous 
Domain 3:  Service Factors that Influence Recovery 
 
  
Total number of services Service Satisfaction Questionnaire Continuous 
Service contact scale Service Satisfaction Questionnaire Continuous 
Satisfaction scale 
 
Service Satisfaction Questionnaire Continuous 
 
Note:  * RAS = Recovery Assessment Scale; PVRQ = Personal Vision of Recovery Questionnaire 
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records.  These errors were corrected.  Concern that data entry error may affect results 
prompted the research to select another 35 records (not duplicating from the first random 
selection) and the same process was completed.  Again, two records with one error each 
was located and corrected.  Estimated data entry error is less than one-quarter of one-
percent and should not have a heavy distortion affect on results.  Also, the delimiters built 
into the database did not allow for accidental entry of an overly large or small data point. 
 Data cleaning is a two-step process of detection and correction.  Several 
procedures were used to detect errors in the data:  frequencies, descriptive statistics, 
scatterplots and histograms.  Frequencies help to locate the inaccurate data among the 
entered variables.  This was a quality check to make sure that the database delimiters 
were working accordingly.  Frequency investigation of all questions and variables 
indicated no out of range variables on any variable.  Crosstabulations (frequencies of the 
variable x variable type) help to learn the data and prepare for future analyses.  
Histograms and scatterplots are the easiest ways to detect outliers and errors in 
distribution.  Descriptive statistics via Univariate procedures in SAS provide means, 
medians, range and standard deviations.  This information is useful if, for instance, the 
standard deviation is found to be higher than the mean this indicates some extreme values 
have somehow been entered that may or may not be appropriate.  For certain variables 
(e.g., total number of hospitalizations), this proved to be true.  However, chart 
abstractions verified that these large data points were, in fact, accurate.  One or two 
individuals with many hospitalizations increased the mean and standard deviation.  
Similar to frequencies, Univariate procedure were run on each variable as well to 
continue assessing and learning the data.  Finally, depending on the distribution of a 
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particular variable, one or even many variables may be standardized if it appears that the 
distribution is having an inflated affect on an analysis (e.g., conversion to standardized t-
scores, z-scores or LOG scores).  This was assessed via skewness and kurtosis (provided 
in the Univariate procedure) for each variable.   
 A risk for any analysis is too much missing data.  Before data collection, 
treatment of missing values was stated to depend on the importance of the variable and 
the amount missing.  Large amounts of missing data may have forced the removal of that 
variable from analysis.  Small levels of missing data would likely be corrected via 
imputation of means or other appropriate values.  However, a strength of this study is that 
there is virtually no missing data negating need for further consideration. 
Factor Analysis:  In the discussion on dependent variable measures and recovery, 
the reader will recall that two separate surveys provide responses for possible recovery 
strategies, the Personal Vision of Recovery Questionnaire (PVRQ) and the Recovery 
Assessment Scale (RAS).  Both of these surveys were developed to capture the construct 
of recovery and were developed in similar ways.  Each survey was developed in 
cooperation with individuals afflicted with mental illness, each are on a five-point 
identical scale, they had similar test-retest time intervals and used similar methods for 
validation.  However, because the recovery construct is still only beginning to be 
investigated, the questions developed and the scales derived from various factor analytic 
procedures share some similarities but are still markedly different.  Further, as noted 
before, the process of following principal components analysis with confirmatory factor 
analysis was questionable when developing the RAS, necessitating the use of the 41-item 
versus 24-item survey.  Finally, how the recovery construct is operationalized is different 
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between the two surveys.  The RAS appears to examine more internal processes and does 
not reference recovery in the questions.  The PVRQ, in contrast, references recovery in 
each question and appears to address more interpersonal processes.   
Potential recovery strategies are investigated by combining the items from the 
RAS and PVRQ for factor analysis.  A factor analysis requires a minimum sample of 100 
participants or, better, five times the number of participants per question (Hatcher, 1994).  
There are a total of 65 questions between the two surveys with an ideal number of 
participants at 325.  Noted earlier, this study requires a minimum of 350 participants to 
power the linear and logistic regression components, providing sufficient numbers for the 
factor analysis.   
The a priori assumption of factor analysis is that any question may be associated 
with any factor.  However, the number of factors predicted was informed by theory and 
the factor structures presented in the development of the PVRQ and RAS.  Thus, a five-
factor or six-factor model was predicted to provide the most comprehensive explanation 
of the recovery construct.    A promax rotation was chosen to capture shared and unique 
variance.  Eigenvalues above 1.00 and scree plots were used to evaluate the findings each 
time through the procedure.  When forced into a five-factor model the fifth factor was 
difficult to interpret with some factors positive and some negative.  A six-factor model 
better fit the theory and also removed interpretive obstacles.  A brief discussion of each 
factor (dependent variable) is offered below and the factor loadings and items for each 
variable are summarized in Table 11. Variables were eliminated if they did not load on a 
factor at an initial stringent .40 level.  Additionally, any variable that loaded on more than 
one factor at the.40 level or above would be scrutinized.  However, no item met the 
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Table 11 
 
Factor Loadings and Items for Dependent Variables 
 
  Factor Numbers and Loadings 
Item # Item Description 1 2 3 4 5 6 
   
Factor 1:  Effective Illness Management 
7 I understand how to control the symptoms of my mental illness 0.71 ns ns ns ns ns 
8 I can handle it if I get sick again 0.75 ns ns ns ns ns 
9 I can identify what triggers the symptoms of my mental illness 0.66 ns ns ns ns ns 
10 I can help myself become better 0.40 ns ns ns ns ns 
11 Fear doesn’t stop me from living the way I want to 0.58 ns ns ns ns ns 
13 There are things that I can do that help me deal with unwanted symptoms 0.49 ns ns ns ns ns 
14 I can handle what happens in my life 0.62 ns ns ns ns ns 
18 Although my symptoms may get worse, I know I can handle it 0.85 ns ns ns ns ns 
27 Coping with my mental illness is no longer the main focus of my life 0.48 ns ns ns ns ns 
28 My symptoms interfere less and less with my life  0.65 ns ns ns ns ns 
29 My symptoms seem to be a problem for shorter periods of time each time 
they occur 
0.45 ns ns ns ns ns 
34 I know what helps me get better 0.39 ns ns ns ns ns 
36 
 
I can handle stress 0.50 ns ns ns ns ns 
  Factor 2:  Positive Future Orientation 
1 I have a desire to succeed ns 0.67 ns ns ns ns 
3 I have goals in life that I want to reach ns 0.82 ns ns ns ns 
4 I believe I can meet my current personal goals ns 0.48 ns ns ns ns 
5 I have a purpose in life ns 0.66 ns ns ns ns 
12 I know that there are mental health services that do help me ns 0.40 ns ns ns ns 
15 I like myself ns 0.47 ns ns ns ns 
16 If people really knew me, they would like me ns 0.46 ns ns ns ns 
20 I have an idea of who I want to become ns 0.69 ns ns ns ns 
22 Something good will eventually happen ns 0.49 ns ns ns ns 
24 I’m hopeful about my future ns 0.65 ns ns ns ns 
25 I continue to have new interests  ns 0.50 ns ns ns ns 
26 It is important to have fun ns 0.46 ns ns ns ns 
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Table 11(cont.) 
 
   
Factor 3:  Meaningfulness, Personal Control and Hope 
40 It is important to have a variety of friends ns ns 0.38 ns ns ns 
41 It is important to have healthy habits ns ns 0.35 ns ns ns 
45 Recovery means becoming satisfied with my life ns ns 0.53 ns ns ns 
46 Hope is important for my recovery ns ns 0.54 ns ns ns 
47 Being diagnosed correctly is necessary for my recovery ns ns 0.66 ns ns ns 
49 Sticking up for clients’ rights is a part of my recovery ns ns 0.52 ns ns ns 
50 Having something meaningful to do is important for my recovery ns ns 0.74 ns ns ns 
51 Helping others is part of my recovery ns ns 0.53 ns ns ns 
52 Asking for help is a part of my recovery ns ns 0.41 ns ns ns 
54 Recovery means my symptoms will be easier to control ns ns 0.53 ns ns ns 
57 Recovery means getting more control of my life ns ns 0.57 ns ns ns 
64 Recovery involves finding new meaning in my life ns ns 0.41 ns ns ns 
65 Support from mental health professionals is important for my recovery ns ns 0.45 ns ns ns 
  Factor 4:  Recognition of Support 
6 Even when I don’t care about myself, other people do  ns ns ns 0.65 ns ns 
37 I have people I can count on ns ns ns 0.72 ns ns 
39 Even when I don’t believe in myself, other people do ns ns ns 0.80 ns ns 
7 Family support is important for my recovery ns ns ns 0.46a ns ns 
  Factor 5:  Help Seeking 
30 I know when to ask for help ns ns ns ns 0.64 ns 
31 I am willing to ask for help ns ns ns ns 0.84 ns 
32 I ask for help when I need it ns ns ns ns 0.83 ns 
  Factor 6:  Symptom Eradication b
14 Recovery means I will be free of symptoms ns ns ns ns ns 0.58 
20 Recovery means I will not be mentally ill anymore 
 
ns ns ns ns ns 0.65 
 
Note:  ns = not significant; a = though significant, this item was dropped due to a substantial decrease in Alpha; b = only two items loaded on this factor and 
will not be treated as a composite variable.  Item number 14 is particularly relevant in the recovery and was treated as a single item dependent variable 
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multi-factor loading criteria.  Lastly, a factor would be retained if it had a minimum of 
three or more items.   
 It must be noted that the factors split almost perfectly across surveys, meaning 
items from the PVRQ and RAS were not combined within factors, raising concern that a 
method effect versus substantive variance was being detected.  There is further concern 
that the lack of common variance (~42.0% of cumulative variance explained across the 
six factors) calls into question whether a single construct is present.  Additional factor 
analysis was completed stratifying by instrument and sample to confirm the six-factor 
model.  There was no substantial difference in the amount of variance explained or items 
loading on the same or different factors.  Further, because subset factor analysis violated 
the necessary ‘n’ for the procedure, Bartlett’s test of sphericity was used to verify 
stability of the procedure.  Finally, items with a loading of 0.35 or higher were included 
in additional factor analyses and assessed whether they affected internal consistency and 
were theoretically consistent.  If they contributed to internal consistency and were 
theoretically constant they were retained in the factor.   
 The five strategies consisting of multiple items were calculated by adding the 
number from each item and dividing by the total number of items in that construct.  The 
six factors are 
1.  Effective illness management:  Thirteen questions with a factor loading range 
of 0.39 to 0.85 encompass this strategy.  This factor captures the most variance (22.26%) 
of the recovery construct and has an eigenvalue of 14.47.  Cronbach’s Alpha is 0.88.  
Handling stress, predicting symptom onset, controlling symptoms, and the perception of 
impairment are included in this strategy. 
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 2.  Positive future orientation:  This strategy consists of 12 questions with a factor 
loading range of 0.40 to 0.82 and a Cronbach’s Alpha of 0.88.  The eigenvalue is 4.01 
and the percent of variance explained is 6.17.  This strategy comprises looking forward, a 
positive future outlook, forming goals, and having meaning in life. 
3.  Meaningfulness, personal control, and hope:  This strategy is harder to define 
due to a wider range of concepts contained within the questions.  Hope, a key concept of 
recovery, satisfaction in life, and being diagnosed accurately comprise this factor.  An 
accurate diagnosis leads to better treatment and greater symptom relief which, in turn, 
may increase hope and lead to general life satisfaction.  Key aspects of clinical 
intervention are present in this factor as well, including accurate diagnosis and support 
from professional providers.  The factor loading for this strategy has a range of 0.35 to 
0.74.  The eigenvalue is 2.47 and the variance explained is 3.81%.   Cronbach’s Alpha is 
0.83. 
 4.  Recognizing support:  Four questions grouped together to delineate this aspect 
of recovery.  Factor loadings ranged from .46 to .80 and the Cronbach’s Alpha is 0.76.  
However, when observing the item individual contribution to internal consistency, one 
question ( PVRQ question 7, ‘Family support is important for my recovery’) reduced 
Cronbach’s Alpha by approximately 0.06 and was only tangentially theoretically 
connected.  The decision was made to reduce this factor from four to three items raising 
Cronbach’s Alpha to 0.82.  The eigenvalue is 2.33 and this factor explains 3.58% of the 
variance.  This strategy describes the ability to recognize that support is available and that 
others hold a positive opinion of the participant. 
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 5.  Help seeking:  The three questions in this strategy have an eigenvalue of 2.07 
and explains 3.12% of the variance.  The factor loadings range from 0.64 to 0.84 with a 
Cronbach’s of .85.  The strategy targets seeking help and the willingness to ask for help. 
 6.  Symptom Eradication:  The final factor violated the criteria of a minimum of 
three items per factor and was initially considered for elimination.  One of the two 
questions (PVRQ question 20, ‘Recovery means I will not be mentally ill anymore’) was 
similar to the Recovery Expectancy Checklist question 1 (‘Do you think that recovery 
from mental illness will ever be possible for you?’), reinforcing the decision to eliminate 
the factor.  However, the second question (PVRQ question 14, ‘Recovery means I will be 
free of symptoms’) addresses a controversial aspect of the recovery literature, specifically 
the degree that a clinical focus should be maintained when targeting recovery.  The 
decision was made to keep this question as the sixth strategy though it encompasses only 
one item. 
Univariate Analyses.  Univariate analyses were used to explore the data, check for 
inconsistencies, look at distributions, and make decisions.  Each question for each survey 
was reviewed.  All variables were checked for violations of distribution and for outliers.   
 Bivariate Analyses.  A priori analyses were completed at the .05 level and family-
wise error rate were not adjusted for in a priori analyses, though a Bonferonni correction 
is used for post hoc analyses, including moderating model evaluation (research questions 
4b, and 5.  This rule applies to all bivariate and multivariate analyses. 
 Bivariate analyses were used to explore the data and to understand the 
relationships between dependent-dependent, dependent-independent, and independent-
independent variables.  Both univariate and bivariate analyses helped to better understand 
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the data and to draw an initial ‘portrait’ of an individual engaged in recovery and one 
who is not. 
The choice of bivariate statistic depended on the measurement level of the 
variable.  Chi-square assessed the relationship between two nominal (categorical) level 
variables.  The independent sample t-test was used for a two-level categorical 
independent variable and a continuous dependent variable.  The one-way ANOVA was 
used for three or more level categorical independent variables and a continuous 
dependent variable.  Finally, many bivariate analyses were completed with the Pearson 
Product Moment Correlation.  Correlation analysis is also helpful in the first steps of 
identifying multicollinearity.  Thus, appropriate analyses (chi-square, ANOVA, 
independent sample t-tests) were conducted on all dependent and independent variables 
to assure that there is sufficient autonomy within the dependent set and the correlate set 
of variables, each according to its measurement attributes.   
I turn next to research question 1 (RQ1) as all of the hypotheses in RQ1 can be 
answered via bivariate analysis.   
Research Question 1:  To what degree does illness severity influence beliefs in recovery 
for the individual? 
The next step of the analysis addresses research question (RQ1) one and related 
hypotheses.  Each hypothesis is reproduced followed by where the data is obtained and 
the type of analysis used.  
 Hyp1.1:  The OP sample will endorse that they will recover from mental illness 
to a greater extent than the SMI sample.  The data for this question are taken from 
question one of the Recovery Efficacy Checklist (REC), ‘Do you think that recovery 
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from mental illness will ever be possible for you?’  The question is dichotomous (yes/no), 
requiring a chi-square analysis. 
Hyp1.2:  The OP sample will endorse complete recovery as possible more than 
the SMI sample.  Question #2 from the REC provides the data (‘To what degree do you 
think you will eventually recover?’) and a chi-square analysis was used to check for 
hypothesized associations.  
Hyp1.3:  There will be no significant difference between samples in whether they 
endorse that there is no degree of recovery expected.  The data for this question is also 
taken from question two of the REC.  The question is dichotomous (yes/no), requiring a 
chi-square analysis. 
Multivariate Analyses.  Multivariate analysis included logistic regression, 
ordinary least squares (OLS) regression, and probit analysis.  These are discussed in the 
order presented to outline the multivariate analysis plan and each step of the analysis is 
linked directly to the relevant research questions and hypotheses.  The goal of an analysis 
is to find the most parsimonious model where the greatest level of variance is explained 
with the least amount of variables.  Before outlining the analysis plan, however, a brief 
discussion of influential data points is required.   
Influential data points are outliers with high leverage that influence regression 
coefficients through changing the slope or intercept of the regression line.  Diagnostic 
statistics are used to ascertain the extent the predicted values of the dependent variable or 
the parameter estimates change when an observation is eliminated from the analysis.  
Three diagnostic statistics were used to detect influential observations.  Hat values 
measure leverage in regression models by summarizing how far the independent 
 162
variables fall from their mean (Agresti and Finlay, 1997).  Since the sample is greater 
than 200 (n > 200), Hat values greater than two times the mean were evaluated as 
possibly too influential.  Cook’s D, a summary index of an individual observations 
influence on regression coefficients, is the second diagnostic statistic.  Cook’s D values 
above 2.0 were flagged for review of influence on the model.  Finally, Studentized 
Residuals, an index for detecting outliers, were also evaluated, utilizing the same cutpoint 
of above 2.0 as Cooks’ D.  If any observation violated criteria for influence on two of 
three of the diagnostic tests they were eliminated before evaluating main effect model 
results (Agresti and Finlay, 1997). 
In addition to the diagnostics just discussed, multicollinearity was assessed.  
Multicollinearity is an unacceptably large degree of correlation among independent 
variables.  Substantial multicollinearity makes conclusions regarding the degree of 
association between the correlated independent variables and the dependent variable 
potentially incorrect.  Muliticollinearity may result in unstable regression coefficients and 
standard errors that make it difficult to detect the degree of association between each 
independent and dependent variable (Zar, 1999).  Indicators of multicollinearity include 
regression coefficients that do not appear to be sensible or have the wrong sign.  Thus, 
using SAS, tolerance was assessed for the predictor variables when examining for 
multicollinearity.  Tolerance is an estimate of the proportion of variance of predictor 
variables not overlapping with other individual variables.  Following statistical 
convention, the tolerance absolute minimum is 0.2, meaning that a minimum level of 
independence required is 20%, or in other words, that 20% of the variable does not 
overlap.   
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Research Question 2:  Are individual, social, or service factors associated with recovery 
expectancy? 
Logistic regression was used when the criterion variable is dichotomous, in this 
case with the Recovery Expectancy Checklist (REC) providing the data for comparison 
of the two samples.  Models were fit with the dependent variable being question one from 
the REC that address if recovery is expected for each participant. 
For research question 2.1, whether individual factors are associated with recovery 
expectancy, the following progression was used to enter variables into logistic regression 
models.  First, control variables (gender, age, income, education) were entered.  Control 
variables remained the same for all multivariate models in this analysis.  After the control 
variables, the independent variables were entered in the following order: Subscales from 
the SCL-90-R, other clinical variables in a block (substance diagnosis, hospitalization 
variables, age of onset, medication variables); employment variables; family history 
variables; and finally abuse/assault variables.  Finally, diagnoses were added one 
diagnosis at a time (and then removed) to check the individual contribution of each 
diagnosis and to see if any diagnosis was significant.  For each analysis that involved 
diagnosis, the following order was entered:  schizophrenia, bipolar disorder, 
schizoaffective disorder, major depression, anxiety disorder, mild/moderate depression, 
adjustment disorder, and other.   
Research question 2.2 (hypotheses 2.2a-2.2q) addresses the question of whether 
social factors are associated with the recovery process.  Again, logistic regression was 
used with question #1 of the REC providing the dichotomous dependent variable.  
Following entry of the control variables, subscales from the ISMI (Internalized Stigma of 
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Mental Illness) were entered in a block (alienation, stereotypes, discrimination 
experiences, social withdrawal, and stigma resistance).  This was followed by the 
subscales from the SCCS (Support and Community Connectedness Survey) (support via 
intimate partner or best friend, support via family members, support via mental health 
providers, support through friendship, community connectedness, and trust in others), 
also in a block.  Finally, the block of empowerment survey (ES) variables (self-esteem 
and self-efficacy ratings, power-powerlessness, community activism and autonomy, 
optimism and control over the future, and righteous anger) were entered.  Again, entry of 
variables in this order directly parallels the corresponding hypotheses. 
Research question 2.3 (hypotheses 2.3a-2.3e) addresses the question of whether 
service factors are associated with the recovery process.  Following entry of the control 
variables, the first independent variable to be entered was total number of services.  This 
was followed, in order, by average number of contact hours per month with a provider, 
and, finally, satisfaction with services. 
Once data analysis for the three sub-research questions (2.1-2.3) was completed, a 
main effects model was generated.  First, the final model from RQ2.1 began the process 
of building the main effects model.  Variables from RQ2.2 and then RQ2.3 were then 
added until all variables had been entered.  Finally, each diagnosis variable was again 
entered one at a time.  This satisfied research question 2 and allowed what may be the 
first look at what happens when variables from all three domains are directed at the 
question of whether or not recovery is expected by individuals with mental illness.   
Once this analysis was completed, the next step required OLS (ordinary least 
squares) regression and targets Research Question #3. 
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Research Question 3:  Are individual, social or service factors associated with recovery 
strategies? 
Noted previously, the dependent variables for research question 3 are the six 
recovery strategy subscales generated via factor analysis.  It is naïve to assume that the 
complexity of each participants life relegates the use of only one strategy.  Indeed, a 
single participant may endorse none, some or all of the strategies as relevant to their 
recovery.  To discover potentially relevant information more in keeping with the lived 
reality of the mentally ill population, it is important to consider how highly endorsed 
combinations of strategies can be detected and then analyzed for associations with 
individual, social, and service factors.  Probit analysis is a technique that allows 
combinations of dependent variables to be investigated as a single multi-level dependent 
variable.  Prior to the analysis it was hoped that recovery strategies would cluster to a 
degree that would make probit analysis useful.  Thus, for research question 3, the 
dependent variables were to be of two sets:  (1) the individual strategies generated via 
factor analysis; and (2) the highly endorsed combination strategies.   
The following approach was used to determine strategy endorsement for each 
participant. A cutpoint of above the median was used to state that an individual endorses 
a particular pathway.  The median was arbitrarily chosen after consultation with 
individuals who serve the mentally ill since a review of the literature yielded no guidance 
(Ellis-Lang, 2005).  Each participant was coded with a one (1) for each pathway they 
endorse and zero (0) if they do not.  Statistical software (SAS, v.9.1) identified 
combinations of pathways endorsed by the participants.  Out of 66 potential combinations 
(which includes endorsing zero strategies above the median point), 63 of the 
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combinations were endorsed.  Some strategy combinations had only one individual 
meeting that combinations criterion.  Twenty-eight (28) individuals sanctioned all six 
strategies above the median and 68 did not endorse any strategy above the median.  
Again after consultation, the cutpoint was raised to 80% endorsement and this reduced 
the number of clusters of research strategies to 36.  This indicates a wide variation of 
strategy use and also is overly cumbersome for including all combinations in a probit 
analysis.  Thus, though theoretically of interest, pragmatically the analysis could not be 
completed.  Probit analysis was discontinued for the rest of the analytic process. 
 Analysis of research question 3.1, whether individual factors are associated with 
recovery strategies, (hypotheses 3.1a-3.1af) utilized the following progression to enter 
variables into OLS regression models.  First, control variables (gender, age, income, 
education) were entered.  After the control variables, the independent variables were 
entered in the following order with careful tracking of changes in betas (OLS) and 
significance for each addition.  Subscales from the SCL-90-R was added as the first 
independent variable.  After symptoms, the variables were entered in the following order:  
substance diagnosis, hospitalization variables, age of onset, familial mental illness 
variables, employment variables, medication variables, and finally abuse/assault 
variables.  As before, diagnoses were added last, one at a time. 
Research question 3.2 (hypotheses 3.2a-3.2q) addresses the question of whether 
social factors are associated with the recovery process.  Following entry of the control 
variables, subscales from the ISMI (Internalized Stigma of Mental Illness) were be 
entered (alienation, stereotypes, discrimination experiences, social withdrawal, and 
stigma resistance).  This was followed by the subscales from the SCCS (Support and 
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Community Connectedness Survey) (support via intimate partner or best friend, support 
via family members, support via mental health providers, support through friendship, 
community connectedness, and trust in others).  Finally, the ES subscales (Empowerment 
Survey) (self-esteem and self-efficacy ratings, power-powerlessness, community activism 
and autonomy, optimism and control over the future, and righteous anger) were entered.   
Research question 3.3 (hypotheses 3.3a-3.3e) addresses the question of whether 
service factors are associated with the recovery process.  Following entry of the control 
variables, the first independent variable to be entered was total number of services.  This 
was followed, in order, by average number of contact hours per month with a provider, 
and satisfaction with services. 
Once data analysis for the three sub-research questions (3.1-3.3) was completed, a 
main effects model was generated.  First, the final model from RQ3.1 was employed to 
begin the process of building the main effects model.  Variables were added to this model 
by following the progression from RQ3.2 and then RQ3.3 until all variables were entered.  
This satisfies research question 3 and displays what happens when variables from all 
three domains are directed at each research strategy individually and what factors are 
associated with these choices.  Following this analysis, the next step required OLS 
regression once again to help detect whether recovery expectances mediate or moderate 
the effects of correlates for each strategy, also targeting research question 3. 
Research Question 4a:  Does the expectation of recovery mediate the relationship 
between individual, social and service factors and recovery strategies? 
 A mediator is a variable that explains the relation between an independent and 
dependent variable (Baron & Kenny, 1986; Hombeck, 1997).  Thus, the mediator is the 
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mechanism through which the independent variable influences the dependent variable by 
reducing the variance explained by an original (already present) variable in magnitude 
and/or significance (Baron & Kenny, 1986).  However, in a cross-sectional study, the 
best that can be said is that the independent variable influences the mediator, which, in 
turn, influences the dependent variable, or outcome (Holmbeck, 1997).  Furthermore, the 
effect of the mediating variable may wholly, or in part, influence the relationship between 
the independent and dependent variable.  If the addition of a new variable reduces the 
magnitude of the parameter estimate for the original variable and changes the 
significance level to non-significant, than the new variable fully mediates the effect of the 
original variable.  If the magnitude of the original variable is reduced but the original 
variable remains significant, then the new variable is said to partially mediate the original 
variable.  
A potentially important mediator operating between individual, social, and service 
factors and recovery is recovery expectancy.  The reader will recall that analysis of data 
to answer research question two utilized recovery expectancy as the dependent variable.  
Here, recovery expectancy is placed on the path between the three domains (individual, 
social, and service) and the individual and combined recovery strategies.  The first 
questions from the Recovery Expectancy Checklist (REC) was used in this capacity and 
is reproduced below. 
1.  Do you think that recovery from mental illness will ever be possible for you? 
Mediating relationships for each question were assessed separately using the following 
procedure.  First, changes in associations were assessed for individual/clinical factors and 
recovery strategies by adding the results from REC question 1, assessing whether or not 
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recovery is possible, to the individual models developed to answer RQ3.1 (Are individual 
factors associated with recovery strategies?).  Variables that were significant in those 
models were monitored for changes in magnitude and significance to assess the degree of 
influence of recovery expectancy (satisfying hypothesis 4a.1).   
 The same procedure was used to assess the association of recovery expectancy on 
the relationship between social factors and recovery strategies (RQ3.2).  By assessing 
whether recovery is expected on the relationship between social factors and recovery 
strategies, information to evaluate hypothesis 4a.2 was generated.  Similarly, the 
relationship between service factors and recovery strategies (individual and combined) 
can be mediated by whether recovery is expected (RQ3.3).  Thus, utilizing the same 
procedure a third time provides the information to assess hypotheses 4a.3.  Finally, to 
directly address RQ4a, assessing the mediating influence of REC question 1 on the 
relationship between individual, social, and service factors and recovery strategies, the 
same process was used to assess the full model developed to satisfy RQ3.   
Research Question 4b:  Does the expectation of recovery moderate the relationship 
between individual, social and service factors and recovery strategies? 
To this point, multivariate analyses were completed to detect relevant associations 
between the independent variables and recovery strategies (main effects), and to 
investigate the mediating effect of recovery expectancy.  The current research question 
and the next explore the moderating influence of recovery expectancy and the label of 
illness severity.  A moderating variable effects the direction or strength of a relationship 
between independent and dependent variables.  The nature of the impact on the 
dependent variable by the independent variable varies by the value of the moderating 
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variable (Baron & Kenny, 1986).  Where as a mediator is additive in its effect, 
moderators are multiplicative or synergistic.  Moderating effects were assessed for 
Question 1 from the REC (whether recovery is expected) for individual, social, and 
service affects (hypotheses 4b.1-4b.3) and then for the full model (RQ4b).     
The choice of which variables to assess in a moderating relationship with 
recovery expectancy was made after the results of the main effect model were assessed.   
The independent variables significantly associated with the six recovery strategies are not 
uniform.  The specifics of these relationships are fully detailed in chapter four.  Though 
there was no independent variable significantly associated with all the recovery 
strategies, there were several that were significantly associated with three or four 
strategies.  These important variables were selected to assess for moderating effects with 
recovery expectancy.   
Research Question 5:  Does severity of mental illness moderate the relationship between 
individual, social and service factors and recovery strategies? 
 Analysis was targeted to examine the moderating effect of inclusion in the SMI or 
OP samples and specific independent variables on recovery strategies.  The label of SMI 
is a proxy for a disease pattern that is expected to profoundly affect the functioning level 
and psychiatric status of an individual compared to those without the label.  This study 
was designed to capture the severity continuum by surveying those with the SMI label 
(SMI sample) and those without (OP sample), with the understanding that the variation in 
symptoms and functional capacity is expected to be great within each sample and even 
greater between them.  This was operationalized by creation of the variable severity of 
mental illness) through assigning a ‘1’ to all individuals in the SMI sample and a ‘2’ to 
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all individuals in the OP sample.  Combined interaction variables were created with 
specific independent variables using the same procedure briefly outlined in the discussion 
of research question 4b above and more fully described in chapter 4.   
 In the psychiatric literature a label of SMI (severe mental illness) is indicative of a 
serious diagnostic label (e.g., schizophrenia) as well as ongoing compromise in one or 
more areas of functioning, and that these individuals are more severe than those typically 
seen in general outpatient therapy (Kessler & Zhao, 1999; Kessler, Zhao, Katz, Kouzis, 
Frank, Edlund, & Leaf, 1999).  A potentially problematic assumption for this research is 
that the individual’s were properly categorized as SMI and non-SMI.  Confidence that 
categorization was accurate was enhanced through (1) the primary clinician of each 
participant certified them as SMI or non-SMI, (2) this was verified by the lead researcher, 
an experienced clinician, in most cases via direct contact with the individual, and (3), 
each participants clinical chart was reviewed and verified for appropriate placement in 
the SMI or OP sample.   
The moderating affects of illness severity are assessed separately for the 
individual, social, and service domains (hypotheses 5.1-5.3) and then for the combined 
domains (main effects model, research question 5) in the same way as described for 
research 4b above.  This concludes the discussion of the analysis plan.  However, due to 
the large number of multivariate analyses conducted a summary of all multivariate 
statistical models by research question and hypotheses is provided in Table 12.  
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Table 12 
 
A Priori Multivariate Models 
 
Research 
Question 
 
Hypotheses 
Range 
Model # Model Label Analysis Dependent 
Variable 
Independent Variables 
RQ2.1  1 Control Logistic 
Regression 
Recovery 
Expectancy 
 
Age, gender, income, education 
 
 Hyp2.1b-11 2 Symptoms Logistic 
Regression 
Recovery 
Expectancy 
Control + somatization, OCD, interpersonal sensitivity, 
depression, anxiety, hostility phobic anxiety, paranoia, 
psychoticism 
 
 Hyp2.1j-1r 3 Other clinical Logistic 
Regression 
Recovery 
Expectancy 
Control + symptoms + substance dx, total hospitalizations, 
hospitalization in last year, age of onset, medication use (anti-
psychotic, anti-depressant, anti-manic, anti-anxiety, other 
psychotropic) 
 
 Hyp2.1s-1t 4 Employment Logistic 
Regression 
Recovery 
Expectancy 
Control + symptoms + other clinical + currently employed, 
total years employed 
 
 Hyp2.1u-1v 5 Family history Logistic 
Regression 
Recovery 
Expectancy 
Control + symptoms + other clinical + employment + nuclear 
family MI history, extended family MI history 
 
 Hyp2.1w-1z 6 Abuse Logistic 
Regression 
Recovery 
Expectancy 
Control + symptoms + other clinical + Employment + Family 
history + child sexual abuse, child physical abuse, adult sexual 
assault, adult physical assault 
  
 Hyp2.1aa 7-14 Diagnosis Logistic 
Regression 
Recovery 
Expectancy 
Control + symptoms + other clinical + employment + family 
history + abuse/assault + diagnosis (schizophrenia, bipolar, 
schizoaffective, major depression, anxiety, depression, 
adjustment, other)* 
 
RQ2.2 
 
Hyp2.2a-2.2e 15 Stigma Logistic 
Regression 
Recovery 
Expectancy 
Control + alienation, stereotype endorsement, discrimination 
occurrence, social withdrawal, stigma resistance 
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Table 12 (cont.) 
 
Research 
Question 
 
Hypotheses 
Range 
Model # Model Label Analysis Dependent 
Variable 
Independent Variables 
 Hyp2.2f-2.2k 16 Social support Logistic 
Regression 
Recovery 
Expectancy 
Control + stigma + support via intimate partner/best friend, 
support via family, support via provider, support via friends, 
community involvement, trust 
 
 Hyp2.2l-2.2q 17 Empowerment Logistic 
Regression 
Recovery 
Expectancy 
Control + stigma + social support + self-esteem/self-efficacy, 
power/powerlessness, community activism and autonomy, 
optimism and control, righteous anger 
 
RQ2.3 Hyp2.3a-3c 18 Current services Logistic 
Regression 
Recovery 
Expectancy 
Control + service variables (total number of services, total 
contact hours, average satisfaction level) 
 
RQ2  19-26 Main effects Logistic 
Regression 
Recovery 
Expectancy 
Control + symptoms + other clinical + employment + family 
history + abuse + stigma + social support + empowerment + 
current services + contact hours + service satisfaction + 
diagnosis* 
 
RQ3 
(RQ3.1-3.3) 
 
Hyp3.1a-1aa 
Hyp3.2a-2q 
Hyp3.3a-3c 
 
27-52 Control ? Main 
effects 
OLS 
Regression 
Illness 
Management 
Same progression as models 1-26 (Full model  = Control + 
symptoms + other clinical + employment + family history + 
abuse + stigma + social support + empowerment + services + 
diagnosis) 
 
RQ3 
(RQ3.1-3.3) 
 
Hyp3.1a-1aa 
Hyp3.2a-2q 
Hyp3.3a-3c 
 
53-78 Control ? Main 
effects 
OLS 
Regression 
Future 
Orientation 
Same progression as models 1-26 (Full model  = Control + 
symptoms + other clinical + employment + family history + 
abuse + stigma + social support + empowerment + services + 
diagnosis*) 
 
RQ3 
(RQ3.1-3.3) 
 
Hyp3.1a-1aa 
Hyp3.2a-2q 
Hyp3.3a-3c 
 
79-104 Control ? Main 
effects 
OLS 
Regression 
Meaning and 
Hope 
Same progression as models 1-26 (Full model  = Control + 
symptoms + other clinical + employment + family history + 
abuse + stigma + social support + empowerment + services + 
diagnosis*) 
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Table 12 (cont.) 
 
Research 
Question 
 
Hypotheses 
Range 
Model # Model Label Analysis Dependent 
Variable 
Independent Variables 
RQ3 
(RQ3.1-3.3) 
 
 
Hyp3.1a-1aa 
Hyp3.2a-2q 
Hyp3.3a-3c 
 
105-130 Control ? Main 
effects 
OLS 
Regression 
Recognizing 
Support 
Same progression as models 1-26 (Full model  = Control + 
symptoms + other clinical + employment + family history + 
abuse + stigma + social support + empowerment + services + 
diagnosis*) 
 
RQ3 
(RQ3.1-3.3) 
 
Hyp3.1a-1aa 
Hyp3.2a-2q 
Hyp3.3a-3c 
 
131-156 Control ?Main 
effects 
OLS 
Regression 
Help Seeking Same progression as models 1-26 (Full model  = Control + 
symptoms + other clinical + employment + family history + 
abuse + stigma + social support + empowerment + services + 
diagnosis*) 
 
RQ3 
(RQ3.1-3.3) 
 
Hyp3.1a-1aa 
Hyp3.2a-2q 
Hyp3.3a-3c 
 
157-182 Control ? Main 
effects 
OLS 
Regression 
Symptom 
Eradication 
Same progression as models 1-26 (Full model  = Control + 
symptoms + other clinical + employment + family history + 
abuse + stigma + social support + empowerment + services + 
diagnosis*) 
 
RQ4.a Hyp4.a.1 183-190 Mediating 
Domain 1 
 
OLS 
Regression 
Illness 
Management 
Control + symptoms + other clinical + employment + family 
history + abuse/assault + diagnosis* + recovery expectation 
RQ4.a Hyp4.a.2 191 Mediating 
Domain 2 
 
OLS 
Regression 
Illness 
Management 
Control + stigma + social support + empowerment + recovery 
expectation 
RQ4.a Hyp4.a.3 192 Mediating 
Domain 3 
 
OLS 
Regression 
Illness 
Management 
Control + service variables + recovery expectation 
RQ4.a  193-200 Mediating  
Main Effects 
 
OLS 
Regression 
Illness 
Management 
Control + symptoms + other clinical + employment + family 
history + abuse + stigma + social support + empowerment + 
current services + contact hours + service satisfaction + 
diagnosis* + recovery expectation 
 
RQ4.a Hyp4.a.1 201-208 Mediating 
Domain 1 
OLS 
Regression 
Future 
Orientation 
Control + symptoms + other clinical + employment + family 
history + abuse/assault + diagnosis* + recovery expectation 
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Table 12 (cont.) 
 
Research 
Question 
 
Hypotheses 
Range 
Model # Model Label Analysis Dependent 
Variable 
Independent Variables 
RQ4.a 
 
Hyp4.a.2 209 Mediating 
Domain 2 
 
OLS 
Regression 
Future 
Orientation 
Control + stigma + social support + empowerment + recovery 
expectation 
RQ4.a 
 
 
Hyp4.a.3 210 Mediating 
Domain 3 
OLS 
Regression 
Future 
Orientation 
Control + service variables + recovery expectation 
RQ4.a  211-218 Mediating  
Main Effects 
 
OLS 
Regression 
Future 
Orientation 
Control + symptoms + other clinical + employment + family 
history + abuse + stigma + social support + empowerment + 
services + recovery expectation 
 
RQ4.a Hyp4.a.1 219-226 Mediating 
Domain 1 
 
OLS 
Regression 
Meaning and 
Hope 
Control + symptoms + other clinical + employment + family 
history + abuse/assault + diagnosis* + recovery expectation 
RQ4.a Hyp4.a.2 227 Mediating 
Domain 2 
 
OLS 
Regression 
Meaning and 
Hope 
Control + stigma + social support + empowerment + recovery 
expectation 
RQ4.a Hyp4.a.3 228 Mediating 
Domain 3 
 
OLS 
Regression 
Meaning and 
Hope 
Control + service variables + recovery expectation 
RQ4.a  229-236 Mediating  
Main Effects 
 
OLS 
Regression 
Meaning and 
Hope 
Control + symptoms + other clinical + employment + family 
history + abuse + stigma + social support + empowerment + 
services + recovery expectation 
 
RQ4.a Hyp4.a.1 237-244 Mediating 
Domain 1 
 
OLS 
Regression 
Recognizing 
Support 
Control + symptoms + other clinical + employment + family 
history + abuse/assault + diagnosis* + recovery expectation 
RQ4.a Hyp4.a.2 245 Mediating 
Domain 2 
 
OLS 
Regression 
Recognizing 
Support 
Control + stigma + social support + empowerment + recovery 
expectation 
RQ4.a Hyp4.a.3 246 Mediating 
Domain 3 
OLS 
Regression 
Recognizing 
Support 
Control + service variables + recovery expectation 
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Table 12 (cont.) 
 
Research 
Question 
 
Hypotheses 
Range 
Model # Model Label Analysis Dependent 
Variable 
Independent Variables 
RQ4.a 
 
 
 247-254 Mediating  
Main Effects 
 
OLS 
Regression 
Recognizing 
Support 
Control + symptoms + other clinical + employment + family 
history + abuse + stigma + social support + empowerment + 
services + recovery expectation 
 
RQ4.a Hyp4.a.1 255-262 Mediating 
Domain 1 
 
OLS 
Regression 
Help Seeking Control + symptoms + other clinical + employment + family 
history + abuse/assault + diagnosis* + recovery expectation 
RQ4.a Hyp4.a.2 263 Mediating 
Domain 2 
OLS 
Regression 
Help Seeking Control + stigma + social support + empowerment + recovery 
expectation 
RQ4.a Hyp4.a.3 264 Mediating 
Domain 3 
 
OLS 
Regression 
Help Seeking Control + service variables + recovery expectation 
RQ4.a  265-272 Mediating  
Main Effects 
 
OLS 
Regression 
Help Seeking Control + symptoms + other clinical + employment + family 
history + abuse + stigma + social support + empowerment + 
services + recovery expectation 
 
RQ4.a Hyp4.a.1 273-280 Mediating 
Domain 1 
 
OLS 
Regression 
Symptom 
Eradication 
Control + symptoms + other clinical + employment + family 
history + abuse/assault + diagnosis* + recovery expectation 
RQ4.a Hyp4.a.2 281 Mediating 
Domain 2 
 
OLS 
Regression 
Symptom 
Eradication 
Control + stigma + social support + empowerment + recovery 
expectation 
RQ4.a Hyp4.a.3 282 Mediating 
Domain 3 
 
OLS 
Regression 
Symptom 
Eradication 
Control + service variables + recovery expectation 
RQ4.a  283-290 Mediating  
Main Effects 
 
OLS 
Regression 
Symptom 
Eradication 
Control + symptoms + other clinical + employment + family 
history + abuse + stigma + social support + empowerment + 
services + recovery expectation 
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Table 12 (cont.) 
 
Research 
Question 
 
Hypotheses 
Range 
Model # Model Label Analysis Dependent 
Variable 
Independent Variables 
RQ4.b Hyp4.b.1 291-298 Moderating 
Domain 1 
 
OLS 
Regression 
Illness 
Management 
Control + symptoms + other clinical + employment + family 
history + abuse/assault + diagnosis + select variables x 
recovery expectation 
 
RQ4.b Hyp4.b.2 299 Moderating 
Domain 2 
 
OLS 
Regression 
Illness 
Management 
Control + stigma + social support + empowerment + recovery 
expectation + select variables x recovery expectation 
 
RQ4.b Hyp4.b.3 300 Moderating 
Domain 3 
 
OLS 
Regression 
Illness 
Management 
Control + service variables + select variables x recovery 
expectation 
RQ4.b 
 
 
 
 301-308 Moderating 
Main Effects 
 
OLS 
Regression 
Illness 
Management 
Control + symptoms + other clinical + employment + family 
history + abuse + stigma + social support + empowerment + 
services + select variables x recovery expectation 
 
RQ4.b Hyp4.b.1 309-316 Moderating 
Domain 1 
 
OLS 
Regression 
Future 
Orientation 
Control + symptoms + other clinical + employment + family 
history + abuse/assault + diagnosis* + select variables x 
recovery expectation 
 
RQ4.b Hyp4.b.2 317 Moderating 
Domain 2 
 
OLS 
Regression 
Future 
Orientation 
Control + stigma + social support + empowerment + recovery 
expectation 
RQ4.b Hyp4.b.3 318 Moderating 
Domain 3 
 
OLS 
Regression 
Future 
Orientation 
Control + service variables + select variables x recovery 
expectation 
RQ4.b 
 
 
 319-326 Moderating 
Main Effects 
 
OLS 
Regression 
Future 
Orientation 
Control + symptoms + other clinical + employment + family 
history + abuse + stigma + social support + empowerment + 
services + select variables x recovery expectation 
 
RQ4.b Hyp4.b.1 327-334 Moderating 
Domain 1 
 
OLS 
Regression 
Meaning and 
Hope 
Control + symptoms + other clinical + employment + family 
history + abuse/assault + diagnosis* + select variables x 
recovery expectation 
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Research 
Question 
 
Hypotheses 
Range 
Model # Model Label Analysis Dependent 
Variable 
Independent Variables 
RQ4.b 
 
 
Hyp4.b.2 335 Moderating 
Domain 2 
OLS 
Regression 
Meaning and 
Hope 
Control + stigma + social support + empowerment + recovery 
expectation 
RQ4.b Hyp4.b.3 336 Moderating 
Domain 3 
OLS 
Regression 
Meaning and 
Hope 
Control + service variables + select variables x recovery 
expectation 
 
RQ4.b  337-344 Moderating 
Main Effects 
 
OLS 
Regression 
Meaning and 
Hope 
Control + symptoms + other clinical + employment + family 
history + abuse + stigma + social support + empowerment + 
services + select variables x recovery expectation 
 
RQ4.b Hyp4.b.1 345-352 Moderating 
Domain 1 
 
OLS 
Regression 
Recognizing 
Support 
Control + symptoms + other clinical + employment + family 
history + abuse/assault + diagnosis* + select variables x 
recovery expectation 
 
RQ4.b Hyp4.b.2 353 Moderating 
Domain 2 
 
OLS 
Regression 
Recognizing 
Support 
Control + stigma + social support + empowerment + recovery 
expectation 
RQ4.b Hyp4.b.3 354 Moderating 
Domain 3 
 
OLS 
Regression 
Recognizing 
Support 
Control + service variables + select variables x recovery 
expectation 
RQ4.b  355-362 Moderating 
Main Effects 
 
OLS 
Regression 
Recognizing 
Support 
Control + symptoms + other clinical + employment + family 
history + abuse + stigma + social support + empowerment + 
services + select variables x recovery expectation 
 
RQ4.b Hyp4.b.1 363-370 Moderating 
Domain 1 
 
OLS 
Regression 
Help Seeking Control + symptoms + other clinical + employment + family 
history + abuse/assault + diagnosis* + select variables x 
recovery expectation 
 
RQ4.b 
 
 
Hyp4.b.2 371 Moderating 
Domain 2 
OLS 
Regression 
Help Seeking Control + stigma + social support + empowerment + recovery 
expectation 
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Table 12 (cont.) 
 
Research 
Question 
 
Hypotheses 
Range 
Model # Model Label Analysis Dependent 
Variable 
Independent Variables 
RQ4.b 
 
 
Hyp4.b.3 372 Moderating 
Domain 3 
 
OLS 
Regression 
Help Seeking Control + service variables + select variables x recovery 
expectation 
RQ4.b  373-380 Moderating 
Main Effects 
 
OLS 
Regression 
Help Seeking Control + symptoms + other clinical + employment + family 
history + abuse + stigma + social support + empowerment + 
services + select variables x recovery expectation 
 
RQ4.b 
 
 
 
Hyp4.b.1 381-388 Moderating 
Domain 1 
 
OLS 
Regression 
Symptom 
Eradication 
Control + symptoms + other clinical + employment + family 
history + abuse/assault + diagnosis* + select variables x 
recovery expectation 
RQ4.b Hyp4.b.2 389 Moderating 
Domain 2 
 
OLS 
Regression 
Symptom 
Eradication 
Control + stigma + social support + empowerment + recovery 
expectation 
RQ4.b Hyp4.b.3 390 Moderating 
Domain 3 
 
OLS 
Regression 
Symptom 
Eradication 
Control + service variables + select variables x recovery 
expectation 
RQ4.b  391-398 Moderating 
Main Effects 
 
OLS 
Regression 
Symptom 
Eradication 
Control + symptoms + other clinical + employment + family 
history + abuse + stigma + social support + empowerment + 
services + select variables x recovery expectation 
 
RQ5 Hyp5.1 399-406 Moderating 
Domain 1 
 
OLS 
Regression 
Illness 
Management 
Control + symptoms + other clinical + employment + family 
history + abuse/assault + diagnosis* + select variables x 
illness severity 
 
RQ5 Hyp5.2 407 Moderating 
Domain 2 
 
OLS 
Regression 
Illness 
Management 
Control + stigma + social support + empowerment + select 
variables x illness severity 
RQ5 
 
Hyp5.3 408 Moderating 
Domain 3 
OLS 
Regression 
Illness 
Management 
Control + service variables + select variables x illness severity 
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Table 12 (cont.) 
 
Research 
Question 
 
Hypotheses 
Range 
Model # Model Label Analysis Dependent 
Variable 
Independent Variables 
RQ5  409-416 Moderating 
Main Effects 
 
OLS 
Regression 
Illness 
Management 
Control + symptoms + other clinical + employment + family 
history + abuse + stigma + social support + empowerment + 
services + select variables x illness severity 
 
RQ5 Hyp5.1 417-424 Moderating 
Domain 1 
 
OLS 
Regression 
Illness 
Management 
Control + symptoms + other clinical + employment + family 
history + abuse/assault + diagnosis* + select variables x 
illness severity 
 
RQ5 Hyp5.2 425 Moderating 
Domain 2 
 
OLS 
Regression 
Illness 
Management 
Control + stigma + social support + empowerment + select 
variables x illness severity 
RQ5 
 
 
Hyp5.3 426 Moderating 
Domain 3 
 
OLS 
Regression 
Illness 
Management 
Control + service variables + select variables x illness severity 
RQ5  427-434 Moderating 
Main Effects 
 
OLS 
Regression 
Illness 
Management 
Control + symptoms + other clinical + employment + family 
history + abuse + stigma + social support + empowerment + 
services + select variables x illness severity 
 
RQ5 Hyp5.1 435-442 Moderating 
Domain 1 
 
OLS 
Regression 
Future 
Orientation 
Control + symptoms + other clinical + employment + family 
history + abuse/assault + diagnosis* + select variables x 
illness severity 
 
RQ5 Hyp5.2 443 Moderating 
Domain 2 
 
OLS 
Regression 
Future 
Orientation 
Control + stigma + social support + empowerment + select 
variables x illness severity 
RQ5 
 
 
Hyp5.3 444 Moderating 
Domain 3 
 
OLS 
Regression 
Future 
Orientation 
Control + service variables + select variables x illness severity 
RQ5  445-452 Moderating 
Main Effects 
 
OLS 
Regression 
Future 
Orientation 
Control + symptoms + other clinical + employment + family 
history + abuse + stigma + social support + empowerment + 
services + select variables x illness severity 
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Research 
Question 
 
Hypotheses 
Range 
Model # Model Label Analysis Dependent 
Variable 
Independent Variables 
RQ5 
 
 
 
Hyp5.1 453-460 Moderating 
Domain 1 
 
OLS 
Regression 
Meaning and 
Hope 
Control + symptoms + other clinical + employment + family 
history + abuse/assault + diagnosis* + select variables x 
illness severity 
 
RQ5 Hyp5.2 461 Moderating 
Domain 2 
 
OLS 
Regression 
Meaning and 
Hope 
Control + stigma + social support + empowerment + select 
variables x illness severity 
RQ5 
 
 
Hyp5.3 462 Moderating 
Domain 3 
 
OLS 
Regression 
Meaning and 
Hope 
Control + service variables + select variables x illness severity 
RQ5  463-470 Moderating 
Main Effects 
 
OLS 
Regression 
Meaning and 
Hope 
Control + symptoms + other clinical + employment + family 
history + abuse + stigma + social support + empowerment + 
services + select variables x illness severity 
 
RQ5 
 
 
Hyp5.1 471-478 Moderating 
Domain 1 
 
OLS 
Regression 
Recognizing 
Support 
Control + symptoms + other clinical + employment + family 
history + abuse/assault + diagnosis* + select variables x 
illness severity 
 
RQ5 Hyp5.2 479 Moderating 
Domain 2 
 
OLS 
Regression 
Recognizing 
Support 
Control + stigma + social support + empowerment + select 
variables x illness severity 
RQ5 
 
 
Hyp5.3 480 Moderating 
Domain 3 
 
OLS 
Regression 
Recognizing 
Support 
Control + service variables + select variables x illness severity 
RQ5  481-488 Moderating 
Main Effects 
 
OLS 
Regression 
Recognizing 
Support 
Control + symptoms + other clinical + employment + family 
history + abuse + stigma + social support + empowerment + 
services + select variables x illness severity 
 
RQ5 
 
 
Hyp5.1 489-496 Moderating 
Domain 1 
 
OLS 
Regression 
Help Seeking Control + symptoms + other clinical + employment + family 
history + abuse/assault + diagnosis* + select variables x 
illness severity 
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Research 
Question 
 
Hypotheses 
Range 
Model # Model Label Analysis Dependent 
Variable 
Independent Variables 
RQ4.b 
 
 
Hyp4.b.2 497 Moderating 
Domain 2 
 
OLS 
Regression 
Help Seeking Control + stigma + social support + empowerment + select 
variables x illness severity 
RQ4.b 
 
 
Hyp4.b.3 498 Moderating 
Domain 3 
 
OLS 
Regression 
Help Seeking Control + service variables + select variables x illness severity 
RQ5  499-506 Moderating 
Main Effects 
 
OLS 
Regression 
Help Seeking Control + symptoms + other clinical + employment + family 
history + abuse + stigma + social support + empowerment + 
services + select variables x illness severity 
 
RQ5 
 
 
Hyp5.1 507-514 Moderating 
Domain 1 
 
OLS 
Regression 
Symptom 
Eradication 
Control + symptoms + other clinical + employment + family 
history + abuse/assault + diagnosis* + select variables x 
illness severity 
 
RQ5 Hyp5.2 515 Moderating 
Domain 2 
 
OLS 
Regression 
Symptom 
Eradication 
Control + stigma + social support + empowerment + select 
variables x illness severity 
RQ5 
 
 
Hyp5.3 516 Moderating 
Domain 3 
 
OLS 
Regression 
Symptom 
Eradication 
Control + service variables + select variables x illness severity 
RQ5  517-524 Moderating 
Main Effects 
 
OLS 
Regression 
Symptom 
Eradication 
Control + symptoms + other clinical + employment + family 
history + abuse + stigma + social support + empowerment + 
services + select variables x illness severity 
 
 
Note:  * Diagnosis is a series of 8 dichotomous variables.  Entering them all into a model violates least square and logistic solutions and cannot be interpreted.  
Thus, the diagnosis variable is entered last, one at a time, to assess affects of individual diagnoses.  This creates a series of domain 1 models and main effects 
models 
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Chapter 4 
 
Results 
 
 This chapter presents results based on the analysis plan and methods outlined in 
Chapter 3.  I begin with a description of the respondents and provide relevant univariate 
results to underscore important differences between the severely mentally ill (SMI) and 
less severe (OP) participants.  Differences are also highlighted that distinguish those who 
feel they will recover from mental illness and those that do not.  This segmentation by 
recovery expectancy traverses the SMI and OP samples and illustrates that low 
expectation of personal recovery is common for those with and without a label  of severe 
mental illness.    Additional bivariate relationships are examined that includes bivariate 
investigation of dependent variables (recovery expectancy and recovery strategies) and 
independent variables (Domain 1: clinical historical, Domain 2: social, Domain 3: 
service).   
Discussion of bivariate analysis results is structured, in part, to follow the research 
questions and hypotheses.  The goal was to intermingle the numeric results with the story 
of the participants.  Too often, research targeting individuals with mental illness neglects 
the essential humanity of the participants. Thus, all effort was made to avoid 
unintentional marginalization by focusing on the lived context.  Further, not all bivariate 
analyses are displayed or referenced in this chapter.  Bivariate analyses were completed 
between all control, dependent, and independent variables (domains 1-3) as part of the 
process of learning the story.  However, only the results relevant to better understanding 
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of the population and the relationships investigated in the research questions are 
displayed in this chapter.  Two additional procedural notes are offered:  first, all bivariate 
and multivariate statistics accompanied by a p-value use the same scale and alphanumeric 
designations consistently throughout analyses to indicate significance.  Thus, an ‘a’ 
indicates that p ≤ 0.05, ‘b’ ≤ 0.01, ‘c’ ≤ 0.001 and ‘d’ ≤ 0.0001.  Second, for t-tests, when 
variances are unequal, the Satterthwaite statistic (SAS/STAT®, Version 9.1) was used in 
place of the pooled statistic for equal variances.  Following bivariate analysis multivariate 
analysis results are presented and are organized by research question and hypothesis. 
 
Study Participants 
Demographic Characteristics 
 Respondents provided information on age, gender, education and income.  A 
targeted description of this information and any differences between samples (SMI and 
OP) will help to deepen understanding of the individuals with mental illness that 
participated in this research and the population they represent.  The first descriptor is age, 
a continuous variable, with results presented in Table 13.  The average age for the pooled 
sample of 350 is 41 years.  The SMI population is slightly older at 42.5 years compared 
to the OP sample at 39.6 and the range is similar between the samples. The age difference 
is significant, t(348) = 2.41, p ≤ .05), although less than a three year difference is of little 
theoretical or practical consequence.    There is also a significant difference between age 
and recovery expectancy.  Individuals that do not endorse recovery (n = 134, M = 41.5, 
SD = 9.0) are significantly older then those that do expect to recover (n = 216, M = 38.1, 
SD = 10.8), t(348) = p ≤ .004. 
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Table 13 
 
Mean and Standard Deviation of Demographic Variable Age 
 
 
 
n Mean (s.d.) Lower Range Upper Range 
SMI 175 42.5 (10.7) 20 64 
OP 
 
175 39.6 (11.8) 18 63 
Total 
 
350 41.1 (11.3) 18 64 
 
Gender, education and income are displayed together in Table 14.  Approximately 
two-thirds (69%) of the participants are female.  The total clinical population of the 
partnering agency is also approximately two-thirds female, see Table 1, page 103). Thus, 
random selection would be expected to favor the female gender and, as predicted, did so.  
There is no significant difference between samples for gender distributions.  Similarly, 
there are no significant differences between the SMI and OP samples for education or 
income distributions.  Limited formal education and low income levels are common.  The 
vast majority have a high school or less than high school education.  For income, most 
individuals have $15,000 or less household income per year.  This is representative of 
mental health consumers in community mental health centers in general and is another 
layer of challenge that these individuals face each day.   
The following three sections help to increase appreciation of the respondents and 
provide further insight into their history, clinical status, beliefs, relationships, and view 
on services.  These sections are not directly linked to the research questions but are 
necessary to help strengthen understanding and empathy for individuals with differing 
levels of mental illness.  The research questions described in Chapter 3 are focused on 
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recovery and not, until the final research question (RQ 5), concerned with severity of 
illness.  However, in order to identify important factors associated with recovery, it is 
imperative to have a greater understanding of the individual’s that participated in this 
study and that are striving for recovery. 
Table 14 
 
Gender, Education, and Income for SMI, OP and Total Sample 
 
  
SMI
 
OP
 
Total
 n =175 
 
n =175 N = 350 
 % % % 
Gender    
     Male 34 28 31 
     Female 
 
66 72 69 
 
Education 
   
     < High School 19 22 21 
     High School 43 34 39 
     1-2 yrs. College 27              31 29 
     2-4 yrs. College 10 11 10 
     5+ yrs. College    1   1   1 
 
Income 
   
     0-10,000 57 46 51 
     10,001-15,000 21 25 23 
     15,001-20,000 10 11 11 
     20,001-25,000   4   5   5 
     25,001-30,000   2   4   3 
     30,001-40,000   3   3   3 
     40,001-50,000   2   2   2 
     50,001-75,000   1   2   1 
     75,001-    1   2   1 
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Univariate Assessment of Clinical and Historical Factors (Independent Variable Domain 
1) by Sample:  Furthering Understanding of the Respondents 
Individuals diagnosed with a mental illness have varied histories, experiences, and 
symptom patterns that differ due to severity of illness with possible associations to 
recovery.  Domain 1 independent variables include diagnosis, symptoms, age of onset, 
substance abuse, hospitalization, medication use, familial mental illness, employment, 
and abuse history.  The following discussion will highlight differences and similarities 
between samples.   
 The SMI sample was categorized per inclusion criteria with diagnoses of 
schizophrenia, bipolar disorder, schizoaffective disorder, and major depression (Table 
15).  Other diagnoses (e.g., severe obsessive compulsive disorder) could have qualified as 
severe mental illness provided there was accompanying impairment of social, 
occupational, or educational functioning.  Documentation of such impairment is 
necessary for the SMI label.  Random sampling did select four individuals outside the 
four main diagnoses for inclusion in the SMI sample and discussions with the 
individual’s clinicians indicated that these individuals met criteria for inclusion.  
Diagnosis is a consistent point of debate in the recovery literature and the decision was 
made to keep all diagnostic categories even if they are few in number. 
The SMI sample contains the majority of individuals with disorders that affect the 
thought process and are characterized by hallucinations and delusions (schizophrenia:  
SMI = 88% and schizoaffective disorder: SMI = 87%).  Unexpectedly, there are nearly 
equal numbers of individuals with bipolar disorder in sample categories, 52% in the SMI 
sample and 48% in the OP sample.  The two individuals diagnosed with anxiety in the 
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SMI sample were diagnosed with a severe obsessive-compulsive disorder and one other 
individual with complex post-traumatic stress disorder.  All individuals diagnosed with a 
depressive disorder that is not major depression are in the OP sample as are all 
individuals with an adjustment disorder.  Finally, the diagnostic category of ‘other’ has 
87% of individuals in the OP sample.  These include individuals diagnosed with adult 
attention deficit disorder, personality disorder, Tourette’s syndrome, head injury, and 
other neurological disorder.  The two individuals in the SMI sample who are in the 
‘other’ diagnostic category were diagnosed with dissociative identity disorder and a head 
injury related psychotic disorder, respectively.   
Table 15 
 
Proportion of Domain 1 Primary Diagnoses by Sample 
 
Primary Diagnosis 
 
SMI 
n = 175 
 
OP 
n = 175 
Total 
N = 350 
 % % % 
Schizophrenia 
 
88   11 15 
Bipolar disorder 
 
52   48 38 
Schizoaffective 
 
87   13 11 
Major depression 
 
44   56 16 
Anxiety Disorder 
 
 6   94  9 
Depression (not major) 
 
 0 100  5 
Adjustment disorder 
 
 0 100  2 
Other 13   87  4 
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 Table 16 contains the results of the Symptom Checklist 90-Revised (SCL-90-R) 
symptom scales by sample.  Each symptom category has a range of 0 to 4 for severity.   
Table 16 
 
Univariate Statistics (Means and Standard Deviations) for Domain 1 Symptom Scales by Sample 
 
Symptom Scales 
 
SMI OP Total 
 n=175 n=175 N =350 
 
 
 
Mean (s.d.) Mean (s.d.) Mean (s.d.) 
Psychosomatic 
 
1.50 (0.95) 1.60 (0.89) 1.53 (0.92) 
OCD 
 
1.92 (0.97) 1.86 (1.03) 1.87 (1.00) 
Interpersonal Sensitivity 
 
1.65 (0.95) 1.62 (1.06) 1.63 (1.01) 
Depression 
 
1.83 (0.97) 1.91 (1.07) 1.87 (1.02) 
Anxiety 
 
1.62 (0.98) 1.61 (1.09) 1.61 (1.03) 
Hostility 
 
1.07 (0.95) 1.25 (1.0) 1.16 (0.98) 
Phobia 
 
1.28 (1.04) 1.14 (1.07) 1.21 (1.06) 
Paranoia 
 
1.79 (1.0) 1.73 (1.05) 1.76 (1.02) 
Psychoticism  
 
1.34 (0.90) 1.13 (0.83) 1.23 (0.87) 
Global Severity Index 
 
1.58 (0.82) 1.57 (0.86) 1.58 (0.84) 
 
The total symptom severity levels for the two samples are markedly similar (SMI =1.58; 
OP = 1.57), measured by the global severity index (GSI).  The GSI is a summary score 
that indicates the overall symptom level of a respondent with scores closer to four 
indicating greater clinical involvement. 
 The three symptoms with the highest averages for the total sample are depression: 
obsessive compulsive symptoms, and paranoia.  Depression is ubiquitous in mental 
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illness and often implicated as a barrier to recovery (Corrigan & Ralph, 2005).  Though 
the SMI sample has higher levels of obsessive compulsive symptoms and paranoia 
compared to the OP sample, the similarity in intensity is surprising. This is particularly 
perplexing for paranoia considering paranoia is often associated with thought disorder 
and yet the OP sample has far less thought disorder (schizophrenia and schizoaffective 
disorder) diagnosed.  Conversely, the OP sample has a higher level of depression.  As 
noted in chapter 2, depression is the symptom most investigated for its effect on recovery, 
yet it can be seen that for this sample that many symptoms may be implicated in recovery 
and symptoms alone do not distinguish between those labeled severely mentally ill and 
those that are not. 
 Other clinical variables investigated include age of onset, hospitalization history, 
substance abuse history (classified as whether the respondent was ever diagnosed with 
dependence or abuse), medication use, abuse/assault history and familial mental illness.  
Results are displayed in Table 17 and Table 18.  Age of onset can be defined as the first 
time a person is ‘officially’ diagnosed with a mental disorder or when the individual can 
first remember being symptomatic to a point of concern.  For this study, beginning of 
symptoms was used as the point in time for age of onset.  The mean age of onset for the 
entire sample is 21.2 years (SD =10.8) (Table 17).  Individuals from the SMI sample had 
an earlier average age of onset compared to the OP sample.    
 Psychiatric hospitalization in the previous 12-months was reported by 34% of the 
respondents (Table 18).  The SMI sample had a much higher average number of lifetime 
hospitalizations then the OP sample (Table 17).  Substance abuse is a critical issue in the 
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recovery from mental illness and can be an additional risk for hospitalization.  Co-
occurring substance use disorders were noted in 34% of participants (Table 18).   
Table 17 
 
Univariate Means and Standard Deviations for Continuous Domain 1 Independent Variables 
(Age of Onset, Hospitalizations, Years Employed, Familial Mental Illness) by Sample 
 
 
 
 
SMI 
n = 175 
 
 
OP 
n = 175 
 
Total 
N = 350 
 
 
Mean (s.d.) Mean (s.d.) Mean (s.d.) 
Age of Onset 
 
19.8 (9.9) 22.7 (11.5) 21.2 (10.8) 
Hospitalizations in 
Lifetime 
 
10.1 (13.8) 3.3 (5.1) 6.7 (10.9) 
Total years 
employed 
 
12.1 (10.7) 15.6 (10.3) 13.9 (10.6) 
Mental illness: 
nuclear family 
 
2.3 (2.0) 2.4 (2.2) 2.3 (2.1) 
Mental illness:  
extended family 
 
0.8 (1.0) 0.8 (1.1) 
 
0.8 (1.1) 
 
 Medication was frequently prescribed to individuals in both clinical samples as an 
avenue to clinical recovery.  For instance, 76% of the total sample is prescribed anti-
depressant medication (Table 18).  Anti-anxiety medication is prescribed the second most 
frequently at 52%.  When comparing SMI to OP samples, the SMI sample is prescribed 
more medication of all types.  This is most marked in anti-psychotic medication and other 
psychotropic medications.   
 Familial mental illness, a potential contributor to mental illness onset, was broken 
into nuclear family members (parents and siblings) and extended family (all others) 
(Table 18).  Individuals in the OP sample have a slightly higher level of nuclear family 
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mental illness.  There is no difference in the number of extended family members 
between the two samples.  Employment is frequently equated with or used as a proxy for 
 
Table 18 
 
Proportion of  Categorical Domain 1 Independent Variables (Hospitalization, Employment, Substance 
Use, Medication, and Child Abuse) by Sample 
 
 SMI 
 n=175 
OP  
n=175 
Total  
N=350 
 
 
 
% % % 
Hospitalized in last year 35 33 34 
Currently Employed 11 31 21 
Co-occurring substance diagnosis 34 34 34 
Anti-psychotic medication 63 25 44 
Anti-depressant medication 79 73 76 
Anti-manic medication 30 25 27 
Anti-anxiety medication 57 48 52 
Other psychotropic medication 40 25 32 
Child sexual abuse    
   Recurrent 34 34 34 
    Single incident   9   8   8 
Child physical abuse    
   Recurrent 42 35 39 
    Single incident   1   0   1 
Adult sexual assault    
   Recurrent 31 23 27 
    Single incident   6   6   6 
Adult physical assault    
   Recurrent 36 36 36 
    Single incident   4   3   4 
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successful recovery.  Only 21% of the pooled sample are currently employed (Table 18).  
Eleven percent of the SMI sample is employed while the OP sample is employed at 31%. 
 The final group of variables in the clinical-historical domain (domain 1) deals 
with abuse and assault experiences (Table 18).  Recurrent child sexual abuse (CSA) was 
experienced by 35% of the full sample.  Recurrent child physical abuse (CPA) for the 
total sample is 39%, with 27% reporting adult sexual assault (ASA) and 36% adult 
physical assault (APA).  The prevalence of CSA and APA is nearly identical between the 
SMI and OP samples for both single episode and recurrent abuse.  For both recurrent 
CPA and ASA, the prevalence is higher for the SMI population.  Recovery is often 
complicated by experiences of abuse and individuals with severe mental illness 
frequently have greater prevalence of abuse (Alexander, Muenzenmaier, Dumont, & 
Auslander, 2005).  A final procedural note regarding abuse targets the number of 
categories defining abuse experiences.  Because of the low numbers of individuals with 
single incident abuse, categories of single-incident and recurrent abuse were collapsed 
into an ‘experienced abuse’ category.  Thus, abuse variables are converted to 
dichotomous for all subsequent bivariate and multivariate analyses. 
 
Univariate Assessment of Social Factors (Independent Variable Domain 2) by Study 
Sample:  Furthering Understanding of the Respondents 
 Domain 2 is comprised of three sets of variables or experiences that target the 
social/interactional areas of stigma, social support and community connection, and 
empowerment.  Each area will be discussed separately and the univariate results for 
domain 2 are summarized in Table 19.   
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Table 19 
 
Univariate Domain 2 Means and Standard Deviations for Stigma, Social Support, and 
Empowerment by Sample 
 
 SMI 
n=175 
OP 
n=175 
Total 
N=350 
 
 Mean (s.d.) 
 
Mean (s.d.) 
 
Mean (s.d.) 
 
Stigma 
 
   
Alienation 
 
2.51 (0.61) 2.42 (0.62) 2.47 (0.61) 
Stereotype endorsement 
 
2.01 (0.48) 1.93 (0.46) 1.97 (0.47) 
Discrimination occurrence  
 
2.51 (0.63) 2.31 (0.61) 2.41 (0.62) 
Social withdrawal 
 
2.42 (0.55) 2.29 (0.63) 2.36 (0.59) 
Stigma resistance 
 
2.14 (0.47) 2.17 (0.45) 2.16 (0.46) 
Social Support and Community Connection 
 
  
Partner or best friend support 
 
4.17 (1.11) 4.12 (1.24) 4.17 (1.11) 
Family Support 
 
3.80 (1.51) 3.63 (1.54) 3.80 (1.51) 
Provider Support 
 
4.22 (0.78) 3.88 (0.91) 4.22 (0.78) 
Friends Support 
 
4.10 (1.12) 4.12 (1.17) 4.10 (1.12) 
Community involvement 
 
3.63 (1.17) 3.34 (1.16) 3.63 (1.17) 
Trust 
 
3.15 (0.98) 2.99 (0.92) 3.15 (0.98) 
Empowerment 
 
   
Self-esteem and self-efficacy 
 
2.86 (0.53) 2.90 (0.53) 2.88 (0.53) 
Power and powerlessness 
 
2.41 (0.42) 2.55 (0.42) 2.48 (0.43) 
Community activism and autonomy 
 
3.15 (0.43) 3.16 (0.38) 3.15 (0.41) 
Optimism and control over the future 
 
2.81 (0.49) 2.82 (0.43) 2.81 (0.46) 
Righteous anger 
 
2.43 (0.55) 2.49 (0.52) 2.46 (0.54) 
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 Stigma is believed to have a powerful influence on recovery and general well 
being for individuals with mental illness (see chapter 2 for a detailed discussion).  Stigma 
is investigated via five scales that correspond with sub-constructs of stigma and include 
alienation, stereotype endorsement, discrimination occurrence, social withdrawal, and 
stigma resistance (Ritsher, Otilingam, & Grajales, 2003).  The range for all responses is  
from 1-5, with higher numbers indicating more negative, stigmatizing, experiences or 
effects for all scales except for stigma resistance where a higher number indicates a 
greater ability to resist the negative effects of stigma.  For the total sample, alienation is 
the scale with the highest mean.  The SMI sample scores higher on the scales of 
alienation, stereotype endorsement, discrimination occurrence, and social withdrawal 
compared to the OP sample.  Conversely, the OP sample has a higher mean score for 
stigma resistance.  Consequently, individuals with severe mental illness are more likely to 
report greater impact of stigma in their lives and appear to have less coping or resistance 
capacity. 
Important relationships that could potentially provide social and instrumental 
support include a partner/best friend, family members, provider(s), and friends.  Results 
from scales matching these relationship clusters are displayed in Table 19.  Related to 
these are two additional scales of community involvement and trust.  Each scale can 
range from 1-6, with higher numbers indicating more support, community involvement, 
or general feelings of trust.  The highest score for the total sample is on the partner or 
best friend support scale and the least is trust.  For nearly all comparisons between the 
SMI and OP samples the SMI sample reports higher levels of support, community 
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involvement, and trust.  The one exception is where the OP sample reports a slightly 
higher level of support from friends compared to the SMI sample.   
The final domain 2 construct addresses empowerment.  The constructs that 
encompass empowerment include self-esteem/self-efficacy, power and powerlessness, 
community activism and autonomy, optimism and control over the future, and righteous 
anger.  The measurement range is 1-5, with higher scores indicating greater levels of self-
esteem, powerfulness, etc.  The results for the empowerment scales are also presented in 
Table 19. 
Community activism and autonomy is the most highly endorsed empowerment 
construct.  The OP sample score slightly higher on all empowerment scales compared to 
the SMI sample.  The most marked difference is in power/powerlessness where the OP 
sample appears to experience a greater sense of personal power or control in their lives.     
 
Univariate Assessment of Service Factors (Independent Variable Domain 3) by Study 
Sample:  Furthering Understanding of the Respondents 
 Domain 3 addresses service factors that include variables for the number of 
services received per month, number of contact hours per month, and average satisfaction 
level with services (Table 20).  For many, recovery involves successful involvement with 
the right combination of therapeutic and support services.  The poverty or near poverty 
income levels, inconsistent transportation, and other obligations are obstacles to 
successful involvement in a comprehensive treatment plan.  The strain and cost incurred 
to arrive at and engage in services is often taken for granted by providers.  A service is a 
specific clinical encounter (e.g., individual therapy, case management, psychiatric 
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medication appointment).  The mean number of services in a month for the pooled 
sample is 2.4 (SD = 1.2).  Mean contact hours are 7.1 (SD = 7.7) per month and the 
average satisfaction level is quite high, 5.1 (SD = 1.0) on a six-point scale with six 
indicating very satisfied.  Average satisfaction is identical for the SMI and OP samples.  
However, average number of services is higher for the SMI population compared to the 
OP population.  Total contact hours also are greater for the SMI sample. 
 
Table 20 
 
Univariate Means and Standard Deviations for Domain 3 Independent Variables:  
Service Factors by Sample 
 
  
SMI 
n=175 
 
OP 
n=175 
 
Total 
N=350 
 
 Mean (s.d.) 
 
Mean (s.d.) Mean (s.d.) 
Total number  of services 
 
3.1 (1.1) 1.7 (0.9) 2.4 (1.2) 
Total contact hours 
 
9.5 (9.2) 4.7 (4.8) 7.1 (7.7) 
Average satisfaction 
 
5.1 (0.9) 5.1 (1.1) 5.1 (1.0) 
 
 
Results of Comprehensive Bivariate Analysis 
 This section details the results of bivariate analyses relevant to the research 
questions detailed in Chapter 3.  First, demographic factors are investigated in relation to 
recovery expectancy and recovery strategies.  Second, recovery expectancy is 
investigated between samples in response to research question 1.  Next, sample 
differences in recovery strategies are targeted followed by an investigation of the 
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relationship between recovery expectancy and recovery strategies.  Finally, bivariate 
results that respond to research questions 2 (associations with recovery expectancy) and 3 
(associations with recovery strategies) are summarized. 
 
Associations between Age, Gender, Education, Income and Recovery 
 The understanding of what influences recovery remains limited.  The following 
describes the contribution of demographic factors to the understanding of the target 
population through investigating the associations between demographic variables (e.g., 
age, gender, education and income) and recovery expectancy and strategies. 
 Recovery expectancy is not significantly associated with gender, χ2  (1, N = 350) 
= 0.42, ns, education, χ2 (3, N = 350) = 4.04, ns, or income, χ2 (3, N = 350) = 3.40, ns.  
However, recovery expectancy is significantly associated with age, t(348) = 2.99, p ≤ 
.003.  Thus, individuals that endorse recovery are significantly younger (M = 39.7, SD = 
11.9 years) compared to those who do not expect to recover (M = 43.3, SD = 10.1 years).   
The relationship between age and the recovery strategies is displayed in Table 21.  
Correlations are susceptible to sample size and often provide a highly significant p-value 
with a moderate or mild magnitude correlation.  The significant relationship between 
effective illness management (r(348) = -0.12, p ≤ .05), positive future orientation (r(348) 
= -0.15, p ≤ .01), recognizing support (r(348) = -0.13, p ≤ .01), and help seeking (r(348) = 
0.10, p ≤ .05) illustrates the need to examine magnitude.  These are not strong 
correlations.  However, it is significant that for three of four associations, use of the 
strategies increases as age decreases.  These findings may reflect the need for 
management skills and support during the stage of illness near or at least closer to onset.   
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Table 21 
 
Pearson Correlations for Age by Recovery Strategies 
 
 Effective 
illness 
management 
 
Positive 
future 
orientation 
Meaningfulness, 
personal control 
and hope 
Recognizing 
support 
Help 
seeking 
Symptom 
eradication 
Age -0.12a 
 
-0.15b 0.02 -0.13b 0.10a -0.02 
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; d ≤ .0001 
 
 
Younger  individuals, in turn, would naturally have a concern about what they are 
experiencing and the effect on their future, especially if changes in plans are required to 
adapt to the illness.  
Gender, income, and education are associated with recovery strategies via the 
independent sample t-test and one-way ANOVA statistics in Table 22.  Gender is 
significantly associated only with strategy one, effective illness management, t(348) = 
3.06, p ≤ .01).  Male respondents, on average, endorse this strategy more than female 
respondents.  This is not indicative of a general trend of male strategy use; however, 
since female respondents score higher on three strategies and males on the other three.  
Income is significantly associated with three strategies: effective illness management 
(F(3,347) = 3.25, p ≤ .05), positive future orientation (F(3,347) = 3.75, p ≤ .05) and 
meaningfulness, personal control and hope (F(3,347) = 3.41, p ≤ .05).   
 Due to the low numbers in upper income categories, the four highest income 
categories were collapsed into a $20,001 or more annual income category.  The mean 
score in the three significant relationships (effective illness management, positive future 
orientation, and meaningfulness, personal control and hope) in the lowest three income 
levels are relatively similar for the three strategies, and the significant relationship is 
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Table 22 
 
Independent Sample T-tests and One-Way ANOVA Results of the Relationship Between Gender, Income, Education and Recovery Strategies 
 
  Effective illness 
management 
 
Positive future 
orientation 
Meaningfulness 
personal control and 
hope 
 
Recognizing 
support 
Help seeking Symptom 
eradication 
 N Mean  
(s.d.) 
t-test Mean 
(s.d.) 
t-test Mean 
(s.d.) 
t-test Mean 
(s.d.) 
t-test Mean 
(s.d.) 
t-test Mean 
(s.d.) 
t-test 
Ge  nder
ome
tion
             
  Male 109 3.48 (0.71) 3.06b 4.05 (0.60) 1.71 4.16 (0.49) -1.15 3.83 (0.91) 0.72 3.94 (0.89) -0.58 3.27 (1.24) 0.96 
  Female 
 
241 3.22 (0.75)  3.92 (0.67)  4.22 (0.44)  3.75 (0.99)  4.00 (0.81)  3.13 (1.24)  
 N Mean  
(s.d.) 
F Mean 
(s.d.) 
F Mean 
(s.d.) 
F Mean 
(s.d.) 
F Mean 
(s.d.) 
F Mean 
(s.d.) 
F 
Inc               
  0 – 10k 180 3.26 (0.69) 3.25a 3.93 (0.64) 2.75a 4.20 (0.43) 3.41a 3.73 (0.91) 2.29 3.96 (0.79) 1.18 3.27 (1.22) 2.49 
  10,001-15k 79 3.28 (0.77)  3.90 (0.65)  4.19 (0.45)  3.62 (1.01)  3.89 (0.90)  3.30 (1.27)  
  15,001-20k 37 3.15 (0.77)  3.94 (0.70)  4.06 (0.56)  3.94 (1.01)  4.03 (0.79)  2.86 (1.25)  
  20,0001- 
 
54 3.58 (0.85)  4.20 (0.64)  4.36 (0.44)  4.01 (1.00)  4.16 (0.90)  2.87 (1.21)  
Educa               
  < H.S. 73 3.24 (0.82) 0.76 3.92 (0.77) 0.84 4.22 (0.43) 0.26 3.74 (1.07) 1.49 3.99 (1.01) 1.74 3.48 (1.21) 4.14b
  H.S. 136 3.37 (0.70)  4.03 (0.58)  4.18 (0.49)  3.89 (0.87)  3.97 (0.81)  3.21 (1.26)  
  2-years     
  college 
102 3.25 (0.70)  3.95 (0.61)  4.21 (0.44)  3.72 (0.88)  4.10 (0.69)  3.10 (1.20)  
  > 2 year  
  college 
 
39 3.31 (0.89)  3.86 (0.78)  4.25 (0.46)  3.55 (1.22)  3.74 (0.88)  2.64 (1.20)  
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; d ≤ .0001 
           H.S. = high school education 
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likely due to the increase in strategy use in the fourth, and highest, income level.  The 
significance of the association might be an artifact of the decision to collapse income 
categories and the significance must be considered with caution.   
 Similar to the handling of income data, low numbers of individuals with higher 
education led to collapsing the top three education categories into one category 
(education greater than 2 years of college).  Education is significant associated only with 
symptom eradication (F(3, 347) = 4.14, p ≤ .01).  Belief in symptom eradication is 
utilized more by individuals with lower education with less endorsement noted with each 
step in educational level.  One explanation is that higher education achievement may 
expose the individual to the accepted explanation of the chronic nature of many 
psychiatric symptoms and thus decrease the emphasis on symptom eradication.  Overall, 
there is no readily discernible pattern of association between education and recovery 
strategy.   
 
Sample Differences in Recovery Expectancy 
 Approximately two-thirds of the 350 participants believed that they will recover 
from mental illness (62%) while one-third did not (38%).  The OP sample participants 
were more likely to believe that they will recover (73%), compared to the SMI sample 
(50%).  The results are summarized in Table 23.  For the total sample, individuals are 
more likely to endorse complete recovery compared to endorsing that they will not 
recover at all, with the OP sample, in general, having greater recovery expectations.  
More specifically, individuals in the OP sample are approximately three times more 
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likely to sanction complete recovery and are only half as likely to believe that they will 
not improve past there current level of health and functioning.  These results pertain 
directly to research question 1 and the three accompanying hypotheses. 
 
Table 23 
 
Chi-square Results for Recovery Expectation Variables by Sample 
 
 SMI OP Total  
 % % % χ2 
Recovery Expectation     
     Yes 50 73 62 19.35d
     No 50 27 38  
     
Complete Recovery Expected     
     Yes 13  20 16 3.54 
     No 87  80 84  
     
No Recovery Expected     
     Yes   7   3   5 3.75 
     No 
 
93 97 95  
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; d ≤ .0001 
 
 
 
variables in domains 1-3 and/or may mediate the relationship of predictor variables and 
recovery strategies.  Multivariate analytic procedures (logistic regression and OLS 
regression) are used to assess these relationships.  However, the relationship between the 
belief that one will recover and severity of illness, dichotomized by the absence or 
presence of the SMI label, can be assessed via chi-square analysis.   
 There is a strong and significant difference between the two samples on recovery 
expectancy (Table 23).  Those who do not believe they will recover are much more likely 
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to be in the SMI sample (50%) compared to the OP sample (27%), χ2 (1, N = 350) = 
19.35, p ≤ .0001).  This directly responds to hypothesis one of research question one 
(RQ1: Hyp1.1).  The accompanying hypotheses to research question 1 are reproduced in 
Table 24. 
 
Table 24 
  
Summary of Support for Hypotheses 1.1 to 1.3 
 
Hypothesis 
 
Statement Supported?
Hyp1.1 The OP sample will endorse that they will recover from 
mental illness to a greater extent than the SMI sample. 
 
Yes 
Hyp1.2 The OP sample will endorse complete recovery as possible 
more than the SMI sample. 
 
No 
Hyp1.3 The SMI sample will endorse no expectation of recovery more 
than the OP sample. 
 
Yes 
 
The second hypothesis (Hyp1.2) states that the OP sample will expect complete 
recovery to a greater degree.  The data does not support this hypothesis, χ2 (1, N = 350) = 
3.54, p ≤ 0.06, though it just misses significance.  The third hypothesis (Hyp1.3), 
representing no difference between samples for endorsing complete lack of recovery, is 
marginally supported, χ2 (1, N = 350) = 3.75, p = 0.053.  The borderline significance for 
hypotheses 1.2 and 1.3 suggests that there might be differences in beliefs of complete 
recovery/non-recovery and that further investigation would not be wasted effort. 
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Differences in Recovery Strategies between Samples and Recovery Expectations 
 Table 25 displays the mean and standard deviation of each recovery strategy 
stratified by sample (SMI and OP).  Chapter 3 provides an initial description of each 
strategy.  There is no significant or consistent direction of relationship due to sample 
membership, a proxy for severity of mental illness.  Symptom eradication is the least 
endorsed strategy for the SMI and OP samples.  This may reflect, in part, that this 
variable is a single item, not a composite of several recovery items.  Both samples 
endorse the strategy of finding meaning, personal control, and hope to a greater degree 
then the other strategies.  However, in general, there is little difference between the 
samples in the extent that they endorse any of the recovery strategies. 
 
Table 25 
 
Independent Sample T-test Results, Means, and Standard Deviations for Recovery 
Strategies (Continuous Dependent Variables) by Sample  
 
 SMI 
n = 175 
 
OP 
n  = 175 
Total  
N = 350 
 
Recovery Strategy 
 
Mean (s.d.) Mean (s.d.) Mean (s.d.) t-test 
   
Effective illness management 
 
 
3.31 (0.70) 
 
3.29 (0.79) 
 
3.30 (0.75) 
0.34 
Positive Future Orientation 
 
3.92 (0.67) 4.01 (0.64) 3.96 (0.65) -1.27 
Meaningfulness, Personal 
Control and Hope 
 
4.19 (0.48) 4.22 (0.44) 4.21 (0.46) -0.51 
Recognizing Support 
 
3.75 (0.92) 3.79 (1.01) 3.77 (0.96) -0.41 
Help Seeking 
 
4.02 (0.83) 3.95 (0.84) 3.98 (0.84) 0.70 
Symptom Eradication 
 
3.13 (1.28) 3.21 (1.21) 3.17 (1.24) -0.60 
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 A different story emerges when examining differences in recovery strategy 
endorsement by recovery expectancy.  Immediately evident is that for each strategy, 
respondents who believe they will recover tend to endorse the recovery strategies to a 
greater degree (Table 26).  These associations are statistically significant for every 
strategy except symptom eradication.  This is a potentially valuable finding when 
considered in the context of the minimal information on recovery expectancy in the 
literature and the drive to identify functional and accurate recovery strategies.  Of equal 
importance to the consistent direction of relationships across strategies is the magnitude 
of associations, with most relationships leaving little room for chance as a reason for the 
associations.  Thus, the results suggest that it would be useful to consider recovery 
expectancy when developing programs designed to improve use of recovery strategies. 
 
Table 26 
 
Independent Sample T-test Results for Recovery Strategies by Recovery Expectation 
 
Recovery Strategy Expect to Recover  
 Yes  
Mean (s.d.) 
(n = 216) 
No  
Mean (s.d.) 
(n = 134) 
 
t-test 
Effective illness management 3.46 (0.71) 3.05 (0.73) -5.22d
Positive future orientation 4.11 (0.61) 3.74 (0.66) -5.31d
Meaningfulness, personal control and hope 4.27 (0.46) 4.12 (0.44) -3.22c
Recognizing support 3.94 (0.90) 3.51 (1.01) -4.07d
Help seeking 4.08 (0.81) 3.83 (0.86) -2.67b
Symptom eradication 
 
3.27 (1.19) 3.01 (1.32) -1.86 
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; pd ≤ .0001 
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Bivariate Analysis for Research Question 2:  Are Individual, Social or Service Factors 
Associated with Recovery Expectancy?   
Research question 2.1: Are individual factors associated with recovery 
expectancy? 
  
 The following analyses investigate the relationship between recovery expectancy 
and each of the predictor variables from Domain 1.  Research question 2.1 is specific to 
Domain 1 and Tables 27-30 display the results of the bivariate analyses.  The relationship 
of diagnosis to recovery expectancy has clinical and recovery implications.   The chi-
square relationships are summarized in Table 27.  Individuals with bipolar disorder are 
significantly less likely to believe they will recover (55% endorse recovery compared to 
66% of the rest of the sample).  Individuals that are depressed but are not severe enough 
to be labeled with major depression are significantly more likely to believe they will 
recover (84%) compared to other sample members (60.  All individuals with an 
adjustment disorder, as would be expected, endorse recovery (Fisher’s Exact, p ≤ .05).  
Unexpectedly, neither of the diagnostic categories that usually indicate impairment in 
cognitive functioning (schizophrenia and schizoaffective disorder) was significantly 
associated with recovery expectancy.  Even more surprising when viewed in the context 
of the recovery literature, individuals diagnosed with schizophrenia are more apt to 
endorse recovery (69%) compared to the rest of the sample (60%) (Torgalsboen, 2005). 
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Table 27 
 
Chi-square Results of Recovery Expectancy by Diagnosis 
 
 
 
Schizophrenia Bipolar Disorder Schizoaffective Disorder Major Depression
Recovery 
Expectancy 
 
Yes 
% 
No 
 % 
χ2 Yes 
% 
No 
 % 
χ2 Yes 
% 
No 
 % 
χ2 Yes 
% 
No 
 % 
χ2 
   Yes 
 
69  60 1.21  55  66 4.61a  55  62 0.75  58  62 0.34 
   No 
 
31 
 
 40   45  34   45  38   42  38  
 Anxiety Disorder 
 
Depression (not Major) Adjustment Disorder Other Disorder
Recovery 
Expectancy 
 
Yes 
% 
No 
 % 
χ2 Yes 
% 
No 
 % 
χ2 Yes 
% 
No 
 % 
χ2 Yes 
% 
No 
 % 
χ2 
   Yes 
 
67  61 0.38  84  60 4.30a  100  61 *Fa 73 61 0.89 
   No  33 
 
 39  16  40      0  39   27 39  
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; pd ≤ .0001; *F = Fishers Exact statistic used due to cell size 
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 The associations between symptom scales and recovery expectancy are 
summarized in Table 28.  Every symptom scale except for hostility is significantly 
associated to recovery expectancy.  All associations are in the same direction, with higher 
levels of symptoms experienced by individuals who do not expect to recover.     
 Depression, in the recovery literature is the symptom most often linked to 
recovery failure (Corrigan & Ralph, 2005), has the largest difference between those that 
sanction recovery and those that do not.  Global severity of symptoms is second and 
strongly illustrates the impact of multiple symptoms on recovery.  Next is psychoticism 
(psychotic symptoms), paralleling the recovery literature that recognizes thought disorder 
as a challenge to recovery (Spaniol, Wewlorski, Gagne, Anthony, 2005; Torgalsboen, 
2005). 
 Having detected a strong association between symptoms and recovery 
expectancy, the next set of associations to investigate are the continuous measures 
domain 1 variables (age of onset, lifetime hospitalizations, years employed and familial 
mental illness).  These associations are summarized in Table 29 by means of the 
independent sample t-tests.  Lifetime hospitalizations are significant though it is 
impossible to tell with this information whether hospitalizations lead to lack of recovery 
expectancy or vice versa.  Two other significant associations are noted, both addressing 
familial mental illness.  The stronger association is with nuclear family mental illness.  
Individuals that lack expectancy have more immediate family members with mental 
illness, t(348) = 3.19, p ≤ .001, as well as extended familial mental illness, t (348) = 2.61, 
p ≤ .01).   
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Table 28 
 
Independent Sample T-test Results of Recovery Expectancy by Symptom Scales 
 
Recovery 
Expectancy 
 
Psychosomatic Obsessive 
Compulsive
Interpersonal 
Sensitivity
Depression Anxiety
 Mean 
(s.d.) 
 
t-test Mean 
(s.d.) 
t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean 
(s.d.) 
t-test 
Recovery  
No 
1.84 
(0.92) 
5.12c 2.44 
(0.94) 
5.47c 1.95 
 (0.98) 
4.78c 2.27 
(0.97) 
6.15c 2.00 
(0.99) 
5.81c
Recovery  
Yes 
1.34 
(0.87) 
 
 1.66 
(0.98) 
 1.44 
 (0.98) 
 1.62  
(0.97) 
 1.51 
(0.99) 
 
 Hostility Phobic 
Anxiety 
 
Paranoia Psychoticism Global Severity Index
Recovery  
No 
1.31 
(1.01) 
1.34 1.59 
(1.03) 
5.58c 20.9 
 (1.00) 
4.94c 1.57 
(0.90) 
5.94c 1.91 
(0.80) 
6.14c
Recovery  
Yes 
 
1.07 
(0.94) 
 0.97 
(1.00) 
 1.56 
 (0.99) 
 1.03  
(0.78) 
 1.37 
(0.79) 
 
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; pd ≤ .0001, Recovery NO, n=134; Recovery YES, n = 216.    
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Table 29 
 
Independent Sample T-test Results for Recovery Expectancy and Domain 1 Variables: 
Age of Onset, Hospitalizations, Employment, and Familial Mental Illness 
 
Variable Recovery NO 
n = 134 
 
Recovery Yes 
n  = 216 
 
 Mean (s.d.) 
 
Mean (s.d.) t-test 
Age of onset 
 
21.8 (15.7) 21.3 (10.8) 0.28 
Lifetime hospitalizations 
 
8.4 (13.9) 5.6 (8.5) 2.12a
Total years employed 
 
15.1 (10.3) 13.1 (10.8) 1.66 
Mental illness:  Nuclear family 
 
2.8 (2.1) 2.1 (2.0) 3.19c
Mental illness: Extended family 
 
1.0 (1.2) 0.7 (1.0) 2.61b
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; d ≤ .0001 
 
 
 The remaining variables from domain 1 are examined in Table 30.  Chi-square 
analysis was used to detect important relationships between recovery expectancy and 
hospitalization in the last year, current employment, substance abuse history, medication 
use, child abuse and adult assault.  Several of the associations are significant.  First, a 
substance abuse history is significantly more likely in individuals with no recovery 
expectancy.  The additional struggle for recovery noted for individuals with a substance 
dependence history emphasized in the literature parallels this finding (White, Boyle, & 
Loveland, 2005).  Four of five medication variables have significant relationships with 
recovery.  Anti-depressant medication is the one that is not related to expectancy and may 
reflect the acceptance of this medication both in the general culture and this sample (76% 
of the individuals in this study are prescribed anti-depressant medication).  Anti-anxiety 
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medication has the strongest link with recovery expectancy with nearly twice as many 
individuals who have no recovery expectancy taking anti-anxiety medications than not.  
This is a potentially interesting finding that reinforces the earlier association wherein all 
three anxiety symptom scales are significantly higher for those not endorsing recovery 
(Table 28).  Anti-manic medication is prescribed more to non-recovery individuals and 
appears to be an indicator for more intense pathology.  Anti-psychotic medication and 
other psychotropic medication are also significantly related to recovery.   
Table 30 
 
Chi-square Results for Recovery Expectancy and Hospitalization in Last Year, 
Current Employment, Substance Abuse, Medication, Abuse and Assault History 
 
Variable Recovery NO 
(n = 134) 
 
Recovery YES 
(n = 216) 
χ2 
 
 
% Yes % Yes  
Hospitalized in last year 37  32 0.88 
Currently Employed  16  24 2.91 
Co-occurring substance use  40  30 3.84a
Anti-psychotic medication  51  40 3.67a
Anti-depressant medication  81  73 3.39 
Anti-manic medication  37  22 9.11c
Anti-anxiety medication 66 44 15.60d
Other Psychotropic 39  28 4.22a
Child sexual abuse  48  38 2.96 
Child physical abuse  46  35 4.63a
Adult sexual assault  42  27 8.65c
Adult physical assault  42  37 1.35 
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; pd ≤ .0001 
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The final variables addressed in domain 1 are child abuse and adult assault history.  The 
association between recovery expectancy and child sexual abuse is surprising in its lack 
of significance considering the prevalence of sexual abuse and the 
effect on recovery noted in the literature (Goodman, Rosenberg, Mueser, Drake, 1997; 
Wexler, Lyons, Lyons, Mazure, 1997).   However, child physical abuse and adult sexual 
assault are both significantly related to recovery expectancy.   
 
Research question 2.2:  Are social factors associated with recovery expectancy? 
 Domain 2 variables of stigma, social support, and empowerment were 
investigated via independent sample t-test analysis to ascertain their relationship to 
recovery expectancy.  These findings are summarized in Table 31.  Regarding stigma, 
each scale (alienation, stereotype endorsement, discrimination occurrence, social 
withdrawal, and stigma resistance) are significantly associated with lack of recovery  
expectation.  Alienation has the most powerful association with discrimination 
occurrence second.  Alienation resulting from discrimination, though not supported with 
cross-sectional data, makes conceptual sense. 
Table 31 also summarizes the results from independent sample t-tests between 
recovery expectancy and social support variables.  Individuals who feel they will recover 
report significantly higher support from a partner or best friend, family members, and 
friends.  This reinforces the literature that suggests, in general, support is necessary for 
recovery (Rogers, Anthony, & Lyass, 2004).  Community involvement is higher for those 
endorsing recovery as well. There is no difference in perceived provider support, 
suggesting that strictly a clinical support function is not required for recovery 
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Table 31 
 
Independent Sample T-test Results, Means and Standard Deviations, for Domain 2 
Variables (Stigma, Social Support, & Empowerment) and Recovery Expectancy 
 
Variable Recovery NO 
(n = 134) 
 
Recovery YES 
(n = 216) 
 
 Mean (s.d) Mean (s.d.) t-test 
Stigma    
Alienation 2.80 (0.59) 2.34 (0.59) 5.07c
Stereotype endorsement 2.08 (0.46) 1.90 (0.47) 3.51b
Discrimination occurrence 2.59 (0.60) 2.30 (0.62) 4.24c
Social withdrawal 2.51 (0.57) 2.26 (0.59) 3.79b
Stigma resistance 
 
2.27 (0.46) 2.09 (0.44) 3.75b
Social Support and Community Connection   
Partner or best friend support 3.86 (1.24) 4.32 (1.11) -3.58c
Family Support 3.40 (1.57) 3.91 (1.47) -3.08b
Provider Support 4.03 (0.94) 4.06 (0.80) -0.39 
Friends Support 3.88 (1.25) 4.25 (1.05) -2.88b
Community involvement 3.10 (1.20) 3.45 (1.14) -2.30a
Trust 
 
3.04 (0.92) 3.09 (0.97) -0.46 
Empowerment    
Self-esteem/ self-efficacy 2.72 (0.56) 2.98 (0.49) -4.67c
Power/powerlessness 2.37 (0.40) 2.55 (0.43) -3.81b
Community activism and autonomy 3.10 (0.41) 3.19 (0.40) -1.99a
Optimism and control over the future 2.72 (0.47) 2.87 (0.44) -2.99b
Righteous anger 
 
2.41 (0.57) 2.49 (0.52) -1.46 
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; pd ≤ .0001 
 
 
expectation or that provider support may influence other aspects of recovery then 
expectancy. 
 The final set of variables for domain 2 independent variables is the empowerment 
cluster.  Self-esteem / self-efficacy have the most powerful association with those 
endorsing recovery having a higher mean score (Table 31).  For all sub-constructs of 
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empowerment the pattern is the same, expectation of recovery is associated with greater 
empowerment.  Only righteous anger does not reach significance in the analysis. 
 The overall pattern of domain 2 variables should be emphasized.  Those 
endorsing recovery recognize less stigmatization and experience more support and more 
empowerment in nearly every instance.  Previous investigations of what comprises 
recovery have assessed this point to a degree, but this current analysis is unique in its 
emphasis on recovery expectancy (Corrigan, Giffort, Rashid, Leary & Ihemoa, 1999).  
Due to the limitations of cross-sectional data, it cannot be determined whether less 
support and empowerment leads to reduced expectation of recovery or the reverse.   
 
Research Question 2.3:  Are service factors associated with recovery expectancy? 
 Domain three is comprised of three service related variables:  number of current 
services, average contact hours per month, and service satisfaction.  Table 32 summarizes 
this information.  Those who do not endorse recovery have more services and more 
contact time, but neither indicator reached significance.  Service satisfaction did reach 
significance, with individuals that state they will recover having significantly more 
satisfaction with services.  This suggests ‘quality over quantity’ in service provision and 
likely the necessity of a good rapport.  What is not considered in this analysis are specific 
services, (e.g., case management, supported employment, outpatient therapy, and their 
relationship to recovery expectancy).  Such an analysis could be considered a logical next 
step in investigating services in relation to recovery. 
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Table 32 
 
Independent Sample T-test Results for Recovery Expectancy and Domain 3 Service 
Variables 
 
 Recovery Expectancy 
 
 
Variable NO 
(n = 134) 
 
YES 
(n = 216) 
 
 
 
Mean (s.d) Mean (s.d.) t-test 
Total number of services 
 
2.57 (1.20) 2.33 (1.19) 1.78 
Total contact hours 
 
7.49 (8.30) 6.84 (7.32) 0.76 
Average satisfaction 
 
4.93 (0.88) 5.20 (0.98) -2.40b
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; pd ≤ .0001 
 
 
 
 Table 33 summarizes the hypotheses linked to research questions 2.1-2.3 and 
whether the result is supported in bivariate analysis.  Bivariate relationships are not 
representative of the complex interactive reality of these concepts, taken in isolation as 
they are.  This is a crude representation designed to understand the relationship of key 
constructs in a limited way, and will be more fully explicated in multivariate analysis.  
Thus, this display is repeated when considering multivariate results and, taken together, 
illustrates how each predictor affects recovery expectancy alone and in combination with 
other variables. 
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Table 33 
 
Summary of Bivariate Results for Research Question 2 Hypotheses 
 
Hypothesis 
 
Statement Supported?
Hyp2.1a Less severe diagnoses will be associated with higher recovery 
expectancy. 
 
Hyp2.1 Lower somatization symptoms reported by participants will be 
associated with higher recovery expectancy. ? 
Hyp2.1c Lower obsessive-compulsive symptoms reported by participants 
will be associated with higher recovery expectancy. ? 
Hyp2.1d Lower interpersonal sensitivity reported by participants will be 
associated with higher recovery expectancy. ? 
Hyp2.1e Lower symptoms of anxiety reported by participants will be 
associated with higher recovery expectancy. ? 
Hyp2.1f Lower symptoms of depression reported by participants will be 
associated with higher recovery expectancy. ? 
Hyp2.1g Lower hostility reported by participants will be associated with 
higher recovery expectancy. 
 
Hyp.1h Lower phobic anxiety reported by participants will be associated 
with higher recovery expectancy. ? 
Hyp2.1i Lower paranoid ideation reported by participants will be associated 
with higher recovery expectancy. ? 
Hyp2.1j Lower psychoticism reported by participants will be associated with 
higher recovery expectancy. ? 
Hyp2.1k Absence of a comorbid substance use disorder will be associated 
with higher recovery expectancy for participants. ? 
Hyp2.1l Lower numbers of lifetime psychiatric hospitalizations will be 
associated with higher recovery expectancy for participants. ? 
Hyp2.1m No psychiatric hospitalization in the last year will be associated 
with higher recovery expectancy for participants. 
 
Hyp2.1n Older age at onset of disorder will be associated with higher 
recovery expectancy for participants. 
 
Hyp2.1o Absence of prescribed anti-depressant medication will be associated 
with higher recovery expectancy for participants. 
 
Hyp2.1p Absence of prescribed anti-psychotic medication will be associated 
with higher recovery expectancy for participants.  ? 
Hyp2.1q 
 
Absence of prescribed anti-mania medication will be associated 
with higher recovery expectancy for participants. ? 
Hyp2.1r Absence of prescribed anti-anxiety medication will be associated 
with higher recovery expectancy for participants. ? 
Hyp2.1s Absence of any other prescribed psychotropic medication will be 
associated with higher recovery expectancy for participants. ? 
Hyp2.1t Being currently employed will be associated with higher recovery 
expectancy for participants. 
 
Hyp2.1u Greater number of years worked will be associated with higher 
recovery expectancy for participants. 
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Table 33 (cont.) 
 
Hypothesis 
 
Hypothesis 
 
Hypothesis 
 
Hyp2.1v Absence of familial mental illness in first-degree relatives will be 
associated with higher recovery expectancy for participants. ? 
Hyp2.1w Absence of familial mental illness in extended family members will 
be associated with higher recovery expectancy for participants. ? 
Hyp2.1x Absence of child sexual abuse will be associated with higher 
recovery expectancy for participants. 
 
Hyp2.1y Absence of child physical abuse will be associated with higher 
recovery expectancy for participants. ? 
Hyp2.1a Absence of adult sexual assault will be associated with higher 
recovery expectancy for participants. ? 
Hyp2.1aa Absence of adult physical assault will be associated with higher 
recovery expectancy for participants. 
 
Hyp2.2a Lower feelings of alienation will be associated with higher recovery 
expectancy for participants. ? 
Hyp2.2b Lower respondent endorsement of mental illness stereotypes will be 
associated with higher recovery expectancy for participants. ? 
Hyp2.2c Lower number of discrimination experiences will be associated with 
higher recovery expectancy for participants. ? 
Hyp2.2d Lower endorsement of social withdrawal will be associated with 
higher recovery expectancy for participants. ? 
Hyp2.2e Greater endorsement of stigma resistance will be associated with 
higher recovery expectancy for participants. ? 
Hyp2.2f Greater support through intimate partner or a best friend will be 
associated with higher recovery expectancy for participants. ? 
Hyp2.2g Greater support through family members will be associated with 
higher recovery expectancy for participants. ? 
Hyp2.2h Greater support via mental health providers will be associated with 
higher recovery expectancy for participants. 
 
Hyp2.2i Greater support through friendship will be associated with higher 
recovery expectancy for participants. ? 
Hyp2.2j Greater feelings of being connected to the community will be 
associated with higher recovery expectancy for participants. ? 
Hyp2.2k Greater trust in the motivation of others will be associated with 
higher recovery expectancy for participants. 
 
Hyp2.2l Higher ratings of self-esteem and self-efficacy will be associated 
with higher recovery expectancy for participants. ? 
Hyp2.2m Higher ratings of personal power will be associated with higher 
recovery expectancy for participants. ? 
Hyp2.2n Greater involvement in the community will be associated with 
higher recovery expectancy for participants. ? 
Hyp2.2o Greater confidence in personal control over the future will be 
associated with higher recovery expectancy for participants. ? 
Hyp2.2p Higher ratings of righteous anger will be positively associated with 
higher recovery expectancy for participants. 
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Table 33 (cont.) 
 
Hypothesis 
 
Hypothesis 
 
Hypothesis 
 
Hyp2.3a Total number of services will be positively associated with higher 
recovery expectancies for participants. 
 
Hyp2.3b The average number of contact hours per month will be positively 
associated with higher recovery expectancies for participants. 
 
Hyp2.3c Satisfaction level with services will be associated with higher 
recovery expectancies for participants. ? 
 
 This next set of bivariate analyses replaces the dichotomous recovery expectancy 
variable, with continuous level recovery strategies.  The recovery strategies investigated 
include (1) effective illness management; (2) positive future orientation; (3) 
meaningfulness, personal control, and hope; (4), recognizing support; (5), help seeking; 
and (6) symptom eradication (a single item variable).  The association between each 
strategy and the predictor variables contained in domain 1 (clinical/historical factors), 
domain 2 (social factors), and domain 3 (service factors) are addressed. 
 
Research Question 3:  Are Individual, Social or Service Factors Associated with 
Recovery Strategies?    
Research question 3.1:  Are individual factors associated with recovery 
strategies? 
 Associations between the recovery strategies and primary clinical diagnosis 
suggest that the first strategy, effective illness management, is significantly associated 
only with adjustment disorder (Table 34).  Adjustment disorder is greatly influenced by 
stressful occurrences and environmental factors for both onset and illness course.  The 
transient and less severe nature of the illness would lend itself to less complex 
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Table 34 
 
Independent Sample T-test Results for Recovery Strategies and Domain 1 Diagnosis Variables 
 
  Effective Illness 
Management 
 
Positive Future 
Orientation 
Meaningfulness, 
Personal Control 
and Hope 
 
Recognizing 
Support 
Help Seeking Symptom 
Eradication 
Diagnosis 
 
n Mean 
(s.d.) 
t-test Mean 
(s.d.) 
t-test Mean 
(s.d.) 
t-test Mean 
(s.d.) 
t-test Mean 
(s.d.) 
t-test Mean 
(s.d.) 
t-test 
Schizophr  enia
olar
tive
sion
rder
             
     Yes 51 3.40 
(0.63) 
-1.04 3.95 
(0.70) 
0.21 4.08 
(0.53) 
2.14a 3.97 
(0.76) 
-1.88 4.10 
(0.73) 
-1.25 3.35 
(1.34) 
-1.13 
     No 299 3.28 
(0.77) 
 3.97 
(0.65) 
 4.23 
(0.44) 
 3.74 
(0.99) 
 3.96 
(0.85) 
 3.14 
(1.23) 
 
Bip               
     Yes 132 3.21 
(0.80) 
1.76 3.92 
(0.69) 
0.89 4.25 
(0.43) 
-1.50 3.74 
(1.01) 
0.43 3.97 
(0.84) 
0.29 3.11 
(1.28) 
0.76 
     No 218 3.36 
(0.71) 
 3.99 
(0.63) 
 4.18 
(0.47) 
 3.79 
(0.94) 
 3.99 
(0.83) 
 3.21 
(1.22) 
 
Schizoaffec               
     Yes 38 3.28 
(0.69) 
0.22 4.04 
(0.58) 
-0.79 4.30 
(0.46) 
-1.38 3.80 
(0.93) 
-0.17 4.10 
(0.69) 
-0.88 2.92 
(1.17) 
1.32 
     No 312 3.31 
(0.75) 
 3.95 
(0.66) 
 4.19 
(0.46) 
 3.77 
(0.97) 
 3.97 
(0.85( 
 3.20 
(1.25) 
 
Major Depres               
     Yes 55 3.32 
(0.77) 
-0.24 3.84 
(0.66) 
1.58 4.13 
(0.46) 
1.32 3.51 
(1.11) 
2.17a 3.99 
(0.80) 
0.46 3.49 
(1.15) 
-2.21a
     No 295 3.30 
(0.74) 
 3.99 
(0.65) 
 4.22 
(0.46) 
 3.82 
(0.93) 
 3.93 
(1.01) 
 3.11 
(1.25) 
 
Anxiety Diso               
     Yes 33 3.20 
(0.70) 
0.80 4.04 
(0.54) 
-0.72 4.09 
(0.39) 
1.51 3.71 
(0.80) 
0.41 3.92 
(0.83) 
0.47 2.82 
(1.07) 
1.72 
     No 
 
 
317 3.31 
(0.75) 
 3.96 
(0.67) 
 4.22 
(0.46) 
 3.78 
(0.98) 
 3.99 
(0.84) 
 3.21 
(1.26) 
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Table 34 (cont.) 
 
  Effective Illness 
Management 
 
Positive Future 
Orientation 
Meaningfulness, 
Personal Control 
and Hope 
 
Recognizing 
Support 
Help Seeking Symptom 
Eradication 
Diagnosis 
 
n Mean 
(s.d.) 
t-test Mean 
(s.d.) 
t-test Mean 
(s.d.) 
t-test Mean 
(s.d.) 
t-test Mean 
(s.d.) 
t-test Mean 
(s.d.) 
t-test 
Depression (not  MD)
rder
ther
             
     Yes 19 3.44 
(0.70) 
-0.84 3.97 
(0.64) 
-0.03 4.24 
(0.33) 
-0.33 3.58 
(1.04) 
0.90 3.89 
(0.80) 
0.48 3.32 
(1.11) 
-0.52 
     No 331 3.29 
(0.75) 
 3.96 
(0.66) 
 4.20 
(0.47) 
 3.78 
(0.96) 
 3.99 
(0.84) 
 3.16 
(1.25) 
 
Adjustment Diso               
     Yes 7 3.95 
(0.64) 
-2.31a 4.42 
(0.37) 
-1.85 4.31 
(0.39) 
-0.60 4.00 
(0.75) 
-0.63 4.24 
(0.71) 
-0.81 4.00 
(1.00) 
-1.79 
     No 343 3.29 
(0.74) 
 3.96 
(0.66) 
 4.20 
(0.46) 
 3.77 
(0.97) 
 3.98 
(0.84) 
 3.15 
(1.24) 
 
O               
     Yes 15 3.47 
(0.79) 
-0.90 4.26 
(0.57) 
-1.77 4.41 
(0.57) 
-1.78 4.53 
(0.65) 
-3.16b 3.78 
(0.90) 
0.97 2.80 
(1.37) 
1.18 
     No 335 3.29 
(0.75) 
 
 3.95 
(0.66) 
 4.20 
(0.45) 
 3.74 
(0.96) 
 3.99 
(0.83) 
 3.12 
(1.24) 
 
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; d p ≤ .0001 
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management and more success.  The second strategy, positive future orientation, is not 
significantly associated with any diagnostic category.  Finding meaning, control and hope 
(strategy 3) is significant only with schizophrenia.  Individuals with schizophrenia report 
significantly less sanctioning of this strategy and is representative of decreased hope and 
meaningfulness pervasive in individuals with this diagnosis. 
 Individuals can only capitalize on support if they recognize it.  The fourth 
strategy, recognizing support, is significant for major depression, with those diagnosed 
having less recognition of support then other participants.  Those categorized as ‘other’ 
diagnoses have the opposite association with higher levels of support recognition then 
other respondents.  The fifth strategy of help seeking has no significant associations and 
symptom eradication is significant only for major depression wherein those without 
major depression are significantly more likely to believe that symptoms will be 
eliminated at some point. 
 Pearson correlations are reported as estimates of the relationship between 
recovery strategies and symptom scale data collected via the Symptom Checklist 90-
Revised (Table 35).  Every association is negative.  This indicates that endorsement of 
recovery strategies decreases as symptoms increase.  The uniformity of this finding is 
noteworthy but the magnitude varies across strategies.  Symptoms are most strongly 
associated with the first strategy of effective illness management.  Each relationship 
between symptom and strategy is significant and of moderate intensity.  Illness 
management, in part, focuses on symptom management. Increased symptoms might mean 
either a failure to utilize the strategy or a lack of skills for effective management.  
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Table 35 
 
Pearson Correlation Results for Recovery Strategies and Symptom Scales 
 
  
Effective 
illness 
management 
 
 
Positive 
future 
orientation 
 
Meaningful-
ness personal 
control, and 
hope 
 
 
Recognizing 
support 
 
Help 
seeking 
 
Symptom 
eradication 
Somatization 
 
-0.34d -0.28d -0.00 -0.21d -0.08 -0.05 
Obsessive 
compulsive 
 
-0.49d -0.37d -0.05 -0.24d -0.15b -0.05 
Interpersonal 
Sensitivity 
 
-0.45d -0.40d -0.03 -0.29d -0.14b -0.01 
Depression 
 
-0.56d -0.49d -0.05 -0.36d -0.21d -0.06 
Anxiety 
 
-0.53d -0.39d -0.09 -0.28d -0.18c -0.07 
Hostility 
 
-0.30d -0.21d -0.06 -0.16b -0.12a -0.02 
Phobic 
Anxiety 
 
-0.47d -0.39d -0.14b -0.26d -0.14b -0.06 
Paranoia 
 
-0.44d -0.33d -0.07 -0.27d -0.14b -0.07 
Psychoticism 
 
-0.42d -0.38d -0.05 -0.24d -0.16b -0.06 
Global 
Severity Index 
 
-0.53d -0.43d -0.06 -0.31d -0.17c -0.06 
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; d p ≤ .0001 
 
 
 The second strategy, positive future orientation, has an identical but less intense 
relationship with symptoms compared to effective illness management.  Disturbing, 
disheartening and possibly chronic symptoms demand attention and interrupt goal 
making and future focus.  It is logical that symptoms would disrupt attention on future 
goals.  The third strategy (meaningfulness, personal control, and hope), however, is 
inconsistent with the literature with associations between symptom and strategy 
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significant only for phobic anxiety.  Recovery literature focuses a great deal on hope and 
often addresses, directly or obliquely, the disruptive effect of symptoms on hope and 
living a meaningful life (Lysaker, Buck, Hammoud, Taylor & Row, 2006; Resnick, 
Rosenheck & Lehman, 2004).  This result might be explained by the wording of some of 
the items (e.g., I have a desire to succeed; I have goals in life I want to reach) that access 
whether a particular thought or desire is present without any mention of whether the 
respondent views these as possible or whether there are obstacles.  The literature 
supports, and it is reasonable to assume, that a desire to succeed can exist even though 
symptoms are present that makes it seem impossible to achieve success. 
 Recognizing support (strategy 4) returns to the earlier pattern with mild to 
moderate significant negative associations between the strategy and each symptom scale.  
Many individuals who are actively symptomatic feel isolated and without necessary 
support.  If symptoms are associated with poor recognition of support then this may 
suggest another problem in obtaining and maintaining support for those with mental 
illness.  Nonetheless, it cannot be dismissed that the problem, in some cases, is true 
abandonment by the support system for those who are symptomatic because of fear, 
disgust, or blame.  The fifth strategy (help seeking) has negative though less intense 
associations with each symptom scale.  Active symptoms appear to reduce help seeking 
behavior.  Chronic or acute symptoms can interfere with the ability to acknowledge the 
need for help and to follow through with a request.  Finally, symptom eradication 
(strategy six) is not significantly related to any symptom scale.  This is rational as the 
belief in a symptom free life would be hard to maintain in the face of active symptoms. 
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 Other Domain 1 variables were correlated with recovery strategies including age 
of onset, lifetime hospitalizations, total years employed and familial mental illness (Table 
36).  Starting with age of onset, the only significant association is with symptom 
eradication.  Specifically, later onset is weakly associated with belief in symptom 
eradication.  Having a longer period of time before onset provides a stronger sense of self 
and history that is disease free and may act as a base and a remembered time of non-
illness that the person believes they will eventually see again. 
 The number of lifetime hospitalizations is not significantly associated with any of 
the recovery strategies except for symptom eradication.  This is unexpected considering 
hospitalization is viewed as a negative occurrence for many clients, though the recovery 
movement has consistently viewed hospitalization and relapse as another part of the  
 
Table 36 
 
Pearson Correlation Results for Recovery Strategies and Age of Onset, Lifetime Hospitalization, Years 
Employed, and Familial Mental Illness 
 
 Effective 
illness 
management 
 
Positive 
future 
orientation 
Meaningfulness 
personal 
control and 
hope 
 
Recognizing 
support 
Help 
seeking 
Symptom 
eradication 
Age of Onset 
 
-0.04 0.02 0.02 0.00 0.02 0.13a
Hospitalizations 
in Lifetime 
 
-0.09 -0.08 -0.01 -0.04 0.05 -0.15b
Total years 
employed 
 
-0.11a -0.12a -0.04 -0.16b -0.01 -0.11a
Mental illness: 
nuclear family 
 
-0.12a -0.10 0.08 -0.08 -0.04 -0.18c
Mental illness:  
extended family 
 
-0.08 -0.10 0.04 -0.10 -0.06 -0.14b
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; d p ≤ .0001 
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recovery journey.  However, examining the difference in recovery strategy endorsement 
between individuals who were and were not hospitalized in the 12-months prior to data  
collection (Table 37) finds that effective illness management is sanctioned less by those 
who were hospitalized compared to those that were not, as is positive future orientation.  
Thus, how recently an individual was hospitalized may have more impact on 
implementation of recovery strategies then the number of hospitalizations. 
 Total years employed correlated with recovery strategies provides additional 
counterintuitive findings (Table 36).  Albeit of minimal magnitude, every strategy is 
negatively correlated with total years employed suggesting that employment reduces 
commitment to recovery strategies.  This is difficult to explain unless employment is 
indicative of some status that does not require recovery strategies, thus the association 
would be non-relevant.  When comparing those that are currently employed to those who 
are not on recovery strategies (Table 37) effective illness management and positive future 
orientation are endorsed significantly more by those that are employed.  This might 
indicate a more specific and immediate association between employment and recovery 
strategies.  Addressing Table 36 a final time, familial mental illness is weakly associated 
with two recovery strategies.  Effective illness management is negatively associated with 
nuclear family mental illness and may be a response to poor role modeling, that is 
growing up with a parent or sibling that is mentally ill may not, in some case, provide 
direction in how to handle ones own onset of symptoms, though this is speculative.  In a 
similar fashion, symptom eradication is negatively associated with familial mental illness,  
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Table 37 
 
Independent Sample T-test Results for Research Strategies and Hospitalization in Last Year, Employment, Substance Abuse, Medication and Abuse/Assault 
Variables 
 
  Effective illness 
management 
 
Positive future 
orientation 
Meaningfulness, 
personal control 
and hope 
Recognizing 
support 
Help seeking Symptom 
eradication 
 n Mean 
(s.d.) 
 
t-test Mean 
(s.d.) 
t-test Mean 
(s.d.) 
t-test Mean 
(s.d.) 
t-test Mean 
(s.d.) 
t-test Mean 
(s.d.) 
t-test 
Hospitalized in last 
year 
             
  NO 230 3.38 
(0.76) 
2.71b 4.03 
(0.62) 
2.71b 4.20 
(0.45) 
-0.44 3.77 
(0.94) 
0.05 3.98 
(0.83) 
-0.22 3.05 
(1.22) 
0.69 
  YES 
 
120 3.02 
(0.71) 
 3.83 
(0.71) 
 4.22 
(0.47) 
 3.77 
(1.01) 
 4.00 
(0.85) 
 2.87 
(1.29) 
 
Currently 
Employed 
             
  NO 276 3.25 
(0.72) 
-2.52b 3.92 
(0.64) 
-2.45b 4.19 
(0.45) 
-1.22 3.76 
(0.95) 
-0.65 4.01 
(0.80) 
0.95 3.14 
(1.26) 
-0.87 
  YES 
 
74 3.49 
(0.81) 
 4.13 
(0.70) 
 4.26 
(0.47) 
 3.84 
(1.03) 
 3.89 
(0.97) 
 3.28 
(1.19) 
 
Co-occurring 
substance use 
             
  NO 231 3.26 
(0.77) 
-1.64 3.91 
(0.69) 
-2.28a 4.20 
(0.47) 
-0.24 3.76 
(0.94) 
-0.23 3.98 
(0.86) 
-0.08 3.22 
(1.28) 
0.94 
  YES 
 
119 3.39 
(0.70) 
 4.07 
(0.57) 
 4.21 
(0.44) 
 3.79 
(1.02) 
 3.99 
(0.80) 
 3.08 
(1.18) 
 
Anti-psychotic 
medication 
             
  NO 195 3.36 
(0.81) 
1.72 4.01 
(0.67) 
1.52 4.23 
(0.45) 
1.36 3.81 
(1.01) 
0.73 4.00 
(0.85) 
0.45 3.21 
(1.21) 
0.65 
  YES 
 
 
155 3.23 
(0.66) 
 3.90 
(0.64) 
 4.17 
(0.47) 
 3.73 
(0.91) 
 3.96 
(0.82) 
 3.12 
(1.29) 
 
227 
Table 37 (cont.) 
 
  
 
Effective illness 
management 
 
Positive future 
orientation 
Meaningfulness 
personal control 
and hope 
Recognizing 
support 
Help seeking Symptom 
eradication 
 n Mean 
(s.d.) 
 
t-test Mean 
(s.d.) 
t-test Mean 
(s.d.) 
t-test Mean 
(s.d.) 
t-test Mean 
(s.d.) 
t-test Mean 
(s.d.) 
t-test 
Anti-depressant 
medication 
             
  NO 84 3.51 
(0.77) 
2.91b 4.18 
(0.60) 
3.55c 4.22 
(0.49) 
0.40 3.86 
(0.99) 
0.91 4.01 
(0.88) 
0.35 3.37 
(1.26) 
1.67 
  YES 
 
266 3.24 
(0.73) 
 3.90 
(0.66) 
 4.20 
(0.45) 
 3.75 
(0.96) 
 3.97 
(0.82) 
 3.11 
(1.23) 
 
Anti-manic 
medication 
             
  NO 254 3.36 
(0.75) 
2.47b 4.01 
(0.65) 
2.14a 4.20 
(0.46) 
0.02 3.83 
(0.94) 
1.73 4.02 
(0.82) 
1.35 3.21 
(1.24) 
0.91 
  YES 
 
96 3.14 
(0.72) 
 3.84 
(0.65) 
 4.20 
(0.47) 
 3.63 
(1.02) 
 3.88 
(0.88) 
 3.07 
(1.26) 
 
Anti-anxiety 
medication 
             
  NO 
 
167 3.53 
(0.74) 
5.74d 4.05 
(0.69) 
2.37a 4.21 
(0.50) 
0.10 3.88 
(0.95) 
2.03a 4.05 
(0.83) 
1.37 3.29 
(1.24) 
1.67 
  YES 
 
183 3.09 
(0.69) 
 3.89 
(0.61) 
 4.20 
(0.42) 
 3.67 
(0.97) 
 3.93 
(0.84) 
 3.07 
(1.24) 
 
Other psychotropic              
  NO 
 
237 3.32 
(0.80) 
0.91 4.00 
(0.67) 
1.51 4.22 
(0.45) 
1.19 3.79 
(1.00) 
0.52 3.98 
(0.85) 
-0.20 3.17 
(1.24) 
-0.06 
  YES 
 
113 3.25 
(0.62) 
 3.89 
(0.62) 
 4.16 
(0.48) 
 3.73 
(0.90) 
 4.00 
(0.81) 
 3.18 
(1.26) 
 
Child sexual abuse              
  NO 
 
203 3.42 
(0.78) 
3.48c 4.02 
(0.67) 
1.85 4.18 
(0.48) 
-1.33 3.82 
(0.94) 
1.12 4.00 
(0.87) 
0.38 3.30 
(1.21) 
2.38a
  YES 
 
147 3.14 
(0.68) 
 3.89 
(0.63) 
 4.24 
(0.43) 
 3.71 
(0.99) 
 3.96 
(0.80) 
 2.99 
(1.27) 
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Table 37 (cont.) 
 
  Effective illness 
management 
 
Positive future 
orientation 
Meaningfulness 
personal control 
and hope 
Recognizing 
support 
Help seeking Symptom 
eradication 
 n Mean 
(s.d.) 
 
t-test Mean 
(s.d.) 
t-test Mean 
(s.d.) 
t-test Mean 
(s.d.) 
t-test Mean 
(s.d.) 
t-test Mean 
(s.d.) 
t-test 
Child physical 
abuse 
             
  NO 
 
213 3.35 
(0.77) 
1.57 3.99 
(0.65) 
0.90 4.19 
(0.46) 
-0.62 3.83 
(0.96) 
1.32 3.99 
(0.82) 
0.28 3.21 
(1.24) 
0.74 
  YES 
 
137 3.22 
(0.70) 
 3.93 
(0.65) 
 4.22 
(0.46) 
 3.69 
(0.97) 
 3.97 
(0.86) 
 3.11 
(1.26) 
 
Adult sexual 
assault 
             
  NO 
 
234 3.39 
(0.76) 
3.18c 4.00 
(0.67) 
1.47 4.21 
(0.46) 
0.19 3.82 
(0.95) 
1.34 4.01 
(0.83) 
0.92 3.30 
(1.24) 
2.85b
  YES 
 
116 3.12 
(0.68) 
 3.89 
(0.62) 
 4.20 
(0.46) 
 3.68 
(0.99) 
 3.93 
(0.85) 
 2.91 
(1.22) 
 
Adult physical 
assault 
             
  NO 
 
212 3.35 
(0.76) 
1.40 3.97 
(0.68) 
0.16 4.19 
(0.47) 
-0.81 3.86 
(0.91) 
2.17a 4.00 
(0.83) 
0.32 3.28 
(1.25) 
2.00a
  YES 
 
138 3.23 
(0.73) 
 3.96 
(0.62) 
 4.23 
(0.45) 
 3.63 
(1.02) 
 3.97 
(0.86) 
 3.01 
(1.22) 
 
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; d p ≤ .0001 
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though this time with extended family as well as nuclear family.  This suggests that belief 
in symptom eradication decreases with an increase in familial mental illness. 
 Being diagnosed with a co-occurring substance use disorder is associated with 
greater endorsement of recovery strategies for those with the substance diagnosis (Table 
37).  However, this is significant only for the strategy of positive future orientation.  This 
may reflect the emphasis on recovery that is considerably more established in substance 
abuse intervention than mental illness and may also indicate commonalities between 
mental health and substance abuse recovery, though there is little empirical research 
targeting both forms of recovery in comparison.  Symptom eradication, though not 
significant, is the one strategy that those who do not have a substance abuse diagnosis 
sanction to a greater degree.  This remains consistent with substance abuse recovery since 
the disease is considered life long and eradication is not one of the beliefs or goals, 
though management of the primary symptom, using substances, is a goal. 
 The association between medication category and recovery strategies indicates 
that those not taking medication have a higher mean score on almost every recovery 
strategy (Table 37).  This does not reach statistical significance in each instance but the 
trend is consistent.  Anti-psychotic and the category of ‘other’ psychotropic medication 
are not significantly related to any recovery strategy.  Non-use of anti-depressant 
medication is significant for the strategy of effective illness management.  Clinically, 
adherence to a medication regimen is a very common, if not the most common, mode of 
symptom and disease management.  This association, however, indicates that effective 
illness management does not rely on medication.  The simplistic bivariate relationship 
dos not offer the opportunity to assess the direction of the relationship and the pattern 
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noted could indicate that individuals with higher levels of symptoms require medication 
and that this is simply a proxy of the relationship noted in Table 35 wherein every 
symptom scale was negatively associated with each recovery strategy.  The pattern of 
non-medication use for effective illness management reaches significance for anti-manic 
medication and anti-anxiety medication as well. 
 Medication use is associated with lower mean scores on recovery strategy 2, 
positive future orientation (Table 37).  For anti-depressant medication, a significant 
association is noted, as it is for anti-manic medication and anti-anxiety medication.  The 
strategies of meaningfulness, personal control and hope (strategy 3), help seeking 
(strategy 4) and symptom eradication (strategy 6) are not significantly associated with 
any medication category.  Recognizing support (strategy 4) is significantly associated 
with anti-anxiety medication only. 
 The last domain 1 variables to be investigated are the abuse related variables.  The 
trend is similar to the one noted in medication use; abuse survivors have lower scores, in 
general, on recovery strategies, and this relationship is significant in a few cases (Table 
37).  It is interesting that the recovery strategy of meaningfulness, personal control, and 
hope has the only negative associations.  Though not significant, this means that those 
who did experience abuse, specifically child sexual abuse, child physical abuse, and adult 
physical assault, have higher mean scores for strategy endorsement.  This may reflect the 
clinical intervention typical for this population:  the focus on finding hope, regaining 
personal control and building a life filled with meaning (Alexander, Muenzenmaier, 
Dumont, & Auslander, 2005).  Survivors of child sexual abuse (CSA) have a significantly 
lower mean score compared to those who did not experience CSA on effective illness 
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management.  Symptom eradication is also significantly associated with CSA with CSA 
survivors sanctioning eradication less than the non-abused.  Child physical abuse is not 
significantly related to any of the recovery strategies. 
 Adult sexual assault (ASA) is significantly associated to the same two strategies 
as CSA:  effective illness management and symptom eradication.  The direction is 
identical for both associations, with survivors scoring lower means on both strategies.  
This may reflect some common underlying process since the correlation between 
experiencing CSA and ASA is significant, though only moderate in magnitude (r(348) = 
0.47, p ≤ .0001).  Adult physical assault is significant in association with recognition of 
support and symptom eradication.  Symptom eradication, thus, is significant for three of 
four abuse variables. 
 
Research question 3.2:  Are social factors associated with recovery expectancy? 
 The three social constructs or sub-domains (stigma, social support, and 
empowerment) are investigated for patterns of association with the recovery strategies 
using Pearson correlations.  The results are displayed in Table 38.  With only two 
exceptions all stigma subscales are negatively associated with recovery strategies.  The 
magnitude of associations is low to moderate with the strongest correlations noted for 
effective illness management and positive future orientation across stigma subscales.  
Symptom eradication is the one subscale not significantly associated with any of the 
stigma subscales while the other five recovery strategies are significantly associated with 
every stigma subscale.  This, as noted, is possibly due to symptom eradication being a  
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Table 38 
 
Pearson Correlation Results for Recovery Strategies and Domain 2 Variables (Stigma, Social Support, and Empowerment) 
 
 Effective illness 
management 
 
Positive future 
orientation 
Meaningfulness, 
personal control 
and hope 
Recognizing 
support 
Help seeking Symptom 
eradication 
Stigma
 
      
Alienation 
 
-.57d -.47d -.25d -.43d -.26d -.05 
Stereotype endorsement 
 
-.35d -.33d -.33d -.22d -.18c .04 
Discrimination occurrence 
 
-.44d -.35d -.16d -.30d -.18c -.06 
Social withdrawal 
 
-.52d -.52d -.26d -.38d -.25d -.06 
Stigma resistance 
 
-.55d -.49d -.39d -.40d -.32d .02 
Social Support 
 
      
Partner/best friend support 
 
.37d .42d .25d .58d .35d .06 
Support via family 
 
.26d .32d .18c .53d .20d .05 
Support via provider 
 
.24d .34d .26d .28d .34d .11a
Support via friends 
 
.32d .37d .27d .48d .31d .06 
Community involvement 
 
.39d .42d .27d .20d .28d .16b
Trust 
 
 
 
 
-.08 .03 .08 .08 .08 -.07 
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Table 38 (cont.) 
 
 Effective illness 
management 
 
Positive future 
orientation 
Meaningfulness, 
personal control 
and hope 
Recognizing 
support 
Help seeking Symptom 
eradication 
Empowerment
 
      
Self-esteem/self-efficacy 
 
.63d .73d .34d .45d .36d .18c
Power/powerlessness 
 
.27d .31d .07 .22d .16b -.17c
Community activism and 
autonomy 
 
.25d .33d .46d .22d .13b .08 
Optimism and control over future 
 
.46d .45d .39d .39d .22d .23d
Righteous anger 
 
.01 .01 -.07 -.07 -.07 -.13a
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; d p ≤ .0001 
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single item measuring a narrow recovery strategy and the other strategies are composite 
variables that measure broader concepts. 
 Social support, community connectedness and trust are, for the most part, 
positively associated with recovery strategies (Table 38).  Recognition of support 
(strategy 4) is significantly associated with increased strategy endorsement in all cases 
except for trust.  All associations are mild to moderate in magnitude.  The strongest 
associations are between the strategies of recognizing support and positive future 
orientation with social support variables.  Considering that it may require the recognition 
of support to benefit from support, the magnitude of the associations are surprisingly 
weak since they are quite conceptually linked.  Though support is necessary for 
immediate needs it also is required for future needs and goals, thus the magnitude of 
these associations match expectations.  Recovery strategies are conceptualized as active 
concepts, requiring behavioral as well as cognitive and emotional investment.  
Community involvement also requires action and is significantly associated with all the 
recovery strategies. 
 The last set of subscales addresses empowerment.  In most cases, empowerment is 
associated with increased sanction of recovery strategies (Table 38). This is particularly 
true for self-esteem/self-efficacy and optimism and control over the future.  Self-esteem 
is highly associated with effective illness management and positive future orientation.  As 
noted previously, the causality of the association cannot be determined, so it is unclear 
whether effective illness management leads to greater self-esteem or vice versa. An 
additional possibility is that some other factor is driving the relationship, which, however, 
is unsupported in this study, considering the link between self-esteem and illness 
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management established in the recovery literature (Rusch, Lieb, Bohus, & Corrigan, 
2006; Shahar & Davidson, 2003).  The absence of association is sometimes relevant and, 
in the case of meaningfulness, personal control and hope (strategy 3) and 
power/powerlessness, this is true.  The expectation is that personal experience of power 
would associate positively with control and meaning.  It is unclear why this association is 
absent. 
Research question 3.3:  Are service factors associated with recovery expectancy? 
 Service factor Pearson correlations with recovery strategies are provided in Table 
39.  Total number of services is not significantly associated with any recovery strategy.  
Total contact hours is significantly associated with positive future orientation and 
recognizing support.  This indicates that a positive future orientation decreases with the 
number of contact hours.  Individuals with chronic mental illness are often counseled to 
limit their lives to manage stress and thus reduce exacerbation of symptoms and this may  
Table 39 
 
Pearson Correlation Results for Recovery Strategies and Domain 3 Service Variables 
 
 Effective 
illness 
management 
 
Positive 
future 
orientation 
Meaningfulness, 
personal control 
and hope 
Recognizing 
support 
Help 
seeking 
Symptom 
eradication 
Total number 
of services 
 
.01 -.07 .02 .08 .04 -.09 
Total contact 
hours 
 
.03 -.13a -.03 .13a .00 -05 
Average 
satisfaction 
 
.31d .35d .13a .40d .30d .01 
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; d p ≤ .0001 
 
 
. 
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be reflected here.  In contrast, recognition of support increases with contact hours, 
possibly reflecting the benefits of clinical intervention. 
Individuals with serious mental illness often appreciate the attention and nurturing 
support of providers and recognize this as supporting.  Average satisfaction demonstrates 
the most consistent and significant relationship with recovery strategies.  Satisfaction 
with services is positively correlated with all recovery strategies and is significant for all 
but symptom eradication.  Client satisfaction is often a combination of adequate service 
and rapport.  This is a positive finding for the interface of recovery and clinical services. 
 A summary of bivariate support for each of the hypotheses by recovery strategy is 
provided in Table 40.  Similar to Table 32, this display is meant to provide a summary of 
two-variable covariance and is not meant as a final word on support for the hypotheses.  
This concludes bivariate analyses.  Attention is next turned to multivariate analysis to 
more directly explore research questions two through five.
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Table 40 
 
Summary of Bivariate Results for Research Question 3 Hypotheses 
 
  Effective 
Illness 
Management 
 
Positive 
Future 
Orientation 
Meaningfulness, 
Personal 
Control and 
Hope 
 
Recognizing 
Support 
Help 
Seeking 
Symptom 
eradication 
Hypothesis 
 
Statement Supported? Supported? Supported? Supported? Supported? Supported?
Hyp3.1a Less severe diagnoses will be associated with 
higher recovery expectancy. 
      
Hyp3.1b Lower somatization symptoms reported by 
participants will be associated with higher recovery 
expectancy. 
? ? 
 
? 
  
Hyp3.1c Lower obsessive-compulsive symptoms reported 
by participants will be associated with higher 
recovery expectancy. 
? ? 
 
? ? 
 
Hyp3.1d Lower interpersonal sensitivity reported by 
participants will be associated with higher recovery 
expectancy. 
? ? 
 
? ? 
 
Hyp3.1e Lower symptoms of anxiety reported by 
participants will be associated with higher recovery 
expectancy. 
? ? 
 
? ? 
 
Hyp3.1f Lower symptoms of depression reported by 
participants will be associated with higher recovery 
expectancy. 
? ? 
 
? ? 
 
Hyp3.1g Lower hostility reported by participants will be 
associated with higher recovery expectancy. ? ? 
 ? ?  
Hyp3.1h Lower phobic anxiety reported by participants will 
be associated with higher recovery expectancy. ? ? ? ? ? 
 
Hyp3.1i Lower paranoid ideation reported by participants 
will be associated with higher recovery 
expectancy. 
 
? ? 
 
? ? 
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Table 40 (cont.) 
 
  Effective 
Illness 
Management 
 
Positive 
Future 
Orientation 
Meaningfulness, 
Personal 
Control and 
Hope 
 
Recognizing 
Support 
Help 
Seeking 
Symptom 
eradication 
Hypothesis 
 
Statement Supported? Supported? Supported? Supported? Supported? Supported?
Hyp3.1j Lower psychoticism reported by participants will 
be associated with higher recovery expectancy. ? ? 
 ? ?  
Hyp3.1k Absence of a comorbid substance use disorder will 
be associated with higher recovery expectancy for 
participants. 
      
Hyp3.1l Lower numbers of lifetime psychiatric 
hospitalizations will be associated with higher 
recovery expectancy for participants. 
      
Hyp3.1m No psychiatric hospitalization in the last year will 
be associated with higher recovery expectancy for 
participants. 
? ? 
    
Hyp3.1n Older age at onset of disorder will be associated 
with higher recovery expectancy for participants. 
     ? 
Hyp3.1o Absence of prescribed anti-depressant medication 
will be associated with higher recovery expectancy 
for participants. 
? ? 
    
Hyp3.1p Absence of prescribed anti-psychotic medication 
will be associated with higher recovery expectancy 
for participants.  
      
Hyp3.1q 
 
 
Absence of prescribed anti-mania medication will 
be associated with higher recovery expectancy for 
participants. 
? ? 
    
Hyp3.1r Absence of prescribed anti-anxiety medication will 
be associated with higher recovery expectancy for 
participants. 
 
 
? ? 
 
? 
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  Effective 
Illness 
Management 
 
Positive 
Future 
Orientation 
Meaningfulness, 
Personal 
Control and 
Hope 
 
Recognizing 
Support 
Help 
Seeking 
Symptom 
eradication 
Hypothesis 
 
Statement Supported? Supported? Supported? Supported? Supported? Supported?
Hyp3.1s Absence of any other prescribed psychotropic 
medication will be associated with higher recovery 
expectancy for participants. 
  
    
Hyp3.1t Being currently employed will be associated with 
higher recovery expectancy for participants. ? ? 
    
Hyp3.1u Greater number of years worked will be associated 
with higher recovery expectancy for participants. 
      
Hyp3.1v Absence of familial mental illness in first-degree 
relatives will be associated with higher recovery 
expectancy for participants. 
? 
    
? 
Hyp3.1w Absence of familial mental illness in extended 
family members will be associated with higher 
recovery expectancy for participants. 
     
? 
Hyp3.1x Absence of child sexual abuse will be associated 
with higher recovery expectancy for participants. ? 
    ? 
Hyp3.1y Absence of child physical abuse will be associated 
with higher recovery expectancy for participants. 
      
Hyp3.1z Absence of adult sexual assault will be associated 
with higher recovery expectancy for participants. ? 
    ? 
Hyp3.1aa Absence of adult physical assault will be 
associated with higher recovery expectancy for 
participants. 
   
? 
 
? 
Hyp3.3a Lower feelings of alienation will be associated 
with higher recovery expectancy for participants. ? ? ? ? ? 
 
Hyp3.3b Lower respondent endorsement of mental illness 
stereotypes will be associated with higher recovery 
expectancy for participants. 
? ? ? ? ? 
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  Effective 
Illness 
Management 
 
Positive 
Future 
Orientation 
Meaningfulness, 
Personal 
Control and 
Hope 
 
Recognizing 
Support 
Help 
Seeking 
Symptom 
eradication 
Hypothesis 
 
Statement Supported? Supported? Supported? Supported? Supported? Supported?
Hyp3.3c Lower number of discrimination experiences will 
be associated with higher recovery expectancy for 
participants. 
 
? ? ? ? ? 
 
Hyp3.3d Lower endorsement of social withdrawal will be 
associated with higher recovery expectancy for 
participants. 
? ? ? ? ? 
 
Hyp3.3e Greater endorsement of stigma resistance will be 
associated with higher recovery expectancy for 
participants. 
? ? ? ? ? 
 
Hyp3.3f Greater support through intimate partner or a best 
friend will be associated with higher recovery 
expectancy for participants. 
? ? ? ? ? 
 
Hyp3.3g Greater support through family members will be 
associated with higher recovery expectancy for 
participants. 
? ? ? ? ? 
 
Hyp3.3h Greater support via mental health providers will be 
associated with higher recovery expectancy for 
participants. 
? ? ? ? ? ? 
Hyp3.3i Greater support through friendship will be 
associated with higher recovery expectancy for 
participants. 
? ? ? ? ? 
 
Hyp3.3j Greater feelings of being connected to the 
community will be associated with higher recovery 
expectancy for participants. 
 
 
? ? ? ? ? 
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  Effective 
Illness 
Management 
 
Positive 
Future 
Orientation 
Meaningfulness, 
Personal 
Control and 
Hope 
 
Recognizing 
Support 
Help 
Seeking 
Symptom 
eradication 
Hypothesis 
 
Statement Supported? Supported? Supported? Supported? Supported? Supported?
Hyp3.3k Greater trust in the motivation of others will be 
associated with higher recovery expectancy for 
participants. 
      
Hyp3.3l Higher ratings of self-esteem and self-efficacy will 
be associated with higher recovery expectancy for 
participants. 
 
? ? ? ? ? ? 
Hyp3.3m Higher ratings of personal power will be associated 
with higher recovery expectancy for participants. ? ? 
 ? ? ? 
Hyp3.3n Greater involvement in the community will be 
associated with higher recovery expectancy for 
participants. 
? ? ? ? ? 
 
Hyp3.3o Greater confidence in personal control over the 
future will be associated with higher recovery 
expectancy for participants. 
? ? ? ? ? ? 
Hyp3.3p Higher ratings of righteous anger will be 
associated with higher recovery expectancy for 
participants. 
     
? 
Hyp3.3a Total number of services will be associated with 
higher recovery expectancies for participants. 
      
Hyp3.3b The average number of contact hours per month 
will be associated with higher recovery 
expectancies for participants. 
      
Hyp3.3c Satisfaction level with services will be associated 
with higher recovery expectancies for participants. 
 
? ? ? ? ? 
 
 
 242
Multivariate Analysis 
 An assessment of multicollinearity was completed prior to following the analysis 
plan outlined below.  Multicollinearity was assessed with the tolerance statistic and one 
variable violated the preset cutpoint.  The Global Severity Index (GSI) of the Symptom 
Checklist 90-Revised was below the cutpoint of .20 and was dropped from further 
analyses.  The GSI tolerance was .08, indicating that it was highly correlated with, most 
likely, other symptom variables.   
Modifications to the Analysis Plan 
 There were two general modifications to the analysis plan.  Previously noted in 
Chapter 3, when attempting to generate the composite dependent variable based on 
number of recovery strategies endorsed per respondent for probit analysis, too many 
combinations of recovery strategies were sanctioned.  Sixty-three of a possible 66 
combinations of recovery strategies were endorsed by one or more respondents.  This 
indicates a wide variance in individual strategy use, supporting the common statement in 
the consumer driven recovery literature that recovery is an idiosyncratic and personal 
process.  From a pragmatic perspective, a dependent variable with 63 levels was judged 
too imprecise and unwieldy to generate usable information and probit analysis was 
dropped from further consideration.   
 The final modification included dropping two variables from the domain three 
service factors.  The variables dropped were: (1) the contribution of services to recovery, 
and (2) the housing variable.  The contribution to recovery variable was a dichotomous 
(yes/no) statement of whether services in general contributed to recovery.  Nearly 99% of 
the respondents answered affirmatively.  When considering the housing variable, 
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approximately 94% of the respondents are living independently, again limiting variance, 
influencing the decision to drop the variable from further analysis. 
Overview 
 This study focused on five overarching research questions that examine (1) 
whether there is a difference in recovery expectancy between the two samples (SMI and 
OP), targeted above in bivariate analysis, (2) what factors are associated with recovery 
expectancy; (3) what factors are associated with each of the six defined recovery 
strategies; (4) whether recovery expectancy mediates or moderates the relationship 
between independent variable domains 1-3 (clinical, social, and service) and recovery 
strategies, and (5) whether membership in the SMI or OP samples (a proxy for severity of 
mental illness) moderates the relationship between variable domains 1-3 and recovery 
strategies. 
 Research questions 2 and 3 are examined via a sequence of statistical models 
beginning with control variables, then domain 1 variables with accompanying 
hypotheses, followed by domain 2, and finishing with domain 3.  Next, the effects of 
diagnostics are detailed followed by discussion of the full or main effects model.  A 
restricted model containing only the independent variables that were significantly 
associated with the dependent variable for each research question assesses the degree in 
which non-significant variables contribute to the variance explained.  This assumes that 
there are significant main effect results.  A final table summarizing the results of the 
analysis for each dependent variable is provided for easier comparison across the 
different models. 
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 The same sequence noted above is used to examine the mediating and moderating 
effect of recovery expectancy, targeting research questions 4a and 4b.  Research question 
5 also uses the same progression to examine moderating effects of illness severity. 
Focus on Recovery Expectancy 
 Recovery expectancy, a dichotomous forced choice variable asking whether the 
respondent expects to recover from mental illness or not, was examined using logistic 
regression.  Research question 2, sub-questions 2.1-2.3, and hypotheses 2.1a-2.3c are 
evaluated in this section (see pages 107-111, Chapter 3).  The logistic regression analysis 
was modeled on those who endorse recovery expectancy.  The general goal was to locate 
factors associated with belief in recovery in hope that this information will assist in 
creating programs that enhance recovery expectancy and the active use of recovery 
strategies.  Using the R-square option in SAS software, the R-square was calculated to 
provide an estimate of variance explained for each model.  The option was included to 
better estimate the usefulness of the results and to maintain consistency with OLS 
regression results addressing research questions 3-5. 
 The control variables of age, gender, income, and education were entered 
simultaneously in a logistic regression model with the dichotomous dependent variable of 
recovery expectancy.  The results are summarized in Table 41.  Gender, income and 
education are not significantly related to recovery expectancy, though income approaches 
significance.  This suggests that higher income may be associated with slightly higher 
expectancy.  Age is significantly related with an odds ratio (OR) of 0.97.  The estimate 
for age is -0.03, indicating that the probability of positively endorsing recovery 
expectancy decreases by .03 with each increase in age.  Thus, younger age is mildly 
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related to increased recovery expectancy.  This may indicate that younger respondents 
have less experience with both illness and the system and thus have greater expectation of 
recovery, a statement reinforced in results from a pilot study for this research (Walby, 
2003a).   
Table 41 
 
Control Variable Logistic Regression Results 
 
Variable 
 
Odds Ratio (95% CI) 
 
p-value 
Age 0.97  (0.95-0.99) .01 
Gender  0.87  (0.54-1.40)   ns 
Income 1.16  (0.95-1.43)   ns 
Education 
 
1.02  (0.80-1.30)   ns 
 
Note:  n = 350; R2 = .03 
  
 
Research Question 2.1:  Are Individual Factors Associated with Recovery Expectancy? 
 Hypotheses 2.1a-2.1aa, pertaining to domain 1 clinical/historical factors, are 
addressed in isolation at this time.  The results of the logistic analysis are summarized in 
Table 42. The full model results at the end of this section provide a more comprehensive 
response. 
 Lower scores on the depression scale are associated with increased recovery 
expectancy.  The estimate for depression is -0.62, meaning there is a probability decrease 
in recovery expectancy of 0.62 for each increase in depression score.  This mirrors 
previous findings of high depression levels associated with poor recovery outcomes 
(Corrigan & Ralph, 2005).  Not being prescribed an anti- anxiety medication increases 
the odds of endorsing recovery, with an estimate of -0.63.  Hence, being prescribed an 
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anti-anxiety medication decreases the probability of endorsing recovery by 0.63.  This 
suggests a link between anxiety and expectancy though it should be noted that none of  
Table 42 
 
Domain 1 (Clinical and Historical Factors)  Logistic Regression Results 
 
H1 Variable  Odds Ratio  
(95% CI) 
 
p-
value 
 Age 0.99  (0.96-1.02)   ns 
 Gender 1.21  (0.64-2.31)   ns 
 Income 1.09  (0.85-1.39)   ns 
 Education 1.17  (0.82-1.52)   ns 
2.1b Somatization 0.83  (0.55-1.26)   ns 
2.1c Obsessive-compulsive 1.07  (0.63-1.81)   ns 
2.1d Interpersonal sensitivity 1.13  (0.84-2.42)   ns 
2.1e Anxiety 0.93  (0.55-1.62)   ns 
2.1f Depression 0.54  (0.31-0.94) .05 
2.1g Hostility 1.19  (0.82-1.71)   ns 
2.1h Phobic anxiety 0.83  (0.56-1.23)   ns 
2.1i Paranoia 0.97  (0.60-1.56)   ns 
2.1j Psychoticism 0.77  (0.47-1.25)   ns 
2.1k Substance abuse history 0.71  (0.41-1.23)   ns 
2.1l Hospitalization history 0.98  (0.96-1.00)   ns 
2.1m Hospitalized in last year 1.36  (0.76-2.46)   ns 
2.1n Age of onset 0.99  (0.97-1.01)   ns 
2.1o Medication:  Anti-depressant 1.54  (0.77-3.09)   ns 
2.1p Medication:  Anti-psychotic 0.82  (0.47-1.43)   ns 
2.1q Medication:  Anti-manic 0.71  (0.40-1.27)   ns 
2.1r Medication:  Anti-anxiety 0.53  (0.30-0.93) .05 
2.1s Medication:  Other psychotropic 0.81  (0.46-1.40)   ns 
2.1t Current employment 0.93  (0.45-1.93)   ns 
2.1u Years of employment 0.99  (0.97-1.02)   ns 
2.1v Nuclear family mental illness 0.93  (0.75-1.15)   ns 
2.1w Extended family mental illness 0.92  (0.61-1.38)   ns 
2.1x Child sexual abuse history 0.92  (0.49-1.70)   ns 
2.1y Child physical abuse history 0.98  (0.54-1.77)   ns 
2.1z Adult sexual assault history 0.65  (0.32-1.33)   ns 
2.1aa Adult physical assault history 1.52  (0.79-2.91)   ns 
 
Note:  n = 350; R2 = .20 
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the anxiety symptom scales were significant in this analysis and that psychiatric 
medications are often prescribed for reasons other then which they were originally 
developed. 
 This domain explains approximately one-fifth of the variance of the expectancy 
construct (R2 = 0.20).   Variance explained is affected, in part, by the number of variables 
entered into the model.   In this case, thirty variables were entered and two were 
significantly associated with recovery expectancy.   
Research Question 2.2:  Are Social Factors Associated with Recovery Expectancy? 
 This section targets hypotheses 2.2a-2.2q, again in isolation, to better understand 
the independent contribution of social factors to recovery expectancy.  The results are 
presented in Table 43.  None of the independent variables are significantly associated 
with recovery expectancy.  Age, a control variable, is significantly associated with 
expectancy in this model and has the same direction and approximate magnitude as age 
did in the control variable model.  It appears that social factors alone have limited 
association with expectancy.  The model does explain approximately 14% of the variance 
without any clear influence by subgroups of social factors (e.g., stigma, social support, or 
empowerment).  When the literature’s focus on social factors in relation to recovery is 
considered, the lack of association between social factors and expectancy is puzzling. 
Research Question 2.3:  Are Service Factors Associated with Recovery Expectancy? 
 The relationship between service factors and recovery expectancy is summarized 
in Table 44, targeting hypotheses 2.3a-2.3c.  Service factors capture relatively little of the 
expectancy variance (R2 = 0.05), though age and average satisfaction with services are  
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Table 43 
 
Domain 2 (Social Factors)  Logistic Regression Results 
 
H1 Variable  Odds Ratio (95% CI) 
 
p-value 
 Age 0.97  (0.95-0.99) .05 
 Gender 1.06  (0.62-1.80)   ns 
 Income 1.09  (0.87-1.37)   ns 
 Education 0.95  (0.72-1.25)   ns 
Stigma    
2.2a Alienation 0.56  (0.29-1.11)   ns 
2.2b Stereotype endorsement 0.60  (0.29-1.27)   ns 
2.2c Discrimination experience 0.64  (0.34-1.20)   ns 
2.2d Social withdrawal 2.23  (0.97-5.09)   ns 
2.2e Stigma resistance 0.88  (0.43-1.78)   ns 
Social Support and Related   
2.2f Partner or best friend support 1.08  (0.81-1.44)   ns 
2.2g Family support 1.17  (0.98-1.39)   ns 
2.2h Provider support 0.86  (0.62-1.19)   ns 
2.2i Friend support 1.05  (0.78-1.41)   ns 
2.2j Community involvement 1.07  (0.84-1.35)   ns 
2.2k Trust 0.95  (0.73-1.24)   ns 
Empowerment   
2.2l Self-esteem/self-efficacy 1.70  (0.84-3.44)   ns 
2.2m Power/powerlessness 1.44  (0.72-2.87)   ns 
2.2n Community activism and 
autonomy 
0.79  (0.39-1.59)   ns 
2.2o Optimism and control over the 
future 
1.07  (0.54-2.13)   ns 
2.2p Righteous anger 1.33  (0.81-2.17)   ns 
 
Note:  n = 350; R2 = .14 
 
 
both significantly associated with expectancy.  Age follows the previous pattern of 
borderline significant, with younger age associated with expectancy endorsement.  
Average satisfaction with services is positively associated with expectancy, with greater 
treatment or service satisfaction increasing the odds of endorsing recovery expectancy by 
34% compared to those with less satisfaction with services.  It is interesting that the 
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subjective satisfaction scale is more highly associated with recovery expectancy then the 
objective scales measuring actual clinical and support contacts, favoring quality over 
quantity. 
Table 44 
 
Domain 3 (Service Factors)  Logistic Regression Results 
 
H1 Variable  Odds Ratio 
 (95% CI) 
 
p-value 
 Age 0.97  0.95-0.99 .01 
 Gender 1.06  0.62-1.80  ns 
 Income 1.09  0.87-1.37  ns 
 Education 0.95  0.72-1.25  ns 
2.3a Total number of services 0.87  0.69-1.09  ns 
2.3b Total service hours per month 1.00  0.97-1.04  ns 
2.3c Average satisfaction score 
 
1.34  1.07-1.68 .01 
 
Note:  n = 350; R2 = .05 
 
 
 
Research Question 2:  Are Individual, Social or Service Factors Associated with 
Recovery Expectancy?:   Main Effects Model 
 As discussed in Chapter 3, diagnostic statistics (e.g., hat values, Cook’s D) were 
used to detect influential observations.  If two of three diagnostic tests were violated then 
an observation was removed from main effect analysis.  A total of eight observations 
violated this criteria and were dropped from the analysis presented next.   Logistic 
regression results for control variables and the three independent variable domains are 
presented in Table 45.  Immediately apparent is the lack of any significant associations in 
the full model, although approximately 25% of the variance is explained.  Several of the 
variables are near significance and may exert greater influence on recovery expectancy  
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Table 45 
 
Main Effects:   Logistic Regression Results 
 
H1 Variable  Odds Ratio (95% CI) p-value 
 Age 0.98  (0.95-1.02) ns 
 Gender 1.12  (0.56-2.25) ns 
 Income 1.10  (0.83-1.44) ns 
 Education 1.15  (0.81-1.63) ns 
Domain 1   
2.1b Somatization 0.75  (0.46-1.21) ns 
2.1c Obsessive-compulsive 1.10  (0.60-2.03) ns 
2.1d Interpersonal sensitivity 1.78  (0.98-3.18) ns 
2.1e Anxiety 0.82  (0.45-1.50) ns 
2.1f Depression 0.60  (0.31-1.16) ns 
2.1g Hostility 1.16  (0.78-1.74) ns 
2.1h Phobic anxiety 0.82  (0.52-1.29) ns 
2.1i Paranoia 1.09  (0.62-1.90) ns 
2.1j Psychoticism 0.80  (0.46-1.38) ns 
2.1k Substance abuse history 0.66  (0.35-1.25) ns 
2.1l Hospitalization history 0.98  (0.95-1.00) ns 
2.1m Hospitalized in last year 1.52  (0.79-2.91) ns 
2.1n Age of onset 1.01  (0.98-1.04) ns 
2.1o Medication:  Anti-depressant 1.31  (0.59-2.87) ns 
2.1p Medication:  Anti-psychotic 0.82  (0.43-1.57) ns 
2.1q Medication:  Anti-manic 0.80  (0.41-1.54) ns 
2.1r Medication:  Anti-anxiety 0.59  (0.32-1.10) ns 
2.1s Medication:  Other psychotropic 0.87  (0.47-1.60) ns 
2.1t Current employment 0.85  (0.38-1.92) ns 
2.1u Years of employment 1.00  (0.97-1.03) ns 
2.1v Nuclear family mental illness 0.89  (0.70-1.13) ns 
2.1w Extended family mental illness 0.88  (0.56-1.38) ns 
2.1x Child sexual abuse history 1.02  (0.52-2.02) ns 
2.1y Child physical abuse history 1.05  (0.54-2.03) ns 
2.1z Adult sexual assault history 0.73  (0.34-1.58) ns 
2.1aa Adult physical assault history 1.30  (0.63-2.65) ns 
Domain 2   
Stigma   
2.2a Alienation 0.48  (0.21-1.11) ns 
2.2b Stereotype endorsement 0.45  (0.18-1.11) ns 
2.2c Discrimination experience 0.80  (0.38-1.70) ns 
2.2d Social withdrawal 2.48  (0.97-6.37) ns 
2.2e Stigma resistance 
 
 
1.06  (0.44-2.52) ns 
 251
Table 45 (cont.) 
 
H1 Variable  Odds Ratio 
 (95% CI) 
p-value 
Social Support and Related   
2.2f Partner or best friend support 1.10  (0.78-1.55) ns 
2.2g Family support 1.11  (0.89-1.38) ns 
2.2h Provider support 0.86  (0.55-1.35) ns 
2.2i Friend support 0.97  (0.68-1.36) ns 
2.2j Community involvement 1.16  (0.87-1.55) ns 
2.2k Trust 1.10  (0.78-1.55) ns 
Empowerment   
2.2l Self-esteem/self-efficacy 0.97  (0.41-2.31) ns 
2.2m Power/powerlessness 1.51  (0.63-3.59) ns 
2.2n Community activism and 
autonomy 
1.17  (0.51-2.67) ns 
2.2o Optimism and control over the 
future 
0.86  (0.38-1.94) ns 
2.2p Righteous anger 1.38  (0.76-2.49) ns 
Domain 3   
2.3a Total number of services 0.97  (0.71-1.34) ns 
2.3b Total service hours per month 1.00  (0.96-1.05) ns 
2.3c Average satisfaction score 
 
1.26  (0.92-1.74) ns 
 
Note:  n = 342; R2 = .25 
 
 
(e.g., interpersonal sensitivity and age of onset).  These might be considered starting 
points for future investigation of recovery expectancy.  It appears that the variables 
chosen for this analysis are not, in general, sufficiently relevant to expectancy. 
 It is important to consider the variables that were significant in the analysis of 
individual domains that were no longer significant in the full model.  Further, other 
variables approached significance in the full model that were clearly unrelated in the 
individual domain analysis.  Table 46 summarizes the models and provides an overview 
of the impact of each independent variable in association with expectancy.  The single 
most consistent variable appears to be age, with younger respondents more likely to 
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Table 46 
 
Summary Table:  Logistic Regression Results for Research Question 2 
 
 Model 1 Model 2 Model 3 Model 4 Model 5 
 
Age ?  ? ?  
Sex      
Income      
Education      
Psychosomatic       
Obsessive Compulsive       
Interpersonal Sensitivity      
Anxiety      
Depression  ?    
Hostility      
Phobia      
Paranoia      
Psychoticism      
Substance History      
Lifetime Hospitalizations      
Hospitalized in Last Year      
Age of Onset      
Anti-Depressant Medication      
Anti-Psychotic Medication      
Anti-Manic Medication      
Anti-Anxiety Medication  ?    
Other Psychotropic Medication      
Currently Employed      
Years Employed Lifetime      
Nuclear Family Mental Illness      
Extended Family Mental Illness      
Child Sexual Abuse      
Child Physical Abuse      
Adult Sexual Assault      
Adult Physical Assault      
Alienation      
Stereotype Endorsement      
Discrimination Occurrence      
Social Withdrawal      
Stigma Resistance      
Partner of Best Friend Support      
Family Support      
Provider Support      
Friends Support      
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Table 46 (cont.) 
 
Community Involvement      
Trust      
Self-Esteem and Self-Efficacy      
Power and Powerlessness      
Community Activism and 
Autonomy 
     
Optimism and Control Over the 
Future 
     
Righteous Anger      
Total Number of Services      
Total Contact Hours      
Average Satisfaction    ?  
 
M1 = Model 1:  n = 350; Control variables 
M2 = Model 2:  n = 350; Control variables + Individual and historical factors 
M3 = Model 3:  n = 350; Control variables + Social factors 
M4 = Model 4:  n = 350; Control variables + Service factors 
M5 = Model 5;  n = 342; Full (main effects) model (post diagnostics) 
 
 
sanction recovery.  Depression and anti-anxiety medication, significant in domain 1 
analysis, are no longer significant in the main effects model.  Similarly, the domain 3 
service variable average satisfaction with services is no longer significant in main effects.  
Joining interpersonal sensitivity and age of onset in approaching significance are 
hospitalization history, years of employment, social withdrawal, and total service hours 
per month. 
 The amount of variance explained in models for each individual domain and 
together in main effects is displayed in Figure 3.  The most influential model for this 
analysis is the clinical/historical, domain 1, variables.  This suggests that altering 
recovery expectancy may begin with clinical factors (e.g., severity of symptoms, types of 
medication prescribed), historical factors (e.g., age when symptoms began, number of  
 
 
Figure 3 
 
Variance Explained by Each Domain of Recovery Expectancy 
 
 
 
 
Control Variables 
(R2 = .03) 
Domain 1: Clinical and 
Historical Factors 
(R2 = .20) 
Full Model 
R2 = .25 
Recovery 
Expectancy 
Domain 3: Service 
Factors 
(R2 = .05) 
Domain 2: Social 
Factors 
(R2 = .14) 
 
  
hospitalizations, when the latest hospitalization occurred), and possibly cognitive or 
intrapsychic factors that were not investigated in this study. 
 Social factors (domain 2) apparently contribute to expectancy as well, though this 
is through the combination of multiple variables in this domain.  Social withdrawal is the 
only social variable that approaches significance.  Number of contact hours per month 
also approaches significance (domain 3).  A future analysis will explore whether type of 
service (e.g., case management, supported living) are associated with expectancy. 
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 The series of logistic regressions presented were targeted to respond to research 
question 2 and the individual hypotheses linked to the research question.  Due to the large 
number of hypotheses it was more comprehensible and less cumbersome to explain each 
model without directly referring to each hypothesis in turn.  However, it is important to 
directly address whether each hypothesis was supported or not.  Thus, Table 47 
summarizes whether sufficient support was found for each hypothesis in the same fashion 
that Table 33 addressed the questions, though at the bivariate level.  As can be seen, no 
hypothesis was supported for research question 2. 
 
Table 47 
 
Summary of Bivariate Results for Research Question 2 Hypotheses 
 
Hypothesis 
 
Statement Supported?
Hyp2.1a The less clinically severe the participant’s diagnosis the more 
recovery expectancy will increase. 
 
Hyp2.1 Lower somatization symptoms reported by participants will be 
associated with higher recovery expectancy. 
 
Hyp2.1c Lower obsessive-compulsive symptoms reported by participants 
will be associated with higher recovery expectancy. 
 
Hyp2.1d Lower interpersonal sensitivity reported by participants will be 
associated with higher recovery expectancy. 
 
Hyp2.1e Lower symptoms of anxiety reported by participants will be 
associated with higher recovery expectancy. 
 
Hyp2.1f Lower symptoms of depression reported by participants will be 
associated with higher recovery expectancy. 
 
Hyp2.1g Lower hostility reported by participants will be associated with 
higher recovery expectancy. 
 
Hyp.1h Lower phobic anxiety reported by participants will be associated 
with higher recovery expectancy. 
 
Hyp2.1i Lower paranoid ideation reported by participants will be associated 
with higher recovery expectancy. 
 
Hyp2.1j Lower psychoticism reported by participants will be associated with 
higher recovery expectancy. 
 
Hyp2.1k Absence of a comorbid substance use disorder will be associated 
with higher recovery expectancy for participants. 
 
Hyp2.1l Lower numbers of lifetime psychiatric hospitalizations will be 
associated with higher recovery expectancy for participants. 
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Table 47 (cont.) 
 
Hypothesis 
 
Hypothesis 
 
Supported? 
 
Hyp2.1m No psychiatric hospitalization in the last year will be associated 
with higher recovery expectancy for participants. 
 
Hyp2.1n Older age at onset of disorder will be associated with higher 
recovery expectancy for participants. 
 
Hyp2.1o Absence of prescribed anti-depressant medication will be associated 
with higher recovery expectancy for participants. 
 
Hyp2.1p Absence of prescribed anti-psychotic medication will be associated 
with higher recovery expectancy for participants.  
 
Hyp2.1q 
 
Absence of prescribed anti-mania medication will be associated 
with higher recovery expectancy for participants. 
 
Hyp2.1r Absence of prescribed anti-anxiety medication will be associated 
with higher recovery expectancy for participants. 
 
Hyp2.1s Absence of any other prescribed psychotropic medication will be 
associated with higher recovery expectancy for participants. 
 
Hyp2.1t Being currently employed will be associated with higher recovery 
expectancy for participants. 
 
Hyp2.1u Greater number of years worked will be associated with higher 
recovery expectancy for participants. 
 
Hyp2.1v Absence of familial mental illness in first-degree relatives will be 
associated with higher recovery expectancy for participants. 
 
Hyp2.1w Absence of familial mental illness in extended family members will 
be associated with higher recovery expectancy for participants. 
 
Hyp2.1x Absence of child sexual abuse will be associated with higher 
recovery expectancy for participants. 
 
Hyp2.1y Absence of child physical abuse will be associated with higher 
recovery expectancy for participants. 
 
Hyp2.1z Absence of adult sexual assault will be associated with higher 
recovery expectancy for participants. 
 
Hyp2.1aa Absence of adult physical assault will be associated with higher 
recovery expectancy for participants. 
 
Hyp2.2a Lower feelings of alienation will be associated with higher recovery 
expectancy for participants. 
 
Hyp2.2b Lower respondent endorsement of mental illness stereotypes will be 
associated with higher recovery expectancy for participants. 
 
Hyp2.2c Lower number of discrimination experiences will be associated with 
higher recovery expectancy for participants. 
 
Hyp2.2d Lower endorsement of social withdrawal will be associated with 
higher recovery expectancy for participants. 
 
Hyp2.2e Greater endorsement of stigma resistance will be associated with 
higher recovery expectancy for participants. 
 
Hyp2.2f Greater support through intimate partner or a best friend will be 
associated with higher recovery expectancy for participants. 
 
Hyp2.2g Greater support through family members will be associated with 
higher recovery expectancy for participants. 
 
Hyp2.2h Greater support via mental health providers will be associated with 
higher recovery expectancy for participants. 
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Table 47 (cont.) 
 
Hypothesis 
 
Hypothesis 
 
Supported? 
 
Hyp2.2i Greater support through friendship will be associated with higher 
recovery expectancy for participants. 
 
Hyp2.2j Greater feelings of being connected to the community will be 
associated with higher recovery expectancy for participants. 
 
Hyp2.2k Greater trust in the motivation of others will be associated with 
higher recovery expectancy for participants. 
 
Hyp2.2l Higher ratings of self-esteem and self-efficacy will be associated 
with higher recovery expectancy for participants. 
 
Hyp2.2m Higher ratings of personal power will be associated with higher 
recovery expectancy for participants. 
 
Hyp2.2n Greater involvement in the community will be associated with 
higher recovery expectancy for participants. 
 
Hyp2.2o Greater confidence in personal control over the future will be 
associated with higher recovery expectancy for participants. 
 
Hyp2.2q Higher ratings of righteous anger will be associated with higher 
recovery expectancy for participants. 
 
Hyp2.3a Total number of services will be associated with higher recovery 
expectancies for participants. 
 
Hyp2.3b The average number of contact hours per month will be associated 
with higher recovery expectancies for participants. 
 
Hyp2.3c Satisfaction level with services will be associated with higher 
recovery expectancies for participants. 
 
 
 
Summary of Research Question 2, Investigating Recovery Expectancy 
 
Recovery expectancy, the belief that one will recover from mental illness, was 
found to be strongly associated with recovery strategy endorsement in bivariate analysis, 
with individuals that do not expect to recover endorsing strategies significantly less for 
all strategies except symptom eradication.  However, in multivariate analysis using 
logistic regression that tested the association between the dichotomous expectancy 
variable and the independent variables in domains 1-3, there were no significant 
relationships detected for direct effects.  Though the variance in the independent 
variables included in the models did account for 25% of the variance of recovery 
expectancy, no significant associations suggests that recovery expectancy is driven by 
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factors not present in this analysis but is supported to a lesser degree by the variables 
included.   
 Despite the lack of multivariate results, there were some intriguing findings in 
bivariate analysis that will be highlighted to better understand expectancy.  Beginning 
with clinical variables, domain 1, a diagnosis of bipolar disorder has the strongest 
relationship to non-belief in recovery compared to other diagnoses.  This is of interest 
considering the almost exclusive focus that schizophrenia has received in the research 
literature on recovery.  Active symptoms are also related to negative belief in recovery, 
with significant associations noted in nine of ten symptom scales.  Psychiatric symptoms 
are often targeted with medication, so it is reasonable to find, in light of increased 
symptoms, an increased use of psychiatric medications in all medication categories 
except anti-depressants by those indicating no expectation of recovery.  Anti-depressants 
are prescribed to 81% of individuals not endorsing recovery and 73% of those that 
believe that they will recover, demonstrating that a prescription for antidepressants is 
ubiquitous, rendering differences irrelevant.  Similarly, more lifetime hospitalizations and 
greater numbers of family members with a mental illness negatively associate with 
expectancy.  Those lacking recovery belief are also more likely to have been physically 
assaulted as a child and sexually assaulted as an adult. 
 Those individuals that believe in recovery have significantly higher average 
scores on 14 of 17 domain 2 social scales that target the constructs of stigma, social 
support and empowerment.  Thus, those that believe in recovery are less likely to report 
alienation, discrimination, and social withdrawal.  They are more likely to express stigma 
resistance and to not endorse stereotypes of the mentally ill.  Support from family and 
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friends are significantly higher for those with recovery beliefs as is an active and positive 
connection to the community.  The self-esteem, optimism, sense of personal power and 
control, belief in community activism and personal autonomy are likewise notably 
elevated in those sanctioning recovery.  Finally, for domain 3, only service satisfaction is 
mildly elevated in those believing in recovery compared to those that are not. 
 As noted, these relationships are not replicated in multivariate analysis.  These are 
preliminary results providing a first look at recovery belief in relation to clinical, social, 
and service factors.  Further research is required to better understand these factors in 
relation to expectancy.  Thus, a summative statement on the results for recovery 
expectancy is that it is a complicated concept that was not adequately modeled in this 
research.  It is reasonable to assume that believing that one will recover is important to 
engaging in and succeeding in recovery.  Further investigation is required to determine 
factors significantly associated with the belief in recovery and to understand their 
relationship with the recovery process. 
 
Focus on Recovery Strategies 
 Analysis pertaining to research question 3 employs the same independent 
variables with recovery strategies as the new dependent variables in place of recovery 
expectancy.  Ordinary least squares (OLS) regression is utilized with the continuous level 
recovery strategy dependent variables.  However, because there are multiple strategies, 
this section will repeat the sequence of analyses used in the previous section six times.  
The six strategies examined include: 
1. Effective illness management 
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2. Positive future orientation 
3. Meaningfulness, personal control, and hope 
4. Recognizing support 
5. Help seeking 
6. Symptom eradication 
Research Question 3:  Are Individual, Social or Service Factors Associated with 
Recovery Strategy #1:  Effective Illness Management? 
 Associations between control variables and effective illness management are 
summarized in Table 48.  The model is significant (F = 4.46, p ≤ .001) and accounts for 
approximately 4% of the variance for strategy 1.  Age and income are just below 
significance with younger age and greater income contributing slightly to strategy 1. 
Gender is significantly associated with strategy 1, with male respondents endorsing 
strategy 1 to a greater degree. 
Research question 3.1:  Are individual factors associated with effective illness 
management? 
 Effective illness management entails active involvement in control of symptoms 
and sequelae (e.g., level of active symptoms, stigma, identifying as a person with mental 
illness, involvement in treatment).  Illness management may include professional services 
or therapy, adjunctive treatments and consumer led interventions.  The following analysis 
examines what factors are important in association with effective illness management for 
individuals with varying levels of diagnosed mental illness.  Hypotheses 3.1a-3.1aa is 
addressed within this analysis as well.  Operating in isolation from social and service 
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Table 48 
 
Results of OLS Regression Testing the Association of Control Variables (Domain 1) on 
Recovery Strategy 1 (Effective Illness Management) 
 
Variable 
 
b SE t 
 
Age -0.01 0.00 -1.90 
Gender -0.26 0.08  -3.03c
Income   0.07 0.04   1.88 
Education 
 
  0.00 0.04   0.11 
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; d ≤ .0001 
           n = 350;  
           R2 = .04; F = 4.46, p ≤ .01 
  
 
factors, the model explains 37% of the variance of effective illness management and the 
model rejects the null hypothesis that R2 = 0 in the population (F = 7.81, p ≤ .0001).  The 
results are summarized in Table 49. 
 The depression symptom score is associated with strategy 1, suggesting that the 
endorsement of this strategy decreases with higher levels of depression.  Likewise, 
prescription of anti-depressant medication is also associated with strategy use, though in 
this case indicating increased endorsement of the strategy with anti-depressant use.  This 
suggests that taking an anti-depressant is a part of active illness management and, when 
effective, would lower depression and possibly increase endorsement of the strategy 
through offsetting the effect of depression.  The effect is reversed for anti-anxiety 
medication, indicating decreased sanctioning of the strategy when prescribed anti-anxiety 
medication.  The majority of recovery research targeting symptoms has focused on 
depression.  However, there is some supporting evidence that anxiety is a key 
impediment to managing symptoms, presenting an obstacle to this recovery strategy  
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Table 49 
 
Results of OLS Regression Testing the Association of Clinical/Historical Variables 
(Domain 1) on Recovery Strategy 1 (Effective Illness Management) 
 
H1 Variable b SE  t 
 Age -0.00 0.00 -0.18 
 Gender -0.08 0.08 -0.93 
 Income  0.04 0.03  1.18 
 Education  0.02 0.04  0.54 
3.1b Somatization  0.15 0.06  2.64 
3.1c Obsessive-compulsive -0.04 0.07 -0.60 
3.1d Interpersonal sensitivity  0.10 0.07  1.39 
3.1e Anxiety -0.13 0.07 -1.88 
3.1f Depression -0.34 0.07  -4.61d
3.1g Hostility -0.02 0.05 -0.37 
3.1h Phobic anxiety -0.09 0.05 -1.76 
3.1i Paranoia -0.04 0.06 -0.58 
3.1j Psychoticism  0.07 0.07  1.03 
3.1k Substance abuse history  0.12 0.07  1.63 
3.1l Hospitalization history -0.00 0.00 -1.03 
3.1m Hospitalized in last year -0.03 0.08 -0.35 
3.1n Age of onset -0.00 0.00 -1.11 
3.1o Medication:  Anti-depressant  0.17 0.09   1.97a
3.1p Medication:  Anti-psychotic -0.01 0.07 -1.41 
3.1q Medication:  Anti-manic -0.05 0.08 -0.59 
3.1r Medication:  Anti-anxiety -0.27 0.07  -3.61c
3.1s Medication:  Other 
psychotropic 
 0.04 0.07  0.50 
3.1t Current employment -0.05 0.09 -0.50 
3.1u Years of employment -0.01 0.00  -2.12a
3.1v Nuclear family mental illness  0.01 0.03  0.47 
3.1w Extended family mental 
illness 
-0.03 0.05 -0.58 
3.1x Child sexual abuse history -0.06 0.08 -0.79 
3.1y Child physical abuse history  0.02 0.08 0.32 
3.1z Adult sexual assault history -0.11 0.09 -1.16 
3.1aa Adult physical assault history 
 
 0.19 0.08   2.27a
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; d ≤ .0001 
           n = 350;  
           R2 = .37; F = 7.81, p ≤ .0001 
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(Bruce, Yonkers, Otto, Eisen, Weisberg, Pagano, 2005; Simon, Otto, Wisniewski, 
Fossey, Sagduyu, Frank et al., 2004). Data was not collected on respondent rated efficacy 
of the medication so it is impossible to investigate this as a potential explanation.  The 
lack of significance noted in the anxiety related symptom subscales (anxiety, phobic 
anxiety, obsessive compulsive) is inconsistent with the anti-anxiety medication finding, 
though anxiety and phobic anxiety do approach significance.  
Two other variables were significantly associated with effective illness 
management.  Total years worked was significantly associated with the strategy.  The 
direction of the association is inconsistent with previous research where work has been 
described as a form of illness management (Walby, 2005).  However, it is unlikely that 
all individuals would think of employment as a form of illness management and might 
view it more as a result of successful illness management (outcome versus process).   
 The final significant association is with adult physical assault.  Assault was not 
defined during data collection and could reflect a stranger assault (e.g. mugging), 
domestic violence or other form of violence.  What can be stated is that increased assault 
experiences increases the likelihood of utilizing illness management.  This might possibly 
reflect the traditional focus in abuse treatment on symptom management due to the high 
levels of depression and post-traumatic stress associated with abusive experiences. 
Research question 3.2:  Are social factors associated with effective illness 
management? 
 Hypotheses 3.2a-3.2q are targeted in this section, evaluating for significance the 
associations between stigma, social support and empowerment with illness management 
(Table 50).  The full model is significant (F = 21.33, p ≤ .0001) and a significant portion 
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of the variance is explained (R2 = .54).  Higher levels of alienation experiences were 
associated with lower endorsement of effective illness management.  Likewise, a lower 
resistance to stigmatization messages and experiences also decreases endorsement of  
Table 50 
 
Results of OLS Regression Testing the Association of  Social Variables (Domain 2) on 
Recovery Strategy 1 (Effective Illness Management) 
 
H1 Variable b SE  t 
 
 Age -0.00 0.00  -1.98a
 Gender -0.08 0.06 -1.36 
 Income -0.01 0.03 -0.26 
 Education -0.02 0.03 -0.60 
Stigma    
3.2a Alienation -0.24 0.08  -3.08c
3.2b Stereotype endorsement -0.06 0.09 -0.75 
3.2c Discrimination experience -0.09 0.07 -1.30 
3.2d Social withdrawal   0.06 0.09  0.68 
3.2e Stigma resistance -0.33 0.08  -4.14d
Social Support and Related    
3.2f Partner or best friend support  0.03 0.03  0.97 
3.2g Family support  0.01 0.02  0.43 
3.2h Provider support  0.06 0.04  1.48 
3.2i Friend support  0.00 0.03  0.06 
3.2j Community involvement  0.08 0.03   3.13c
3.2k Trust -0.04 0.03 -1.15 
Empowerment    
3.2l Self-esteem/self-efficacy  0.42 0.08    5.20d
3.2m Power/powerlessness -0.01 0.06  1.10 
3.2n Community activism and 
autonomy 
-0.13 0.08 -1.65   
3.2o Optimism and control over the 
future 
 0.13 0.08  1.66 
3.2p Righteous anger 
 
 0.06 0.08 -0.17 
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; d ≤ .0001 
           n = 350;  
           R2 = .54; F = 21.33, p ≤ .0001 
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effective illness management.  Social support and related factors are significantly 
correlated with effective illness management for one construct only.  Greater degree of 
community involvement increases effective illness management, but, when compared 
with the two stigma constructs noted above, community involvement does not increase 
effective illness management as much as alienation and lack of resistance decreases it.   
 The most powerful association between a social construct variable and effective 
illness management is with the empowerment construct of self-esteem/self-efficacy.  
Individuals possessed of high self-esteem are more likely to sanction effective illness 
management.  The cross-sectional nature of the study does not supply the direction of the 
relationship.  An argument can be made for either direction:  increased self-esteem 
leading to greater illness management or greater illness management leading to higher 
self-esteem.  In summary, several associations of moderate to high magnitude reflect the 
relationship between social factors effective illness management, again operating in 
isolation from clinical and service factors. 
Research question 3.3:  Are service factors associated with effective illness 
management? 
 Hypotheses 3.3a-3.3c was explored in this analysis.  Table 51 summarizes the 
information.  Age and gender are both significantly associated with effective illness 
management when modeled with service variables only.  As age increases, effective 
illness management is slightly less likely to be endorsed.  Males are more likely to 
engage in effective illness management in association with services factors.  The one 
significant service factor is average satisfaction with services, indicating increased 
satisfaction is associated with increased endorsement of strategy 1.  This is consistent 
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with the recovery literature that indicates a positive and empowering relationship 
increases recovery potential as well as adherence to clinical regimen (Tait, Birchwood, & 
Trower, 2003). 
 
Table 51 
 
Results of OLS Regression Testing the Impact of  Service Variables (Domain 3) on 
Recovery Strategy 1 (Effective Illness Management) 
 
 Variable b SE t 
 Age -0.01 0.00  -2.26a
 Gender -0.24 0.81  -2.94b
 Income  0.05 0.03  1.44 
 Education -0.00 0.04 -0.01 
3.3a Total number of services  0.01 0.04  0.32 
3.3b Total service hours per month -0.00 0.01 -0.15 
3.3c Average satisfaction score 
 
 0.23 0.04   5.93d
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; d ≤ .0001 
           n = 350;  
           R2 = .12; F = 7.91, p ≤ .0001 
  
 
Research question 3:  Are individual, social or service factors associated with 
effective illness management?  Main effects model  
 As discussed in chapter 3 and again above when describing logistic regression 
results, diagnostic statistics (e.g., hat values or Cook’s D) were used to detect influential 
observations.  To remind the reader, if two of three diagnostic tests were violated then an 
observation was removed from main effect analysis.  A total of fifteen observations 
violated this criteria and were dropped from the analysis presented next.    
 The main effect model combines domains 1-3 to assess association with effective 
illness management (Table 52).  The adjusted R2 for this model is 0.67, indicating that  
 267
Table 52 
 
Main Effects Results of OLS Regression Testing the Impact of  Domain 1-3  Variables on 
Recovery Strategy 1 (Effective Illness Management) 
 
H1 Variable b SE t 
 Age -0.00 0.00 -1.32 
 Gender -0.04 0.06 -0.66 
 Income -0.03 0.02 -1.36 
 Education -0.00 0.03 -0.03 
Domain 1    
3.1a Anxiety diagnosis -0.20 0.09  -2.30a
3.1b Somatization  0.05 0.04   1.10 
3.1c Obsessive-compulsive -0.07 0.05 -1.28 
3.1d Interpersonal sensitivity  0.15 0.05    2.82b
3.1e Anxiety -0.08 0.05 -1.51 
3.1f Depression -0.10 0.06 -1.68 
3.1g Hostility -0.03 0.04 -0.78 
3.1h Phobic anxiety -0.05 0.04 -1.15 
3.1i Paranoia -0.04 0.05 -0.75 
3.1j Psychoticism -0.01 0.05 -0.22 
3.1k Substance abuse history  0.06 0.06  1.02 
3.1l Hospitalization history -0.00 0.00 -0.57 
3.1m Hospitalized in last year -0.05 0.06 -0.93 
3.1n Age of onset  0.00 0.00  0.12 
3.1o Medication:  Anti-depressant  0.01 0.07  0.19 
3.1p Medication:  Anti-psychotic -0.11 0.06 -1.82 
3.1q Medication:  Anti-manic -0.02 0.06 -0.27 
3.1r Medication:  Anti-anxiety -0.16 0.06   -2.99b
3.1s Medication:  Other psychotropic  0.02 0.05  0.51 
3.1t Current employment -0.04 0.07 -0.60 
3.1u Years of employment -0.00 0.00 -0.87 
3.1v Nuclear family mental illness -0.00 0.02 -0.15 
3.1w Extended family mental illness -0.01 0.04 -0.35 
3.1x Child sexual abuse history -0.08 0.06 -1.30 
3.1y Child physical abuse history  0.04 0.06  0.67 
3.1z Adult sexual assault history -0.00 0.07 -0.08 
3.1aa Adult physical assault history  0.10 0.06  1.63 
Domain 2    
Stigma    
3.2a Alienation -0.07 0.07 -0.97 
3.2b Stereotype endorsement -0.03 0.08 -0.42 
3.2c Discrimination experience -0.05 0.06 -0.72 
3.2d Social withdrawal  0.02 0.08  0.28 
3.2e Stigma resistance -0.40 0.08   -5.31d
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Table 52 (cont.) 
 
 Variable 
 
b SE t 
Social Support and Related    
3.2f Partner or best friend support 0.03 0.03  1.18 
3.2g Family support 0.01 0.02  0.47 
3.2h Provider support 0.01 0.04  0.20 
3.2i Friend support 0.01 0.03  0.34 
3.2j Community involvement 0.08 0.02   3.18b
3.2k Trust 0.00 0.03  0.11 
Empowerment    
3.2l Self-esteem/self-efficacy 0.28 0.08   3.69c
3.2m Power/powerlessness 0.04 0.07  0.55 
3.2n Community activism and 
autonomy 
-0.09 0.07 -1.25 
3.2o Optimism and control over the 
future 
0.18 0.07   2.57b
3.2p Righteous anger -0.02 0.05 -0.51 
Domain 3    
3.3a Total number of services 0.02 0.03 0.70 
3.3b Total service hours per month 0.00 0.00 1.31 
3.3c Average satisfaction score 
 
0.03 0.03 0.92 
 
Note:  a ≤ .05; b ≤ .01; c ≤ .001; d ≤ .0001 
           n = 335  
           R2 = .67; F = 14.64, p ≤ .0001 
  
 
67% of the variance of the dependent variable effective illness management can be 
explained by the variations in the independent variables of the full model.  The null 
hypothesis that the variance captured is zero (R2 = 0) is rejected (F = 14.64, p ≤ .0001).   
 Anxiety related associations are again significant.  A diagnosis of an anxiety 
disorder (cluster of diagnoses including post-traumatic stress disorder, generalized 
anxiety disorder, etc.) is negatively associated with illness management.  The prescription 
of anti-anxiety medications is also significantly negatively associated.  Having the 
opposite effect, interpersonal sensitivity is positively associated with illness management.   
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Whereas increased indicators of anxiety are associated with less effective management 
(though this cannot be interpreted as causal), increased feelings of inferiority, self-doubt, 
and inadequacy (key aspects of interpersonal sensitivity) are associated with greater 
endorsement of illness management.  This could reflect a need for and willingness to 
accept direction and the desire to follow a management plan to offset uncomfortable 
affective states. 
 Examining domain 2 (social) independent variables, poor stigma resistance is 
associated with decreased illness management.  However, a small group of social and 
empowerment variables are positively associated with illness management.  Involvement 
with the community increases illness management.  Increased self-esteem/self-efficacy is 
associated with better illness management as is optimism and control over the future.  
None of the domain 3 (service) variables are significantly associated with illness 
management in the full model. 
 When attempting to detect the most parsimonious model of association between a 
set of independent variables and a dependent variable, it can be useful to assess only the 
significant variables in a reduced or truncated model.  Changes in R2 can be evaluated to 
see how much of the full model variance may be associated with non-significant 
coefficients or that may even be suppressing variance if the limited model has an increase 
in R2.  Table 53 displays the results of the reduced model.  Variance explained diminishes 
by 4%.  Thus, most of the variance is related to the significant associations in the main 
effects model.  Figure 4 summarizes the variance explained by each domain, the main 
effect (full) model and the reduced model.  The largest change is in the parameter 
estimate for interpersonal sensitivity.  The magnitude is increased and the direction of the 
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association changes from positive to negative. The regression coefficient for anxiety 
diagnosis drops slightly in magnitude in the reduced model while the coefficient for anti-
anxiety medication increases in size.  The direction of the coefficient for interpersonal 
sensitivity changes to the same direction as the other clinical variables, indicating that 
increased interpersonal sensitivity is associated with a decrease in effective illness 
management.  With clinical variables assessed in isolation (Table 49) the effects of social 
and service variables were absent and interpersonal sensitivity had a positive association 
with illness management.  Community involvement is slightly less potent in the reduced 
or limited model and optimism is approximately the same, as evidenced by changes in 
their coefficients.  Stigma resistance and self-esteem are both of greater magnitude.  
Limited stigma resistance may, in part, be a function of low self-esteem.  The Pearson 
correlation between stigma resistance and self-esteem appears to reinforce this possibility  
Table 53 
 
Reduced Model Results of OLS Regression Testing the Impact of  Domain 1-3  
Variables on Recovery Strategy 1 (Effective Illness Management) 
 
Variable 
 
b SE t 
Interpersonal sensitivity -0.11 0.03   -4.30d
Anxiety diagnosis  0.08 0.08  -1.88 
Medication:  Anti-anxiety -0.21 0.05   -4.08d
Stigma resistance -0.52 0.06   -8.26d
Community involvement  0.07 0.02     3.02b
Self-esteem/self-efficacy  0.42 0.07    6.31d
Optimism and control over the future 
 
 0.07 0.07    2.56b
 
Note:   a ≤ .05; b ≤ .01; c ≤ .001; d ≤ .0001 
           n = 335;  
           R2 = .63; F = 81.10, p ≤ .0001 
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(r(348) = -0.48, p ≤ .0001).   
 A summary of the models presented in Tables 48-53 is presented in Table 54.  
Age and gender are the two control variables with some consistency in association with 
effective illness management, with younger age and male gender associated with greater 
endorsement of the strategy.  Depression in the clinical model (Table 49) gives way to a 
more anxiety focus in the full model (Table 52).  Employment and adult assault 
associations are no longer significant in the full model.  Optimism and control over the 
future becoming significant in the main effect model is reasonable since effective illness 
management is in effect an investment in future health and goal attainment, free of 
debilitating symptoms and hospitalizations.   Satisfaction with services drops out in the 
full model.  Effective illness management can involve professional services as well as 
more consumer driven and holistic approaches.  Still, it is unexpected that no service 
variable would be significantly associated with a strategy that is potentially somewhat 
treatment dependent.   
 Consistent between models are stigma resistance, community involvement, and 
self-esteem/self-efficacy.  Noted above, high levels of self-esteem and low levels of 
stigma resistance appear to be inversely related.  It appears that self-esteem and stigma 
resistance are both associated with increased illness management.  Community 
involvement, positively associated with illness management, may reflect the consumer 
recovery literature addressing the need for connection and feeling a part of the 
community, even if not consistent with active engagement (Deegan, 2005). 
 
 
 
Figure 4 
 
Amount of Variance Explained by Each Domain for Effective Illness Management 
 
 
 
 
 
 
Research Question 3:  Are Individual, Social or Service Factors Associated with 
Recovery Strategy #2:  Positive Future Orientation? 
Control Variables 
(R2 = .04) 
Domain 1: Clinical and 
Historical Factors 
(R2 = .37) 
Main Effects Model 
R2 = .67 
Reduced Main Effects Model 
R2 = .63
Effective 
Illness 
Management 
Domain 3: Service 
Factors 
(R2 = .12) 
Domain 2: Social 
Factors 
(R2 = .54) 
 Associations between control variables and positive future orientation are 
summarized in Table 55.  The model is significant (F = 3.48, p ≤ .01) and accounts for 
approximately 3% of the variance for strategy 2.  Age is significantly associated with 
positive future orientation, with younger respondents sanctioning the strategy slightly 
more than older respondents. 
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Table 54 
 
Summary Table: Results of OLS Regression Testing the Impact of  Domain 1-3  Variables 
on Recovery Strategy 1 (Effective Illness Management) 
 
 Model 1 Model 2 Model 3 Model 4 Model 5 
 
Age   ? ?  
Sex ?   ?  
Income      
Education      
Psychosomatic       
Obsessive Compulsive       
Interpersonal Sensitivity     ? 
Anxiety      
Depression  ?    
Hostility      
Phobia      
Paranoia      
Psychoticism      
Anxiety Diagnosis     ? 
Substance History      
Lifetime Hospitalizations      
Hospitalized in Last Year      
Age of Onset      
Anti-Depressant Medication  ?    
Anti-Psychotic Medication      
Anti-Manic Medication      
Anti-Anxiety Medication  ?   ? 
Other Psychotropic Medication      
Currently Employed      
Years Employed Lifetime  ?    
Nuclear Family Mental Illness      
Extended Family Mental Illness      
Child Sexual Abuse      
Child Physical Abuse      
Adult Sexual Assault      
Adult Physical Assault  ?    
Alienation      
Stereotype Endorsement      
Discrimination Occurrence      
Social Withdrawal      
Stigma Resistance   ?  ? 
Partner of Best Friend Support      
Family Support      
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Table 54 (cont.) 
 
Provider Support      
Friends Support      
Community Involvement   ?  ? 
Trust      
Self-Esteem and Self-Efficacy   ?  ? 
Power and Powerlessness      
Community Activism and 
Autonomy 
     
Optimism and Control Over the 
Future 
  ?   
Righteous Anger      
Total Number of Services      
Total Contact Hours      
Average Satisfaction    ?  
 
M1 = Model 1:  n = 350; Control variables 
M2 = Model 2:  n = 350; Control variables + Individual and historical factors 
M3 = Model 3:  n = 350; Control variables + Social factors 
M4 = Model 4:  n = 350; Control variables + Service factors 
M5 = Model 5;  n = 335; Full (main effects) model (post diagnostics) 
 
 
 
Table 55 
 
Results of OLS Regression Testing the Impact of Control Variables on Recovery 
Strategy 2 (Positive Future Orientation) 
 
Variable 
 
b SE t 
 
Age -0.01 0.00  -2.42a
Gender -0.13 0.07 -1.69 
Income  0.06 0.03  2.04 
Education 
 
-0.01 0.04 -0.17 
 
Note:  a ≤ .05; b ≤ .01; c ≤ .001; d ≤ .0001 
           n = 350;  
           R2 = .03; F = 3.48, p ≤ .01 
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Research question 3.1:  Are individual factors associated with positive future 
orientation? 
 Clinical/historical factors are significantly associated with strategy 23 (F = 4.95, p 
≤ .0001) with an adjusted R2 of 0.26 (Table 56).  Like the first strategy investigated, this 
analysis targets hypotheses 3.1a-3.1aa, though specific to future orientation.  
Schizophrenia was the only diagnostic category significantly associated with positive 
future orientation, with individuals with a diagnosis of schizophrenia less likely then 
other diagnoses to endorse positive future orientation.   Two symptom categories, 
depression and phobic anxiety are negatively associated with strategy 2.  Individuals with 
a substance history are actually more likely to endorse a positive future orientation.  
Noted in the section on bivariate analysis, individuals with a substance history and that 
are in treatment at a mental health center have likely experienced substance abuse 
recovery services that are focused on the present (one day at a time) and on future good 
works based on sobriety. 
Research question 3.2:  Are social factors associated with positive future 
orientation? 
 Social variables are significantly associated with positive future orientation (F = 
32.02, p≤ .0001) and account for 64% of the variance, while addressing hypotheses 3.2a-
3.2p (Table 57).  Social withdrawal is significantly negatively associated with positive 
future orientation.  Social contact and the support it engenders is an integral part of 
recovery, especially as described by the consumer recovery movement (Chadwick, 1997).  
Support variables were predicted to be positively associated with strategy 2.  However, 
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Table 56 
 
Results of OLS Regression Testing the Impact of Clinical/Historical (Domain 1) on 
Recovery Strategy 2 (Positive Future Orientation) 
 
H1 Variable b SE  t 
 Age -0.00 0.00 -0.63 
 Gender -0.01 0.08 -0.17 
 Income  0.04 0.03  1.28 
 Education -0.01 0.04 -0.46 
3.1a Schizophrenia diagnosis -0.21 0.10  -2.02a
3.1b Somatization  0.05 0.05  0.98 
3.1c Obsessive-compulsive  0.05 0.07  0.73 
3.1d Interpersonal sensitivity  0.00 0.07  0.02 
3.1e Anxiety  0.08 0.07  1.25 
3.1f Depression -0.37 0.07  -5.17d
3.1g Hostility  0.00 0.05  0.11 
3.1h Phobic anxiety -0.14 0.05  -2.72b
3.1i Paranoia  0.05 0.06  0.75 
3.1j Psychoticism -0.04 0.06 -0.57 
3.1k Substance abuse history  0.14 0.07   2.09a
3.1l Hospitalization history -0.00 0.00 -0.99 
3.1m Hospitalized in last year -0.10 0.07 -1.34 
3.1n Age of onset  0.00 0.00  0.09 
3.1o Medication:  Anti-depressant -0.07 0.08 -0.82 
3.1p Medication:  Anti-psychotic  0.01 0.08  0.13 
3.1q Medication:  Anti-manic -0.05 0.08 -0.71 
3.1r Medication:  Anti-anxiety  0.00 0.07  0.02 
3.1s Medication:  Other 
psychotropic 
-0.02 0.07 -0.34 
3.1t Current employment -0.08 0.09 -0.85 
3.1u Years of employment -0.01 0.00 -1.80 
3.1v Nuclear family mental illness  0.01 0.03  0.34 
3.1w Extended family mental 
illness 
-0.02 0.05 -0.42 
3.1x Child sexual abuse history -0.04 0.08 -0.61 
3.1y Child physical abuse history  0.02 0.07  0.26 
3.1z Adult sexual assault history -0.00 0.09 -0.06 
3.1aa Adult physical assault history 
 
 0.15 0.08  1.89 
 
Note:  a ≤ .05; b ≤ .01; c ≤ .001; d ≤ .0001 
           n = 350;  
           R2 = .26; F = 4.95, p ≤ .0001 
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Table 57 
 
Results of OLS Regression Testing the Association of  Social Variables (Domain 2) on 
Recovery Strategy 2 (Positive Future Orientation) 
 
H1 Variable b SE  t 
 
 Age -0.00 0.00    -2.35a
 Gender  0.06 0.05   1.19 
 Income -0.00 0.02  -0.30 
 Education -0.03 0.02  -1.25 
Stigma    
3.2a Alienation  0.06 0.06   0.93 
3.2b Stereotype endorsement -0.09 0.07  -1.31 
3.2c Discrimination experience  0.10 0.06   1.85 
3.2d Social withdrawal -0.21 0.07   -2.99b
3.2e Stigma resistance -0.07 0.06  -1.12 
Social Support and Related    
3.2f Partner or best friend support  0.01 0.03   0.47 
3.2g Family support  0.04 0.02   2.38 
3.2h Provider support  0.13 0.03    4.41d
3.2i Friend support -0.00 0.03  -0.04 
3.2j Community involvement  0.04 0.02   1.92 
3.2k Trust  0.01 0.02   0.43 
Empowerment    
3.2l Self-esteem/self-efficacy  0.69 0.06   11.09d
3.2m Power/powerlessness  0.14 0.06   2.38 
3.2n Community activism and 
autonomy 
 0.06 0.06   0.95 
3.2o Optimism and control over the 
future 
-0.03 0.06  -0.49 
3.2p Righteous anger 
 
 0.03 0.04   0.83 
 
Note:  a ≤ .05; b ≤ .01; c ≤ .001; d ≤ .0001 
           n = 350;  
           R2 = .64; F = 32.02, p ≤ .0001 
  
 
only provider support was associated with positive future orientation, again, however, in 
isolation from the other predictor domains.  The clinicians at the partnering agency have 
been exposed to the ‘role recovery program’ in recent months.  This has emphasized the 
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recovery philosophy and may be biasing this data, albeit in a way that is positive for the 
consumer.  The emphasis is on planning for the future and coping with current limitations 
while capitalizing on strengths.  Historically, individuals with mental illness, especially 
severe mental illness, have not enjoyed relationships that supported planning for careers, 
family, and other aspects of future most others expect automatically (Yanos, Rosenfield, 
Horwitz, 2001).  Providers often provide substitute support, though systematic 
investigation of provider support is negligible (Meeks & Murrell, 1994). 
 Of the empowerment scales only self-esteem/self-efficacy is significantly 
associated with positive future orientation.  This is by far the largest estimate for domain  
2 variables.  Self-esteem is linked to confidence and the expectation of success and is 
logically linked with future orientation (Rogers, Chamberlin, Ellison, & Crean, 1997; 
Wood, Heimpel, Newby-Clark, & Ross, 2005). 
Research question 3.3:  Are service factors associated with positive future 
orientation? 
 Positive future orientation is significantly associated with service variables (F = 
7.91, p ≤ .0001), accounting for 12% of the variance (Table 58).  Average satisfaction 
score, as expected, is positively associated with future orientation.  Counter to what was 
hypothesized, total service hours per month have an inverse relationship with positive 
future orientation, though the strength of the association is weak.  A likely explanation is 
that the number of service hours increases with severity of illness.  This apparent 
association may be a proxy for illness severity, with severity known to be negatively 
correlated with a positive future outlook. 
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Table 58 
 
Results of OLS Regression Testing the Impact of  Service Variables (Domain 3) on 
Recovery Strategy 2 (Positive Future Orientation) 
 
 Variable b SE t 
 Age -0.01 0.00  -2.58b
 Gender -0.12 0.07 -1.75 
 Income  0.05 0.03  1.56 
 Education -0.02 0.04 -0.66 
3.3a Total number of services  0.03 0.03  1.04 
3.3b Total service hours per month -0.02 0.00  -3.37c
3.3c Average satisfaction score 
 
 0.25 0.03   7.60d
 
Note:  a ≤ .05; b ≤ .01; c ≤ .001; d ≤ .0001 
           n = 350;  
           R2 = .12; F = 7.91, p ≤ .0001 
  
 
Research question 3:  Are individual, social or service factors associated with 
positive future orientation?  Main effects model  
 Identical to the discussion of logistic regression and the analysis of recovery 
strategy one, diagnostic statistics were applied and evaluated for the main effects model 
targeting positive future orientation.  Fifteen observations violated the cutpoint of the 
criteria identifying overly influential observations and were dropped from the subsequent 
analysis.  The main effect model is significant (F = 17.72, p ≤ .0001) with an adjusted R-
square of 0.71 (Table 59). 
 Three symptom scales are associated with positive future orientation.  Depression 
and phobic anxiety decrease endorsement of positive future orientation.  Much like the 
confusing relationship in the main effects model for strategy 1, involving interpersonal 
sensitivity, anxiety is positively associated with the positive future orientation recovery  
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Table 59 
 
Main Effects Results of OLS Regression Testing the Impact of  Domain 1-3  Variables on 
Recovery Strategy 2 (Positive Future Orientation) 
 
H1 Variable b SE t 
 Age -0.00 0.00 -0.96 
 Gender  0.03 0.05  0.66 
 Income -0.03 0.02 -1.39 
 Education -0.05 0.02  -2.07a
Domain 1    
3.1a Schizophrenia diagnosis -0.19 0.07   -2.68a
3.1b Somatization -0.06 0.03 -1.78 
3.1c Obsessive-compulsive 0.04 0.04 0.98 
3.1d Interpersonal sensitivity 0.07 0.04  1.61 
3.1e Anxiety   0.12 0.05   2.73b
3.1f Depression -0.11 0.05  -2.21a
3.1g Hostility -0.00 0.03 -0.14 
3.1h Phobic anxiety -0.12 0.03  -3.31c
3.1i Paranoia -0.03 0.04 -0.60 
3.1j Psychoticism -0.06 0.04 -1.42 
3.1k Substance abuse history  0.10 0.05   2.05a
3.1l Hospitalization history  0.00 0.00  0.15 
3.1m Hospitalized in last year -0.10 0.05  -2.07a
3.1n Age of onset  0.00 0.00  0.30 
3.1o Medication:  Anti-depressant -0.10 0.06 -1.78 
3.1p Medication:  Anti-psychotic  0.03 0.05  0.66 
3.1q Medication:  Anti-manic -0.02 0.05 -0.57 
3.1r Medication:  Anti-anxiety  0.08 0.05  1.79 
3.1s Medication:  Other psychotropic -0.02 0.05 -0.43 
3.1t Current employment  0.04 0.06  0.63 
3.1u Years of employment -0.00 0.00 -0.61 
3.1v Nuclear family mental illness  0.02 0.02  1.20 
3.1w Extended family mental illness -0.02 0.03 -0.74 
3.1x Child sexual abuse history  0.02 0.05  0.37 
3.1y Child physical abuse history  0.03 0.05  0.70 
3.1z Adult sexual assault history  0.03 0.06  0.45 
3.1aa Adult physical assault history  0.05 0.05  0.94 
Domain 2    
Stigma    
3.2a Alienation  0.09 0.06  1.46 
3.2b Stereotype endorsement -0.07 0.07 -1.02 
3.2c Discrimination experience  0.09 0.05  1.71 
3.2d Social withdrawal -0.18 0.07  -2.59b
3.2e Stigma resistance -0.07 0.06 -1.16 
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Table 59 (cont.) 
 
H1 Variable b SE t 
Social Support and Related    
3.2f Partner or best friend support 0.01 0.02  0.43 
3.2g Family support 0.05 0.02   3.11b
3.2h Provider support 0.10 0.03   3.25c
3.2i Friend support 0.01 0.02  0.32 
3.2j Community involvement 0.05 0.02   2.47b
3.2k Trust 0.01 0.02  0.28 
Empowerment    
3.2l Self-esteem/self-efficacy 0.67 0.06   10.34d
3.2m Power/powerlessness 0.04 0.06 0.65 
3.2n Community activism and 
autonomy 
0.09 0.06  1.43 
3.2o Optimism and control over the 
future 
-0.06 0.06 -1.07 
3.2p Righteous anger 0.02 0.04  0.56 
Domain 3    
3.3a Total number of services -0.01 0.02 -0.26 
3.3b Total service hours per month -0.01 0.00 -1.61 
3.3c Average satisfaction score 
 
 0.05 0.03  1.82 
 
Note:  a ≤ .05; b ≤ .01; c ≤ .001; d ≤ .0001 
           n = 335;  
           R2 = .71; F = 17.72, p ≤ .0001 
  
 
strategy.  This finding runs counter to phobic anxiety noted above, furthering the 
confusion.  However, turning to the items in the SCL-90-R that combine for the anxiety 
scale, the majority appear to be written to capture panic disorder and the somatic 
symptoms that are the essential criteria for that disorder (e.g., heart pounding or racing; 
spells of terror or panic) and generalized anxiety disorder (GAD) (e.g., feeling tense or 
keyed up; feeling so restless you couldn’t sit still).  Mild to moderate panic disorder is 
often internalized by clients as something to monitor and to have a plan for, not 
something as life altering as schizophrenia.  The same is true for GAD though these 
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symptoms are often more continuous and unsettling, but respond well to medication.  
Anti-anxiety medication is highly efficacious for the two disorders listed, and of the 
seventeen individuals with either panic disorder or GAD, sixteen are prescribed anti-
anxiety medication. 
 Positive future orientation is negatively associated with being hospitalized in the 
last year.  This result is in the hypothesized direction for this study.  Even though every 
attempt is made to maintain individuals in the community, it can be difficult for some 
individuals who find themselves inpatient on a relatively regular basis.  There is 
substantial variance in number of lifetime hospitalizations for respondents in this study, 
ranging from zero to over one hundred.  Despite the recovery movements attempts at 
normalizing hospitalization as a learning encounter that can aid in future recovery 
(Mueser, Corrigan, Hilton, Tanzman, Schaub, Gingerich, et al., 2002; Xie, McHugo, 
Helmstetter, Drake, 2005), it is still considered a personal failure and disrupts both 
present day and future plans (Walby, 2003a).  The final domain 1 significant association 
is substance abuse history, which is positively associated with strategy 2.  This might 
reflect the experience and belief in recovery many individuals with substance diagnoses 
are exposed to through professional and consumer run interventions. 
 The social variables (domain 2) appear to have a strong influence on the large 
degree of variance captured in this model, similar to their impact in isolation noted in the 
discussion of Table 57.  The stigma variable of social withdrawal is significantly 
negatively associated with positive future orientation.  As predicted, support variables 
are, as a group, positively associated with strategy 2, three of which are significant.  
Family support is weakly but significantly associated and provider support is also 
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associated.  Community involvement is also positively associated at a low magnitude.  
The only domain 2 empowerment variable that is associated with future orientation in the 
main effect model is self-esteem/self-efficacy.  This is a powerful association with 
endorsement of future orientation increasing by 0.67 for each unit increase in self-
efficacy. 
 Identical to the analysis approach used with strategy 1, a limited model was 
created containing only the significant variables from the main effect model.  The results 
are displayed in Table 60.  All the variables remain significant and maintain the same 
direction.  The amount of variance explained drops 3% for a total of 67%.  Anxiety and 
phobic anxiety decrease in effect while depression gains strength in the association with  
Table 60 
 
Reduced Model Results of OLS Regression Testing the Impact of  Domain 1-3  
Variables on Recovery Strategy 2 (Positive Future Orientation) 
 
Variable 
 
b SE t 
Education  -0.05 0.02   -2.42b
Anxiety   0.10 0.04    2.49b
Depression  -0.10 0.04   -2.53b
Phobic anxiety  -0.10 0.03   -3.18c
Schizophrenia diagnosis  -0.27 0.06   -4.38d
Substance abuse history   0.10 0.04    2.18a
Hospitalized in last year  -0.09 0.04   -2.11a
Social withdrawal  -0.13 0.43   -3.11b
Family support   0.03 0.01    2.10a
Provider support   0.13 0.03    4.94d
Community involvement   0.05 0.02    2.51b
Self-esteem/self-efficacy 
 
  0.67 0.05 13.38d
 
Note:  a ≤ .05; b ≤ .01; c ≤ .001; d ≤ .0001 
           n = 335;  
           R2 = .68; F = 61.46, p ≤ .0001 
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strategy 2.  A diagnosis of schizophrenia is stronger in its association in the limited model 
(b = -0.27 compared to b = -0.21) and is the most powerful negative covariate.  Substance 
abuse, hospitalization in the last year and community involvement are approximately of 
equal strength compared to the full model.  Family support actually decreases in strength 
while social withdrawal, provider support and self-esteem/self-efficacy gain strength in 
the association.  Self-esteem/self-efficacy is the most powerful positive covariate with 
strategy 2 and is of equal strength in main effects or limited models (b = 0.67). 
 Figure 5 displays the variance explained in each model detailed above.  Social 
factors explain the most variance in the isolated models and appear to contribute the most 
in the main effects model as well.  Clinical/historical factors are not insignificant, nor are 
service factors.  However, there is more fluctuation in these domains when comparing 
number of significant contributors as well as magnitude.  There appears to be minimal 
‘noise’ in the main effects model as the  significant variables in the main effects model 
explain the majority of the variance with only a minimal loss (3%) between the main 
effects and reduced models. 
 Table 61 summarizes the models for positive future orientation.  Age is the most 
influential of the control variables.  For the majority, if a variable was significant in an 
isolated model, then it was likely significant in the main effects model.  This is accurate 
for diagnosis of schizophrenia, depressive symptoms, phobic anxiety, substance use 
history, social withdrawal, provider support, and self-esteem/self-efficacy.  Anxiety,  
 
 
 
Figure 5 
 
Amount of Variance Explained by Each Domain for Positive Future Orientation 
 
 
 
 
Control Variables 
(R2 = .03) 
Domain 1: Clinical and 
Historical Factors 
(R2 = .26) 
Main Effects Model 
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Reduced Main Effects Model 
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Positive 
Future 
Orientation Domain 2: Social 
Factors 
(R2 = .64) 
Domain 3: Service 
Factors 
(R2 = .18) 
 
 
being hospitalized in the last year, family support and community involvement are 
significant in the main effects model but not in the isolated models.  Conversely, none of 
the service variables are significant in the main effects model though total service hours 
in a month and average satisfaction were significant in isolation.   
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Table 61 
 
Summary Table: Results of OLS Regression Testing the Impact of  Domain 1-3  Variables 
on Recovery Strategy 2 (Positive Future Orientation) 
 
 Model 1 Model 2 Model 3 Model 4 Model 5 
Age ?  ? ?  
Sex      
Income      
Education ?     
Psychosomatic       
Obsessive Compulsive       
Interpersonal Sensitivity      
Anxiety     ? 
Depression  ?   ? 
Hostility      
Phobia  ?   ? 
Paranoia      
Psychoticism      
Schizophrenia Diagnosis  ?   ? 
Substance History  ?   ? 
Lifetime Hospitalizations      
Hospitalized in Last Year  ?    
Age of Onset      
Anti-Depressant Medication      
Anti-Psychotic Medication      
Anti-Manic Medication      
Anti-Anxiety Medication      
Other Psychotropic Medication      
Currently Employed      
Years Employed Lifetime      
Nuclear Family Mental Illness      
Extended Family Mental Illness      
Child Sexual Abuse      
Child Physical Abuse      
Adult Sexual Assault      
Adult Physical Assault      
Alienation      
Stereotype Endorsement      
Discrimination Occurrence      
Social Withdrawal   ?  ? 
Stigma Resistance      
Partner of Best Friend Support      
Family Support     ? 
Provider Support   ?  ? 
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Table 61 (cont.) 
 
Friends Support      
Community Involvement     ? 
Trust      
Self-Esteem and Self-Efficacy   ?  ? 
Power and Powerlessness      
Community Activism and 
Autonomy 
     
Optimism and Control Over the 
Future 
     
Righteous Anger      
Total Number of Services    ?  
Total Contact Hours    ?  
Average Satisfaction      
 
M1 = Model 1:  n = 350; Control variables 
M2 = Model 2:  n = 350; Control variables + Individual and historical factors 
M3 = Model 3:  n = 350; Control variables + Social factors 
M4 = Model 4:  n = 350; Control variables + Service factors 
M5 = Model 5;  n = 335; Full (main effects) model (post diagnostics) 
 
 
 
Research Question 3:  Are Individual, Social or Service Factors Associated with 
Recovery Strategy #3:  Meaningfulness, Personal Control, and Hope? 
 Hope and meaningfulness are cornerstones of the recovery movement (Deegan, 
2001; Lysaker, Buck, Hammoud, Taylor, & Roe, 2006; Repper & Perkins, 2003; 
Resnick, Rosenheck, & Lehman, 2004).  Indeed, hope is considered the most necessary 
component for personal recovery (Deegan, 2001; Walby, 2003b).  The presence of hope 
and meaning provide guidance and purpose, supporting an individual to structure their 
time and plan ahead, whether it is for the next few minutes or few decades.  The 
importance of hope to recovery and potentially recovery program development adds a 
level of importance to detecting significant covariates.  This is especially true in the 
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current climate of reduction in services and tightening of spending on treating mental 
illness.  Interventions, whether professional or consumer, which fosters hope and 
provides meaning has the potential to partially offset systemic deficiencies.
 Utilizing the same analysis steps as the two previous recovery strategies, Table 62 
confirms that there are no observed significant associations present between the control 
variables of age, gender, income, and education and recovery strategy 3.   
Table 62 
 
Results of OLS Regression Testing the Impact of Control Variables on Recovery 
Strategy 3 (Meaningfulness, Personal Control, and Hope) 
 
Variable 
 
b SE t 
 
Age 0.00 0.00 0.49 
Gender 0.06 0.05 1.11 
Income 0.03 0.02 1.30 
Education 
 
0.00 0.03 0.01 
 
Note:  n = 350;  
           R2 = .00; F = 0.81, ns 
  
 
Research question 3.1:  Are individual factors associated with meaningfulness, 
personal control, and hope? 
 Table 63 summarizes the results of the OLS regression of strategy three on the 
domain 1 clinical/historical variables.  The model is not significant, indicating that the 
null hypothesis of R2 = 0 is supported (F = 1.08, ns).  Approximately 1% of the variance 
for hope, meaning and personal control is explained by clinical factors.  The lack of 
supporting evidence in the statistical model supports the recovery movement’s emphasis 
on non-clinical factors in relation to this key aspect of recovery (Anthony, 1993; Deegan,  
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Table 63 
 
Results of OLS Regression Testing the Impact of Clinical/Historical (Domain 1) on 
Recovery Strategy 3 (Meaningfulness, Personal Control, and Hope) 
 
H1 Variable b SE  t 
 Age  0.05 0.00  1.74 
 Gender  0.03 0.06  0.56 
 Income  0.03 0.02  1.38 
 Education  0.01 0.03  0.19 
3.1b Somatization  0.07 0.04  1.62 
3.1c Obsessive-compulsive  0.00 0.05  0.04 
3.1d Interpersonal sensitivity  0.09 0.05  1.67 
3.1e Anxiety -0.02 0.06 -0.32 
3.1f Depression -0.03 0.06 -0.48 
3.1g Hostility -0.02 0.04 -0.67 
3.1h Phobic anxiety -0.12 0.04   -3.06b
3.1i Paranoia -0.04 0.05 -0.88 
3.1j Psychoticism  0.04 0.05  0.80 
3.1k Substance abuse history  0.03 0.06  0.49 
3.1l Hospitalization history -0.00 0.00 -0.57 
3.1m Hospitalized in last year  0.07 0.06  1.20 
3.1n Age of onset  0.00 0.00  0.13 
3.1o Medication:  Anti-depressant  0.00 0.07  0.01 
3.1p Medication:  Anti-psychotic -0.03 0.06 -0.60 
3.1q Medication:  Anti-manic  0.03 0.06  0.48 
3.1r Medication:  Anti-anxiety -0.00 0.06 -0.05 
3.1s Medication:  Other 
psychotropic 
-0.07 0.06 -1.18 
3.1t Current employment  0.04 0.07  0.60 
3.1u Years of employment -0.01 0.00   -2.37a
3.1v Nuclear family mental illness  0.02 0.02  0.95 
3.1w Extended family mental 
illness 
-0.02 0.04 -0.48 
3.1x Child sexual abuse history  0.07 0.06  1.13 
3.1y Child physical abuse history  0.02 0.06  0.35 
3.1z Adult sexual assault history -0.06 0.07 -0.87 
3.1aa Adult physical assault history 
 
 0.06 0.06  0.95 
 
Note:  a ≤ .05; b ≤ .01 
           n = 350  
           R2 = .01; F = 1.08, ns 
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2005).  Two independent variables, phobic anxiety and years of employment are 
negatively associated with strategy 3.  Decreased endorsement of hope and meaning due 
to higher levels of phobic anxiety is logically linked.   The relationship between higher 
reported years of employment and decreased hope is less clear.  Taken in the context of 
what jobs were endorsed by the respondents, however, it becomes apparent that nearly all 
the employed respondents are members of the working poor, putting in long hours for 
minimal pay and often not being eligible for state assistance due to just surpassing 
assistance cutpoints (21% currently employed, 87% of the employed at or below $15,000 
annual income, 99% in service or labor related jobs).   
Research question 3.2:  Are social factors associated with meaningfulness, 
personal control, and hope? 
 Table 64 summarizes the associations between domain 2 variables and strategy 3.  
Hypotheses 3.2a-3.2p are addressed in the analysis and the model is significant (F = 
10.71, p ≤ .0001) and accounts for 36% of the variance.  Female participants endorse the 
strategy significantly more than male participants.  The isolated effects of domain 2 
stigma variables indicates that higher endorsement of stereotypes and lower resistance to 
stigma are negatively associated with hope and meaning.  There is a conceptual link 
between accepting societal stereotypes of mental illness as relevant to the self (e.g., 
mentally ill individuals are dangerous, unpredictable, lazy, etc.) and poor resistance to the 
stigmatizing messages and behaviors that stem from the stereotypes. 
 The single significant support variable is provider support, suggesting that hope 
and meaning increases in association with a positive relationship with a provider.  There 
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is not, as hypothesized, a significant positive relationship between self-esteem and hope.  
However, community activism and autonomy is positively associated.  The items on this  
Table 64 
 
Results of OLS Regression Testing the Impact of  Social Variables (Domain 2) on 
Recovery Strategy 3 (Meaningfulness, Personal Control, and Hope) 
 
H1 Variable b SE  t 
 
 Age  0.00 0.00  1.41 
 Gender  0.10 0.04   2.16a
 Income -0.00 0.02 -0.32 
 Education -0.01 0.02 -0.42 
Stigma    
3.2a Alienation  0.03 0.06  0.59 
3.2b Stereotype endorsement -0.20 0.06   -3.21c
3.2c Discrimination experience  0.09 0.05  1.65 
3.2d Social withdrawal -0.01 0.07 -0.10 
3.2e Stigma resistance -0.16 0.06   -2.76b
Social Support and Related    
3.2f Partner or best friend support -0.02 0.02 -0.65 
3.2g Family support  0.01 0.01  1.02 
3.2h Provider support  0.06 0.03   2.08a
3.2i Friend support  0.04 0.02  1.70 
3.2j Community involvement  0.02 0.02  0.89 
3.2k Trust  0.02 0.02  0.71 
Empowerment    
3.2l Self-esteem/self-efficacy  0.03 0.06  0.57 
3.2m Power/powerlessness -0.04 0.06 -0.67 
3.2n Community activism and 
autonomy 
 0.35 0.06   5.95d
3.2o Optimism and control over the 
future 
 0.15 0.06   2.60b
3.2p Righteous anger 
 
-0.05 0.04 -1.29 
 
Note:  a ≤ .05; b ≤ .01; d ≤ .0001 
           n = 350;  
           R2 = .36; F = 10.71, p ≤ .0001 
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 scale encompass, as the scale name suggests, a proactive relationship with the 
community that challenges the negative beliefs about the mentally ill.  A related 
empowerment construct, optimism and control over the future, is also significantly 
associated with hope and meaning.   
Research question 3.3:  Are service factors associated with meaningfulness, 
personal control, and hope? 
 Service factors are not significantly associated with hope and meaning (F = 1.59, 
ns), accounting for only 1% of the variance (Table 65).  Average satisfaction with 
services (hypothesis 3.3c) is positively associated with hope and meaning suggesting 
again that the relationship or competent mental health services may be important in 
relation to recovery. 
Table 65 
 
Results of OLS Regression Testing the Impact of  Service Variables (Domain 3) on 
Recovery Strategy 3 (Meaningfulness, Personal Control, and Hope) 
 
 Variable b SE t 
 Age  0.00 0.00  0.39 
 Gender  0.06 0.05  1.20 
 Income  0.02 0.02  1.12 
 Education -0.00 0.03 -0.04 
3.3a Total number of services  0.03 0.03  1.12 
3.3b Total service hours per month -0.00 0.00 -1.30 
3.3c Average satisfaction score 
 
  0.06 0.02    2.61b
 
Note:  b ≤ .01            
           n = 350 
           R2 = .01; F = 1.59, ns 
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Research question 3:  Are individual, social or service factors associated with 
meaningfulness, personal control, and hope?  Main effects model  
 The model, summarized in Table 66, that investigates the association between 
independent variables from domains 1-3 with recovery strategy 3 is significant (F = 7.27, 
p ≤ .0001), and accounts for 48% of the variance.  The main effect model has a sample 
size of 334, signifying that 16 observations violated diagnostic criteria and were dropped 
from analysis.  Several clinical variables that were not significant in the isolated model 
are now significant in the main effect model.  A diagnosed anxiety disorder is negatively 
associated with the strategy of generating hope and meaning.  While anti-anxiety 
medication is not significantly associated with strategy 3, which might be expected given 
the significant relationship with anxiety disorders, the use of anti-psychotic medication is.  
Recovery research has focused the most on psychotic disorders and the literature shows a 
clear association between schizophrenia spectrum disorders and reduction in hope 
(Lysaker, et al., 2006, Lysaker, Campbell, & Johannesen, 2005).  However, contrary to 
expectation, schizophrenia or schizoaffective disorder were not significant in the model.   
 Interpersonal sensitivity was significantly associated with strategy 3, though not 
in the hypothesized direction. The mechanisms driving this association can only be 
conjectured and, if not a statistical artifact, might indicate a careful planning for control 
and meaning to offset the negative emotions associated with interpersonal sensitivity.  
Child sexual abuse experiences is significantly associated but also in the direction other 
than what was hypothesized.  This may reflect the emphasis on recovery and finding 
hope consistent with the treatment of abuse survivors.  Indeed, the evidence-based group  
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Table 66 
 
Main Effects Results of OLS Regression Testing the Impact of  Domain 1-3  Variables on 
Recovery Strategy 3 (Meaningfulness, Personal Control, and Hope) 
 
H1 Variable b SE t 
 Age  0.00 0.00  1.42 
 Gender  0.06 0.05  1.22 
 Income -0.02 0.02 -0.94 
 Education -0.02 0.02 -0.75 
Domain 1    
3.1a Anxiety diagnosis -0.24 0.07   -3.43c
3.1b Somatization  0.01 0.03  0.44 
3.1c Obsessive-compulsive -0.06 0.04 -1.44 
3.1d Interpersonal sensitivity  0.11 0.04   2.76b
3.1e Anxiety  0.02 0.04  0.52 
3.1f Depression  0.06 0.04  1.33 
3.1g Hostility -0.08 0.03 - 2.55b
3.1h Phobic anxiety -0.04 0.03 -1.35 
3.1i Paranoia -0.04 0.04 -0.97 
3.1j Psychoticism  0.04 0.04  1.07 
3.1k Substance abuse history -0.00 0.04 -0.02 
3.1l Hospitalization history  0.00 0.00  0.75 
3.1m Hospitalized in last year  0.01 0.05  0.19 
3.1n Age of onset -0.00 0.00 -0.14 
3.1o Medication:  Anti-depressant -0.03 0.05 -0.56 
3.1p Medication:  Anti-psychotic -0.12 0.05   -2.58b
3.1q Medication:  Anti-manic  0.02 0.05  0.51 
3.1r Medication:  Anti-anxiety  0.06 0.04  1.40 
3.1s Medication:  Other psychotropic -0.05 0.04 -1.16 
3.1t Current employment  0.06 0.06  1.14 
3.1u Years of employment -0.00 0.00 -1.19 
3.1v Nuclear family mental illness  0.03 0.02  1.80 
3.1w Extended family mental illness -0.04 0.03 -1.40 
3.1x Child sexual abuse history  0.10 0.05   2.08a
3.1y Child physical abuse history  0.02 0.05  0.40 
3.1z Adult sexual assault history -0.03 0.06 -0.49 
3.1aa Adult physical assault history -0.03 0.05 -0.48 
Domain 2    
Stigma    
3.2a Alienation -0.02 0.06 -0.40 
3.2b Stereotype endorsement -0.20 0.06   -3.34c
3.2c Discrimination experience  0.08 0.05  1.55 
3.2d Social withdrawal -0.00 0.07 -0.05 
3.2e Stigma resistance -0.16 0.06   -2.79b
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Table 66 (cont.) 
 
H1 Variable 
 
b SE t 
Social Support and Related    
3.2f Partner or best friend support -0.01 0.02 -0.44 
3.2g Family support  0.04 0.02   2.46b
3.2h Provider support  0.07 0.03   2.55b
3.2i Friend support  0.06 0.02   2.46b
3.2j Community involvement  0.03 0.02  1.50 
3.2k Trust  0.00 0.02  0.08 
Empowerment    
3.2l Self-esteem/self-efficacy  0.07 0.06  1.11 
3.2m Power/powerlessness -0.03 0.06 -0.47 
3.2n Community activism and 
autonomy 
 0.35 0.06   5.92d
3.2o Optimism and control over the 
future 
 0.11 0.06   1.98a
3.2p Righteous anger -0.06 0.04 -1.45 
Domain 3    
3.3a Total number of services -0.01 0.02 -0.36 
3.3b Total service hours per month  0.00 0.00  0.06 
3.3c Average satisfaction score 
 
 0.01 0.02  0.34 
 
Note:  a ≤ .05; b ≤ .01; c ≤ .001; d ≤ .0001 
           n = 334;  
           R2 = .48; F = 7.27, p ≤ .0001 
  
 
method used at the partnering agency, which many of the respondents have been exposed 
to, has hope as its key criteria. 
 Domain 2 social variables specific to stigma are, in general, negatively associated 
with hope and meaning.  Stereotype endorsement and stigma resistance are significantly 
associated.  As hypothesized, support variables are also related to hope and meaning.  
Family support, provider support, and support from friends are positively associated with 
meaning and hope.  Support from a best friend or partner, though not significant, is 
negatively associated with strategy 3 and may reflect what previous research has revealed 
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as the mixed burden and support that individuals with mental illness experience in close 
relationships (Walby, 2003a).  Finally, exploring the impact of empowerment, two 
variables, community activism and autonomy and optimism and control over the future 
are associated with increased meaning and hope. 
 The final domain, services domain, are absent significant associations with 
strategy 3.  Average satisfaction, significant in the isolated model, is no longer 
significant. When combined with social and clinical factors, services are not associated 
with increased hope, again reinforcing the consumer recovery literature (Deegan, 2003). 
 The results from the limited model that tested the association between only the 
significant variables from the main effects model (Table 66) are presented in Table 67.  
The model is significant (F = 27.51, p ≤ .0001) and explains slightly more variance (49%) 
then the main effects model (48%).  Figure 6 provides a synopsis of the variance 
explained for each domain and the main effects (full and limited) models.  The direction 
of association is the same and magnitude of association for each variable in the model is 
increased over the main effects.  There are, however, no overwhelming associations 
contained in the model.  The two most powerful associations could possibly be 
conceptually linked if the assumption that an anxiety diagnosis (the strongest negative 
association) and community activism (the strongest positive) act as counterpoints if 
anxiety is a limitation to activities associated with community activism.  When 
considering models separately, social factors explain far more variance then clinical or 
service factors.  However, the emergence of clinical factors in the main effects model 
compared to the isolated model likely is a closer step to the lived reality of the 
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Table 67 
 
Reduced Model Results of OLS Regression Testing the Impact of  Domain 1-3  
Variables on Recovery Strategy 3 (Meaningfulness, Personal Control, and Hope) 
 
Variable 
 
b SE t 
Anxiety Diagnosis -0.24 0.06 -3.69c
Interpersonal sensitivity  0.12 0.02   5.08d
Hostility -0.09 0.02 -3.74c
Medication:  Anti-psychotic -0.13 0.04 -3.44c
Child sexual abuse history  0.10 0.04   2.71b
Stereotype endorsement -0.17 0.05 -3.67c
Stigma resistance -0.15 0.05 -2.99b
Family support  0.03 0.01   2.52b
Provider support  0.09 0.02   3.89d
Friend support  0.06 0.02   3.14c
Community activism and autonomy  0.38 0.05   7.18d
Optimism and control over the future 
 
 0.13 0.05   2.75b
 
Note:  a ≤ .05; b ≤ .01; c ≤ .001; d ≤ .0001 
           n = 334;  
           R2 = .49; F = 27.51, p ≤ .0001 
  
 
respondents.  A summary table (Table 68) is offered to better understand the interaction 
of the isolated models in relation to the main effects model.  Variables significant in early 
models are, except for average satisfaction with services and years employed, significant 
in main effects (phobic anxiety, stereotype endorsement, provider support, community 
activism, and optimism), with similar magnitudes.  Clinical factors emerge only in 
relation to social variables, suggesting a more complex relationship between domain 1 
and 2 variables then can be explained in the current analysis. 
 
Figure 6 
 
Amount of Variance Explained by Each Domain for Meaningfulness, Personal Control, 
and Hope 
 
 
 
 
 
Research Question 3:  Are Individual, Social or Service Factors Associated with 
Recovery Strategy #4:  Recognizing Support? 
Control Variables 
(R2 = .00) 
Domain 1: Clinical and 
Historical Factors 
(R2 = .01) 
Main Effects Model 
R2 = .48 
Reduced Main Effects Model 
R2 = .49
Meaningfulness, 
Personal Control, 
and Hope 
Domain 2: Social 
Factors 
(R2 = .36) 
Domain 3: Service 
Factors 
(R2 = .01) 
 Recognition of support means that the individual is aware that they are not alone 
and that there are avenues for support whether or not they choose to access them or not.  
Actively seeking assistance (help seeking) is the next strategy (#5) evaluated.  Some 
individuals with mental illness actively seek isolation, usually out of a concern that 
relationships or even social interaction is stressful and exacerbates symptoms (Marrone & 
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Table 68 
 
Summary Table: Results of OLS Regression Testing the Impact of  Domain 1-3  Variables 
on Recovery Strategy 3 (Meaningfulness, Personal Control, & Hope) 
 
 Model 1 Model 2 Model 3 Model 4 Model 5 
 
Age      
Sex   ?   
Income      
Education      
Psychosomatic       
Obsessive Compulsive       
Interpersonal Sensitivity     ? 
Anxiety      
Depression      
Hostility     ? 
Phobia  ?   ? 
Paranoia      
Psychoticism      
Anxiety Diagnosis      
Substance History     ? 
Lifetime Hospitalizations      
Hospitalized in Last Year      
Age of Onset      
Anti-Depressant Medication      
Anti-Psychotic Medication     ? 
Anti-Manic Medication      
Anti-Anxiety Medication      
Other Psychotropic Medication      
Currently Employed      
Years Employed Lifetime  ?    
Nuclear Family Mental Illness      
Extended Family Mental Illness      
Child Sexual Abuse      
Child Physical Abuse      
Adult Sexual Assault      
Adult Physical Assault      
Alienation      
Stereotype Endorsement   ?  ? 
Discrimination Occurrence      
Social Withdrawal      
Stigma Resistance   ?  ? 
Partner of Best Friend Support      
Provider Support   ?  ? 
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Table 68 (cont.) 
 
Family Support     ? 
Friends Support     ? 
Community Involvement      
Trust      
Self-Esteem and Self-Efficacy      
Power and Powerlessness      
Community Activism and 
Autonomy 
  ?  ? 
Optimism and Control Over the 
Future 
  ?  ? 
Righteous Anger      
Total Number of Services      
Total Contact Hours      
Average Satisfaction    ?  
 
M1 = Model 1:  n = 350; Control variables 
M2 = Model 2:  n = 350; Control variables + Individual and historical factors 
M3 = Model 3:  n = 350; Control variables + Social factors 
M4 = Model 4:  n = 350; Control variables + Service factors 
M5 = Model 5;  n = 334; Full (main effects) model (post diagnostics) 
 
 
Golowka, 2005; Walby, 2003b).  However, the recovery movement strongly endorses the 
healing provided by support and views the ability to recognize when help is needed or 
companionship is desired and who best to contact as necessary abilities for those in 
recovery (Corrigan & Phelan, 2004; Johnson, Lundstrom, Aberg-Wistedt, & Mathe, 
2003; Laudet, Magura, Vogel, & Knight, 2000). 
 The control model for support recognition is displayed in Table 69.  The model is 
significant (F = 2.65, ≤ .05) and accounts for 2% of the variance.  Age is the variable that 
drives the model, with younger age associated with a higher likelihood of recognizing 
support.  Younger individuals may naturally be in a sate of greater need for support 
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Table 69 
 
Results of OLS Regression Testing the Impact of Control Variables on Recovery 
Strategy 4 (Recognizing Support) 
 
Variable 
 
b SE t 
 
Age -0.01 0.00  -1.98a
Gender -0.08 0.11 -0.75 
Income  0.08 0.05  1.82 
Education 
 
-0.05 0.06 -0.89 
 
Note:  a ≤ .05 
           n = 350;  
           R2 = .02; F = 2.65, p ≤ .05 
  
 
and may be in living situations that more naturally provide support.  Income approaches 
significance with higher levels of income associated with more support recognition.   
Research question 3.1:  Are individual factors associated with recognizing 
support? 
 The results of the OLS regression model examining the relationship between 
domain 1 variables and recognition of support are summarized in Table 70.  The model is 
significant (F = 2.83, p ≤ .0001, adjusted R2 = .14).  Depression has a significant effect in 
lowering the endorsement of support recognition.  Anti-depressant medication 
approaches significance and has the opposite association of depression symptoms.  The 
diagnostic category of other has a positive association with strategy.  Individuals in this 
category have a range of diagnoses including dissociative disorders, head injury, and 
other neurological disorders that may appear more obvious to casual observation then 
individuals with other illnesses.  On the other hand, these disorders are more likely to be 
viewed as beyond the control of the respondent and subsequently less susceptible to 
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Table 70 
 
Results of OLS Regression Testing the Impact of Clinical/Historical (Domain 1) on 
Recovery Strategy 4 (Recognizing Support) 
 
H1 Variable b SE  t 
 Age -0.00 0.01 -0.27 
 Gender  0.06 0.12  0.53 
 Income  0.06 0.05  1.27 
 Education -0.03 0.06 -0.57 
3.1a Other diagnosis  0.74 0.25   2.95b
3.1b Somatization  0.04 0.08  0.51 
3.1c Obsessive-compulsive  0.19 0.11  1.71 
3.1d Interpersonal sensitivity -0.01 0.11 -0.12 
3.1e Anxiety -0.00 0.11 -0.02 
3.1f Depression -0.45 0.11   -3.98d
3.1g Hostility -0.01 0.07 -0.22 
3.1h Phobic anxiety -0.08 0.08 -0.99 
3.1i Paranoia -0.09 0.11 -.095 
3.1j Psychoticism  0.12 0.10  1.16 
3.1k Substance abuse history  0.05 0.11  0.47 
3.1l Hospitalization history -0.00 0.00 -0.84 
3.1m Hospitalized in last year  0.08 0.11  0.73 
3.1n Age of onset -0.00 0.00 -0.10 
3.1o Medication:  Anti-depressant  0.23 0.12  1.75 
3.1p Medication:  Anti-psychotic  0.02 0.11  0.18 
3.1q Medication:  Anti-manic -0.11 0.12 -0.93 
3.1r Medication:  Anti-anxiety -0.09 0.11 -0.80 
3.1s Medication:  Other psychotropic -0.03 0.11 -0.29 
3.1t Current employment -0.09 0.14 -0.62 
3.1u Years of employment -0.01 0.01 -1.90 
3.1v Nuclear family mental illness  0.04 0.04  1.13 
3.1w Extended family mental illness -0.09 0.08 -1.08 
3.1x Child sexual abuse history -0.00 0.12 -0.00 
3.1y Child physical abuse history -0.03 0.12 -0.28 
3.1z Adult sexual assault history  0.02 0.14  0.18 
3.1aa Adult physical assault history 
 
-0.10 0.12 -0.79 
 
Note:  b ≤ .01; d ≤ .0001 
           n = 350  
           R2 = .14; F = 2.83, p ≤ .0001 
  
 
 303
societal stereotyping and endorsement (Hinshaw & Cicchetti, 2002; Phelan, 2002).  This 
may, in turn, lead to greater recognition of support. 
Research question 3.2:  Are social factors associated with recognizing support? 
 The social factors contained in domain 2 explain 52% of the variance of 
recognizing support (F = 20.12, p ≤ .0001) (Table 71).  Only one stigma scale, alienation, 
was significantly associated with recognition of support with more alienation associated 
with less recognition of support.  Alienation is an expression of internalized stigma that 
reduces contact with others (Goffman, 1963).  Alienation also has been linked to denial 
and development of an overly individualistic ‘loner’ personality style (Mahoney-Holst, 
2005). 
 Support variables were expected to be highly associated with support recognition.  
Partner or best friend support and family support followed the expected pattern.  Against 
prediction, provider support and support from friends were not significantly associated.  
Further, community involvement was negatively associated with recognizing support.  
The assumption was that exposure to community members and organizations would 
increase recognition of support.  A possible explanation is community involvement could 
have been viewed as provision of support and not recognition of support needed by 
respondents. 
 The empowerment variables were relatively unassociated with recognition of 
support.  Self-esteem is positively, though weakly, associated with support recognition.  
Self-esteem in previous studies has been found to mediate the relationship between 
negative emotion and the executive decision making functions of the self, which by 
extension could include the ability to recognize support and the willingness to seek 
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assistance when in need (Neiss, Stevenson, Sedikidas, Kumashiro, Finkel, & Rusbuilt, 
2005). 
Table 71 
 
Results of OLS Regression Testing the Impact of Social Variables (Domain 2) on 
Recovery Strategy 4 (Recognizing Support) 
 
H1 Variable b SE  t 
 
 Age -0.00 0.00 -1.67 
 Gender  0.06 0.08  0.69 
 Income -0.01 0.03 -0.27 
 Education  0.00 0.04  0.02 
Stigma    
3.2a Alienation -0.25 0.10   -2.42b
3.2b Stereotype endorsement -0.01 0.11 -0.13 
3.2c Discrimination experience  0.03 0.09  0.34 
3.2d Social withdrawal -0.01 0.12 -0.06 
3.2e Stigma resistance -0.16 0.10 -1.56 
Social Support and Related    
3.2f Partner or best friend support  0.25 0.04    5.66d
3.2g Family support  0.21 0.03    7.94d
3.2h Provider support  0.06 0.05  1.11 
3.2i Friend support  0.03 0.04   0.78 
3.2j Community involvement -0.08 0.04   -2.18a
3.2k Trust  0.00 0.04   0.12 
Empowerment    
3.2l Self-esteem/self-efficacy  0.21 0.10   2.01a
3.2m Power/powerlessness  0.05 0.10  0.46 
3.2n Community activism and 
autonomy 
 0.01 0.10  0.08 
3.2o Optimism and control over the 
future 
 0.11 0.10  1.06 
3.2p Righteous anger 
 
 0.10 0.07  1.40 
 
Note:  a ≤ .05; b ≤ .01; d ≤ .0001 
           n = 350;  
           R2 = .52; F = 20.12, p ≤ .0001 
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Research question 3.3:  Are service factors associated with recognizing support? 
 The results of OLS regression examining the relationship of support recognition 
and service variables are summarized in Table 72.  Younger individuals are more likely 
to recognize support in this model.  Satisfaction with services are strongly associated with 
recognition of support.  The number of services and contact hours per month were not 
significant. 
Table 72 
 
Results of OLS Regression Testing the Impact of Service Variables (Domain 3) on 
Recovery Strategy 4 (Recognizing Support) 
 
 Variable b SE t 
 Age -0.01 0.00   -2.82b
 Gender -0.04 0.10 -0.37 
 Income -0.06 0.04  1.32 
 Education -0.05 0.05 -0.98 
3.3a Total number of services  0.05 0.05  1.09 
3.3b Total service hours per month  0.01 0.01  0.85 
3.3c Average satisfaction score 
 
 0.38 0.05    8.03d
 
Note:  b ≤ .01; d ≤ .0001 
           n = 350 
           R2 = .18; F = 12.21, p ≤ .0001 
  
 
Research question 3:  Are individual, social or service factors associated with 
recognizing support?  Main effects model  
 The main effects model targeting support recognition accounts for 60% of the 
variance (F = 10.98, p ≤ .0001). The results are displayed in Table 73.   Diagnostic 
analysis of overly influential scores resulted in the removal of thirteen observations from 
main effect analysis due to violation of preset cutpoints.   
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Table 73 
 
Main Effects Results of OLS Regression Testing the Impact of  Domain 1-3  Variables on 
Recovery Strategy 4 (Recognizing Support) 
 
H1 Variable b SE t 
 Age -0.00 0.00 -1.11 
 Gender -0.03 0.09 -0.39 
 Income -0.02 0.03 -0.64 
 Education  0.01 0.04  0.25 
Domain 1    
3.1a Other diagnosis  0.39 0.18   2.14a
3.1b Somatization  0.02 0.06  0.28 
3.1c Obsessive-compulsive -0.02 0.08 -0.22 
3.1d Interpersonal sensitivity  0.03 0.08  0.37 
3.1e Anxiety -0.04 0.08 -0.49 
3.1f Depression -0.07 0.08 -0.78 
3.1g Hostility -0.02 0.05 -0.34 
3.1h Phobic anxiety -0.01 0.06 -0.19 
3.1i Paranoia  0.03 0.07  0.40 
3.1j Psychoticism  0.02 0.08  0.31 
3.1k Substance abuse history -0.04 0.08 -0.48 
3.1l Hospitalization history  0.00 0.00  0.06 
3.1m Hospitalized in last year  0.03 0.08  0.37 
3.1n Age of onset -0.00 0.00 -0.40 
3.1o Medication:  Anti-depressant  0.11 0.10  1.16 
3.1p Medication:  Anti-psychotic -0.05 0.09 -0.59 
3.1q Medication:  Anti-manic -0.09 0.09 -1.00 
3.1r Medication:  Anti-anxiety -0.01 0.08 -0.18 
3.1s Medication:  Other psychotropic  0.11 0.08  1.34 
3.1t Current employment -0.00 0.10 -0.03 
3.1u Years of employment -0.00 0.00 -0.57 
3.1v Nuclear family mental illness  0.07 0.03   2.15a
3.1w Extended family mental illness -0.11 0.06  -1.95a
3.1x Child sexual abuse history  0.08 0.09  0.87 
3.1y Child physical abuse history -0.05 0.09 -0.56 
3.1z Adult sexual assault history  0.03 0.10  0.34 
3.1aa Adult physical assault history -0.03 0.09 -0.38 
Domain 2    
Stigma    
3.2a Alienation -0.22 0.10   -2.15a
3.2b Stereotype endorsement -0.01 0.11 -0.10 
3.2c Discrimination experience -0.03 0.09 -0.29 
3.2d Social withdrawal  0.04 0.12  0.34 
3.2e Stigma resistance -0.11 0.11 -1.06 
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Table 73 (cont.) 
 
H1 Variable 
 
b SE t 
Social Support and Related    
3.2f Partner or best friend support   0.22 0.04     5.09d
3.2g Family support   0.23 0.03     8.02d
3.2h Provider support -0.07 0.05 -1.32 
3.2i Friend support   0.07 0.04   1.58 
3.2j Community involvement -0.08 0.04    -2.08a
3.2k Trust   0.05 0.04   1.28 
Empowerment    
3.2l Self-esteem/self-efficacy  0.06 0.11  0.52 
3.2m Power/powerlessness  0.09 0.11  0.89 
3.2n Community activism and 
autonomy 
 0.05 0.11  0.52 
3.2o Optimism and control over the 
future 
 0.24 0.11   2.22a
3.2p Righteous anger  0.07 0.07  0.94 
Domain 3    
3.3a Total number of services  0.06 0.04  1.39 
3.3b Total service hours per month  0.00 0.01  0.40 
3.3c Average satisfaction score 
 
 0.17 0.04   3.98d
 
Note:  a ≤ .05; d ≤ .0001 
           n = 337;  
           R2 = .60; F = 10.98, p ≤ .0001 
  
  
The domain 1 clinical/historical variables are weakly associated in the model with only 
other diagnosis and nuclear family mental illness significantly positively associated with 
support recognition.  Having close relatives that are mentally ill may model recognition 
of appropriate supports, setting the stage for help seeking.  Conversely, extended family 
mental illness is negatively associated with support recognition.  There is no evidence in 
the current analysis to explain why nuclear and extended family members with mental 
illness would have the opposite association.  One hypothesis is that extended family 
members may have had less direct effect and interaction with the respondent, generating 
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stigma that was later internalized when the respondents mental illness developed 
(Goffman, 1963).   
 Domain 2 social variables have the strongest association with the dependent 
variable.  The stigma alienation scale is negatively associated with support recognition.  
Partner, best friend support and family support are positively associated and explain the 
bulk of the variance.  Community involvement is negatively associated with support 
recognition.  Optimism and control over the future is the one empowerment variable 
significantly associated with recognizing support.  Optimism and control accrue over 
time and it is reasonable that positive support contributed to the growth of these traits.  A 
reciprocal process of support and optimism may then perpetuate recovery (Resnick, 
Rosenheck, & Lehman, 2004). 
 Domain 3 variables contribute to explanation of the relationship with support 
recognition chiefly through average satisfaction.  Similar to the service model described 
in Table 72, satisfaction with services suggests a comfort and attachment that could allow 
a person to be more open to the possibility of support, and thus recognizing it when it is 
present. 
 The limited model (Table 74) is significant (F = 58.80, p ≤ .0001) and explains 
slightly more of the variance (61%) compared to the main effects model (60%).  Each of 
the nine significant variables for main effects increased in degree of association and 
maintained direction of association.  By maintaining, and even slightly surpassing, the 
variance explained, these variables appear to contribute the bulk of the associative power 
in relation to support recognition in this study.  Partner or best friend support and 
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Table 74 
 
Reduced Model Results of OLS Regression Testing the Impact of Domain 1-3 Variables 
on Recovery Strategy 4 (Recognizing Support) 
 
Variable 
 
b SE t 
Other Diagnosis  0.44 0.17   2.63b
Nuclear family mental illness  0.08 0.03   2.78b
Extended family mental illness -0.12 0.05 -2.26a
Alienation -0.32 0.06 -5.14d
Partner or best friend support  0.28 0.03   8.59d
Family support  0.23 0.02   9.44d
Community involvement -0.07 0.03 -2.31a
Optimism and control over the future  0.28 0.08   3.43c
Average satisfaction score 
 
 0.15 0.04   4.19d
 
Note:  a ≤ .05; b ≤ .01; c ≤ .001; d ≤ .0001 
           n = 337;  
           R2 = .61; F = 58.80, p ≤ .0001 
  
 
alienation gained the most in the limited model and would benefit from additional 
investigation into their effects. 
 Figure 7 provides a graphic that brings together the contribution of each model to 
variance explained.  Social factors contribute the most to variance explained with service 
and clinical factors approximately equal in magnitude.  As noted, alienation and best 
friend support require additional attention to distinguish the mechanism(s) in which they 
influence support recognition.  In addition, the processes that juxtapose the association 
between nuclear and extended family mental illness would benefit from systematic 
inquiry, as would the unexpected negative association between recognition of support and 
community involvement. 
 
 
Figure 7 
 
Amount of Variance Explained by Each Domain for Recognizing Support 
 
 
 
 
 
 
Control Variables 
(R2 = .02) 
Domain 1: Clinical and 
Historical Factors 
(R2 = .14) 
Main Effects Model 
R2 = .60 
Reduced Main Effects Model 
R2 = .61
Recognizing 
Support 
Domain 2: Social 
Factors 
(R2 = .52) 
Domain 3: Service 
Factors 
(R2 = .18) 
 Significant associations remained relatively stable across models (Table 75).  
Clinical variable are often investigated in isolation from social and service factors.  The 
changes noted in the clinical domain, and to a lesser extent in the social domain, suggest 
that this is an inappropriate practice.  For instance, depression was significant in the 
isolated clinical model in its association with support recognition, but this effect was not 
significant after controlling for other variables across domains.  Similarly, familial mental 
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Table 75 
 
Summary Table: Results of OLS Regression Testing the Impact of Domain 1-3 Variables 
on Recovery Strategy 4 (Recognizing Support) 
 
 Model 1 Model 2 Model 3 Model 4 Model 5 
 
Age ?   ?  
Sex      
Income      
Education      
Psychosomatic       
Obsessive Compulsive       
Interpersonal Sensitivity      
Anxiety      
Depression  ?    
Hostility      
Phobia      
Paranoia      
Psychoticism      
Other Diagnosis  ?   ? 
Substance History      
Lifetime Hospitalizations      
Hospitalized in Last Year      
Age of Onset      
Anti-Depressant Medication      
Anti-Psychotic Medication      
Anti-Manic Medication      
Anti-Anxiety Medication      
Other Psychotropic Medication      
Currently Employed      
Years Employed Lifetime      
Nuclear Family Mental Illness     ? 
Extended Family Mental Illness     ? 
Child Sexual Abuse      
Child Physical Abuse      
Adult Sexual Assault      
Adult Physical Assault      
Alienation   ?  ? 
Stereotype Endorsement      
Discrimination Occurrence      
Social Withdrawal      
Stigma Resistance      
Partner of Best Friend Support   ?  ? 
Family Support   ?  ? 
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Table 75 (cont.) 
 
Provider Support      
Friends Support      
Community Involvement   ?  ? 
Trust      
Self-Esteem and Self-Efficacy     ? 
Power and Powerlessness      
Community Activism and 
Autonomy 
     
Optimism and Control Over the 
Future 
  ?   
Righteous Anger      
Total Number of Services      
Total Contact Hours      
Average Satisfaction    ? ? 
 
M1 = Model 1:  n = 350; Control variables 
M2 = Model 2:  n = 350; Control variables + Individual and historical factors 
M3 = Model 3:  n = 350; Control variables + Social factors 
M4 = Model 4:  n = 350; Control variables + Service factors 
M5 = Model 5;  n = 337; Full (main effects) model (post diagnostics) 
 
 
illness was not significant when considering clinical variables only, though something 
within the combined model altered the association and familial illness was then 
significant.  Further, the direction of association was different depending on whether 
nuclear or extended family members illness was measured.   
 Consistency across models lends support for the strength of an association as 
well.  For this strategy, other diagnosis, alienation, partner or best friend support, familial 
support, community involvement, and service satisfaction remained significant across 
models two through five.  This information adds to the growing empirical evidence that 
different recovery strategies exist and that different factors are associated with them. 
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Research Question 3:  Are Individual, Social, or Service Factors Associated with 
Recovery Strategy #5:  Help Seeking? 
 The recovery movement has consistently acknowledged that active help seeking 
should be utilized when a problem that cannot be handled by the individual arises (Borg 
& Kristiansen, 2004).  The strategy reduces isolation and promotes trust.  The holistic 
approach views help seeking as more then a clinical intervention.  Help seeking includes 
asking directions, acquiring assistance for household repairs and all other non-mental 
illness related needs and activities.  Further, psychiatric assistance can be supplemented 
with consumer led interventions (Young, Chinman, Forquer, Knight, Vogel, Miller, et al., 
2005).  A concern for help seeking is that the individual, if currently symptomatic to the 
point of impairment in cognition and/or judgment, may not make the correct decision or 
may ignore their need for assistance (Wilder-Willis, Shear, Steffen, & Borkin, 2002).  
The concept of recovery does not ignore this possibility, but does view it as a state that 
will, for the majority of individuals, be transient and remit in time. 
 The important role of help seeking in recovery is clear, though there is little 
empirical information that has identified factors that are strongly associated with the 
strategy of help seeking.  Help seeking was regressed against age, gender, income, and 
education (control variables, Table 76), with age as the only significant result.  The 
estimate is small, but it indicates that help seeking increases slightly with increasing age.   
The model is not significant and explains 1% of the variance. 
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Table 76 
 
Results of OLS Regression Testing the Impact of Control Variables on Recovery 
Strategy 5 (Help Seeking) 
 
Variable 
 
b SE t 
 
Age  0.01 0.00   2.35b
Gender  0.04 0.10  0.39 
Income  0.07 0.04  1.79 
Education 
 
-0.06 0.05 -1.17 
 
Note:  b ≤ .01 
           n = 350 
           R2 = .01; F = 2.06, ns 
  
 
Research question 3.1:  Are individual factors associated with help seeking? 
 Domain 1 clinical/historical variables were next evaluated for significant 
associations with help seeking (Table 77).  The domain 1 model is not significant (F = 
1.44, ns), and accounts for only 4% of the variance.  For some individuals, disturbing or 
debilitating psychiatric symptoms and/or a history of disturbing experience (e.g., abuse, 
hospitalizations) would increase help seeking behavior.  For others, symptoms such as 
severe depression may lead to hopelessness sufficient to prevent help seeking.  The 
evidence from this study does not support the supposition.  Age is again significant, with 
older individuals more likely to employ help seeking.  One independent variable, 
depression (b is significantly associated with help seeking, suggesting that increased 
depression limits help seeking.  
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Table 77 
 
Results of OLS Regression Testing the Impact of Clinical/Historical (Domain 1) on 
Recovery Strategy 5 (Help Seeking) 
 
H1 Variable b SE  t 
 Age 0.02 0.01   2.96b
 Gender  0.13 0.11  1.15 
 Income  0.07 0.04  1.70 
 Education -0.03 0.06 -0.60 
3.1b Somatization  0.11 0.08  1.45 
3.1c Obsessive-compulsive  0.03 0.10  0.32 
3.1d Interpersonal sensitivity  0.07 0.10  0.74 
3.1e Anxiety -0.04 0.10 -0.38 
3.1f Depression -0.27 0.10   -2.64b
3.1g Hostility  0.01 0.07  0.22 
3.1h Phobic anxiety -0.06 0.07 -0.77 
3.1i Paranoia  0.03 0.09  0.36 
3.1j Psychoticism -0.04 0.09 -0.45 
3.1k Substance abuse history  0.09 0.10  0.87 
3.1l Hospitalization history  0.00 0.00  0.91 
3.1m Hospitalized in last year  0.14 0.11  1.28 
3.1n Age of onset -0.00 0.00 -0.77 
3.1o Medication:  Anti-depressant  0.07 0.12  0.60 
3.1p Medication:  Anti-psychotic -0.03 0.10 -0.32 
3.1q Medication:  Anti-manic -0.12 0.11 -1.07 
3.1r Medication:  Anti-anxiety -0.16 0.10 -1.57 
3.1s Medication:  Other psychotropic  0.01 0.10  0.07 
3.1t Current employment -0.10 0.13 -0.84 
3.1u Years of employment -0.00 0.00 -1.11 
3.1v Nuclear family mental illness  0.02 0.04  0.51 
3.1w Extended family mental illness -0.08 0.08 -1.03 
3.1x Child sexual abuse history  0.06 0.11  0.57 
3.1y Child physical abuse history  0.04 0.11  0.37 
3.1z Adult sexual assault history -0.15 0.13 -1.13 
3.1aa Adult physical assault history 
 
 0.05 0.11  0.42 
 
Note:  b ≤ .01 
           n = 350  
           R2 = .04; F = 1.44, ns 
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Research question 3.2:  Are social factors associated with help seeking? 
 Help seeking was next regressed on the combined stigma, social support, and 
empowerment variables, resulting in a significant model (F = 6.61, p ≤ .0001), explaining 
Table 78 
 
Results of OLS Regression Testing the Impact of Social Variables (Domain 2) on 
Recovery Strategy 5 (Help Seeking) 
 
H1 Variable b SE  t 
 
 Age  0.01 0.00    2.97b
 Gender  0.13 0.09  1.50 
 Income  0.01 0.04  0.41 
 Education -0.04 0.05 -0.86 
Stigma    
3.2a Alienation -0.03 0.11 -0.23 
3.2b Stereotype endorsement -0.04 0.12 -0.31 
3.2c Discrimination experience -0.03 0.10 -0.31 
3.2d Social withdrawal  0.07 0.13  0.51 
3.2e Stigma resistance -0.21 0.11 -1.81 
Social Support and Related    
3.2f Partner or best friend support  0.08 0.05  1.60 
3.2g Family support  0.00 0.03  0.09 
3.2h Provider support  0.19 0.05    3.52c
3.2i Friend support  0.03 0.05  0.63 
3.2j Community involvement  0.03 0.04  0.86 
3.2k Trust  0.05 0.04  1.13 
Empowerment    
3.2l Self-esteem/self-efficacy 0.37 0.12    3.24c
3.2m Power/powerlessness 0.16 0.11   1.42 
3.2n Community activism and 
autonomy 
-0.05 0.11 -0.13 
3.2o Optimism and control over the 
future 
-0.07 0.11 -0.68 
3.2p Righteous anger 
 
-0.09 0.08 -1.19 
 
Note:  b ≤ .01; c ≤ .001 
           n = 350;  
           R2 = .24; F = 6.61, p ≤ .0001 
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24% of the variance (Table 78).  Age again was significant with increased age associated 
with more help seeking.  Defying prediction, none of the stigma scales were significant, 
though impaired stigma resistance approached significance.  Provider support was the 
only social support variable significantly related to help seeking.  The lack of significance 
for the other potential sources of help (significant other, family, friends) may be due, in 
part, to the wording of the questions that comprise the dependent variable.  The questions 
are non-specific, such that they do not reference sources of help, only whether the 
individual is willing to seek and accept assistance.  Considering also that respondents 
took the surveys inside a mental health center, there may have been a context bias 
operating.  Lastly, only self-esteem/self-efficacy was significant for the empowerment 
construct.  Thus, for each increase in self-esteem score, help seeking endorsement 
increases by 0.37, holding all other variables constant. 
Research question 3.3:  Are service factors associated with help seeking? 
 The next group of variables evaluated was the domain 3 service variables.  The 
model was significant (F = 6.24, p ≤ .0001), and explains 10% of the variance (Table 79).  
Age was significant in this model once again.  Number of services and contact hours 
were not associated with help seeking.  However, satisfaction with services was strongly 
associated, with help seeking though the mechanism explaining this association is 
unclear.  This finding has been consistent and likely, as stated previously, reflects the 
safety and attachment of a positive therapeutic relationship that generates the trust needed 
to ask for and accept help from others as well as the benefits of competent service 
provision.   
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Table 79 
 
Results of OLS Regression Testing the Impact of Service Variables (Domain 3) on 
Recovery Strategy 5 (Help Seeking) 
 
 Variable b SE t 
 Age  0.01 0.00    2.17a
 Gender  0.06 0.09   0.61 
 Income  0.05 0.04  1.40 
 Education -0.07 0.05 -1.43 
3.3a Total number of services  0.06 0.04  1.43 
3.3b Total service hours per month -0.01 0.01 -1.57 
3.3c Average satisfaction score 
 
 0.25 0.04    5.81d
 
Note:  a ≤ .05; d ≤ .0001 
           n = 350 
           R2 = .10; F = 6.24, p ≤ .0001 
  
 
Research question 3:  Are individual, social or service factors associated with 
help seeking?  Main effects model  
 Using the same modeling plan as previous recovery strategies, the main effects 
model examines the associations between help seeking and the three independent variable 
domains.  The results of the diagnostic analysis for overly influential scores was the 
removal of seven observations due to cutpoint violations (n = 343 for the model).  The 
model testing whether R2 = 0 was significant, indicating that R2 is not zero with a fair 
degree of confidence (F = 3.32, p ≤ .0001), accounting for 25% of the variance (Table 
80).  Age remains significant in this model at approximately the same magnitude and in 
the same direction.  Higher levels of interpersonal sensitivity are associated with 
increased help seeking, representing the only significant clinical variable.  The central 
aspect of interpersonal sensitivity, noted earlier, is a pervasive lack of confidence, self- 
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Table 80 
 
Main Effects Results of OLS Regression Testing the Impact of Domain 1-3 Variables on 
Recovery Strategy 5 (Help Seeking) 
 
H1 Variable b SE t 
 Age  0.01 0.00    2.10a
 Gender  0.16 0.10  1.57 
 Income  0.02 0.04  0.59 
 Education -0.01 0.05 -0.11 
Domain 1    
3.1b Somatization  0.02 0.07  0.31 
3.1c Obsessive-compulsive  0.02 0.09  0.28 
3.1d Interpersonal sensitivity  0.20 0.09    2.18a
3.1e Anxiety  0.03 0.09  0.35 
3.1f Depression -0.12 0.10 -1.25 
3.1g Hostility -0.01 0.06 -0.19 
3.1h Phobic anxiety -0.09 0.07 -1.27 
3.1i Paranoia  0.04 0.08  0.51 
3.1j Psychoticism -0.07 0.09 -0.84 
3.1k Substance abuse history  0.01 0.09  0.07 
3.1l Hospitalization history  0.00 0.00  0.71 
3.1m Hospitalized in last year  0.11 0.10  1.15 
3.1n Age of onset -0.00 0.00 -0.37 
3.1o Medication:  Anti-depressant  0.03 0.11  0.29 
3.1p Medication:  Anti-psychotic -0.05 0.10 -0.47 
3.1q Medication:  Anti-manic -0.05 0.10 -0.46 
3.1r Medication:  Anti-anxiety -0.10 0.09 -1.02 
3.1s Medication:  Other psychotropic  0.01 0.10  0.13 
3.1t Current employment -0.06 0.12 -0.48 
3.1u Years of employment  0.00 0.00  0.38 
3.1v Nuclear family mental illness  0.01 0.04  0.28 
3.1w Extended family mental illness -0.07 0.07 -1.07 
3.1x Child sexual abuse history  0.08 0.10  0.76 
3.1y Child physical abuse history  0.02 0.10  0.19 
3.1z Adult sexual assault history -0.04 0.12 -0.32 
3.1aa Adult physical assault history -0.06 0.10 -0.58 
Domain 2    
Stigma    
3.2a Alienation -0.02 0.12 -0.16 
3.2b Stereotype endorsement  0.06 0.13  0.44 
3.2c Discrimination experience -0.08 0.11 -0.74 
3.2d Social withdrawal  0.02 0.14  0.15 
3.2e Stigma resistance 
 
-0.17 0.13 -1.35 
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Table 80 (cont.) 
 
H1 Variable 
 
b SE t 
Social Support and Related    
3.2f Partner or best friend support  0.06 0.05  1.09 
3.2g Family support -0.01 0.03 -0.32 
3.2h Provider support  0.14 0.06    2.19a
3.2i Friend support  0.01 0.05  0.23 
3.2j Community involvement  0.07 0.04  1.65 
3.2k Trust  0.08 0.05  1.59 
Empowerment    
3.2l Self-esteem/self-efficacy  0.36 0.13    2.73b
3.2m Power/powerlessness  0.25 0.12    2.05a
3.2n Community activism and 
autonomy 
-0.65 0.13 -0.50 
3.2o Optimism and control over the 
future 
-0.02 0.12 -0.14 
3.2p Righteous anger -0.19 0.09   -2.20a
Domain 3    
3.3a Total number of services  0.02 0.05  0.58 
3.3b Total service hours per month -0.00 0.01 -0.41 
3.3c Average satisfaction score 
 
 0.12 0.05    2.52b
 
Note:  a ≤ .05; b ≤ .01 
           n = 343  
           R2 = .25; F = 3.32, p ≤ .0001 
  
 
consciousness and feelings of inferiority.  Willingness to seek help may be a 
compensatory approach to meet needs with as little challenge to a fragile self as possible.
 Domain 2 social variables are moderately associated with help seeking.  However, 
none of the stigma variables and only support from providers was significantly associated 
with help seeking, consistent with the domain 2 model in isolation.  Empowerment 
appears to be the construct most related to help seeking.  Self-esteem/self-efficacy is 
positively associated with help seeking as is power/powerlessness.  Positive self 
evaluations and experiences of personal power may ease the way to ask for help and also 
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protect from negative self reflections based on having to need help.  Further, experiences 
of righteous anger are negatively associated with help seeking, suggesting that this 
expression of empowerment interferes with help seeking behavior.  Righteous anger may 
lead to righteous rejection of assistance.  Finally, the services domain is significant only 
for average satisfaction. 
 Next presented is the reduced model that contains only the variables that were 
significant in main effects (Table 81).  The model is significant (F = 19.26, p ≤ .0001) 
and explains 27% of the variance, an increase over the main effect variance explained of 
24%.  Several changes are noted in these results compared to the main effects.  
Interpersonal sensitivity is no longer significant in this model.  The direction remains the 
same but the magnitude is diminished.  Power/powerlessness, an empowerment construct 
scale, is also no longer significant, but also reverses direction (b = -0.13, t = -1.62, ns).   
Table 81 
 
Reduced Model Results of OLS Regression Testing the Impact of Domain 1-3 Variables 
on Recovery Strategy 5 (Help Seeking) 
 
Variable 
 
b SE t 
Age  0.01 0.00    2.29a
Interpersonal sensitivity  0.08 0.04  1.73 
Provider support  0.24 0.05    5.05d
Self-esteem/self-efficacy  0.54 0.09    6.11d
Power/powerlessness -0.13 0.08 -1.62 
Righteous anger  0.29 0.10    2.82b
Average satisfaction score 
 
 0.10 0.04    2.30a
 
Note:  a ≤ .05; d ≤ .0001 
           n = 343  
           R2 = .27; F = 19.26, p ≤ .0001 
  
Righteous anger remains significant but the degree is less and the direction is reversed, 
which now indicates that increased righteous anger is associated with help seeking.  Both 
provider support and self-esteem/self-efficacy substantially increase in magnitude. 
 Figure 8 displays the contribution of each model towards explanation of variance.  
Help seeking appears to be heavily associated with social factors.  However, the role of 
some of the social variables in association with help seeking is confused when comparing 
the main effects to the limited model.  Noted earlier, the impact of clinical pressures  
 
Figure 8 
 
Amount of Variance Explained by Each Domain for Help Seeking 
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would arguably justify help seeking behavior, though the data does not support this.   
The contribution of domain 3 is relegated to satisfaction with services, though this is a 
powerful enough association to account for an appreciable amount of variance. 
 The final analytic step for this recovery strategy is to review and assess for 
consistencies across models (Table 82).  Age is significant for models 1-5.  All models 
suggest that increasing age is associated with help seeking.  Clinical domain variables are 
generally unrelated to help seeking.  Depression is significant in the isolated model and 
interpersonal sensitivity in the full model, though both sign and magnitude for 
interpersonal sensitivity changes in the limited model.  Provider support, self-esteem and 
satisfaction with services are consistently associated with help seeking across models. 
 
Research Question 3:  Are Individual, Social or Service Factors Associated with 
Recovery Strategy #6:  Symptom Eradication? 
 Symptom eradication is a point of concern and even contention when discussing 
recovery.  Individuals in the consumer movement consistently ask that symptoms be less 
of a focus when discussing recovery, and go so far as to state that complete symptom 
relief is an artificial goal advocated by clinical services and is not necessary (Deegan, 
2005).  Further, empirical investigations of the effects of symptoms on quality of life 
have found that many individuals are able to live fulfilling lives with some symptoms 
present (Lysaker, et al., 2006).   
 Chapter 3 discussed how the dependent variable recovery strategies were initially 
generated.  The reader will recall that the sixth strategy, symptom eradication, is a one 
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Table 82 
 
Summary Table: Results of OLS Regression Testing the Impact of Domain 1-3 Variables 
on Recovery Strategy 5 (Help Seeking) 
 
 Model 1 Model 2 Model 3 Model 4 Model 5 
 
Age ? ? ? ? ? 
Sex      
Income      
Education      
Psychosomatic       
Obsessive Compulsive       
Interpersonal Sensitivity     ? 
Anxiety      
Depression  ?    
Hostility      
Phobia      
Paranoia      
Psychoticism      
Substance History      
Lifetime Hospitalizations      
Hospitalized in Last Year      
Age of Onset      
Anti-Depressant Medication      
Anti-Psychotic Medication      
Anti-Manic Medication      
Anti-Anxiety Medication      
Other Psychotropic Medication      
Currently Employed      
Years Employed Lifetime      
Nuclear Family Mental Illness      
Extended Family Mental Illness      
Child Sexual Abuse      
Child Physical Abuse      
Adult Sexual Assault      
Adult Physical Assault      
Alienation      
Stereotype Endorsement      
Discrimination Occurrence      
Social Withdrawal      
Stigma Resistance      
Partner of Best Friend Support      
Family Support      
Provider Support   ?  ? 
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Table 82 (cont.) 
 
Friends Support      
Community Involvement      
Trust      
Self-Esteem and Self-Efficacy   ?  ? 
Power and Powerlessness      
Community Activism and 
Autonomy 
     
Optimism and Control Over the 
Future 
     
Righteous Anger     ? 
Total Number of Services      
Total Contact Hours      
Average Satisfaction    ? ? 
 
M1 = Model 1:  n = 350; Control variables 
M2 = Model 2:  n = 350; Control variables + Individual and historical factors 
M3 = Model 3:  n = 350; Control variables + Social factors 
M4 = Model 4:  n = 350; Control variables + Service factors 
M5 = Model 5;  n = 343; Full (main effects) model (post diagnostics) 
 
 
item variable that was originally part of a two question factor that failed for inclusion as a 
multiple item strategy.  However, the one item investigating the need for symptoms to be 
eliminated as necessary for recovery addressed the issue of symptoms in recovery noted 
above.  Because of the controversy, the decision was made to retain this single item 
variable and investigate it as a strategy to assess potential covariates of importance.  In 
keeping with the analysis pattern displayed in the first five strategies, control variables 
are first assessed for association with symptom eradication. 
 Age, gender, income, and education (control variables) account for 4% of the 
variance of symptom eradication (F = 4.22, p ≤ .01).  The results are summarized in 
Table 83.  Both income and education are negatively associated with eradication, 
indicating that higher income and education are associated with less likelihood of 
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endorsing symptom eradication.  Income and education are highly correlated (χ2 (2, 350) 
= 3.45, p ≤ .0001) and may reflect greater exposure to psychiatric literature and 
internalization of the stereotypic, and generally inaccurate, message that symptoms and 
mental illness are chronic conditions, much like diabetes, that requires constant care over 
the lifetime. 
Table 83 
 
Results of OLS Regression Testing the Impact of Control Variables on Recovery 
Strategy 6 (Symptom Eradication) 
 
Variable 
 
b SE t 
 
Age  0.00 0.01  0.12 
Gender -0.16 0.14 -1.12 
Income -0.12 0.06  -2.08a
Education 
 
-0.23 0.07  -3.19c
 
Note:  a ≤ .05; c ≤ .001 
           n = 350 
           R2 = .04; F = 4.33, p ≤ .01 
  
 
Research question 3.1:  Are individual factors associated with symptom 
eradication? 
Symptom eradication was regressed on domain 1 clinical/historical variables with 
a significant result (F = 1.89, p ≤ .01) that explained 7% of the variance (Table 84).  
Income and education, similar to the control variable analysis discussed above, are 
negatively associated with symptom eradication. 
Interpersonal sensitivity is positively associated with symptom eradication.  This 
is contrary to the predicted direction.  Hypothetically, increased sensitivity may be  
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Table 84 
 
Results of OLS Regression Testing the Impact of Clinical/Historical (Domain 1) on 
Recovery Strategy 6 (Symptom Eradication) 
 
H1 Variable b SE  t 
 Age  0.01 0.01   0.29 
 Gender  0.03 0.17   0.18 
 Income -0.14 0.06   -2.25a
 Education -0.15 0.08   -1.98a
     
3.1a Major depression diagnosis  0.44 0.19    2.28a
3.1b Somatization -0.01 0.11 -0.06 
3.1c Obsessive-compulsive  0.03 0.14   0.20 
3.1d Interpersonal sensitivity  0.39 0.14    2.72b
3.1e Anxiety  0.01 0.15  0.09 
3.1f Depression -0.14 0.15 -0.90 
3.1g Hostility  0.05 0.10  0.55 
3.1h Phobic anxiety -0.07 0.11 -0.69 
3.1i Paranoia -0.23 0.13 -1.76 
3.1j Psychoticism -0.03 0.14 -0.20 
3.1k Substance abuse history -0.04 0.15 -0.25 
3.1l Hospitalization history -0.01 0.01  -2.06a
3.1m Hospitalized in last year  0.07 0.16  0.43 
3.1n Age of onset  0.01 0.01  1.77 
3.1o Medication:  Anti-depressant -0.17 0.18 -0.93 
3.1p Medication:  Anti-psychotic  0.02 0.15  0.13 
3.1q Medication:  Anti-manic  0.12 0.16  0.71 
3.1r Medication:  Anti-anxiety -0.03 0.15 -0.20 
3.1s Medication:  Other psychotropic  0.01 0.15  0.09 
3.1t Current employment  0.13 0.19  0.71 
3.1u Years of employment -0.01 0.01 -0.96 
3.1v Nuclear family mental illness -0.09 0.06 -1.60 
3.1w Extended family mental illness  0.06 0.11  0.51 
3.1x Child sexual abuse history -0.25 0.17 -1.53 
3.1y Child physical abuse history  0.27 0.16  1.72 
3.1z Adult sexual assault history -0.16 0.19 -0.86 
3.1aa Adult physical assault history 
 
-0.01 0.17 -0.03 
 
Note:  a ≤ .05; b ≤ .01 
           n = 350  
           R2 = .07; F = 1.89, p ≤ .01 
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confused with shyness, fear of public speaking, or other common experiences that may 
not be considered clinical but still add to the burden of needed treatment.  As noted 
before, individuals with high levels of interpersonal sensitivity may have greater  
compliance potential as they likely rely on others to a greater extent and thus may 
internalize messages suggesting that what they experience is transient. 
A diagnosis of major depression is also positively associated with symptom 
eradication and again defies the predicted direction.  This may be an artifact of the data or 
a more complex process.  The two variables that would be expected to at least approach 
significance in support of major depression are depression symptoms and anti-depressant 
medication.  Neither of these variables is significant though both are in the predicted 
direction of increased symptoms or medication use would be negatively associated with 
symptom eradication.   
 One additional variable, lifetime hospitalizations, is negatively associated with 
symptom eradication.  Larger numbers of hospitalizations usually indicate a more severe 
course of illness, implying a more constant state of active symptoms that, in turn, reduces 
belief in being symptom free.  However, though statistically significant, the low 
parameter estimate suggests that this is not an issue of critical clinical relevance. 
Research question 3.2:  Are social factors associated with symptom eradication? 
 The next analysis focuses on the relationship between domain 2 social variables 
and symptom eradication.  The model is significant (F = 3.80, p ≤ .0001) and accounts for 
14% of the variance, indicating that social factors have a greater association with belief in 
symptom eradication then clinical factors.  The results are summarized in Table 85.  
Income and education follow the same pattern as noted in discussion of the control 
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variable model above (Table 82).  Higher levels of income and education are associated 
with decreased belief in symptom eradication.  Stigma resistance is the lone stigma scale 
significantly associated with eradication.  The positive association demonstrates  
 
Table 85 
 
Results of OLS Regression Testing the Impact of Social Variables (Domain 2) on 
Recovery Strategy 6 (Symptom Eradication) 
 
H1 Variable b SE  t 
 
 Age -0.00 0.00 -0.57 
 Gender -0.01 0.14 -0.09 
 Income -0.16 0.06   -2.71b
 Education -0.18 0.07   -2.46b
Stigma    
3.2a Alienation  0.11 0.18  0.66 
3.2b Stereotype endorsement -0.06 0.20 -0.31 
3.2c Discrimination experience -0.12 0.16 -0.73 
3.2d Social withdrawal -0.14 0.21 -0.67 
3.2e Stigma resistance  0.41 0.18    2.29a
Social Support and Related    
3.2f Partner or best friend support  0.02 0.08  0.29 
3.2g Family support -0.03 0.05 -0.56 
3.2h Provider support  0.09 0.09  1.07 
3.2i Friend support -0.02 0.08 -0.38 
3.2j Community involvement  0.12 0.06    2.00a
3.2k Trust -0.11 0.07 -1.63 
Empowerment    
3.2l Self-esteem/self-efficacy  0.23 0.18  1.25 
3.2m Power/powerlessness -0.54 0.18   -3.07b
3.2n Community activism and 
autonomy 
-0.06 0.18 -0.35 
3.2o Optimism and control over the 
future 
 0.62 0.18    3.51c
3.2p Righteous anger 
 
-0.09 0.12 -0.69 
 
Note:  a ≤ .05; b ≤ .01; c ≤ .001 
           n = 350;  
           R2 = .14; F = 3.80, p ≤ .0001 
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resistance to stigmatizing messages is accompanied by an increased belief in eradication.  
 Community involvement is also positively associated with eradication.  
Experiences of community integration may enhance belongingness and increase hope in 
achieving a symptom free lifestyle, though this is speculative as the mechanisms that 
drive this and other associations noted can only be hypothesized.  The empowerment 
scales have two significant associations.  Contrary to the hypothesized direction, 
increased endorsement of personal power is associated with decreased sanctioning of 
eradication.  In this case, power may not be related to symptom eradication but with 
increased ability to cope with symptoms.    The final significant association is in line with 
the predicted direction showing optimism and control over the future to be positively 
associated with symptom eradication.   
Research question 3.3:  Are service factors associated with symptom eradication? 
 Service variables were assessed in association with symptom eradication and the 
model was found to have an overall significant relationship (F = 3.09, p ≤ .01), 
explaining 4% of the variance.  However, only the control variables of income and 
education were significant contributors to the model (Table 86) and were negatively 
associated.  None of the service variables approached significance. 
Research question 3:  Are individual, social or service factors associated with 
symptom eradication?  Main effects model  
 Symptom eradication was regressed on the combined independent variable 
domains 1-3 with a significant result explaining 19% of the variance (F = 2.62, p ≤ .0001) 
(Table 87).  The variables selected for their theoretical and empirical relations to 
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Table 86 
 
Results of OLS Regression Testing the Impact of Service Variables (Domain 3) on 
Recovery Strategy 6 (Symptom Eradication) 
 
 Variable b SE t 
 Age  0.00 0.01  0.40 
 Gender -0.18 0.14 -1.28 
 Income -0.13 0.06  -2.18a
 Education -0.24 0.07  -3.31c
3.3a Total number of services -0.10 0.07 -1.47 
3.3b Total service hours per month -0.00 0.01 -0.27 
3.3c Average satisfaction score 
 
 0.03 0.07  0.46 
 
Note:  a ≤ .05; c ≤ .001 
           n = 350 
           R2 = .04; F = 3.09, p ≤ .01 
  
 
recovery are the least associated with this dependent variable in comparison to the other 
five recovery strategies investigated.  Factors associated with symptom eradication are 
not substantially contained in this model.  The final sample size for the main effect model 
was 342, indicating eight observations were deleted from the analysis due to violations of 
at least two of three cutpoints for the diagnostic tests used to evaluate the data.  The 
full model no longer shows a significant association between education and eradication.  
Income remains significant in association with the dependent variable.  Likewise, major 
depression and interpersonal sensitivity remains positively associated with symptom 
eradication, opposite of the predicted direction.  Paranoia was negatively correlated with 
the strategy, signifying a drop in the expectation of symptom eradication of .33 for each 
one point increase in paranoia. 
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Table 87 
 
Main Effects Results of OLS Regression Testing the Impact of Domain 1-3 Variables on 
Recovery Strategy 6 (Symptom Eradication) 
 
H1 Variable b SE t 
 Age  0.00 0.01  0.22 
 Gender  0.12 0.16  0.75 
 Income -0.17 0.06  -2.90b
 Education -0.14 0.08 -1.78 
Domain 1    
3.1a Major depression diagnosis  0.47 0.19    2.49b
3.1b Somatization -0.03 0.11 -0.31 
3.1c Obsessive-compulsive  0.03 0.14  0.25 
3.1d Interpersonal sensitivity  0.40 0.14   2.92b
3.1e Anxiety -0.03 0.14 -0.23 
3.1f Depression -0.02 0.15 -0.13 
3.1g Hostility  0.08 0.10  0.85 
3.1h Phobic anxiety  0.01 0.11  0.09 
3.1i Paranoia -0.33 0.13   -2.52b
3.1j Psychoticism -0.05 0.13 -0.41 
3.1k Substance abuse history  0.05 0.14  0.36 
3.1l Hospitalization history -0.01 0.01 -1.31 
3.1m Hospitalized in last year  0.12 0.15  0.79 
3.1n Age of onset  0.00 0.01  0.49 
3.1o Medication:  Anti-depressant -0.27 0.18 -1.53 
3.1p Medication:  Anti-psychotic  0.03 0.15  0.20 
3.1q Medication:  Anti-manic  0.12 0.16  0.78 
3.1r Medication:  Anti-anxiety  0.03 0.14  0.19 
3.1s Medication:  Other psychotropic  0.05 0.15  0.33 
3.1t Current employment  0.17 0.18  0.96 
3.1u Years of employment -0.00 0.01 -0.69 
3.1v Nuclear family mental illness -0.07 0.06 -1.28 
3.1w Extended family mental illness  0.02 0.11  0.21 
3.1x Child sexual abuse history -0.22 0.16 -1.37 
3.1y Child physical abuse history  0.23 0.15  1.51 
3.1z Adult sexual assault history -0.19 0.18 -1.02 
3.1aa Adult physical assault history -0.01 0.16 -0.08 
Domain 2    
Stigma    
3.2a Alienation  0.19 0.18  1.01 
3.2b Stereotype endorsement -0.27 0.20 -1.33 
3.2c Discrimination experience -0.02 0.17 -0.10 
3.2d Social withdrawal -0.13 0.22 -0.61 
3.2e Stigma resistance  0.29 0.19  1.47 
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Table 87 (cont.) 
 
H1 Variable 
 
b SE t 
Social Support and Related    
3.2f Partner or best friend support  0.11 0.08  1.38 
3.2g Family support -0.03 0.05 -0.68 
3.2h Provider support  0.13 0.10  1.31 
3.2i Friend support -0.09 0.08 -1.23 
3.2j Community involvement  0.19 0.06    2.84b
3.2k Trust -0.12 0.08 -1.56 
Empowerment    
3.2l Self-esteem/self-efficacy  0.23 0.20  1.17 
3.2m Power/powerlessness -0.65 0.19   -3.46c
3.2n Community activism and 
autonomy 
-0.30 0.19 -1.55 
3.2o Optimism and control over the 
future 
 0.70 0.19    3.77c
3.2p Righteous anger -0.08 0.13 -0.61 
Domain 3    
3.3a Total number of services -0.04 0.08 -0.52 
3.3b Total service hours per month -0.01 0.01 -0.60 
3.3c Average satisfaction score 
 
-0.10 0.07 -1.31 
 
Note:  b ≤ .01; c ≤ .001 
           n = 342  
           R2 = .19; F = 2.62, p ≤ .0001 
  
 
 Turning attention to the domain 2 social variables, none of the stigma scales are 
significantly associated with eradication.  Community involvement is the only support 
variable associated with eradication.  Possible secondary gains from community 
involvement may place symptoms in a different perspective or distract attention away 
from symptoms, lessening impact and raising endorsement of eradication.  The same 
process may be working for the positive association noted for optimism and control over 
the future, an empowerment scale.  The strong negative association highlighted in the 
domain 1 isolated model (Table 84) between power/powerlessness and symptom 
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eradication is repeated in the full model.  As noted, this relation is against the predicted 
direction.  Lastly, none of the service (domain 3) variables were significant. 
 The limited model investigating significant factors from the main effects model 
with symptom eradication is presented next (Table 88).  The model is significant (F = 
11.96, p ≤ .0001) and explains slightly less variance (18%) compared to the main effects 
model (19%).  The majority of the variables increased in magnitude with the exception of 
interpersonal sensitivity and there were no changes in direction of associations. Figure 9 
displays the variance explained for each model where eradication was regressed on sets 
of independent variables.  Social factors explain the most variance in this model.  The 
lack of explanation from the clinical domain 1 variables, considering the focus on 
symptoms in the strategy, was unexpected.  However, with only 19% of the variance 
explained, it is conceivable that appropriate clinical variables remain untapped.  The 
Table 88 
 
Reduced Model Results of OLS Regression Testing the Impact of Domain 1-3 Variables 
on Recovery Strategy 6 (Symptom Eradication) 
 
Variable 
 
b SE t 
Income -0.17 0.05 -3.09c
Interpersonal sensitivity  0.25 0.10  2.36b
Paranoia -0.30 0.10 -3.02c
Major depression diagnosis  0.47 0.16  2.85b
Community involvement  0.17 0.05  3.24c
Power/powerlessness -0.71 0.15 -4.64d
Optimism and control over the future 
 
 0.72 0.14  5.17d
 
Note:  b ≤ .01; c ≤ .001 
           n = 342  
           R2 = .18; F = 11.96, p ≤ .0001 
  
same argument can be used for service variables.  Services are, obviously, a primary 
avenue for symptom control.  Specific types of services may have a greater impact on 
symptom eradication then others, though this is beyond the scope of the current study to 
evaluate. 
 Table 89 summarizes the significant findings from each model pertaining to 
symptom eradication.  Higher levels of income are associated with less endorsement of 
symptom eradication in all models.  More education was also negatively associated with  
 
 
Figure 9 
 
Amount of Variance Explained by Each Domain for Symptom Eradication 
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Table 89 
 
Summary Table: Results of OLS Regression Testing the Impact of Domain 1-3 Variables 
on Recovery Strategy 6 (Symptom Eradication) 
 
 Model 1 Model 2 Model 3 Model 4 Model 5 
 
Age      
Sex      
Income ? ? ? ? ? 
Education ? ? ? ?  
Psychosomatic       
Obsessive Compulsive       
Interpersonal Sensitivity  ?   ? 
Anxiety      
Depression      
Hostility      
Phobia      
Paranoia     ? 
Psychoticism      
Major Depression Diagnosis  ?   ? 
Substance History      
Lifetime Hospitalizations  ?    
Hospitalized in Last Year      
Age of Onset      
Anti-Depressant Medication      
Anti-Psychotic Medication      
Anti-Manic Medication      
Anti-Anxiety Medication      
Other Psychotropic Medication      
Currently Employed      
Years Employed Lifetime      
Nuclear Family Mental Illness      
Extended Family Mental Illness      
Child Sexual Abuse      
Child Physical Abuse      
Adult Sexual Assault      
Adult Physical Assault      
Alienation      
Stereotype Endorsement      
Discrimination Occurrence      
Social Withdrawal      
Stigma Resistance   ?   
Partner of Best Friend Support      
Family Support      
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Table 89 (cont.) 
 
Provider Support      
Friends Support      
Community Involvement   ?  ? 
Trust      
Self-Esteem and Self-Efficacy      
Power and Powerlessness   ?  ? 
Community Activism and 
Autonomy 
     
Optimism and Control Over the 
Future 
  ?  ? 
Righteous Anger      
Total Number of Services      
Total Contact Hours      
Average Satisfaction      
 
M1 = Model 1:  n = 350; Control variables 
M2 = Model 2:  n = 350; Control variables + Individual and historical factors 
M3 = Model 3:  n = 350; Control variables + Social factors 
M4 = Model 4:  n = 350; Control variables + Service factors 
M5 = Model 5;  n = 342; Full (main effects) model (post diagnostics) 
 
 
eradication in four of five models, with the main effects model approaching but not 
achieving significance.  Interpersonal sensitivity and power/powerlessness were 
significant in the two models they were entered but in the direction opposite of what were 
predicted in both models.  The diagnosis of major depression was also positively 
associated with eradication, against prediction, but could represent a combination of the 
desire to be depression free and the hope that this may occur, and the burgeoning public 
awareness, mostly generated by pharmaceutical company advertisement, of depression 
and claims for potential symptom free lifestyles.   
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Community involvement and optimism were consistently and positively 
associated with the belief in symptom eradication and represent openings for further 
investigation.  Variables significant in earlier models that were not significant in main 
effects include lifetime hospitalizations (domain 1) and stigma resistance (domain 2). 
 
Summary of Research Question 3, Investigation of Recovery Strategies 
 All the analyses targeting the six recovery strategies were performed in response 
to the hypotheses embedded in research question 3.  The point was made earlier in the 
chapter that addressing each hypothesis in turn was unwieldy.  Instead, the presentation 
of results summarized in Tables 48-89 addressed in more general terms the findings for 
each hypothesis.  Table 90 reports specifically for each hypothesis whether it was 
supported in multivariate analysis.  The following criteria were used for deciding whether 
the hypothesis was supported or not:   
• Yes, if the main effects model supports the hypothesis 
• No, if the main effects model does not support the hypothesis 
• Partial, if the hypothesis is supported in a partial (singular domain) model but not 
in the main effects model 
• Reverse, if the association was significant but in the opposite direction then 
predicted in the main effects model 
• The results for yes, no, or partial are generally consistent with the literature base 
available 
 The clinical/historical domain (domain 1) had multiple significant associations 
with recovery strategies, though with no clear pattern.  Out of seventeen variables that 
 339
were significantly associated, only the symptom scale interpersonal sensitivity 
(significant to four recovery strategies, of which one dropped out in analysis of the 
reduced model) and a primary diagnosis of an anxiety disorder (significant to two 
strategies, though one dropped out in the reduced model) were significant to more than 
one strategy.  Thus, clinical covariates are important to recovery strategies, but different 
ones are important to different strategies.  This further suggests that operationalization of 
the strategies described in this study could be effected by specific clinical or historical 
factors that would need to be accounted for in development of recovery programs. 
Symptom levels in bivariate analysis are negatively associated with virtually every 
recovery strategy.  This uniformity of direction indicates that symptom control and 
coping strategies, if duplicated in a future causal research design, could be an important 
prerequisite for strategy utilization.  In multivariate results, three recovery strategies - 
positive future orientation, meaningfulness, personal control, and hope, and symptom 
eradication - were significantly negatively associated with anxiety, depression, hostility 
or paranoia.  Anxiety requires special mention.  Recovery literature, when focused at all 
on specific symptoms, has concentrated the bulk of effort on studying the relationship of 
depression to recovery.  Depression was significantly but weakly associated with positive 
future orientation only and, diagnostically, major depression was significant only to 
symptom eradication.  A diagnosis of anxiety along with symptoms of anxiety including 
phobia are associated with three strategies.  Anxiety, in this study, has a more powerful 
negative association then depression when considering the strength of association and 
number of strategies affected.  Indeed, symptoms have the highest degree of association 
with recovery strategies of the different clinical/historical groupings in this study.  Other  
 340
Table 90 
 
Summary of Multivariate Results for Research Question 3 Hypotheses 
 
  Effective 
Illness 
Management 
 
Positive 
Future 
Orientation 
Meaningfulness, 
Personal 
Control and 
Hope 
 
Recognizing 
Support 
Help 
Seeking 
Symptom 
eradication 
Hypothesis 
 
Statement Supported? Supported? Supported? Supported? Supported? Supported?
Hyp3.1a Less clinically severe diagnoses for participants 
will be associated with greater endorsement for a 
recovery strategy 
 Yes  Yes  Reverse 
Hyp3.1b Lower somatization symptoms reported by 
participants will be associated with greater 
endorsement for a recovery strategy 
      
Hyp3.1c Lower obsessive-compulsive symptoms reported 
by participants will be associated with greater 
endorsement for a recovery strategy 
      
Hyp3.1d Lower interpersonal sensitivity reported by 
participants will be associated with greater 
endorsement for a recovery strategy 
Reverse  Reverse  Reverse Reverse 
Hyp3.1e Lower symptoms of anxiety reported by 
participants will be associated with greater 
endorsement for a recovery strategy 
 Reverse     
Hyp3.1f Lower symptoms of depression reported by 
participants will be associated with greater 
endorsement for a recovery strategy 
Partial Yes  Partial Partial  
Hyp3.1g Lower hostility reported by participants will be 
associated with greater endorsement for a recovery 
strategy 
  Yes    
Hyp3.1h Lower phobic anxiety reported by participants will 
be associated with greater endorsement for a 
recovery strategy 
 
 Yes Partial    
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Table 90 (cont.) 
 
  Effective 
Illness 
Management 
 
Positive 
Future 
Orientation 
Meaningfulness, 
Personal 
Control and 
Hope 
 
Recognizing 
Support 
Help 
Seeking 
Symptom 
eradication 
Hypothesis 
 
Statement Supported? Supported? Supported? Supported? Supported? Supported?
Hyp3.1i Lower paranoid ideation reported by participants 
will be associated with greater endorsement for a 
recovery strategy 
     Yes 
Hyp3.1j Lower psychoticism reported by participants will 
be associated with greater endorsement for a 
recovery strategy 
      
Hyp3.1k Absence of a comorbid substance use disorder will 
be associated with greater endorsement for a 
recovery strategy for participants 
 Reverse     
Hyp3.1l Lower numbers of lifetime psychiatric 
hospitalizations will be associated with greater 
endorsement for a recovery strategy for 
participants 
     Yes 
Hyp3.1m No psychiatric hospitalization in the last year will 
be associated with greater endorsement for a 
recovery strategy for participants 
 Yes     
Hyp3.1n Older age at onset of disorder will be associated 
with greater endorsement for a recovery strategy 
for participants 
      
Hyp3.1o Absence of prescribed anti-depressant medication 
will be associated with greater endorsement for a 
recovery strategy for participants 
Reverse 
Partial 
     
Hyp3.1p Absence of prescribed anti-psychotic medication 
will be associated with greater endorsement for a 
recovery strategy for participants 
 
 
  Yes    
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Table 90 (cont.) 
 
  Effective 
Illness 
Management 
 
Positive 
Future 
Orientation 
Meaningfulness, 
Personal 
Control and 
Hope 
 
Recognizing 
Support 
Help 
Seeking 
Symptom 
eradication 
Hypothesis 
 
Statement Supported? Supported? Supported? Supported? Supported? Supported?
Hyp3.1q 
 
 
Absence of prescribed anti-manic medication will 
be associated with greater endorsement for a 
recovery strategy for participants 
      
Hyp3.1r Absence of prescribed anti-anxiety medication will 
be associated with greater endorsement for a 
recovery strategy for participants 
Yes      
Hyp3.1s Absence of any other prescribed psychotropic 
medication will be associated with greater 
endorsement for a recovery strategy for 
participants 
      
Hyp3.1t Being currently employed will be associated with 
greater endorsement for a recovery strategy for 
participants 
      
Hyp3.1u Greater number of years worked will be associated 
with greater endorsement for a recovery strategy 
for participants 
Reverse 
Partial 
 Reverse 
Partial 
   
Hyp3.1v Absence of familial mental illness in first-degree 
relatives will be associated with greater 
endorsement for a recovery strategy for 
participants 
   Reverse   
Hyp3.1w Absence of familial mental illness in extended 
family members will be associated with greater 
endorsement for a recovery strategy for 
participants 
   Yes   
Hyp3.1x Absence of child sexual abuse will be associated 
with greater endorsement for a recovery strategy 
for participants 
  Yes    
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Table 90 (cont.) 
 
  Effective 
Illness 
Management 
 
Positive 
Future 
Orientation 
Meaningfulness, 
Personal 
Control and 
Hope 
 
Recognizing 
Support 
Help 
Seeking 
Symptom 
eradication 
Hypothesis 
 
Statement Supported? Supported? Supported? Supported? Supported? Supported?
Hyp3.1y Absence of child physical abuse will be associated 
with greater endorsement for a recovery strategy 
for participants 
      
Hyp3.1z Absence of adult sexual assault will be associated 
with greater endorsement for a recovery strategy 
for participants 
      
Hyp3.1aa Absence of adult physical assault will be 
associated with greater endorsement for a recovery 
strategy for participants 
Reverse 
Partial 
     
Hyp3.3a Lower feelings of alienation will be associated 
with higher recovery expectancy for participants 
Partial   Yes   
Hyp3.3b Lower respondent endorsement of mental illness 
stereotypes will be associated with higher recovery 
expectancy for participants 
  Yes    
Hyp3.3c Lower number of discrimination experiences will 
be associated with higher recovery expectancy for 
participants 
      
Hyp3.3d Lower endorsement of social withdrawal will be 
associated with higher recovery expectancy for 
participants 
 Yes     
Hyp3.3e Greater endorsement of stigma resistance will be 
associated with higher recovery expectancy for 
participants 
Yes   Yes   Yes 
Hyp3.3f Greater support through intimate partner or a best 
friend will be associated with higher recovery 
expectancy for participants 
 
   Yes   
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Table 90 (cont.) 
 
  Effective 
Illness 
Management 
 
Positive 
Future 
Orientation 
Meaningfulness, 
Personal 
Control and 
Hope 
 
Recognizing 
Support 
Help 
Seeking 
Symptom 
eradication 
Hypothesis 
 
Statement Supported? Supported? Supported? Supported? Supported? Supported?
Hyp3.3g Greater support through family members will be 
associated with higher recovery expectancy for 
participants 
 Yes Yes    
Hyp3.3h Greater support via mental health providers will be 
associated with higher recovery expectancy for 
participants 
 Yes Yes  Yes  
Hyp3.3i Greater support through friendship will be 
associated with higher recovery expectancy for 
participants 
  Yes    
Hyp3.3j Greater feelings of being connected to the 
community will be associated with higher recovery 
expectancy for participants 
Yes Yes  Reverse  Yes 
Hyp3.3k Greater trust in the motivation of others will be 
associated with higher recovery expectancy for 
participants 
      
Hyp3.3l Higher ratings of self-esteem and self-efficacy will 
be associated with higher recovery expectancy for 
participants 
Yes Yes  Partial Yes  
Hyp3.3m Higher ratings of personal power will be associated 
with higher recovery expectancy for participants 
    Yes Yes 
Hyp3.3n Greater involvement in the community will be 
associated with higher recovery expectancy for 
participants 
  Yes    
Hyp3.3o Greater optimism  and confidence in personal 
control over the future will be associated with 
higher recovery expectancy for participants 
 
Yes  Yes Yes  Yes 
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Table 90 (cont.) 
 
  Effective 
Illness 
Management 
 
Positive 
Future 
Orientation 
Meaningfulness, 
Personal 
Control and 
Hope 
 
Recognizing 
Support 
Help 
Seeking 
Symptom 
eradication 
Hypothesis 
 
Statement Supported? Supported? Supported? Supported? Supported? Supported?
Hyp3.3p Higher ratings of righteous anger will be 
associated with higher recovery expectancy for 
participants 
    Reverse  
Hyp3.3a Total number of services will be associated with 
higher recovery expectancies for participants 
      
Hyp3.3b The average number of contact hours per month 
(averaged over one year of service) will be 
associated with higher recovery expectancies for 
participants 
 Partial     
Hyp3.3c Satisfaction level with services will be associated 
with higher recovery expectancies for participants 
 
Partial Partial Partial Yes Yes  
 
Note:  Partial indicates that the hypothesis is supported in an isolated (singular domain) model but not in the main effects model 
           Reverse indicates that the association was significant but in the opposite direction then predicted in the main effects model 
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groupings include diagnosis, medication, hospitalization, familial mental illness, 
employment, and abuse history. 
 Historical factors such as child abuse, familial mental illness, employment, and 
hospitalization history were not strongly associated with recovery strategies.  Of special 
interest is the lack of significance for abuse and assault experiences in multivariate 
analysis.  Though 41% of males and 65% of females in the study admitted to one or more 
experiences with child sexual abuse, child physical abuse, adult sexual assault and/or 
adult physical assault, the lack of association with recovery strategies was surprising.   
 There are fourteen social independent variables in significant relationship with 
recovery strategies from domain 2, out of sixteen variables tested.  Unlike domain 1 
clinical variables, fully half of the variables are significantly associated with two or more 
recovery strategies.  Each strategy is significant with at least three covariates, accounting 
for the highest level of variance explained of the three domains.  This provides direction 
for future research and potential recovery program planning with hope that 
operationalizing the social domain will affect multiple strategies, theoretically 
maximizing resource investment.  The three sub-domains are not equally influential.  
Social support independent variables have the most powerful association with recovery 
strategies followed closely by empowerment variables, with all six strategies significantly 
associated with at least one support or empowerment variable.  Stigmatization and 
discrimination vary in the magnitude of association with strategies 1-4 and have no 
significant association with strategies 5 (help seeking) and 6 (symptom eradication).  A 
brief summary of results separately for each construct of domain 2 is provided next due 
to the high degree of significant association with each recovery strategy. 
 347
Social support. 
 Social support variables include support from an intimate partner or best friend, 
family support, provider support, support from friends, community involvement and trust.  
Both in bivariate and multivariate analysis, trust was not significantly associated with any 
recovery strategy.  Partner, family, friend, and provider support were each significantly 
positively associated with all recovery strategies except symptom eradication in bivariate 
analysis.  For symptom eradication, only provider support and community involvement 
were significant.  None of the correlations were of exceptional magnitude ranging from 
low to barely moderate in strength.   
 In multivariate analysis, it is interesting that social support is significantly 
associated with each recovery strategy, though which variables are significant is not 
consistent across strategies.  Support from family members and by a provider is the two 
most powerfully associated support variables.  Importance of familial support is 
consistent with previous research and will be elaborated in Chapter 5.  Provider support 
has not been measured as a support covariate to recovery in previous research and was 
significant in association with positive future orientation, meaningfulness, personal 
control, and hope, and help seeking.  What cannot be detected in this data is why provider 
support is so significant and whether providers are substitute supports for other, more 
mainstream, relationships.  Chapter 2 detailed the limited social networks of many 
individuals with mental illness, which lends credence to the idea of provider as 
replacement of trusted support normally given by family and friends. 
 Community involvement is significantly associated with four recovery strategies.  
This supports the recovery movement’s emphasis on being part of and valued by 
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community while at the same time valuing the community in return.  In retrospect, more 
precise measurement of whether the respondent felt that they were valued by their 
community would have measured the reciprocity aspect of this variable with greater 
precision.  What can be stated is that belongingness to community is a significant aspect 
of recovery that is more diffuse than the targeted personal relationships measured by the 
other scales of the support construct and yet of equal importance. 
Empowerment. 
 Empowerment variables of self-esteem/self-efficacy, power/powerlessness, 
community activism and autonomy, and optimism and control over the future were 
significantly positively associated with recovery strategies 1-5 (excluding strategy 6, 
symptom eradication) in bivariate analysis, except for power/powerless correlated with 
strategy 3 (meaningfulness, personal control, and hope), which was surprisingly weak 
(r(348) = .07, ns).  The magnitude of the associations between empowerment, as a central 
concept of recovery, and recovery strategies would be expected to be strong.  However, 
the majority of the correlations are mild to moderate with only strategies 1-2 correlated 
above .60 with self-esteem/self-efficacy.  A future analysis will investigate whether the 
SMI or OP population samples or stratification by recovery expectancy would explain the 
unexpectedly weak associations noted. 
 In multivariate analysis, self-esteem/self-efficacy was the most consistently 
significant covariate across recovery strategies.  Indeed, much like social support, one or 
more empowerment variables were strongly associated with each of the recovery 
strategies.  A surprise was power/powerlessness being only significant in association with 
help seeking and symptom eradication.  A sense of personal power is consistently 
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mentioned in the recovery literature and this study may be measuring the construct 
differently then how the qualitative and first person literature describes it at a more 
individual level.  Optimism and control over the future was weakly associated with two 
recovery strategies (meaningfulness, personal control, and hope and recognizing support), 
moderately associated with effective illness management and strongly associated with 
symptom eradication.  Surprisingly, optimism and control over the future was not 
significantly associated with strategy 2, positive future orientation though it was 
positively associated with effective illness management, meaningfulness, personal control 
and hope, and symptom eradication. 
Stigma. 
 The results outlined earlier in this chapter shows that the bivariate correlations 
between stigma variables and recovery strategies are, but for two exceptions, negative.  
All relationships are statistically significant between the stigma variables (alienation, 
stereotype endorsement, discrimination occurrence, social withdrawal and stigma 
resistance) and five of six recovery strategies.  Only strategy 6, symptom eradication, is 
not significantly associated with stigma measures.  This finding supports the results from 
the qualitative literature, which will be fully discussed in Chapter 5.  Stigma does 
negatively affect recovery for respondents with the SMI sample reporting more stigma 
experiences and the OP sample greater stigma resistance.  The reader will also recall 
from the discussion of recovery expectancy above that individuals that do not believe 
they will recover experience more stigmatization effects as evidenced by significantly 
higher scores on every stigma scale.  Thus, severity of illness and non-belief in recovery 
are associated with stigma experiences in direct bivariate relationships. 
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 In multivariate analysis, stigma variables are not significantly related to help 
seeking or symptom eradication.  Alienation, a cornerstone of concern for the recovery 
movement, is only weakly associated with one recovery strategy, recognizing support.  
Personal endorsement of mental illness stereotypes is significant only with 
meaningfulness, personal control, and hope (strategy 3).  Social withdrawal is also only 
associated with one strategy, in this case positive future orientation.  Stigma resistance is 
the only stigma variable significant to two strategies, effective illness management and 
meaningfulness, personal control, and hope.  Thus, much like the clinical variables 
discussed in the beginning of this summary section, stigma does appear to play a role in 
sanctioning of recovery strategies, with different aspects of stigma associating with 
different strategies. 
 When considering domain 3, services are a fact of life for individuals with mental 
illness.  Not all the afflicted are served and many in need of services cannot access them.  
Clinical services are still the mainstay of treatment and the number of services, the 
amount of time spent receiving services, and satisfaction with services are reasonable 
proxies for severity of mental illness.  Thus, the SMI sample received significantly more 
services and total number of contact hours per month compared to the OP sample.  
Satisfaction with services was not significantly different.  The results are reversed when 
segmenting by recovery expectancy instead of severity.  There is no significant difference 
in number of services or time spent in services by expectancy status.  However, those not 
expecting to recover are significantly less satisfied with the services they receive. 
 Noted at several points in this document, the service domain (domain 3) was the 
least rigorous in analysis.  Of the three variables assessed, only satisfaction with services 
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was consistently significant in bivariate analysis with recovery strategies.  In multivariate 
analysis, service satisfaction was exceptionally significant in association with strategy 4 
(recognizing support) and strategy 5 (help seeking).  A point of concern is the lack of 
association between service related variables and effective illness management and 
symptom eradication, arguably the most clinically related recovery strategies, as well as 
positive future orientation and meaningfulness, personal control, and hope, the two non-
associated strategies that reflect the recovery movement. 
 This concludes the presentation of results targeting research question three.  The 
following sections will address the effects of recovery expectancy (the dependent 
variable for research question 2) as a mediator between domains 1-3, for evaluating 
research question 4a,  and in interaction with specific variables (moderating effects) for 
research question 4b.  In addition, the moderating effects of severity of mental illness will 
be assessed. 
 
Focus on Mediation 
 Figure 1, page 6, Chapter 1, displays a proposed direct relationship between 
domain 1-3 independent variables and recovery strategies (dependent variables).  The 
results pertinent to these relationships were described in the section above addressing 
research question 3.  Figure 1 also displays with recovery strategies are arbitrated by 
recovery expectancy.  Research question 4a, addressing mediation, and accompanying 
hypotheses are reproduced below and targeted in the following analysis.   
RQ4a:  Does the expectation of recovery mediate the relationship between individual, 
social and service factors and recovery strategies? 
 352
Hyp4a.1:  Participants expectation of recovery will mediate the relationship 
between individual factors and recovery strategies. 
Hyp4a.2:  Participants expectation of recovery will mediate the relationship 
between social factors and recovery strategies. 
Hyp4a.3:  Participants expectation of recovery will mediate the relationship 
between service factors and recovery strategies. 
 The subsequent discussion will present the results from the main effects models 
only.  The process articulated when describing results for research questions 2 and 3 that 
included reporting on each model in turn will not be duplicated in the discussion of this 
section.  Using a progression of models allows observation of changes when new 
variables are entered.  However, the results of all main effects mediating relationships 
investigated were non-significant, meaning only very minor partial mediating effects 
were noted, if present at all, and no full mediation of effects due to recovery expectancy 
were uncovered.  Some of the singular domain models had slightly more intense 
mediating effects.  Tables summarizing the partial mediating models separately for each 
domain and recovery strategy are included in Appendix E.   
 The focus of this research from the start was to describe the respondents and the 
information they offered with full appreciation of the context in which the respondents 
live.  Main effects models capture the context to the greatest degree since the lived 
experience of each respondent includes clinical, social and service factors, experiences, 
and relationships simultaneously.  However, though non-significant, it is still useful to 
briefly review the results of mediated main effect models and present them in summary 
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tables to fully appreciate the results with and without the addition of the mediating 
variable. 
 Mediating effects are detected primarily by observing the change in the parameter 
estimate and standard error.  To aid in observation of changes, the following tables 
contain only the significant variables of the main effect and mediating models for each of 
the six recovery strategies.  To detect mediation, the main effect model was run with the 
mediating variable added and then comparisons between parameter estimates, full model 
F-statistics and changes in variance explained (R2) were assessed. 
 
What is the Mediating Effect of Recovery Expectancy on Domains 1-3 for each of the 
Recovery Strategies? 
 Tables 91-96 summarizes the findings from the mediating model and compares it 
to the main effects model for each strategy.  Discussion of strategy 1, effective illness 
management, summarized in Table 91, is offered as an example.  The same points could 
be made in a discussion of each of the other strategies and their relationship to the 
mediating effect of recovery expectancy.  Referencing Table 91, there is no change in 
variance explained (0.67 for both models) and the strength of the full model is only 
slightly reduced (F = 14.31, p ≤ .0001 versus 14.64, p ≤ .0001).  Every parameter 
estimate is approximately the same with some minor fluctuation noted in the 
corresponding t-test with the exception of interpersonal sensitivity which has a .01 
change in the estimate.  Thus, there is neither full nor substantive partial mediation via 
recovery expectation of any independent variable in relation to its association with 
effective illness management.  Such minute changes in parameter estimates would predict 
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a very small and non- significant parameter estimate for recovery expectancy, and this 
prediction is met. 
  Table 92 summarizes the mediating model results for positive future 
orientation and is followed by Table 93 (meaningfulness, personal control, and hope), 
Table 94 (recognizing support), Table 95 (help seeking), and Table 96 (symptom 
eradication).  The lack of mediating effect for recovery expectancy demonstrates no 
support for research question 4a and hypotheses 4a.1 to 4a.3.  Possible reasons for the 
lack of significance as a mediator will be discussed in Chapter 5. 
 
Table 91 
 
Mediating Effect of Recovery Expectancy for the Association Between Domain 1-3 Variables and 
Recovery Strategy 1 (Effective Illness Management) 
 
 Main Effects Model Mediating Model
Variable b (SE) t b (SE) t 
Interpersonal sensitivity   0.15 (0.05)  2.82b   0.14 (0.05)  2.74b
Anxiety diagnosis -0.20 (0.09) -2.30a -0.20 (0.09) -2.30a
Medication:  Anti-anxiety -0.16 (0.06) -2.99b -0.16 (0.06) -2.93b
Stigma resistance -0.40 (0.08) -5.31d -0.40 (0.07) -5.30d
Community involvement  0.08 (0.03)  3.18b  0.08 (0.02)  3.15b
Self-esteem/self-efficacy  0.28 (0.08)  3.69c  0.28 (0.08)  3.68c
Optimism and control over the future  0.18 (0.07)  2.57b  0.18 (0.07) 2.58b
Recovery expectancy 
 
  0.02 (0.05)    0.41 
Model Fit Statistics
Model F 14.64d 14.31d
Adjusted R2 0.67 0.67 
 
Note:  a ≤ .05; b ≤ .01; c ≤ .001; d ≤ .0001 
           n = 335 
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Table 92 
 
Mediating Effect of Recovery Expectancy in the Association Between Domain 1-3 Variables and 
Recovery Strategy 2 (Positive Future Orientation) 
 
 Main Effects Model Mediating Model
Variable b t b t 
Education -0.05 (0.03)   -2.07a -0.05 (0.02)  -2.09b
Anxiety  0.12 (0.04)    2.73b  0.13 (0.05)   2.77b
Depression -0.11 (0.05)   -2.21a -0.10 (0.05)  -2.05a
Phobic anxiety -0.12 (0.03)   -3.31c -0.11 (0.03)  -3.23c
Schizophrenia diagnosis -0.19 (0.07)   -2.68b -0.19 (0.07)  -2.67b
Substance abuse history  0.10 (0.05)    2.05a  0.10 (0.05)   2.15a
Hospitalized in last year -0.10 (0.05)   -2.07a -0.10 (0.05)  -2.15a
Social withdrawal -0.18 (0.07)   -2.59b -0.19 (0.07)  -2.77b
Family support  0.05 (0.02)    3.11b  0.05 (0.02)   3.03b
Provider support  0.10 (0.03)    3.25c  0.10 (0.03)   3.31c
Community involvement  0.05 (0.02)    2.47b  0.05 (0.02)   2.40a
Self-esteem/self-efficacy  0.67 (0.06) 10.34d  0.66 (0.06) 10.37d
Recovery expectancy   0.07 (0.04)  1.45 
Model Fit Statistics
Model F 17.72d 17.48d
Adjusted R2 0.71 0.71 
 
Note:  a ≤ .05; b ≤ .01; c ≤ .001; d ≤ .0001 
          n = 335 
 
 
Table 93 
 
Mediating Effect of Recovery Expectancy in the Association Between Domain 1-3 Variables and 
Recovery Strategy 3 (Meaningfulness, Personal Control, and Hope) 
 
 Main Effects Model Mediating Model
Variable b t b t 
Interpersonal sensitivity  0.11 (0.04)    2.76b  .0.11 (0.04)  2.59b
Hostility -0.08 (0.03) - 2.55b -0.08 (0.03) -2.57b
Anxiety Diagnosis -0.24 (0.07)   -3.43c -0.24 (0.07) -3.42c
Medication:  Anti-psychotic -0.12 (0.05)   -2.58b -0.12 (0.05) -2.49b
Child sexual abuse history  0.10 (0.05)    2.08a  0.10 (0.05)  2.03a
Stereotype endorsement -0.20 (0.06)   -3.34c -0.19 (0.06) -3.18c
Stigma resistance -0.16 (0.06)   -2.79b -0.16 (0.06) -2.77b
Family support  0.04 (0.01)    2.46b  0.04 (0.01)  2.36b
Provider support  0.07 (0.03)    2.55b  0.08 (0.03)  2.62b
Friend support  0.06 (0.02)    2.46b  0.06 (0.02)  2.48b
Community activism and autonomy  0.35 (0.06)    5.92d  0.35 (0.06)  5.89d
Optimism and control over the future  0.11 (0.06)    1.98a  0.11 (0.06)  2.04a
Recovery expectancy   0.07 (0.04) 1.63 
Model Fit Statistics
Model F 7.27d 7.22d
Adjusted R2 0.48 0.49 
 
Note:  a ≤ .05; b ≤ .01; c ≤ .001; d ≤ .0001 
          n = 334 
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Table 94 
 
Mediating Effect of Recovery Expectancy in the Association Between Domain 1-3 Variables and 
Recovery Strategy 4 (Recognizing Support) 
 
 Main Effects Model Mediating Model
Variable b t b t 
Other Diagnosis  0.39 (0.18)  2.14a  0.39 (0.18)  2.14a
Nuclear family mental illness  0.07 (0.03)  2.15a  0.07 (0.03)  2.13a
Extended family mental illness -0.11 (0.06) -1.95a -0.12 (0.06) -1.96a
Alienation -0.22 (0.10) -2.15a -0.22 (0.10) -2.16a
Partner or best friend support  0.22 (0.04)  5.09d  0.22 (0.04)  5.09d
Family support  0.23 (0.03)  8.02d  0.23 (0.03)  8.01d
Community involvement -0.08 (0.04) -2.08a -0.07 (0.04) -2.06a
Optimism and control over the future  0.24 (0.11)  2.22a  0.24 (0.11)  2.21a
Average satisfaction score  0.17 (0.04)   3.98d  0.17 (0.04)  3.99d
Recovery expectancy   -0.02 (0.08) -0.30 
Model Fit Statistics
Model F 10.98d 10.73d
Adjusted R2 0.60 0.60 
 
Note:  a ≤ .05; b ≤ .01; c ≤ .001; d ≤ .0001 
          n = 337 
 
 
 
Table 95 
 
Mediating Effect of Recovery Expectancy in the Association Between Domain 1-3 Variables and 
Recovery Strategy 5 (Help Seeking) 
 
 Main Effects Model Mediating Model
Variable b t b t 
Age  0.01 (0.00)  2.10a  0.01 (0.00)  2.11a
Interpersonal sensitivity  0.20 (0.09)  2.18a  0.19 (0.09)  2.13a
Provider support  0.14 (0.06)  2.19a  0.14 (0.06)  2.19a
Self-esteem/self-efficacy  0.36 (0.13)  2.73b  0.36 (0.13)  2.72b
Power/powerlessness  0.25 (0.12)  2.05a  0.25 (0.12)  2.04a
Righteous anger -0.19 (0.08) -2.20a -0.19 (0.09) -2.20a
Average satisfaction score  0.12 (0.05)  2.52b  0.12 (0.05)  2.49b
Recovery expectancy   0.02 (0.09) 0.25 
Model Fit Statistics
Model F 3.32d 3.25d
Adjusted R2 0.25 0.25 
 
Note:  a ≤ .05; b ≤ .01; c ≤ .001; d ≤ .0001 
          n = 343 
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Table 96 
 
Mediating Effect of Recovery Expectancy in the Association Between Domain 1-3 Variables and 
Recovery Strategy 6 (Symptom Eradication) 
 
 Main Effects Model Mediating Model
Variable b t b t 
Income -0.17 (0.06) -2.90b -0.18 (0.06) -2.95b
Interpersonal sensitivity  0.40 (0.14)  2.92b  0.37 (0.14)  2.74b
Paranoia -0.33 (0.13) -2.52b -0.33 (0.13 ) -2.56b
Major depression diagnosis  0.47 (0.19)  2.49b  0.49 (0.19)  2.63b
Community involvement  0.19 (0.06)  2.84b  0.18 (0.06)  2.74b
Power/powerlessness -0.65 (0.19) -3.46c -0.66 (0.19) -3.53c
Optimism and control over the future  0.70 (0.19)  3.77c  0.71 (0.18)  3.81c
Recovery expectancy   0.23 (0.14) 1.60 
Model Fit Statistics
Model F  2.62d  2.63d
Adjusted R2 0.19 0.20 
 
Note:  a ≤ .05; b ≤ .01; c ≤ .001; d ≤ .0001 
          n = 342 
 
 
 
Focus on Moderation 
 Referring again to Figure 1, page 6, Chapter 1, two variables will be considered 
for moderating, or interaction effects with select independent variables.  Recovery 
expectancy, thus far, has not been significantly associated with independent variables 
(see discussion of research question 2) nor has expectancy had a mediating effect (see 
previous section).  Recovery expectancy will now be tested for moderating effects to 
satisfy research question 4b and its hypotheses.  The second variable, severity of illness, 
will be assessed for moderating effects, addressing research question 5 and the connected 
hypotheses.  Moderating effects, also known as interaction effects, simultaneously test 
the independent effect of two variables (e.g. interpersonal sensitivity and recovery 
expectancy) with the addition of an interaction term (e.g., interpersonal sensitivity x 
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recovery expectancy).  A moderating effect is present if the interaction term is 
significant.   
  The following criteria were used to systematically choose variables to assess for 
moderating effects. 
• The variable was significant in main effect analysis with at least 3 recovery 
strategies 
• The variable was significantly related to the moderator (either recovery 
expectancy or severity of illness) in bivariate analysis 
• The interaction terms created were consistent with the current literature 
A total of six variables met the criteria.  Thus, the following six interaction terms were 
created:  
1. Recovery expectancy x interpersonal sensitivity 
2. Recovery expectancy x family support 
3. Recovery expectancy x provider support 
4. Recovery expectancy x community involvement 
5. Recovery expectancy x self-esteem/self-efficacy 
6. Recovery expectancy x optimism and control 
 Each interaction was evaluated separately for each domain and then together with 
the main effects models for each recovery strategy.  Previously mentioned in chapter 3, 
though initially hypothesized, evaluation of these models could be considered ad hoc, and 
a Bonferonni correction was used (.05 / 6 interaction terms), with a p-value of .0083 
required for an association to be considered significant.  In addition, because of the 
addition of several new variables, multicollinearity was again assessed, this time for the 
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largest potential model, main effects plus the six interaction terms.  No variables violated 
the .20 tolerance limit and all variables were retained in analysis. 
Research Question 4b:  Evaluation of Recovery Expectancy Moderating Effects 
 Research question 4b and hypotheses 4b.1-4b.3 inquire whether recovery 
expectancy in interaction with select variables will produce a significant interaction 
effect.  The research question and hypotheses are reproduced below. 
RQ4b:  Does the expectation of recovery moderate the relationship between individual, 
social and service factors and recovery strategies? 
Hyp4b.1:  Participants expectation of recovery will moderate the relationship 
between individual factors and recovery strategies. 
Post Hoc:  Post hoc analyses will target specific variables that are found to 
be statistically and clinically relevant to recovery 
Hyp4b.2:  Participants expectation of recovery will moderate the relationship 
between social factors and recovery strategies. 
Post Hoc:  Post hoc analyses will target specific variables that are found to 
be statistically and clinically relevant to recovery 
Hyp4b.3:  Participants expectation of recovery will moderate the relationship 
between service factors and recovery strategies. 
Post Hoc:  Post hoc analyses will target specific variables that are found to 
be statistically and clinically relevant to recovery 
 Identical to mediating analysis, there were no significant moderating effects, 
either in domain specific or main effect models.   Thus, hypotheses 4b.1-4b.3 are not 
confirmed.  Tables 97-102 summarize the interaction statistics for each recovery strategy.  
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Table 97 
 
Moderating Effects of Recovery Expectancy in the Association of Domain 1-3 Variables 
on Recovery Strategy 1 (Effective Illness Management) 
 
 Moderating Variables 
 
b SE t 
Recovery expectancy x interpersonal sensitivity -0.01 0.05 -0.27 
Recovery expectancy x family support  0.02 0.04  0.63 
Recovery expectancy x provider support  0.01 0.06  0.20 
Recovery expectancy x community involvement  0.03 0.05  0.53 
Recovery expectancy x self-esteem/self-efficacy -0.20 0.12 -1.58 
Recovery expectancy x optimism and control 
 
 0.13 0.13  1.05 
 
Note:  n = 335  
           F = 12.99, p ≤ .0001; R2 = .67 
 
 
 
Table 98 
 
Moderating Effects of Recovery Expectancy in the Association of Domain 1-3 Variables 
on Recovery Strategy 2 (Positive Future Orientation) 
 
 Moderating Variables 
 
b SE t 
Recovery expectancy x interpersonal sensitivity -0.07 0.04 -1.82 
Recovery expectancy x family support -0.04 0.03 -1.27 
Recovery expectancy x provider support  0.03 0.05  0.67 
Recovery expectancy x community involvement -0.02 0.04 -0.59 
Recovery expectancy x self-esteem/self-efficacy -0.05 0.10 -0.50 
Recovery expectancy x optimism and control 
 
 0.15 0.10  1.46 
 
Note:  n = 335  
           F = 16.10, p ≤ .0001; R2 = .72 
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Table 99 
 
Moderating Effects of Recovery Expectancy in the Association of Domain 1-3 Variables 
on Recovery Strategy 3 (Meaningfulness, Personal Control, and Hope) 
 
 Moderating Variables 
 
b SE t 
Recovery expectancy x interpersonal sensitivity -0.04 0.04 -1.14 
Recovery expectancy x family support -0.03 0.03 -0.92 
Recovery expectancy x provider support -0.02 0.05 -0.44 
Recovery expectancy x community involvement  0.01 0.04  0.33 
Recovery expectancy x self-esteem/self-efficacy  0.02 0.10  0.25 
Recovery expectancy x optimism and control 
 
 0.08 0.10  0.80 
 
Note:  n = 334  
           F = 6.63, p ≤ .0001; R2 = .49 
 
 
Table 100 
 
Moderating Effects of Recovery Expectancy in the Association of Domain 1-3 Variables 
on Recovery Strategy 4 (Support Recognition) 
 
 Moderating Variables 
 
b SE t 
Recovery expectancy x interpersonal sensitivity  0.03 0.07  0.38 
Recovery expectancy x family support -0.03 0.06 -0.56 
Recovery expectancy x provider support  0.00 0.09  0.02 
Recovery expectancy x community involvement -0.02 0.08 -0.35 
Recovery expectancy x self-esteem/self-efficacy  0.22 0.19  1.13 
Recovery expectancy x optimism and control 
 
-0.17 0.20 -0.88 
 
Note:  n = 337  
           F = 9.69, p ≤ .0001; R2 = .59 
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Table 101 
 
Moderating Effects of Recovery Expectancy in the Association of Domain 1-3 Variables 
on Recovery Strategy 5 (Help Seeking) 
 
 Moderating Variables 
 
b SE t 
Recovery expectancy x interpersonal sensitivity -0.14 0.08 -1.71 
Recovery expectancy x family support  0.00 0.06  0.06 
Recovery expectancy x provider support  0.14 0.10  1.37 
Recovery expectancy x community involvement  0.03 0.09  0.34 
Recovery expectancy x self-esteem/self-efficacy -0.29 0.21 -1.36 
Recovery expectancy x optimism and control 
 
 0.15 0.22  0.67 
 
Note:  n = 337  
           F = 3.05, p ≤ .0001; R2 = .25 
 
 
Table 102 
 
Moderating Effects of Recovery Expectancy in the Association of Domain 1-3 Variables 
on Recovery Strategy 6 (Symptom Eradication) 
 
 Moderating Variables 
 
b SE t 
Recovery expectancy x interpersonal sensitivity -0.24 0.12 -1.94 
Recovery expectancy x family support -0.01 0.09 -0.19 
Recovery expectancy x provider support -0.20 0.15 -1.34 
Recovery expectancy x community involvement -0.05 0.13 -0.37 
Recovery expectancy x self-esteem/self-efficacy  0.27 0.32  0.85 
Recovery expectancy x optimism and control 
 
 0.35 0.33  1.06 
 
Note:  n = 342  
           F = 2.64, p ≤ .0001; R2 = .21 
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The tables reflect only the interaction terms since there was minimal effect on the main 
effects models.  For all strategies, there was a minute reduction in the full model statistic 
(F-statistic) with no change in significance level and a slight fluctuation in variance 
explained of less then one-half of a percentage point.   
Research Question 5:  Evaluation of Illness Severity Moderating Effects 
 Illness severity was dichotomized by creating a variable that distinguished 
between the severely mentally ill (SMI) sample and the outpatient (OP) sample.  
Interaction terms were created with the same six variables in the previous moderating 
effect analysis (interpersonal sensitivity, family support, provider support, community 
involvement, self-esteem, and optimism).  The Bonferroni correction was used (p ≤ .0083 
to be considered significant) and multicollinearity was again assessed via the tolerance 
statistic.  No variable breached the cutpoint and all were retained.  Each interaction term 
was evaluated independently for each domain and then with the main effect models.  
Since there was little variance in the results, the grouped model is presented for their 
association with each strategy. 
 Research question 5 and accompanying hypotheses were evaluated in this analysis 
and are reproduced next: 
RQ5:  Does severity of mental illness moderate the relationship between individual, 
social and service factors and recovery strategies? 
Hyp5.1:  Severity of mental illness will moderate the relationship between 
individual factors and recovery strategies for participants. 
Post Hoc:  Post hoc analyses will target specific variables that are found to 
be statistically and clinically relevant to recovery 
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Hyp5.2:  Severity of mental illness will moderate the relationship between social 
factors and recovery strategies for participants. 
Post Hoc:  Post hoc analyses will target specific variables that are found to 
be statistically and clinically relevant to recovery 
Hyp5.3:  Severity of mental illness will moderate the relationship between service 
factors and recovery strategies for participants. 
 Identical to the previous moderating analysis, there was no interaction effects 
detected at the single domain (partial models) or main effect models.  Only the 
interaction terms are presented in Tables 103-108, summarizing the interaction effects for 
each recovery strategy.  Tables summarizing the moderating models separately for each 
domain and recovery strategy are included in appendix E.  Once again, there were small, 
non-significant, changes in the full model statistic and adjusted R2.  
 This analysis targets the label of severe mental illness.  Many respondents 
spontaneously spoke about the label during data collection.  Mental illness labels have 
been empirically tested and found to have less effect then first suspected (Link, Cullen, 
Struening, Shrout, Dohrenwend, 1989), though it is still significant as part of the lived 
context when examined in qualitative research (Angermeyer & Matschinger, 2005; 
Walby, 2003b), and is considered a reason to alter behavior and perception.  In this light, 
the lack of moderating effects involving severity of mental illness was unexpected. 
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Table 103 
 
Moderating Effects of Illness Severity in the Association of Domain 1-3 Variables on Recovery 
Strategy 1 (Effective Illness Management) 
 
 Moderating Variables 
 
b SE t 
Illness Severity x interpersonal sensitivity -0.06 0.05 -1.20 
Illness Severity x family support  0.01 0.04  0.33 
Illness Severity x provider support -0.08 0.06 -1.39 
Illness Severity x community involvement  0.07 0.05  1.50 
Illness Severity x self-esteem/self-efficacy -0.09 0.12 -0.74 
Illness Severity x optimism and control 
 
 0.13 0.13  1.01 
 
Note:  n = 335  
           F = 13.18, p ≤ .0001; R2 = 0.67 
 
 
 
 
Table 104 
 
Moderating Effects of Illness Severity in the Association of Domain 1-3 Variables on 
Recovery Strategy 2 (Positive Future Orientation) 
 
 Moderating Variables 
 
b SE t 
Illness Severity x interpersonal sensitivity  0.00 0.04  0.15 
Illness Severity x family support -0.03 0.03 -0.90 
Illness Severity x provider support -0.11 0.05 -2.13 
Illness Severity x community involvement -0.01 0.04 -0.25 
Illness Severity x self-esteem/self-efficacy  0.08 0.10 -0.76 
Illness Severity x optimism and control 
 
 0.30 0.11  2.66 
 
Note:  n = 335  
           F = 16.37, p ≤ .0001; R2 = 72 
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Table 105 
 
Moderating Effects of Illness Severity in the Association of Domain 1-3 Variables on 
Recovery Strategy 3 (Meaningfulness, Personal Control, and Hope) 
 
 Moderating Variables 
 
b SE t 
Illness Severity x interpersonal sensitivity  0.08 0.04  2.09 
Illness Severity x family support  0.00 0.03  0.10 
Illness Severity x provider support -0.09 0.05 -1.94 
Illness Severity x community involvement -0.00 0.04 -0.09 
Illness Severity x self-esteem/self-efficacy -0.07 0.10 -0.73 
Illness Severity x optimism and control 
 
 0.16 0.10  1.59 
 
Note:  n = 334  
           F = 6.73, p ≤ .0001; R2 = 0.49 
 
 
 
Table 106 
 
Moderating Effects of Illness Severity in the Association of Domain 1-3 Variables on 
Recovery Strategy 4 (Recognizing Support) 
 
 Moderating Variables 
 
b SE t 
Illness Severity x interpersonal sensitivity  0.10 0.07  1.46 
Illness Severity x family support -0.02 0.05 -0.41 
Illness Severity x provider support  0.04 0.09  0.41 
Illness Severity x community involvement -0.03 0.07 -0.38 
Illness Severity x self-esteem/self-efficacy  0.02 0.19  0.10 
Illness Severity x optimism and control 
 
-0.00 0.20 -0.02 
 
Note:  n = 337  
           F = 9.92, p ≤ .0001; R2 = 0.60 
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Table 107 
 
Moderating Effects of Illness Severity in the Association of Domain 1-3 Variables on 
Recovery Strategy 5 (Help Seeking) 
 
 Moderating Variables 
 
b SE t 
Illness Severity x interpersonal sensitivity -0.01 0.08 -0.14 
Illness Severity x family support   0.05 0.06   0.90 
Illness Severity x provider support -0.11 0.10 -1.16 
Illness Severity x community involvement   0.04 0.08   0.45 
Illness Severity x self-esteem/self-efficacy -0.50 0.22 -2.29 
Illness Severity x optimism and control 
 
  0.57 0.23   2.50 
 
Note:  n = 337  
           F = 3.13, p ≤ .0001; R2 = 0.25 
 
 
 
Table 108 
 
Moderating Effects of Illness Severity in the Association of Domain 1-3 Variables on 
Recovery Strategy 6 (Symptom Eradication) 
 
 Moderating Variables 
 
b SE t 
Illness Severity x interpersonal sensitivity  0.01 0.12  0.11 
Illness Severity x family support -0.08 0.09 -0.89 
Illness Severity x provider support  0.19 0.16  1.18 
Illness Severity x community involvement -0.12 0.13 -0.96 
Illness Severity x self-esteem/self-efficacy -0.15 0.33 -0.46 
Illness Severity x optimism and control 
 
 0.14 0.35  0.42 
 
Note:  n = 342  
           F = 2.38, p ≤ .0001; R2 = 0.18 
 
 
 The absence of significant mediating and moderating relationships does not rule 
out that other factors or constructs untested in this study could operate in that capacity or 
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that other variables that were included might have significant interaction effects that were 
not tested.  What can be stated from the evidence presented is that all the hypotheses 
attached to research questions 4a, 4b, and 5 are not supported. 
 The direct effects captured in the discussion of research question 3 that assessed 
the associations between the three domains of independent variables and the dependent 
recovery strategies constitute the main results of this analysis.  The strong model fit and 
percentage of variance captured (ranging from 19-71%) argues for continued 
investigation into direct effects.  However, recovery is a complicated concept for an 
individual to grasp and utilize and is even more so when considering commonalities 
within and across samples.  Thus, other potential mediators and moderators should note 
be neglected for affect on recovery strategies in future research. 
Summary of Associations with Recovery Strategies 
 Multiple significant associations were noted in bivariate and multivariate analyses 
investigating associations between recovery expectancy, recovery strategies and 
independent variables partitioned into historical/clinical (domain 1), social (domain 2), 
and service (domain 3) domains.  Recovery expectancy was tested first in association 
with domains 1-3 independent variables using logistic regression.  There were no 
significant associations detected.  Recovery expectancy is, however, significantly 
negatively associated with each recovery strategy in bivariate analysis suggesting that the 
belief in recovery may play an important role in proactive use of recovery strategies.  
However, significant associations were observed only in direct effect models testing 
associations between recovery strategies and domains 1-3 independent variables.  
Regarding recovery expectancy, there were no significant mediating or moderating 
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associations detected when investigating recovery expectancy as a mediating or 
moderating effect in the association between recovery strategies and domains 1-3.  
Severity of mental illness was also found to be non-significant as a potential moderating 
variable.   
 Analysis of direct effects suggests that for each recovery strategy investigated, 
domain 2 social support variables have the strongest association.  Historical/clinical 
factors vary in the degree they associate with each strategy.  Service factors are generally 
unimportant in this analysis, but it should be emphasized that only a few service factors 
were investigated and that all are summary measures of number of services, contact hours 
and satisfaction.  An analysis of specific clinical and support services may provide a 
different result.   
 Table 109 summarizes the significant associations between domains 1-3 
independent variables and the six strategies of (1) effective illness management, (2) 
positive future orientation, (3) meaningfulness, personal control, and hope, (4) support 
recognition, (5) help seeking, and (6) symptom eradication.  Information from Table 109 
will be used to highlight a brief summary of the significant associations with each 
recovery strategy in turn. 
 Strategy 1:  Effective illness management. 
Effective illness management is surprisingly unrelated to clinical/historical 
factors.  Interpersonal sensitivity and anti-anxiety medication are the two clinical 
variables significant in the full model and reduced full model analyses.  The literature on 
recovery would suggest a stronger relationship with a diagnosis of depression, symptoms 
of depression and experiences of child abuse or adult assault.  Similarly important to the 
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current study and future research is the general lack of association between measurements 
of symptom levels and endorsement of effective illness management and the other 
recovery strategies of this study.  Though highly significant in bivariate analysis, 
symptoms lose their significance in multivariate analysis.  This may lend credence to the 
call to understand recovery as a complex phenomenon that reduces the focus on 
symptoms in the recovery movement literature. 
Significant to this strategy, and the other five strategies as well, is the importance 
of domain 2 social factors.  Significantly associated with strategy 1 is community 
involvement, a social support variable, self-esteem/self-efficacy and optimism and 
control over the future, both empowerment variables.  Collectively with stigma 
resistance, these variables explain 54% of the variance in effective illness management, 
with the reduced full model explaining 63%.  Taken together, the combination of these 
variables suggests that illness management not be addressed in isolation.  Community 
involvement and stigma resistance are logically linked by their underlying dimension of 
relating to others.  A belief in future success is also associated with illness management 
but the glue to these relationships, strictly from an interpretive basis, is self-esteem.  Self-
esteem is, in part, the confidence to interact and be involved.  It is also to believe in 
oneself in spite of barriers and obstacles.  The lack of any significant service variables  
(domain 3) and the relative lack of significant association with clinical variables leads to 
the observation that illness management be considered more then adherence to treatment, 
but should also emphasize the reinforcement potential of social interaction coupled with 
an assessment of stigma resistance and steps to increase self-esteem. 
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Table 109 
 
Summary of full model significant associations between recovery strategies and independent variables (domains 1-3)  
 
 
T
o
t
a
l
 Effective 
Illness 
Management 
Positive 
Future 
Orientation 
Meaningfulness, 
Personal Control, 
and Hope 
Recognizing 
Support 
Help 
Seeking 
Symptom 
Eradication 
Control        
Age 1     X  
Education 1  X     
Income 1      XX 
Domain 1        
Interpersonal sensitivity 4 XX  XX  X* XX 
Anxiety  1  XX     
Depression 1  X     
Hostility 1   XX    
Phobia 1  XXX     
Paranoia 1      XX 
Schizophrenia 1  XX     
Major depression 1      XX 
Anxiety diagnosis 2 X*  XXX    
Other diagnosis 1    X   
Anti-anxiety medication 1 XX      
Anti-psychotic medication 1   XX    
Substance use diagnosis 1  X     
Hospitalized in last year 1  X     
Nuclear family mental illness 1    X   
Extended family mental illness 1    X   
Child sexual abuse 
 
 
 
1   X    
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Table 109 (continued) 
 
  Effective 
Illness 
Management 
Positive 
Future 
Orientation 
Meaningfulness, 
Personal Control, 
and Hope 
Recognizing 
Support 
Help 
Seeking 
Symptom 
Eradication 
Domain 2        
Alienation 1    X   
Stereotype endorsement 1   XXX    
Social withdrawal 1  XX     
Stigma resistance 2 XXXX  XX    
Support:  Partner or best friend 1    XXXX   
Support:  Family 3  XX XX XXXX   
Support:  Provider 3  XXX XX  X  
Support:  Friends 1   XX    
Community Involvement 4 XXX XX  X  XX 
Self-esteem/efficacy 3 XXX XXXX   XX  
Power/Powerlessness 2     X XXX 
Community activism and autonomy 1   XXXX    
Optimism and control over the 
future 
4 XX  X X  XXX 
Righteous anger 1     XX*  
Domain 3        
Average satisfaction 
 
2    XXXX XX  
R2 (full model)  67% 71% 48% 60% 25% 19% 
R2 (reduced model) 18% 27%  63% 68% 49% 61% 
 
Note:  XXXX = p ≤ .0001; XXX = p ≤ .001; XX = p ≤ .01; X = p ≤ .05 
           *These variables are no longer significantly associated in the reduced models 
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 Strategy 2:  Positive future orientation. 
A positive future orientation is negatively associated with three of nine symptom 
scales, the most highly associated strategy with the symptom scales.  General anxiety and 
phobic anxiety are moderately to highly associated with a future outlook and only mildly 
associated with depression.  This is consistent with the literature that indicates that 
pervasive anxiety and depression limit planning and belief in the future.  Only 
schizophrenia is associated with a limited future orientation, which may be a factor of the 
illness or a byproduct of the clinical system that consistently presents the message of a 
life long debilitating illness.  Psychotropic medication is not associated with a positive 
future orientation, nor is child abuse, adult assault or familial mental illness.  However, 
this is the only strategy that is significantly associated with hospitalization, in this case 
negatively associated with hospitalization in the last year.  Noted earlier, a substance 
abuse diagnosis is positively associated with this strategy, perhaps reflecting the 
emphasis on a positive future in the recovery emphasis of substance abuse treatment. 
 Multivariate analysis of domain 2 variables demonstrates an association of 
moderate magnitude only with social withdrawal for stigma variables.  This suggests that 
being socially connected is relevant to a positive future.  Being socially involved is 
reinforced by family and provider support, community involvement and self-esteem/self-
efficacy, all in significant association with positive future orientation.  Hypothetically, 
provider support plays an apparent positive role in supporting future growth and 
happiness, without forgetting that there is no evidence to support a causal relationship.  It 
is intriguing that provider support was more strongly associated with strategy 2 then 
familial support and that support from friends and a best friend or partner were not 
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significant.  In isolation these factors explain 64% of the variance.  Together with domain 
1 and domain 3 independent variables 68% of the variance in positive future orientation 
is explained in the reduced main effects model.  Like strategy 1, there is no significant 
association with any of the three domain 3 covariates. 
 Strategy 3:  Meaningfulness, personal control, and hope. 
 Strategy 3 also has several significant associations with domain 1 
clinical/historical variables.  A diagnosis of an anxiety disorder is significant, yet there 
are no significant anxiety symptoms.  Interpersonal sensitivity and hostility symptom 
scales are positively associated but these do not make sense in conjunction with the other 
domain 1 significant variables.  Another example is the significance of anti-psychotic 
medication, almost uniformly prescribed to individuals with schizophrenia or 
schizoaffective disorder, neither of which are significant, and the additional non-
significance of psychoticism and paranoid symptom scales.  Child sexual abuse is 
significantly associated to meaningfulness, personal control, and hope, and logically so as 
there is considerable research support of diminished hope for untreated survivors of 
abuse, representing the only significant relationship between any abuse/assault variable 
and any recovery strategy.  It should be noted that in the description of the development 
of the strategies via factor analysis in Chapter 3, that this strategy was the least 
conceptually coherent, which may explain why the pattern of results from domain 1 are 
similarly confusing. 
Focusing on domain 2, this strategy has the highest number of significant 
covariates that, together with domain 1 covariates, explain 49% of the variance in the 
reduced main effects model.  In isolation, domain 2 social variables explain 36% of the 
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variance.  Two stigma variables are found to be significantly associated with strategy 3:  
stereotype endorsement and stigma resistance.  It is sensible that a person that does not 
endorse stereotypes for others would not endorse them for his or herself either.  Unlike 
strategy 1, however, social support variables of family, provider and friends are 
significantly related while self-esteem/self-efficacy is not.  A possible explanation is that 
meaning and hope are based in part on others supporting our efforts paired with resisting 
negative messages.  Liking and believing in our abilities (self-esteem) is surprising in its 
absence, but might indicate that, for this sample at least, that hope, meaning, and control 
comes more from without then within.  This is partially supported by a weak association 
with optimism and control over the future, what can reasonably be described as reflecting 
a more internal belief that the person has agency.  This might also suggest that both 
internal and external factors are involved in meaning, control, and hope, with external 
having a greater effect.   
 The most powerful social variable in association with strategy 3 is community 
activism and autonomy.  Being active is logically connected with non-endorsement of 
stereotypes and stigma resistance, what can be viewed as having the courage to interact 
with the community.  It also makes sense that activism and autonomy require a degree of 
support and interaction to maintain ones sense of control and hope.  However, because of 
the large number of clinical variables that were also significant, these reflections on 
social variables acting in isolation are attempts to understand meaningfulness, personal 
control, and hope in an artificial separation. 
  
 
 376
Strategy 4:  Recognizing support. 
 Recognition of support is only weakly associated with three domain 1 variables.  
A diagnosis of ‘other,’ though mildly significant, is generally uninterpretable.  It is 
interesting that familial mental illness is significant to only this strategy and may 
represent the recognition of the inability to look to a mentally ill close or extended family 
member for support.   
Recognition of support is closely associated, as would be expected, with support 
variables.  Domain 2 variables independently account for 52% of the variance in support 
recognition.  The reduced full model explains 61%, again favoring domain 2 variables for 
percent of variance explained.   
 Support recognition is strongly associated with support from a partner or best 
friend and support from family.  This is reasonable as these are generally the most 
intimate relationships and offer comfort and advice if an individual is not sure on whether 
someone or something is supportive.  These are also primary sources of support in their 
own right.   
 Decreased alienation is also mildly associated with strategy 4.  This is the only 
recovery strategy that alienation is significantly associated with both in social variable 
only models and full models.  Alienation has been called the key to stigmatization 
(Goffman, 1963) and was predicted to be powerfully associated with all strategies.  In 
reviewing the items encompassing the stigma scale, this is the one stigma scale that may 
leave some doubt in the label used to describe its items (see Table 9, Chapter 3, page 
144).  The scale is supposed to measure the level of disenfranchisement experienced by 
the respondent, but may instead be measuring instead of or in addition to shame, guilt and 
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disappointment due to the realization of having a mental illness and the subsequent 
feelings of inferiority.  This may not be alienation which is likely related to interpersonal 
relating, in other words shame, guilt and disappointment provoked by negative 
interactions.  A more accurate descriptive label then alienation might be negative identity.   
 Community involvement is mildly associated with support recognition.  
Interacting with the environment in which help is being assessed only makes sense.  The 
mildly significant association with optimism and control over the future, the only 
empowerment variable significant with this strategy, could reflect security and 
confidence to appraise for help and, if needed, seek help, the subject of the next recovery 
strategy. 
 Average satisfaction with services, the only domain 3 variable significantly 
associated with any recovery strategy, is highly positively associated with recognizing 
support.  This would suggest that provider support would be highly associated as well, 
yet there is no significant association with the domain 2 provider support variable.  
However, this may reflect a general sense of support from the clinical/support system 
instead of a primary provider relationship, which is feasible since over 90% of the 
respondents are seen by multiple providers at the partnering mental health center. 
 Strategy 5:  Help seeking. 
 Help seeking is not significantly associated with any domain 1 clinical/historical 
variables in the reduced main effect model and only weakly associated with interpersonal 
sensitivity in the full model analysis.  It appears that help seeking is socially and not 
clinically based. 
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 Within the social domain help seeking is not significantly associated with any 
stigma scales.  Provider support, a natural relationship to seek help in, is the one 
significant social support variable.  Empowerment carries the bulk of the responsibility 
for explaining the change in variance in help seeking.  Self-esteem/self-efficacy and 
power/powerlessness are the two variables associated with help seeking.  Righteous anger 
is also significantly related to help seeking in main effects, but drops from significance in 
the reduced main effects model.  Individuals with low self-esteem are less likely to ask 
for help due to lack of confidence and fear of embarrassment and a reduction in self-
worth.  Help seeking is a risk and individuals contending with mental illness are, for the 
most part, not usually risk takers, preferring to remain as unobtrusive as possible.  
Preliminary research for this study asked individuals diagnosed with a severe mental 
illness who they went to for help and why.  Not surprisingly, almost every respondent 
stated their provider, perhaps one other person, usually a parent, and most stated that they 
avoided asking for assistance out of concern of appearing weak or foolish or because they 
didn’t believe they would receive the help they sought (Walby, 2003b).  The power of the 
domain 2 covariates are marked when considering that the reduced main effects model 
explains 27% of the variance for help seeking while the social domain tested alone 
explains 24%.   
 Similar to strategy 4, but with less magnitude, average satisfaction is strongly 
associated with help seeking.  This is reasonable when considering that a mental health 
center is normally a place that individuals seek help from and would expect to receive 
said help from their providers. 
 
 379
 Strategy 6:  Symptom eradication. 
 Symptom eradication is the single item strategy included to gain greater 
understanding of a primary controversy between clinical recovery and the recovery 
movement.  This is not to imply that every clinician seeks to totally eliminate symptoms 
in each consumer they serve.  The emphasis does appear to be different, with discussions 
of recovery focused on symptoms for many clinicians while focused away from 
symptoms unless they become problematic for recovery oriented services.  Noted 
previously in this document, individuals with mental illness are willing to tolerate a 
certain level of symptoms in order to avoid overmedication and changes in their 
appearance and personality as a medication side effect (Walby, 2003c).  Symptom 
eradication is most highly associated with the social domain (R2 = .14) with the reduced 
main effects model explaining 18% of the variance.  However, domain 1 variables of 
interpersonal sensitivity, active symptoms of paranoia, and a diagnosis of major 
depression are negatively associated with endorsement of symptom eradication.  Noted 
earlier in this chapter, paranoia and recurrent depression are highly taxing symptoms that 
would complicate a belief in living a symptom free life. 
 Symptom eradication is not significantly associated with any stigma sub-domains 
in main effect models.  Community involvement is the lone social support scale of 
significance.  Increased community involvement could point toward less severe illness 
and the ability to cope and interact, leading the individual to believe that symptoms will 
eliminate permanently.  This is certainly not out of the question for individuals dealing 
with mild anxiety or an adjustment disorder.  This hypothesis is reinforced by the two 
empowerment variables significantly associated with strategy 6.  Power/powerlessness 
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and optimism and control over the future are both highly significant.  Optimism and 
perceived personal power also denote a belief in the future, a belief that could include a 
symptom free life. 
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Chapter 5 
 
Synthesis of Research Findings 
 Investigation into correlates of recovery, indeed, even defining recovery, is still a 
relatively new field of research.  Whereas clinical recovery is concerned with empirically 
based symptom reduction delivered through clinical services and expertise, the recovery 
movement emphasizes self directed and personalized approaches to recovery.  Only 
recently have researchers begun to explore potential strategies for recovery that reflect 
recovery choices, behaviors, and beliefs based on the principles of the recovery 
movement.  Despite some confusion and fragmentation in research efforts and defining of 
concepts, the recovery movement is likely here to stay as it is central to the New Freedom 
Commission on Mental Health (New Freedom Commission on Mental Health, 2003) and 
is a primary focus for the State of Florida (J. Watts, personal communication, January 18, 
2007).  Thus, this chapter will begin with a discussion of the findings regarding recovery 
expectancy as it pertained to research questions 1 and 2.  A principal focus of this 
discussion will be recovery expectancy and severity of illness and how this contributes in 
theoretical terms to future research on recovery. 
Recovery strategies will be reviewed and evaluated in the context of research 
question 3.  The explanatory contribution of each domain will follow discussion of 
research strategies and in turn will be followed by a discussion of theoretical implications 
382 
for empowerment, stigma, social comparison and social support theories.  A brief 
discussion of additional factors that may influence both belief in recovery and strategy 
will be offered.  Finally, subsequent sections will address study limitations and strengths, 
the relevance of this research to public health, and will conclude with suggestions for 
future research. 
 
Recovery Expectancy 
 Research question 2 asked whether there were significant associations between 
the belief in recovery and specific clinical/historical (domain 1), social (domain 2), and 
service (domain 3) covariates.  The question of recovery expectancy or belief that one 
will recover, as far as can be determined, is unique to this study.  In the recovery 
literature, the expectation or belief in ones recovery has not been explicitly included in 
recovery research, though recovery strategies (also called themes or pathways in the 
literature) have received attention (Corrigan & Ralph, 2005; Resnick, Fontana, Lehman, 
Rosenheck, 2005), and are the topic of the next section.   
As noted in Chapter 4, bivariate analysis revealed many significant associations 
between domains 1-3 variables and recovery expectancy, with significance also noted in 
multivariate analysis after controlling for specific factors.  Factors that are significantly 
related to recovery expectancy in multivariate analysis are worthy of future research 
given the strength of association between recovery expectancy and recovery strategies.  
However, since this is a first attempt at investigating recovery beliefs and the distinction 
between severe mental illness and less severe illness is relevant in research and clinical 
practice, a brief discussion of belief in recovery and severity of illness is warranted. 
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Recovery expectancy and severity of mental illness. 
 If one was to assume that results from bivariate analysis told the whole tale, then a 
profile of someone that believes in recovery could be depicted as someone with limited 
active symptoms, not diagnosed with bipolar disorder, restricted dependence on 
psychiatric medications, who is socially connected and supported by his or her 
community, family and friends, and that has internalized a sense of power, self-esteem, 
and concern for others.   With this description, it is easy to see why belief in recovery is 
more difficult for individuals labeled SMI since these are often areas of greater challenge 
for any socially and economically marginalized population.  Belief in recovery may hinge 
on more subtle gradations of support, empowerment, and stigma resistance as well as 
stable control of active symptoms and access to recovery and/or empowerment based 
services.  Belief in recovery may also relate to other factors not included in this study 
such as the experience of hope, the promise of a future that includes quality of life and 
access to necessary financial, educational, and employment resources.   
 Belief in recovery may vary due to emotionally compelling turning points.  As 
this study was cross-sectional, the stability of beliefs across time is unknown.  However, 
belief in anything will change with new information and experience and there is no 
reason to assume that recovery beliefs are impervious to changes in perception of self and 
environment.  Research with individuals with disabilities, the closest parallel the 
literature can offer at this time, found that meaning making coupled with social support 
and self-understanding, actively replacing losses with gains and accommodating to 
384 
changes enhanced self-belief (King, et al., 2003).  This is consistent with the recovery 
and empowerment literature with its emphasis on personal growth, planning for 
obstacles, being willing to change and increasing supports.  However, this comparison is 
based on two assumptions.  First, that self-belief is similar to belief in one’s recovery and 
second, that belief in recovery would be processed similarly for SMI and OP sample 
participants.  These assumptions, though logical, are without empirical validation.  To 
reiterate, this study attempted to broaden the concept of recovery to include individuals 
not labeled SMI, though those labeled SMI have been an almost exclusive focus of the 
recovery and related empowerment literature.  In addition, it is important to remember 
that the recovery and empowerment literature addresses belief implicitly.  Being 
admonished to believe in one’s recovery is not the same as having the belief that one will 
recover and there is an apparent but not yet understood impact of severity of illness on 
this belief, as demonstrated in this study via the significant results from research question 
1 that found that individuals from the OP sample were much more likely to endorse their 
own recovery. 
Assuming that self-belief in disabled individuals is similar to the belief that one 
will recover, the findings in this study are consistent with the literature, especially the 
emphasis on symptom control (reflecting self-understanding and self-care) and the 
powerful association with social support on recovery beliefs and strategies.  The main 
point is that change in recovery belief is likely to occur due to alterations in relationships, 
intrapsychic processes, and the lived environment, identical to areas of change considered 
important to individuals with disabilities.  
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There is evidence from this study to support that recovery expectancy is important 
for utilization of recovery strategies, though the mechanism of how this works is not 
clear.  The lack of clarity is due, in part, to a methodological issue in this study.  The 
strategies derived and investigated were structured more on a ‘is this important or 
relevant to you’ question format than a ‘how do you implement or operationalize this’ 
format.  The question of belief in recovery may very well reflect a more action oriented 
or behavioral aspect of recovery.  Believing in recovery may access in respondents a 
cognitive process of recalling behaviors that facilitate their own recovery, resulting in 
belief or lack of belief in their own recovery based on the evaluation of success of their 
actions.  Operationalizing beliefs can include planning and action. When considering how 
beliefs are operationalized, models in which recovery beliefs as well as strategies could 
be included would require attention to beliefs of the individual and how they act upon 
these beliefs to reinforce expectancy, choice of strategy and action taken in response to 
the strategy (Hughes, Hill, Budd, 1997; Kinderman, Setzu, Lobban, Salmon, 2006). 
Noted above, those labeled SMI in this study were significantly less likely to 
believe in their own recovery.  However, it is important to not lose sight that there are 
individuals labeled SMI that believe in their recovery.  Future research could ascertain 
the differences between this subgroup and those that do not sanction their own recovery 
within the SMI labeled population.  In the future, efforts should be made to determine the 
effect of changes in recovery beliefs on utilization of recovery strategies, important in 
order to understand the bridge between clinical recovery and the recovery movement.  
However, a key component missing in this study is the cognitive impact of mental illness 
over time and its effect on recovery belief.  Though this could certainly be considered a 
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limitation to this study neurocognitive deficit is discussed at this point because of the 
potential impact on recovery that is relevant more for the SMI than the OP sample. 
Neurocognitive deficit as impediment to recovery expectancy. 
Deficits in neurocognition were not measured in this study but could be exerting 
influence on recovery expectancy, as well as choice of recovery strategy, perceived 
empowerment, susceptibility to stigma, and indeed nearly every factor investigated.  
Deficits are important predictors of functional outcome in chronic mental conditions like 
the one’s faced by all in the SMI sample and perhaps the more severe members of the OP 
sample.  Memory deficits alter social behavior and perception of self and symptoms over 
time and could impact perception of recovery beliefs as well.  Further, intact memory 
predicts better recovery of social and interpersonal skills (Smith, Hull, Huppert, 
Silverstein, 2002).  The few respondents who needed extended time to complete the 
surveys were at highest risk of neurocognitive deficits.  However, there answers were 
consistent across surveys and the small number, four total respondents, are unlikely to 
affect the results in this study.   
Cognitive deficits increase the risk for aversive life experiences, which leads to 
dysfunctional behavior and beliefs.  Deficits are more profound and impact more 
domains of functioning for individuals diagnosed with schizophrenia or schizoaffective 
disorder, the vast majority of which are in the SMI population.  Negative beliefs of self 
and others, misattribution of interactions, jumping to conclusions, low expectation of 
success and pleasure, and withdrawal from interaction to conserve what is perceived as 
limited intellectual capacities are common experiences for individuals with mental 
illness, with increasing impairment the longer and more severe that symptoms are 
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experienced (Beck & Rector, 2005).  Together, memory and other deficits unmeasured in 
this study may negatively impact recovery expectancy.  Not to screen for neuroncognitive 
deficits was a design choice that imposes a limit that should be considered.  Cognitive 
deficit impact on data collection will be more fully explicated in the limitations section 
below. 
 
Recovery Strategies 
Recovery strategies were tested for direct associations with domains 1-3 
independent variables in research question 3.  Prior to that analysis a factor analysis was 
completed on the combined items from the Recovery Assessment Scale (Corrigan et al., 
2005) and the Personal Vision of Recovery Questionnaire (Borowitz-Ensfield, 1998).  
The recovery strategies derived from factor analysis and investigated for this research are 
consistent with, but not identical, with other research on recovery.  The strategies include 
(1) effective illness management, (2) positive future orientation, (3) meaningfulness, 
personal control, and hope, (4), recognizing support, (5) help seeking, and (6) symptom 
eradication.   
Corrigan, Salzer, Ralph, Sangster, Keck (2004), developers of the RAS, described 
five factors that included: (1) personal confidence and hope: (2) willingness to ask for 
help: (3) goal and success orientation: (4) reliance on others: and (5) no domination by 
symptoms.  The five factors of the PVRQ (Borowitz-Ensfield, 1998) included: (1) 
recovery through support: (2) recovery through personal challenges; (3) recovery through 
professional assistance; (4) recovery through action and help-seeking; and (5) recovery 
through affirmation.  The factors or recovery strategies for this study are markedly close 
388 
to the RAS in items and description with a minor contribution from the PVRQ.   Why the 
RAS was favored over the PVRQ in this study’s factor analysis cannot be determined 
with confidence.  Perhaps the RAS resonated to a greater degree with respondents or the 
PVRQ’s more direct referencing of recovery in each item was somehow processed by the 
respondent’s in a way that disallowed the items to mesh in analysis.  A future analysis is 
planned that will test for differences on the RAS and PVRQ scales as designed by their 
authors to compare SMI and OP responses and determine if there are significant 
differences between samples on the two recovery instruments. 
 During the course of this research other instruments targeting recovery strategies 
or pathways were tested by other research groups.  A brief review of recovery 
instruments was conducted to establish whether the RAS and PVRQ items remained 
consistent with current measurements of recovery.  The Mental Health Recovery Measure 
(MHRM) was designed utilizing a grounded theory analysis of interview sessions 
targeting recovery (Bullock & Young, 2003).  Reliability and Rasch modeling reduced 
the 41 original items to a 30-item instrument.  Subscales and internal consistency of the 
MHRM are: (1) overcoming stuckness (α = .60); (2) self-empowerment (α = .82); (3) 
learning and self-redefinition (α = .79); (4) basic functioning (α = .62); (5) overall well-
being (α = .86); (6) new potentials (α = .62); and (7) advocacy/enrichment (α = .66).  A 
comparison of the scales reveals that the stuckness and basic functioning scales are 
similar to the effective illness management strategy in this study (strategy 1).  Similarly, 
the learning and redefinition scale of the MHRM parallels strategy 2, positive future 
orientation.  Strategy 3, meaningfulness, personal control, and hope are consistent with 
overall well-being and new potential scales of the MHRM.   
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 The Consumer Recovery Outcomes System (CROS) was developed through focus 
groups and interviews with consumers and providers of mental health services, resulting 
in 38-item consumer and provider versions of the CROS (Bloom & Miller, 2005).  The 
scales, internal consistency (α) and test re-test (r) of the CROS consumer version are as 
follows:  (1) hope for the future (α = .90, r = .70); (2) daily functioning (α = .83, r = .69); 
(3) coping with clinical symptoms (α = .86, r = .76); (4) quality of life (α = .84, r = .75); 
and (5) treatment satisfaction (α = .79, r = .74).  Review of scale descriptions finds 
parallels with strategy 1 (effective illness management) and scales 2 and 3 of the CROS.  
Positive future orientation (strategy 2) is somewhat related to some items and the 
description of scale 4 of the CROS.  Strategy 3 (meaningfulness, personal control and 
hope) appears to be strongly related to scale 1 of the CROS.    
 The Recovery Process Inventory (RPI) was designed with the assistance of 459 
individuals using focus groups and preliminary surveys with severe mental illness 
resulting in a 22-item 6-factor instrument that include: (1) anguish (α = .78); (2) 
connected to others (α = .71); (3) confidence and purpose (α = .77); (4) others care and 
help (α = 56); (5), living situation (α = .71); and (6) hopeful and cares for self (α = 81) 
(Jerrell, Cousins, & Roberts, 2006).  The first scale, anguish, appears unique compared to 
this study and the instruments developed in other studies that were reviewed.  Items in 
this scale are similar to the stigma scale used in this study, for example ‘discriminated 
against, ‘isolated and alone,’ and ‘lost and hopeless.’  This is a consistent problem when 
investigating recovery, determining which are components of recovery and which are 
covariates.  Scale 2 of the RPI is similar to the help seeking scale in this study.  
Confidence and purpose (scale 3 of the RPI) has several nearly identical items to strategy 
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2, positive future orientation.  The fourth scale of the RPI is similar to the recognizing 
support strategy.  The final two scales of the RPI are comprised of only two items, 
violating a fundamental rule in development of scales via factor analysis and are not well 
matched with any of the recovery strategies in this study. 
 The Hamilton County Recovery Initiative developed a 21 item survey that was 
reduced to 7 items loading only on two factors (Borkin, et al., 2000).  Factor 1 was 
‘recovery is possible and needs faith’ and factor 2 was ‘recovery is difficult and differs 
among people.’  The description of the analysis revealed fragmented response patterns 
likely due to including individual’s diagnosed with a mental disorder, professionals, 
family members, students and others (no further information provided), all answering the 
same questions.  Further, as the respondents were allowed to self-identify what response 
group they belonged to, there was evidence that some individual’s were not clear on what 
a particular category was and misidentified themselves.  However, the purpose of this 
survey was to provide a fast screening instrument to determine the recovery readiness of 
individuals and their supports. The 7-items from the two factors have items similar to 
strategies 1 and 2 for this study with the exception of one item that states ‘to recover 
requires faith,’ which does resemble one item from the RAS that was not incorporated in 
the strategies for this study. 
 Scales referencing help seeking (scale 5) in this study are not represented in the 
MHRM, CROS, RPI or Hamilton County studies, though there are some items that bear a 
resemblance.  It appears reasonable to state that other published surveys remain 
consistent with the types of information regarding recovery that this research 
investigated.  This is important for placing this effort into the larger context of recovery 
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research as well as supporting generalizability.  An additional methodological point is 
that all the surveys described in this study were created with the assistance of individuals 
labeled severely mentally ill or severely and persistently mentally ill.  Thus, none of the 
surveys were developed with input from individuals with less severity, represented in this 
study by the OP sample.  As far as can be ascertained, input from individuals 
representative of the OP population has never been included in recovery measurement 
development.   This is consistent with the focus on the severely afflicted in recovery 
research and intervention.  As the concept of recovery has been found to be useful to the 
less severely ill in this study, a future research project might consider investigating what 
aspects of recovery would be endorsed for measurement development by a less severe 
sample and to compare for significant differences with a SMI sample. 
 The strategies examined in this study are also consistent with the literature 
developed by individuals in recovery and those investigating the recovery movement.   
This is likely due, in part, to the phrasing and emphasis on recovery.  The RAS only 
references symptoms five of 41 questions and mentions services only once.  The 
symptom questions are general and left to the respondent to identify internally what 
symptoms mean to them.  The PVRQ mentions symptoms and diagnosis once and 
medications twice.  Services and hospitalization are mentioned once each as well.  Both 
instruments leaned heavily towards recovery movement concepts and phrasing and 
steered relatively clear of clinical recovery concepts.  A more comprehensive approach 
would be achieved if this study were replicated to include more measures of clinical 
recovery and to evaluate the impact of the three domains of independent variables on 
clinical recovery measures as dependent variables.  Considering the high number of 
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hospitalizations for many of the SMI group and the near equal measures of symptom 
levels for SMI and OP samples, clinical recovery may have relevance not detected in this 
study. 
  
Explanatory Contribution of Independent Variable Domains 
 Next offered is a brief discussion of each independent variable domain and, when 
available, comparisons to results from relevant studies.  In general, the social domain has 
the highest degree of association with utilization of recovery strategies and with recovery 
expectancy.  The clinical domain has a less consistent relationship with recovery 
strategies or expectancy but cannot be discounted and might actually play a larger role in 
recovery than some advocates of the recovery movement may desire to sanction.  The 
service domain was not especially pertinent in this analysis though there was an 
intriguing pattern that will be noted.  
 Domain 1:  Clinical/historical factors. 
The clinical/historical domain has obvious relevance to recovery with increased 
symptoms and recent hospitalizations decreasing endorsement of recovery expectancy 
and recovery strategies.  Symptoms may interfere with planning or executing recovery 
actions, implicating cognitive, emotional and behavioral effects on recovery.  Active 
symptoms demand attention and could be interpreted as a failure to recover.  The 
recovery literature reduces the importance of symptoms by suggesting that recovery can 
occur in the face of some symptoms (Chadwick, 1997; Marshall, Crowe, Oakes, Deane, 
Kavanagh, 2007).  However, when confronted with overwhelming symptoms there 
appears to be agreement with the clinical literature that suggests directing all necessary 
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resources toward symptom reduction (Fava, Ruini, Beliase, 2007; McCay, et al., 2006; 
Wilson, et al, 2006).  Findings from the literature are consistent with this study where 
elevated symptoms were negatively associated with recovery belief and strategy 
endorsement in nearly every case of bivariate analysis and in some cases in multivariate 
analysis as well. 
Focusing next on diagnosis, the SMI and OP samples were, for the most part, 
categorized as expected.  Schizophrenia and schizoaffective disorder were far more likely 
to be diagnosed in the SMI population, while anxiety disorders, dysthymia and 
adjustment disorders were diagnosed more in the OP sample.  The one surprising finding 
was the diagnosis of bipolar disorder, which was nearly identical in number for both 
samples.  This may reflect an increase in diagnosis of less severe cases.  However, a 
dialogue with medical and administrative professionals at the community mental health 
partner agency did not clarify the unexpected level of inclusion of bipolar diagnosis in the 
OP sample.  However, since bipolar disorder was the most prevalent disorder for the total 
sample, it may be a contributor to some of the unexpected similarities between the SMI 
and OP samples, especially symptom levels.  It should be reemphasized that psychiatric 
diagnosis is not especially accurate in the community mental health setting where 
psychiatrists and nurse practitioners are often given only 45-minutes to complete an 
initial psychiatric history and diagnostic evaluation without the assistance of any formal 
diagnostic instruments.  Other studies of recovery have included much higher numbers of 
individuals diagnosed with schizophrenia and schizoaffective disorder than found in this 
sample.  For instance, nearly 50% of the respondents were diagnosed with schizophrenia 
or schizoaffective disorder in the study validating the Recovery Process Inventory 
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(Jerrell, Cousins, & Roberts, 2006), while the percentages were from 15% to 20% higher 
for the study developing the Health Recovery Measure (MHRM) (Bullock & Young, 
2003), and the Consumer Recovery Outcomes System (CROS) (Bloom & Miller, 2005), 
compared to only 22% in this study.   
 As hypothesized, the SMI sample was prescribed considerably more medications 
both in types, number of distinct medications, and dosages.  These differences were 
verified in chart abstractions as a check against reporting bias for medication usage.  To 
review, in bivariate association with recovery strategies, anti-depressant, anti-anxiety and 
anti-manic medications were significant only with strategy 1 (effective illness 
management), and strategy 2 (positive future orientation), with higher average scores on 
the strategy associated with less use of the medication.  Only anti-anxiety medication 
remained significant in multivariate analysis and only for effective illness management.  
Noted earlier, anti-psychotic medication was significantly associated with strategy 3 
(meaningfulness, personal control, and hope) in multivariate analysis and not significant 
with any strategy in bivariate analysis.  Individuals from the OP sample may have 
qualitatively different symptoms or have more effective non-prescription based coping 
strategies compared to the SMI sample.  Medications are prescribed for symptom control 
in the majority of cases and it was noted earlier that the symptom levels were nearly 
identical for the OP and SMI samples, leading to the expectation of approximately equal 
levels of medication use. 
 The prevalence of assault by type and gender in this study is below what has been 
reported in the literature.  For instance, the findings of Goodman, et al. (2001) in an 
investigation of victimization of individuals with mental illness found that lifetime sexual 
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assault for females was 68% and males 40%, whereas for females in this study it was 
49% and males 12%.  Listing results of the Goodman, et al. (2001) study by type of 
assault and gender group, with this studies results in parentheses, we find child sexual 
abuse for females at 49% (54%) and males 29% (15%), child physical assault for females 
at 54% (44%) and males 58% (27%), adult sexual assault for females at 57% (44%) and 
males 25% (10%), and, lastly, adult physical assault for females at 75% (47%) and males 
79% (19%).  Only for child sexual abuse is the prevalence in this study greater than the 
Goodman et al., study.  Similar discrepancies are noted with other studies of 
victimization and the mentally ill (Mueser, et al., 1998; Shack, Averill, Kopecky, 
Krajewski, Gummattira, 2004).  One plausible explanation is that this sample is a mix of 
severe and less severe respondents whereas all of the studies cited were exclusively made 
up of individuals with a severe mental illness.  Another possible explanation is the 
method used to collect the data.  Four questions at the end of data collection asked 
whether the participant had even been sexually abused or physically abused as a child and 
sexually or physically assaulted as an adult.  If affirmative, a follow-up question asked 
whether the abuse/assault had occurred more than once.  The goal was to limit stress on 
the participant during data collection in order to buffer against symptom exacerbation, 
which, though successful, might have allowed respondents to respond incorrectly.   
As described in Chapter 3, a follow-up chart abstraction was completed to obtain 
additional information relevant to this analysis as well as to provide a double-check on 
participant responses.  The chart abstractions did not identify additional abuse 
experiences for any participant.  However, it should be noted that the number of 
respondents admitting to abuse or assault was 34% higher than the abuse recorded in the 
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charts reviewed.  This suggests an information collection bias by clinical staff regarding 
abuse or at least a lack of recording this data in the clinical records.  Regardless, the 
literature supports abuse experiences as salient to the onset and course of mental illness 
and an impediment to recovery (Alexander, Meunxenmaier, Dumont, Auslander, 2005).  
The lack of association of abuse variables with endorsement of recovery strategies in this 
study is counter to the literature and requires further exploration. 
 In summary, the clinical and historical factors surveyed in this study were more 
comprehensive than in other studies investigating recovery.  Efforts were made to target 
factors that had either theoretical or empirical support for a significant association with 
recovery.  This is the first study to include familial mental illness, hospitalization history, 
or prescribed psychotropic medications in analysis.  The majority of findings were 
consistent with the empirical literature.  Some results were inconsistent and this may be 
due, in part, to differences in diagnostic composition, trauma experiences, and other 
factors.  Clinical and historical factors have a potentially powerful role in affecting belief 
in recovery and use of recovery strategies. 
 Domain 2:  Social factors. 
 Domain 2 social factors have the largest number and magnitude of significant 
associations of the three predictor domains with the six dependent recovery strategies.  
This provides empirical support for the recovery movements focus on social support, 
community cohesion, fairness and availability of employment, empowerment, and social 
justice (Brown, 2001; Fisher & Chamberlin, 2007; Masterson & Owen, 2006).  This also 
provides indirect support for recovery oriented services provided in clinical settings 
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(Marshall, Crowe, Oades, Deane, Kavanagh, 2007; Ratzlaff, McDiarmid, Marty, Rapp, 
2006).   
 Social support was powerfully associated with all six recovery strategies, though 
from where the support was received was different for most strategies.  Support from 
partners/best friends or from friends in general was surprisingly associated with only 
recognizing support (strategy 4) and meaningfulness, personal control, and hope (strategy 
3).  This differs from what was voiced in preliminary qualitative research for this study 
(Walby, 2003a).  In that study, 90% of the individuals stated that support from friends 
was their greatest support or at least tied with familial support.  However, the pilot study 
sample was recruited from a psychiatric day treatment program where socialization and 
building of peer support was emphasized, possibly biasing results.   
Support from family and providers were the most highly associated support 
variables in this study with both recovery expectancy and four of six strategies.  This 
could partially reflect a population bias since for many individuals with mental illness 
these are the key supports left them as friends, partners and even extended family 
distance themselves after onset of illness and possible changes in behavior interacting 
with stigmatizing beliefs and expectations (MacDonald, et al, 2004).  The majority of 
consumer social network support is provided by families, limited numbers of friendships, 
informal groups and, in some cases, provider support.  Drop-in centers, clubhouses and 
support groups offer more formal and consistent support when available, but the supply 
of such organizations is still far below the demand (Cowell, et al., 2003; Macias, Propst, 
Rodican, Boyd, 2001).  
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What is unique in this study is the evaluation of separate networks of support 
whereas other studies utilized general measures of overall support.  In order to compare 
with other studies, the importance of social support in this study must be evaluated in the 
context of the recovery strategies identified.  This makes it difficult to contrast directly 
with other studies that generated slightly different recovery strategies or conceptualized 
social support differently, but some general comparisons can be made.  A study by 
Skarsater, et al. (2003) emphasized how important social support was for recovery from 
major depression.  This study was limited to women with major depression and thus 
reduces comparability, but the qualitative research described strongly emphasized the 
need for social support in nearly all aspects of recovery.  A quantitative study targeting 
individuals with bipolar disorder found similar results (Johnson, Lundstrom, Aberg-
Wistedt, & Mathe, 2003).  In this study, low social support was positively associated with 
relapse and partial versus full remission.  Social support measured in this effort appears 
consistent with the findings of other studies and provides additional reinforcement for the 
role of support in the recovery literature. 
Empowerment is a core feature of recovery oriented services offered in 
community mental health settings.  Supported living, supported employment and 
supported education as well as strengths based case management share features in 
common with the recovery movement and are often described as empowering.  The level 
of empowerment depends on how the services are delivered with some supported services 
considered more empowering through providing choices to the individual while others 
are viewed as coercive with choices dictated.  To be sure, while community-based 
programs in clinical settings discuss empowerment of consumers, there is seldom a focus 
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on different aspects of empowerment, for instance in strengthening personal power and 
choice, raising self-esteem and promoting community involvement.  Likewise, while 
consumers are encouraged to increase their social networks, it is rare that they are 
provided financial support to do so.   
An important aspect of giving back to the community is community involvement 
and activism.  Together, these were significant for five of six recovery strategies and 
were highly significant in bivariate analysis with recovery expectancy.  In a study by 
Corrigan (2002), the benefit of empowering community opportunities was found to 
increase recovery though anti-stigma effects and integration opportunities, especially 
when coupled with empowering and collaborative services that reinforce positive 
community messages.  This study reflects the majority of the literature that emphasizes 
having the community accommodate to the afflicted individual and less with the 
reciprocity of giving back to the community.  A separate study that investigated micro, 
meso and macro level of empowerment and their affect on recovery found that 
community integration, choice and control (similar to the power/powerlessness factor in 
this study) were significantly related to positive recovery (Nelson, Lord, & Ochocka, 
2001).  This study emphasized the benefits for the consumer of giving back to the 
community and how this facilitates true integration versus a feeling of belonging that 
maintains the separateness of the individual as a ‘sick’ person.  This is more in line with 
the concept of community involvement investigated in this study and provides support for 
the results of this study. 
Self-esteem is central to empowerment and was the most consistent and powerful 
covariate with recovery strategies in this research, a finding duplicated in the recovery 
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literature (Corrigan, et al., 1999; Hutchinson, Anthony, Massaro, & Rogers, 2007).  In 
both studies cited, self-esteem was related to confidence, educational achievement, and 
perceived success in recovery based activities or training and were investigated in an 
empowerment framework.  However, self-esteem is more often investigated with 
recovery as a separate construct, not embedded in an empowerment model.  Though not 
measured in this study, self-esteem in the context of its influences on recovery has been 
empirically linked with quality of life (Guerje, Harvey, & Herman, 2004), a possible 
construct for future research discussed below.  Supportive services have also been 
recognized for their benefits to recovery, mediated by the effects of higher versus lower 
self-esteem (Ratzlaff, McDiamid, Marty, & Rapp, 2006).  What this study and the 
literature in the field lack is evaluating for causal direction of self-esteem and recovery.  
Does self-esteem lead to recovery or is recovery enhancing for self-esteem?  Or is the 
relationship bidirectional? 
Stigma is a powerful reality in the lives of many individuals with mental illness.  
It is a barrier recognized by the recovery movement and research, but is often not 
specifically addressed in clinical settings.  The preliminary qualitative research for this 
study included questions regarding stigmatization and discrimination experiences.  Of 
over thirty in-depth interviews, all reported discriminatory and stigmatizing experiences 
and yet all stated that they had never discussed these experiences with their provider nor 
had the provider broached the subject (Walby, 2003a; Walby 2003b).  The same 
respondents spoke eloquently about their need for recovery and their fear in discussing 
recovery with anyone outside of the mental health field or with other consumers for fear 
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of ridicule and rejection.  This lived experience of consumers is congruent with the 
results derived from both bivariate and multivariate analysis in this study.   
Despite expectations, stigma was not as powerful a construct as anticipated in this 
study.  Alienation and social withdrawal were the two scales that were expected to be 
strongly negatively associated with recovery expectancy and strategies.  Though bivariate 
analysis was consistent with this prediction, multivariate analysis found both scales only 
mildly to moderately associated with one recovery strategy each.  Similarly, stigma 
resistance was only associated with two strategies in multivariate analysis.  Noted in a 
previous chapter, a methodologic decision was made to concentrate on internalized 
stigma versus recollection of discriminatory experiences.  This may have affected the 
results as individuals would be expected to generate greater emotional resistance to 
facing internalized stigma then recounting discrete discriminatory experiences.  Whereas 
internalized stigma could prompt feelings of shame, guilt, and lowered self-esteem, 
discriminatory experiences could be expressed with anger and righteous indignation. 
Though lacking intensity and breadth of association, the results of stigma in 
analysis with recovery expectancy and strategies was in the predicted direction.  Stigma 
has been found to be negatively associated with different aspects of recovery in multiple 
studies.  Stigma and employment was researched in the context of recovery and found 
that a key for success in employment for severely mentally ill individuals was in part 
building successful small enterprises with flexible scheduling in order to maximize the 
return for the employer and limit the opportunities for discrimination and stigmatizing 
interactions (Warner & Mandiberg, 2004).  This in turn led to increased recovery 
expectations and experiences.  Longitudinal survey data from a sample of 610 
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participants with severe mental illness demonstrated that stigma, symptoms, self-concept 
and life satisfaction (as aspects of empowerment) were all part of the recovery process 
and have a reciprocal effect on each other (Markowitz, 2001).  During the course of 
analysis for this study, there was a positive significant association found in bivariate 
correlational analysis between every symptom scale and each stigma scale with mild to 
moderate magnitudes (see Appendix F, Table 161).  Stigma and empowerment were 
found to be negatively associated and significant as well (Appendix F, Table 179).  These 
findings are consistent with the Warner and Mandiberg (2004) and Markowitz (2001) 
studies.  It can be stated that the results of the stigma analysis in relation to recovery and 
in relation to other independent variables is consistent with the overall pattern in the 
literature.   
Domain 3:  Service factors.  
The only consistent finding in bivariate and multivariate analysis was the 
significant association between satisfaction with services and endorsement of recovery 
expectancy and strategies.  The research on recovery and services has taken two tracks.  
First, research has evaluated the degree that traditional services have served an 
empowerment or recovery purpose.  Second, recovery oriented services were developed 
and tested to ascertain the degree that the services met the recovery expectations of 
choice, collaboration, consumer led, and empowerment orientation.  However, research 
into the effectiveness of traditional therapies has consistently emphasized the quality of 
the relationship and satisfaction with the service offered as the key to therapeutic change, 
regardless of the treatment modality or technique used (Hill, 1989).   
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The concept of service satisfaction guided the operationalization of the service 
domain.  This concept resonates in the recovery and medical literature with remarkably 
similar results to this study.  The recovery movement emphasizes recovery principle 
based services for all aspects of care, not just psychiatric.  Satisfaction with primary care 
treatment was found to be related to the quality of the consultation, the influence of 
stereotypes on the behavior of the physician, giving of hope to the consumer by the 
doctor, and the ‘user friendliness’ of the primary care organization (Lester, Tritter, & 
England, 2003).  The American Association of Community Psychiatrists Guidelines for 
Recovery Oriented Services in Community Mental Health Systems recognizes recovery 
based services as a major cultural shift that replaces paternalistic services with 
collaborative and satisfying services (Sowers, 2005).  Service satisfaction based on 
recovery principles is central to the guidelines and the expectation is that community 
mental health centers nationally will adopt and act within these guidelines.  These studies 
stress the importance of choice in medical and psychiatric service utilization.   However, 
an important difference in the Sowers review of the guidelines and this study is that 
service satisfaction was measured in general for all services, whether ostensibly recovery 
oriented (e.g., supported housing) or clinical in nature (e.g., a medication review 
appointment).  The Sowers article addresses recovery based services only.  However, 
service satisfaction in clinical services is key to success (Hill, 1989) and this apparently 
translates to recovery based services as well. 
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Implications for Underlying Theories Used to Generate and Assess Study Results 
 Multiple theoretical perspectives were evaluated when developing the 
background, methods, and analytic plan of this effort.  The findings of this research have 
been, in general, consistent with theories of social support, empowerment, and stigma.  
Attribution theory and labeling theory were also considered and will be discussed under 
stigma theory.  Brief discussion targeting each theoretical area is provided next to more 
firmly embed the results into the theoretical perspectives used to generate the study. 
  Social support theory. 
Social support theory emphasizes the health benefits of being connected to others 
and the receipt of different forms of support, including emotional, instrumental, appraisal 
and informational support.  Social support theory also emphasizes the reciprocal nature of 
support and its relevance for establishing and maintaining positive and mutual 
relationships.   
The benefits to recovery from mental illness from social support have been 
documented (Corrigan, et al., 1999; Corrigan & Phelan, 2004; Frese, Stanley, Kress, & 
Vogel-Scibilia, 2001).  Comparison of social support reporting between SMI and OP 
samples found the SMI sample with slightly higher scores for support for all scales 
except support from friends.  Though not significant, it is interesting that the sample 
expected to be the most socially isolated reported that they are the least.  The same 
comparison based on recovery expectancy is in the predicted direction, with individuals 
sanctioning recovery with higher scores on all six social support scales and significant for 
partner or best friend, family, and friend support as well as community involvement.   
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 Recovery and social support have been linked conceptually from the beginning of 
the recovery movement and recovery research (Anthony, 1993; Leavy, 1983).  Social 
support was first investigated in the context of recovery from substance abuse and then in 
recovery for those with co-occurring substance abuse and mental health diagnoses 
(Laudet, Magura, Vogel, & Knight, 2000).  Securing and maintaining a positive and 
flexible social network is a cornerstone of peer supported recovery.  Social support means 
more than acquaintanceship or alleviation of boredom in recovery.  It is a network of 
friends, family, and professionals that assist the consumer with emotional stability, choice 
making, practical needs, to challenge them when needed and, important to the mutual 
aspect of recovery, to expect the consumer to give back to the level they are able when 
reasonable.  Reciprocation is considered vital to personal growth and the lack of 
reciprocation that is inherent in the clinical relationship is a stumbling block to the 
joining of the clinical and peer supported recovery initiatives.   
 Provider support was measured in part to assess whether such support is 
significant to recovery strategies as a small step toward unifying clinical recovery and the 
recovery movement.  In this study, provider support was not significantly different in 
association with recovery expectancy between the SMI and OP samples.  However, in 
multivariate analysis provider support is significantly associated with three strategies, 
positive future orientation, meaningfulness, personal control and hope, and help seeking.  
It should be noted that provider support in significant association with recovery strategies 
may be in part due to all respondents having one or more providers.  It is unknown if the 
same significance would be found for individuals that were no longer in a provider-
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consumer relationship and were asked to recall whether provide support was significant 
to their recovery efforts. 
 The significance of provider support compared to other forms of support is 
relevant to a new theoretical process in assessing correlates of recovery.  Support from a 
provider is a one-way expectation.  Indeed, the provider that receives substantial support 
in return will be viewed as having crossed professional boundaries.  Genuine affection 
does often develop between a provider and consumer, but once the consumer has 
received from the provider sufficient resources where the provider is no longer needed, 
then the relationship is expected to end.  This is counter to the recovery movement that 
values and expects relationships to continue until and unless they become unhealthy, and 
only then are they terminated.  Social support is intended to be healthy and positive, but 
may not always be welcome and could be perceived as negative.  This type of negative 
support is known as dissupport. 
 The social support, social dissupport continuum was described in a brief article by 
Malone (1988).  In this article, the author describes the negative consequences of clingy, 
angry, selfish and demanding aspects of support that force one individual onto another.  
This was found to be anxiety and stress producing to the recipients of this unwanted 
support.  Though little more was written about dissupport, it conceptually fits with 
another concept that began to gain popularity around the same time, expressed emotion, 
which will be described later in this chapter (Anderson, Hogarty, Bayer, Needleman, 
1984).  Dissupport can be organized by type of support as social support is.  Emotional 
support remains relatively constant across time and age and when not desired is 
experienced as intrusive, confusing, and manipulative.  Instrumental (practical) supports 
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tend to decline with age and when offered when not wanted or desired can be perceived 
by the recipient or others as enabling.  This is particularly relevant to individuals with 
mental illness who may adapt a victim role and begin to lose benefit from social support.  
Dissupport in general, which can also be conceptualized as relational strain, tends to 
decline with age as well (Due, Holstein, Rikke, Modvig, & Avlund, 1999).  Though not 
investigated in this study, a secondary analysis by age, gender and provider of support 
would better evaluate whether social support from this study is consistent with current 
theoretical expectations.  Two additional theoretical sub-constructs or pathways to 
investigate in social support include the effect of social distance and the degree that social 
support acts as a buffer between stress and symptomatic illness and the subsequent effect 
on recovery belief and active use of recovery strategies. 
 Level of desired social distance may mediate the level of social support received 
by an individual with mental illness.  Social distance is the degree that one individual 
would agree to be in a relationship with another that in turn may reduce stigma and 
increase social support through contact (Alexander & Link, 2003).  Preferences and 
levels of contact reduce fears of violence and unexplainable behavior, increasing the 
comfort level of contact and providing increased support and decreased perception of 
stereotypes (Angermeyer, Beck & Matschinger, 2003).  Social distance may be how 
stigma operationalizes its impact on social support and thus affecting the course of illness 
and sequela faced by the afflicted.  Though the relationship between social distance and 
perception of dangerous and fear is particularly strong (Corrigan, Green, Lundin, Kubiak, 
Penn, 2001), the mediating relationship of social distance on stigma and social support 
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and that relationship on recovery has not been evaluated.  This would be an additional 
level of theory to investigate when considering the effects of social support on health. 
Social support has been investigated as both moderator and mediator of the 
impact of stress on illness for at least thirty years (Cobb, 1976; Lin, Ensel, Simeone, & 
Kuo, 1979).  Social support buffers stress in vulnerable groups including those with 
mental illness (Strous, Ratner, Gibel, Ponizovsky, Ristner, 2005; Thoits, 1982).  Common 
stressors for mentally ill populations are consistent with other marginalized groups and 
include financial problems, unsafe neighborhoods, unstable housing, discrimination and 
impaired access to resources.  The vulnerability and damage caused by these stressors are 
magnified with the addition of a mental illness that may exacerbate further due to these 
same stressors.  In effect, a cyclical process may occur.  Recovery is meant to target the 
clinical and social aspects of mental illness, but often in the same environment of these 
more structural stress agents.  What is not known is the effect of stressors like financial 
problems and unsafe neighborhoods on recovery belief and use of recovery strategies 
while targeting recovery based services to the consumer and whether social support 
mediates this relationship.  The direct effect of aspects of social support on recovery 
strategies was supported in this study and thus it would be a reasonable assumption to test 
features of social support theory for mediating and/or moderating effects. 
 Empowerment theory. 
 When assessing the impact of empowerment variables in this study, the majority 
of correlations are in the expected direction for bivariate and multivariate analyses.  The 
association of empowerment variables with recovery strategies was not as powerful or 
uniform as predicted, though there were several instances of strong association.  
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Increased perceived empowerment is positively associated with increased endorsement of 
recovery strategies.  Personal empowerment, considering the rigidity of the mental health 
system and funding/reimbursement streams, is inextricably linked with organizational 
and community empowerment.  Empowerment is contextually dependent and alters over 
time due to changes in resource allocation, community programming, provider 
philosophies, and personal successes (Foster-Fishman, Salem, Chibnall, Legler, 
&Yapachai, 1998; Zimmerman, Israel & Schulz, 1992).   
 Described in chapter 2, empowerment is a multi-level construct that includes the 
individual, organizations, community, and society, though the majority of research has 
focused on individual empowerment.  Deficient organizational empowerment can be 
considered a possible explanation for the depressed magnitude of empowerment 
associations with recovery strategies.  The survey accessing self-reported empowerment 
was administered in the community mental health center building.  Preliminary 
qualitative research for this project revealed a general satisfaction with the services 
offered by the center but also a pervasive feeling of disempowerment, lack of choices, 
and concern that the consumer needed to fit the setting and that the setting was inflexible 
to consumer needs (Walby, 2005).  In other words, organizational empowerment, defined 
as a system of services that, from the top down, are responsive to and consider the 
empowerment of each staff member and consumer a high priority, was considered below 
expectation by the consumers.  Interviews with providers and administrators reinforced 
this perception and were frustrating for a staff that can accurately be described as 
compassionate and wanting to provide empowering services, but are constrained by 
systemic and financial limitations.  Thus, reflecting on personal empowerment while 
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seated in a setting of organizational disempowerment could have biased the scores 
downward. 
 Empowerment across disciplines shares the concepts of mobilizing, liberating, 
and transforming (Hur, 2006).  A broader and more ecologically valid understanding of 
empowerment and recovery strategies should include these concepts.  Recovery strategies 
at their core are organizing concepts of personal growth that strive for resource access, 
building supports through mobilization of personal assets, liberation of the constraints of 
mental illness and discrimination, and transforming or improving a sense of self that is 
less restricted by mental illness.  These processes are nurtured and reinforced in peer run 
recovery organizations and need to be enhanced in clinical organizations that strive for an 
empowerment orientation. 
 Along with being multi-level, empowerment is multidimensional as well as 
interactive since power and empowering are inevitably acted out in relationships and are 
based on resource acquisition.  Similar to the discussion on social support, the 
disempowering attributes of unsafe neighborhoods, unsafe housing and financial distress 
embody the multidimensionality of empowerment and include psychological, political 
and sociological components.  A cognitive component of empowerment should be 
incorporated when considering the relationship of the many dimensions and levels of 
empowerment and how these in turn are related to recovery.  Though cognition is a 
individual level experience, this discussion does not suggest that empowerment in the 
context of recovery be relegated to individual level empowerment.  On the contrary, 
recovery, like empowerment, is based on multi-levels and requires the cooperation of 
communities, organizations, families and individuals.  Recovery oriented services, 
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research, and even publishing are subject, in part, to political and power preferences and 
beliefs.   
Returning to the cognitive, the impact on the complex thought process of mental 
illness has not been considered when investigating the relationship of empowerment and 
recovery.  Expanding the theory of empowerment to account for the changes in cognition 
and how altered perceptions accommodate empowerment principles and the desire and 
ability to recover is a logical next step.  Further, the topic of active symptom distortion 
should only be part of the discussion, and a small part at that.  Active symptoms for the 
vast majority of individuals with a mental illness are short term and transient compared to 
times of lucidity and focus.  There is, however, a long term, subtle and pervasive effect of 
mental illness that affects perceptions.  The slight distortions in long term processing 
should be considered when investigating empowerment, recovery and the mentally ill.  
Whether these changes are structural, neurological, psychological, or stress induced is 
irrelevant.  What is hypothesized here is that the experience of empowerment in current 
theory may be different for individuals with mental illness compared to empowering non-
mentally ill and non-symptomatic individuals. 
Stigma theory. 
 There are many different models of stigma and most do not meet the requirements 
to be considered a theory.  However, there are several theories that appear related to 
stigma that can be considered.  For this discussion, attribution theory and modified 
labeling theory will be considered in relation to the findings of this study.  In addition, 
self-stigmatization theory will be evaluated since internalized stigma was measured 
instead of discrimination experiences. 
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In multivariate analysis, the association between stigma variables and recovery 
strategies is not as uniform as noted in bivariate analysis, but several associations are 
strong.  Stigma resistance emerged as the most relevant aspect of stigmatization to 
recovery measured in this study.  A possible interpretation of this relationship 
incorporates the theory of self-stigmatization described by Goffman (1961).  Managing 
the illness requires admitting the illness and coping with external stigmatization.  Even 
more threatening because of its insidious nature is internalized stigma based in part on 
self-disappointment over perceived weakness as well as activation of attributions of 
blame, shame and disgust that were learned before the illness manifested and projected 
outward toward anyone deemed to be abnormal (Corrigan, 2000; Corrigan, Markowitz, 
Watson, Rowan, & Kubiak, 2003).  The person must come to terms with an illness that 
was formally derided in others.  Self-stigma involves focusing on the self what was once 
transmitted to others in the form of negative and discriminatory thoughts, feelings, and 
actions.  Resisting stigma includes resisting self-stigma and caring enough for the self to 
take care of the illness to maximize quality of life.  Self-stigma would benefit from 
additional research, especially for better defining the role of stigma resistance, identifying 
relevant correlates, and how to operationalize the concept for practical usage.  A useful 
first step might be to identify how the OP sample generates and demonstrates stigma 
resistance as they are significantly more likely to endorse resistance and then use the 
information obtained as a basis for improving stigma resistance for individuals labeled 
SMI. 
‘Structural violence’ including imprisonment, economic hardship, lack of 
opportunities to gain and maintain resources, systematic exclusion, homelessness, 
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neighborhood violence and denial of rights are shaped by stigma when conceptualized as 
an ecologic construct operating at individual, organizational, community and societal 
levels (Kelly, 2005).  Aspects of structural violence are then internalized as self-stigma.  
It should be noted that this is similar to the processes described above when considering 
stressors affecting social support and impediments to empowerment.  Together, this 
reinforces the ecological perspective noted in Chapter 2 as relevant to the understanding 
and support for recovery.  Recovery occurs daily in the face of structural violence and 
empowerment barriers.  Returning to and adding the concept of cognition, how an 
individual internalizes these experiences may reinforce internalized stigma or, if 
cognitive processes allow, protect the individual as well.  Thus, internalization of stigma 
is a product of early learning, internalized societal messages regarding the 
unpredictability and undesireability of mentally ill individuals, reinforced by structural 
violence and maintained via paternalistic provision of services to the afflicted.  A 
complete understanding of recovery requires the ecological framework discussed here.  
Internalization of stigma can also be considered via attribution and labeling theory. 
Attribution theory postulates that human beings take into account the possible 
reasons for a person’s behavior or illness and that when the illness is considered self-
induced, e.g., alcoholism, then the person is to blame and will be considered via emotions 
of anger and fear, resulting in coercive and discriminatory behavior (Corrigan, et al, 
2003).  Unfortunately, many hold the opinion that mental illness is self-induced through 
inappropriate lifestyle choices and behaviors.  Thus, attribution theory is an interpersonal 
not intrapersonal theory.  But must it be so? 
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There was no direct measure of attributions in this study.  However, what was 
measured was internalized stigma based on, in all likelihood, the negative internalizations 
of non-mentally ill individuals beliefs projected on the respondents.  In addition, 
however, it is possible that the respondents themselves have internalized negative 
attributes of mental illness and of themselves as mentally ill individuals in the form of 
self-stigma.  Thus, internalized negative attributes of the self may be projected back onto 
the self, increasing self-stigma and the sequela that follow.  This theoretically links self-
stigma and attribution theory in such a way that is testable in the future. 
 The final theoretical construct that is also considered with stigma theory is 
modified labeling theory.  Link (1989) found that psychiatric patients as well as 
community respondents felt that psychiatric patients would be rejected by society and 
that secrecy and withdrawal are necessary to cope with the societal response.  However, 
subsequent research found that the label is rejected if perceived to include an unrealistic 
or negative stereotype that is experienced as foreign to the individual (Camp, Finlay, & 
Lyons, 2002).   Thus, it can be argued that those that do not reject the label have 
internalized the attributes projected by others in the form of self-stigma.  The theme of 
self-stigma noted throughout this chapter is not an accident.  The relative lack of current 
research on self-stigma processes and their relevance to recovery is considered a large 
gap in the current understanding of recovery based services. 
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Additional Factors or Constructs That Might Influence Recovery Expectancy and  
 
Recovery Strategies  
 
 During the course of the analysis and interpretation of the data, three additional 
concepts with apparent relevance to recovery were noted.  These were not investigated in 
this study; however the following discussion will explain each concept and place it in the 
context of recovery.  
 Expressed emotion (EE) is a measure of the amount of emotion displayed to an 
afflicted individual, usually by immediate family members or other close relationships in 
extended family and friendships.   Negative aspects of EE have received, by far, the most 
attention in the literature.  Parents of individuals diagnosed with schizophrenia have 
received the most attention in the EE literature.  There are three agreed upon components 
of EE that include hostility, emotional over-involvement, and critical comments 
(Kreisman & Blementhal, 1995).  High levels of EE are communicated as hostility, 
blame, non-tolerance and critical appraisal of the individual.  Individuals with high-EE 
tend to view the illness as under the person’s control and were more likely to criticize 
behavioral deficits (Weisman, Nuechterlein, Goldstein, & Snyder, 1998).  This is similar 
to attribution theory and self-stigma noted above (Weisman, Nuechterlein, Goldstein, & 
Snyder, 1998).  For individuals with schizophrenia, life satisfaction and quality of life 
were improved when their parents had low-EE and engaged in mutually supportive 
interactions (Greenberg, Knudsen, Aschbrenner, 2006).   
 Recovery may be influenced by the degree to which an individual is exposed to 
EE.  Expressed emotion has been linked to increases in active symptoms and this study 
established that active symptoms reduce belief in recovery and endorsement of recovery 
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strategies (Pourmand, Kavanagh, & Vaughan, 2005).  High EE families express less 
emotional support though there may be little difference in instrumental support, though 
when offered the support is often given grudgingly, maximizing shame.  Reinforcement 
of self-stigma is also theoretically feasible with high EE families though there is no 
empirical support for this assertion.  Indeed, the simultaneous investigation of social 
support, stigma, and empowerment with EE has received surprisingly little attention.  
Thus, expressed emotion is discussed here as a potentially useful avenue of future 
research to identify how social support affects recovery and how dissupport, enacted as 
EE, can inhibit recovery. 
 Insight is the second additional construct to be briefly considered.  Previous 
research has demonstrated that active illness management is strongly associated with 
level of insight (Watson, et al., 2006), especially medication adherence.  It can be 
hypothesized that sufficient insight into the presence of mental illness and the 
accompanying sequela would lead to increased belief in the expectation of recovery, 
leading to active use of recovery strategies.  However, depending on the quality and 
strength of internalized illness attributions, the opposite effect is possible, with decreased 
belief in recovery and less strategy use.   
Insight in relation to mental illness is defined as illness awareness, belief in the 
necessity of intervention (professional, peer and/or personal), and the attribution of 
symptoms to an illness process that is responsive to intervention.  However, insight is 
only weakly responsive to psychosocial interventions (Startup, Jackson, & Startup, 2006), 
and there is no evidence that belief in recovery can be ‘taught’ with any more success.  
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Nevertheless, it appears reasonable that recovery strategies might be the core concepts for 
recovery based programs that operationalizes and teaches the ‘how to’ of recovery. 
 Quality of life is the final construct that may influence recovery and that was not 
included in this study.  Measures of quality of life and recovery pathways are positively 
associated (Corrigan, et al., 1999).  Returning to a stable level of baseline functioning and 
then improving quality of life are basic tenets of the recovery movement and indicates a 
conceptual link between quality of life and recovery (Young & Ensing, 1999).  Quality of 
life has also been linked to self-esteem, empowerment, and social support, all sub-groups 
of the most highly associated domain, the social domain, in this study (Guraje, Harvey, & 
Herman, 2004; Rogers, Anthony, & Lyass, 2004; Young & Ensing, 1999).  A belief in 
one’s ability to recover may be, in part, a reflection of current quality of life as an 
indicator of how life is and thus how life may remain.   
Quality of life measurement has been measured frequently in the investigation of 
severe mental illness.  However, it has only received limited attention in the recovery 
literature.  Low self-esteem was found to be a risk factor for impaired quality of life for 
individuals that had clinically recovered from psychosis (Gureji, Harvey, & Herman, 
2004).  Clinical recovery was defined as complete amelioration of positive psychotic 
symptoms and the continued presence of negative symptoms.  Factors of social support, 
stigma, insight and other aspects of empowerment were not included in this study.  This 
limits interpretability from the perspective of the recovery movement and is 
representative of the more limited and targeted studies that address recovery and quality 
of life simultaneously. 
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To summarize, this section was included to draw attention once again to the 
complexity of recovery and, despite all attempts to develop a comprehensive study, the 
potential covariates and constructs not included in this study.  This is a form of limitation 
of this study, with other limitations the subject of the next section. 
Study Limitations 
 There are several key limitations to this study that affects both internal validity 
and generalizability.  When appropriate, other limitations were noted in previous 
sections.  First is the cross-sectional design of the study that limits understanding of the 
directionality of effects.  Next, the measurement of recovery expectancy lacked rigor, 
which may have contributed to the lack of significant results in multivariate analysis.  
Specific threats to internal validity are limitations of the data collection instruments, 
potential misclassification of respondents to the severely mentally ill (SMI) and 
outpatient (OP) samples, and the effect of symptom levels on attentional behavior and 
cognitive processing of respondents during data collection.  Limitations to 
generalizability (external validity) include the representativeness of the study sample and 
the limited geographic area where the study was located. 
 The direction of effects cannot be directly observed in a cross-section design.  
Though in some cases a reasonable argument can be made that, for instance, symptoms 
were present before a type of medication was prescribed, in most cases the direction of 
association can be determined, but not the question of causality.  Other study designs are 
required to test these results for direction and longevity of effects. 
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Limitations to measurement of recovery expectancy. 
 Recovery expectancy was introduced as a new concept in understanding the 
concept of recovery.  When conceptualized, it was expected to perhaps have a limited 
relationship with endorsement of recovery strategies.  Similarly, the concept was not 
expected to be strongly related to the three independent variables domains.  However, the 
results outlined in Chapter 4 indicate that the concept is strongly related in bivariate 
analysis with recovery strategies and independent variables.  However, the dichotomous 
measure of recovery expectancy does not provide sufficient variance of what appears to 
be a complex construct.  This could explain, in association with the independent 
variables, the lack of significant results in multivariate analysis.  Thus, recovery 
expectancy results should be carefully considered in light of the somewhat crude measure 
of the construct.  There is sufficient evidence to consider the construct for further 
investigation into its definition and conceptualization. 
 Limitations to instrument choice and availability. 
 The instrument measuring recovery expectancy was developed specifically for 
this study.  It has the benefit of being simple and straightforward, but did not measure 
explicitly what each participant believed recovery means to them.  Thus, what a 
respondent was considering when indicating a non-endorsement of personal recovery 
may be due to unrealistic expectations of oneself, a belief that mental illness is never 
cured or controlled, inability to attain wealth or education, or many other possible 
explanations.  Understanding why individuals do not believe they will recover and using 
this information to develop categories of recovery of social, clinical, service related or 
other groupings would allow for targeted program development and unity between 
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professional and peer run recovery programs, increasing the chance of recovery program 
success at a population level. 
 Recovery expectancy was measured as a dichotomous variable that lacks 
variance.  Expectancy is likely a complex construct that the simple measure used in this 
study does not sufficiently represent.  Thus, the results from the analyses involving 
recovery expectancy should be considered with caution. 
 The Personal Vision of Recovery Questionnaire (PVRQ) has not been used 
outside of the study that developed the instrument.  It was chosen because it was one of 
few measures available at the design stage of the study and that it was developed in 
consensus with individuals recovering from mental illness, an a priori critical point when 
seeking instruments for this study.  The lack of additional exposure and evidence of 
validity should be acknowledged as a limitation to measuring the primary criterion of the 
study.  Another reason the instrument was chosen was that each question in the PVRQ 
directly references the recovery of the individual by stating that the content of the 
question is relevant to ‘my recovery’.  This was different from the question format used 
in the Recovery Assessment Scale (RAS) where each question references the individual 
in an “I” statement but does not mention recovery specifically in any question.  The goal 
was to offer both personalized and more general question formats to better capture the 
breadth of recovery belief and experience.  The RAS has had more exposure in 
subsequent research and was included in a recent list of recovery measurement 
instruments with proven validity where the PVRQ was not (Campbell-Orde, Chamberlin, 
Carpenter, & Stephen, 2005; Corrigan, et al. 2005).  The RAS has also been used to 
validate a more recently developed recovery instrument (Jerrell, Cousins, & Roberts, 
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2006) and is considered to be a valid and generalizable instrument in the field of recovery 
research and measurement.  Like the PVRQ, it has the benefit of being developed in 
cooperation with individuals recovering from mental illness.   
 The Support and Community Connectedness Survey (SCCS) was developed 
specifically for this study and has not been independently validated.  Though other social 
support surveys do exist, they were not viewed as specific enough for tapping into unique 
social support, trust, and community connection needs and experiences of the mentally ill 
population.  The development of the instrument did allow for a thorough reliability 
analysis using both internal consistency and test re-test correlation.  However, there was 
not sufficient opportunity for a thorough validity analysis, limiting the confidence in the 
results of the analysis. 
 The Internalized Stigma of Mental Illness (ISMI) scale was also not validated 
beyond the initial study that developed the scale.  This, again, is an important limitation 
to consider when interpreting study findings.  Other scales were available but tended to 
measure discrimination and stigmatizing experiences not specific to mental illness or, in 
some cases, specific to mental illness, for instance the Stigma Discrimination Survey 
(SDS) (Wahl, 1999), but concentrated on how many discrimination and stigmatization 
experiences each respondent recalled.  Knowing how often or to what degree an 
individual has experienced discrimination does not indicate how such experiences are 
internalized and how they affect the recovery beliefs and strategies of the respondent, a 
focus considered of more importance in this study.  Thus, the ISMI was selected as it was 
designed to measure the internalized response to stigma and discrimination. 
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 The final measurement concern pertains to domain 3 (the service domain).  The 
service domain was analyzed with less rigor compared to domains 1 and 2.  In measuring 
for service factors, there was considerable care taken in determining which services, how 
long the individual was involved with each service and the number of contact hours per 
month for each service.  The respondent’s information was validated in chart reviews and 
found to be approximately 99% accurate.  However, the choice was made to utilize only 
the summary measures of number of services, average satisfaction, and average contact 
hours per month in order to control the number of independent variables to maximize 
efficiency of statistical power.  This choice may account for the lack of significant 
associations noted with the exception of service satisfaction.   
 Limitations due to respondent characteristics. 
 Measuring by self-report is difficult under ideal conditions due to recall bias and 
other confounding factors.  Adding the potentially distracting and limiting experience of 
psychiatric symptoms compounds the concern.  Additionally, many of the respondents 
were prescribed one or more psychotropic medications, often at high dosages.  Several 
respondents talked freely about active symptoms they were experiencing and life 
stressors that they were managing.  Needing to redirect respondents back to survey 
response was reported consistently by the student assistants and experienced by the lead 
researcher as well.  No formal data were kept to quantify this potential issue but the 
anecdotal information indicates that this might have been an issue beyond what is 
normally experienced in survey research.  This concern was likely offset to a degree by 
the empathic and non-pressured atmosphere facilitated by the research team but it is 
important to acknowledge that the study design did not account for perceptual distortions 
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experienced by any respondent.  This is a common dilemma for research with individuals 
diagnosed with a mental illness and all effort was made to provide empathic 
communication for rapport building and adequate time required for a non-stressful 
experience (Dworkin, 1992). 
 Limitations to generalizability. 
 One issue of generalizability is the representativeness of the study sample to the 
population it is tasked to represent.  This sample represents individuals with mental 
illness that are in some phase of recovery but that are also receiving clinical and/or 
supportive services in a community mental health center setting.  It is likely that 
individuals with mental illness that are working for recovery with no assistance from or 
belonging to a clinical setting might have significant differences from those that are 
receiving services.  Further, nearly all data were collected in the community mental 
health center setting and this could have affected the responses of the respondents. It is 
reasonable to assume that the responses that they might have given in their home or some 
other setting might have been different from the responses provided in the clinical setting.  
 The study location was a semi-rural county in the southeastern United States that 
has limited minority representation, mainly middle level incomes, and is proximate to a 
large metropolitan area but without readily available transportation between the County 
and the city.  Further research will be required to see if the results of this study are 
replicated in other geographic locations with a more diverse population and 
socioeconomics. 
 Finally, and this is both a strength and a limitation, the inclusion of individuals 
that were not labeled severely mentally is unique to this study and represents an 
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expansion of the recovery concept.  However, the similarity of the OP and SMI samples 
on key clinical domain 1 variables, for instance bipolar disorder in the diagnostic 
variable, the majority of the symptom scales, familial mental illness and others, indicates 
a parallel between the samples that was unexpected.  Because of this, it cannot be stated 
with certainty whether these samples are actually two samples or whether this degree of 
likeness is consistent in other clinical settings.  This should not be overstated as a major 
concern, considering the number of other variables in which there were significant 
differences, but caution is still suggested.  In addition, the majority of results are reported 
based on belief in recovery and degree of endorsement of recovery strategies, and thus 
crossover the two samples and are unaffected by the similarity between OP and SMI.  At 
worst, this does limit interpretation of results until the question of one or two samples is 
fully clarified.   
 
Study Strengths 
 A primary strength of this study was the research design that virtually eliminated 
missing data.  Missing data was a design issue of paramount importance during the 
formative stage of the study.  Minimal missing data increases confidence in internal 
validity and was a key factor in training of the research team (see Appendix D).  Each 
research assistant role-played the data collection process from greeting to incentive 
multiple times with emphasis on double checking each instrument as it was completed to 
quickly locate missing values and to ask the respondent to reconsider a response.  In 
addition, if a value was found to be missing and the deletion was not intentional, the staff 
was trained to help the respondent review the questions from that point forward to ensure 
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that an incorrect value wasn’t populating the rest of the questions.  Because of the 
exploratory nature of this study, it was emphasized how missing data hinders the ability 
to explain and understand the phenomena under investigation.  Data may be missing due 
to the study respondents, the study design, or the interaction of the study design and the 
respondents (McKnight, McKnight, Sidani, & Figueredo, 2007).  Any of these can affect 
sample size, reducing statistical power and casting doubt on results, and potentially result 
in poor representation of the population studied.   
 An additional strength of this study is the capture of multiple domains of possible 
covariates that are contextually representative of the recovery literature and related 
concepts, i.e. reintegration literature.  As far as can be determined, this is the first study to 
explore multiple clinical, social and service variables for effects on recovery strategies 
simultaneously.  Other studies have included a limited number of clinical variables, 
usually represented by a short symptom survey (Corrigan, et al., 2005).  Such a limited 
perspective was not deemed adequate for understanding the complexity of recovery.  The 
results of this study indicates that multiple significant direct effects were found for 
clinical and service factors, with the domain 2 social factors (stigma, social support, 
empowerment) being the domain with the strongest associations.  However, that all 
domains were significantly represented serves to highlight the complexity of mental 
illness recovery while suggesting that social factors receive increased attention. 
 What may be another first was the introduction of the belief in personal recovery, 
what was titled recovery expectancy throughout the study, into relevance as an additional 
concept influencing recovery.  Although the factors that influence recovery expectancy 
were not significantly detected, the association between expectancy and each strategy is 
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intriguing and warrants further theoretical and empirical investigation.  Belief in an 
ultimate positive outcome motivates individuals to accomplish many life tasks other than 
recovery from mental illness, or other illnesses for that matter.  Education, employment, a 
good relationship and other goals are based, in part, on believing that the goal is 
worthwhile and the energy and resources worth investing.  Preliminary qualitative 
research that helped direct the development of this study indicated that individuals with 
mental illness seek to find meaning and direction in their lives and work to limit the 
effect of the illness while at the same time growing outside of the illness (Walby, 2003b).  
These are all facets of what the recovery movement has described as necessary for an 
individual to be walking a recovery path.  In fact, a consistent complaint of the 
respondents in the qualitative studies was the focus on symptom reduction and illness 
management that clinical services and professional relationships tended toward.  Thus, 
expectancy has been touched on in other qualitative research (Chadwick, 1997; Corrigan, 
Calabrese, Diwan, Keogh, Keck, & Mussey, 2002), but has not been investigated 
systematically. 
 A final strength of this study was the expansion of the recovery concept to include 
individuals with less severe mental illness.  Noted in the limitations section above, a 
significant difference between the OP and SMI samples was not obvious within the 
clinical domain.  However, there were significant differences in the social and service 
domains.  Although the majority of those who report they will recover were in the OP 
sample, it is important to note that there were also individuals in the SMI sample that 
believed they would recover while some individuals in the OP sample believed that they 
would never recover.  Expanding the recovery concept to include more variance in illness 
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would increase resources available for the focus on recovery while also reducing the 
isolation of individuals with a severe mental illness and allowing mental illness to be 
thought of as a continuum based not only on clinical impairment but also on level of 
support, degree of empowerment, and other factors shown to be relevant in this and other 
studies. 
 
Implications for Public Health 
 Mental illness remains a highly prevalent category of illness in the United States, 
contributing to substantial morbidity and increased mortality (Miller, Paschall, & 
Swendsen, 2006; Wasylenki, 1994).  Due to the high prevalence of individuals with 
mental illness, as well as multilevel stigma ranging from individual acts of stigmatization 
to societal stigma, and lack of parity in insurance coverage, many individuals often go 
without treatment.  This increases the burden of disease in the population and, via co-
occurring disorders, negatively affects medical conditions in need of treatment and 
prevention efforts relevant to public health as a whole.  There has been considerable 
effort to bring worthwhile programs to individuals in need.  Clinical and research 
professionals have worked in unison to develop and test evidence-based programs that 
are effective for many types of mental illness (Drake, Merrens, & Lynde, 2005).  
However, evidence-based programs are often poorly disseminated and/or implemented 
with little fidelity.  The gaps in evidence-based program access as well as the need for 
community based supports are being targeted by the consumer recovery and 
empowerment movement.  The recovery movement has begun to demonstrate empirical 
support for peer run programs, supportive services (e.g., supported employment and 
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housing), and self help organizations.  The artificial divide between professional and peer 
run services is being challenged in some locations and with greater consistency (Nelson, 
Lord, Ochocka, 2001).  The research detailed in this document adds to the recovery 
literature and consumer movement by contributing to the literature targeting the health of 
a large subset of the population dealing with increased morbidity and risk of mortality 
due to mental illness. 
 The social domain in this research effort is the most highly associated domain for 
virtually all the recovery strategies when taking into account both the number of 
independent variables in significant association with the strategies and the strength of the 
relationships.  This implication of non-clinical factors endorsed by individuals in 
recovery both supports the consumer perspective as valid in conjunction with clinical 
services and is consistent with the emphasis on social factors when considering public 
health’s contribution to population health.   
 Public health research into social factors often targets social capital and/or social 
support.  Disagreement continues on whether bonding social capital is associated with 
individuals and their social networks or whether social capital is a collective resource 
associated with communities (Poortinga, 2006).  However, there is agreement that social 
support and social capital are related and that both lead to better health outcomes 
(Berkman & Clark, 2003; Kawachi & Berkman, 2001).  Indeed, a comparison of 
prevention efforts that target social support and community cohesion or connectedness 
fair well against more individualized health behavior approaches when targeting 
depression or heart disease (Leskela, Rytsala, Komulainen, Melartin, Sokero, Lestela-
Mielonen, 2006; Lomas, 1998).  Poor social ties and support are a consistent risk factor 
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for morbidity related to depression and heart disease (Everson-Rose & Lewis, 2005).  In 
this study, community connectedness was found to be significantly associated with 
effective illness management, positive future orientation, recognizing support and 
symptom eradication.  This research also found that support from family members, 
providers, intimate partners and friendships are strongly associated with sanctioning of 
recovery strategies.  It is a reasonable assumption that such support is ameliorative for 
active disease processes as well as preventative for relapse or onset of disorder.  Thus, 
this research is consistent with public health’s focus on community intervention and 
provision of social support. 
 Public health’s focus on social justice parallels the empowerment focus of the 
recovery movement, with social justice considered a macro-level organizing construct 
and empowerment focused more on individual or organizational development (Fondacaro 
& Weinberg, 2002).  The recovery movement views empowerment as a central concept 
and is dedicated to operationalizing the concept and making it more accessible, and 
teachable, to individuals with mental illness.  This reflects the previously mentioned 
relationship between population level social capital and individual or familial level social 
support.  Whereas social support is easier to target programmatically compared to social 
capital, empowerment is easier to target then social justice. One aspect of empowerment 
that is strongly associated with recovery strategies in this research is self-esteem/self-
efficacy.   Optimism and personal power are also significantly associated.  Together, 
empowerment factors are strongly correlated with all six of the recovery strategies in this 
study, resonating with public health’s social justice priority.   
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 Public health consistently attempts to champion health and resource access for all 
individuals in need.  This goal is in part what stimulated the decision to investigate the 
relevance of recovery for individuals not labeled severely mentally ill.  Recovery services 
increase social contact, provide emotional and, when possible, instrumental support, 
encourages self-direction and empowerment, and brings together diverse responses for 
responding to symptoms, suicidal behavior and other potential aspects of living with 
mental illness.  Though individuals in this study from the OP sample have been 
hospitalized less in their lifetime, have greater levels of employment, and are less likely 
to have been abused as children, they are as symptomatic as the SMI sample, are not 
significantly different in education or income, and are as likely to have been hospitalized 
for psychiatric reasons in the last year.  Thus, there is impaired quality of life for both the 
SMI and the OP samples.  However, individual’s that have reduced quality of life but are 
not labeled SMI usually do not have access to a recovery network or program.  In fact, 
the mental health center that supported this research has a recovery program in 
development that will focus on empowerment and assistance to consumers, but only SMI 
consumers will be eligible.  The results of this study supports that the concept of recovery 
is relevant to individuals not labeled SMI.  More importantly, the distinction between 
belief and non-belief in personal recovery crosses the SMI and OP sample distinction 
reinforcing the spectrum conceptualization of mental illness.  What is not known is 
whether exposure to recovery related services would assist the less severe individual in 
overcoming the debilitating aspects of mental illness, a potentially productive focus of 
continued research.   
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 A counter-argument is that the SMI label is itself a negative label that may add to 
the need for specialized recovery services.  Further, individuals that do not meet the 
criteria for the SMI label may resent the implication of receiving the same services as 
those with the label.  Anecdotally, individuals from the OP sample often verbalized that 
they enjoyed helping the mental health center and others dealing with symptoms whereas 
the SMI sample often expressed hope that participation in the research would be helpful 
to themselves and help to provide more resources for their needs.  Discussion during 
team meetings of the research team revealed that this was consistent in the experience of 
each team member.  So, while individuals in the OP sample share some characteristics 
with the SMI sample, there is no indication that they would agree that recovery based 
services would be relevant to them. 
 A final implication for public health is that this study adds to the knowledge 
needed for developing a more comprehensive recovery program.  Recovery program is 
defined here as a program that focuses on clinical, social, and service factors as well as 
the independent peer service process more typical of the recovery movement.  What is 
needed is a comprehensive, logically and scientifically developed program that embraces 
the best of both sides of what is the same coin, a melding of clinical and consumer based 
recovery programming.  Noted above, there are researchers that are challenging the 
division between clinical/professional and peer run services, considering both to be 
correct and complimentary if given the opportunity.  There are clearly clinical issues that 
must be taken into consideration, with the consumer having the freedom to choose a 
course of treatment and even to reject professional assistance if they choose a complete 
peer assisted or even a lone path.  The option to reassess and engage in services as part of 
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a team with professionally trained service providers must remain open, however.  This 
study will hopefully make a professional aware of the important social support, 
stigmatization, and empowerment facets of recovery as well and promote a consumer as 
expert model that increases team work between the social and professional network of 
each consumer. 
 
Suggestions for Future Research 
 Suggestions for research include both a broader research agenda targeting 
recovery and associated constructs and ‘next steps’ for the current study.  In addition, 
throughout this chapter several brief comments were made suggesting a new course of 
research or an additional analysis planned with the data collected. 
Future research should utilize multiple research designs that target the recovery 
construct as well as covariates that have evidence supporting a relationship with 
recovery.  Though not used to the extent it used to be, the use of case study methodology 
could be useful for understanding the subtleties of recovery as well as for tracking 
changes in recovery expectancy and use of recovery strategies over the course of 
different disorders, all while collecting and understanding the contextual data that appears 
vital for a complete understanding of recovery.  For instance, though a particular 
diagnosis was seldom significant in the current study, no attempts were made to validate 
the diagnosis, review diagnostic history, or assess the symptom scales in relation to 
diagnostic criteria.  Thus, diagnosis might play a more powerful role than detected in this 
study.  Nested case studies tend to smaller sample sizes than survey research, but a larger 
sample could be used to investigate diagnosis and other factors with greater depth.  Case 
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studies could be aggregated and supported with qualitative research targeting recovery.  
Though there is some qualitative research publishede, there is certainly room for 
addressing recovery qualitatively and learning from the individuals engaged in their own 
recovery.  In addition, policy analysis from the federal level on down to local would be 
useful to more fully understand how policy is being developed in support of recovery as 
well as how it is implemented.  Further, evaluation of current recovery programs with a 
mixed focus on consumer internalization and change within the recovery model as well 
as how service providers are embracing and implementing the model would add 
additional information for a thorough understanding of recovery. 
 Information derived from qualitative and case study methodology, policy analysis 
and evaluations of current program efforts could be used to identify correlates of 
recovery as well as aid in the design of evidence-based recovery programs.  Further, 
larger studies with greater power in order to identify potential mediators and moderators 
could elaborate on the strategic information obtained in other studies and analyses.  
Finally, more sophisticated research designs targeting individual, organizational (clinical, 
consumer run, social welfare or support), community and policy variables of interest 
utilizing multilevel modeling such as HLM or similar analyses that utilizes nested data 
would capture both the individual and contextual information. 
An immediate improvement to the current study would be to repeat the study in a 
different sample population using a longitudinal framework.  Currently, there are no 
published studies that track recovery strategies or pathways overtime.  As noted, this 
might also be the first study to measure recovery expectancy.  Assessing expectancy 
longitudinally would be of interest to detect the clinical, social and service factors that 
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associate significantly with expectancy and to understand if these factors change over 
time.  This is especially important considering none of the independent variables in this 
study were significantly associated with expectancy. 
 Prior to the longitudinal study discussed above, an in-depth, qualitative 
investigation of the operationalization of recovery beliefs and how strategies are 
behaviorally enacted would offer opportunities to improve the choice of independent 
variables to be addressed as well as possibly suggest other, more contextually specific, 
recovery strategies.  In addition, effort should be made to categorize the reasons that 
individuals do not believe they will recover.  A stratified sample utilizing a semi-
structured interview schedule of the current study, stratified by expectancy (yes/no) and 
degree of strategy endorsement (high/medium/low), would be one way to structure the 
sampling for the qualitative study.  The use of mixed methods either simultaneously or 
sequentially would, as noted in the discussion above, include important contextual factors 
and capitalize on the strengths of both qualitative and quantitative research paradigms. 
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Appendix A 
 
 
Measurement Tools 
 
 
Recovery Expectancy Checklist (REC) 
Recovery Assessment Scale (RAS) 
Personal Vision of Recovery Questionnaire (PVRQ) 
Symptom Checklist 90-Revised (SCL-90-R) (Copyrighted, unable to duplicate)  
Support and Community Connection Survey (SCCS) 
Empowerment Survey (ES) 
Internalized Stigma of Mental Illness Scale (ISMI) 
Service Satisfaction Questionnaire (SSQ) 
History and Demographic Form (HDF) 
Chart Abstraction Tool 
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REC 
 
 
Age in Years ____________________ Gender _________________________ 
 
Test Date ____________________________  
  MM/DD/YY 
 
 
Please answer the following four (4) questions by indicating the response that best fits 
your personal beliefs and choices on the subject of recovery from mental illness. 
 
 
1.  Do you think that recovery from mental illness will ever be possible for 
you?  
YES    NO 
 
 
2.  To what degree do you think you will eventually recover? 
 
__1_____________2______________3_______________4_______________5____ 
None               A Little        Somewhat       A Lot           Completely 
 
 
3.  What will ‘recovery’ mean to you?  Please select all that apply… 
  
a. I will be without mental illness a.  ________ 
b. I will be symptom free b.  ________ 
c. I will be able to function, even with some symptoms c.  ________ 
d. I will be able to stay out of the hospital/crisis unit d.  ________ 
e. I will be off psychiatric medications e.  ________ 
f. I will be able to work full time f.  ________ 
g. I will be able to work part time g.  ________ 
 
3. h.  In a few brief sentences, please describe in your own words what ‘recovery’ 
means to you… 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
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4.  Which of the following are important for your recovery?  Please check all 
that apply. 
 
a. Contact with my primary provider/case 
manager/therapist   
a.  ________ 
b. Contact with my psychiatrist or nurse practitioner b.  ________ 
c. Contact with other individuals with mental illness c.  ________ 
d. Psychiatric medication d.  ________ 
e. Parents e.  ________ 
f. Siblings (brothers and sisters) f.  ________ 
g. Other family g.  ________ 
h. Spouse or significant other h.  ________ 
i. Friends i.  _________ 
j. School/Attending class/Education j.  _________ 
k. Learning about or studying mental disorders k.  ________ 
l. Work (paid) l.   ________ 
m. Work (volunteer) m.  ________ 
n. Art or other creative expression n.  ________ 
o. Reading o.  ________ 
p. Quiet time/time alone p.  ________ 
q. Exercise or following an exercise program q.  ________ 
r. Eating a healthy diet r.  ________ 
s. Spirituality (NOT attending services, religious 
functions) 
s.  ________ 
t. Religious affiliation (e.g. attending services) t.  ________ 
u. Meditation, relaxation or other similar experience u.  ________ 
v. Travel v.  ________ 
w. Being hopeful w.  ________ 
x. Having choices in different aspects of life 
 
x.  ________ 
y1. Other y1.  
__________________________________________________ 
y2. Other y2.  
__________________________________________________ 
y3. Other y3.  
__________________________________________________ 
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RAS 
 
Age in Years ____________________ Gender _________________________ 
 
Test Date ____________________________  
  MM/DD/YY 
 
I am going to read a list of statements that describe how people sometimes feel about 
themselves and their lives.  Please listen carefully to each one and indicate the response 
that best describes the extent to which you agree or disagree with the statement.  For 
each of these statements, please indicate whether you strongly disagree (1), disagree 
(2), not sure (3), agree (4), or strongly agree (5) with these statements. 
 
 
  Strongly 
Disagree 
 
Disagree Not 
Sure 
Agree Strongly 
Agree 
1 I have a desire to succeed 
 
1 2 3 4 5 
2 I have my own plan for how to 
stay or become well 
 
1 2 3 4 5 
3 I have goals in life that I want to 
reach 
 
1 2 3 4 5 
4 I believe I can meet my current 
personal goals 
 
1 2 3 4 5 
5 I have a purpose in life 
 
1 2 3 4 5 
6 Even when I don’t care about 
myself, other people do 
 
1 2 3 4 5 
7 I understand how to control the 
symptoms of my mental illness 
 
1 2 3 4 5 
8 I can handle it if I get sick again 
 
1 2 3 4 5 
9 I can identify what triggers the 
symptoms of my mental illness 
 
1 2 3 4 5 
10 I can help myself become better 
 
1 2 3 4 5 
11 Fear doesn’t stop me from living 
the way I want to 
 
 
1 2 3 4 5 
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  Strongly 
Disagree 
 
Disagree Not 
Sure 
Agree Strongly 
Agree 
12 I know that there are mental 
health services that do help me 
 
1 2 3 4 5 
13 There are things that I can do that 
help me deal with unwanted 
symptoms 
 
1 2 3 4 5 
14 I can handle what happens in my 
life 
 
1 2 3 4 5 
15 I like myself 
 
1 2 3 4 5 
16 If people really knew me, they 
would like me 
 
1 2 3 4 5 
17 I am a better person than before 
my experience with mental 
illness 
 
1 2 3 4 5 
18 Although my symptoms may get 
worse, I know I can handle it 
 
1 2 3 4 5 
19 If I keep trying, I will continue to 
get better 
 
1 2 3 4 5 
20 I have an idea of who I want to 
become 
 
1 2 3 4 5 
21 Things happen for a reason 
 
1 2 3 4 5 
22 Something good will eventually 
happen 
 
1 2 3 4 5 
23 I am the person most responsible 
for my own improvement 
 
1 2 3 4 5 
24 I’m hopeful about my future 
 
1 2 3 4 5 
25 I continue to have new interests 
 
1 2 3 4 5 
26 It is important to have fun 
 
1 2 3 4 5 
27 Coping with my mental illness is 
no longer the main focus of my 
life 
 
1 2 3 4 5 
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  Strongly 
Disagree 
 
Disagree Not 
Sure 
Agree Strongly 
Agree 
28 My symptoms interfere less and 
less with my life 
 
1 2 3 4 5 
29 My symptoms seem to be a 
problem for shorter periods of 
time each time they occur 
 
1 2 3 4 5 
30 I know when to ask for help 
 
1 2 3 4 5 
31 I am willing to ask for help 
 
1 2 3 4 5 
32 I ask for help when I need it 
 
1 2 3 4 5 
33 Being able to work is important 
to me 
 
1 2 3 4 5 
34 I know what helps me get better 
 
1 2 3 4 5 
35 I can learn from my mistakes 
 
1 2 3 4 5 
36 I can handle stress 
 
1 2 3 4 5 
37 I have people I can count on 
 
1 2 3 4 5 
38 I can identify the early warning 
signs of becoming sick 
 
1 2 3 4 5 
39 Even when I don’t believe in 
myself, other people do 
 
1 2 3 4 5 
40 It is important to have a variety 
of friends 
 
1 2 3 4 5 
41 It is important to have healthy 
habits 
 
1 2 3 4 5 
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PVRQ 
 
Age in Years ____________________ Gender _________________________ 
 
Test Date ____________________________  
  MM/DD/YY 
 
We are interested in your beliefs about your own recovery from mental illness.  By 
recovery we mean the way you have learned to cope with your mental illness and go 
forward with your life.  Please answer all the questions, whether or not you consider 
yourself to be in recovery right now. 
 
Please read each of the following statements.  Circle the rating that most closely  
matches your opinion:  Strongly Agree (5); Agree (4): Neither Agree nor Disagree (3); 
Disagree (2); or Strongly Disagree (1) 
 
 
1.  Spirituality is a part of my recovery 
 
          5  4    3       2   1____ 
      Strongly         Agree        Neither Agree          Disagree      Strongly 
        Agree                 nor Disagree                               Disagree 
 
2.  I am responsible for my own recovery 
 
          5  4    3       2   1____ 
      Strongly         Agree        Neither Agree          Disagree      Strongly 
        Agree                 nor Disagree                               Disagree 
 
3.  People who expect very little of me interfere with my recovery 
 
          5  4    3       2   1____ 
      Strongly         Agree        Neither Agree          Disagree      Strongly 
        Agree                 nor Disagree                               Disagree 
 
4.  Recovery means becoming satisfied with my life 
 
          5  4    3       2   1  
      Strongly         Agree        Neither Agree          Disagree      Strongly 
        Agree                 nor Disagree                               Disagree 
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5.  Hope is important for my recovery 
 
          5  4    3       2   1____ 
      Strongly         Agree        Neither Agree          Disagree      Strongly 
        Agree                 nor Disagree                               Disagree 
 
6.  Being diagnosed correctly is necessary for my recovery 
 
          5  4    3       2   1  
      Strongly         Agree        Neither Agree          Disagree      Strongly 
        Agree                 nor Disagree                               Disagree 
 
7.  Family support is important for my recovery 
 
          5  4    3       2   1____ 
      Strongly         Agree        Neither Agree          Disagree      Strongly 
        Agree                 nor Disagree                               Disagree 
 
8.  Sticking up for clients’ rights is a part of my recovery 
 
          5  4    3       2   1____ 
      Strongly         Agree        Neither Agree          Disagree      Strongly 
        Agree                 nor Disagree                               Disagree 
 
9.  Having something meaningful to do is important for my recovery 
 
          5  4    3       2   1____ 
      Strongly         Agree        Neither Agree          Disagree      Strongly 
        Agree                 nor Disagree                               Disagree 
 
10.  Helping others is part of my recovery 
 
          5  4    3       2   1____ 
      Strongly         Agree        Neither Agree          Disagree      Strongly 
        Agree                 nor Disagree                               Disagree 
 
11.  Asking for help is a part of my recovery 
 
          5  4    3       2   1____ 
      Strongly         Agree        Neither Agree          Disagree      Strongly 
        Agree                 nor Disagree                               Disagree 
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12.  I know people who are recovering from problems similar to mine 
 
          5  4    3       2   1____ 
      Strongly         Agree        Neither Agree          Disagree      Strongly 
        Agree                 nor Disagree                               Disagree 
 
13.  Recovery means my symptoms will be easier to control 
 
          5  4    3       2   1____ 
      Strongly         Agree        Neither Agree          Disagree      Strongly 
        Agree                 nor Disagree                               Disagree 
 
14.  Recovery means I will be free of symptoms 
 
          5  4    3       2   1  
      Strongly         Agree        Neither Agree          Disagree      Strongly 
        Agree                 nor Disagree                               Disagree 
 
15.  Self-help groups are important to my recovery 
 
          5  4    3       2   1  
      Strongly         Agree        Neither Agree          Disagree      Strongly 
        Agree                 nor Disagree                               Disagree 
 
16.  Recovery means getting more control of my life 
 
          5  4    3       2   1  
      Strongly         Agree        Neither Agree          Disagree      Strongly 
        Agree                 nor Disagree                               Disagree 
 
17.  The cause of mental illness is not important for my recovery 
 
          5  4    3       2   1  
      Strongly         Agree        Neither Agree          Disagree      Strongly 
        Agree                 nor Disagree                               Disagree 
 
18.  At times, treatment against my wishes is necessary for my recovery.  
For example, involuntary hospitalization, forced medication, or community 
probate 
 
          5  4    3       2   1____ 
      Strongly         Agree        Neither Agree          Disagree      Strongly 
        Agree                 nor Disagree                               Disagree 
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19.  Support from a special person, such as a spouse or partner, is important 
for my recovery 
 
          5  4    3       2   1____ 
      Strongly         Agree        Neither Agree          Disagree      Strongly 
        Agree                 nor Disagree                               Disagree 
 
20.  Recovery means I will not be mentally ill anymore 
 
          5  4    3       2   1  
      Strongly         Agree        Neither Agree          Disagree      Strongly 
        Agree                 nor Disagree                               Disagree 
 
21.  I am convinced that medication can help me to recover 
 
          5  4    3       2   1  
      Strongly         Agree        Neither Agree          Disagree      Strongly 
        Agree                 nor Disagree                               Disagree 
 
22.  Side effects from my medication make it harder for me to recover 
 
          5  4    3       2   1  
      Strongly         Agree        Neither Agree          Disagree      Strongly 
        Agree                 nor Disagree                               Disagree 
 
23.  Recovery involves finding new meaning in my life 
 
          5  4    3       2   1  
      Strongly         Agree        Neither Agree          Disagree      Strongly 
        Agree                 nor Disagree                               Disagree 
 
24.  Support from mental health professionals is important for my recovery 
 
          5  4    3       2   1____ 
      Strongly         Agree        Neither Agree          Disagree      Strongly 
        Agree                 nor Disagree                               Disagree 
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SCCS 
 
 
Age in Years ____________________ Gender _________________________ 
 
Test Date ____________________________  
  MM/DD/YY 
 
Instructions:  This survey is designed to assess how a person feels they fit in their 
community and among their family and friends.  Please read each question carefully, and 
circle the number that best describes how much that statement describes you.  Please take 
your time and answer all questions. 
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1 My partner (or best friend) and I support each 
other equally 
1 2 3 4 5 6 
2 My friends help me feel good about myself 1 2 3 4 5 6 
3 My provider helps me with my emotional 
stability 
1 2 3 4 5 6 
4 I have a close relationship with my family 1 2 3 4 5 6 
5 If I make a mistake, my friends point it out so 
I will correct it 
1 2 3 4 5 6 
6 There are only a few people I completely trust 1 2 3 4 5 6 
7 My family meets many of my needs 1 2 3 4 5 6 
8 Most of my friends help me in whatever way I 
need 
1 2 3 4 5 6 
9 People are trustworthy, but society is not 1 2 3 4 5 6 
10 If I am making a mistake, my provider will 
always point it out 
1 2 3 4 5 6 
11 My intimate partner (or best friend) helps me 
in many ways 
1 2 3 4 5 6 
12 I can always turn to my partner (or best 
friend) for advice if I am confused 
1 2 3 4 5 6 
13 My partner (or best friend) praises me and 
cheers for me when I accomplish something 
1 2 3 4 5 6 
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14 Most people will do the wrong thing if they 
know they will not be caught 
1 2 3 4 5 6 
15 When I am sad or feeling blue, I can always 
turn to my family 
1 2 3 4 5 6 
16 I wish my partner (or best friend) would try 
harder not to hurt my feelings 
1 2 3 4 5 6 
17 When I do something wrong, my partner (or 
best friend) points it out to me 
1 2 3 4 5 6 
18 Helping me feel good is what my partner or 
best friend does best 
1 2 3 4 5 6 
19 I volunteer my time to organizations when I 
can 
1 2 3 4 5 6 
20 Sometimes I feel that my provider does not 
take the time to hear me 
1 2 3 4 5 6 
21 When my back is in a corner, I can count on 
my partner (or best friend) to support me 
1 2 3 4 5 6 
22 My friends spend time with my intimate 
partner (or best friend) and I 
1 2 3 4 5 6 
23 My closest relationships usually last for two 
years or more 
1 2 3 4 5 6 
24 If I need money or help with a bill, my family 
almost always gives it to me 
1 2 3 4 5 6 
25 Most of the time people are looking out for 
themselves, not trying to be helpful to others 
1 2 3 4 5 6 
26 The more I give to the community, the more I 
want to 
1 2 3 4 5 6 
27 My friends know who my provider is 1 2 3 4 5 6 
28 I keep myself informed on community issues 1 2 3 4 5 6 
29 If I need to know something, I ask my 
provider 
1 2 3 4 5 6 
30 If I need help fixing or making something, my 
family helps me 
1 2 3 4 5 6 
31 I am one of the first to contribute to 
community projects or concerns 
1 2 3 4 5 6 
32 I feel I give back to the community for what I 
take 
1 2 3 4 5 6 
33 If I need to know something my family 
usually has the answer 
1 2 3 4 5 6 
34 My partner (or best friend) gives me things or 
helps me do things to make my life easier 
1 2 3 4 5 6 
 484
  
ES 
 
 
Age in Years ____________________ Gender _________________________ 
 
Test Date ____________________________  
  MM/DD/YY 
 
Please respond to each item.  Read each question carefully, and circle the response that 
best describes your level of agreement with the statement. 
 
1 I generally accomplish what I set out to 
do 
 
Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
2 I feel powerless most of the time 
 
 
Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
3 People have a right to make their own 
decisions, even if they are bad ones 
 
Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
4 People are limited only by what they 
think possible 
 
Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
5 Getting angry about something is often 
the first step toward changing it 
 
Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
6 I have a positive attitude about myself 
 
 
Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
7 Making waves never gets you anywhere 
 
Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
8 People should try to live their lives the 
way they want to 
 
Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
9 I can pretty much determine what will 
happen in my life 
 
Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
10 People have no right to get angry just 
because they don’t like something 
 
Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
11 When I make plans, I am almost certain 
to make them work 
 
 
Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
12 You can’t fight city hall 
 
Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
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13 People working together can have an 
effect on their community 
 
Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
14 I am generally optimistic about the future 
 
Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
15 Getting angry about something never 
helps 
 
Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
16 I am usually confident about the 
decisions I make 
 
Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
17 When I am unsure about something, I 
usually go along with the group 
 
Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
18 People have more power if they join 
together as a group 
 
Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
19 Very often a problem can be solved by 
taking action 
 
Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
20 I am often able to overcome barriers 
 
 
Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
21 Experts are in the best position to decide 
what people should do or learn 
 
Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
22 Working with others in my community 
can help to change things for the better 
 
Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
23 I feel I am a person of worth, at least on 
an equal basis with others 
 
Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
24 Most of the misfortunes in my life were 
due to bad luck 
 
Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
25 I see myself as a capable person 
 
 
Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
26 Usually, I feel alone 
 
 
Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
27 I am able to do things as well as most 
other people 
 
Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
28 I feel I have a number of good qualities 
 
 
Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
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ISMI 
 
 
Age in Years ____________________ Gender _________________________ 
 
Test Date ____________________________  
  MM/DD/YY 
 
Please respond to each item.  We are going to use the term ‘mental illness’ in the rest of 
this questionnaire, but please think of it as whatever you feel is the best term for it. For 
each question, please mark whether you strongly disagree (1), disagree (2), agree (3) or 
strongly agree (4). 
 
1 In general, I am able to live life the way I 
want to 
 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
2 I feel out of place in the world because I 
have a mental illness 
 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
3 Stereotypes about the mentally ill apply 
to me 
 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
4 People discriminate against me because I 
have a mental illness 
 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
5 I don’t talk about myself much because I 
don’t want to burden others with my 
mental illness 
 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
6 Having a mental illness has spoiled my 
life 
 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
7 People can tell that I have a mental illness 
by the way I look 
 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
8 Others think that I can’t achieve much in 
life because I have a mental illness 
 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
9 I don’t socialize as much as I used to 
because my mental illness might make 
me look or behave ‘weird’ 
 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
10 I feel comfortable being seen in public 
with an obviously mentally ill person 
 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
11 People without mental illness could not 
possibly understand me 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
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12 Mentally ill people tend to be violent 
 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
13 People ignore me or take me less 
seriously just because I have a mental 
illness 
 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
14 Negative stereotypes about mental illness 
keep me isolated from the ‘normal’ world 
 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
15 I can have a good, fulfilling life, despite 
my mental illness 
 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
16 I am embarrassed or ashamed that I have 
a mental illness 
 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
17 Because I have a mental illness, I need 
others to make most decisions for me 
 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
18 People often patronize me, or treat me 
like a child, just because I have a mental 
illness 
 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
19 I stay away from social situations in order 
to protect my family or friends from 
embarrassment 
 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
20 People with mental illness make 
important contributions to society 
 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
21 I am disappointed in myself for having a 
mental illness 
 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
22 People with mental illness cannot live a 
good, rewarding life 
 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
23 Nobody would be interested in getting 
close to me because I have a mental 
illness 
 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
24 Being around people who don’t have a 
mental illness makes me feel out of place 
or inadequate 
 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
25 Living with mental illness has made me a 
tough survivor 
 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
26 I feel inferior to others who don’t have a 
mental illness 
 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
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27 Mentally ill people shouldn’t get married 
 
 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
28 I avoid getting close to people who don’t 
have a mental illness to avoid rejection 
 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
29 I can’t contribute anything to society 
because I have a mental illness 
 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
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SSQ 
 
 
Age in Years ____________________ Gender _________________________ 
 
Test Date ____________________________  
  MM/DD/YY 
 
Note:  For Level of Satisfaction:  6 = Very Satisfied; 5= Satisfied; 4= Somewhat 
Satisfied; 3 = Somewhat Dissatisfied; 2=Dissatisfied; 1=Very Dissatisfied 
 
Service Type Receiving
? 
Hours/ 
Month 
Level of Satisfaction Contributes to 
Recovery? 
Outpatient Medical/Medication    Y       N    6    5    4    3    2    1    Y       N 
Outpatient therapy (individual)    Y       N    6    5    4    3    2    1    Y       N 
Outpatient therapy 
(relationship/couple) 
   Y       N    6    5    4    3    2    1    Y       N 
Case management (general)    Y       N    6    5    4    3    2    1    Y       N 
Case management (intensive)    Y       N    6    5    4    3    2    1    Y       N 
Recovery Program    Y       N    6    5    4    3    2    1    Y       N 
Supported living (financial only)    Y       N    6    5    4    3    2    1    Y       N 
Supported living (agency/low 
supervision) 
   Y       N    6    5    4    3    2    1    Y       N 
Supported living 
(agency/supervised) 
   Y       N    6    5    4    3    2    1    Y       N 
Supported employment    Y       N    6    5    4    3    2    1    Y       N 
Dialectical Behavior Therapy 
(DBT) 
   Y       N    6    5    4    3    2    1    Y       N 
Forensic Services    Y       N    6    5    4    3    2    1    Y       N 
PREP day program    Y       N    6    5    4    3    2    1    Y       N 
Drop-In Center    Y       N    6    5    4    3    2    1    Y       N 
 
Totals/Averages 
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HDF 
 
 
Age in Years ____________________ Gender _________________________ 
 
Test Date ____________________________  
  MM/DD/YY 
 
 
1.  Education:  Please check which response most applies to you 
 
1.  Less than High School     _______ 
2.  High School Graduate     _______ 
3.  1-2 years of College or Associates Degree  _______ 
4.  More than 2 years of college or Bachelors Degree _______ 
5.  Graduate School      _______ 
 
If a degree(s) was/were earned, what degree was obtained and what was the 
degree in? 
 
_______________________________________________________________ 
 
_______________________________________________________________ 
 
 
2.A  Income:  Please indicate your approximate personal annual income 
 
$0.0 - $10,000   _______ 
$10,001 - $15,000   _______ 
$15,001 - $20,000  _______ 
$20,001 - $25,000  _______ 
$25,001 - $30,000  _______ 
$30,001 - $40,000  _______ 
$40,001 - $50,000  _______ 
$50,001 - $75,000  _______ 
$75,001 – more  _______ 
 
2.B  Income:  Please indicate your approximate combined annual income if different  
than personal income (if more than yourself contributes financially to your household).   
(circle if N/A) 
 
$0.0 - $10,000   _______ 
$10,001 - $15,000   _______ 
$15,001 - $20,000  _______ 
$20,001 - $25,000  _______ 
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$25,001 - $30,000  _______ 
$30,001 - $40,000  _______ 
$40,001 - $50,000  _______ 
$50,001 - $75,000  _______ 
$75,001 – more  _______ 
 
 
3.  Employment:   
 
3.A  How many years were you employed full time in your life?
 _______________ 
 
3.B  How many years were you employed part time in your life?
 _______________ 
 
3.C  Are you currently working? (YES / NO)  _____________  
(if no, skip to question 4) 
 
3.D  If you are working how would you describe your employment (please check 
one)? 
 
     1.  Fulltime paid employment           _______  (# of hours/week _______) 
                 2.  Part time paid employment          _______  (# of hours/week _______) 
                 3.  Volunteer/non-paid employment _______       (# of hours/week _______) 
 
3.E  What is your job? 
____________________________________________________ 
 
4.  Diagnosis 
 
What is your psychiatric diagnosis?   
_________________________________________ 
 
5.  Hospitalization 
 
5.A  How many times have you been in a hospital or crisis unit because of mental 
health reasons over your life time?  ___________________________ 
 
5.B  When was the last time you were in the hospital or crisis unit (indicate in 
number of years or months back)?  ________________________________ 
 
5.C   How old were you the first time you were in a hospital or crisis unit for 
mental health reasons?  ______________________________ 
 
 492
6.  Age of Onset 
 
6.A  How old were you when you were first officially diagnosed?  ____________ 
 
6.B  How old were you when you first realized that you had a mental health 
problem?  _________ 
 
7.  Family History of Mental Illness 
 
7.A  Do you have any family members that you know were officially diagnosed 
with a mental health problem?  For each of the following, indicate yes or no and 
the diagnosis if know. 
 
1.  Father     YES   NO   Diagnosis ___________________ 
2.  Mother    YES   NO   Diagnosis ___________________ 
3.  Brother    YES   NO    Diagnosis ___________________ 
4.  Sister    YES   NO   Diagnosis ___________________ 
5.  Aunt or Uncle   YES   NO   Diagnosis ___________________ 
6.  Grandparent   YES   NO   Diagnosis ___________________ 
7.  Other (e.g. cousin)   YES   NO   Diagnosis ___________________ 
 
7.B  Do you have any family members that you suspect had a mental illness but 
were not officially diagnosed as far as you know?  For each of the following, 
indicate yes or no and what they were showing that made you believe this. 
 
1.  Father     YES   NO Symptom ____________________ 
2.  Mother    YES   NO Symptom ____________________ 
3.  Brother    YES   NO  Symptom ____________________ 
4.  Sister    YES   NO Symptom ____________________ 
5.  Aunt or Uncle   YES   NO Symptom ____________________ 
6.  Grandparent   YES   NO Symptom ____________________ 
7.  Other (e.g. cousin)   YES   NO Symptom ____________________ 
 
8.  Medication 
 
Please indicate if you are currently prescribed and taking any of the following 
(check all that apply) 
 
1.  Anti-Depressant Medication   YES NO 
2.  Anti-Psychotic Medication  YES NO 
3.  Anti-Manic Medication   YES NO 
4.  Anti-Anxiety Medication   YES NO 
5.  Other Psychiatric Medication  YES NO 
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9.  Substance Use History 
 
Please indicate if you have ever been diagnosed with an alcohol or substance 
dependence diagnosis (e.g. alcoholism, alcohol dependence, cocaine addiction, 
etc.) 
 
YES NO If yes, what was the addictive substance? 
____________________________________________________________ 
 
10.  History of Abuse 
 
It is recognized that this is an area of sensitivity and privacy.  Please do not 
answer these questions if you feel that it is too stressful for you.  If you do answer 
the questions, please understand that we are not seeking details but simply an 
acknowledgement of whether you have experienced any of the following.   
 
Please note for the purposes of this study, child sexual abuse is defined as 
touching with or without penetration an individual younger than age 18, by 
someone at least 5 years older than the individual, for the purposes of sexual 
gratification. 
 
10.A  Child Sexual Abuse    YES     NO   More than one time?  YES NO 
10.B  Child Physical Abuse    YES     NO   More than one time?  YES NO 
10.C  Adult Sexual Assault    YES     NO   More than one time?  YES NO 
10.D  Adult Physical Assault    YES     NO   More than one time?  YES NO 
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Chart Abstraction Tool 
 
 
Participant #____________ Age ________________ Gender ________  
Date__________ 
 
Education: 
 
List greatest level of education completed noted in record (e.g. high school 
graduate, college graduate (BA or BS), associates degree, etc.): 
___________________________________________________ 
 
Income: 
 
Indicate annual income in thousands.  If monthly income is given multiply x12. 
____________________________ 
 
Employment 
 
Is the participant currently employed? YES NO 
Fulltime (hours/week)  _____________ 
Part time  (hours/week)  _____________ 
Volunteer (hours/week)  _____________ 
Total number of years employed (if available) _____________________ 
 
Age of Onset 
 
Indicate how old respondent was at first diagnosis (if available) 
___________________ 
Indicate how old respondent was when first symptoms are noted (if available) 
___________________ 
 
Diagnostic History 
 
Axis 1 Diagnoses (listed in order) (psychiatric and substance related) – go back 
two years (start at most recent) 
 
Diagnosis 1: Name ______________________ DSM-IV# _______________ 
Diagnosis 2:   Name ______________________ DSM-IV# _______________ 
Diagnosis 3: Name ______________________ DSM-IV# _______________ 
Diagnosis 4: Name ______________________ DSM-IV# _______________ 
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Axis 2 Diagnoses (listed in order) (Number and Name) – go back two years (start 
as most recent) 
 
Diagnosis 1: Name ______________________ DSM-IV# _______________ 
Diagnosis 2:   Name ______________________ DSM-IV# _______________ 
Diagnosis 3: Name ______________________ DSM-IV# _______________ 
 
Axis 3 Diagnoses (listed in order) (Name) – go back two years (start at most 
recent) 
 
Medical Diagnosis/Problem 1: _________________________________________ 
Medical Diagnosis/Problem 2: _________________________________________ 
Medical Diagnosis/Problem 3: _________________________________________ 
 
Axis 5:  Most recent Global Assessment of Functioning (GAF) score  
___________________ 
 
Substance Use 
 
If a substance use problem is indicated but not listed as a diagnosis indicate here  
 YES NO 
What substance or substances were involved? 
_________________________________________________________________ 
 
Hospitalization 
 
Dates of hospitalizations or crisis unit admissions in the last two (2) years – start 
with most recent. 
 
Date Admitted ___________     Length of Stay __________    Hospital     CSU 
Date Admitted ___________     Length of Stay __________    Hospital     CSU 
Date Admitted ___________     Length of Stay __________    Hospital     CSU 
Date Admitted ___________     Length of Stay __________    Hospital     CSU 
Date Admitted ___________     Length of Stay __________    Hospital     CSU 
Date Admitted ___________     Length of Stay __________    Hospital     CSU 
Date Admitted ___________     Length of Stay __________    Hospital     CSU 
Date Admitted ___________     Length of Stay __________    Hospital     CSU 
Date Admitted ___________     Length of Stay __________    Hospital     CSU 
Date Admitted ___________     Length of Stay __________    Hospital     CSU 
Date Admitted ___________     Length of Stay __________    Hospital     CSU 
Date Admitted ___________     Length of Stay __________    Hospital     CSU 
Date Admitted ___________     Length of Stay __________    Hospital     CSU 
Date Admitted ___________     Length of Stay __________    Hospital     CSU 
Date Admitted ___________     Length of Stay __________    Hospital     CSU 
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Medication 
 
Indicate medications prescribed for the last two years – start with most recent. 
 
           Type of Medication 
Date Name   Psychosis   Depress   Manic  Anxiety Other 
 
Child Abuse 
 
Evidence of child abuse (child sexual abuse (CSA), child physical abuse (PSA) 
 
Single Incident CSA   YES NO 
Multiple Incident CSA  YES NO 
Single Incident PSA   YES  NO 
Multiple Incident PSA  YES NO 
 
Adult Assault/Abuse 
 
Evidence of adult sexual assault (SA) or adult physical assault (PA) 
 
Single Incident Adult SA  YES NO 
Multiple Incident Adult SA  YES NO 
Single Incident Adult PA  YES NO 
Multiple Incident Adult PA  YES NO 
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Familial Mental Illness 
 
Indication of DIAGNOSED mental illness for 
 
1.  Father    YES NO Diagnosis _____________________ 
2.  Mother   YES NO Diagnosis _____________________ 
3.  Brother   YES NO  Diagnosis _____________________ 
4.  Sister   YES NO Diagnosis _____________________ 
5.  Aunt or Uncle  YES NO Diagnosis _____________________ 
6.  Grandparent  YES NO Diagnosis _____________________ 
7.  Other (e.g. cousin)  YES NO Diagnosis _____________________ 
 
Indication of SYMPTOMATIC individual without official diagnosis 
 
1.  Father    YES NO Symptom _____________________ 
2.  Mother   YES NO Symptom _____________________ 
3.  Brother   YES NO  Symptom _____________________ 
4.  Sister   YES NO Symptom _____________________ 
5.  Aunt or Uncle  YES NO Symptom _____________________ 
6.  Grandparent  YES NO Symptom _____________________ 
7.  Other (e.g. cousin)  YES NO Symptom _____________________ 
 
Services 
 
Indicate if the respondent is currently utilizing the following services 
 
Outpatient Medical (psychiatrist/nurse practitioner) YES NO 
Outpatient Therapy (Individual)   YES NO 
Outpatient Therapy (Couple/Family)   YES NO 
Case Management (Standard)    YES NO 
Case Management (Intensive)   YES NO 
Recovery Program     YES NO 
Supported Living (Financial Only)   YES NO 
Supported Living (Agency/Low Supervision) YES NO 
Supported Living (Agency/Supervised)  YES NO 
Supported Employment    YES NO 
Dialectical Behavior Therapy    YES NO 
Forensic Services     YES NO 
PREP Day Program     YES NO 
Drop-In Center     YES NO 
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Appendix B 
 
Development of the Support and Community Connectedness Survey 
 
 
Background and Theoretical Constructs 
 For many with a severe mental illness (SMI), the chronic course of the disease 
process leads to escalating levels of social exclusion.  The 1998 white paper  
‘Modernizing mental health’ highlighted how the prejudice attached to mental ill health 
“…and the failure to understand its causes, leads to discrimination and social exclusion” 
(DoH 1998, p. 1.11).  There have been several studies that have addressed social 
networks in the SMI population (Becker, Leese, Clarkson, Taylor, et al, 1998; Brugha, 
Wing, Brewin, MacCarthy, & Lesage, 1993; Brunt & Hansson, 2002; Homes-Ebor & 
Riger, 1992).  Evidence suggests that the SMI population would have better treatment 
compliance and success in remaining out of psychiatric facilities if their social 
network/social support structure was both larger and more flexible (Fried, Johnsen, 
Starrett, Calloway & Morrissey, 1998; Goering, Durbin, Foster, Boyles, Babiak, & 
Lancee, 1992; MacDonald, Hayes & Baglioni, 2000).  There have been fewer studies 
directed to perceived social support for those with a SMI (Letvak, 2002).  Very few 
studies have looked at the structural implications of social networks in relation to 
interactional aspects of social support (Hall & Nelson, 1996).  There are currently no 
studies that address empirically the SMI population and their perceptions of community 
support (perceived social cohesion, the individual or micro-level of social capital) or 
studies that link these constructs with treatment compliance, maintenance in the 
community or social inclusion.  Thus, there is no evidence for or against the idea that 
 499
perceived community level integration is beneficial to client stability or that it enhances 
social inclusion.       
 In an attempt to extend current social theory, the construct of Perceived Social 
Integration (PSI) was developed to understand the relationships between the constructs 
that appear to make up PSI.  These constructs include social network satisfaction (SSN), 
perceived social support (PSS) and perceived social cohesion (PSC).  Together, 
information related to the three sub-constructs noted were evaluated in a survey 
developed to capture the constructs individually and to lend support to the hypothesis that 
these constructs together partially mediate between life as a psychiatric patient and 
marginalization from society.  The instrument consists of Likert style questions that can 
be completed quickly and can be administered by a client’s provider.  The purpose of this 
additional appended information is to describe the development of the instrument that 
gathers data simultaneously on each of the three sub-constructs and to explicate their 
relationship to the construct of PSI. 
Procedure 
 Two rounds of content validity were completed.  The first was focused on the 112 
questions generated to represent the three constructs SNS, PSS, and PSC.  Each question 
was developed with a construct and sub-construct in mind, targeting the questions to the 
cluster x sub-construct models in Table 110 and Table 111.  The methods and tables are 
fully described in the next section.  Before item construction was completed, local 
experts were contacted and asked if they would participate in the content validity phase 
of a new instrument.  Two groups were queried.  The first was five professors at USF 
who were experts in the social constructs being investigated.  Four agreed to participate.  
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A second group of reviewers consisted of experts in the SMI population.  Population 
experts had to have a minimum of a Masters degree in psychology or a related field and 
at least three years working with the SMI population.  All five contacted agreed to 
participate. 
 All participants were sent a packet of information that included an introduction 
section, description of the constructs and sub-constructs, detailed instructions on how to 
proceed, a separate page with the sub-constructs listed and numbered to make scoring 
easier, and a large, multi-page matrix of the questions.  For each question, the respondent 
was asked to decide which construct the question pertained to, which sub-construct 
within each construct, how appropriate they viewed the question and how clear the 
phrasing was (1=clear, 2=needs work, 3=poor for appropriateness and phrasing).  A 
comment section was included for each question in case the participant had an alternative 
choice to wording or some other comment.  Finally, a brief description of the question 
development and a list of references were included in each packet.  It was suggested that 
each participant read these only after completing the task. 
 Once the information was returned, a large table was created with each question 
and response included to ascertain the accuracy of responses compared to the author’s 
beliefs of which construct each item fit.  Decision rules were generated to determine 
which questions advanced to round two of the content validity assessment.  As noted 
there were a total of four professors and five clinicians who participated by answering all 
or nearly all the questions.  Each professor had their answer multiplied by two (2.0) 
because the knowledge of the constructs was considered of higher importance then 
knowledge of the population.  Clinician responses were not weighted.  A perfect score 
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was 13 ((4 professors x 2) + (5 clinicians x 1) = 13).  If a question received a score of 10 
or greater, it was included with no or minor modifications.  For instance, all questions 
with ‘partner’ or ‘intimate partner’ in them were altered by adding ‘or best friend’ in 
response to one professors suggestion that many of the SMI may not have intimate 
partners but may have a best friend.  This level of alteration is not expected to affect the 
respondent’s answer, but will allow more respondents to answer.  Questions with a final 
score of 7-9 were considered feasible with modification.  Few of these were considered 
modifiable after review and most were discarded.  Any question scoring a six or below 
was automatically discarded. 
 The original concept was to have the participants review all the questions a 
second time.  This was not followed because several participants complained of the time 
needed to complete the first pass.  It was decided that the second pass would involve only 
those questions with sufficient substantive change that a more careful check was needed 
(total of nine) and any additional questions generated (total of four).  Thus, the second 
round of content validity assessment was on thirteen questions.  The information sent to 
the participants for the first review of items is included at the end of this appendix and is 
titled “Content Validity – First Pass”.  Four additional questions were generated to fit 
gaps in the theoretical matrices (tables 1 and 2) where original questions were all 
eliminated.  These questions and the second review for content validity are also included 
at the end of this appendix and is titled “Content Validity – Second Pass.” 
Item Development 
All items for this survey were designed following an in-depth examination of the 
literature.  Social networks and social support were conceptualized using both clusters 
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and sub-constructs.  For both constructs, the clusters were family, friends, 
neighbors/acquaintances, intimate partners and mental health providers.  Not all sub-
constructs were considered of equal importance for each cluster.  Regarding social 
networks, the direction and clustering sub-constructs were considered of primary 
importance, with magnitude (size) of secondary importance (Table 110).  This deductive 
process was used for each cluster, generating items for evaluation. 
 
Table 110 
 
Social networks:  Cluster x sub-construct 
 
Cluster Dimensions 
 Magnitude Directionality Durability Homogeneity Clustering
 
Family 
 
–  
 
+ 
   
+ 
Friends + – + + + 
Neighbors – –  +  
Intimates  – + + + 
Providers  + –  + 
Note:  + = primary importance;  – = secondary importance, empty = no importance, not 
addressed 
 
 
Social support was evaluated along the same clusters but different dimensions.  
The importance of the sub-construct for each construct is demonstrated in Table 111.  
Social cohesion did not have literature support for addressing the concepts of community 
involvement, reciprocity and trust in relation to the clusters noted above.  Because of this, 
items were constructed independent of clusters, thus more generally.  However, the 
concepts of trust and community involvement were considered of slightly higher 
importance than reciprocity, generating a few more items in each than in reciprocity.  The 
belief is that a sense of community involvement, caring and trust will lead to higher 
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levels of reciprocity.  However, reciprocity might require higher levels of proactive 
behavior and access to resources such as transportation, money and time.  This is  
Table 111 
 
Social support:  Cluster x sub-construct 
 
Cluster Dimensions 
 Emotional Instrumental Informational Appraisal Dissonance
 
Family 
 
+ 
 
+ 
 
– 
 
+ 
 
+ 
Friends + – – + + 
Neighbors – –  –  
Intimates + + – + + 
Providers +  – + + 
Note:  + = primary importance;  – = secondary importance, empty = no importance, not 
addressed 
 
 
especially true  for active involvement, i.e. volunteering, that would require investment of 
scare resources, but the more passive aspects of community involvement would not.  The 
lack of resources available to the SMI population is, unfortunately, a daily aspect of their 
lives.  Thus, reciprocity was considered of less importance for both pragmatic and 
theoretical reasons. 
 
Content Validity Results – First Pass. 
 Of the 112 original questions, 76 scored a 10 or higher.  Not all of these were 
included in the pilot instrument and four additional questions were designed for the 
second round.  Table 112, in the column labeled ‘CV1 – Results’, summarizes which 
questions were retained, eliminated, and updated.  If a question was updated, the altered 
question is included below that question in bold- face.  These questions formed the  
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Table 112 
 
Question and Results Matrix 
 
Q # Question Construct 
 
Sub-Construct CV1 
Score
CV1 
Results
CV2 
Results
1 Most people will do the wrong 
thing if they know they won’t be 
caught 
Cohesion Trust 11 Keep  
2 When I do something wrong, my 
partner or best friend points it out 
to me 
Support Appraisal 12 Keep  
3 I would like to have different 
friends than I do now 
Support Emotional 4 Drop  
4 When I am sad or feeling blue, I 
can always turn to my family 
Support Emotional 11 Keep  
5 I feel comfortable openly 
expressing my feelings 
Support Emotional 11 Drop  
6 My family spends time with my 
friends and I 
Network Clustering 12 Keep  
7 I am not lonely because I know 
my neighbors 
Support Emotional 4 Drop  
8 I wish my partner or best friend 
would try harder not to hurt my 
feelings 
Support Dissonance 13 Keep  
9 I can count on my counselors to 
be honest about how they see me 
Support Appraisal 4 Drop  
10 People are trustworthy, but 
society is not 
Cohesion Trust 12 Keep  
11 I belong to a group that is not a 
church group 
Cohesion Community 8 Updated  
 I belong to a church or other 
community group 
    Keep 
12 It is okay that I don’t work 
because I am mentally ill 
Cohesion Community 7 Drop  
13 My friends are often angry with 
me 
Support Dissonance 10 Keep  
14 I have a close relationship with 
my family 
Support Emotional 12 Keep  
15 I volunteer my time to 
organizations when I can 
Cohesion Community 13 Keep  
16 Sometimes I feel that my 
counselor doesn’t take the time to 
hear me 
Support Dissonance 11 Keep  
17 People without mental illness 
have more people to help them 
then I do 
Support General 3 Drop  
18 Overall, I feel that enough people 
care about me and support me 
Support General 7 Drop  
19 Most of my friends help me feel 
good, but help me in many other 
ways too 
Support Instrumental 12 Keep  
20 I change friends quickly Network Durability 12 Keep  
21 My intimate partner has the same 
types of problems as I do 
Network Homogeneity 4 Drop  
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Table 112 (cont.) 
 
Q # Question Construct 
 
Sub-Construct CV1 
Score
CV1 
Results
CV2 
Results
22 Sometimes I help my providers 
with their problems 
Network Directionality 4 Drop  
23 I take more than I give in 
relationships 
Support Directionality 8 Drop  
24 I feel criticized when my family 
says they’re trying to help me 
Support Dissonance 12 Keep  
25 I generally trust the federal 
government to do what is right 
Cohesion Trust 13 Keep  
26 I am close to my mental health 
providers 
Support Emotional 9 Updated  
 My counselor helps me with my 
emotional stability 
    Keep 
27 As far as society is concerned, 
people without a mental illness 
are better than people with a 
mental illness 
Cohesion Reciprocity 8 Updated  
 As far as society is concerned, 
people without a mental illness 
do more for the community 
then people with a mental 
illness 
    Keep 
28 I feel safe to walk in my 
neighborhood 
Cohesion Trust 10 Keep  
29 I often visit with my neighbors at 
my home or theirs 
Network Directionality 8 Drop  
30 My symptoms get in the way of 
my having a good relationship 
Support General 9 Drop 
 
31 When my back is in a corner, I 
can count on my partner or best 
friend to support me 
Support Instrumental 12 Keep 
 
32 When I need to know something, 
my friends usually have the 
answer 
Support Information 13 Keep 
 
33 I provide as much for my partner 
or best friend as my he or she 
does for me 
Network Directionality 5 Drop 
 
34 My friends spend time with my 
intimate partner or best friend 
and I 
Network Clustering 12 Keep 
 
35 My family helps me Network Directionality 2 Drop  
36 My partner or best friend doesn’t 
feel I can do anything right 
Support Dissonance 13 Keep 
 
37 I make a point to vote during 
elections 
Cohesion Community 13 Keep 
 
38 My closest relationships usually 
last for two years or more 
Network Durability 10 Keep 
 
39 I have had some of the same 
friends for many years 
Network Durability 12 Keep 
 
40 Sometimes when I need advice or 
information, friends or family 
make sure I can’t get it 
Support General 11 Keep 
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Table 112 (cont.) 
 
 
Q #
 
Question
 
Construct 
 
Sub-Construct CV1 
Score
CV1 
Results
CV2 
Results
41 My counselor knows or has met 
my intimate partner or best friend 
Network Clustering 11 Keep 
 
42 If I need money or help with a 
bill, my family almost always 
gives it to me 
Support Instrumental 12 Keep 
 
43 I can laugh with my neighbors 
and feel good about myself with 
them 
Support Appraisal 8 Drop 
 
44 When I need a shoulder to cry 
on, I have at least one good 
friend to turn to 
Support Emotional 9 Updated 
 
 I have at least one good friend 
to turn to if I am feeling sad or 
afraid 
    Keep 
45 I can’t disagree with others 
because I am mentally ill 
Support General 4 Drop 
 
46 My intimate partner or best 
friend helps me in many ways 
Support Emotional 13 Keep 
 
47 My friends won’t leave me alone 
when I ask them to 
Support Dissonance 12 Keep 
 
48 I would say that I have a large 
family 
Network Magnitude 12 Keep 
 
49 I need to be careful because my 
community won’t help me 
Cohesion Community 13 Keep 
 
50 My family meets several of my 
needs 
Support Instrumental 13 Keep 
 
51 Most of the time people are 
looking out for themselves, not 
trying to be helpful to others 
Cohesion Reciprocity 12 Keep 
 
52 If I make a mistake, my friends 
point it out so I will correct it 
Support Appraisal 13 Keep 
 
53 You can trust family but no one 
else 
Cohesion Trust 7 Drop 
 
54 I feel that I belong and I’m at 
home in the community 
Cohesion Community 11 Keep 
 
55 Helping me feel good is what my 
partner or best friend does best 
Support Emotional 13 Keep 
 
56 Other people with a mental 
illness have more fun in life than 
I do 
Support General 5 Drop 
 
57 My family has had contact with 
my counselor(s) 
Network Clustering 11 Keep 
 
58 I have lacked friendships most of 
my life 
Network Magnitude 10 Keep 
 
59 My family isn’t honest with me 
about what I am doing 
Support Appraisal 11 Keep 
 
60 If I am making a mistake, my 
counselor will always point it out 
Support Appraisal 10 Keep 
 
61 I know most of my neighbors by 
name 
Network Magnitude 8 Drop 
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Table 112 (cont.) 
 
 
Q #
 
Question
 
Construct 
 
Sub-Construct CV1 
Score
CV1 
Results
CV2 
Results
62 In too many of my relationships, 
people take advantage of me 
Support General 7 Drop 
 
63 I feel comfortable going to a 
neighbor and borrowing 
something 
Support Instrumental 5 Drop 
 
64 I generally trust my local 
government to do what is right 
Cohesion Trust 12 Keep 
 
65 The more I give to the 
community, the more I want to 
Cohesion Reciprocity 12 Keep 
 
66 My friends know who my 
counselors are 
 
Network Clustering 12 Keep 
 
67 In many ways, most of my 
neighbors are a lot like me 
Network Homogeneity 10 Keep  
68 I have friendships with people 
who are not mental health clients 
Network Homogeneity 12 Keep  
69 I keep myself informed on 
community issues 
Cohesion Community 12 Keep  
70 If I need to know something, I 
ask my counselor(s) 
Support Information 12 Keep  
71 I have many friendships with 
mental health clients 
Network Homogeneity 9 Updated  
 Most of my friends are also 
mental health clients 
    Keep 
72 My family spends time with my 
intimate partner (or best friend) 
and I 
Network Clustering 11 Keep  
73 I choose intimate partners 
partially by how much we have 
in common 
Network Homogeneity 9 Updated  
 I choose my friends by how 
much we have in common 
    Keep 
74 If I need help fixing or making 
something, my family helps me 
Support Instrumental 12 Keep  
75 My counselor tells me too much 
what to do without fully talking it 
over with me 
Support Dissonance 12 Keep  
76 If I am in trouble, I can go to a 
neighbor for help 
Cohesion Trust 5 Drop  
77 I care that the community does 
well 
Cohesion Community 9 Updated  
 I care for my community and 
try to help it when I can 
    Keep 
78 There are only a few people I 
completely trust 
Cohesion Trust 10 Keep  
79 I want to have my family living 
closer to me 
Support Emotional 3 Drop  
80 I know that many of my 
neighbors are mental health 
clients 
Network Homogeneity 10 Keep  
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Table 112 (cont.) 
 
 
Q #
 
Question
 
Construct 
 
Sub-Construct CV1 
Score
CV1 
Results
CV2 
Results
81 I am able to help my family when 
they need or ask 
Network Directionality 2 Drop  
82 I cannot be in a relationship 
because I am mentally ill 
Support General 6 Drop  
83 I feel I give back to the 
community for what I take 
Cohesion Reciprocity 13 Keep  
84 I know whom to call if I have a 
concern about my local 
government 
Cohesion Community 10  
Keep 
 
85 My partner gives me things or 
helps me do things to make my 
life easier 
Support Instrumental 12  
Keep 
 
86 There must be a lot wrong for me 
to end an intimate relationship 
Network Durability 5  
Drop 
 
87 Sometimes I feel that my family 
is too close to me 
Support Dissonance 11 Keep  
88 I find I get a new counselor too 
often 
Network Durability 12 Keep  
89 If I need food, money, or other 
help, my friends are always there Support 
 
Instrumental 
 
11 
 
Keep  
90 I generally trust my state 
government to do what is right Cohesion 
Trust 13 Keep 
 
91 My counselor(s) lift my spirits Support Emotional 11 Drop  
92 My partner or best friend is 
always telling me what to do Support 
Dissonance 13 Keep 
 
93 Too many people block me from 
expressing what I feel Support 
General 13 Drop 
 
94 In general, I have enough friends Network Magnitude 12 Keep  
95 My counselor talks about his or 
her life with me Network 
Directionality 13 Keep 
 
96 Only people who are also 
mentally ill are honest with me Support 
General 0 Drop 
 
97 My friends say nice things to me 
and help me feel good about 
myself Support 
 
Appraisal 
 
12 
 
Keep 
 
98 I am a trusting person Network Trust 7 Drop  
99 My partner or best friend praises 
me and cheers for me when I 
accomplish something Support 
 
Appraisal 
 
13 
 
Keep 
 
100 I worry about bad things 
happening in my community Cohesion 
Trust 8 Drop 
 
101 I help my friends as much as they 
help me Network 
Directionality 6 Drop 
 
102 My family comes over or offers 
advice when I don’t want them to Support 
 
Dissonance 
 
13 
 
Keep  
103 I can always turn to my best 
friend or partner for advice if I 
am confused Support 
 
Information 
 
11 
 
Keep 
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Table 112 (cont.) 
 
 
Q #
 
Question
 
Construct 
 
Sub-Construct CV1 
Score
CV1 
Results
CV2 
Results
104 If I were NOT mentally ill, I 
would care more about things in 
the community Cohesion 
 
Community 
 
8 
 
Updated 
 
 Mental illness stops a person 
from caring about their 
community  
   Keep 
105 My community doesn’t care 
about me, so I stay to myself Cohesion 
Reciprocity 11 Keep 
 
106 I believe that most people are 
basically good Cohesion 
Trust 9 Updated 
 
 I believe that in a pinch, I could 
trust a stranger to help me  
   Keep 
107 If I need to know something my 
family usually has the answer Support 
 
Information 
 
13 
 
Keep  
108 My counselor helps me in more 
ways then talking and counseling Support 
 
Emotional 
 
9 
 
Drop  
109 Because of my mental illness, I 
can’t give back to the community Cohesion 
 
Reciprocity 
 
10 
 
Drop  
110 I believe that you can’t be too 
careful in life Cohesion 
Trust 7 Drop 
 
111 I feel I have a voice in local 
government Cohesion 
Community 13 Keep 
 
112 I belong to a church Cohesion Community 8 Drop  
Additional Questions – Round Two Content Validity 
 
113 I try to provide for my family 
as much as they provide for me 
 
Network 
 
Directionality 
   
Keep 
114 My friends give to me to the 
same degree I give to them 
Network Directionality   Keep 
115 My best friend or partner and I 
support each other equally 
 
Network 
 
Directionality 
   
Keep 
116 I am one of the first to 
contribute to community 
projects or concerns 
 
Cohesion 
 
Reciprocity 
   
Keep 
       
 
Note:  Questions in bold face represent questions altered or added for round two of content validity 
assessment 
 
 
majority of round two of content validity assessment (see below).  Table 113 breaks 
down by construct the questions retained and eliminated.  A retention rate of 68% 
appears inordinately high for a first pass.  Discussion with the participants indicated that 
they had a high degree of confidence in their responses.  Also, several iterations and a  
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Table 113 
 
Question retention – first round content validity assessment 
 
 Social Network 
 
Social Support Social Cohesion Total
Original 28 53 31 112 
Kept 19 34 23 76 
Discarded 9 19 8 36 
Total 28 53 31 112 
     
 
great deal of time were invested in initial question construction along with the theoretical 
basis supporting each question.   
The weighting of professor over clinician was also considered as a possible reason 
for the high retention rate.  As noted, this group’s knowledge of the constructs was 
considered more important, and also was predicted to be more accurate.  Comparison of 
the average number of correct responses between the two groups was also completed.  
Table 114 displays the results by participant for number attempted of 112, number 
correct, percent right and percent wrong.  The prediction of the construct group having a 
higher percentage of agreement with the author due to knowledge of the constructs was 
relatively accurate.  Only one respondent in the construct group (#3) scored lower than 
any of the population group.  Conversely, and against expectation, one member of the 
population group (#1) actually scored the highest of all participants. 
Assessing the correct item responses, three patterns were located in the response 
data that should be mentioned.  First, only one of the questions that targeted the sub-
construct of directionality in the construct of social networks was retained.  It is 
hypothesized that this sub-construct, which is similar to the social support concept of 
reciprocity, was confusing to the respondents.  Because the directionality of social  
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Table 114 
 
Accuracy of content validity respondents – first pass 
 
 Construct Group* 
 
Population Group** 
Respondent 1 2 3 4 1 2 3 4 5 
 
Attempted 
 
106 
 
112 
 
110 
 
91 
 
107 
 
112 
 
112 
 
112 
 
112 
Correct 90 93 84 79 95 65 86 61 74 
% Incorrect 15.89 16.96 24.32 14.13 12.04 41.96 23.21 45.54 33.93 
% Correct 84.11 83.04 75.68 85.87 87.96 58.04 76.79 54.46 66.07 
 
Note:  *Construct group = university professors 
           **Population group = clinicians from community agencies  
 
 
support within social networks is important, three new questions were developed and 
targeted to this sub-construct.  These questions are included in bold-face at the bottom of 
Table 112.  One additional question was also created to reflect the reciprocity sub-
construct of social cohesion due to a slightly higher elimination rate for that sub-
construct.  Second, for both social networks and social support, the ‘neighbor’ cluster had 
nearly all questions eliminated.  Upon scrutiny, it was noted that many of the neighbor 
questions pertained directly to those with a mental illness and were eliminated.  This is 
related with the third finding, all questions pertaining directly to mental illness were 
eliminated through the process of question verification.  The unsuccessful attempt to 
make items specific to the mentally ill was discussed with a few of the respondents.  
Uniformly, they agreed that items such as these would form a separate instrument, if they 
were legitimate at all.  Measuring the constructs across samples with varying degrees of 
mental illness requires a uniform approach.  Those without a mental illness would have a 
difficult time answering these questions.  A few questions more specific to the mentally 
 512
ill do remain, in less direct form, and will form a nucleus for contrasting the samples after 
future data collection and analysis. 
 
Content Validity Results – Second Pass. 
 The second pass of the content validity was completed only with the 
construct sample.  The number of questions and the time involved for clinicians who 
have considerably less flexibility in their time drove this choice.  The decision rule for 
passing any question was the requirement of three out of four respondents finding no 
problem with each question.  All questions passed this level of scrutiny and were 
included in the final survey.  The decision to keep questions is noted in the last column of 
Table 112.  
Reliability Analysis 
The final pilot survey contained 80 items and was administered first to 125 
individuals afflicted with mental illness who were asked to comment on item content, 
language and format.  The 80 item version of the SCCS is included at the end of this 
appendix.  There were few changes suggested and any changes required some 
consistency in those reviewing the survey.  Once the changes were incorporated, 350 
individuals agreed to pilot the survey.  One hundred of these respondents were 
administered the survey a second time from 6-8 weeks later.  Together, both test-retest 
and internal consistency were measured.  A factor analysis of test items revealed a six-
factor structure that encompassed 34 items.  Details on factors and reliability estimates 
are provided in Chapter 3 (pp 135-140). 
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Appendix B – “Content Validity – First Pass” 
Introduction 
Thank you so much for agreeing to be a part of this process.  You are being asked 
to participate in this task because you are either an expert in the population being 
investigated and/or the constructs.  This is an effort to design an instrument that will 
measure simultaneously perceptions of social networks, social support, and social capital 
in a severely mentally ill (SMI) population.  You are helping with the content validation 
of the instrument, a fundamental and essential aspect of instrument development 
necessary for acceptance of the information obtained by the instrument.   Also, in order to 
truly understand the perceptions of the SMI, it is important to be able to compare their 
perceptions to those without a diagnosed mental illness.  Thus, this instrument will be 
given to other populations as well.  The design, then, will need to be simple and 
comprehensive, a task I’m counting on your input to assist me with. 
For the vast majority of people with a SMI, their symptoms come and go.  They 
are not perpetually in a state of active psychosis or depression.  Yet, the effect of the 
illness appears to continue unimpeded.  Little research has investigated this aspect of the 
mental illness, and this instrument will hopefully move that line of research forward in 
some small way.  It is hypothesized that a combination of perception of self and 
perception of self in the community maintains the negative aspects of mental illness 
during non-symptomatic phases in addition to the fear of relapse.  Through measuring 
these three constructs, it is hoped that the results will contribute to understanding how the 
mentally ill see themselves in the world, their sense of belonging and their perception of 
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the cohesiveness of society.  This information will be useful in developing appropriate 
interventions. 
The style of the finished instrument is still in development.  Currently, it will be a 
set of forced choice (yes/no) questions and Likert style questions (six point – strongly 
agree, agree, mildly agree, mildly disagree, disagree, strongly agree).  The forced choice 
questions will help to guide the respondent through the questions, allowing them to skip 
sections that do not pertain to them.  Six points was chosen over four to allow more 
variance to be captured and because more choices has a positive effect on reliability.  The 
exact number of questions has not been decided, and this process will help to establish 
that answer as well.  The rationale for how questions were chosen is included in a 
separate appendix.  I ask each participant to complete the scoring process before 
reviewing (or skipping!) the appendix. 
I am hoping to be able to solidify this instrument with one pass at establishing the 
content validity with your assistance.  However, it may require one additional iteration if 
substantial changes are suggested. 
 
Construct Definitions 
The following provides brief descriptions of each construct.  Since the constructs 
are complex, some effort was made to capture the construct through addressing sub-
dimensions found in the literature.  Because of the complexity of the constructs, please 
note that a thorough investigation of each sub-dimension is not being attempted.  It is 
hoped that by touching on the sub-dimensions, the greater construct will be adequately 
measured.  However, having a brief description of the sub-dimensions may assist you in 
identifying the larger construct that the question is aimed at. 
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Social Networks – Mitchell has defined a social network as “a specific set of linkages 
among a defined set of persons, with the additional property that the characteristics of 
these linkages as a whole be used to interpret the social behavior of the person involved 
(Mitchell, 1969 p. 4).”  Thus, SNs refer to the structural aspects of social relationships.  
They are the channels through which pragmatic help as well as emotional and 
psychological support can be exchanged between individuals (Achat, Kawachi, Levine, 
Berkey, Coakley & Colditz, 1998).  The overall SN represents the potential for support, 
whereas the perceived SN is composed of actual supports by those whom an individual 
knows by name, sees at least monthly, and identifies as an important support in his or her 
life (Walsh, 1994).  Perceived SN is the concept of greatest importance to this 
investigation.   
The questions pertaining to SNs are not expected to be comprehensive.  The study 
being considered will also include a separate social network analysis.  These questions 
are designed to provide information that will be used to compare the satisfaction of 
current SNs to the perceived SN.  The following sub-constructs were considered 
important and included in question development: 
Magnitude – size of network cluster. 
Directionality – unidirectional versus reciprocal support that passes between the network 
participants 
Durability – length of time in relationships. 
Homogeneity – the degree to which network members share similar social or personal 
attributes. 
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Cross Clustering – to what degree different members of a social network are in contact 
with each other. 
Social Support – Social support is the provision of actual assistance or feelings of 
attachment to individuals by other persons who are perceived as caring (Hobfoll, Freedy, 
Lane, & Geller, 1990). Social Support is considered a multi-dimensional construct.  The 
concept of social support is operationalized in many different ways:  on the basis of who 
is providing the support; quantity and quality of support; availability of support; and 
satisfaction with support (Letvak, 2002).     
An important aspect of support that is frequently overlooked in the literature is the 
concept of ‘dissupport’ (Malone, 1988; Avison, 1996).  The general assumption 
underlying findings is that social support has a positive value.  The problem is that it can 
also be viewed as a source of unwelcome demands.  Indeed, Wing (1978) has suggested 
that social withdrawal may actually be protective for someone with schizophrenia who 
may have damaged social skills.  A theoretical link exists between negative aspects of the 
affective dimension of SN and social dissupport.  Dissupport, as a source of stress, can be 
received through critical, bossy or intrusive linkages.  Both support and dissupport will 
be measured in the proposed instrument.  Sub-dimensions of social support to be 
measured include: 
General/Descriptive – aspects of the self that are important to giving or receiving social 
support 
Emotional – affection, esteem, concern, respect 
Instrumental – aid in labor, time, or money 
Informational – suggestion, information, advice 
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Appraisal – affirmation, feedback, insight into the self from the other 
Dissonance – Negative aspects of support, i.e. criticism, insults, lack of respect 
Social Capital – Social capital has received many definitions.  Portes (1998) suggest that 
social capital has come to mean “the ability to secure benefits through membership in 
networks and other social structures.”  Social capital can be investigated at the macro 
(population) level and at the micro (individual) level.  The development of this 
instrument will address the individual perception of community level support as well as 
the interaction between the self and the community.  Social capital is frequently 
considered a population level asset, making it difficult to capture in small samples.  
However, I believe that perceived social capital, even if the person may not think of it in 
that term, can be captured in small samples and compared between these samples. 
Both intra-community ties (integration) and extra-community ties (linkage) will 
be addressed (Hawe & Schiell, 2000).  Three areas commonly examined in SC are: 
Volunteering/community involvement – This aspect of social capital will be measured 
through questions regarding current perceived involvement in the community.  An SMI 
individual who is a volunteer may volunteer for reasons different from the non-SMI.  For 
many with an SMI, volunteering is a safer and less stressful decision than competitive 
employment and has nothing to do with altruism as measured by social capital.  
Additionally, perceived worth to the community and how well one fits in may affect how 
much one engages or perceives oneself to be involved in a reciprocal relationship with 
society.  It is hoped that data from this instrument will help to elaborate this hypothesized 
connection. 
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Reciprocity – looks at how a person believes that they are a contributor as well as a 
consumer of community assets, as noted above.  Questions will directly investigate how 
much give and take with society each individual perceives they are involved in.  
Reciprocity may have a positive affect on individual level self-esteem, self-worth and, 
important for this study, psychiatric stability.  Qualitative data from a pilot study just 
completed appears to reinforce this hypothesis. 
Trust – in community safety, availability of support outside immediate SNs and in 
providers is a poorly researched area regarding the SMI population.  Additionally, trust 
that people will behave in a certain way, trust in the government, and trust in ones 
neighbors has been under researched in the SMI population. 
 
Instructions 
1. Please make sure you have reviewed the constructs above and are comfortable 
with the definitions.  You may not completely agree with how the constructs are 
defined.  If you have a serious reservation, please feel free to comment on this 
separately.  Do keep in mind that none of these constructs have an absolute 
consensus of definition in the literature, so I do not expect consensus at this time 
either. 
2. Once you have reviewed the constructs, you’ll begin to address the questions 
themselves in the table provided.  Please note that there are five tasks for each 
question: 
a. In the first column indicate whether you think this question addresses 
social networks (N), social support (S) or social capital (C) by placing the 
appropriate letter in the column.  Each question was developed in relation 
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to a single construct.  However, with the level of shared variance and 
explanatory ability between these constructs it is difficult to completely 
exclude two while addressing one.  Comparing your responses will allow 
me to see how accurate I was in development of the question. 
b. This next column can be skipped if you wish.  However, I am including it 
in case you want to take a stab at which sub-dimension I am attempting to 
capture.  Below, you’ll find a list of numbers.  You can include the 
number for the sub-dimension that matches the construct in the Sub-
Dimension column of the table. 
c. The last two columns address appropriateness (A) and phrasing (P) of the 
question.  Using a three level scale, please indicate if you feel the question 
is (1) clear, (2) needs work, or (3) you haven’t the faintest idea what I’m 
talking about. 
i. Appropriateness indicates the level that you feel the question fits 
the construct you chose for that question. 
ii. Phrasing evaluates the words chosen and word order.  In your 
opinion, is the question clear and easily understood 
d. Under each question is a blank area.  Please feel free (if you answered 2 or 
3 to the A, C or P columns) to suggest a different phrasing or to make any 
other comments. 
For part 2.b. above, please use the following numbers if you choose to address the 
optional column – I’ve included this on a separate page in case you would like to print 
this page for ease of use. 
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Social Networks 
1. Magnitude 
2. Directionality 
3. Durability 
4. Homogeneity 
5. Cross Clustering 
Social Support 
6. Emotional 
7. Instrumental 
8. Informational 
9. Appraisal 
10. Dissonance 
Social Capital 
11. Volunteering / Community involvement 
12. Reciprocity 
13. Trust 
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Q# 
 
 
 
 
 
 
Question 
C
on
st
ru
ct
 
Su
b-
D
im
en
si
on
 
A
pp
ro
pr
ia
te
ne
ss
 
Ph
ra
si
ng
 
1 Most people will do the wrong thing if they know they 
won’t be caught 
    
Comment: 
2 When I do something wrong, my partner points it out for 
me 
    
Comment: 
3 I would like to have different friends than I do now     
Comment: 
4 When I am sad or feeling blue, I can always turn to my 
family 
    
Comment: 
5 I feel comfortable openly expressing my feelings     
Comment: 
6 My family spends time with my friends     
Comment: 
7 I am not lonely because I know my neighbors     
Comment: 
8 I wish my partner would try harder not to hurt my 
feelings 
    
Comment: 
9 I can count on my counselors to be honest about how 
they see me 
    
Comment: 
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10 People are trustworthy, but society is not     
Comment: 
11 I belong to a group that is not a church group     
Comment: 
12 It is okay that I don’t work because I am mentally ill     
Comment: 
13 My friends are often angry with me     
Comment: 
14 I have a close relationship with my family     
Comment: 
15 I volunteer my time to organizations when I can     
Comment: 
16 Sometimes I feel that my provider doesn’t take the time 
to hear me 
    
Comment: 
17 People without mental illness have more people to help 
them then I do 
    
Comment: 
18 Overall, I feel that enough people care about me and 
support me 
    
Comment: 
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19 
Most of my friends help me feel good, but help me in 
many other ways too 
    
Comment: 
20 My friendships tend to change quickly     
Comment: 
21 My intimate partner has the same types of problems as I 
do 
    
Comment: 
22 Sometimes I help my providers with their problems     
Comment: 
23 I take more than I give in relationships     
Comment: 
24 I often feel criticized when my family says they’re 
trying to help me 
    
Comment: 
25 I generally trust the federal government to do what is 
right 
    
Comment: 
26 I am close to my mental health providers     
Comment: 
27 As far as society is concerned, people without a mental 
illness are better than people with a mental illness 
    
Comment: 
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28 I feel safe to walk in my neighborhood     
Comment:: 
29 I often visit with my neighbors at my home or theirs     
Comment: 
30 My symptoms get in the way of my having a good 
relationship 
    
Comment: 
31 When my backs in a corner, I can count on my partner to 
support me 
    
Comment: 
32 When I need to know something, my friends usually 
have the answer 
    
Comment: 
33 I provide as much for my partner as my partner does for 
me 
    
Comment: 
34 My friends spend time with my intimate partner and me     
Comment: 
35 My family helps me     
Comment: 
36 My partner doesn’t feel I can do anything right     
Comment: 
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37 I make a point to vote during elections     
Comment: 
38 My intimate relationships usually last for a year or more     
Comment: 
39 I have had some of the same friends for many years     
Comment: 
40 Sometimes when I need advice or information, some 
people make sure I can’t get it 
    
Comment: 
41 My mental health providers know or have met my 
intimate partner 
    
Comment: 
42 If I need money or help with a bill, my family almost 
always gives it to me 
    
Comment: 
43 I can laugh with my neighbors and feel good about 
myself with them 
    
Comment: 
44 When I need a shoulder to cry on, I have at least one 
good friend to turn to 
    
Comment: 
45 I can’t disagree with others because I am mentally ill     
Comment: 
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46 My intimate partner helps me in many ways     
Comment: 
47 My friends won’t leave me alone when I want them to     
Comment: 
48 I would say that I have a large family     
Comment: 
49 I need to be careful because my community won’t help 
me 
    
Comment: 
50 My family meets several of my needs     
Comment: 
51 Most of the time people are looking out for themselves, 
not trying to be helpful 
    
Comment: 
52 If I make a mistake, my friends point it out so I will 
correct it 
    
Comment: 
53 You can trust family but no one else     
Comment: 
54 I feel that I belong and I’m at home in the community     
Comment: 
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55 Helping me feel good is what my partner does best     
Comment: 
56 Other people with a mental illness have more fun in life 
than I do 
    
Comment: 
57 My family has had contact with my mental health 
providers 
    
Comment: 
58 I have lacked friendships most of my life     
Comment: 
59 My family isn’t honest with me about what I am doing       
Comment: 
60 If I am making a mistake, my counselor will always 
point it out 
    
Comment: 
61 I know most of my neighbors by name     
Comment: 
62 In too many of my relationships, people take advantage 
of me 
    
Comment: 
63 I feel comfortable going to a neighbor and borrowing 
something 
    
Comment: 
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64 I generally trust my local government to do what is right     
Comment: 
65 The more I give to the community, the more I want to     
Comment: 
66 My friends know who my mental health providers are     
Comment: 
67 In many ways, most of my neighbors are a lot like me     
Comment: 
68 I have friendships with people who are not mental health 
clients 
    
Comment: 
69 I keep myself informed on community issues     
Comment: 
70 If I need to know something, I ask my counselor(s)     
Comment: 
71 I have many friendships with mental health clients     
Comment: 
72 My family spends time with my intimate partner     
Comment: 
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73 I choose intimate partners partially by how much we 
have in common 
    
Comment: 
74 If I need help fixing or making something, my family 
helps me 
    
Comment: 
75 My counselor tells me too much what to do without 
fully talking it over with me 
    
Comment: 
76 If I am in trouble, I can go to a neighbor for help     
Comment: 
77 I care that the community does well     
Comment: 
78 There are only a few people I completely trust     
Comment: 
79 I want to have my family living closer to me     
Comment: 
80 I know that many of my neighbors are mental health 
clients 
    
Comment: 
81 I am able to help my family when they need or ask     
Comment: 
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82 I cannot be in a relationship because I am mentally ill     
Comment: 
83 I feel I give back to the community for what I take     
Comment: 
84 I know whom to call if I have a concern about my local 
government 
    
Comment: 
85 My partner gives me things or helps me do things to 
make my life easier 
    
Comment: 
86 There must be a lot wrong for me to end an intimate 
relationship 
    
Comment: 
87 Sometimes I feel that my family is too close to me     
Comment: 
88 I find I get new mental health providers too often     
Comment: 
89 If I need food, money, or other help, my friends are 
always there 
    
Comment: 
90 I generally trust my state government to do what is right     
Comment: 
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91 My counselor(s) lift my spirits     
Comment: 
92 My partner is always telling me what to do     
Comment: 
93 Too many people block me from expressing what I feel     
Comment: 
94 In general, I have enough friends     
Comment: 
95 My mental health providers talk about their lives with 
me 
    
Comment: 
96 Only people who are also mentally ill are honest with 
me 
    
Comment: 
97 My friends say nice things to me and help me feel good 
about myself 
    
Comment: 
98 I am a trusting person     
Comment: 
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99 My partner praises me and cheers for me when I 
accomplish something 
    
Comment: 
100 I worry about bad things happening in my 
community 
    
Comment: 
101 I help my friends as much as they help me     
Comment: 
102 My family comes over or offers advice when I 
don’t want them to 
    
Comment: 
103 I can always turn to my partner for advice if I 
am confused 
    
Comment: 
104 If I were NOT mentally ill, I would care more 
about things in the community 
    
Comment: 
105 My community doesn’t care about me, so I stay to 
myself 
    
Comment: 
106 I believe that most people are basically good     
Comment: 
107 If I need to know something my family usually has the 
answer 
    
Comment: 
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108 My counselor helps me in more ways then talking and 
counseling 
    
Comment: 
109 Because of my mental illness, I can’t give back to the 
community 
    
Comment: 
110 I believe that you can’t be too careful in life     
Comment: 
111 I feel I have a voice in local government     
Comment: 
112 I belong to a church     
Comment: 
 
 534
Appendix B – “Content Validity – Second Pass” 
Results from first pass – content validity 
 Retained Retained 
and Updated 
Discarded 
Social Networks Satisfaction 22 2 9 
Sub-Constructs    
Magnitude 3   
Directionality 4   
Durability 4   
Homogeneity 5   
Clustering 6   
    
Perceived Social Support 34 2 19 
Sub-Constructs    
Emotional 7   
Instrumental 7   
Informational 5   
Appraisal 5   
Dissonance 10   
    
Perceived Social Cohesion 24 5 8 
Sub-Constructs    
Community 
Involvement 
10   
Reciprocity 6   
Trust 8   
    
 
The original total number of questions was 112.  Of these 76 were sufficient for 
inclusion in the instrument.  This was determined by the following:  There were a total of 
four professors and five clinicians who participated through answering all or nearly all 
the questions.  Each professor had their answer multiplied by two (2.0) because the 
knowledge of the constructs was considered of higher importance then knowledge of the 
population.  Clinician responses were not weighted.  A perfect score was 13 ((4 
professors x 2) + (5 clinicians x 1) = 13).  If a question received a score of 10 or greater, 
it was included with no or minor modifications.  For instance, all questions with ‘partner’ 
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or ‘intimate partner’ in them were altered by adding ‘or best friend’ in response to one 
professors suggestion that many of the SMI may not have intimate partners but may have 
a best friend.  Questions with a final score of 7-9 were considered feasible with 
modification.  Few of these were considered modifiable after review and most were 
discarded.  Any question scoring a six or below was automatically discarded. 
The next task:  Included are a few questions with modifications that I hope you 
will have time for review.  Also, four new questions were developed.  Three were 
developed to target the social network sub-dimension of directionality.  I believe that 
‘directionality’ in social networks is the same as ‘reciprocity’ in social support theory.  
For networks, this merely measures the direction of support or aid – from the respondent 
to those in his or her environment, the environment to the respondent, or both.  These 
questions target family, friends and intimate partners.  One additional question was added 
to the social cohesion construct under the reciprocity sub-dimension to bring the 
questions for that area closer to the other two sub-dimensions. 
  If you would simply review the questions I’m including that received the most 
alterations (both old and new questions are included) and also the four new questions.  
There are nine questions (table above, column labeled retained and updated) that were 
‘overhauled.’  Simply indicate to what level you agree with the questions and if you have 
an alternative wording – toss it in!  I’ve identified the constructs and sub-dimensions 
already.  
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Reworded and New Questions –  
Q #
Question
Wording Construct Sub-
Dimension
1 Old I belong to a group that is not a church 
group 
Cohesion Community 
 New I belong to a church or other community 
group 
  
 Comments    
     
2 Old I am close to my mental health providers Support Emotional 
 New Me mental health provider helps me with 
my emotional stability 
  
 Comments    
     
3 Old As far as society is concerned, people 
without a mental illness are better than 
people with a mental illness 
Cohesion Reciprocity 
 New As far as society is concerned, people 
without a mental illness do more for the 
community then people with a mental 
illness 
  
 Comments    
     
4 Old When I need a shoulder to cry on, I have 
at least one good friend to turn to 
Support Emotional 
 New I have at least one good friend to turn to 
if I am feeling sad or afraid 
  
 Comments    
     
5 Old I have many friendships with mental 
health clients 
Network Homogeneity 
 New Most of my friendships are with mental 
health clients 
  
 Comments    
     
6 Old I choose intimate partners partially by 
how much we have in common 
Network Homogeneity 
 New I choose my friends by how much we 
have in common 
  
 Comments    
     
7 Old I care that the community does well Cohesion Community 
 New I care for my community and try to help 
it when I can 
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 Comments    
     
8 Old If I were NOT mentally ill, I would care 
more about things in the community Cohesion 
 
Community 
 New Mental illness stops a person from caring 
about their community  
 
 Comments    
     
9 Old I believe that most people are basically 
good 
Cohesion Trust 
 New I believe that most people are basically 
trustworthy 
  
 Comments    
     
  NEW QUESTIONS   
     
1 New I try to provide for my family as much as 
they provide for me 
Network Directionality
 Comments    
     
2 New My friends give to me to the same 
degree I give to them 
Network Directionality
 Comments    
     
3 New My best friend or partner and I support 
each other equally 
Network Directionality
 Comments    
     
4 New I’m one of the first to involve myself 
with community projects or concerns 
Cohesion Community 
 Comments    
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Survey Measuring Perceived Social Integration 
Pilot Draft 
 
 
Name (Optional) _____________________________ 
 
 
 Birth Date _______________________  Test Date _____________________ 
      MM/DD/YY        MM/DD/YY 
 
Age in Years _____________________  Gender _______________________ 
 
 
Instructions:  This survey is designed to assess how a person feels they fit in society and 
among their family and friends.  Please read each question carefully, and circle the 
number that best describes how much that statement describes you.  Please take your time 
and answer all questions.  If you feel that a question does not pertain to you, answer N/A 
(circle 99) instead of leaving it blank.  If you have any questions please ask them now. 
 
 
  
 
 
 
  N
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1 My best friend (or partner) and I 
support each other equally 
99 0 1 2 3 4 5 
2 My friends say nice things to me and 
help me feel good about myself 
99 0 1 2 3 4 5 
3 I generally trust my local 
government to do what is right 
99 0 1 2 3 4 5 
4 My counselor helps me with my 
emotional stability 
99 0 1 2 3 4 5 
5 I have a close relationship with my 
family 
99 0 1 2 3 4 5 
6 My friends are often angry with me 99 0 1 2 3 4 5 
7 If I make a mistake, my friends point 
it out so I will correct it 
99 0 1 2 3 4 5 
8 I have friendships with people who 
are not mental health clients 
99 0 1 2 3 4 5 
9 I care for my community and try to 
help it when I can 
99 0 1 2 3 4 5 
10 There are only a few people I 
completely trust 
99 0 1 2 3 4 5 
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11 My partner (or best friend) is always 
telling me what to do 
99 0 1 2 3 4 5 
12 My friends give to me to the same 
degree I give to them 
99 0 1 2 3 4 5 
13 I find I get a new counselor too often 99 0 1 2 3 4 5 
14 I have lacked friendships most of my 
life 
99 0 1 2 3 4 5 
15 My family meets many of my needs 99 0 1 2 3 4 5 
16 My partner (or best friend) doesn’t 
feel I can do anything right 
99 0 1 2 3 4 5 
17 Most of my friends help me feel 
good, but help me in many other 
ways too 
99 0 1 2 3 4 5 
18 My family spends time with me and 
my friends 
99 0 1 2 3 4 5 
19 People are trustworthy, but society is 
not 
99 0 1 2 3 4 5 
20 When I need to know something, my 
friends usually have the answer 
99 0 1 2 3 4 5 
21 If I am making a mistake, my 
counselor will always point it out 
99 0 1 2 3 4 5 
22 My intimate partner (or best friend) 
helps me in many ways 
99 0 1 2 3 4 5 
23 Sometimes I feel that my family is 
too close to me 
99 0 1 2 3 4 5 
24 I can always turn to my best friend 
(or partner) for advice if I am 
confused 
99 0 1 2 3 4 5 
25 Mental illness stops a person from 
caring about their community 
99 0 1 2 3 4 5 
26 I know whom to call if I have a 
concern about my local government 
99 0 1 2 3 4 5 
27 I believe that in a pinch, I could trust 
a stranger to help me 
99 0 1 2 3 4 5 
28 My counselor talks about his or her 
life with me 
99 0 1 2 3 4 5 
29 My family spends time with me and 
my intimate partner (or best friend) 
99 0 1 2 3 4 5 
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30 My partner (or best friend) praises 
me and cheers for me when I 
accomplish something 
99 0 1 2 3 4 5 
31 In general, I have enough friends 99 0 1 2 3 4 5 
32 Most people will do the wrong thing 
if they know they won’t be caught 
99 0 1 2 3 4 5 
33 When I am sad or feeling blue, I can 
always turn to my family 
99 0 1 2 3 4 5 
34 I belong to a church or other 
community group 
99 0 1 2 3 4 5 
35 I wish my partner (or best friend) 
would try harder not to hurt my 
feelings 
99 0 1 2 3 4 5 
36 I change friends quickly 99 0 1 2 3 4 5 
37 I feel criticized when my family says 
they’re trying to help me 
       
38 I generally trust the federal 
government to do what is right 
99 0 1 2 3 4 5 
39 As far as society is concerned, 
people without a mental illness can 
do more for the community then 
people with a mental illness 
99 0 1 2 3 4 5 
40 I have at least one good friend to 
turn to if I am feeling sad or afraid 
99 0 1 2 3 4 5 
41 My family has had contact with my 
counselor(s) 
99 0 1 2 3 4 5 
42 Helping me feel good is what my 
partner or best friend does best 
99 0 1 2 3 4 5 
43 Most of my friends are also mental 
health clients 
99 0 1 2 3 4 5 
44 My community doesn’t care about 
me, so I stay to myself 
99 0 1 2 3 4 5 
45 I feel I have a voice in local 
government 
99 0 1 2 3 4 5 
46 I have had some of the same friends 
for many years 
99 0 1 2 3 4 5 
47 When I do something wrong, my 
partner or best friend points it out to 
me 
99 0 1 2 3 4 5 
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48 I volunteer my time to organizations 
when I can 
99 0 1 2 3 4 5 
49 Sometimes I feel that my counselor 
doesn’t take the time to hear me 
99 0 1 2 3 4 5 
50 I feel safe to walk in my 
neighborhood 
99 0 1 2 3 4 5 
51 When my back is in a corner, I can 
count on my partner or best friend to 
support me 
99 0 1 2 3 4 5 
52 My friends spend time with my 
intimate partner (or best friend) and 
I 
99 0 1 2 3 4 5 
53 I make a point to vote during 
elections 
99 0 1 2 3 4 5 
54 My closest relationships usually last 
for two years or more 
99 0 1 2 3 4 5 
55 Sometimes when I need advice or 
information, friends or family make 
sure I can’t get it 
99 0 1 2 3 4 5 
56 My counselor knows or has met my 
intimate partner or best friend 
99 0 1 2 3 4 5 
57 If I need money or help with a bill, 
my family almost always gives it to 
me 
99 0 1 2 3 4 5 
58 My friends won’t leave me alone 
when I ask them to 
99 0 1 2 3 4 5 
59 I would say that I have a large 
family 
99 0 1 2 3 4 5 
60 I need to be careful because my 
community won’t help me 
99 0 1 2 3 4 5 
61 Most of the time people are looking 
out for themselves, not trying to be 
helpful to others 
99 0 1 2 3 4 5 
62 I feel that I belong and I’m at home 
in the community 
99 0 1 2 3 4 5 
63 My family isn’t honest with me 
about what I am doing 
99 0 1 2 3 4 5 
64 The more I give to the community, 
the more I want to 
99 0 1 2 3 4 5 
65 My friends know who my 
counselors are 
99 0 1 2 3 4 5 
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66 In many ways, most of my 
neighbors are a lot like me 
99 0 1 2 3 4 5 
67 I keep myself informed on 
community issues 
99 0 1 2 3 4 5 
68 If I need to know something, I ask 
my counselor(s) 
99 0 1 2 3 4 5 
69 I choose my friends by how much 
we have in common 
99 0 1 2 3 4 5 
70 If I need help fixing or making 
something, my family helps me 
99 0 1 2 3 4 5 
71 I try to provide for my family as 
much as they provide for me 
       
72 I am one of the first to contribute to 
community projects or concerns 
99 0 1 2 3 4 5 
73 I feel I give back to the community 
for what I take 
99 0 1 2 3 4 5 
74 If I need to know something my 
family usually has the answer 
99 0 1 2 3 4 5 
75 My counselor tells me too much 
what to do without fully talking it 
over with me 
99 0 1 2 3 4 5 
76 My family comes over or offers 
advice when I don’t want them to 
99 0 1 2 3 4 5 
77 I know that many of my neighbors 
are mental health clients 
99 0 1 2 3 4 5 
78 I generally trust my state 
government to do what is right 
99 0 1 2 3 4 5 
79 If I need food, money, or other help, 
my friends are always there 
99 0 1 2 3 4 5 
80 My partner gives me things or helps 
me do things to make my life easier 
99 0 1 2 3 4 5 
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DO NOT WRITE BELOW THIS POINT 
 
 
SNS Score = 
____________ 
 
MAG Sub-Score = 
__________ 
 
HOM Sub-Score = 
__________ 
 DIR Sub-Score =   
__________ 
CLU Sub-Score =  
__________ 
 
DUR Sub-Score = 
__________ 
 
   
PSS Score = 
____________ 
EMO Sub-Score = 
__________ 
APP Sub-Score = 
__________ 
 
INS Sub-Score =   
__________ 
DIS Sub-Score =  
__________ 
 
INF Sub-Score =   
__________ 
 
   
PSC Score = 
____________ 
COM Sub-Score = 
__________ 
TRU Sub-Score = 
__________ 
 
REC Sub-Score =  
__________ 
 
   
PSI Score = 
____________ 
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Appendix C 
 
 
Forms 
 
 
Participant Contact Letter 
Participant Follow-Up Contact Letter 
Informed Consent 
Informed Consent Checklist 
Compensation Reception Form 
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Participant Contact Letter 
 
August 18, 2005 
 
Dear Sir or Madam: 
 
 This letter is an invitation to participate in a research project that the Harbor and 
the University of South Florida are working on in cooperation.  The study is titled 
“Factors Related to Recovery from Mental Illness.”  Please take a moment to read this 
letter and to decide if you would like to participate. 
 
You are 1 of 350 people being asked to participate.  In order for you to 
participate, it is important for you to understand what the study is about and what your 
part in it will be.  First, the study is looking at how factors related to the individual (e.g., 
symptoms, diagnosis, hospitalization, experiences of stigma, social support, etc.) and the 
services they receive (e.g., how satisfied you are, etc.) are related to your recovery.  
Second, we are interested in what helps you in your recovery process and what you think 
is important in order to recover. 
 
So what do you have to do?  If you are interested, you need to contact us through 
the lead researcher (Gary Walby) at the following number: 727-858-3335. Please leave a 
message if he does not answer.  Your primary provider (e.g. therapist, case manager) will 
know about this project as well, so you can talk to them if you want to.  Next, an 
appointment will be made to meet at the Harbor offices nearest you.  You will only have 
to attend one appointment.  During this appointment you will have the study explained 
in more detail, you will review an informed consent so you absolutely understand what 
is being asked of you, and then you will answer a series of surveys.  The total time 
involved will range from 60-90 minutes.  For your time, each individual will be paid 
$10.00 as a thank you for your effort.   
 
At this appointment you will be guided through the process by one of our team 
members.  They include John Adams, Amy Bradd, Jessica Burns, Christina Rickus or 
Gary Walby.  We very much hope to hear from you and will look forward to our meeting. 
 
Sincerely, 
 
 
 
Gary W. Walby, M.S., M.S.P.H. 
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Follow-Up Contact Letter 
 
<DATE> 
 
Dear <NAME> 
 
 Thank you for your interest in the research study titled “Factors Related to 
Recovery from Mental Illness.”  We have either spoken to you on the phone, or you 
returned a postcard to us that your provider provided, or you let your primary provider 
know that you were interested and they contacted us via the telephone.  This letter is to 
confirm the appointment time and date that was agreed upon in our prior conversation. 
 
Appointment Location: ______________________________________________ 
 
Appointment Date and Time __________________________________________ 
 
 
As a reminder, you will only have to attend one appointment.  During this 
appointment you will have the study explained in more detail, you will review an 
informed consent so you absolutely understand what is being asked of you, and then 
you will answer a series of surveys.  The total time involved will range from 60-90 
minutes.  For your time, each individual will be given $10.00 as a thank you for your 
effort.   
 
If the time, date, and or location of the appointment noted above is either incorrect 
or something has happened that you must change the appointment time, please contact us 
as soon as possible.  First attempt to contact the person listed below.  If they are not 
available or do not return your call within 48 hours then please contact the lead 
researcher (Gary Walby) at 727-858-3335. 
 
Researcher Name ___________________________________ 
 
Phone Number _____________________________________ 
 
 
Thank you very much for your interest and assistance in this research effort. 
 
 
Sincerely, 
 
 
 
Gary W. Walby, M.S., M.S.P.H. 
 
  
Informed Consent for an Adult 
Social and Behavioral Sciences  
University of South Florida 
Morton Plant Mease BayCare 
 
Information for People Who Take Part in Research Studies 
 
Researchers at the University of South Florida (USF) study many topics.  For instance, 
information on how people cope or recover from mental illness, what factors are 
important for recovery, and how people feel about services for mental illness.  To do this, 
we need the help of people who agree to take part in a research study.  
Title of research study:   Factors Related to Recovery From Mental Illness 
Person in charge of study:   Gary Walby, M.S., M.S.P.H. 
Study staff who can act on behalf of the person in charge: Jessica Burns, Christina 
Rickus, John Adams, and Amy Bradd 
Where the study will be done:  The Harbor Behavioral Health Care Institute 
Should you take part in this study? 
This form tells you about this research study.  You can decide if you want to take part in 
it.  You do not have to take part.  Reading this form can help you decide. 
Before you decide: 
• Read this form. 
• Talk about this study with the person in charge of the study or the person 
explaining the study.  You can have someone with you when you talk about the 
study. 
• Find out what the study is about. 
You can ask questions: 
• You may have questions this form does not answer.  If you do, ask the person in 
charge of the study or study staff as you go along. 
• You don’t have to guess at things you don’t understand.  Ask the people doing 
the study to explain things in a way you can understand. 
After you read this form, you can: 
• Take your time to think about it.  
• Have a friend or family member read it. 
• Talk it over with someone you trust. 
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It’s up to you.  If you choose to be in the study, then you can sign the form.  If you do not 
want to take part in this study, do not sign the form.   
Why is this research being done? 
The purpose of this study is to find out if individuals believe they will recover from 
mental illness, what ways they use to recover, and what factors are related to beliefs in 
recovery and choice of ways to recover. 
Why are you being asked to take part? 
We are asking you to take part in this study because you are a consumer/client at the 
Harbor and have been diagnosed with an illness. 
How long will you be asked to stay in the study? 
You will be asked to spend part of one day in the study answering questions.  You will 
have the option to pause answering questions if you choose and start again on a different 
day.  If this happens then you will spend a maximum of two days in the study. 
How often will you need to come for study visits? 
A study visit is one you have with the person in charge of the study or study staff.  You 
will need to come for one study visit, or two if you decide to pause and resume data 
collection.  After agreeing to be in the study by understanding and signing this form, you 
will be asked a series of questions from several surveys. 
Most study visits, and your total time in this study, will take about 45-90 minutes.    
At each visit, the person in charge of the study or staff will assist you in answering 
several surveys that cover recovery beliefs, symptoms, personal and family history, 
experiences of stigma or empowerment and related factors. 
How do you get started?  
If you decide to take part in this study, you will need to sign this consent form.   
Also, to make sure that you understand what you are agreeing to, a quick assessment will 
also be completed to make sure that you know what is being asked of you.  This is called 
an independent capacity assessment.  Once the consent form is signed, the researcher will 
begin to ask you questions and provide you with the surveys. 
It is important that each individual knows that this form also gives permission for the 
researcher to look at the Harbor clinical records of the participant in order to get 
background information of importance (e.g. diagnostic history, hospitalization history, 
services provided, etc.) 
Will you be paid for taking part in this study? 
We will pay you for the time you volunteer in this study. You will be paid $10.00 for 
your time in answering the survey questions.  There is no other compensation available. 
What will it cost you to take part in this study? 
There is no cost to you for this research. 
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What are the potential benefits if you take part in this study? 
We don’t know if you will get any benefits by taking part in this study.  It is hoped that 
this research will assist in program development to increase the success in recovery, but 
this may or may not benefit you directly. 
What are the risks if you take part in this study? 
There are no known risks to those who take part in this study.   
What if you get sick or hurt while you are in the study?  
If you need emergency care:  
• USF does not provide emergency care. 
• Morton Plant Mease Statement:  You may be exposed to risk of injury from taking 
part in this study. In the event of an injury, which you believe is related to this 
clinical trial, medical care (including hospitalization) is available. Such treatment 
will be at your expense, the expense of the sponsor, or your medical insurance. 
Morton Plant Mease Health Care and its hospitals do not have funds available to 
provide payment for such injuries. You are not giving up any legal rights by 
signing this document, nor are you releasing Morton Plant Mease Health Care, 
its hospitals, or doctors, from responsibility for negligence unrelated to the nature 
and risk of the treatment. Further information on the above, as well as 
information regarding this research may be obtained from Morton Plant Mease 
Health Care Department of Clinical Research at (727) 461-8311. 
• Call the person in charge of this study as soon as you can.  They will need to 
know that you are hurt or ill.  Call Gary Walby at 727-858-3335 or Emergency 
Services at 727-841-4455. 
What will we do to keep your study records private? 
Federal law requires us to keep your study records private.  All study records will have 
only an identification code other than this consent.  All records will be stored in separate 
locked cabinets in a locked office.  All computer records will be password protected. 
However, certain people may need to see your study records.  By law, anyone who looks 
at your records must keep them confidential.  The only people who will be allowed to see 
these records are: 
• The study staff. 
• People who make sure that we are doing the study in the right way.  They also 
make sure that we protect your rights and safety: 
o The USF Institutional Review Board (IRB), its staff and other individuals 
acting on the behalf of USF 
o Morton Plant Mease Institutional Review Board 
o The United States Department of Health and Human Services (DHHS) 
We may publish what we find out from this study.  Also, we have agreed to inform the 
Harbor management and clinical staff of the results of the study to assist them in 
 550
developing better recovery programs.  Whether for publication or the Harbor, we will not 
use your name or anything else that would let people know who you are. 
What happens if you decide not to take part in this study? 
You should only take part in this study if you want to take part.   
If you decide not to take part: 
• You won’t be in trouble or lose any rights you normally have. 
• You will still receive the same services at the Harbor you would normally have. 
What if you join the study and then later decide you want to stop? 
• If you choose to stop while filling out the surveys, simply tell the researcher and 
the process will end. 
You can get the answers to your questions. 
If you have any questions about this study, call Gary Walby at 727-858-3335. 
If you have questions about your rights as a person who is taking part in a study, call USF 
Research Compliance at (813) 974-5638. 
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Consent to Take Part in this Research Study 
It’s up to you.  You can decide if you want to take part in this study. 
I freely give my consent to take part in this study.  I understand that this is 
research.  I have received a copy of this consent form. 
 
________________________ ________________________ ___________ 
Signature Printed Name Date 
of Person taking part in study of Person taking part in study 
 
Statement of Person Obtaining Informed Consent 
I have carefully explained to the person taking part in the study what he or she can 
expect.  
The person who is giving consent to take part in this study 
• Understands the language that is used. 
• Reads well enough to understand this form.  Or is able to hear and understand 
when the form is read to him or her. 
• Does not have any problems that could make it hard to understand what it means 
to take part in this study.  
• Is not taking drugs that make it hard to understand what is being explained.   
To the best of my knowledge, when this person signs this form, he or she understands: 
• What the study is about. 
• What needs to be done. 
• What the potential benefits might be.  
• What the known risks might be. 
• That taking part in the study is voluntary. 
 
________________________ ________________________ ___________ 
Signature of Investigator Printed Name of Investigator Date 
or authorized research 
investigator designated by 
the Principal Investigator 
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Informed Consent Checklist 
 
Respondent #  _______________ Date ______________      
Attempt # ______________ 
 
Directions:  The participant must answer all questions correctly and in order to be in the 
study.  If an incorrect answer is given, re-explain the section that was missed and begin 
the checklist again with a new form.  Keep and attach ALL checklists used to the signed 
informed consent. 
 
 
Do you have the right to say no to this study? 
 
Correct _____ Incorrect  _____ 
 
 
What is this study about? 
 
Correct _____ Incorrect  _____ 
 
 
How long will you be asked to be in the study? 
 
Correct _____ Incorrect  _____ 
 
 
How many times will you need to see someone in the study? 
 
Correct _____ Incorrect  _____ 
 
 
Are there any potential risks to this study? 
 
Correct _____ Incorrect  _____ 
 
 
What can happen if you decide not to join the study? 
 
Correct _____ Incorrect  _____ 
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What happens if you decide to stop being in the study? 
 
Correct _____ Incorrect  _____ 
 
 
Is there a payment for being in the study and what is it? 
 
Correct _____ Incorrect  ____ 
 
 
 
 
Signature of Researcher__________________________________________ 
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Compensation Receipt Form 
 
 
Participant # ____________________ Gender _________________________ 
 
Test Date ____________________________  
  MM/DD/YY 
 
 
By signing this, I am stating that I have received the compensation for taking part in this 
study.  This compensation is exactly $10.00 for my time in answering the survey 
questions with the researcher. 
 
 
 
___________________________________________ ________________ 
Participant Name      Date and Time 
 
 
 
___________________________________________ ________________ 
Researcher Witness       Date and Time 
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Appendix D 
 
Training Material for Research Assistants 
 
 
Training Schedule 
Training Week 2 Information 
Training Week 3 Information 
Psychotropic Medication Handout 
Medication Tables 
Scripts: 
 Opening Script 
 Consent Process Script 
 Opening Steps 
 Data Collection Instruments 
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College of Public Health 
Recovery Research Team 
Weekly Training Schedule 
June 22 – July 27 
All meeting times are 2:00 p.m. to 5:00 p.m. 
 
 
Week One – June 22 
Introduction to study 
Confidentiality and human subjects protection 
Consent form and procedures 
Introduction to study forms 
Dissemination plan 
Q & A 
 
Week Two – June 29 
Introduction to the study population 
Diagnoses 
Study forms in-depth 
Possible stressful scenarios 
Adverse events 
What to do in a crisis 
 
Week Three – July 6 
Medications 
Services 
Data collection protocol – the nitty gritty 
No missing data 
 
Week Four – July 13 
Data collection practice 
No missing data 
 
Week Five – July 20 
Data collection practice 
No missing data 
 
Week Six – July 27 
Data collection practice 
No missing data 
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Recovery Research Training – Week 2 
June 29, 2005 
 
Introduction to the study population 
 
 The study population will be comprised of individuals on a continuum of mental 
illness.  The artificial differences between the SMI (severely mentally ill) and OP 
(outpatient therapy clients) samples may or may not accurate until confirmed via 
analysis.  Thus, we cannot assume that the OP sample will be high functioning or that the 
SMI sample will be low functioning.  However, there are differences between individuals 
with higher levels of severity and those with less severity of mental illness.  To reiterate, 
these differences may not accurately distinguish the two samples.  These differences will 
be emphasized via looking briefly at clinical, social, history, occupation and education, 
and health factors.   
Clinical –  
Diagnosis:  Diagnostically, we can expect some key differences due to severity of 
mental illness.  Individuals in the SMI sample will be required to have a diagnosis 
of:  (1) schizophrenia or a schizophrenia spectrum disorder (e.g. paranoid 
disorder, delusional disorder, or schizoaffective disorder), (2) bipolar disorder 
(bipolar I or bipolar II, manic or depressive dominant, slow or rapid cycling), and 
(3) major depression, most likely recurrent, with or without psychotic features.  A 
fourth category (other) will be used to capture individuals with features related to 
the above AND who have been designated severely mentally ill by the partnering 
agency. 
 Thinking outside the sample inclusion criteria, it is possible that 
individuals in the OP sample will also have one of these diagnoses but with the 
additional designation of ‘in remission’ or ‘in partial remission.’  Those with less 
severe illnesses will be labeled with many possible diagnoses.  For instance, 
dysthymia and post-traumatic stress disorder are likely, as are other anxiety 
disorders, somatization disorders, behavioral disorders and dissociative disorders.  
Codes/diagnoses likely in less severe cases and not in severe cases are adjustment 
disorders and V-codes.  Adjustment disorders are limited, reactive symptom 
clusters related to some discernible life event.  For instance, an adult who is 
processing through a divorce and becomes clinically depressed at a mild-moderate 
level may be diagnosed with ‘adjustment disorder with depression.’  There are 
also adjustment disorders with anxiety or conduct problems, and several others.  
V-Codes are definitive of environmental problems, events, or relationship issues 
that are the focus of treatment.  This does not preclude heightened clinical 
symptoms but the focus will be on the presenting issue.  For example, V-codes 
include marital problem, family issues, parent-child problem, etc. 
 Axis 2 diagnoses of personality disorders are likely to be somewhat 
common.  For some less severe individuals these may be the primary diagnosis of 
clinical interest with a less severe axis one diagnosis as comorbid.  For individuals 
with more serious illnesses personality disorders may be secondary comorbid 
conditions.  Keep in mind that the National Comorbidity Survey found that 
individuals labeled as SMI have a minimum of three psychiatric diagnoses in 
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approximately 93% of cases.  This may or may not be reflected in the clinical 
records but should be kept in mind. 
 Substance abuse diagnoses are allowed for the study providing that it is 
not the Axis 1 primary diagnosis.  A comorbid abuse or dependence diagnosis 
does not disqualify an individual.  However, the burgeoning literature on co-
occurring disorders strongly suggest that said individuals have more intractable 
illnesses and may be experiencing, in general, more psychiatric burden from 
moment to moment. 
Impact on Data Collection:  Current diagnosis and diagnostic history will 
impact data collection indirectly.  Individuals with more serious diagnoses 
will be at risk for cognitive and emotional processing deficits that may 
interfere with the pace of data collection, their ability to maintain 
attention, and require more assistance in understanding the questions.  
Further, they may become more easily frustrated and may also choose to 
discontinue the study.  The study is focused on recovery from mental 
illness and having a bias introduced via more severe cases quitting is a 
potential, and worrisome, occurrence.  Extra care to establish and maintain 
rapport is needed with more severe cases.   Individuals with diagnoses of 
borderline, narcissistic, or antisocial personality disorders are more apt to 
be difficult respondents and these diagnoses, if offered by the respondent, 
should heighten the researchers attention.  The same is true if a co-
occurring addictive process or substance abuse history are indicated. 
 A very KEY POINT to keep in mind is to never lose sight of the 
human being behind the diagnosis.  Thus, terms such as ‘a borderline’ or 
‘a schizophrenic’ are derogatory and will be viewed as insensitive by 
consumers and providers alike. 
 
Symptoms – Current:  Current symptom levels will be detected by the Symptom 
Checklist-90R.  This instrument will be administered first for three reasons:  (1) it 
asks questions that many of the consumers will be familiar with, easing anxiety.  
(2) it is the longest instrument and the consumer will feel that they have made 
immediate headway and will be less resistant for other instruments and less likely 
to stop/quit.  (3) there are several questions that are cues to potential 
behaviors/problems that can interrupt the collection process and the researcher 
will be able to mentally mark these and adjust his or her behavior/demeanor 
accordingly.  These questions include: 
11. Feeling easily annoyed or irritated 
15. Thoughts of ending your life 
24. Temper outbursts that you can’t control 
38. Having to do things very slowly to insure correctness 
43. Feeling that you are being watched or talked about by others\ 
45.  Having to check or double-check what you do 
46. Difficult making decisions 
54. Feeling hopeless about the future 
55. Trouble concentrating 
59. Having thoughts of death or dying 
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67. Having urges to break or smash things 
74. Getting into frequent arguments 
78. Feeling so restless you couldn’t sit still 
81. Shouting or throwing things 
84. Having thoughts about sex that bother you a lot 
Be alert to patterns within these questions and be aware that, though the SCL-90-
R instructs the respondent to indicate their experience with these in the last seven 
days, he or she may be experiencing these at the moment of data collection.   
Impact on Data Collection:  Like diagnosis, an elevated symptom picture 
will influence data collection in many of the same potential ways.  
Symptoms may interfere with cognitive and emotional processing.  It is 
important that if the individual is revealing symptoms or discernibly 
symptomatic that you stay focused on the task of data collection:  
maintaining rapport/empathy, pacing the data collection toward its 
endpoint, staying organized and ensuring as neat and complete a process 
as possible.  Always remember that assistance is just a few steps away. 
 
Symptoms – Prodromal:  The developmental period that is non-symptomatic to 
first symptoms and then age of full onset varies by the individual and can have a 
great impact on current functioning.  Statistically, the following nine individual 
symptoms are considered predictive of the onset of serious mental illness: 
1. Reduced attention and concentration 
2. Reduced energy, motivation and anergia 
3. Depressive mood 
4. Sleeping disturbances 
5. Anxiety 
6. Social withdrawal 
7. Mistrust 
8. Social dysfunctioning 
9. Social constructs (self-esteem, self-efficacy) 
Other areas that could impact ability to focus on the data collection process 
include impact on cognitive functioning, focus and attention, and the capacity to 
work independently.  The earlier the onset of serious illness the more likely that 
the brain has received inalterable structural and neurochemical changes.  In most 
cases these are subtle and it is difficult to predict the direct impact on data 
collection.  Attention deficit problems are predictive of potential later serious 
mental illness and may continue into adulthood.  Further, serous illness may de-
energize an individual and or impact on their self-efficacy (belief in ability to 
accomplish something), increasing the time needed to complete tasks. 
Impact on Data Collection:  The above prodromal-to-current 
developmental factors may slow the data collection process.  Extra care 
should be taken to assist the individual in maintaining focus, offering 
breaks when needed, assisting the respondent in understanding what 
specific words mean (assisting with vocabulary, not with interpreting the 
question) and consistently reminding them that they are in the position of 
helping us, that we need them, and that they are in control. 
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Social –  
Social Networks:  A social network is the number of social contacts or 
relationships that an individual has.  This includes the network density (how many 
individuals the person is in contact with) and composition (who makes up each 
cluster).  Individuals with a more severe illness history will have smaller numbers 
(less density) and fewer clusters.  Increased severity also means that these 
individuals are much more likely to rely on family members, other individuals 
who are mentally ill, and families of origin for social contacts.  Individuals  
Social and Familial Roles:  The more severe the illness the greater the probability 
that the individual will be the identified patient (the ‘sick one’) in any or all social 
interactions.  This role will in time become part of the self-structure.  This will 
have a negative effect on self-esteem and confidence.  Family members may 
lower expectations of the individual when a mental illness arises.  It is not 
uncommon for the family to assume that all abilities and functioning are 
compromised.  Internalization of lower familial expectations is often followed 
with lowered expectations of self as well.  Further, the emotional expression of 
family members can range from far too empathic and enmeshed to cold and 
distant.  Internalization and hypersensitivity to expressed emotion is relatively 
common for individuals with severe mental illness. 
Social Skills, Social Comfort, and Social Resources:  The more severe the illness 
the higher the probability that the individual will have social skill deficits.  This 
may also extend to being uncomfortable in situations like the research situation.  
Keep in mind that many of the individuals with severe mental illness have very 
limited, often non-existent, money for social events.  This level of isolation 
contributes to their marginalized existence and often increases eagerness for 
social contact. 
Hygiene:  Individuals with mental illness may, usually during periods of 
decompensation, but not always, have poor hygiene.  Individuals who are 
psychiatrically fragile will be screened from entering the study, decreasing this 
problem.  However, because it may occur, I will be dispensing room fresheners to 
each member as part of their data collection equipment.   
Impact on Data Collection:  Limited social networks and, possibly, 
reduced social participation may channel the more severe individual into 
viewing the researcher as a clinician.  This in turn could trigger the 
individual to stray into areas of discussion that are clinical in nature.  It is 
imperative at these moments for the researcher to restate their role and 
purpose for the respondent.  This should be done empathically but directly 
followed with an immediate return to data collection.  Addressing role 
functions, individuals with mental illness may adapt the sick role and 
expect assistance when none is needed.  However, the point of this 
research is data collection.  If the researcher is asked to read the questions 
and provide more direct assistance for data collection then please do so.  
Do not become embroiled in a control struggle if you sense that the 
individual is more capable then he or she lets on.  That assumes that they 
are aware of their capacity and may be deliberately downplaying their 
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abilities.  It is equally likely that they are responding in habitual patterns 
or role scripts and data collection is not the point to challenge these.  If 
hygiene is a problem it is important to tolerate this issue, if it occurs, and 
not to comment on it, as this is a clinical issue and not a research issue.  
 
History –  
Individuals with mental illness have experienced varying levels of loneliness and 
isolation, difficult familial relations and abnormal developmental experiences.  
Development is influenced by biology and environmental factors.  In fact, it is a 
common belief that for most severe mental illnesses that biology determines onset 
and environment determines course and (to a great extent) recovery.  Two areas of 
historic concern are abuse and trauma, and substance history/self-medication.   
Abuse and trauma are common experiences for individuals with mental 
illness.  These experiences are linked to onset, course, symptoms, and recovery.  
It is very likely that many of the respondents will have sexual or physical abuse or 
assault in their childhood and adulthood.  Individuals with this history are more 
likely to have been abused, further complicating the clinical picture.  It is 
important to remember this potential history from the moment of first contact, 
even if the actual questions are not until nearly the end of data collection. 
Finally, not only do many of these individuals live near or in poverty, 
many of them grew up in poverty.  Poverty is one of many structural, macro level 
risk factors for mental illness.  Indeed, the lower SES is a risk for earlier onset and 
poor course of illness. 
Impact on Data Collection:  These varying historical factors will have 
many of the same effects as previously noted.  Together, they indicate 
both vulnerability and an uncommon resilience.  It cannot be assumed 
individuals with mental illness are uniformly fragile.  It also cannot be 
assumed that each individual is well along on their recovery journey or 
that they even believe in the concept of recovery.  Thus, each research 
team member will need to understand their beliefs about recovery before 
beginning any data collection and remain as objective, empathic and 
pleasant as possible during data collection. 
 
Occupation and Education
More severely ill individuals (currently and/or historically) are less likely to be 
employed or to have a successful history of competitive employment.  Similarly, 
the more severely ill are less likely to have college experience and are more likely 
to not have graduated from high school.   
Implications for Data Collection:  With a potential poor history of work 
and education, it is imperative to connect with the humanity of the 
respondent and to actively work against being viewed as superior or better.  
This can be difficult as consumers are used to adopting a general 
subservience around individuals with considerable education.  It is 
important to engage them in a collaborative process where the consumer is 
helping the researcher.  There is evidence in the literature that this 
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improves effort and thus accuracy of research data and, more importantly, 
it is compatible with the public health values of equity and social justice. 
 
Health
Mental illness has a profound affect on perceived health, years lived with 
morbidity and disability, and reduction in life expectancy.  General health is 
associated with quality of life and both are depressed due to mental illness.  The 
more severe the history of mental illness the more chronic health conditions 
potentially afflict the individual.  Individuals with severe mental illness are at a 
much higher risk for coronary conditions, neoplasm, diabetes and other illnesses.  
Further, for some illnesses (e.g. schizophrenia) there is an increased risk of 
medical conditions due to the psychiatric medications (e.g. diabetes due to 
atypical antipsychotics).  Individuals with severe mental illness are also at a 
higher risk for blood-borne illnesses (e.g. hepatitis B and C, and HIV) compared 
to the non-mentally ill population.  Finally, mental illness is often accompanied 
by poor health habits (e.g. smoking and drinking) as well as poor nutrition and 
inactive lifestyles.  Part of the bad habits is learned and part stem from lack of 
resources.  Interestingly, nicotine has demonstrated an anti-hallucinatory affect, 
which may account in part for the number of individuals with schizophrenia who 
are nicotine addicted 
Implications for Data Collection:  Mental illness takes a toll not only 
mentally but also physically.  Many individuals interviewed might be in 
poor condition and suffering from physical illnesses.  This may slow 
response time, necessitate additional breaks, and disrupt concentration.  
The individual may be thinking about these problems to a degree and 
some questions may initiate discussion of these problems.  It is important 
to be polite, listen, and steer the conversation and focus back to the data 
collection task. 
 
Possible stressful/frustrating scenarios 
The following are a sample of potentially frustrating experiences or 
habits/behaviors of the respondent.  If other situations arise, please contact me 
directly and immediately.  A list will be kept to update all team members. 
1. Argumentative respondent:  Some respondents may argue for the sake of 
arguing or have a disorder that is characterized with a difficult interpersonal 
style (e.g. borderline or antisocial personality disorders).  For these 
individuals the researcher is asked to remain calm, do not respond negatively, 
defuse through low tones and possibly a positive use of humor, and stay 
focused on the data collection task. 
2. Frequent breaks/poor attention:  This is more likely for individuals with 
severe illnesses who have a legitimate reason for needing to break or who may 
be enjoying the attention and are seeking to prolong the encounter.  Less 
severe individuals may have other items on their agenda and will complete the 
process with few to no interruptions. 
3. Slow responders:  Some individuals may spend more time than others over 
some or all questions.  If this is a function of cognitive deficit then no amount 
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of encouragement will speed them up.  However, if the individual appears to 
be spending too much time trying to find the ‘right’ answer, then the 
researcher can encourage them by pointing out that their first is nearly always 
the one that fits them best and that there is no ‘right’ answer to any of these 
questions. 
4. Consistent misinterpretation or misunderstanding of question content:  For 
some individuals this is a consequence of their illness and the researcher 
should handle this with patience and compassion.  The researcher needs to be 
careful to alter the meaning of the question when explaining it or to map his or 
her own experience onto the question, as this will likely be confusing to the 
respondent.  As much as possible, give meaning to misunderstood words only. 
5. Wanting to bring a friend or family member to the data collection 
appointment:  This should be discouraged as much as possible.  Simply stating 
that this is not a possibility will deter most attempts without losing the 
respondent.  However, if the respondent insists and there is a danger of non-
participation due to this, then one person may accompany with the following 
rules:  They do not participate or offer any responses.  If they do so they must 
be warned once and asked to leave on the second infraction.  If the respondent 
asks the person that accompanies them for an answer or an opinion, the 
researcher will interrupt this and will use the same guidelines as just noted 
(one warning then asking the accompanier to leave). 
6. Respondent who makes personal inquiries:  Many individuals with mental 
illness are lonely and isolated.  They are curious about your life and may form 
a relatively quick attachment to you as well.  Inquiries will range from jobs 
and hobbies to relationships and children.  This may include your ‘status’ as a 
prelude to asking you out or inquiring if they could see you again some time.  
At all times the researcher will maintain their respect for the individual, 
remembering that the researcher is often in a far more stable and productive 
situation.  It is recommended that the researcher reveal as little about him or 
herself as possible as the goal is a one-time data collection and not a social 
interaction.  Confirming that the researcher is in a relationship in a matter-of-
fact tone with an immediate return to data collection will often defuse other 
questions. 
7. Flirting or sexually suggestive behavior:  This could range from mildly 
suggestive and even humorous to quite explicit and uncomfortable.  The latter 
will, in all likelihood, never occur.  However, if the researcher becomes 
uncomfortable it is suggested that they directly state this to the participant and 
ask them to return to task.  If an uncomfortable situation remains please feel 
free to end the data collection, pay the incentive, and ask the person to leave. 
8. Do not keep appointments or frequent reschedules:  Unfortunately, not 
keeping appointments is common, especially for those with a SMI.  Each 
participant will be able to reschedule one time only.  If they do not attend the 
rescheduled appointment than this should be communicated to me, and he or 
she will be dropped from the study. 
9. Wanting to quit early and still receive the incentive:  This will be seldom, if 
ever, I hope.  If there is a legitimate reason (e.g. forgot another appointment) 
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then ask them to reschedule and state that the incentive is part of the contract 
(the consent) that they will receive after putting forth his or her agreed upon 
effort.  If they are obviously not coming back or interested then do not 
become involved in a confrontation.  If this does occur, pay the incentive and 
let them leave. 
 
Adverse events/What to do in a crisis 
For the following adverse events (more serious than stressful or frustrating 
situations) please follow the procedures as outlined below: 
 
If the participant becomes agitated or belligerent 
1. Tell them that they appear frustrated and a break is in order 
2. Leave the area 
3. Locate or call the provider contact person 
4. Have them come into the session with you and inform the participant 
that the session is over 
5. Do NOT reschedule 
6. Pay the incentive only if they pause to ask.  Do not interrupt their 
leaving to offer the incentive.  It is important for you to separate 
yourself from them.  If they inquire later with their primary provider 
about the incentive then it will be paid through the provider. 
 
If the participant becomes sad/weepy/distraught 
1. Ask them if they want a break 
2. If a break appears in order then explicitly state a break will be taken 
3. Ask them if they wish to continue with data collection 
4. If they continue to be distraught then find the provider contact person 
5. Inform the contact person what is happening and ask them to come to 
the session 
6. Reschedule to finish data collection if possible 
 
If the participant states that they are feeling harmful to self or others 
1. Tell them that you are concerned and that you need to speak to the 
provider contact person at your location 
2. If the participant attempts to leave do NOT block their path 
3. Immediately contact the provider and inform them of EXACTLY what 
the participant stated 
4. Follow the directions of the provider 
 
Study forms in-depth 
Word by word… 
Question by question… 
Line by line… 
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Recovery Research Training – Week 3 
June 6, 2005 
 
 
1. Finish critique/review of instruments 
2. Medications – See handouts 
3. Harbor Services – See handout  
4. Data collection – step by step 
 
Introduction 
Greetings/making the respondent comfortable 
General description of the study 
See document titled ‘Opening Script’ 
Consent Process 
Hand copy of consent to the respondent 
Describe the consent procedure 
Read through the consent with the respondent 
Administer the Independent Capacity Assessment 
Have respondent sign TWO (2) copies of the consent 
Witness/sign both copies 
Retain one copy and give the other copy to the respondent 
See document titled ‘Consent Process’ 
Data Collection Process 
Explain the process of using surveys 
Briefly overview what the information generally covers 
Ask if they are comfortable or need a break before beginning the collection 
process 
See document titled ‘Data Collection – Opening Steps’ 
Data Collection Procedure 
Follow the order of the instruments in the same order they are distributed 
Introduce each survey before using it – never move to a survey without 
introduction 
Read the instructions from the top of each survey 
See document titled ‘Data Collection – Instruments’ 
Incentive Procedure 
After the final survey is completed introduce the Incentive Receipt Form 
Have the respondent sign it and then witness it 
Pay the incentive 
Say good bye (nicely)! 
See document titled ‘Incentive Procedure’ 
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Psychotropic Medications – Overview and Classification of Four Types for Data 
Collection 
 
Symptom Relief, Not Cure 
 
Just as aspirin can reduce a fever without clearing up the infection that causes it, 
psychotherapeutic medications act by controlling symptoms. Like most drugs used in 
medicine, they correct or compensate for some malfunction in the body. 
Psychotherapeutic medications do not cure mental illness, but they do lessen its burden. 
In many cases, these medications can help a person get on with life despite some 
continuing mental pain and difficulty coping with problems. For example, drugs like 
chlorpromazine can turn off the "voices" heard by some people with schizophrenia and 
help them to perceive reality more accurately. And antidepressants can lift the dark, 
heavy moods of depression. The degree of response ranging from little relief of 
symptoms to complete remission depends on a variety of factors related to the individual 
and the particular disorder being treated.  
 
How long someone must take a psychotherapeutic medication depends on the disorder. 
Many depressed and anxious people may need medication for a single period perhaps for 
several months and then never have to take it again. For some conditions, such as 
schizophrenia or manic-depressive illness, medication may have to be taken indefinitely 
or, perhaps, intermittently.  
 
Like any medication, psychotherapeutic medications do not produce the same effect in 
everyone. Some people may respond better to one medication than another. Some may 
need larger dosages than others do. Some experience annoying side effects, while others 
do not. Age, sex, body size, body chemistry, physical illnesses and their treatments, diet, 
and habits such as smoking, are some of the factors that can influence a medication's 
effect. 
 
Antianxiety Medications 
 
Everyone experiences anxiety at one time or another "butterflies in the stomach" before 
giving a speech or sweaty palms during a job interview are common symptoms. Other 
symptoms of anxiety include irritability, uneasiness, jumpiness, feelings of apprehension, 
rapid or irregular heartbeat, stomachache, nausea, faintness, and breathing problems.  
 
Anxiety is often manageable and mild. But sometimes it can present serious problems. A 
high level or prolonged state of anxiety can be very incapacitating, making the activities 
of daily life difficult or impossible. Besides generalized anxiety, other anxiety disorders 
are panic, phobia, obsessive-compulsive disorder (OCD), and posttraumatic stress 
disorder.  
 
Phobias, which are persistent, irrational fears and are characterized by avoidance of 
certain objects, places, and things, sometimes accompany anxiety. A panic attack is a 
severe form of anxiety that may occur suddenly and is marked with symptoms of 
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nervousness, breathlessness, pounding heart, and sweating. Sometimes the fear that one 
may die is present.  
 
Antianxiety medications help to calm and relax the anxious person and remove the 
troubling symptoms. There are a number of antianxiety medications currently available. 
The preferred medications for most anxiety disorders are the benzodiazepines. In addition 
to the benzodiazepines, a non-benzodiazepine, buspirone (BuSpar), is used for 
generalized anxiety disorders. Antidepressants are also effective for panic attacks and 
some phobias and are often prescribed for these conditions. They are also sometimes used 
for more generalized forms of anxiety, especially when it is accompanied by depression. 
The medications approved by the FDA for use in OCD are all antidepressants 
clomipramine, fluoxetine, and fluvoxamine.  
 
The most commonly used benzodiazepines are alprazolam (Xanax) and diazepam 
(Valium), followed by chlordiazepoxide (Librium, Librax, Libritabs). Benzodiazepines 
are relatively fast-acting medications; in contrast, buspirone must be taken daily for 2 or 
3 weeks prior to exerting its antianxiety effect. Most benzodiazepines will begin to take 
effect within hours, some in even less time. Benzodiazepines differ in duration of action 
in different individuals; they may be taken two or three times a day, or sometimes only 
once a day. Dosage is generally started at a low level and gradually raised until symptoms 
are diminished or removed. The dosage will vary a great deal depending on the 
symptoms and the individual's body chemistry.  
 
Benzodiazepines have few side effects. Drowsiness and loss of coordination are most 
common; fatigue and mental slowing or confusion can also occur. These effects make it 
dangerous to drive or operate some machinery when taking benzodiazepines especially 
when the patient is just beginning treatment. Other side effects are rare.  
 
Benzodiazepines combined with other medications can present a problem, notably when 
taken together with commonly used substances such as alcohol. It is wise to abstain from 
alcohol when taking benzodiazepines, as the interaction between benzodiazepines and 
alcohol can lead to serious and possibly life-threatening complications. Following the 
doctor's instructions is important. The doctor should be informed of all other medications 
the patient is taking, including over-the-counter preparations. Benzodiazepines increase 
central nervous system depression when combined with alcohol, anesthetics, 
antihistamines, sedatives, muscle relaxants, and some prescription pain medications. 
Particular benzodiazepines may influence the action of some anticonvulsant and cardiac 
medications. Benzodiazepines have also been associated with abnormalities in babies 
born to mothers who were taking these medications during pregnancy.  
 
With benzodiazepines, there is a potential for the development of tolerance and 
dependence as well as the possibility of abuse and withdrawal reactions. For these 
reasons, the medications are generally prescribed for brief periods of time days or weeks 
and sometimes intermittently, for stressful situations or anxiety attacks. For the same 
reason, ongoing or continuous treatment with benzodiazepines is not recommended for 
most people. Some patients may, however, need long-term treatment.  
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A withdrawal reaction may occur if the treatment is abruptly stopped. Symptoms may 
include anxiety, shakiness, headache, dizziness, sleeplessness, loss of appetite, and, in 
more severe cases, fever, seizures, and psychosis. A withdrawal reaction may be 
mistaken for a return of the anxiety, since many of the symptoms are similar. Thus, after 
benzodiazepines are taken for an extended period, the dosage is gradually tapered off 
before being completely stopped.  
 
Although benzodiazepines, buspirone, tricyclic antidepressants, or SSRIs are the 
preferred medications for most anxiety disorders, occasionally, for specific reasons, one 
of the following medications may be prescribed: antipsychotic medications; 
antihistamines (such as Atarax, Vistaril, and others); barbiturates such as phenobarbital; 
and beta-blockers such as propranolol (Inderal, Inderide). Propanediols such as 
meprobamate (Equanil) were commonly prescribed prior to the introduction of the 
benzodiazepines, but today rarely are used.  
 
Antidepressant Medications 
 
The kind of depression that will most likely benefit from treatment with medications is 
more than just "the blues." It's a condition that's prolonged, lasting 2 weeks or more, and 
interferes with a person's ability to carry on daily tasks and to enjoy activities that 
previously brought pleasure.  
 
The depressed person will seem sad, or "down," or may show a lack of interest in his 
surroundings. He may have trouble eating and lose weight (although some people eat 
more and gain weight when depressed). He may sleep too much or too little, have 
difficulty going to sleep, sleep restlessly, or awaken very early in the morning. He may 
speak of feeling guilty, worthless, or hopeless. He may complain that his thinking is 
slowed down. He may lack energy, feeling "everything's too much," or he might be 
agitated and jumpy. A person who is depressed may cry. He may think and talk about 
killing him or herself and may even make a suicide attempt. Some people who are 
depressed have psychotic symptoms, such as delusions (false ideas) that are related to 
their depression. For instance, a psychotically depressed person might imagine that he is 
already dead, or "in hell," being punished.  
 
Not everyone who is depressed has all these symptoms, but everyone who is depressed 
has at least some of them. A depression can range in intensity from mild to severe.  
 
Antidepressants are used most widely for serious depressions, but they can also be 
helpful for some milder depressions. Antidepressants, although they are not "uppers" or 
stimulants, take away or reduce the symptoms of depression and help the depressed 
person feel the way he did before he became depressed.  
 
Antidepressants are also used for disorders characterized principally by anxiety. They can 
block the symptoms of panic, including rapid heartbeat, terror, dizziness, chest pains, 
nausea, and breathing problems. They can also be used to treat some phobias.  
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The physician chooses the particular antidepressant to prescribe based on the individual 
patient's symptoms. When someone begins taking an antidepressant, improvement 
generally will not begin to show immediately. With most of these medications, it will 
take from 1 to 3 weeks before changes begin to occur. Some symptoms diminish early in 
treatment; others, later. For instance, a person's energy level or sleeping or eating patterns 
may improve before his depressed mood lifts. If there is little or no change in symptoms 
after 5 to 6 weeks, a different medication may be tried. Some people will respond better 
to one than another. Since there is no certain way of determining beforehand which 
medication will be effective, the doctor may have to prescribe first one, then another, 
until an effective one is found. Treatment is continued for a minimum of several months 
and may last up to a year or more.  
 
While some people have one episode of depression and then never have another, or 
remain symptom-free for years, others have more frequent episodes or very long-lasting 
depressions that may go on for years. Some people find that their depressions become 
more frequent and severe as they get older. For these people, continuing (maintenance) 
treatment with antidepressants can be an effective way of reducing the frequency and 
severity of depressions. Those that are commonly used have no known long-term side 
effects and may be continued indefinitely. The prescribed dosage of the medication may 
be lowered if side effects become troublesome. Lithium can also be used for maintenance 
treatment of repeated depressions whether or not there is evidence of a manic or manic-
like episode in the past.  
 
Dosage of antidepressants varies, depending on the type of drug, the person's body 
chemistry, age, and, sometimes, body weight. Dosages are generally started low and 
raised gradually over time until the desired effect is reached without the appearance of 
troublesome side effects.  
 
There are a number of antidepressant medications available. They differ in their side 
effects and, to some extent, in their level of effectiveness. Tricyclic antidepressants 
(named for their chemical structure) are more commonly used for treatment of major 
depressions than are monoamine oxidase inhibitors (MAOIs); but MAOIs are often 
helpful in so-called "atypical" depressions in which there are symptoms like 
oversleeping, anxiety, panic attacks, and phobias.  
 
The last few years have seen the introduction of a number of new antidepressants. 
Several of them are called "selective serotonin reuptake inhibitors" (SSRIs). Those 
available at the present time in the United States are fluoxetine (Prozac), fluvoxamine 
(Luvox), paroxetine (Paxil), and sertraline (Zoloft). (Luvox has been approved for 
obsessive-compulsive disorder , and Paxil has been approved for panic disorder.) Though 
structurally different from each other, all the SSRIs' antidepressant effects are due to their 
action on one specific neurotransmitter, serotonin. The FDA has also approved two other 
antidepressants that affect two neurotransmitters: serotonin and norepinephrine. They are 
venlafaxine (Effexor) and nefazodone (Serzone). All of these newer antidepressants seem 
to have less bothersome side effects than the older tricyclic antidepressants.  
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The tricyclic antidepressant clomipramine (Anafranil) affects serotonin but is not as 
selective as the SSRIs. It was the first medication specifically approved for use in the 
treatment of obsessive- compulsive disorder (OCD). Prozac and Luvox have now been 
approved for use with OCD.  
 
Another of the newer antidepressants, bupropion (Wellbutrin), is chemically unrelated to 
the other antidepressants. It has more effect on norepinephrine and dopamine than on 
serotonin. Wellbutrin has not been associated with weight gain or sexual dysfunction. It 
is contraindicated for individuals with, or at risk for, a seizure disorder or who have been 
diagnosed with bulimia or anorexia nervosa.  
 
 
 
Side Effects of Antidepressant Medications  
 
1. Tricyclic Antidepressants  
 
There are a number of possible side effects with tricyclic antidepressants that vary, 
depending on the medication. For example, amitriptyline (Elavil) may make people feel 
drowsy, while protriptyline (Vivactil) hardly does this at all and, in some people, may 
have an opposite effect, producing feelings of anxiety and restlessness. Because of this 
kind of variation in side effects, one antidepressant might be highly desirable for one 
person and not recommended for another. Tricyclics on occasion may complicate specific 
heart problems, and for this reason the physician should be aware of all such difficulties. 
Other side effects with tricyclics may include blurred vision, dry mouth, constipation, 
weight gain, dizziness when changing position, increased sweating, difficulty urinating, 
changes in sexual desire, decrease in sexual ability, muscle twitches, fatigue, and 
weakness. Not all these medications produce all side effects, and not everybody gets 
them. Some will disappear quickly, while others may remain for the length of treatment. 
Some side effects are similar to symptoms of depression (for instance, fatigue and 
constipation). For this reason, the patient or family should discuss all symptoms with the 
doctor, who may change the medication or dosage.  
 
Tricyclics also may interact with thyroid hormone, antihypertensive medications, oral 
contraceptives, some blood coagulants, some sleeping medications, antipsychotic 
medications, diuretics, antihistamines, aspirin, bicarbonate of soda, vitamin C, alcohol, 
and tobacco.  
 
An overdose of antidepressants is serious and potentially lethal. It requires immediate 
medical attention. Symptoms of an overdose of tricyclic antidepressant medication 
develop within an hour and may start with rapid heartbeat, dilated pupils, flushed face, 
and agitation, and progress to confusion, loss of consciousness, seizures, irregular heart 
beats, cardiorespiratory collapse, and death.  
 
2. The Newer Antidepressants  
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The most common side effects of these antidepressants are gastrointestinal problems and 
headache. Others are insomnia, anxiety, and agitation. Because of potentially serious 
interaction between these medications and monoamine oxidase inhibitors, it is advisable 
to stop taking one medication from 2 to 4 or 5 weeks before starting the other, depending 
on the specific medications involved. In addition, some SSRIs have been found to affect 
metabolism of certain other medications in the liver, creating possible drug interactions.  
 
3. Monoamine Oxidase Inhibitors (MAOIs)  
 
MAOIs may cause some side effects similar to those of the other antidepressants. 
Dizziness when changing position and rapid heartbeat are common. MAOIs also react 
with certain foods and alcoholic beverages (such as aged cheeses, foods containing 
monosodium glutamate (MSG), Chianti and other red wines), and other medications 
(such as over-the-counter cold and allergy preparations, local anesthetics, amphetamines, 
insulin, some narcotics, and antiparkinsonian medications). These reactions often do not 
appear for several hours. Signs may include severe high blood pressure, headache, 
nausea, vomiting, rapid heartbeat, possible confusion, psychotic symptoms, seizures, 
stroke, and coma. For this reason, people taking MAOIs must stay away from restricted 
foods, drinks, and medications. They should be sure that they are furnished by their 
doctor or pharmacist, a list of all foods, beverages, and other medications that should be 
avoided.  
 
Precautions to be Observed When Taking Antidepressants  
 
When taking antidepressants, it is important to tell all doctors (and dentists) being seen 
not just the one who is treating the depression about all medications being used, including 
over-the-counter preparations and alcohol. Antidepressants should be taken only in the 
amount prescribed and should be kept in a secure place away from children. When used 
with proper care, following doctors' instructions, antidepressants are extremely useful 
medications that can reverse the misery of a depression and help a person feel like him or 
herself again. 
 
Antimanic Medications 
 
Bipolar disorder (manic-depressive illness) is characterized by cycling mood changes: 
severe highs (mania) and lows (depression). Cycles may be predominantly manic or 
depressive with normal mood between cycles. Mood swings may follow each other very 
closely, within hours or days, or may be separated by months to years. These "highs" and 
"lows" may vary in intensity and severity.  
 
When someone is in a manic "high," he may be overactive, over-talkative, and have a 
great deal of energy. He will switch quickly from one topic to another, as if he cannot get 
his thoughts out fast enough; his attention span is often short, and he can easily be 
distracted. Sometimes, the "high" person is irritable or angry and has false or inflated 
ideas about his position or importance in the world. He may be very elated, full of grand 
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schemes that might range from business deals to romantic sprees. Often, he shows poor 
judgment in these ventures. Mania, untreated, may worsen to a psychotic state.  
 
Depression will show in a "low" mood, lack of energy, changes in eating and sleeping 
patterns, feelings of hopelessness, helplessness, sadness, worthlessness, and guilt, and 
sometimes thoughts of suicide.  
 
Lithium  
 
The medication used most often to combat a manic "high" is lithium. It is unusual to find 
mania without a subsequent or preceding period of depression. Lithium evens out mood 
swings in both directions, so that it is used not just for acute manic attacks or flare-ups of 
the illness, but also as an ongoing treatment of bipolar disorder.  
 
Lithium will diminish severe manic symptoms in about 5 to 14 days, but it may be 
anywhere from days to several months until the condition is fully controlled. 
Antipsychotic medications are sometimes used in the first several days of treatment to 
control manic symptoms until the lithium begins to take effect. Likewise, antidepressants 
may be needed in addition to lithium during the depressive phase of bipolar disorder.  
 
Someone may have one episode of bipolar disorder and never have another, or be free of 
illness for several years. However, for those who have more than one episode, continuing 
(maintenance) treatment on lithium is usually given serious consideration.  
 
Some people respond well to maintenance treatment and have no further episodes, while 
others may have moderate mood swings that lessen as treatment continues. Some people 
may continue to have episodes that are diminished in frequency and severity. 
Unfortunately, some manic-depressive patients may not be helped at all. Response to 
treatment with lithium varies, and it cannot be determined beforehand who will or will 
not respond to treatment.  
 
Regular blood tests are an important part of treatment with lithium. A lithium level must 
be checked periodically to measure the amount of the drug in the body. If too little is 
taken, lithium will not be effective. If too much is taken, a variety of side effects may 
occur. The range between an effective dose and a toxic one is small. A lithium level is 
routinely checked at the beginning of treatment to determine the best lithium dosage for 
the patient. Once a person is stable and on maintenance dosage, a lithium level should be 
checked every few months. How much lithium a person needs to take may vary over 
time, depending on how ill he is, his body chemistry, and his physical condition.  
 
Anything that lowers the level of sodium (table salt is sodium chloride) in the body may 
cause a lithium buildup and lead to toxicity. Reduced salt intake, heavy sweating, fever, 
vomiting, or diarrhea may do this. An unusual amount of exercise or a switch to a low-
salt diet is examples. It's important to be aware of conditions that lower sodium and to 
share this information with the doctor. The lithium dosage may have to be adjusted.  
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When a person first takes lithium, he may experience side effects, such as drowsiness, 
weakness, nausea, vomiting, fatigue, hand tremor, or increased thirst and urination. These 
usually disappear or subside quickly, although hand tremor may persist. Weight gain may 
also occur. Dieting will help, but crash diets should be avoided because they may affect 
the lithium level. Drinking low-calorie or no-calorie beverages will help keep weight 
down. Kidney changes, accompanied by increased thirst and urination, may develop 
during treatment. These conditions that may occur are generally manageable and are 
reduced by lowering the dosage. Because lithium may cause the thyroid gland to become 
underactive (hypothyroidism) or sometimes enlarged (goiter), thyroid function 
monitoring is a part of the therapy. To restore normal thyroid function, thyroid hormone 
is given along with lithium.  
 
Because of possible complications, lithium may either not be recommended or may be 
given with caution when a person has existing thyroid, kidney, or heart disorders, 
epilepsy, or brain damage. Women of child-bearing age should be aware that lithium 
increases the risk of congenital malformations in babies born to women taking lithium. 
Special caution should be taken during the first 3 months of pregnancy.  
 
Lithium, when combined with certain other medications, can have unwanted effects. 
Some diuretics substances that remove water from the body increase the level of lithium 
and can cause toxicity. Other diuretics, like coffee and tea, can lower the level of lithium. 
Signs of lithium toxicity may include nausea, vomiting, drowsiness, mental dullness, 
slurred speech, confusion, dizziness, muscle twitching, irregular heartbeat, and blurred 
vision. A serious lithium overdose can be life-threatening. Someone who is taking lithium 
should tell all the doctors including dentistshe sees about all other medications he is 
taking.  
 
With regular monitoring, lithium is a safe and effective drug that enables many people, 
who otherwise would suffer from incapacitating mood swings, to lead normal lives.  
 
Anticonvulsants  
 
Not all patients with symptoms of mania benefit from lithium. Some have been found to 
respond to another type of medication, the anticonvulsant medications that are usually 
used to treat epilepsy. Carbamazepine (Tegretol) is the anticonvulsant that has been most 
widely used. Manic-depressive patients who cycle rapidly that is, they change from 
mania to depression and back again over the course of hours or days, rather than months 
seem to respond particularly well to carbamazepine.  
 
Early side effects of carbamazepine, although generally mild, include drowsiness, 
dizziness, confusion, disturbed vision, perceptual distortions, memory impairment, and 
nausea. They are usually transient and often respond to temporary dosage reduction. 
Another common but generally mild adverse effect is the lowering of the white blood cell 
count which requires periodic blood tests to monitor against the rare possibility of more 
serious, even life-threatening, bone marrow depression. Also serious are the skin rashes 
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that can occur in 15 to 20 percent of patients. These rashes are sometimes severe enough 
to require discontinuation of the medication.  
 
In 1995, the anticonvulsant divalproex sodium (Depakote) was approved by the Food and 
Drug Administration for manic-depressive illness. Clinical trials have shown it to have 
effectiveness in controlling manic symptoms equivalent to that of lithium; it is effective 
in both rapid-cycling and non-rapid-cycling bipolar.  
 
Though divalproex can cause gastrointestinal side effects, the incidence is low. Other 
adverse effects occasionally reported are headache, double vision, dizziness, anxiety, or 
confusion. Because in some cases divalproex has caused liver disfunction, liver function 
tests should be performed prior to therapy and at frequent intervals thereafter, particularly 
during the first six months of therapy. 
 
Antipsychotic Medications 
 
A person who is psychotic is out of touch with reality. He may "hear voices" or have 
strange and untrue ideas (for example, thinking that others can hear his thoughts, or are 
trying to harm him, or that he is the President of the United States or some other famous 
person).* He may get excited or angry for no apparent reason, or spend a lot of time off 
by himself, or in bed, sleeping during the day and staying awake at night. He may neglect 
his appearance, not bathing or changing clothes, and may become difficult to 
communicate with saying things that make no sense, or barely talking at all.  
 
These kinds of behaviors are symptoms of psychotic illness, the principal form of which 
is schizophrenia. All of the symptoms may not be present when someone is psychotic, but 
some of them always are. Antipsychotic medications, as their name suggests, act against 
these symptoms. These medications cannot "cure" the illness, but they can take away 
many of the symptoms or make them milder. In some cases, they can shorten the course 
of the illness as well.  
 
There are a number of antipsychotic (neuroleptic) medications available. They all work; 
the main differences are in the potency that is, the dosage (amount) prescribed to produce 
therapeutic effects and the side effects. Some people might think that the higher the dose 
of medication, the more serious the illness, but this is not always true.  
 
A doctor will consider several factors when prescribing an antipsychotic medication, 
besides how "ill" someone is. These include the patient's age, body weight, and type of 
medication. Past history is important, too. If a person took a particular medication before 
and it worked, the doctor is likely to prescribe the same one again. Some less potent 
drugs, like chlorpromazine (Thorazine), are prescribed in higher numbers of milligrams 
than others of high potency, like haloperidol (Haldol).  
 
If a person has to take a large amount of a "high-dose" antipsychotic medication, such as 
chlorpromazine, to get the same effect as a small amount of a "low-dose" medication, 
such as haloperidol, why doesn't the doctor just prescribe "low-dose" medications? The 
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main reason is the difference in their side effects (actions of the medication other than the 
one intended for the illness). These medications vary in their side effects, and some 
people have more trouble with certain side effects than others. A side effect may 
sometimes be desirable. For instance, the sedative effect of some antipsychotic 
medications is useful for patients who have trouble sleeping or who become agitated 
during the day.  
 
Unlike some prescription drugs, which must be taken several times during the day, 
antipsychotic medications can usually be taken just once a day. Thus, patients can reduce 
daytime side effects by taking the medications once, before bed. Some antipsychotic 
medications are available in forms that can be injected once or twice a month, thus 
assuring that the medicine is being taken reliably.  
 
Most side effects of antipsychotic medications are mild. Many common ones disappear 
after the first few weeks of treatment. These include drowsiness, rapid heartbeat, and 
dizziness when changing position.  
 
Some people gain weight while taking antipsychotic medications and may have to change 
their diet to control their weight. Other side effects that may be caused by some 
antipsychotic medications include decrease in sexual ability or interest, problems with 
menstrual periods, sunburn, or skin rashes. If a side effect is especially troublesome, it 
should be discussed with the doctor who may prescribe a different medication, change the 
dosage level or schedule, or prescribe an additional medication to control the side effects.  
 
Movement difficulties may occur with the use of antipsychotic medications, although 
most of them can be controlled with an anticholinergic medication. These movement 
problems include muscle spasms of the neck, eye, back, or other muscles; restlessness 
and pacing; a general slowing-down of movement and speech; and a shuffling walk. 
Some of these side effects may look like psychotic or neurologic (Parkinson's disease) 
symptoms, but aren't. If they are severe, or persist with continued treatment with an 
antipsychotic, it is important to notify the doctor, who might either change the medication 
or prescribe an additional one to control the side effects.  
 
Just as people vary in their responses to antipsychotic medications, they also vary in their 
speed of improvement. Some symptoms diminish in days, while others take weeks or 
months. For many patients, substantial improvement is seen by the sixth week of 
treatment, although this is not true in every case. If someone does not seem to be 
improving, a different type of medication may be tried.  
 
Even if a person is feeling better or completely well, he should not just stop taking the 
medication. Continuing to see the doctor while tapering off medication is important. 
Some people may need to take medication for an extended period of time, or even 
indefinitely. These people usually have chronic (long-term, continuous) schizophrenic 
disorders, or have a history of repeated schizophrenic episodes, and are likely to become 
ill again. Also, in some cases a person who has experienced one or two severe episodes 
may need medication indefinitely. In these cases, medication may be continued in as low 
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a dosage as possible to maintain control of symptoms. This approach, called maintenance 
treatment, prevents relapse in many people and removes or reduces symptoms for others.  
 
While maintenance treatment is helpful for many people, a drawback for some is the 
possibility of developing long-term side effects, particularly a condition called tardive 
dyskinesia. Involuntary movements characterize this condition. These abnormal 
movements most often occur around the mouth, but are sometimes seen in other muscle 
areas such as the trunk, pelvis, or diaphragm. The disorder may range from mild to 
severe. For some people, it cannot be reversed, while others recover partially or 
completely. Tardive dyskinesia is seen most often after long-term treatment with 
antipsychotic medications. There is a higher incidence in women, with the risk rising 
with age. There is no way to determine whether someone will develop this condition, and 
if it develops, whether the patient will recover. At present, there is no effective treatment 
for tardive dyskinesia. The possible risks of long-term treatment with antipsychotic 
medications must be weighed against the benefits in each individual case by patient, 
family, and doctor.  
 
Antipsychotic medications can produce unwanted effects when taken in combination with 
other medications. Therefore, the doctor should be told about all medicine being taken, 
including over-the-counter preparations, and the extent of the use of alcohol. Some 
antipsychotic medications interfere with the action of antihypertensive medications 
(taken for high blood pressure), anticonvulsants (taken for epilepsy), and medications 
used for Parkinson's disease. Some antipsychotic medications add to the effects of 
alcohol and other central nervous system depressants, such as antihistamines, 
antidepressants, barbiturates, some sleeping and pain medications, and narcotics.  
Atypical neuroleptics  
 
In 1990, clozapine (Clozaril), an "atypical neuroleptic," was introduced in the United 
States. In clinical trials, this medication was found to be more effective than traditional 
antipsychotic medications in individuals with treatment-resistant schizophrenia, and the 
risk of tardive dyskinesia is lower. However, because of the potential side effect of a 
serious blood disorder, agranulocytosis, patients who are on clozapine must have a blood 
test each week. The expense involved in this monitoring, together with the cost of the 
medication, has made maintenance on clozapine difficult for many persons with 
schizophrenia. However, 5 years after its introduction in the United States, approximately 
58,000 persons were being treated with clozapine.  
 
Since clozapine's approval in the United States, other atypical neuroleptics (also called 
atypical antipsychotics) have been introduced. Risperidone (Risperdal) was released in 
1994, olanzapine (Zyprexa) in 1996, and quetiapine (Seroquel) in 1997. Several other 
atypical neuroleptics are in development. While they have some side effects, these newer 
medications are generally better tolerated than either clozapine or the the traditional 
antipsychotics, and they do not cause agranulocytosis. Like clozapine, they have shown 
little tendency to give rise to tardive dyskinesia or other movement difficulties. Their 
main disadvantages compared to the older medications are a greater tendency to produce 
weight gain, and much higher cost. 
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ANTI-DEPRESSANTS 
Name Generic Name Comments 
 
TRICYCLICS  
Anafranil  clomipramine  OCD (Obsessive Compulsive Disorder)  
Elavil  amitriptyline  
Norpramin  desipramine  
Pamelor  nortriptyline  
Sinequan  doxepin  
Surmontil  trimipramine  
TCA's discovered in the 1960's. Anticholinergic side 
effects: dry mouth, constipation, blurred vision, 
urinary retention, dizziness, etc.  
Tofranil  imipramine   
Vivactil  protriptyline    
 
MAOIs (monoamine oxidase inhibitors)  
Marplan  isocarboxazid  
Nardil  phenelzine  
Parnate  tranylcypromine  
Inhibits action of the MAO enzyme; restricted 
tyramine diet and use of other medications; atypical 
depression; panic and phobic disorders  
 
SSRIs (selective serotonin reuptake inhibitors)  
Luvox fluvoxamine 
Paxil  paroxetine  
Prozac  fluoxetine  
Zoloft  sertraline  
Wide applicability; panic disorder and OCD; quick 
acting; fewer side effects; simpler dosage  
 
OTHER  
Asendin  amoxapine  Quick acting; potential tardive dyskinesia; seizures, psychotic depression 
Desyrel  trazodone  Depression with anxiety  
Effexor  venlafaxine  Blocks reuptake of serotonin and norepinephrine  
Ludiomil  maprotiline    
Remeron Mirtazapine  
Serzone nefazodone  
Wellbutrin  buproprion  Dopamine reuptake inhibitor; rapid cycler bipolar; seizure risk  
 
MOOD STABILIZER 
Brand Name Generic Name Comments 
Lithium Carbonate  lithium  
Eskalith    
Discovered effective for mania in 1949; 
increased thirst and urination; fine hand tremor  
 
LITHIUM SUBSTITUTES (anticonvulsants)*  
Depakene/Depakote valproic acid  
Increases levels of GABA neurotransmitter and 
inhibits abnormal nerve impulses which cause 
seizures; used with wide and rapid mood changes 
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(rapid cyclers)  
Klonopin  clonazepam  Adjunctive drug for BP (bipolar); anti-anxiety drug with potential physical dependence  
Tegretol  carbamazepine  
Used for forms of epilepsy in the 1960's; helpful 
for BP (bipolar) who are nonresponsive to 
lithium; atypical depression (increased sleep and 
weight gain)  
*Use of anticonvulsants developed from the theory of mania known as kindling 
(persistent excitability in the brain causes an affective seizure or manic attack)  
 
HYPNOTICS 
Brand Name Generic Name Comments 
 
BENZODIAZEPINES (acts on the thalamus, hypothalamus, and limbic system)  
Dalmane  flurazepam   
Doral  quazepam    
Halcion  triazolam  Shortest acting, potential anterograde amnesia (impairs recall of new information)  
Pro-Som  estazolam  short-acting  
Restoril  temazepam   
 
BARBITURATES  
Amytal  amobarbital  very sedating/addictive  
Nembutal  pentobarbital    
Seconal  secobarbital    
 
ANTIHISTAMINES   
Atarax  hydroxyzine   
Benadryl  diphenhydramine 
Unisom  doxylamine  over-the-counter medication with sedative qualities  
 
OTHER  
Ambien  zolpidem   
Noctec  chloral hydrate  one of the oldest (1860) - "Mickey Finn" short term effect (two weeks)  
Noludar  methyprylon    
Placidyl  ethclorvynol  high abuse potential  
PSYCHOSTIMULANTS 
Brand Name Generic Name Comments 
Ritalin  methylphenidate    
Cylert  pemoline  periodic liver function tests  
Dexedrine  dextroamphetamine   
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ANTI-ANXIETY 
Brand Name Generic Name Comments 
 
BENZODIAZEPINES  
Ativan  lorazepam  Short-acting  
Centrax  prazepam   
Klonopin  clonazepam  Used for seizure disorder; adjunctive with BP (bipolar) and psychoses  
Librium  chlordiazepoxide  Used with alcohol/drug withdrawal  
Paxipam  halazepam   
Serax  oxazepam  
Tranxene  chlorazepate  
Valium  diazepam  
Short-acting  
Xanax  alprazolam  
Short-acting; anxiety with depression, panic and 
phobias; potential anterograde memory (forget things 
that occur a few hours before taking the drug)  
 
OTHER  
Benadryl  diphenhydramine  Antihistamines; mild sedation with anti-anxiety qualities 
BuSpar  buspirone  
Affects dopamine, norepinephrine and serotonin; 
effective long-term with generalized anxiety; non-
sedating with few side effects  
Equanil  Meprobamate  High risk for dependency  
Vistaril  hydroxyzine  Antihistamines; mild sedation with anti-anxiety qualities 
 
BETA-BLOCKING AGENTS  
Inderal  propranolol  
Short-term relief of social phobia, performance anxiety; 
blocks action of sympathetic nervous system; lowers 
oxygen demand and blood pressure; relief from 
migraine headaches  
Tenormin  atenolol  Social phobia/performance anxiety; relieves high blood pressure and angina  
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ANTI-PSYCHOTICS 
Brand Name Generic Name Comments 
 
TYPICAL  
Mellaril  thioridazine  
Serentil  
 
mesoridazine  
 
Thorazine  
 
chlorpromazine  
 
Low potency  
  
Haldol  haloperidol  
Loxitane  loxapine  
Moban  molindone  
Navane  thiothixene  
Prolixin  fluphenazine  
Stelazine  trifuoperazine  
Trilafon  perphenazine  
High potency - high risk for EPS (extrapyramidal 
symptoms) parkinsonian-like symptoms: muscle 
weakness, slow rigid movement, muscle spasms, 
restlessness, involuntary movement of the face, mouth, 
eyes, neck, etc.  
 
ATYPICAL (dopamine and serotonin inhibitors)  
Clorazil  clozapine  
FDA approved in 1990; this has fewer side effects; 
targets lethargy, mood and withdrawn behavior; 
requires weekly blood tests to avoid risk of 
agranulocytosis (white blood cell abnormality)  
Geodon ziprasidone  
Orap  pimozide  Requires weekly monitoring; Tourette's syndrome  
Risperdal  risperidone   
Seroquel quetiapine  
Zeldox ziprasidone  
Zyprexa olanzapine  
 
DRUGS TO COUNTERACT SIDE EFFECTS (ANTIDYSKINETICS)  
Artane  trihexyphenidyl    
Benadryl  diphenhydramine   
Cogentin  benztropine   
Symmetrel  amantadine    
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Script One – Opening Script 
 
“Hello  <__________________>.”  
 
“My name is <____________________> and I am a researcher from the University of 
South Florida.” 
 
“Thank you for choosing to be a part of this study.  As a reminder, you were selected 
through a random selection process (meaning by chance).  Do you have any questions 
about that?” 
 
IF YES = “All the eligible clients of the Harbor were put on a list.  We need 350 
people to complete the study.  You were one of the 350 people on the list who 
was selected by putting all the names together and picking out 350, like a lottery.” 
 
“Before we begin I want to point out that this process will take from 45-90 minutes.  For 
your time we will pay you $10.00.” 
 
“If you need to take a break at any time just say so and we can pause.  This is important if 
you become fatigued, as it is very important that we have the most accurate information 
from you as possible.” 
 
“In brief, this study is investigating the process of recovery from mental illness.  It is not 
important if you identify yourself as having a mental illness.  What we need from you is 
for you to answer all the questions as accurately as possible.  What we hope to find out is  
…whether people feel they will recover from what is troubling them mentally,  
…what strategies they use to recover,  
…and what factors influence their choice of strategy or belief in recovery.”  
 
“In order to get started we will have to complete a process where you are given a little 
more detail about the study and what we are asking of you.  Then you will have to sign an 
informed consent.  However, before signing the consent, we will complete an additional 
assessment to make sure that you really understand what we are asking of you.  This is a 
short series of additional questions to make sure that you understood the consent.” 
 
“After that, you will be asked a series of questions from several surveys.” 
 
“Are you ready to begin?” 
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Script 2 – Consent Process 
 
HAND COPY OF CONSENT TO THE RESPONDENT 
 
“This is the consent that you will need to read, understand, and sign before we begin.” 
 
“First, we will read the consent together and then I’ll ask you a brief series of questions to 
make sure you understand what is expected of you.” 
 
READ THROUGH CONSENT WITH RESPONDENT.  ONCE COMPLETED BEGIN 
THE INDEPENDENT CAPACITY ASSESSMENT (ICA) 
 
“Now that you have read through the consent, let me ask you a brief series of questions.  
In order for us to proceed you’ll need to get them all right.  Do not worry, if you get one 
wrong we’ll review that section of the consent.” 
 
PLACE A CHECK MARK NEXT TO EACH ANSWER THAT IS CORRECT.  PLACE 
A ‘N’ IN A QUESTION THAT IS ANSWERED WRONG.  STOP THE PROCEDURE 
AT THAT POINT.  REVIEW THE SECTION THAT WAS WRONG.  BEGIN THE 
ICA AGAIN.  CONTINUE THE PROCESS UNTIL THEY HAVE ALL THE 
QUESTIONS CORRECT.   
 
NOTE:  IF THEY DO NOT COMPLETE THE CONSENT AFTER THE FOURTH 
PASS THROUGH THE ICA THEN THEY WILL NEED TO BE DISMISSED FROM 
THE STUDY.  SEE BELOW FOR SCRIPT.  PLEASE KEEP AND SIGN EACH COPY 
AND RETURN IT WITH THE CONSENT FORM. 
 
“Now that you fully understand what is being asked, please sign two copies of the 
consent.  One is for you to take with you and the other is for the study records.” 
 
“Now that the consent process is complete, let me briefly explain the data collection 
process.” 
 
IF THE ICA IS FAILED, PLEASE STATE THE FOLLOWING 
 
“Because this is the fourth pass through the assessment, I am forced to inform you that 
we will not be able to have you complete the study.  I am very sorry but it is very 
important that each person in the study knows exactly what they are supposed to do and 
why.  If we do not make sure of this then we are not protecting you as we are expected to.  
However, because you have tried so hard we would still like you to have the $10.00 
incentive for your time.  Do you have any questions about this?” 
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Script 3 – Opening Steps 
 
“As I noted earlier, I am going to be asking you a series of questions from several 
different surveys.  You have the option of answering these on your own while we sit 
together or I can more directly assist you by reading each question out loud.  Which 
would you prefer?”    
 
ALLOW TIME FOR THEM TO MAKE CHOICE OF INDEPENDENT OR ASSISTED. 
 
[IF INDEPENDENT]  “Since you have chosen to answer them on your own I will 
sit quietly with you and be available to answer any questions that you may have.” 
 
[IF ASSISTED]  “That’s fine, I would be happy to read through the questions 
with you, you can either mark your choices on your own or I can do that for you.”   
 
ALLOW TIME TO MAKE CHOICE OF MARKING CHOICES ON OWN OR 
YOU MARKING CHOICES FOR THEM. 
 
“[IF MARKING FOR THEM…]  For me to mark your responses for you, 
I will first give you these cards with the response scales for each survey [HAND 
LAMINATED CARD FOR SCL-90-R TO RESPONDENT].  This way I can 
make sure that I am hearing your choice correctly.  If you will state your response 
and point to it I would appreciate your help.” 
 
“I just wanted to state again that, whether working alone or with me, it is very 
important that you take your time and answer each question to the best of your ability.  
This study may have a direct affect on what services are developed and we need the most 
accurate information that we can get.” 
 
“You might be wondering about the questions you will be asked.  There are 
several different areas that we will cover.  For instance, the first survey looks at 
symptoms you may be experiencing at the present or within the last seven days.   
Other questions will ask about your beliefs in recovery… whether you feel 
supported… experiences with being stigmatized…services at the Harbor…  and 
we will finish with experiences you may have had growing up.” 
 
“Do you have any questions?” 
 
“Are you comfortable?  Would you like to take a quick break before we begin?” 
 
[IF YES] “That’s fine.  If you would please be back in a couple of minutes as we 
still have lots to do.” 
            [IF NO]  “That’s great.  Let’s get started…” 
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Script 4 – Data Collection and Wrap Up 
 
[INTRODUCE EACH SURVEY BEFORE USING IT – NEVER MOVE TO A 
SURVEY WITHOUT INTRODUCTION] 
 
[READ THE INSTRUCTIONS FROM THE TOP OF EACH SURVEY] 
 
[AT ALL TIMES, IF RESPONDENT IS ANSWERING INDEPENDENTLY, 
MONITOR TO MAKE SURE THAT THEY SEEM TO UNDERSTAND THE 
QUESTION AND ARE TAKING THEIR TIME FOR EACH SURVEY] 
 
[REMEMBER TO PERIODICALLY ASK IF A BREAK IS NEEDED] 
 
1.  [SCL-90-R]   “This first survey takes a look at the symptoms you experience.  For this 
and all the surveys we’ll read through the instructions together, make sure you understand 
the scoring scale and how to mark your response, and then answer the questions.  Please 
remember that there are no right or wrong answers for any question on any survey and it 
is important that you only choose one answer for each question.” 
 
“For all surveys, if on any question you feel in the middle of two choices, it’s 
usually best to go with your first thought or instinct.  We cannot use data that is in 
the middle so please make a choice for each question.” 
 
 “This first survey has 90 questions.  Don’t worry because this is the longest of all 
the surveys” 
 
 
2.  [SCCS]   “This second survey looks at your relationships and how supported you feel 
in your relationships.  There are 34 questions.  Please circle the number in the box that 
fits your response the best.  Make sure you are only circling one response.  Let’s read the 
directions together.” 
 
 
3.  [REC]   “This next survey is a little different.  This survey will look at your 
expectations for recovery from mental health issues.  The first two questions are like the 
ones you’ve been answering.  The third question explores what recovery means to you.  
This will also give you the opportunity to think about what recovery is in your own words 
and write it down.   The final question allows you to check what things are important for 
your recovery and also to indicate things that are important to you that we did not think 
of and to write them down.” 
 
[FOR QUESTION 3:  INQUIRE INTO HANDWRITING AND ASK THEM TO 
PRINT]   
[FOR QUESTION 3:  IF THE RESPONDENT CANNOT/WILL NOT PROVIDE ANY 
WRITING, SKIP AND MOVE ON] 
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4.  [RAS]   “This next instrument also looks at recovery and asks questions in the same 
general way as the first two.  Please answer each question (there are 41 of them) and only 
mark one response per question.  Circle the number in the box that best fits you.” 
 
 
5.  [PVRQ]  “This survey also looks closely at recovery.  It’s important to really 
understand recovery in this study, which is why we have three surveys on it.  Like the 
other surveys, please answer the question by circling the number that most fits you.  
There are 24 questions for this survey.  This survey looks a little different and it may 
seem like you can answer anywhere on the line.  This is not true.  We are not allowed to 
change how a survey looks but we want you to, as I noted, circle the number that best 
fits.” 
 
 
6.  [ES]   “This survey looks at how you are feeling about yourself and others.  It has 28 
short questions.  Each is on a 4-point scale from ‘strongly agree’ to ‘strongly disagree’.” 
 
 
7.  [ISMI]   “This survey is a little different from the rest.  Sometimes people who seek 
mental health care are put down or made to feel bad, what you may have heard of as 
‘being stigmatized.’  This survey has 29-questions that look at your experiences of being 
stigmatized and the feelings that came from the experience.” 
 
 
8.  [SSQ]   “This survey looks at the services you are receiving at the Harbor, your 
satisfaction with them, and how important they are to your personal recovery.  First, 
under the receiving column I want you to indicate by circling ‘yes’ or ‘no’ if you are 
receiving that service.” 
 
[GIVE HIM OR HER A MOMENT TO DO THIS] 
 
“Next, for each service that you indicated a YES for ONLY, please estimate how 
many hours/month that you receive this service.” 
 
[IF HE OR SHE IS UNSURE OF WHAT TYPE OF CASE MANAGER, 
ASK FOR THE NAME AND CONSULT THE LIST OF SPECIALIZED 
CASE MANAGERS AND HAVE THEM CIRCLE THE APPROPRIATE 
RESPONSE] 
 
[SUPPORTED LIVING FINANCIAL ONLY = HUD OR SECTION 8 
HOUSING] 
 
[SUPERVISED HOUSING INTENSITY IS BY STREET NAME.  
CONSULT LIST IF THE RESPONDENT DOES NOT KNOW] 
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 “Next, please indicate how satisfied with the service you are.  This is on a 6-point 
scale that ranges from ‘very satisfied’ to ‘very dissatisfied,’” 
 
“Finally, circle either ‘yes’ or ‘no’ to indicate whether you think this service helps 
you in your recovery.” 
 
9.  [HDF]   “This survey looks at some personal and historical information about you and 
people you are involved with.  Please remember that ALL RESPONSES will be kept 
absolutely confidential.  The questions cover information about your history, 
hospitalizations (if any), family, and other topics.”   
 
“The first question looks at your education background.” 
 
“The next two questions address your yearly income and the yearly income of 
your household.  By household we mean anyone who has an income that lives 
with you.” 
 
“The third question, or group of questions, looks at your employment, both 
current and in your past.” 
 
“This fourth question is simply asking you to indicate what you believe to be or 
have been told is your diagnosis.  If you haven’t been told one just indicate with a 
N/A.” 
 
“The fifth question asks you about your hospitalization history.  We are interested 
only in psychiatric hospitalizations.  Please include stays in the Crisis 
Stabilization Unit (CSU) when you answer this question.” 
 
“The sixth question looks at your age when you first began to experience 
symptoms and how old you were when you were diagnosed.” 
 
“The seventh group of questions looks at mental health problems in your family.  
Sometimes people have problems because they learn them or inherit them.  These 
questions are not asking for names or descriptions.  We just want to know what 
you remember and your opinion.” 
 
“The eighth question addresses whether you are on certain types of medication.  
You do not have to tell us what the name is, how high a dosage, and that kind of 
information.  Just tell us if you are on any of these types of medication.” 
 
[FOR QUESTION NINE PLEASE READ DIRECTLY OFF THE FORM] 
 
[FOR QUESTION TEN PLEASE READ DIRECTLY OFF THE FORM] 
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“This completes the final survey.  I can’t thank you enough for your time and attention to 
this important research.  The last thing we need to do is have you sign a form that 
indicates that you are being paid the $10.00 dollars for your time.” 
 
HAND FORM TO RESPONDENT.  AFTER THEY SIGN THE FORM, WITNESS BY 
SIGNING YOUR NAME IN THE APPROPRIATE BLANK.  AFTER BOTH 
SIGNATURES ARE SECURED PRESENT THE $10.00 TO THE RESPONDENT 
“Thank you again for your time and assistance in this research.” 
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Appendix E 
 
Main Effect Mediating and Moderating Tables 
 
Table 115 Recovery Expectancy Mediating Model Results of OLS Regression Testing 
Recovery Strategy 1 (Effective Illness Management) 
Table 116 Recovery Expectancy Mediating Model Results of OLS Regression Testing 
Recovery Strategy 2 (Positive Future Orientation) 
Table 117 Recovery Expectancy Mediating Model Results of OLS Regression Testing 
Recovery Strategy 3 (Meaningfulness, Personal Control, and Hope) 
Table 118 Recovery Expectancy Mediating Model Results of OLS Regression Testing 
Recovery Strategy 4 (Recognizing Support) 
Table 119 Recovery Expectancy Mediating Model Results of OLS Regression Testing 
Recovery  Strategy 5 (Help Seeking) 
Table 120 Recovery Expectancy Mediating Model Results of OLS Regression Testing 
Recovery Strategy 6 (Symptom Eradication) 
Table 121 Recovery Expectancy Moderating Effect Results of OLS Regression 
Testing Recovery Strategy 1 (Effective Illness Management) 
Table 122 Recovery Expectancy Moderating Effect Results of OLS Regression 
Testing Recovery Strategy 2 (Positive Future Orientation) 
Table 123 Recovery Expectancy Moderating Effect Results of OLS Regression 
Testing Recovery Strategy 3 (Meaningfulness, Personal Control, and Hope) 
Table 124 Recovery Expectancy Moderating Effect Results of OLS Regression 
Testing Recovery Strategy 4 (Recognizing Support) 
Table 125 Recovery Expectancy Moderating Effect Results of OLS Regression 
Testing Recovery Strategy 5 (Help Seeking) 
Table 126 Recovery Expectancy Moderating Effect Results of OLS Regression 
Testing Recovery Strategy 6 (Symptom Eradication) 
Table 127 Illness Severity Moderating Effect Results of OLS Regression Testing 
Recovery Strategy 1 (Effective Illness Management) 
Table 128 Illness Severity Moderating Effect Results of OLS Regression Testing 
Recovery Strategy 2 (Positive Future Orientation) 
Table 129 Illness Severity Moderating Effect Results of OLS Regression Testing 
Recovery Strategy 3 (Meaningfulness, Personal Control, and Hope) 
Table 130 Illness Severity Moderating Effect Results of OLS Regression Testing 
Recovery Strategy 4 (Recognizing Support) 
Table 131 Illness Severity Moderating Effect Results of OLS Regression Testing 
Recovery Strategy 5 (Help Seeking) 
Table 132 Illness Severity Moderating Effect Results of OLS Regression Testing 
Recovery Strategy 6 (Symptom Eradication) 
 
 
 589
 
Table 115 
 
Recovery Expectancy Mediating Model Results of OLS Regression Testing Recovery 
Strategy 1 (Effective Illness Management) 
 
H1 Variable b SE t 
 Age -0.00 0.00 -1.30 
 Gender -0.04 0.06 -0.67 
 Income -0.03 0.02 -1.36 
 Education -0.00 0.03 -0.03 
Domain 1    
3.1a Anxiety diagnosis -0.20 0.09  -2.30a
3.1b Somatization  0.05 0.04   1.13 
3.1c Obsessive-compulsive -0.07 0.05 -1.28 
3.1d Interpersonal sensitivity  0.14 0.05    2.74b
3.1e Anxiety -0.08 0.05 -1.51 
3.1f Depression -0.10 0.06 -1.63 
3.1g Hostility -0.03 0.04 -0.80 
3.1h Phobic anxiety -0.05 0.04 -1.12 
3.1i Paranoia -0.04 0.05 -0.75 
3.1j Psychoticism -0.01 0.05 -0.21 
3.1k Substance abuse history  0.06 0.06  1.05 
3.1l Hospitalization history -0.00 0.00 -0.54 
3.1m Hospitalized in last year -0.05 0.06 -0.95 
3.1n Age of onset  0.00 0.00  0.12 
3.1o Medication:  Anti-depressant  0.01 0.07  0.18 
3.1p Medication:  Anti-psychotic -0.11 0.06 -1.82 
3.1q Medication:  Anti-manic -0.01 0.06 -0.25 
3.1r Medication:  Anti-anxiety -0.16 0.06   -2.93b
3.1s Medication:  Other psychotropic  0.03 0.06  0.51 
3.1t Current employment -0.04 0.07 -0.60 
3.1u Years of employment -0.00 0.00 -0.87 
3.1v Nuclear family mental illness -0.00 0.02 -0.13 
3.1w Extended family mental illness -0.01 0.04 -0.34 
3.1x Child sexual abuse history -0.08 0.06 -1.31 
3.1y Child physical abuse history  0.04 0.06  0.67 
3.1z Adult sexual assault history -0.00 0.07 -0.08 
3.1aa Adult physical assault history  0.10 0.06  1.61 
Domain 2    
Stigma    
3.2a Alienation -0.07 0.07 -0.95 
3.2b Stereotype endorsement -0.03 0.08 -0.38 
3.2c Discrimination experience -0.04 0.06 -0.72 
3.2d Social withdrawal  0.02 0.08  0.24 
3.2e Stigma resistance -0.40 0.08   -5.30d
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Table 115 (cont.) 
 
0.11Variable 
 
b SE T 
Social Support and Related    
3.2f Partner or best friend support 0.03 0.03  1.16 
3.2g Family support 0.01 0.02  0.47 
3.2h Provider support 0.01 0.04  0.21 
3.2i Friend support 0.01 0.03  0.35 
3.2j Community involvement 0.08 0.02   3.15b
3.2k Trust 0.00 0.03  0.11 
Empowerment    
3.2l Self-esteem/self-efficacy 0.28 0.08   3.68c
3.2m Power/powerlessness 0.04 0.07  0.53 
3.2n Community activism and 
autonomy 
-0.09 0.07 -1.25 
3.2o Optimism and control over the 
future 
0.18 0.07   2.58b
3.2p Righteous anger -0.03 0.05 -0.53 
Domain 3    
3.3a Total number of services 0.02 0.03 0.70 
3.3b Total service hours per month 0.01 0.00 1.31 
3.3c Average satisfaction score 0.03 0.03 0.90 
4.a Recovery expectancy 
 
0.02 0.05 0.41 
 
Note:  a ≤ .05; b ≤ .01; c ≤ .001; d ≤ .0001 
           n = 335  
           R2 = .67; F = 14.31, p ≤ .0001 
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Table 116 
 
Recovery Expectancy Mediating Model Results of OLS Regression Testing Recovery 
Strategy 2 (Positive Future Orientation) 
 
H1 Variable b SE t 
 Age -0.00 0.00 -0.91 
 Gender  0.03 0.05  0.64 
 Income -0.03 0.02 -1.46 
 Education -0.05 0.02  -2.09a
Domain 1    
3.1a Schizophrenia diagnosis -0.19 0.07 -2.67a
3.1b Somatization -0.06 0.03 -1.72 
3.1c Obsessive-compulsive 0.04 0.04 0.98 
3.1d Interpersonal sensitivity 0.06 0.04  1.45 
3.1e Anxiety   0.13 0.05   2.77b
3.1f Depression -0.10 0.05  -2.05a
3.1g Hostility -0.01 0.03 -0.20 
3.1h Phobic anxiety -0.11 0.03  -3.23c
3.1i Paranoia -0.03 0.04 -0.63 
3.1j Psychoticism -0.06 0.04 -1.36 
3.1k Substance abuse history  0.10 0.05   2.15a
3.1l Hospitalization history  0.00 0.00  0.23 
3.1m Hospitalized in last year -0.10 0.05  -2.15a
3.1n Age of onset  0.00 0.00  0.27 
3.1o Medication:  Anti-depressant -0.10 0.06 -1.85 
3.1p Medication:  Anti-psychotic  0.04 0.05  0.70 
3.1q Medication:  Anti-manic -0.02 0.05 -0.46 
3.1r Medication:  Anti-anxiety  0.09 0.05  1.92 
3.1s Medication:  Other psychotropic -0.02 0.05 -0.42 
3.1t Current employment  0.04 0.06  0.64 
3.1u Years of employment -0.00 0.00 -0.58 
3.1v Nuclear family mental illness  0.02 0.02  1.27 
3.1w Extended family mental illness -0.02 0.03 -0.70 
3.1x Child sexual abuse history  0.02 0.05  0.32 
3.1y Child physical abuse history  0.03 0.05  0.71 
3.1z Adult sexual assault history  0.03 0.06  0.54 
3.1aa Adult physical assault history  0.05 0.05  0.91 
Domain 2    
Stigma    
3.2a Alienation  0.09 0.06  1.55 
3.2b Stereotype endorsement -0.06 0.07 -0.87 
3.2c Discrimination experience  0.10 0.05  1.82 
3.2d Social withdrawal -0.19 0.07  -2.77b
3.2e Stigma resistance -0.07 0.06 -1.13 
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Table 116 (cont.) 
 
0.11Variable 
 
b SE T 
Social Support and Related    
3.2f Partner or best friend support 0.01 0.02  0.32 
3.2g Family support 0.05 0.02   3.03b
3.2h Provider support 0.10 0.03   3.31c
3.2i Friend support 0.01 0.02  0.32 
3.2j Community involvement 0.05 0.02   2.40b
3.2k Trust 0.01 0.02  0.27 
Empowerment    
3.2l Self-esteem/self-efficacy 0.66 0.06   10.37d
3.2m Power/powerlessness 0.04 0.06 0.63 
3.2n Community activism and 
autonomy 
0.09 0.06  1.42 
3.2o Optimism and control over the 
future 
-0.06 0.06 -1.06 
3.2p Righteous anger 0.02 0.04  0.50 
Domain 3    
3.3a Total number of services -0.01 0.02 -0.26 
3.3b Total service hours per month -0.01 0.00 -1.60 
3.3c Average satisfaction score  0.04 0.02  1.78 
4.a Recovery expectancy 
 
0.07 0.04  1.45 
 
Note:  a ≤ .05; b ≤ .01; c ≤ .001; d ≤ .0001 
           n = 335;  
           R2 = .72; F = 17.48, p ≤ .0001 
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Table 117 
 
Recovery Expectancy Mediating Model Results of OLS Regression Testing Recovery 
Strategy 3 (Meaningfulness, Personal Control, and Hope) 
 
H1 Variable b SE t 
 Age  0.00 0.00  1.49 
 Gender  0.06 0.05  1.19 
 Income -0.02 0.02 -1.00 
 Education -0.02 0.02 -0.80 
Domain 1    
3.1a Anxiety diagnosis -0.24 0.07   -3.42c
3.1b Somatization  0.02 0.03   0.53 
3.1c Obsessive-compulsive -0.06 0.04 -1.43 
3.1d Interpersonal sensitivity  0.11 0.04   2.59b
3.1e Anxiety  0.02 0.04  0.53 
3.1f Depression  0.07 0.05  1.49 
3.1g Hostility -0.08 0.03 - 2.57b
3.1h Phobic anxiety -0.04 0.03 -1.25 
3.1i Paranoia -0.04 0.04 -1.02 
3.1j Psychoticism  0.05 0.04  1.15 
3.1k Substance abuse history  0.00 0.04 -0.08 
3.1l Hospitalization history  0.00 0.00  0.84 
3.1m Hospitalized in last year  0.01 0.05  0.09 
3.1n Age of onset -0.00 0.00 -0.16 
3.1o Medication:  Anti-depressant -0.03 0.05 -0.65 
3.1p Medication:  Anti-psychotic -0.12 0.05   -2.49b
3.1q Medication:  Anti-manic  0.03 0.05  0.64 
3.1r Medication:  Anti-anxiety  0.07 0.04  1.57 
3.1s Medication:  Other psychotropic -0.05 0.04 -1.13 
3.1t Current employment  0.06 0.06  1.16 
3.1u Years of employment -0.00 0.00 -1.17 
3.1v Nuclear family mental illness  0.03 0.02  1.88 
3.1w Extended family mental illness -0.04 0.03 -1.37 
3.1x Child sexual abuse history  0.10 0.05   2.03a
3.1y Child physical abuse history  0.02 0.05  0.39 
3.1z Adult sexual assault history -0.02 0.06 -0.37 
3.1aa Adult physical assault history -0.03 0.05 -0.54 
Domain 2    
Stigma    
3.2a Alienation -0.02 0.06 -0.29 
3.2b Stereotype endorsement -0.20 0.06   -3.18c
3.2c Discrimination experience  0.08 0.05  1.67 
3.2d Social withdrawal -0.02 0.07 -0.25 
3.2e Stigma resistance -0.16 0.06   -2.77b
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Table 117 (cont.) 
 
H1 Variable 
 
b SE t 
Social Support and Related    
3.2f Partner or best friend support -0.01 0.02 -0.54 
3.2g Family support  0.04 0.01   2.36b
3.2h Provider support  0.08 0.03   2.62b
3.2i Friend support  0.06 0.02   2.48b
3.2j Community involvement  0.03 0.02  1.41 
3.2k Trust  0.00 0.02  0.07 
Empowerment    
3.2l Self-esteem/self-efficacy  0.06 0.06  1.11 
3.2m Power/powerlessness -0.03 0.06 -0.47 
3.2n Community activism and 
autonomy 
 0.35 0.06   5.89d
3.2o Optimism and control over the 
future 
 0.11 0.06   2.04a
3.2p Righteous anger -0.06 0.04 -1.53 
Domain 3    
3.3a Total number of services -0.01 0.02 -0.38 
3.3b Total service hours per month  0.00 0.00  0.08 
3.3c Average satisfaction score  0.01 0.02  0.27 
4.a Recovery expectancy 
 
0.07 0.04 1.63 
 
Note:  a ≤ .05; b ≤ .01; c ≤ .001; d ≤ .0001 
           n = 334;  
           R2 = .49; F = 7.22, p ≤ .0001 
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Table 118 
 
Recovery Expectancy Mediating Model Results of OLS Regression Testing Recovery 
Strategy 4 (Recognizing Support) 
 
H1 Variable b SE t 
 Age -0.00 0.00 -1.12 
 Gender -0.03 0.09 -0.38 
 Income -0.02 0.03 -0.62 
 Education  0.01 0.04  0.25 
Domain 1    
3.1a Other diagnosis  0.39 0.18   2.14a
3.1b Somatization  0.02 0.06  0.27 
3.1c Obsessive-compulsive -0.02 0.08 -0.22 
3.1d Interpersonal sensitivity  0.03 0.08  0.40 
3.1e Anxiety -0.04 0.08 -0.50 
3.1f Depression -0.07 0.08 -0.81 
3.1g Hostility -0.02 0.05 -0.33 
3.1h Phobic anxiety -0.01 0.06 -0.21 
3.1i Paranoia  0.03 0.07  0.41 
3.1j Psychoticism  0.02 0.07  0.30 
3.1k Substance abuse history -0.04 0.08 -0.50 
3.1l Hospitalization history  0.00 0.00  0.04 
3.1m Hospitalized in last year  0.03 0.08  0.39 
3.1n Age of onset -0.00 0.00 -0.39 
3.1o Medication:  Anti-depressant  0.11 0.10  1.17 
3.1p Medication:  Anti-psychotic -0.05 0.09 -0.60 
3.1q Medication:  Anti-manic -0.09 0.09 -1.02 
3.1r Medication:  Anti-anxiety -0.01 0.08 -0.21 
3.1s Medication:  Other psychotropic  0.11 0.08  1.33 
3.1t Current employment -0.00 0.10 -0.03 
3.1u Years of employment -0.00 0.00 -0.58 
3.1v Nuclear family mental illness  0.07 0.03   2.13a
3.1w Extended family mental illness -0.12 0.06  -1.96a
3.1x Child sexual abuse history  0.08 0.09  0.87 
3.1y Child physical abuse history -0.05 0.09 -0.56 
3.1z Adult sexual assault history  0.03 0.10  0.34 
3.1aa Adult physical assault history -0.03 0.09 -0.37 
Domain 2    
Stigma    
3.2a Alienation -0.22 0.10   -2.16a
3.2b Stereotype endorsement -0.01 0.11 -0.12 
3.2c Discrimination experience -0.03 0.09 -0.31 
3.2d Social withdrawal  0.05 0.12  0.38 
3.2e Stigma resistance -0.11 0.11 -1.06 
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Table 118 (cont.) 
 
H1 Variable 
 
b SE t 
Social Support and Related    
3.2f Partner or best friend support   0.22 0.04     5.09d
3.2g Family support   0.23 0.03     8.01d
3.2h Provider support -0.07 0.05 -1.32 
3.2i Friend support   0.07 0.04   1.57 
3.2j Community involvement -0.07 0.04    -2.06a
3.2k Trust   0.05 0.04   1.28 
Empowerment    
3.2l Self-esteem/self-efficacy  0.06 0.12  0.53 
3.2m Power/powerlessness  0.09 0.11  0.95 
3.2n Community activism and 
autonomy 
 0.06 0.11  0.52 
3.2o Optimism and control over the 
future 
 0.24 0.11   2.21a
3.2p Righteous anger  0.07 0.07  0.90 
Domain 3    
3.3a Total number of services  0.06 0.04  1.38 
3.3b Total service hours per month  0.00 0.01  0.40 
3.3c Average satisfaction score  0.17 0.04   3.99d
4.a Recovery expectancy 
 
-0.02 0.08 -0.30 
 
Note:  a ≤ .05; b ≤ .01; c ≤ .001; d ≤ .0001 
           n = 337;  
           R2 = .60; F = 10.73, p ≤ .0001 
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Table 119 
 
Recovery Expectancy Mediating Model Results of OLS Regression Testing Recovery  
Strategy 5 (Help Seeking) 
 
H1 Variable b SE t 
 Age  0.01 0.00    2.11a
 Gender  0.16 0.10  1.56 
 Income  0.02 0.04  0.58 
 Education -0.01 0.05 -0.12 
Domain 1    
3.1b Somatization  0.02 0.07  0.32 
3.1c Obsessive-compulsive  0.02 0.09  0.27 
3.1d Interpersonal sensitivity  0.19 0.09    2.13a
3.1e Anxiety  0.03 0.09  0.35 
3.1f Depression -0.12 0.10 -1.21 
3.1g Hostility -0.01 0.06 -0.21 
3.1h Phobic anxiety -0.09 0.07 -1.25 
3.1i Paranoia  0.04 0.08  0.50 
3.1j Psychoticism -0.07 0.09 -0.83 
3.1k Substance abuse history  0.01 0.10  0.09 
3.1l Hospitalization history  0.00 0.00  0.72 
3.1m Hospitalized in last year  0.11 0.10  1.13 
3.1n Age of onset -0.00 0.00 -0.37 
3.1o Medication:  Anti-depressant  0.03 0.11  0.28 
3.1p Medication:  Anti-psychotic -0.04 0.10 -0.45 
3.1q Medication:  Anti-manic -0.04 0.10 -0.44 
3.1r Medication:  Anti-anxiety -0.09 0.09 -1.00 
3.1s Medication:  Other psychotropic  0.01 0.10  0.14 
3.1t Current employment -0.06 0.12 -0.48 
3.1u Years of employment  0.00 0.00  0.38 
3.1v Nuclear family mental illness  0.01 0.04  0.29 
3.1w Extended family mental illness -0.07 0.07 -1.07 
3.1x Child sexual abuse history  0.08 0.10  0.76 
3.1y Child physical abuse history  0.02 0.10  0.19 
3.1z Adult sexual assault history -0.04 0.12 -0.31 
3.1aa Adult physical assault history -0.06 0.11 -0.59 
Domain 2    
Stigma    
3.2a Alienation -0.02 0.12 -0.15 
3.2b Stereotype endorsement  0.06 0.13  0.46 
3.2c Discrimination experience -0.08 0.11 -0.73 
3.2d Social withdrawal  0.02 0.14  0.12 
3.2e Stigma resistance 
 
-0.17 0.13 -1.34 
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Table 119 (cont.) 
 
H1 Variable 
 
b SE t 
Social Support and Related    
3.2f Partner or best friend support  0.06 0.05  1.08 
3.2g Family support -0.01 0.03 -0.34 
3.2h Provider support  0.14 0.06    2.19a
3.2i Friend support  0.01 0.05  0.23 
3.2j Community involvement  0.07 0.04  1.63 
3.2k Trust  0.08 0.05  1.59 
Empowerment    
3.2l Self-esteem/self-efficacy  0.36 0.13    2.72b
3.2m Power/powerlessness  0.25 0.12    2.04a
3.2n Community activism and 
autonomy 
-0.06 0.13 -0.50 
3.2o Optimism and control over the 
future 
-0.02 0.12 -0.14 
3.2p Righteous anger -0.19 0.09   -2.20a
Domain 3    
3.3a Total number of services  0.03 0.05  0.58 
3.3b Total service hours per month -0.00 0.01 -0.41 
3.3c Average satisfaction score  0.12 0.05    2.49b
4.a Recovery expectancy 
 
0.02 0.09 0.25 
 
Note:  a ≤ .05; b ≤ .01; c ≤ .001; d ≤ .0001 
           n = 343  
           R2 = .25; F = 3.25, p ≤ .0001 
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Table 120 
 
Recovery Expectancy Mediating Model Results of OLS Regression Testing Recovery 
Strategy 6 (Symptom Eradication) 
 
H1 Variable b SE t 
 Age  0.00 0.01  0.29 
 Gender  0.11 0.16  0.72 
 Income -0.18 0.06   -2.95b
 Education -0.14 0.08 -1.83 
Domain 1    
3.1a Major depression diagnosis  0.49 0.19    2.63b
3.1b Somatization -0.02 0.11 -0.21 
3.1c Obsessive-compulsive  0.03 0.14  0.25 
3.1d Interpersonal sensitivity  0.37 0.14   2.74b
3.1e Anxiety -0.03 0.14 -0.20 
3.1f Depression  0.00 0.15  0.03 
3.1g Hostility  0.08 0.10  0.79 
3.1h Phobic anxiety  0.02 0.11  0.19 
3.1i Paranoia -0.33 0.13   -2.56b
3.1j Psychoticism -0.05 0.13 -0.34 
3.1k Substance abuse history  0.07 0.14  0.46 
3.1l Hospitalization history -0.01 0.01 -1.21 
3.1m Hospitalized in last year  0.10 0.15  0.66 
3.1n Age of onset  0.00 0.01  0.44 
3.1o Medication:  Anti-depressant -0.29 0.18 -1.63 
3.1p Medication:  Anti-psychotic  0.03 0.15  0.29 
3.1q Medication:  Anti-manic  0.15 0.16  0.93 
3.1r Medication:  Anti-anxiety  0.05 0.14  0.34 
3.1s Medication:  Other psychotropic  0.05 0.14  0.36 
3.1t Current employment  0.18 0.18  0.99 
3.1u Years of employment -0.00 0.01 -0.67 
3.1v Nuclear family mental illness -0.07 0.06 -1.22 
3.1w Extended family mental illness  0.03 0.11  0.26 
3.1x Child sexual abuse history -0.22 0.16 -1.38 
3.1y Child physical abuse history  0.24 0.15  1.53 
3.1z Adult sexual assault history -0.17 0.18 -0.93 
3.1aa Adult physical assault history -0.02 0.16 -0.14 
Domain 2    
Stigma    
3.2a Alienation  0.20 0.18  1.09 
3.2b Stereotype endorsement -0.23 0.20 -1.16 
3.2c Discrimination experience  0.00 0.17  0.02 
3.2d Social withdrawal -0.17 0.22 -0.79 
3.2e Stigma resistance  0.29 0.19  1.48 
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Table 120 (cont.) 
 
H1 Variable 
 
b SE t 
Social Support and Related    
3.2f Partner or best friend support  0.10 0.08  1.32 
3.2g Family support -0.04 0.05 -0.75 
3.2h Provider support  0.13 0.10  1.38 
3.2i Friend support -0.09 0.08 -1.21 
3.2j Community involvement  0.19 0.06    2.74b
3.2k Trust -0.12 0.08 -1.59 
Empowerment    
3.2l Self-esteem/self-efficacy  0.23 0.20  1.17 
3.2m Power/powerlessness -0.66 0.19   -3.53c
3.2n Community activism and 
autonomy 
-0.31 0.19 -1.59 
3.2o Optimism and control over the 
future 
 0.71 0.19    3.81c
3.2p Righteous anger -0.09 0.13 -0.69 
Domain 3    
3.3a Total number of services -0.04 0.08 -0.53 
3.3b Total service hours per month -0.01 0.01 -0.58 
3.3c Average satisfaction score -0.10 0.07 -1.42 
4.a Recovery expectancy 
 
0.23 0.14   1.60 
 
Note:  a ≤ .05; b ≤ .01; c ≤ .001; d ≤ .0001 
           n = 342  
           R2 = .20; F = 2.63, p ≤ .0001 
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Table 121 
 
Recovery Expectancy Moderating Effect Results of OLS Regression Testing Recovery 
Strategy 1 (Effective Illness Management) 
 
H1 Variable b SE t 
 Age -0.00 0.00 -1.37 
 Gender -0.05 0.06 -0.79 
 Income -0.03 0.02 -1.29 
 Education -0.00 0.03 -0.01 
Domain 1    
3.1a Anxiety diagnosis -0.21 0.09  -2.35 
3.1b Somatization   0.05 0.04   1.17 
3.1c Obsessive-compulsive -0.06 0.05 -1.21 
3.1d Interpersonal sensitivity  0.16 0.09   1.77 
3.1e Anxiety -0.09 0.05 -1.63 
3.1f Depression -0.09 0.06 -1.55 
3.1g Hostility -0.02 0.04 -0.66 
3.1h Phobic anxiety -0.04 0.04 -1.06 
3.1i Paranoia -0.04 0.05 -0.84 
3.1j Psychoticism -0.01 0.05 -0.19 
3.1k Substance abuse history   0.06 0.06  1.02 
3.1l Hospitalization history -0.00 0.00 -0.59 
3.1m Hospitalized in last year -0.06 0.06 -1.02 
3.1n Age of onset   0.00 0.00   0.01 
3.1o Medication:  Anti-depressant   0.01 0.07   0.17 
3.1p Medication:  Anti-psychotic -0.10 0.06 -1.69 
3.1q Medication:  Anti-manic -0.02 0.06 -0.31 
3.1r Medication:  Anti-anxiety -0.16 0.06   -2.86* 
3.1s Medication:  Other psychotropic   0.03 0.06   0.55 
3.1t Current employment -0.04 0.07 -0.51 
3.1u Years of employment -0.00 0.00 -0.76 
3.1v Nuclear family mental illness -0.00 0.02 -0.12 
3.1w Extended family mental illness -0.02 0.04 -0.40 
3.1x Child sexual abuse history -0.08 0.06 -1.25 
3.1y Child physical abuse history   0.03 0.06   0.58 
3.1z Adult sexual assault history   0.00 0.07   0.07 
3.1aa Adult physical assault history   0.09 0.06   1.50 
Domain 2    
Stigma    
3.2a Alienation -0.07 0.07 -1.01 
3.2b Stereotype endorsement -0.05 0.08 -0.61 
3.2c Discrimination experience -0.04 0.06 -0.61 
3.2d Social withdrawal   0.03 0.08  0.36 
3.2e Stigma resistance -0.40 0.08  -5.20* 
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Table 121 (cont.) 
 
0.11Variable 
 
b SE T 
Social Support and Related    
3.2f Partner or best friend support   0.03 0.03    1.09 
3.2g Family support -0.03 0.06  -0.45 
3.2h Provider support -0.00 0.10  -0.06 
3.2i Friend support   0.01 0.03    0.43 
3.2j Community involvement   0.03 0.09    0.35 
3.2k Trust   0.00 0.03    0.00 
Empowerment    
3.2l Self-esteem/self-efficacy   0.59 0.21    2.81* 
3.2m Power/powerlessness   0.03 0.07   0.53 
3.2n Community activism and 
autonomy 
-0.09 0.08 -1.13 
3.2o Optimism and control over the 
future 
-0.02 0.21  -0.10 
3.2p Righteous anger -0.02 0.05 -0.44 
Domain 3    
3.3a Total number of services   0.01 0.03  0.50 
3.3b Total service hours per month   0.01 0.00  1.30 
3.3c Average satisfaction score   0.02 0.03  0.81 
 Moderating Variables    
4.b RE x Interpersonal sensitivity -0.01 0.05 -0.27 
4.b RE x Support from family   0.02 0.04  0.63 
4.b RE x Support from provider   0.01 0.06  0.20 
4.b RE x Community involvement   0.03 0.05  0.53 
4.b RE x Self-esteem/Self-efficacy -0.20 0.12 -1.58 
4.b RE x Optimism and control over 
the future 
 
  0.13 0.13  1.05 
 
Note:  * Bonferonni correction utilized for post hoc analyses (.05 / 6 interaction terms),  
           required p-value of .0083 for significance 
           n = 335  
           R2 = .67; F = 12.99, p ≤ .0001 
           RE = Recovery Expectancy 
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Table 122 
 
Recovery Expectancy Moderating Effect Results of OLS Regression Testing Recovery 
Strategy 2 (Positive Future Orientation) 
 
H1 Variable b SE t 
 Age -0.00 0.00 -0.99 
 Gender  0.02 0.05   0.41 
 Income -0.03 0.02 -1.60 
 Education -0.05 0.02 -1.88 
Domain 1    
3.1a Schizophrenia diagnosis -0.18 0.07 -2.55 
3.1b Somatization -0.06 0.03 -1.54 
3.1c Obsessive-compulsive 0.04 0.04 0.97 
3.1d Interpersonal sensitivity 0.17 0.08  2.26 
3.1e Anxiety   0.13 0.05   2.83* 
3.1f Depression -0.09 0.05 -1.95 
3.1g Hostility -0.00 0.03 -0.13 
3.1h Phobic anxiety -0.11 0.03  -3.18* 
3.1i Paranoia -0.03 0.04 -0.68 
3.1j Psychoticism -0.07 0.04 -1.54 
3.1k Substance abuse history  0.11 0.05   2.22 
3.1l Hospitalization history  0.00 0.00  0.54 
3.1m Hospitalized in last year -0.12 0.05 -2.40 
3.1n Age of onset  0.00 0.00  0.19 
3.1o Medication:  Anti-depressant -0.11 0.06 -1.97 
3.1p Medication:  Anti-psychotic  0.03 0.05  0.53 
3.1q Medication:  Anti-manic -0.02 0.05 -0.46 
3.1r Medication:  Anti-anxiety  0.10 0.05  2.08 
3.1s Medication:  Other psychotropic -0.01 0.05 -0.31 
3.1t Current employment  0.04 0.06  0.70 
3.1u Years of employment -0.00 0.00 -0.56 
3.1v Nuclear family mental illness  0.02 0.02  1.23 
3.1w Extended family mental illness -0.02 0.03 -0.62 
3.1x Child sexual abuse history  0.02 0.05  0.40 
3.1y Child physical abuse history  0.03 0.05  0.56 
3.1z Adult sexual assault history  0.03 0.06  0.44 
3.1aa Adult physical assault history  0.06 0.05  1.12 
Domain 2    
Stigma    
3.2a Alienation  0.09 0.06  1.45 
3.2b Stereotype endorsement -0.06 0.07 -0.88 
3.2c Discrimination experience  0.11 0.05  2.00 
3.2d Social withdrawal -0.18 0.07 -2.61 
3.2e Stigma resistance -0.07 0.06 -1.08 
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Table 122 (cont.) 
 
0.11Variable 
 
b SE T 
Social Support and Related    
3.2f Partner or best friend support 0.01 0.02  0.29 
3.2g Family support 0.11 0.05  2.14 
3.2h Provider support 0.05 0.08  0.57 
3.2i Friend support 0.02 0.02  0.70 
3.2j Community involvement 0.09 0.08   1.21 
3.2k Trust 0.01 0.02  0.32 
Empowerment    
3.2l Self-esteem/self-efficacy 0.73 0.17   4.24* 
3.2m Power/powerlessness 0.03 0.06  0.43 
3.2n Community activism and 
autonomy 
0.10 0.06  1.59 
3.2o Optimism and control over the 
future 
-0.30 0.06 -1.70 
3.2p Righteous anger 0.02 0.04  0.42 
Domain 3    
3.3a Total number of services -0.01 0.02 -0.30 
3.3b Total service hours per month -0.00 0.00 -1.45 
3.3c Average satisfaction score  0.05 0.02  1.86 
 Moderating Variables    
4.b RE x Interpersonal sensitivity -0.07 0.04 -1.82 
4.b RE x Support from family -0.04 0.03 -1.27 
4.b RE x Support from provider  0.03 0.05  0.67 
4.b RE x Community involvement -0.02 0.04 -0.59 
4.b RE x Self-esteem/Self-efficacy -0.05 0.10 -0.50 
4.b RE x Optimism and control over 
the future 
 
 0.15 0.10  1.46 
 
Note:  * Bonferonni correction utilized for post hoc analyses (.05 / 6 interaction terms),  
           required p-value of .0083 for significance            
           n = 335;  
           R2 = .72; F = 16.10, p ≤ .0001 
           RE = Recovery Expectancy 
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Table 123 
 
Recovery Expectancy Moderating Effect Results of OLS Regression Testing Recovery 
Strategy 3 (Meaningfulness, Personal Control, and Hope) 
 
H1 Variable b SE t 
 Age  0.00 0.00  1.46 
 Gender  0.05 0.05  1.06 
 Income -0.02 0.02 -1.09 
 Education -0.02 0.02 -0.65 
Domain 1    
3.1a Anxiety diagnosis -0.23 0.07   -3.28* 
3.1b Somatization  0.02 0.03   0.70 
3.1c Obsessive-compulsive -0.06 0.04 -1.25 
3.1d Interpersonal sensitivity  0.17 0.07  2.36 
3.1e Anxiety  0.02 0.04  0.51 
3.1f Depression  0.07 0.05  1.47 
3.1g Hostility -0.08 0.03 - 2.54 
3.1h Phobic anxiety -0.04 0.03 -1.18 
3.1i Paranoia -0.04 0.04 -1.11 
3.1j Psychoticism  0.05 0.04  1.15 
3.1k Substance abuse history  0.00 0.04  0.17 
3.1l Hospitalization history  0.00 0.00  0.99 
3.1m Hospitalized in last year -0.00 0.05 -0.06 
3.1n Age of onset -0.00 0.00 -0.12 
3.1o Medication:  Anti-depressant -0.04 0.05 -0.70 
3.1p Medication:  Anti-psychotic -0.12 0.05  -2.60 
3.1q Medication:  Anti-manic  0.03 0.05  0.65 
3.1r Medication:  Anti-anxiety  0.08 0.04  1.71 
3.1s Medication:  Other psychotropic -0.05 0.04 -1.03 
3.1t Current employment  0.06 0.06  1.17 
3.1u Years of employment -0.00 0.00 -1.19 
3.1v Nuclear family mental illness  0.03 0.02  1.88 
3.1w Extended family mental illness -0.04 0.03 -1.29 
3.1x Child sexual abuse history  0.10 0.05  2.11 
3.1y Child physical abuse history  0.01 0.05  0.21 
3.1z Adult sexual assault history -0.02 0.06 -0.41 
3.1aa Adult physical assault history -0.02 0.05 -0.40 
Domain 2    
Stigma    
3.2a Alienation -0.01 0.06  -0.20 
3.2b Stereotype endorsement -0.18 0.06   -2.93* 
3.2c Discrimination experience  0.08 0.05   1.64 
3.2d Social withdrawal -0.01 0.07 -0.22 
3.2e Stigma resistance -0.16 0.06   -2.71* 
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Table 123 (cont.) 
 
H1 Variable 
 
b SE t 
Social Support and Related    
3.2f Partner or best friend support -0.01 0.02 -0.61 
3.2g Family support  0.08 0.05  1.61 
3.2h Provider support  0.10 0.08  1.33 
3.2i Friend support  0.06 0.02  2.64 
3.2j Community involvement  0.01 0.07  0.08 
3.2k Trust  0.01 0.02  0.24 
Empowerment    
3.2l Self-esteem/self-efficacy  0.03 0.16  0.19 
3.2m Power/powerlessness -0.03 0.06 -0.47 
3.2n Community activism and 
autonomy 
 0.35 0.06   5.90* 
3.2o Optimism and control over the 
future 
-0.11 0.17   -0.07 
3.2p Righteous anger -0.06 0.04 -1.41 
Domain 3    
3.3a Total number of services -0.01 0.02 -0.35 
3.3b Total service hours per month  0.00 0.00  0.17 
3.3c Average satisfaction score  0.00 0.02  0.15 
 Moderating Variables    
4.b RE x Interpersonal sensitivity -0.04 0.04 -1.14 
4.b RE x Support from family -0.03 0.03 -0.92 
4.b RE x Support from provider -0.02 0.05 -0.44 
4.b RE x Community involvement  0.01 0.04  0.33 
4.b RE x Self-esteem/Self-efficacy  0.02 0.10  0.25 
4.b RE x Optimism and control over 
the future 
 
 0.08 0.10  0.80 
 
Note:  * Bonferonni correction utilized for post hoc analyses (.05 / 6 interaction terms),  
           required p-value of .0083 for significance 
           n = 334;  
           R2 = .49; F = 6.63, p ≤ .0001 
           RE = Recovery Expectancy 
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Table 124 
 
Recovery Expectancy Moderating Effect Results of OLS Regression Testing Recovery 
Strategy 4 (Recognizing Support) 
 
H1 Variable b SE t 
 Age -0.00 0.00 -1.05 
 Gender -0.02 0.09 -0.25 
 Income -0.02 0.03 -0.63 
 Education  0.01 0.04  0.24 
Domain 1    
3.1a Other diagnosis  0.34 0.19  1.82 
3.1b Somatization  0.01 0.06  0.17 
3.1c Obsessive-compulsive -0.01 0.08 -0.19 
3.1d Interpersonal sensitivity -0.01 0.14  0.10 
3.1e Anxiety -0.03 0.08 -0.33 
3.1f Depression -0.07 0.09 -0.85 
3.1g Hostility -0.02 0.05 -0.41 
3.1h Phobic anxiety -0.02 0.06 -0.27 
3.1i Paranoia  0.03 0.07  0.45 
3.1j Psychoticism  0.02 0.08  0.30 
3.1k Substance abuse history -0.04 0.08 -0.48 
3.1l Hospitalization history  0.00 0.00  0.14 
3.1m Hospitalized in last year  0.04 0.09  0.41 
3.1n Age of onset -0.00 0.00 -0.35 
3.1o Medication:  Anti-depressant  0.12 0.10  1.17 
3.1p Medication:  Anti-psychotic -0.06 0.09 -0.66 
3.1q Medication:  Anti-manic -0.09 0.09 -0.98 
3.1r Medication:  Anti-anxiety -0.02 0.08 -0.29 
3.1s Medication:  Other psychotropic  0.10 0.08  1.23 
3.1t Current employment -0.01 0.10 -0.11 
3.1u Years of employment -0.00 0.00 -0.61 
3.1v Nuclear family mental illness  0.07 0.03  2.11 
3.1w Extended family mental illness -0.11 0.06 -1.87 
3.1x Child sexual abuse history  0.08 0.09  0.82 
3.1y Child physical abuse history -0.04 0.09 -0.49 
3.1z Adult sexual assault history  0.02 0.10  0.24 
3.1aa Adult physical assault history -0.03 0.09 -0.30 
Domain 2    
Stigma    
3.2a Alienation -0.22 0.10  -2.07 
3.2b Stereotype endorsement -0.01 0.12 -0.07 
3.2c Discrimination experience -0.03 0.10 -0.33 
3.2d Social withdrawal  0.03 0.13  0.25 
3.2e Stigma resistance -0.12 0.11 -1.08 
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Table 124 (cont.) 
 
H1 Variable 
 
B SE T 
Social Support and Related    
3.2f Partner or best friend support   0.22 0.04     5.02* 
3.2g Family support   0.27 0.09     2.99* 
3.2h Provider support -0.08 0.15 -0.52 
3.2i Friend support   0.07 0.04   1.48 
3.2j Community involvement -0.03 0.13   -0.25 
3.2k Trust   0.06 0.04   1.34 
Empowerment    
3.2l Self-esteem/self-efficacy -0.28 0.32  -0.87 
3.2m Power/powerlessness  0.11 0.11   0.99 
3.2n Community activism and 
autonomy 
 0.05 0.11   0.46 
3.2o Optimism and control over the 
future 
 0.51 0.33  1.52 
3.2p Righteous anger  0.07 0.07  0.90 
Domain 3    
3.3a Total number of services  0.06 0.04  1.42 
3.3b Total service hours per month  0.00 0.01  0.45 
3.3c Average satisfaction score  0.17 0.04   3.96* 
 Moderating Variables    
4.b RE x Interpersonal sensitivity   0.03 0.07  0.38 
4.b RE x Support from family -0.03 0.06 -0.56 
4.b RE x Support from provider  0.00 0.09  0.02 
4.b RE x Community involvement -0.03 0.07 -0.35 
4.b RE x Self-esteem/Self-efficacy  0.22 0.19  1.13 
4.b RE x Optimism and control over 
the future 
 
-0.17 0.20 -0.88 
 
Note:  * Bonferonni correction utilized for post hoc analyses (.05 / 6 interaction terms),  
           required p-value of .0083 for significance 
           n = 337;  
           R2 = .59; F = 9.68, p ≤ .0001 
           RE = Recovery Expectancy 
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Table 125 
 
Recovery Expectancy Moderating Effect Results of OLS Regression Testing Recovery 
Strategy 5 (Help Seeking) 
 
H1 Variable b SE t 
 Age  0.01 0.00   1.95 
 Gender  0.13 0.11  1.22 
 Income  0.02 0.04  0.51 
 Education -0.00 0.05 -0.09 
Domain 1    
3.1b Somatization  0.03 0.07  0.45 
3.1c Obsessive-compulsive  0.03 0.09  0.31 
3.1d Interpersonal sensitivity  0.41 0.16   2.60 
3.1e Anxiety  0.03 0.09  0.29 
3.1f Depression -0.10 0.10 -1.02 
3.1g Hostility -0.01 0.06 -0.11 
3.1h Phobic anxiety -0.09 0.07 -1.29 
3.1i Paranoia  0.05 0.08  0.59 
3.1j Psychoticism -0.10 0.09 -1.10 
3.1k Substance abuse history  0.00 0.10  0.02 
3.1l Hospitalization history  0.00 0.00  0.82 
3.1m Hospitalized in last year  0.11 0.10  1.06 
3.1n Age of onset -0.00 0.00 -0.33 
3.1o Medication:  Anti-depressant  0.03 0.11  0.26 
3.1p Medication:  Anti-psychotic -0.03 0.10 -0.34 
3.1q Medication:  Anti-manic -0.06 0.10 -0.58 
3.1r Medication:  Anti-anxiety -0.08 0.09 -0.89 
3.1s Medication:  Other psychotropic  0.03 0.10  0.29 
3.1t Current employment -0.05 0.12 -0.45 
3.1u Years of employment  0.00 0.00  0.40 
3.1v Nuclear family mental illness  0.01 0.04  0.27 
3.1w Extended family mental illness -0.07 0.07 -0.96 
3.1x Child sexual abuse history  0.08 0.11  0.79 
3.1y Child physical abuse history  0.01 0.10  0.10 
3.1z Adult sexual assault history -0.01 0.12 -0.12 
3.1aa Adult physical assault history -0.07 0.11 -0.62 
Domain 2    
Stigma    
3.2a Alienation -0.03 0.12 -0.24 
3.2b Stereotype endorsement  0.03 0.14  0.21 
3.2c Discrimination experience -0.08 0.11 -0.73 
3.2d Social withdrawal  0.05 0.14  0.34 
3.2e Stigma resistance 
 
-0.16 0.13 -1.25 
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Table 125 (cont.) 
 
H1 Variable 
 
B SE t 
Social Support and Related    
3.2f Partner or best friend support  0.05 0.05  1.07 
3.2g Family support -0.02 0.11 -0.17 
3.2h Provider support -0.08 0.17 -0.44 
3.2i Friend support  0.02 0.05  0.49 
3.2j Community involvement  0.02 0.15  0.10 
3.2k Trust  0.07 0.05  1.48 
Empowerment    
3.2l Self-esteem/self-efficacy  0.81 0.36   2.27 
3.2m Power/powerlessness  0.21 0.12   1.69 
3.2n Community activism and 
autonomy 
-0.05 0.13 -0.40 
3.2o Optimism and control over the 
future 
-0.22 0.36 -0.61 
3.2p Righteous anger -0.18 0.09  -2.05 
Domain 3    
3.3a Total number of services  0.02 0.05  0.38 
3.3b Total service hours per month -0.00 0.01 -0.43 
3.3c Average satisfaction score  0.13 0.05   2.53 
 Moderating Variables    
4.b RE x Interpersonal sensitivity -0.14 0.08 -1.71 
4.b RE x Support from family  0.00 0.06  0.06 
4.b RE x Support from provider  0.14 0.10  1.37 
4.b RE x Community involvement  0.03 0.09  0.34 
4.b RE x Self-esteem/Self-efficacy -0.29 0.21 -1.36 
4.b RE x Optimism and control over 
the future 
 0.15 0.22  0.67 
 
Note:  * Bonferonni correction utilized for post hoc analyses (.05 / 6 interaction terms),  
           required p-value of .0083 for significance 
           n = 343  
           R2 = .25; F = 3.05, p ≤ .0001 
           RE = Recovery Expectancy 
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Table 126 
 
Recovery Expectancy Moderating Effect Results of OLS Regression Testing Recovery 
Strategy 6 (Symptom Eradication) 
 
H1 Variable b SE t 
 Age  0.00 0.01  0.39 
 Gender  0.09 0.16  0.60 
 Income -0.19 0.06  -3.13 
 Education -0.13 0.08 -1.65 
Domain 1    
3.1a Major depression diagnosis  0.48 0.19   2.56 
3.1b Somatization -0.03 0.11 -0.21 
3.1c Obsessive-compulsive  0.04 0.14  0.25 
3.1d Interpersonal sensitivity  0.74 0.23  2.74 
3.1e Anxiety -0.03 0.14 -0.20 
3.1f Depression  0.02 0.15  0.03 
3.1g Hostility  0.07 0.09  0.79 
3.1h Phobic anxiety  0.02 0.11  0.19 
3.1i Paranoia -0.35 0.13  -2.56 
3.1j Psychoticism -0.04 0.13 -0.34 
3.1k Substance abuse history  0.08 0.14  0.46 
3.1l Hospitalization history -0.01 0.01 -1.21 
3.1m Hospitalized in last year  0.08 0.15  0.66 
3.1n Age of onset  0.00 0.01  0.44 
3.1o Medication:  Anti-depressant -0.30 0.18 -1.63 
3.1p Medication:  Anti-psychotic  0.03 0.15  0.29 
3.1q Medication:  Anti-manic  0.14 0.16  0.93 
3.1r Medication:  Anti-anxiety  0.08 0.14  0.34 
3.1s Medication:  Other psychotropic  0.08 0.14  0.36 
3.1t Current employment  0.15 0.18  0.99 
3.1u Years of employment -0.01 0.01 -0.67 
3.1v Nuclear family mental illness -0.06 0.06 -1.22 
3.1w Extended family mental illness  0.02 0.11  0.26 
3.1x Child sexual abuse history -0.19 0.16 -1.38 
3.1y Child physical abuse history  0.20 0.15  1.53 
3.1z Adult sexual assault history -0.18 0.18 -0.93 
3.1aa Adult physical assault history   0.02 0.16 -0.14 
Domain 2    
Stigma    
3.2a Alienation  0.21 0.18  1.09 
3.2b Stereotype endorsement -0.16 0.20 -1.16 
3.2c Discrimination experience  0.01 0.17  0.02 
3.2d Social withdrawal -0.19 0.22 -0.79 
3.2e Stigma resistance  0.31 0.19  1.48 
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Table 126 (cont.) 
 
H1 Variable 
 
b SE t 
Social Support and Related    
3.2f Partner or best friend support  0.10 0.08  1.32 
3.2g Family support -0.01 0.16 -0.75 
3.2h Provider support  0.45 0.26  1.38 
3.2i Friend support -0.08 0.08 -1.21 
3.2j Community involvement  0.26 0.22   2.74 
3.2k Trust -0.10 0.08 -1.59 
Empowerment    
3.2l Self-esteem/self-efficacy  0.17 0.53  1.17 
3.2m Power/powerlessness -0.64 0.19   -3.53*
3.2n Community activism and 
autonomy 
-0.30 0.19 -1.59 
3.2o Optimism and control over the 
future 
 0.71 0.55    3.81*
3.2p Righteous anger -0.06 0.13 -0.69 
Domain 3    
3.3a Total number of services -0.03 0.08 -0.53 
3.3b Total service hours per month -0.01 0.01 -0.58 
3.3c Average satisfaction score -0.11 0.07 -1.42 
 Moderating Variables    
4.b RE x Interpersonal sensitivity -0.24 0.12 -1.94 
4.b RE x Support from family -0.02 0.09 -0.19 
4.b RE x Support from provider -0.21 0.15 -1.34 
4.b RE x Community involvement -0.05 0.13 -0.37 
4.b RE x Self-esteem/Self-efficacy  0.27 0.32  0.85 
4.b RE x Optimism and control over 
the future 
 0.35 0.33  1.06 
 
Note:  * Bonferonni correction utilized for post hoc analyses (.05 / 6 interaction terms),  
           required p-value of .0083 for significance 
           n = 342  
           R2 = .21; F = 2.64, p ≤ .0001 
           RE = Recovery Expectancy 
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Table 127 
 
Illness Severity Moderating Effect Results of OLS Regression Testing Recovery Strategy 
1 (Effective Illness Management) 
 
H1 Variable b SE t 
 Age -0.00 0.00 -1.16 
 Gender -0.05 0.06 -0.78 
 Income -0.03 0.02 -1.46 
 Education  0.00 0.03  0.11 
Domain 1    
3.1a Anxiety diagnosis -0.20 0.09  -2.25 
3.1b Somatization   0.03 0.04   0.81 
3.1c Obsessive-compulsive -0.06 0.05 -1.15 
3.1d Interpersonal sensitivity  0.24 0.09    2.75* 
3.1e Anxiety -0.07 0.05 -1.36 
3.1f Depression -0.11 0.06 -1.76 
3.1g Hostility -0.02 0.04 -0.55 
3.1h Phobic anxiety -0.05 0.04 -1.20 
3.1i Paranoia -0.04 0.05 -0.71 
3.1j Psychoticism -0.02 0.05 -0.45 
3.1k Substance abuse history   0.06 0.06  1.01 
3.1l Hospitalization history -0.00 0.00 -0.86 
3.1m Hospitalized in last year -0.06 0.06 -0.99 
3.1n Age of onset   0.00 0.00   0.17 
3.1o Medication:  Anti-depressant   0.02 0.07   0.31 
3.1p Medication:  Anti-psychotic -0.11 0.06 -1.88 
3.1q Medication:  Anti-manic -0.01 0.06 -0.25 
3.1r Medication:  Anti-anxiety -0.16 0.06   -2.92* 
3.1s Medication:  Other psychotropic   0.04 0.06   0.64 
3.1t Current employment -0.04 0.07 -0.53 
3.1u Years of employment -0.00 0.00 -0.89 
3.1v Nuclear family mental illness -0.01 0.02 -0.26 
3.1w Extended family mental illness -0.01 0.04 -0.30 
3.1x Child sexual abuse history -0.07 0.06 -1.09 
3.1y Child physical abuse history   0.03 0.06   0.51 
3.1z Adult sexual assault history  -0.00 0.07  -0.01 
3.1aa Adult physical assault history   0.10 0.06   1.71 
Domain 2    
Stigma    
3.2a Alienation -0.07 0.07 -0.98 
3.2b Stereotype endorsement -0.02 0.08 -0.23 
3.2c Discrimination experience -0.05 0.07 -0.84 
3.2d Social withdrawal   0.02 0.08  0.29 
3.2e Stigma resistance -0.41 0.08 -5.35* 
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Table 127 (cont.) 
 
0.11Variable 
 
b SE T 
Social Support and Related    
3.2f Partner or best friend support   0.03 0.03    1.11 
3.2g Family support -0.01 0.06  -0.18 
3.2h Provider support   0.14 0.10   1.38 
3.2i Friend support   0.01 0.03    0.28 
3.2j Community involvement  -0.04 0.08   -0.45 
3.2k Trust   0.00 0.03    0.12 
Empowerment    
3.2l Self-esteem/self-efficacy   0.43 0.21   2.06 
3.2m Power/powerlessness   0.04 0.07   0.59 
3.2n Community activism and 
autonomy 
-0.09 0.08 -1.18 
3.2o Optimism and control over the 
future 
-0.02 0.21  -0.11 
3.2p Righteous anger -0.02 0.05 -0.34 
Domain 3    
3.3a Total number of services   0.02 0.03  0.56 
3.3b Total service hours per month   0.00 0.00  1.15 
3.3c Average satisfaction score   0.03 0.03  0.90 
 Moderating Variables    
4.b IS x Interpersonal sensitivity -0.06 0.05 -1.20 
4.b IS x Support from family   0.01 0.04  0.33 
4.b IS x Support from provider  -0.08 0.06 -1.39 
4.b IS x Community involvement   0.08 0.05  1.50 
4.b IS x Self-esteem/Self-efficacy -0.09 0.12 -0.74 
4.b IS x Optimism and control over 
the future 
 
  0.13 0.13  1.01 
 
Note:  * Bonferonni correction utilized for post hoc analyses (.05 / 6 interaction terms),  
           required p-value of .0083 for significance 
           n = 335  
           R2 = .67; F = 13.18, p ≤ .0001 
           IS = Illness Severity 
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Table 128 
 
Illness Severity Moderating Effect Results of OLS Regression Testing Recovery Strategy 
2 (Positive Future Orientation) 
 
H1 Variable b SE t 
 Age -0.00 0.00 -1.18 
 Gender  0.03 0.05   0.54 
 Income -0.04 0.02 -1.90 
 Education -0.04 0.02 -1.77 
Domain 1    
3.1a Schizophrenia diagnosis -0.18 0.07 -2.51 
3.1b Somatization -0.06 0.03 -1.73 
3.1c Obsessive-compulsive  0.05 0.04  1.16 
3.1d Interpersonal sensitivity  0.05 0.07  0.70 
3.1e Anxiety  0.12 0.05   2.61 
3.1f Depression -0.12 0.05 -2.38 
3.1g Hostility -0.00 0.03 -0.09 
3.1h Phobic anxiety -0.10 0.03  -2.90* 
3.1i Paranoia -0.04 0.04 -1.03 
3.1j Psychoticism -0.05 0.04 -1.10 
3.1k Substance abuse history  0.12 0.05   2.29 
3.1l Hospitalization history  0.00 0.00  0.54 
3.1m Hospitalized in last year -0.12 0.05 -2.43 
3.1n Age of onset  0.00 0.00  0.47 
3.1o Medication:  Anti-depressant -0.11 0.06 -1.87 
3.1p Medication:  Anti-psychotic  0.02 0.05  0.40 
3.1q Medication:  Anti-manic -0.03 0.05 -0.55 
3.1r Medication:  Anti-anxiety  0.09 0.05  2.01 
3.1s Medication:  Other psychotropic -0.03 0.05 -0.60 
3.1t Current employment  0.03 0.06  0.53 
3.1u Years of employment -0.00 0.00 -0.47 
3.1v Nuclear family mental illness  0.02 0.02  1.27 
3.1w Extended family mental illness -0.02 0.03 -0.70 
3.1x Child sexual abuse history  0.02 0.05  0.43 
3.1y Child physical abuse history  0.03 0.05  0.70 
3.1z Adult sexual assault history  0.03 0.06  0.45 
3.1aa Adult physical assault history  0.07 0.05  1.32 
Domain 2    
Stigma    
3.2a Alienation  0.08 0.06  1.26 
3.2b Stereotype endorsement -0.04 0.07 -0.59 
3.2c Discrimination experience  0.11 0.05  2.00 
3.2d Social withdrawal -0.19 0.07   -2.70* 
3.2e Stigma resistance -0.07 0.06 -1.08 
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Table 128 (cont.) 
 
0.11Variable 
 
B SE T 
Social Support and Related    
3.2f Partner or best friend support 0.01 0.02  0.46 
3.2g Family support 0.09 0.05  1.88 
3.2h Provider support 0.28 0.09    3.22* 
3.2i Friend support      -0.00 0.02 -0.19 
3.2j Community involvement 0.06 0.07   0.97 
3.2k Trust 0.01 0.02  0.30 
Empowerment    
3.2l Self-esteem/self-efficacy 0.79 0.17   4.57* 
3.2m Power/powerlessness 0.02 0.06  0.39 
3.2n Community activism and 
autonomy 
0.10 0.06  1.57 
3.2o Optimism and control over the 
future 
-0.52 0.18   -2.88* 
3.2p Righteous anger 0.04 0.04  0.90 
Domain 3    
3.3a Total number of services  0.00 0.03  0.05 
3.3b Total service hours per month -0.00 0.00 -1.42 
3.3c Average satisfaction score  0.06 0.02  2.28 
 Moderating Variables    
4.b IS x Interpersonal sensitivity  0.00 0.04   0.15 
4.b IS x Support from family -0.03 0.03 -0.90 
4.b IS x Support from provider -0.11 0.05 -2.13 
4.b IS x Community involvement -0.01 0.04 -0.25 
4.b IS x Self-esteem/Self-efficacy -0.08 0.10 -0.76 
4.b IS x Optimism and control over 
the future 
 
 0.30 0.10  2.66 
 
Note:  * Bonferonni correction utilized for post hoc analyses (.05 / 6 interaction terms),  
           required p-value of .0083 for significance            
           n = 335;  
           R2 = .72; F = 16.37, p ≤ .0001 
           IS = Illness Severity 
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Table 129 
 
Illness Severity Moderating Effect Results of OLS Regression Testing Recovery Strategy 
3 (Meaningfulness, Personal Control, and Hope) 
 
H1 Variable b SE t 
 Age  0.00 0.00  1.18 
 Gender  0.06 0.05  1.34 
 Income -0.02 0.02 -1.03 
 Education -0.01 0.02 -0.46 
Domain 1    
3.1a Anxiety diagnosis -0.25 0.07   -3.50* 
3.1b Somatization  0.02 0.03   0.57 
3.1c Obsessive-compulsive -0.05 0.04 -1.21 
3.1d Interpersonal sensitivity -0.01 0.07 -0.15 
3.1e Anxiety  0.01 0.04  0.29 
3.1f Depression  0.05 0.05  1.12 
3.1g Hostility -0.08 0.03 - 2.54 
3.1h Phobic anxiety -0.04 0.03 -1.18 
3.1i Paranoia -0.05 0.04 -1.18 
3.1j Psychoticism  0.06 0.04  1.51 
3.1k Substance abuse history  0.00 0.04  0.10 
3.1l Hospitalization history  0.00 0.00  0.65 
3.1m Hospitalized in last year -0.00 0.05 -0.01 
3.1n Age of onset -0.00 0.00 -0.02 
3.1o Medication:  Anti-depressant -0.03 0.05 -0.59 
3.1p Medication:  Anti-psychotic -0.13 0.05   -2.80* 
3.1q Medication:  Anti-manic  0.02 0.05  0.47 
3.1r Medication:  Anti-anxiety  0.06 0.04  1.45 
3.1s Medication:  Other psychotropic -0.06 0.04 -1.34 
3.1t Current employment  0.07 0.06  1.20 
3.1u Years of employment -0.00 0.00 -0.89 
3.1v Nuclear family mental illness  0.03 0.02  1.62 
3.1w Extended family mental illness -0.04 0.03 -1.32 
3.1x Child sexual abuse history  0.10 0.05  1.99 
3.1y Child physical abuse history  0.03 0.05  0.59 
3.1z Adult sexual assault history -0.03 0.06 -0.56 
3.1aa Adult physical assault history -0.01 0.05 -0.26 
Domain 2    
Stigma    
3.2a Alienation -0.03 0.05  -0.46 
3.2b Stereotype endorsement -0.18 0.06   -2.99* 
3.2c Discrimination experience  0.09 0.05   1.65 
3.2d Social withdrawal -0.01 0.07 -0.20 
3.2e Stigma resistance -0.15 0.06  -2.61 
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Table 129 (cont.) 
 
H1 Variable 
 
b SE t 
Social Support and Related    
3.2f Partner or best friend support -0.01 0.02 -0.36 
3.2g Family support  0.03 0.05  0.73 
3.2h Provider support  0.23 0.08    2.77* 
3.2i Friend support  0.05 0.02  2.10 
3.2j Community involvement  0.03 0.06  0.50 
3.2k Trust  0.00 0.02  0.13 
Empowerment    
3.2l Self-esteem/self-efficacy  0.19 0.16  1.18 
3.2m Power/powerlessness -0.02 0.06 -0.43 
3.2n Community activism and 
autonomy 
 0.35 0.06    5.90* 
3.2o Optimism and control over the 
future 
-0.15 0.17   -0.90 
3.2p Righteous anger -0.05 0.04 -1.30 
Domain 3    
3.3a Total number of services -0.01 0.02 -0.33 
3.3b Total service hours per month  0.00 0.00  0.45 
3.3c Average satisfaction score  0.01 0.02  0.52 
 Moderating Variables    
4.b IS x Interpersonal sensitivity  0.08 0.04   2.09 
4.b IS x Support from family  0.00 0.03   0.10 
4.b IS x Support from provider -0.09 0.05 -1.94 
4.b IS x Community involvement -0.00 0.04 -0.09 
4.b IS x Self-esteem/Self-efficacy -0.07 0.10 -0.73 
4.b IS x Optimism and control over 
the future 
 
 0.17 0.10  1.59 
 
Note:  * Bonferonni correction utilized for post hoc analyses (.05 / 6 interaction terms),  
           required p-value of .0083 for significance 
           n = 334;  
           R2 = .49; F = 6.73, p ≤ .0001 
           IS = Illness Severity 
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Table 130 
 
Illness Severity Moderating Effect Results of OLS Regression Testing Recovery Strategy 
4 (Recognizing Support) 
 
H1 Variable b SE t 
 Age -0.01 0.00 -1.26 
 Gender -0.02 0.09 -0.22 
 Income -0.02 0.03 -0.55 
 Education  0.01 0.04  0.28 
Domain 1    
3.1a Other diagnosis  0.34 0.18  1.89 
3.1b Somatization  0.02 0.06  0.40 
3.1c Obsessive-compulsive -0.01 0.08 -0.07 
3.1d Interpersonal sensitivity -0.15 0.13 -1.12 
3.1e Anxiety -0.05 0.08 -0.60 
3.1f Depression -0.07 0.09 -0.85 
3.1g Hostility -0.02 0.05 -0.46 
3.1h Phobic anxiety  0.00 0.06  0.04 
3.1i Paranoia  0.02 0.07  0.26 
3.1j Psychoticism  0.05 0.08  0.62 
3.1k Substance abuse history -0.03 0.08 -0.38 
3.1l Hospitalization history  0.00 0.00  0.54 
3.1m Hospitalized in last year  0.01 0.08  0.16 
3.1n Age of onset -0.00 0.00 -0.43 
3.1o Medication:  Anti-depressant  0.09 0.10  0.93 
3.1p Medication:  Anti-psychotic -0.04 0.09 -0.47 
3.1q Medication:  Anti-manic -0.10 0.09 -1.20 
3.1r Medication:  Anti-anxiety -0.03 0.08 -0.35 
3.1s Medication:  Other psychotropic  0.11 0.08  1.30 
3.1t Current employment -0.04 0.10 -0.36 
3.1u Years of employment -0.00 0.00 -0.60 
3.1v Nuclear family mental illness  0.07 0.03  2.06 
3.1w Extended family mental illness -0.11 0.06 -1.84 
3.1x Child sexual abuse history  0.06 0.09  0.70 
3.1y Child physical abuse history -0.03 0.09 -0.34 
3.1z Adult sexual assault history  0.04 0.10  0.41 
3.1aa Adult physical assault history -0.04 0.09 -0.41 
Domain 2    
Stigma    
3.2a Alienation -0.23 0.10  -2.19 
3.2b Stereotype endorsement -0.02 0.12 -0.16 
3.2c Discrimination experience  0.01 0.10  0.07 
3.2d Social withdrawal  0.03 0.12  0.26 
3.2e Stigma resistance -0.12 0.11 -1.10 
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Table 130 (cont.) 
 
H1 Variable 
 
B SE T 
Social Support and Related    
3.2f Partner or best friend support   0.24 0.04     5.31* 
3.2g Family support   0.26 0.09     2.99* 
3.2h Provider support -0.12 0.15 -0.79 
3.2i Friend support   0.06 0.04   1.37 
3.2j Community involvement -0.03 0.12   -0.23 
3.2k Trust   0.04 0.04   1.05 
Empowerment    
3.2l Self-esteem/self-efficacy  0.04 0.32   0.12 
3.2m Power/powerlessness  0.08 0.11   0.72 
3.2n Community activism and 
autonomy 
 0.04 0.11   0.34 
3.2o Optimism and control over the 
future 
 0.24 0.33  0.74 
3.2p Righteous anger  0.06 0.07  0.82 
Domain 3    
3.3a Total number of services  0.09 0.05  1.96 
3.3b Total service hours per month  0.00 0.01  0.40 
3.3c Average satisfaction score  0.16 0.04   3.83* 
 Moderating Variables    
4.b IS x Interpersonal sensitivity   0.03 0.07  1.46 
4.b IS x Support from family -0.03 0.05 -0.41 
4.b IS x Support from provider  0.00 0.09  0.41 
4.b IS x Community involvement -0.03 0.07 -0.38 
4.b IS x Self-esteem/Self-efficacy  0.22 0.19  1.10 
4.b IS x Optimism and control over 
the future 
 
-0.17 0.20 -0.02 
 
Note:  * Bonferonni correction utilized for post hoc analyses (.05 / 6 interaction terms),  
           required p-value of .0083 for significance 
           n = 337;  
           R2 = .60; F = 9.92, p ≤ .0001 
           IS = Illness Severity 
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Table 131 
 
Illness Severity Moderating Effect Results of OLS Regression Testing Recovery Strategy 
5 (Help Seeking) 
 
H1 Variable b SE t 
 Age  0.01 0.00   1.98 
 Gender  0.17 0.10  1.61 
 Income  0.01 0.04  0.32 
 Education  0.00 0.05  0.07 
Domain 1    
3.1b Somatization  0.00 0.07  0.08 
3.1c Obsessive-compulsive  0.07 0.09  0.73 
3.1d Interpersonal sensitivity  0.19 0.15   1.27 
3.1e Anxiety  0.02 0.09  0.27 
3.1f Depression -0.13 0.10 -1.25 
3.1g Hostility -0.01 0.06 -0.20 
3.1h Phobic anxiety -0.08 0.07 -1.08 
3.1i Paranoia  0.02 0.09  0.23 
3.1j Psychoticism -0.05 0.09 -0.62 
3.1k Substance abuse history  0.01 0.10  0.07 
3.1l Hospitalization history  0.00 0.00  0.61 
3.1m Hospitalized in last year  0.10 0.10  1.00 
3.1n Age of onset -0.00 0.00 -0.29 
3.1o Medication:  Anti-depressant  0.03 0.11  0.31 
3.1p Medication:  Anti-psychotic -0.05 0.10 -0.48 
3.1q Medication:  Anti-manic -0.05 0.10 -0.52 
3.1r Medication:  Anti-anxiety -0.09 0.09 -0.98 
3.1s Medication:  Other psychotropic  0.00 0.10  0.06 
3.1t Current employment -0.07 0.12 -0.56 
3.1u Years of employment  0.00 0.00  0.62 
3.1v Nuclear family mental illness  0.01 0.04  0.25 
3.1w Extended family mental illness -0.07 0.07 -1.03 
3.1x Child sexual abuse history  0.10 0.11  0.93 
3.1y Child physical abuse history  0.02 0.10  0.19 
3.1z Adult sexual assault history -0.04 0.12 -0.34 
3.1aa Adult physical assault history -0.04 0.11 -0.36 
Domain 2    
Stigma    
3.2a Alienation -0.04 0.12 -0.31 
3.2b Stereotype endorsement  0.12 0.14  0.91 
3.2c Discrimination experience -0.10 0.11 -0.93 
3.2d Social withdrawal  0.03 0.14  0.21 
3.2e Stigma resistance 
 
-0.18 0.13 -1.38 
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Table 131 (cont.) 
 
H1 Variable 
 
B SE t 
Social Support and Related    
3.2f Partner or best friend support  0.05 0.05  1.01 
3.2g Family support -0.09 0.10 -0.92 
3.2h Provider support  0.35 0.18  2.00 
3.2i Friend support -0.00 0.05 -0.06 
3.2j Community involvement  0.00 0.14  0.04 
3.2k Trust  0.08 0.05  1.59 
Empowerment    
3.2l Self-esteem/self-efficacy  1.14 0.36     3.14* 
3.2m Power/powerlessness  0.26 0.12   2.08 
3.2n Community activism and 
autonomy 
-0.06 0.13 -0.43 
3.2o Optimism and control over the 
future 
-0.89 0.36 -2.42 
3.2p Righteous anger -0.16 0.09  -1.83 
Domain 3    
3.3a Total number of services  0.02 0.05  0.28 
3.3b Total service hours per month  0.00 0.01  0.01 
3.3c Average satisfaction score  0.13 0.05   2.60 
 Moderating Variables    
4.b IS x Interpersonal sensitivity -0.01 0.08 -0.14 
4.b IS x Support from family  0.05 0.06  0.90 
4.b IS x Support from provider -0.12 0.10 -1.16 
4.b IS x Community involvement  0.04 0.08  0.45 
4.b IS x Self-esteem/Self-efficacy -0.50 0.22 -2.29 
4.b IS x Optimism and control over 
the future 
 0.57 0.23  2.50 
 
Note:  * Bonferonni correction utilized for post hoc analyses (.05 / 6 interaction terms),  
           required p-value of .0083 for significance 
           n = 343  
           R2 = .25; F = 3.13, p ≤ .0001 
           IS = Illness Severity 
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Table 132 
 
Illness Severity Moderating Effect Results of OLS Regression Testing Recovery Strategy 
6 (Symptom Eradication) 
 
H1 Variable b SE t 
 Age -0.00 0.01 -0.04 
 Gender  0.12 0.16  0.80 
 Income -0.18 0.06   -2.93* 
 Education -0.14 0.08 -1.80 
Domain 1    
3.1a Major depression diagnosis  0.48 0.19   2.52 
3.1b Somatization -0.01 0.11 -0.13 
3.1c Obsessive-compulsive  0.03 0.14  0.19 
3.1d Interpersonal sensitivity  0.33 0.23  1.45 
3.1e Anxiety -0.06 0.14 -0.42 
3.1f Depression  0.02 0.16  0.10 
3.1g Hostility  0.07 0.10  0.74 
3.1h Phobic anxiety  0.04 0.11  0.33 
3.1i Paranoia -0.34 0.13 -2.57 
3.1j Psychoticism -0.04 0.14 -0.27 
3.1k Substance abuse history  0.07 0.15  0.49 
3.1l Hospitalization history -0.01 0.01 -0.98 
3.1m Hospitalized in last year  0.11 0.15  0.75 
3.1n Age of onset  0.00 0.01  0.52 
3.1o Medication:  Anti-depressant -0.30 0.18 -1.68 
3.1p Medication:  Anti-psychotic  0.03 0.16  0.21 
3.1q Medication:  Anti-manic  0.12 0.16  0.74 
3.1r Medication:  Anti-anxiety  0.03 0.14  0.25 
3.1s Medication:  Other psychotropic  0.02 0.15  0.13 
3.1t Current employment  0.15 0.18  0.81 
3.1u Years of employment -0.00 0.01 -0.53 
3.1v Nuclear family mental illness -0.06 0.06 -1.07 
3.1w Extended family mental illness  0.02 0.11  0.16 
3.1x Child sexual abuse history -0.22 0.16 -1.38 
3.1y Child physical abuse history  0.24 0.16  1.53 
3.1z Adult sexual assault history -0.19 0.18 -1.01 
3.1aa Adult physical assault history   0.01 0.16 -0.07 
Domain 2    
Stigma    
3.2a Alienation  0.18 0.19  0.95 
3.2b Stereotype endorsement -0.26 0.21 -1.26 
3.2c Discrimination experience -0.00 0.17 -0.02 
3.2d Social withdrawal -0.12 0.22 -0.54 
3.2e Stigma resistance  0.27 0.20  1.37 
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Table 132 (cont.) 
 
H1 Variable 
 
b SE t 
Social Support and Related    
3.2f Partner or best friend support  0.11 0.08  1.37 
3.2g Family support  0.10 0.15  0.66 
3.2h Provider support -0.17 0.27 -0.62 
3.2i Friend support -0.10 0.08 -1.24 
3.2j Community involvement  0.37 0.21   1.76 
3.2k Trust -0.12 0.08 -1.51 
Empowerment    
3.2l Self-esteem/self-efficacy  0.45 0.55  0.83 
3.2m Power/powerlessness -0.64 0.19   -3.34* 
3.2n Community activism and 
autonomy 
-0.30 0.19 -1.54 
3.2o Optimism and control over the 
future 
 0.49 0.56   0.87 
3.2p Righteous anger -0.07 0.13 -0.53 
Domain 3    
3.3a Total number of services -0.05 0.08 -0.54 
3.3b Total service hours per month -0.00 0.01 -0.36 
3.3c Average satisfaction score -0.09 0.08 -1.19 
 Moderating Variables    
4.b IS x Interpersonal sensitivity  0.01 0.12  0.11 
4.b IS x Support from family -0.08 0.09 -0.89 
4.b IS x Support from provider  0.19 0.16  1.18 
4.b IS x Community involvement -0.13 0.13 -0.96 
4.b IS x Self-esteem/Self-efficacy -0.15 0.33 -0.46 
4.b IS x Optimism and control over 
the future 
 0.15 0.35  0.42 
 
Note:  * Bonferonni correction utilized for post hoc analyses (.05 / 6 interaction terms),  
           required p-value of .0083 for significance 
           n = 342  
           R2 = .18; F = 2.38, p ≤ .0001 
           IS = Illness Severity 
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Appendix F 
 
 
Comprehensive Tables of Bivariate Analyses Not Presented in Chapter 4 
 
 
 Control Variables 
 
Table 133 Age by Diagnosis 
Table 134 Age by Symptoms 
Table 135 Age by Continuous Domain 1 Variables (Age of onset, hospitalizations, 
years employed and familial mental illness) 
Table 136 Age by Categorical Domain 1 Variables (Hospitalized in last year, 
employed, substance history, medication, and assault history) 
Table 137 Age by Social Support 
Table 138 Age by Empowerment 
Table 139 Age by Stigma 
Table 140 Age by Service Variables 
Table 141 Gender, Income and Education by Diagnosis 
Table 142 Gender, Income and Education by Symptoms 
Table 143 Gender, Income and Education by Continuous Domain 1 Variables (Age of 
onset, hospitalizations, years employed and familial mental illness) 
Table 144 Gender, Income and Education by Categorical Domain 1 Variables 
(Hospitalized in last year, employed, substance history, medication, and 
assault history) 
Table 145 Gender, Income and Education by Social Support 
Table 146 Gender, Income and Education by Empowerment 
Table 147 Gender, Income and Education by Stigma 
Table 148 Gender, Income and Education by Service Variables 
 
 Independent Variables 
 
Table 149 Diagnosis by Symptoms 
Table 150 Diagnosis by Continuous Domain 1 Variables (Age of onset, 
hospitalizations, years employed and familial mental illness) 
Table 151 Diagnosis by Categorical Domain 1 Variables (Hospitalized in last year, 
employed, substance history, medication, and assault history) 
Table 152 Diagnosis by Social Support 
Table 153 Diagnosis by Empowerment 
Table 154 Diagnosis by Stigma 
Table 155 Diagnosis by Service Variables 
Table 156 Symptom Correlation Table 
Table 157 Symptoms by Continuous Domain 1 Variables (Age of onset, 
hospitalizations, years employed and familial mental illness) 
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Table 158 Symptoms by Categorical Domain 1 Variables (Hospitalized in last year, 
employed, substance history, medication, and assault history) 
Table 159 Symptoms by Social Support 
Table 160 Symptoms by Empowerment 
Table 161 Symptoms by Stigma 
Table 162 Symptoms by Service Variables 
Table 163 Continuous Domain 1 Variables (Age of onset, hospitalizations, years 
employed and familial mental illness) Correlation Table 
Table 164 Continuous Domain 1 Variables (Age of onset, hospitalizations, years 
employed and familial mental illness) by Categorical Domain 1 Variables 
(Hospitalized in last year, employed, substance history, medication, and 
assault history) 
Table 165 Continuous Domain 1 Variables (Age of onset, hospitalizations, years 
employed and familial mental illness) by Social Support 
Table 166 Continuous Domain 1 Variables (Age of onset, hospitalizations, years 
employed and familial mental illness) by Empowerment 
Table 167 Continuous Domain 1 Variables (Age of onset, hospitalizations, years 
employed and familial mental illness) by Stigma 
Table 168 Continuous Domain 1 Variables (Age of onset, hospitalizations, years 
employed and familial mental illness) by Service Variables 
Table 169 Categorical Domain 1 Variables (Hospitalized in last year, employed, 
substance history, medication, and assault history) by Categorical Domain 1 
Variables 
Table 170 Categorical Domain 1 Variables (Hospitalized in last year, employed, 
substance history, medication, and assault history) by Social Support 
Table 171 Categorical Domain 1 Variables (Hospitalized in last year, employed, 
substance history, medication, and assault history) by Empowerment 
Table 172 Categorical Domain 1 Variables (Hospitalized in last year, employed, 
substance history, medication, and assault history) by Stigma 
Table 173 Categorical Domain 1 Variables (Hospitalized in last year, employed, 
substance history, medication, and assault history) by Service Variables 
Table 174 Social Support Correlation Table 
Table 175 Social Support by Empowerment 
Table 176 Social Support by Stigma 
Table 177 Social Support by Service Variables 
Table 178 Empowerment Correlation Table 
Table 179 Empowerment by Stigma 
Table 180 Empowerment by Service Variables 
Table 181 Stigma Correlation Table 
Table 182 Stigma by Service Variables 
Table 183 Service Domain Correlation Table 
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Table 133   
 
Age by Diagnosis 
 
Diagnosis  Age    Age  
 N Mean (s.d.) t-test  N Mean (s.d.) t-test
Schizophrenia    Anxiety    
     Yes 51 38.7 (42.0) -0.62      Yes 33 36.6 (40.2) 0.44 
     No 
 
299 39.6 (40.9)       No 
 
317 39.9 (41.1)  
Bipolar    Depression 
(not MD) 
   
     Yes 132 39.5 (41.4)       Yes 19 32.1 (38.5) 1.00 
     No 
 
218 39.3 (40.1) -0.42      No 
 
331 40.0 (41.2)  
Schizoaffective    Adjustment 
Disorder 
   
     Yes 38 41.1 (44.1) -1.74      Yes 7 23.2 (33.3) 1.84 
     No 
 
312 39.4 (40.1)       No 
 
343 40.0 (41.2)  
Major 
Depression 
   Other    
     Yes 295 39.5 (40.8) -0.90      Yes 15 25.4 (31.5) 3.46c
     No 
 
55 39.2 (42.3)       No 
 
335 40.3 (41.5)  
 
Note:  a = p≤.05; b = p≤.01; c = p≤.001; d = p ≤ .0001 
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Table 134   
 
Age by Symptoms 
 
 Somatization OCD Interpersonal 
Sensitivity 
Depression Anxiety 
Age  
0.06 
 
 
0.05 
 
0.04 
 
0.08 
 
0.02 
 Hostility Phobic 
Anxiety 
Paranoia Psychoticism Global 
Severity 
Age  
-0.21d
 
 
0.09 
 
-0.02 
 
0.07 
 
0.04 
 
Note:  a = p≤.05; b = p≤.01; c = p≤.001; d = p ≤ .0001 
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Table 135   
 
Age by Continuous Domain 1 Variables 
 
 Age of onset Lifetime 
hospitalizations 
Total years 
employed 
Mental 
illness: 
Nuclear 
family 
 
Mental 
illness: 
Extended 
family 
Age 0.26a
 
-0.03 0.47a 0.09 0.09 
 
Note:  a = p≤.05; b = p≤.01; c = p≤.001; d = p ≤ .0001 
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Table 136  
 
Age by Categorical Domain 1 Variables  
 
  Age    Age  
 n 
 
Mean (s.d.) t-test  n Mean (s.d.) t-test
Hospitalized in 
last year 
   Meds:  Anti-
anxiety 
   
   Yes 120 39.3 (10.9) 2.10a    Yes 186 43.2 (9.9) -3.71c
   No 120 42.0 (11.5)     No 167 38.8 (12.3)  
Employed?    Meds:  Other     
   Yes 74 34.4 (11.0) 6.00d    Yes 113 44.0 (10.7) -3.36c
   No 276 42.9 (10.8)     No 237 39.7 (11.4)  
Co-occurring 
substance dx 
   Child sexual 
abuse 
   
   Yes 119 40.7 (11.1) 0.46    Yes 147 40.0 (10.7) 1.45 
   No 231 41.3 (11.5)     No 203 41.8 (11.7)  
Meds:  Anti-
psychotic 
   Child 
physical 
abuse 
   
   Yes 155 42.3 (10.4) -1.81    Yes 137 40.6 (11.1) 0.61 
   No 195 41.8 (12.0)     No 213 41.4 (11.5)  
Meds:  Anti- 
depressant 
   Adult sexual 
assault 
   
   Yes 266 41.9 (10.9) -2.59b    Yes 116 42.3 (10.2) -1.42 
   No 84 38.3 (12.3)     No 234 40.5 (11.8)  
Meds:  Anti-
manic 
   Adult 
physical 
assault 
   
   Yes 96 42.9 (11.2) -1.90a    Yes 138 41.8 (10.7) -0.97 
   No 
 
254 40.4 (11.3)     No 212 40.6 (11.7)  
 
Note:  a = p≤.05; b = p≤.01; c = p≤.001; d = p ≤ .0001 
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Table 137   
 
Age by Social Support  
 
 Partner/best 
friend 
support 
 
Support 
via family 
Support 
via 
provider 
Support 
via friends 
 
Community 
involvement 
Trust 
 
Age -0.13b 0.02 0.05 -0.08 0.03 0.15c
 
Note:  a = p≤.05; b = p≤.01; c = p≤.001; d = p ≤ .0001 
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Table 138  
 
Age by Empowerment  
 
 Self-
esteem/self-
efficacy 
 
Power/ 
powerlessness
 
Community 
activism and 
autonomy 
 
Optimism 
and control 
over the 
future 
 
Righteous 
anger 
 
Age -0.09 -0.06 -0.14b -0.04 -0.11a
 
Note:  a = p≤.05; b = p≤.01; c = p≤.001; d = p ≤ .0001 
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Table 139   
 
Age by Stigma  
 
 Alienation 
 
Stereotype 
endorsement 
Discrimination 
occurrence 
Social 
withdrawal 
 
Stigma 
resistance 
 
Age 0.04 -0.01 0.03 0.04 0.04 
 
Note:  a = p≤.05; b = p≤.01; c = p≤.001; d = p ≤ .0001 
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Table 140 
 
Age by Service Variables  
 
 Total number of 
services 
 
Total contact hours 
 
Average satisfaction 
 
Age 
 
0.13b 0.11a 0.04 
 
Note:  a = p≤.05; b = p≤.01; c = p≤.001; d = p ≤ .0001 
 
 
Table 141 
 
Gender, Income and Education by Diagnosis  
 
 Schizophrenia 
 
Bipolar Schizoaffective Major Depression
 Yes No χ2 Yes No χ2 Yes No χ2 Yes No χ2 
 N (%) N (%)  N (%) N (%)  N (%) N (%)  N (%) N (%)  
Gender             
  Male 26 
 (51.0) 
83  
(27.8) 
10.96c 37  
(28.0) 
72  
(33.0) 
0.96 16 
 (42.1) 
93 
 (29.8) 
2.39 14  
(25.5) 
200 
 (32.2) 
0.98 
  Female 25 
 (49.0) 
216 
 (72.2) 
 95 
 (72.0) 
146  
(67.0) 
 22 
 (57.9) 
219 
 (70.2) 
 95 
 (74.5) 
41 
(67.8) 
 
 
Income
            
 0 – 10k 37 
 (72.6) 
143 
 (47.8) 
10.73b 71 
 (53.8) 
109 
 (50.0) 
2.76 20 
 (52.6) 
160 
 (51.3) 
1.50 21 
 (38.2) 
159 
 (53.9) 
6.69 
 10,001-15k 6 
 (11.8) 
73 
 (24.4) 
 32 
 (24.2) 
47 
 (21.6) 
 7  
 (18.4) 
72  
(23.1) 
 19 
 (34.6) 
60 
 (20.3) 
 
 15,001-20k 3 
 (5.9) 
34 
 (11.4) 
 14 
 (10.6) 
23 
 (10.6) 
 3 
 (7.9) 
34  
10.9) 
 7 
 (12.7) 
30 
 (10.2) 
 
 20,0001- 5 
 (9.8) 
49 
 (16.4) 
 15 
 (11.4) 
39 
 (17.9) 
 8 
(21.1) 
46  
(14.7) 
 8 
 (14.5) 
46 
 (15.6) 
 
 
Education
            
 < H.S. 11 
 (21.6) 
62 
 (20.7) 
3.73 28 
 (21.2) 
45 
 (20.6) 
0.09 5  
(13.2) 
68  
(21.8) 
3.37 9 
 (16.4) 
64 
 (21.7) 
1.31 
 H.S. 25 
 (49.0) 
111 
 (37.1) 
 52 
 (39.4) 
84  
(38.5) 
 14  
(36.8) 
122 
 (39.1) 
 23 
 (41.8) 
113 
 (38.3) 
 
2-years college 12 
 (23.5) 
90  
(30.1) 
 38 
 (28.8) 
64 
 (29.4) 
 12 
 (31.6) 
90 
 (28.9) 
 18  
(32.7) 
84 
 (28.5) 
 
 >2 year college 3 
 (5.9) 
 
36 
 (12.0) 
 14 
 (11.5) 
25 
 (11.5) 
 7 
 (18.4) 
32 
 (10.3) 
 5 
 (9.1) 
34 
 (11.5) 
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Table 141 (cont.) 
 
 Anxiety 
 
Depression (not MD) Adjustment Disorder Other
 Yes No χ2 Yes No χ2 Yes No χ2 Yes No χ2 
 N (%) N (%)  N (%) N (%)  N (%) N (%)  N (%) N (%)  
Gender             
  Male 6   
(18.2) 
103 
 (32.5) 
2.85 4  
(21.0) 
105 
 (31.7) 
0.95 3 
 (42.9) 
106 
 (30.9) 
0.46 3   
(20.0) 
106 
(31.6) 
0.91 
  Female 27  
(81.8) 
214 
 (67.5) 
 15 
(17.0) 
226 
 (68.3) 
 4  
(57.1) 
237 
 (69.1) 
 12 
 (80.0) 
229 
(68.4) 
 
 
Income
            
 0 – 10k 15 
 (45.5) 
165 
 (52.1) 
0.56 9 
 (47.4) 
171 
 (51.7) 
*F 1 
(14.3)     
179 
 (52.2) 
*Fb 6 
 (40.0) 
174 
(52.0) 
*F 
 10,001-15k 8  
(124.2) 
71 
 (22.4) 
 4  
(21.0) 
75  
(22.7) 
 2 
 (28.6) 
77  
(22.5) 
 1 
 (6.7) 
78 
 (23.3) 
 
 15,001-20k 4  
(12.1) 
33 
 (10.4) 
 3 
 (15.8) 
34 
 (10.3) 
 0 
 (0.0) 
37 
(10.8) 
 3 
 (20.0) 
34  
(10.2) 
 
 20,0001- 6  
(18.2) 
48 
 (15.1) 
 3 
 (15.8) 
51  
(15.4) 
 4 
 (57.1) 
50 
 (14.6) 
 5 
 (33.3) 
49 
 (14.6) 
 
 
Education
            
 < H.S. 8 
 (24.2) 
65 
 (20.5) 
3.04 7  
(36.8) 
66 
 (19.9) 
*F 1 
 (14.3 
72 
 (21.0) 
*F 4  
(26.7) 
69 
 (20.6) 
*F 
 H.S. 10 
 (30.3) 
126 
 (39.8) 
 6 
 (31.6) 
130 
 (39.3) 
 2 
 (28.6) 
134 
 (39.1) 
 4 
 (26.7) 
132 
(39.4) 
 
2-years college 13 
 (39.4) 
89 
 (28.1) 
 3 
 (10.8) 
99 
 (29.9) 
 3 
 (42.9) 
99 
 (28.9) 
 3 
 (20.0) 
99 
 (29.6) 
 
 >2 year college 2 
 (6.1) 
37 
 (11.7) 
 3 
 (15.8) 
36 
 (10.9) 
 1 
 (14.3) 
38 
 (11.1) 
 4 
 (26.7) 
35 
 (10.4) 
 
 
Note:  a = p≤.05; b = p≤.01; c = p≤.001; d = p ≤ .0001; *F = Fishers Exact statistic used due to cell size 
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Table 142 
 
Gender, Income and Education by Symptoms 
 
  Soma 
 
OCD Interpersonal Sensitivity Depression Anxiety
 n Mean (s.d.) F Mean (s.d.) F Mean (s.d.) F Mean (s.d.) F Mean (s.d.) F 
Gender            
  Male 109 1.30 (0.92) 10.13c 1.62 (0.97) 11.98d 1.41 (1.02) 7.84c 1.56 (1.00) 15.56d 1.39 (1.04) 7.24c
  Female 
 
241 1.63 (0.90)  2.01 (0.99)  1.73 (0.99)  2.01 (1.00)  1.71 (1.02)  
Income            
 0 – 10k 180 1.59 (0.88) 1.67 1.98 (0.92) 4.24c 1.72 (0.99) 2.83a 1.95 (0.98) 2.24 1.67 (0.96) 1.27 
 10,001-15k 79 1.51 (0.96)  1.84 (1.03)  1.55 (1.00)  1.84 (1.00)  1.56 (1.15)  
 15,001-20k 37 1.62 (0.97)  2.11 (1.11)  1.84 (1.07)  1.96 (1.11)  1.76 (1.04)  
 20,0001- 
 
54 1.29 (0.95)  1.49 (1.05)  1.34 (0.98)  1.56 (1.09)  1.40 (1.10)  
Education            
 < H.S. 73 1.64 (1.01) 0.89 2.00 (1.00) 1.54 1.90 (1.05) 2.40 2.04 (1.02) 1.27 1.78 (1.02) 1.20 
 H.S. 136 1.46 (0.87)  1.90 (1.04)  1.57 (0.97)  1.77 (1.01)  1.51 (1.02)  
2-years college 102 1.59 (0.91)  1.90 (1.00)  1.58 (1.01)  1.90 (0.99)  1.65 (1.08)  
 >2 year college 
 
39 1.43 (0.97  1.59 (0.83)  1.49 (1.01)  1.59 (0.83)  1.59 (1.00)  
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Table 142 (cont.) 
 
   
Hostility
 
Phobic Anxiety
 
Paranoia
 
Psychoticism
 
Global Severity Index 
 
 n Mean (s.d.) F Mean (s.d.) F Mean (s.d.) F Mean (s.d.) F Mean (s.d.) F 
Gender            
  Male 109 1.13 (1.12) 0.02 0.96 (0.97) 9.62c 1.57 (1.03) 5.72b 1.20 (0.92) 0.22 1.38 (0.87) 9.38c
  Female 
 
241 1.18 (0.90)  1.32 (1.07)  1.85 (1.01)  1.25 (0.84)  1.68 (0.81)  
Income            
 0 – 10k 180 1.12 (0.94) 1.79 1.27 (1.00) 1.19 1.85 (0.99) 4.01c 1.30 (0.83) 2.72a 1.64 (0.78) 2.79a
 10,001-15k 79 1.10 (0.96)  1.22 (1.07)  1.66 (1.01)  1.13 (0.83)  1.53 (0.85)  
 15,001-20k 37 1.55 (1.03)  1.24 (1.16)  2.04 (1.06)  1.47 (1.00)  1.75 (0.89)  
 20,0001- 
 
54 1.15 (1.05)  0.97 (1.15)  1.41 (1.05)  1.02 (0.90)  1.32 (0.91)  
Education            
 < H.S. 73 1.26 (0.99) 0.43 1.53 (1.04) 3.80b 2.02 (1.00) 2.35 1.39 (0.90) 1.06 1.75 (0.86) 0.19 
 H.S. 136 1.13 (0.92)  1.05 (1.00)  1.71 (1.00)  1.20 (0.86)  1.51 (0.81)  
2-years college 102 1.18 (1.06)  1.25 (1.11)  1.73 (1.04)  1.18 (0.86)  1.59 (0.85)  
 >2 year college 
 
39 1.06 (0.95)  1.07 (1.00)  1.55 (1.07)  1.21 (0.84)  1.48 (0.81)  
 
Note:  a = p≤.05; b = p≤.01; c = p≤.001; d = p ≤ .0001; GSI = Global Severity Index 
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Table 143   
 
Gender, Income and Education by Continuous Domain 1 Variables  
 
  Age of Onset  Number of 
Mental 
Health 
Hospital 
Stays 
 
 Total Years 
Employed 
 Mental 
Illness:  
Nuclear 
Family 
 Mental 
Illness:  
Extended 
Family 
 
 
 N Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test 
Gender            
  Male 109 21.1 (11.6) 0.14 6.7 (8.8) 0.00 14.2 (11.8) 0.24 1.9 (2.0) 7.04b 0.6 (1.0) 3.57a
  Female 
 
241 21.7 (13.4)  6.7 (11.8)  13.7 (10.1)  2.5 (2.1)  0.9 (1.1)  
 N Mean (s.d.) F Mean (s.d.) F Mean (s.d.) F Mean (s.d.) F Mean (s.d.) F 
Income            
 0 – 10k 180 21.5 (14.7) 0.23 7.4 (10.8) 0.49 12.6 (10.4) 2.19 2.2 (2.0) 1.20 0.7 (1.0) 0.65 
 10,001-15k 79 22.2 (11.2)  5.7 (8.6)  15.9 (10.3)  2.6 (2.2)  0.9 (1.2)  
 15,001-20k 37 21.5 (11.2)  5.9 (9.5)  14.2 (12.4)  2.5 (2.2)  0.8 (1.1)  
 20,0001- 
 
54 20.3 (9.6)  6.5 (14.7)  14.7(10.4)  2.4 (2.1)  0.9 (1.1)  
Education            
 < H.S. 73 21.3 (17.9) 0.01 5.9 (7.4) 0.27 8.4 (8.3) 16.84c 1.8 (1.9) 8.11c 0.6 (0.9) 9.72c
 H.S. 136 21.6 (10.6)  6.6 (9.8)  12.4 (10.2)  2.0 (1.9)  0.6 (0.8)  
2-years college 102 21.6 (12.2)  7.2 (14.4)  17.7 (9.7)  2.9 (2.1)  1.0 (1.2)  
 >2 year college 
 
39 21.3 (10.9)  7.5 (9.8)  19.0 (12.4)  3.3 (2.5)  1.5 (1.4)  
 
Note:  a = p≤.05; b = p≤.01; c = p≤.001; d = p ≤ .0001 
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Table 144 
 
Gender, Income and Education by Categorical Domain 1 Variables  
 
 Hospitalized in Last Year 
 
Currently Employed Co-occurring Substance Use Anti-psychotic medication
 Yes No χ2 Yes No χ2 Yes No χ2 Yes No χ2 
 N (%) N (%)  N (%) N (%)  N (%) N (%)  N (%) N (%)  
Gender             
  Male 37 
(30.8) 
72 
(31.3) 
0.01 23 
(31.1) 
86 
(31.2) 
0.00 49 
(41.2) 
60 
(26.0) 
8.46c 63 
(40.7) 
46 
(23.6) 
11.71d
  Female 83 
(69.2) 
158 
(68.7) 
 51 
(68.9) 
190 
(78.8) 
 70 
(58.8) 
171 
(74.0) 
 92 
(59.3) 
149 
(76.4) 
 
 
Income
            
 0 – 10k 71 
(59.7) 
109 
(47.4) 
7.29 30 
(40.5) 
150 
(54.4) 
13.78c 63 
(52.9) 
117 
(50.7) 
3.05 92 
(59.4) 
88 
(45.3) 
10.62b
 10,001-15k 18 
(15.0) 
61 
(26.5) 
 18 
(24.3) 
61 
(22.1) 
 31 
(26.0) 
48 
(20.8) 
 35 
(22.6) 
44 
(22.6) 
 
 15,001-20k 11  
(9.2) 
26 
(11.3) 
 5 
(6.8) 
32 
(11.6) 
 9 
(7.6) 
28 
(12.1) 
 13  
(8.4) 
24 
(12.3) 
 
 20,0001- 20 
(16.7) 
34 
(14.8) 
 21 
(28.4) 
33 
(12.0) 
 16 
(13.5) 
38 
(16.5) 
 15  
(9.7) 
39 
(20.0) 
 
 
Education
            
 < H.S. 25 
(20.8) 
48 
(20.8) 
1.74 20 
(27.0) 
53 
(19.2) 
2.24 24 
(20.2) 
49 
(21.2) 
2.56 29 
(18.7) 
44 
(22.5) 
0.97 
 H.S. 51 
(42.5) 
85 
(37.0) 
 27 
(36.5) 
109 
(39.5) 
 42 
(35.3) 
94 
(40.7) 
 61 
(39.3) 
75 
(38.5) 
 
2-years college 30 
(25.0) 
72 
(31.3) 
 19 
(25.7) 
83 
(30.1) 
 41 
(34.4) 
61 
(26.4) 
 46 
(29.7) 
56 
(28.7) 
 
 >2 year college 14 
(11.7) 
25 
(10.9) 
 
 8 
(10.8) 
31 
(11.2) 
 12 
(10.1) 
27 
(11.7) 
 19 
(12.3) 
20 
(10.3) 
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Table 144 (cont.) 
 
 Anti-depressant medication 
 
Anti-manic medication Anti-anxiety medication Other psychotropic medication
 Yes No χ2 Yes No χ2 Yes No χ2 Yes No χ2 
 N (%) N (%)  N (%) N (%)  N (%) N (%)  N (%) N (%)  
Gender             
  Male 72 
(27.1) 
37 
(44.0) 
8.58c 32 
(33.3) 
77 
(30.3) 
0.30 48 
(26.2) 
61 
(36.5) 
4.32a 36 
(31.9) 
73 
(30.8) 
0.04 
  Female 194 
(72.9) 
47 
(56.0) 
 64 
(66.7) 
177 
(73.4) 
 135 
(73.8) 
106 
(63.5) 
 77 
(68.1) 
164 
(69.2) 
 
 
Income
            
 0 – 10k 141 
(53.0) 
39 
(46.4) 
3.72 52 
(54.2) 
128 
(50.4) 
0.94 97 
(53.0) 
83 
(49.6) 
4.42 64 
(56.4) 
116 
(49.0) 
2.68 
 10,001-15k 59 
(22.2) 
20 
(23.8) 
 22 
(22.9) 
57 
(22.4) 
 38 
(20.8) 
41 
(24.6) 
 24 
(21.2) 
55 
(23.2) 
 
 15,001-20k 30 
(11.3) 
7 
(8.3) 
 10 
(10.4) 
27 
(10.6) 
 24 
(13.1) 
13  
(7.8) 
 12 
(10.6) 
25 
(10.6) 
 
 20,0001- 36 
(13.5) 
18 
(21.4) 
 12 
(12.5) 
42 
(16.5) 
 24 
(13.1) 
30 
(18.0) 
 13 
(11.5) 
41 
(17.3) 
 
 
Education
            
 < H.S. 53 
(19.9) 
20 
(23.8) 
1.14 16 
(16.7) 
57 
(22.4) 
6.34 35 
(19.1) 
38 
(22.7) 
2.88 24 
(21.2) 
49 
(20.7) 
4.54 
 H.S. 107 
(40.2) 
29 
(34.5) 
 36 
(37.5) 
100 
(39.4) 
 69 
(37.7) 
67 
(40.1) 
 51 
(45.1) 
85 
(35.9) 
 
2-years college 76 
(28.6) 
26 
(31.0) 
 27 
(28.1) 
75 
(29.5) 
 54 
(29.5) 
48 
(28.7) 
 25 
(22.1) 
77 
(32.5) 
 
 >2 year college 30 
(11.3) 
9 
(10.7) 
 17 
(17.7) 
22  
(8.7) 
 25 
(13.7) 
14  
(8.4) 
 13 
(11.5) 
26 
(11.0) 
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Table 144 (cont.) 
 
 Child sexual abuse 
 
Child physical abuse Adult sexual assault Adult physical assault
 Yes No χ2 Yes No χ2 Yes No χ2 Yes No χ2 
 N (%) N (%)  N (%) N (%)  N (%) N (%)  N (%) N (%)  
Gender            
  Male 16 
(10.9) 
93 
(45.8) 
48.51d 32 
(23.4) 
77 
(36.2) 
6.36b 11  
(9.5) 
98 
(41.9) 
37.96d 21 
(15.2) 
88 
(41.5) 
26.95d
  Female 131 
(89.1) 
110 
(54.2) 
 105 
(76.6) 
136 
(63.8) 
 105 
(90.5) 
136 
(58.1) 
 117 
(84.8) 
124 
(58.5) 
 
 
Income
           
 0 – 10k 74 
(50.3) 
106 
(52.2) 
5.88 74 
(54.0) 
106 
(49.8) 
7.93a 62 
(53.4) 
118 
(50.4) 
5.01 75 
(54.4) 
105 
(49.5) 
0.79 
 10,001-15k 39 
(26.5) 
40 
(19.7) 
 35 
(25.5) 
44 
(20.7) 
 30 
(25.9) 
49 
(20.9) 
 29 
(21.0) 
50 
(23.6) 
 
 15,001-20k 18 
(12.2) 
19  
(9.4) 
 16 
(11.7) 
21  
(9.9) 
 13 
(11.2) 
24 
(10.3) 
 14 
(10.1) 
23 
(10.9) 
 
 20,0001- 16 
(10.9) 
38 
(18.7) 
 12  
(8.8) 
42 
(19.7) 
 11  
(9.5) 
43 
(18.4) 
 20 
(14.5) 
34 
(16.0) 
 
 
Education
           
 < H.S. 35 
(23.8) 
38 
(18.7) 
5.32 27 
(19.7) 
46 
(21.6) 
0.77 21 
(18.1) 
52 
(22.2) 
0.78 27 
(19.6) 
46 
(21.7) 
0.69 
 H.S. 55 
(37.4) 
81 
(39.9) 
 51 
(37.2) 
85 
(39.9) 
 48 
(41.4) 
88 
(37.6) 
 50 
(36.2) 
86 
(40.6) 
 
2-years college 36 
(24.5) 
66 
(32.5) 
 41 
(29.9) 
61 
(28.6) 
 33 
(28.4) 
69 
(29.5) 
 44 
(31.9) 
58 
(27.3) 
 
 >2 year college 21 
(14.3) 
18 
 (8.9) 
 18 
(13.1) 
21  
(9.9) 
 14 
(12.1) 
25 
(10.7) 
 17 
(12.3) 
22 
(10.4) 
 
 
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; d p ≤ .0001 
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Table 145 
 
Gender, Income and Education by Social Support  
 
  Partner/best friend 
support 
 
Support via family Support via provider 
 n Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test 
Gender        
  Male 109 4.05 (1.20) -1.02 3.99 (1.52) 2.25a 4.06 (0.88) 0.12 
  Female 241 4.19 (1.17)  3.59 (1.52)  4.05 (0.85)  
 
 
 
n 
 
Mean (s.d.) 
 
F 
 
Mean (s.d.) 
 
F 
 
Mean (s.d.) 
 
F 
Income        
 0 – 10k 180 4.04 (1.19) 1.33 3.70 (1.49) 2.13 4.03 (0.85) 0.66 
 10,001-15k 79 4.14 (1.23)  3.46 (1.59)  4.01 (0.84)  
 15,001-20k 37 4.30 (1.27)  3.72 (1.49)  4.04 (0.95)  
 20,0001- 54 4.37 (0.96)  4.14 (1.52)  4.20 (0.87)  
 
Education
       
 < H.S. 73 4.33 (1.21) 4.84c 3.68 (1.53) 0.44 4.14 (0.82) 1.62 
 H.S. 136 4.27 (1.04)  3.77 (1.50)  4.09 (0.84)  
2-years college 102 4.08 (1.22)  3.76 (1.53)  4.03 (0.87)  
 >2 year college 39 3.53 (1.27) 
 
 3.47 (1.63)  3.78 (0.94)  
  Support via friends 
 
Community 
involvement 
 
Trust 
 
 n Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test 
Gender        
  Male 109 4.02 (1.17) -1.00 3.57 (1.18) 0.90 3.17 (1.01) 1.37 
  Female 241 4.15 (1.14)  3.45 (1.17)  3.02 (0.92)  
  
n 
 
Mean (s.d.) 
 
F 
 
Mean (s.d.) 
 
F 
 
Mean (s.d.) 
 
F 
Income        
 0 – 10k 180 4.15 (1.16) 1.70 3.43 (1.17) 1.49 3.11 (0.98) 0.72 
 10,001-15k 79 3.99 (1.10)  3.53 (1.13)  2.97 (0.91)  
 15,001-20k 37 3.85 (1.37)  3.28 (1.29)  2.96 (0.94)  
 20,0001- 54 4.34 (0.95)  3.76 (1.14)  3.17 (0.95)  
 
Education
       
 < H.S. 73 4.20 (1.13) 4.86c 3.47 (1.32) 1.26 2.81 (0.93) 3.08a
 H.S. 136 4.21 (1.10)  3.42 (1.07)  3.13 (0.95)  
2-years college 102 4.17 (1.03)  3.66 (1.14)  3.08 (0.96)  
 >2 year college 
 
39 3.46 (1.43)  3.30 (1.26)  3.33 (0.89)  
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; d p ≤ .0001 
 
 
Table 146  
 
Gender, Income and Education by Empowerment  
 
  Self-esteem and 
self-efficacy 
Power and 
powerlessness 
 
Community activism 
and autonomy 
Optimism and control 
over the future 
 
Righteous anger 
 
 N Mean (s.d.) 
 
t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test 
Gender            
  Male 109 3.04 (0.53) 3.91d 2.51 (0.42) 1.04 3.17 (0.42) 0.48 2.91 (0.42) 2.59b 2.39 (0.55) -1.78 
  Female 241 2.81 (0.52)  2.46 (0.43)  3.14 (0.40)  2.77 (0.47)  2.50 (0.53)  
  
N 
 
Mean (s.d.) 
 
F 
 
Mean (s.d.) 
 
F 
 
Mean (s.d.) 
 
F 
 
Mean (s.d.) 
 
F 
 
Mean (s.d.) 
 
F 
 
Income
           
 0 – 10k 180 2.84 (0.49) 2.69a 2.44 (0.41) 1.96 3.13 (0.40) 4.11c 2.79 (0.42) 2.56a 2.47 (0.54) 0.46 
 10,001-15k 79 2.88 (0.51)  2.50 (0.42)  3.13 (0.40)  2.81 (0.50)  2.47 (0.46)  
 15,001-20k 37 2.80 (0.58)  2.43 (0.42)  3.07 (0.44)  2.74 (0.47)  2.51 (0.65)  
 20,0001- 54 3.06 (0.63)  2.60 (0.47)  3.32 (0.38)  2.97 (0.50)  2.39 (0.55)  
 
Education
           
 < H.S. 73 2.79 (0.57) 0.97 2.36 (0.33) 4.53b 3.10 (0.42) 0.66 2.78 (0.43) 0.27 2.41 (0.50) 0.78 
 H.S. 136 2.92 (0.50)  2.45 (0.43)  3.18 (0.38)  2.84 (0.47)  2.51 (0.53)  
2-years college 102 2.89 (0.52)  2.59 (0.42)  3.14 (0.42)  2.81 (0.41)  2.42 (0.55)  
 >2 year college 
 
39 2.88 (0.58)  2.52 (0.52)  3.19 (0.42)  2.79 (0.59)  2.47 (0.59)  
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; d p ≤ .0001 
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Table 147 
 
 Gender, Income and Education by Stigma  
 
  Alienation 
 
Stereotype endorsement Discrimination 
occurrence 
 
Social withdrawal 
 
Stigma resistance 
 
 N Mean (s.d.) 
 
t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test 
Gender            
  Male 109 2.37 (0.65) -2.01a 1.96 (0.52) -0.23 2.34 (0.65) -1.42 2.30 (0.63) -1.21 2.13 (0.49) -0.81 
  Female 241 2.51 (0.59)  1.97 (0.45)  2.44 (0.61)  2.38 (0.58)  2.17 (0.44)  
  
N 
 
Mean (s.d.) 
 
F 
 
Mean (s.d.) 
 
F 
 
Mean (s.d.) 
 
F 
 
Mean (s.d.) 
 
F 
 
Mean (s.d.) 
 
F 
 
Income
           
 0 – 10k 180 2.55 (0.57) 4.07b 2.03 (0.44) 4.91c 2.51 (0.60) 5.36c 2.45 (0.54) 6.77c 2.19 (0.43) 5.60c
 10,001-15k 79 2.37 (0.69)  1.86 (0.45)  2.27 (0.66)  2.24 (0.63)  2.17 (0.49)  
 15,001-20k 37 2.58 (0.59)  2.10 (0.51)  2.51 (0.68)  2.50 (0.63)  2.29 (0.36)  
 20,0001- 54 2.27 (0.61)  1.84 (0.53)  2.21 (0.55)  2.11 (0.59)  1.94 (0.48)  
 
Education
           
 < H.S. 73 2.56 (0.62) 0.76 2.08 (0.45) 3.44b 2.49 (0.62) 0.55 2.49 (0.60) 1.68 2.32 (0.43) 1.07 
 H.S. 136 2.46 (0.57)  1.99 (0.45)  2.39 (0.60)  2.32 (0.56)  2.16 (0.46)  
2-years college 102 2.43 (0.63)  1.92 (0.47)  2.38 (0.65)  2.32 (0.63)  2.12 (0.44)  
 >2 year college 
 
39 2.43 (0.70)  1.80 (0.55)  2.39 (0.66)  2.32 (0.57)  2.10 (0.53)  
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; d p ≤ .0001 
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Table 148 
 
Gender, Income and Education by Service Variables 
 
  Total number of services Total contact hours 
 
Average satisfaction 
 
 N Mean (s.d.) 
 
t-test Mean (s.d.) t-test Mean (s.d.) t-test 
Gender        
  Male 109 2.56 (1.31) 1.44 7.76 (8.62) 1.03 5.14 (1.01) 0.56 
  Female 241 2.36 (1.14)  6.78 (7.25)  5.08 (0.98)  
  
N 
 
Mean (s.d.) 
 
F 
 
Mean (s.d.) 
 
F 
 
Mean (s.d.) 
 
F 
 
Income
       
 0 – 10k 180 2.49 (1.21) 0.48 7.65 (8.69) 1.25 5.04 (0.91) 0.90 
 10,001-15k 79 2.38 (1.23  5.95 (5.87)  5.08 (1.17)  
 15,001-20k 37 2.41 (1.14)  5.97 (6.57)  5.14 (0.86)  
 20,0001- 54 2.28 (1.19)  7.63 (7.20)  5.29 (1.03)  
 
Education
       
 < H.S. 73 2.26 (1.19) 2.71a 7.09 (7.70) 1.44 4.92 (1.25) 1.24 
 H.S. 136 2.64 (1.26)  8.05 (8.65)  5.18 (0.81)  
2-years college 102 2.24 (1.17)  6.01 (7.01)  5.14 (0.92)  
 >2 year college 39 2.44 (0.97)  6.54 (5.46)  5.04 (1.17)  
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; d p ≤ .0001 
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Table 149 
 
Diagnosis by Symptoms  
 
  Psychosomatic OCD Interpersonal 
Sensitivity
Depression Anxiety
Diagnosis 
 
N Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test 
Schizophrenia            
     Yes 51 1.11 (0.79) 5.42c 1.43 (0.74) 4.52d 1.28 (0.89) 2.71c 1.41 (0.85) 3.56c 1.26 )0.82) 3.18c
     No 299 1.60 (0.93) 1.96 (1.02)  1.69 (1.02)  1.95 (1.03)  1.67 (1.05)  
Bipolar Disorder            
     Yes 132  1.66 (0.91) -1.97a 2.13 (0.97) -3.55c 1.81 (0.97) -2.62b 2.05 (0.94) -2.68b 1.81 (1.01) -2.71b
     No 218 1.46 (0.92)  1.74 (0.99)  1.52 (1.02)  1.76 (1.05)  1.50 (1.04)  
Schizoaffective            
     Yes 38 1.57 (1.03) -0.26 1.98 (0.94) -0.58 1.85 (0.94) -1.43 1.96 (0.93) -0.60 1.79 (1.00) -1.14 
     No 312 1.53 (0.91)  1.88 (1.01)  1.61 (1.01)  1.86 (1.03)  1.59 (1.04)  
Major Depression            
     Yes 55 1.64 (0.85) -0.95 1.88 (1.04) 0.02 1.65 (1.02) 0.55 1.94 (1.16) -0.59 1.48 (1.06) 1.08 
     No 295 1.51 (0.93)  1.89 (1.00)  1.57 (0.95)  1.85 (0.99)  1.64 (1.03)  
Anxiety Disorder            
     Yes 33 1.58 (1.03) -0.33 1.70 (1.12) 1.14 1.56 (1.17) 0.43 1.78 (1.16) 0.50 1.61 (1.20) 0.03 
     No 317 1.53 (0.91)  1.91 (0.99)  1.64 (0.99)  1.88 (1.00)  1.61 (1.02)  
Depression (not MD)            
     Yes 19 1.45 (0.87) 0.41 1.85 (1.89) 0.15 1.64 (1.00) 0.69 1.82 (1.15)) 0.22 1.48 (1.10) 0.56 
     No 331 1.54 (0.93)  1.02 (1.00)  1.48 (1.21)  1.87 (1.01)  1.62 (1.03)  
Adjustment Disorder            
     Yes 7 0.79 (0.87) 2.17a 0.67 (0.76) 3.29c 0.49 (0.76) 3.07b 0.81 (0.74) 2.79b 0.66 (0.88) 2.49b
     No 343 1.55 (0.92)  1.91 (1.00)  1.66 (1.00)  1.89 (1.01)  1.63 (1.03)  
Other            
     Yes 15 1.52 (0.92) -0.77 1.88 (1.00) -1.00 1.63 (1.01) -0.74 1.86 (1.02) -0.65 1.61 (1.04) -0.76 
     No 335 1.71 (0.85)  2.14 (1.03)  1.82 (0.96)  2.04 (0.93)  1.81 (1.03)  
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Table 149 (cont.) 
 
  Hostility Phobic Anxiety Paranoia Psychoticism Global Severity 
Index
Diagnosis 
 
N Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test 
Schizophrenia            
     Yes 51 0.68 (0.63) 3.58c 0.86 (0.85) 3.06c 1.42 (0.94) 2.59b 1.10 (0.80) 1.18 1.19 (0.69) 3.62c
     No 299 1.25 (1.00)  1.27 (1.08)  1.82 (1.03)  1.26 (0.88)  1.64 (0.84)  
Bipolar Disorder            
     Yes 132 1.35 (0.98) -2.78b 1.40 (1.07) -2.67b 1.94 (0.98) -2.59b 1.39 (0.85) -2.56b 1.76 (0.79) -3.18c
     No 218 1.05 (0.96)  1.09 (1.03)  1.65 (1.04)  1.14 (0.87)  1.47 (0.85)  
Schizoaffective            
     Yes 38 1.22 (1.18) -0.31 1.34 (0.92) -0.80 2.07 (0.99) -2.01a 1.55 (0.98) -2.39b 1.73 (0.84) -1.16 
     No 312 1.16 (0.95)  1.19 (1.07)  1.72 (1.02)  1.20 (0.85)  1.56 (0.84)  
Major Depression            
     Yes 55 1.13 (0.94) 0.30 1.15 (1.11) 0.49 1.73 (1.00) 0.25 1.21 (0.74) 2.07a 1.76 (0.83) 0.35 
     No 295 1.17 (0.98)  1.22 (1.05)  1.77 (1.03)  1.28 (0.89)  1.68 (0.84)  
Anxiety Disorder            
     Yes 33 1.09 (1.01) 0.45 1.29 (1.23) -0.46 1.65 (1.14) 0.65 1.16 (0.95) 0.51 1.53 (0.97) 0.36 
     No 317 1.17 (0.98)  1.20 (1.04)  1.77 (1.01)  1.24 (0.86)  1.58 (0.82)  
Depression (not MD)            
     Yes 19 1.23 (0.94) -0.29 0.89 (1.02) 1.34 1.50 (0.93) 1.15 0.92 (0.90) 1.65 1.45 (0.87) 0.66 
     No 331 1.16 (0.98)  1.23 (1.06)  1.78 (1.03)  1.25 (0.87)  1.58 (0.83)  
Adjustment Disorder            
     Yes 7 0.52 (0.51) 1.76 0.33 (0.80) 2.25a 0.50 (0.82) 3.34c 0.33 (0.43) 2.81b 0.62 (0.63) 3.09b
     No 343 1.18 (0.98)  1.23 (1.05)  1.79 (1.01)  1.25 (0.87)  1.60 (0.83)  
Other            
     Yes 15 1.15 (0.97) -1.64 1.21 (1.06) -0.18 1.76 (1.02) -0.19 1.22 (0.87) -0.54 1.57 (0.84) -0.92 
     No 335 1.57 (1.07)  1.26 (0.95)  1.81 (1.10)  1.35 (0.83)  1.77 (0.81)  
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; d p ≤ .0001 
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Table 150 
 
Diagnosis by Continuous Domain 1 Variables  
 
  Age of Onset Number of Hospital 
Admits 
 
Total Years Employed MI:  Nuclear Family MI:  Extended Family 
 
 N Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test 
Schizophrenia            
     Yes 51 20.14 (8.1) 1.15 7.31 (9.18) -0.44 9.33 (11.5) 3.33c 1.08 (1.5) 6.23d 0.39 (0.8) 3.86c
     No 299 21.72 (13.5)  6.59 (11.2)  14.63 (10.3)  2.56 (2.1)  0.87 (1.1)  
Bipolar            
     Yes 132 20.07 (11.5) 1.69 7.97 (11.9) -1.70 15.13 (10.6) -1.74 2.86 (2.0) -3.62c 1.00 (1.1) -2.78b
     No 218 22.36 (13.6)  5.93 (10.3)  13.09 (10.6)  2.03 (2.1)  0.67 (1.0)  
Schizoaffective            
     Yes 38 21.13 (22.8) 0.11 12.18 (17.3) -2.15a 13.42 (9.2) 0.27 2.60 (2.0) -0.82 0.89 (0.9) -0.59 
     No 312 21.54 (11.2)  6.03 (9.7)  13.91 (10.8)  2.31 (2.1)  0.78 (1.1)  
Major Depression            
     Yes 55 24.95 (11.6) -2.17a 4.25 (6.0) 2.75b 15.47 (11.4) -1.23 2.45 (2.3) -0.43 0.80 (1.2) -0.02 
     No 295 20.85 (13.0)  7.15 (11.6)  13.56 (10.5)  2.32 (2.1)  0.80 (1.0)  
Anxiety disorder            
     Yes 33 21.88 (11.6) -0.18 2.00 (3.6) 5.82d 15.4 (8.9) -0.88 2.27 (2.2) 0.20 0.79 (1.1) 0.05 
     No 317 21.46 (13.0)  7.19 (11.3)  13.7 (10.8)  2.35 (2.1)  0.80 (1.1)  
Depression (not MD)            
     Yes 19 25.16 (12.0) -1.27 1.58 (2.2) 6.79d 14.08 (10.0) -0.09 1.63 (2.0) 1.52 0.37 (0.6) 1.80 
     No 331 21.29 (12.9)  6.99 (11.2)  13.84 (10.7)  2.38 (2.1)  0.82 (1.1)  
Adjustment disorder            
     Yes 7 28.57 (11.1) -1.47 0.14 (0.4) 10.94d 14.64 (9.0) -0.20 1.00 (1.0) 3.47b 0.14 (0.4) 4.33b
     No 
O
343 21.35 (12.1)  6.83 (11.0)  13.84 (10.7)  2.37 (2.1)  0.81 (1.1)  
ther            
     Yes 15 18.2 (9.9) 1.01 8.33 (13.0) -0.59 9.2 (9.1) 1.74 2.73 (2.8) -0.55 1.00 (1.6) -0.49 
     No 335 21.65 (12.0)  6.62 (10.9)  14.07 (10.7)  2.33 (2.1)  0.79 (1.0)  
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; d p ≤ .0001 
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Table 151 
 
Diagnosis by Categorical Domain 1 Variables 
 
 Schizophrenia 
 
Bipolar Disorder Schizoaffective Disorder Major Depression
 Y (%) N (%) χ2 Y (%) N (%) χ2 Y (%) N (%) χ2 Y (%) N (%) χ2 
Hospital last year             
   Yes 11 
(21.6) 
109 
(36.5) 
4.29a 55 
(41.7) 
65 
(29.8) 
5.12a 16 
(42.1) 
104 
(33.3) 
1.16 19 
(34.5) 
101 (34.2) 0.00 
   No 40 
(78.4) 
190 
(63.5) 
 77 
(58.3) 
153 
(70.2) 
 22 
(57.9) 
208 
(67.7) 
 36 
(65.5) 
194 (65.8)  
Employed?             
   Yes 4  
(7.8) 
70 
(23.4) 
6.33b 23 
(17.4) 
51 
(23.4) 
1.76 6 
(15.8) 
68 
(21.8) 
0.73 10 
(18.2) 
64 (21.7) 0.34 
   No 47 
(92.2) 
229 
(76.6) 
 109 
(82.6) 
167 
(76.6) 
 32 
(84.2) 
244 
(78.2) 
 45 
(81.8) 
231 (78.3)  
Substance use dx             
   Yes 15 
(29.4) 
104 
(34.8) 
0.56 47 
(35.6) 
72 
(33.0) 
0.24 17 
(44.7) 
102 
(32.7) 
2.19 14 
(25.5) 
105 (35.6) 2.12 
   No 36 
(70.6) 
195 
(65.2) 
 85 
(64.4) 
146 
(67.0) 
 21 
(55.3) 
210 
(67.3) 
 41 
(74.5) 
190 (64.4)  
Med:  Psychosis             
   Yes 46 
(90.2) 
109 
(36.5) 
51.00d 55 
(41.7) 
100 
(45.9) 
0.59 37 
(97.4) 
118 
(37.8) 
48.68d 12 
(21.8) 
143 (48.5) 13.35c
   No 5  
(9.8) 
190 
(63.5) 
 77 
(58.3) 
118 
(54.1) 
 1 
(2.6) 
194 
(62.2) 
 43 
(78.2) 
152 (51.5)  
Med:  Depression             
   Yes 29 
(56.7) 
237 
(79.3) 
11.99c 109 
(82.6) 
157 
(72.0) 
5.02a 35 
(92.1) 
231 
(74.0) 
6.06b 50 
(90.9) 
216 (73.2) 7.95b
   No 
 
22 
(43.1) 
62 
(20.7) 
 23 
(17.4) 
61 
(28.0) 
 3 
(7.9) 
81 
(26.0) 
 5  
(9.1) 
79 (26.8)  
Med:  Mania             
   Yes 5 
(9.8) 
91 
(30.4) 
9.32b 65 
(49.2) 
31 
(14.2) 
50.66d 16 
(42.1) 
80 
(25.6) 
4.61a 4 
(7.3) 
92 (31.2) 13.32c
   No 46 
(90.2) 
208 
(69.6) 
 67 
(50.8) 
187 
(85.8) 
 22 
(57.9) 
232 
(74.4) 
 51 
(92.7) 
203 (68.8)  
 650
Table 151 (cont.) 
 
 Schizophrenia 
 
Bipolar Disorder Schizoaffective Disorder Major Depression
 Y (%) N (%) χ2 Y (%) N (%) χ2 Y (%) N (%) χ2 Y (%) N (%) χ2 
Med:  Anxiety             
   Yes 18 
(35.3) 
165 
(55.2) 
6.91b 79 
(59.9) 
104 
(47.7) 
4.86a 24 
(63.2) 
159 
(51.0) 
2.02 30 
(54.5) 
153 (51.9) 0.13 
   No 33 
(64.7) 
134 
(44.8) 
 53 
(40.1) 
114 
(52.3) 
 14 
(36.8) 
153 
(49.0) 
 25 
(45.5) 
142 (48.1)  
Med:  Other             
   Yes 21 
(41.2) 
92 
(30.8) 
2.16 46 
(34.9) 
67 
(30.7) 
0.64 20 
(52.6) 
93 
(29.8) 
8.07b 13 
(23.6) 
100 (33.9) 2.23 
   No 30 
(58.8) 
207 
(69.2) 
 86 
(65.1) 
151 
(69.3) 
 18 
(47.4) 
219 
(70.2) 
 42 
(76.4) 
195 (66.1)  
Child sexual abuse             
   Yes 11 
(21.6) 
136 
(45.5) 
10.23c 65 
(49.2) 
82 
(37.6) 
4.56a 14 
(36.8) 
133 
(42.6) 
0.47 21 
(38.2) 
126 (42.7) 0.39 
   No 40 
(78.4) 
163 
(55.5) 
 67 
(50.8) 
136 
(62.4) 
 24 
(63.2) 
179 
(57.4) 
 34 
(61.8) 
169 (57.3)  
Child physical abuse             
   Yes 12 
(23.5) 
125 
(41.8) 
6.11b 60 
(45.5) 
77 
(35.3) 
3.54a 19 
(50.0) 
118 
(37.8) 
2.11 18 
(32.7) 
119 (40.3) 1.13 
   No 39 
(76.5) 
174 
(58.2) 
 72 
(54.5) 
141 
(64.7) 
 19 
(50.0) 
194 
(62.2) 
 37 
(67.3) 
176 (59.7)  
Adult sexual assault             
   Yes 8  
(15.7) 
108 
(36.1) 
8.21b 49 
(37.1) 
67 
(30.7) 
1.51 20 
(52.6) 
96 
(30.8) 
7.31b 15 
(27.3) 
101 (34.2) 1.01 
   No 43 
(84.3) 
 
191 
(63.9) 
 83 
(62.9) 
151 
(69.3) 
 18 
(47.4) 
216 
(69.2) 
 40 
(72.7) 
194 (65.8)  
Adult physical assault            
   Yes 10 
(19.6) 
128 
(42.8) 
9.82b 55 
(41.7) 
83 
(38.1) 
0.44 20 
(52.6) 
118 
(37.8) 
3.11 20 
(36.4) 
118 
(40.0) 
0.26 
   No 
 
 
41 
(80.4) 
171 
(57.2) 
 77 
(58.3) 
135 
(61.9) 
 18 
(47.4) 
194 
(62.2) 
 35 
(63.6) 
177 
(60.0) 
 
 651
Table 151 (cont.) 
 
 Anxiety Disorder 
 
Depression (not major) Adjustment Disorder Other Disorder
 Y (%) N (%) χ2 Y (%) N (%) χ2 Y (%) N (%) χ2 Y (%) N (%) χ2 
Hospital last year             
   Yes 5 
(15.2) 
115 
(36.3) 
5.92b 6  
(31.6) 
114 
(34.4) 
0.07 0 
(0.0) 
120 
(35.0) 
*F 8 
 (53.3) 
112 
(33.4) 
2.52 
   No 28 
(84.8) 
202 
(63.7) 
 13 
(68.4) 
217 
(65.6) 
 7 
(100.0) 
223 
(65.0) 
 7 
 (46.7) 
223 
(66.6) 
 
Emplo  yed?
osis
sion
ania
            
   Yes 13 
(39.4) 
61 
(19.2) 
7.28b 8 
(42.1) 
66 
(20.0) 
*Fa 6  
(85.7) 
68 
(19.8) 
*Fd 4 
(26.7) 
70 
(20.9) 
0.29 
   No 20 
(60.6) 
256 
(80.8) 
 11 
(57.9) 
265 
(80.0) 
 1 
(14.3) 
275 
(80.2) 
 11 
(73.3) 
265 
(79.1) 
 
Substance use dx             
   Yes 15 
(45.5) 
104 
(32.8) 
2.13 5  
(26.3) 
114 
(34.4) 
0.53 2 
(28.6) 
117 
(34.1) 
*F 4 
(26.7) 
115 
(34.3) 
0.38 
   No 18 
(54.5) 
213 
(67.2) 
 14 
(73.7) 
217 
(65.6) 
 5 
(71.4) 
226 
(65.9) 
 11 
(73.3) 
220 
(65.7) 
 
Med:  Psych              
   Yes 3  
(9.1) 
152 
(48.0) 
18.29d 0 
(0.0) 
155 
(46.8) 
15.97d 0 
(0.0) 
155 
(45.2) 
*Fb 2 
(13.3) 
153 
(45.7) 
6.08b
   No 30 
(90.9) 
165 
(52.0) 
 19 
(100.0) 
176 
(53.2) 
 7 
(100.0) 
188 
(54.8) 
 13 
(86.7) 
182 
(54.3) 
 
Med:  Depres              
   Yes 21 
(63.6) 
245 
(77.3) 
3.05 13 
(68.4) 
253 
(76.4) 
*F 0 
(0.0) 
266 
(77.6) 
*Fd 9  
(60.0) 
257 
(76.7) 
*F 
   No 12 
(36.4) 
72 
(22.7) 
 6  
(31.6) 
78 
(23.6) 
 7 
(100.0) 
77 
(22.4) 
 6 
(40.0) 
78 
(23.3) 
 
Med:  M              
   Yes 2 
(6.1) 
94 
(29.6) 
8.36 2 
(10.5) 
94 
(28.4) 
2.88 0 
(0.0) 
96 
(28.0) 
*F 2 
(13.3) 
94 
(28.1) 
*F 
   No 
 
 
 
31 
(93.9) 
223 
(70.4) 
 17 
(89.5) 
237 
(71.6) 
 7 
(100.0) 
247 
(72.0) 
 13 
(86.7) 
241 
(71.9) 
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Table 151 (cont.) 
 
 Anxiety Disorder Depression (not major) Adjustment Disorder Other Disorder
 Y (%) N (%) χ2 Y (%) N (%) χ2 Y (%) N (%) χ2 Y (%) N (%) χ2 
Med:  Anx  iety
ther
buse
            
   Yes 17 
(51.5) 
166 
(52.4) 
0.01 8 
(42.1) 
175 
(52.9) 
0.83 0 
(0.0) 
183 
(53.4) 
*Fb 7 
(46.7) 
176 
(52.5) 
0.20 
   No 16 
(48.5) 
151 
(47.6) 
 11 
(57.9) 
156 
(47.1) 
 7 
(100.0) 
160 
(46.6) 
 8 
(53.3) 
159 
(47.5) 
 
Med:  O              
   Yes 4  
(12.1) 
109 
(34.4) 
6.76b 4  
(21.0) 
109 
(32.9) 
1.16 0 
(0.0) 
113 
(33.0) 
*F 5 
(33.3) 
108 
(32.2) 
*F 
   No 29 
(87.9) 
208 
(65.6) 
 15 
(79.0) 
222 
(67.1) 
 7 
(100.0) 
230 
(67.0) 
 10 
(66.7) 
227 
(67.8) 
 
Child sexual a              
   Yes 17 
(51.5) 
130 
(41.0) 
1.35 8 
(42.1) 
139 
(42.0) 
0.00 1 
(14.3) 
146 
(42.6) 
*F 10 
(66.7) 
137 
(40.9) 
3.91a
   No 16 
(48.5) 
187 
(59.0) 
 11 
(57.9) 
192 
(58.0) 
 6 
(85.7) 
197 
(57.4) 
 5 
(33.3) 
198 
(59.1) 
 
Child physical abuse             
   Yes 12 
(36.4) 
125 
(39.4) 
0.12 8 
(42.1) 
129 
(39.0) 
0.07 2 
(28.6) 
135 
(39.4) 
*F 6 
(40.0) 
131 
(39.1) 
0.00 
   No 21 
(63.6) 
192 
(60.6) 
 11 
(57.9) 
202 
(61.0) 
 5 
(71.4) 
208 
(60.6) 
 9 
(60.0) 
204 
(60.9) 
 
Adult sexual assault             
   Yes 14 
(42.4) 
102 
(32.2) 
0.23 3 
(15.8) 
113 
(34.1) 
2.73 0 
(0.0) 
116 
(33.8) 
*F 7 
(46.7) 
109 
(32.5) 
*F 
   No 
 
19 
(57.6) 
215 
(67.8) 
 16 
(84.2) 
218 
(65.9) 
 7 
(100.0) 
227 
(66.2) 
 8 
(53.3) 
226 
(67.5) 
 
Adult physical assault            
   Yes 17 
(51.5) 
121 
(38.2) 
2.23 7 
(36.8) 
131 
(39.6) 
0.06 2 
(28.6) 
136 
(39.7) 
*F 7 
(46.7) 
131 
(39.1) 
0.34 
   No 16 
(48.5) 
196 
(61.8) 
 12 
(63.2) 
200 
(60.4) 
 5 
(71.4) 
207 
(60.3) 
 8 204 
(60.9) 
 
(53.3) 
 
Note:  a = p≤.05; b = p≤.01; c = p≤.001; d = p ≤ .0001; *F = Fisher’s exact test used in place of chi-square 
 
Table 152 
 
Diagnosis by Social Support 
 
  Partner or best friend 
support 
 
Family Support 
 
Provider Support 
 
 N Mean  
(s.d.) 
t-test Mean (s.d.) t-test Mean  
(s.d.) 
t-test 
Schizophrenia        
     Yes 51 4.12 (1.13) 0.18 3.61 (1.55) -3.61c 4.01 (0.88) -2.33a
     No 299 4.15 (1.19)  4.31(1.23)  4.26 (0.67)  
Bipolar        
     Yes 132 4.19 (1.17) -0.63 3.44 (1.48) 2.62b 4.02 (0.92) 0.52 
     No 218 4.11 (1.19)  3.88 (1.53)  4.07(0.82)  
Schizoaffective        
     Yes 38 4.18 (1.21) -0.22 4.29 (1.51) -2.48b 4.31 (0.68) -2.38a
     No 312 4.14 (1.18)  3.64 (1.52)  4.02 (0.87)  
Major Depression        
     Yes 55 3.87 (1.26) 1.90a 3.38 (1.61) 1.78 3.86 (1.01) 1.58 
     No 295 4.19 (1.16)  3.78 (1.51)  4.09 (0.83)  
Anxiety Disorder        
     Yes 33 3.90 (1.13) 1.26 3.90 (1.55) -0.73 3.98 (0.85) 0.52 
     No 317 4.17 (1.18)  3.70 (1.53)  4.01 (0.86)  
Depression (not MD)        
     Yes 19 4.29 (1.10) -0.56 3.23 (1.32) 1.43 3.99 (0.86) 0.32 
     No 331 4.13 (1.18)  3.74 (1.53)  4.05 (0.86)  
Adjustment Disorder        
     Yes 7 4.53 (1.42) -0.88 4.21 (1.73) -0.87 3.86 (0.72) 0.60 
     No 343 4.13 (1.17)  3.70 (1.52)  4.05 (0.86)  
Other Diagnosis        
     Yes 15 4.87 (0.95) -2.45b 3.82 (1.80) -0.28 3.99 (0.57) 0.29 
     No 
 
335 4.11 (1.18)  3.71 (1.52)  4.05 (0.87)  
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Table 152 (cont.) 
 
  Friends Support 
 
Community 
involvement 
 
Trust 
 
 N Mean  
(s.d.) 
t-test Mean (s.d.) t-test Mean  
(s.d.) 
t-test 
Schizophrenia        
     Yes 51 4.20 (1.27) -0.60 3.60 (1.08) -0.71 3.34 (0.99) -2.18a
     No 299 4.10 (1.13)  3.47 (1.19)  3.03 (0.94)  
Bipolar        
     Yes 132 4.17 (1.10) -0.75 3.38 (1.18) 1.33 2.95 (0.94) 1.84 
     No 218 4.08 (1.18)  3.55 (1.16)  3.14 (0.95)  
Schizoaffective        
     Yes 38 4.12 (1.14) -0.04 3.85 (1.24) -2.01a 3.14 (1.02) -0.51 
     No 312 4.11 (1.15)  3.44 (1.15)  3.06 (0.94)  
Major Depression        
     Yes 55 3.74 (1.24) 2.66b 3.47 (1.16) -0.72 3.16 (1.00) -0.79 
     No 295 4.18 (1.12)  3.59 (1.22)  3.05 (0.94)  
Anxiety Disorder        
     Yes 33 4.11 (1.03) 0.03 3.50 (1.19) 0.68 2.98 (0.79) 0.59 
     No 317 4.11 (1.16)  3.36 (1.00)  3.08 (0.97)  
Depression (not MD)        
     Yes 19 3.95 (1.15) 0.64 2.87 (0.94) 2.37b 2.95 (0.69) 0.58 
     No 331 4.12 (1.15)  3.52 (1.17)  3.08 (0.97)  
Adjustment Disorder        
     Yes 7 4.71 (0.83) -1.41 3.97 (1.07) -1.10 3.43 (1.28) -1.00 
     No 343 4.10 (0.83)  3.48 (1.17)  3.06 (0.94)  
Other Diagnosis        
     Yes 15 4.58 (0.96) -1.63 3.61 (1.41) -0.42 2.88 (0.88) 0.78 
     No 
 
335 4.09 (1.15)  3.48 (1.16)  3.08 (0.96)  
 
Note:  a = p≤.05; b = p≤.01; c = p≤.001; d = p ≤ .0001 
 
 
Table 153 
 
Diagnosis by Empowerment  
 
 
 
 Self-Esteem and  
Self-Efficacy 
 
Power-Powerlessness 
 
Community Activism 
and Autonomy 
 
Optimism and Control 
Over the Future 
 
Righteous Anger 
 
 N Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test 
Schizophrenia            
     Yes 51 2.96 (0.52) -1.20 2.43 (0.41) 0.83 3.13 (0.49) 0.42 2.87 (0.54) -0.98 2.39 (0.49) 0.99 
     No 299 2.87 (0.53)  2.49 (0.43)  3.16 (0.39)  2.80 (0.44)  2.47 (0.55)  
Bipolar            
     Yes 132 2.82 (0.57) 1.57 2.46 (0.45) 0.54 3.15 (0.40) -0.06 2.81 (0.47) 0.12 2.47 (0.55) -0.17 
     No 218 2.91 (0.51)  2.49 (0.41)  3.15 (0.41)  2.82 (0.46)  2.46 (0.53)  
Schizoaffective            
     Yes 38 2.87 (0.51) 0.15 2.42 (0.41) 0.85 3.17 (0.38) -0.36 2.79 (0.44) 0.35 2.39 (0.53) 0.91 
     No 312 2.88 (0.54)  2.49 (0.43)  3.15 (0.41)  2.82 (0.46)  2.47 (0.54)  
Major Depression            
     Yes 55 2.81 (0.50) 1.01 2.48 (0.45) 0.04 3.13 (0.41) 0.48 2.76 (0.50) 0.97 2.54 (0.56) -1.18 
     No 295 2.89 (0.54)  2.48 (0.42)  3.16 (0.41)  2.82 (0.45)  2.45 (0.53)  
Anxiety Disorder            
     Yes 33 2.92 (0.34) -0.60 2.58 (0.33) -1.71 3.18 (0.30) -0.59 2.81 (0.32) 0.07 2.49 (0.44) -0.38 
     No 317 2.88 (0.55)  2.47 (0.43)  3.15 (0.42)  2.81 (0.47)  2.46 (0.55)  
Depression (not MD)            
     Yes 19 2.80 (0.55) 0.65 2.50 (0.37) -0.25 3.02 (0.42) 1.44 2.70 (0.36) 1.14 2.42 (0.51) 0.33 
     No 331 2.88 (0.53)  2.48 (0.43)  3.16 (0.40)  2.82 (0.46)  2.46 (0.54)  
Adjustment Disorder            
     Yes 7 3.36 (0.36) -2.41a 2.73 (0.37) -1.60 3.14 (0.40) 0.06 3.18 (0.47) -2.13a 2.62 (0.36) -0.79 
     No 343 2.87 (0.53)  2.47 (0.43)  3.15 (0.41)  2.81 (0.46)  2.46 (0.54)  
Other Diagnosis            
     Yes 15 3.18 (0.64) -2.20a 2.56 (0.45) -0.76 3.36 (0.38) -2.05a 2.90 (0.32) -0.74 2.44 (0.80) 0.08 
     No 
 
335 2.87 (0.52)  2.48 (0.42)  3.14 (0.40)  2.81 (0.47)  2.46 (0.52)  
 
Note:  a = p ≤ .05; b = p ≤ .01; c = p ≤ .001; d = p ≤ .0001 
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Table 154 
 
Diagnosis by Stigma  
 
 
 
 Alienation 
 
Stereotype 
endorsement 
 
Discrimination 
occurrence 
Social withdrawal 
 
Stigma resistance 
 
 N Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test 
Schizophrenia            
     Yes 51 2.38 (0.58) 1.11 2.05 (0.44) -1.35 2.37 (0.54) 0.51 2.35 (0.47) 0.07 2.11 (0.47) 0.85 
     No 299 2.48 (0.62)  1.95 (0.48)  2.42 (0.64)  2.36 (0.61)  2.16 (0.46)  
Bipolar            
     Yes 132 2.60 (0.62) -3.24c 1.99 (0.49) -0.61 2.51 (0.65) -2.33a 2.47 (0.61) -2.78b 2.18 (0.49) -0.63 
     No 218 2.39 (0.60)  1.96 (0.46)  2.35 (0.60)  2.29 (0.57)  2.14 (0.44)  
Schizoaffective            
     Yes 38 2.47 (0.52) -0.06 2.05 (0.53) -1.06 2.63 (0.61) -2.34a 2.44 (0.57) -0.92 2.15 (0.43) 0.12 
     No 312 2.47 (0.62)  1.96 (0.46)  2.38 (0.62)  2.35 (0.60)  2.16 (0.46)  
Major Depression            
     Yes 55 2.49 (0.62) -0.31 1.90 (0.43) 1.23 2.32 (0.61) 1.11 2.25 (0.53) 1.37 2.19 (0.43) -0.58 
     No 295 2.46 (0.61)  1.98 (0.48)  2.43 (0.63)  2.37 (0.60)  2.15 (0.46)  
Anxiety Disorder            
     Yes 33 2.25 (0.51) 2.18a 1.88 (0.43) 1.14 2.20 (0.51) 2.04a 2.11 (0.52) 2.50b 2.16 (0.44) -0.10 
     No 317 1.88 (0.43)  1.98 (0.48)  2.43 (0.63)  2.38 (0.60)  2.16 (0.46)  
Depression (not MD)            
     Yes 19 2.37 (0.70) 0.72 1.92 (0.44) 0.48 2.21 (0.64) 1.43 2.36 (0.65) -0.03 2.18 (0.45) -0.22 
     No 331 2.47 (0.61)  1.97 (0.47)  2.42 (0.62)  2.36 (0.59)  2.15 (0.46)  
Adjustment Disorder            
     Yes 7 1.76 (0.69) 3.11b 1.73 (0.33) 1.32 1.74 (0.66) 2.89b 1.86 (0.73) 2.26a 2.11 (0.43) 0.24 
     No 343 2.48 (0.60)  1.97 (0.47)  2.42 (0.62)  2.37 (0.59)  2.16 (0.46)  
Other Diagnosis            
     Yes 15 2.42 (0.62) 0.29 1.95 (0.57) 0.13 2.45 (0.62) -0.28 2.31 (0.84) 0.21 2.03 (0.44) 1.12 
     No 
 
335 2.47 (0.61)  1.97 (0.47)  2.41 (0.62) 
 
Note:  a = p ≤ .05; b = p ≤ .01; c = p ≤ .001; d = p ≤ .0001 
 
 2.36 (0.58)  2.16 (0.46)  
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Table 155 
 
Diagnosis by Service Variables  
 
 
 
 Total number 
of services 
 
Total contact hours 
 
Average 
satisfaction 
 
Diagnosis N Mean 
(s.d.) 
t-test Mean  
(s.d.) 
t-test Mean 
(s.d.) 
t-test 
Schizophrenia        
     Yes 51 3.0 (1.2) -3.78c 12.0 (11.0) -2.51b 5.2 (0.8) -0.58 
     No 299 2.3 (1.2)  6.2 (6.7)  5.1 (1.0)  
Bipolar        
     Yes 132 2.5 (1.2) -0.93 6.7 (7.5) 1.27 5.0 (1.2) 1.07 
     No 218 2.4 (1.2)  7.3 (7.8)  5.1 (0.9)  
Schizoaffective        
     Yes 38 3.2 (1.2) -4.08d 9.0 (8.0) -1.73 5.0 (0.9) 0.38 
     No 312 2.3 (1.2)  6.9 (7.6)  5.1 (1.0)  
Major Depression        
     Yes 55 2.3 (1.0) 1.19 5.0 (5.1) 2.94c 5.0 (1.0) 0.40 
     No 295 2.5 (1.2)  7.5 (8.0)  5.1 (1.0)  
Anxiety Disorder        
     Yes 33 1.6 (0.9) 5.47d 5.5 (5.7) 1.15 5.3 (0.8) -1.20 
     No 317 2.5 (1.2)  7.3 (7.9)  5.1 (1.0)  
Depression (not MD)        
     Yes 19 1.7 (0.7) 4.66d 4.1 (2.2) 4.79d 5.2 (0.8) -0.47 
     No 331 2.5 (1.2)  7.3 (7.9)  5.1 (1.0)  
Adjustment Disorder        
     Yes 7 1.3 (0.5) 5.94c 5.7 (4.1) 0.48 5.4 (0.9) -0.70 
     No 343 2.4 (1.2)  7.1 (7.8)  5.1 (1.0)  
Other Diagnosis        
     Yes 15 1.7 (0.9) 2.29a 4.9 (4.7) 1.80 5.2 (0.8) -0.27 
     No 
 
335 2.5 (1.2)  7.2 (7.8)  5.1 (1.0)  
 
Note:  a = p ≤ .05; b = p ≤ .01; c = p ≤ .001; d = p ≤ .0001; not MD = not major depression 
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Table 156 
 
Symptom Correlation Table  
 
 Soma OCD Interpersonal 
Sensitivity 
Depression Anxiety Hostility Phobic 
Anxiety 
Paranoia Psychoticism 
OCD 
 
0.70         
Interpersonal 
Sensitivity 
0.61 0.76        
Depression 
 
0.67 0.83 0.81       
Anxiety 
 
0.72 0.79 0.74 0.83      
Hostility 
 
0.54 0.60 0.56 0.56 0.60     
Phobic Anxiety 
 
0.60 0.68 0.73 0.68 0.75 0.43    
Paranoia 
 
0.65 0.79 0.81 0.75 0.73 0.59 0.68   
Psychoticism 
 
0.60 0.73 0.73 0.74 0.74 0.56 0.64 0.74  
GSI 
 
0.81 0.90 0.88 0.85 
 
Note:  All correlations significant at p ≤ .0001 
 
 
0.92 0.91 0.69 0.80 0.86 
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Table 157 
 
Symptoms by Continuous Domain 1 Variables  
 
 Age of 
Onset 
Hospitalizations 
in Lifetime 
Total years 
employed 
Mental 
illness: 
nuclear 
family 
 
Mental 
illness:  
extended 
family 
Psychosomatic 
 
-0.03 0.03 0.12a 0.19c 0.11a
OCD 
 
-0.08 0.03 0.04 0.21d 0.14b
Interpersonal 
Sensitivity 
-0.13b 0.10a 0.01 0.24d 0.19c
Depression 
 
-0.09 0.05 0.08 0.21d 0.16b
Anxiety 
 
-0.06 0.08 0.04 0.16c 0.08 
Hostility 
 
-0.15b 0.04 -0.01 0.09 0.10 
Phobic 
Anxiety 
-0.04 0.07 -0.00 0.18c 0.14b
Paranoia 
 
-0.10a 0.09 0.02 0.21d 0.18c
Psychoticism 
 
-0.09 0.11a 0.08 0.15b 0.14b
Global 
Severity Index 
 
-0.09 0.08 0.06 0.22d 0.17b
 
Note:  a = p ≤ .05; b = p ≤ .01; c = p ≤ .001; d = p ≤ .0001 
 
 
Table 158 
 
Symptoms by Categorical Domain 1 Variables  
 
  Psychosomatic OCD Interpersonal 
Sensitivity 
 
Depression Anxiety
 N Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test 
Hospitalized in last 
year 
           
     Yes 120 1.71 (0.90) -2.60b 2.08 (0.96) -2.68b 1.82 (0.96) -2.57b 2.07 (0.92) -2.72b 1.93 (0.97) -4.28d
     No 230 
ed
1.44 (0.92) 1.78 (1.01)  1.53 (1.02)  1.76 (1.05)  1.45 (1.03)  
Currently Empl  oy            
     Yes 74 1.33 (0.92) 2.13a 1.57 (1.10) 3.05b 1.33 (1.03) 2.94b 1.57 (1.07) 2.85b 1.24 (1.07) 3.58c
     No 276 1.59 (0.92)  1.97 (0.96)  1.72 (0.99)  1.95 (0.99)  1.72 (1.00)  
Co-occurring 
substance diagnosis 
           
     Yes 119 1.54 (0.96) -00.6 1.88 (0.99) 0.03 1.58 (1.02) 0.67 1.81 (0.99) 0.76 1.61 (1.07) 0.08 
     No 231 1.53 (0.91)  1.89 (1.01)  1.66 (1.00)  1.90 (1.04)  1.62 (1.02)  
Anti-psychotic 
medication 
           
     Yes 155 1.47 (0.90) 1.10 1.90 (0.90) -0.15 1.74 (0.97) -1.82 1.88 (0.90) -0.19 1.70 (0.95) -1.38 
     No 195 1.58 (0.94)  1.88 (1.08)  1.55 (1.03)  1.86 (1.10)  1.55 (1.10)  
Anti-depressant 
medication 
           
     Yes 266 1.66 (0.90) -4.71d 2.06 (0.96) -6.17d 1.79 (0.96) -5.18d 2.04 (0.98) -5.92d 1.76 (1.02) -4.99d
     No 84 1.13 (0.87)  1.33 (0.94)  1.15 (0.99)  1.32 (0.95)  1.14 (0.95)  
Anti-manic 
medication 
           
     Yes 96  1.66 (0.91) -1.63 2.17 (0.91) -3.27c 1.78 (0.97) -1.70 2.08 (0.92) -2.42b 1.86 (0.94) -2.73c
     No 254 1.48 (0.92)  1.78 (1.02)  1.58 (1.02)  1.79 (1.04)  1.52 (1.06)  
Anti-anxiety 
medication 
           
     Yes 183 1.73 (0.92) -4.34d 2.14 (0.96) -5.11d 1.87 (0.96) -4.74d 2.10 (0.97) -4.58d 1.88 (0.99) -5.23d
     No 
 
 
167 1.31 (0.87)  1.61 (0.98)  1.37 (1.00)  1.61 (1.01)  1.32 (1.00)  
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Table 158 (cont.) 
 
  Psychosomatic OCD Interpersonal 
Sensitivity 
 
Depression Anxiety
 N Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test 
Other psychotropic 
medication 
           
     Yes 113 1.57 (0.94) -0.60 2.03 (0.96) -1.83 1.74 (0.95) -1.32 1.96 (0.97) -1.18 1.71 (0.99) -1.24 
     No 237 1.51 (0.91)  1.82 (1.02)  1.59 (1.03)  1.82 (1.04)  1.57 (1.06)  
Diagnosis 
 
N Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test 
Child sexual abuse            
     Yes 147 -2.99b 2.14 (0.94) -4.19d 1.93 (1.00) -4.78d 2.13 (0.93) -4.18d 1.84 (0.96) -3.58c1.70 (0.90) 
     No 203 1.41 (0.92)  1.70 (1.01)  1.42 (0.96)  1.68 (1.04)  1.45 (1.06)  
Child physical abuse            
     Yes 137 1.77 (0.93) -3.96d 2.14 (0.96) -3.87d 1.85 (1.02) -3.30c 2.09 (0.99) -3.22c 1.83 (1.00) -3.15c
     No 213 1.38 (0.89)  1.72 (1.00)  1.49 (0.98)  1.73 (1.01)  1.48 (1.03)  
Adult sexual assault            
     Yes -4.11d 2.15 (0.99) -3.53c 1.92 (0.94) -3.83c116 1.81 (0.91) 2.13 (0.95) -3.43c 1.92 (1.00) -3.95d
     No 234 1.39 (0.90)  1.76 (0.98)  1.49 (1.01)  1.74 (1.03)  1.46 (1.02)  
Adult physical 
assault 
           
     Yes 138 1.75 (0.92) -3.68c 2.13 (1.02) -3.74c 1.89 (0.98) -3.91d 2.12 (1.00) -3.74c 1.83 (1.04) -3.18b
     No 
 
 
 
 
 
 
 
 
 
 
 
 
212 1.39 (0.90)  1.73 (0.96)  1.47 (1.00)  1.71 (1.00)  1.47 (1.01)  
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Table 158 (cont.) 
 
  
 
Hostility Phobic Anxiety Paranoia Psychoticism Global Severity Index
 N Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test 
Hospitalized in last 
year 
           
     Yes 120 1.33 (0.99) -2.28a 1.43 (1.05) -2.87b 1.97 (1.01) -2.74b 1.44 (0.86) 3.18c 1.79 (0.77) -3.47c
     No 230 
ed
1.08 (0.96)  1.09 (1.04)  1.65 (1.02)  1.13 (0.86)  1.47 (0.85)  
Currently Empl  oy            
     Yes 74 1.05 (1.00) 1.13 0.68 (0.80) 5.96d 1.48 (1.04) 2.71b 0.97 (0.83) 2.95b 1.29 (0.86) 3.36c
     No 276 1.19 (0.97)  1.35 (1.07)  1.84 (1.01)  1.30 (0.87)  1.65 (0.81)  
Co-occurring 
substance diagnosis 
           
     Yes 119 1.12 (1.00) 0.56 1.16 (1.02) 0.68 1.74 (1.04) 0.32 1.31 (0.88) -1.24 1.57 (0.84) 0.16 
     No 231 1.18 (0.97)  1.24 (1.07)  1.77 (1.01)  1.19 (0.86)  1.58 (0.84)  
Anti-psychotic 
medication 
           
     Yes 155 1.07 (0.93) 1.65 1.31 (1.03) -1.60 1.85 (0.95) -1.44 1.37 (0.83) -2.53b 1.62 (0.77) -0.78 
     No 195 1.24 (1.01)  1.13 (1.07)  1.69 (1.07)  1.13 (0.88)  1.55 (0.89)  
Anti-depressant 
medication 
           
     Yes 266 1.25 (0.98) -2.86c 1.38 (1.08) -6.50d 1.91 (0.98) -4.99d 1.34 (0.78) -4.34d 1.72 (0.80) -6.03d
     No 84 0.90 (0.91)  0.68 (0.77)  1.29 (1.00)  0.88 (0.83)  1.12 (0.79)  
Anti-manic 
medication 
           
     Yes 96 1.36 (1.01) -2.32a 1.44 (1.06) -2.59b 2.01 (0.97) -2.81b 1.49 (0.84) -3.45c 1.79 (0.76) -3.03b
     No 254 1.09 (0.95)  1.12 (1.04)  1.67 (1.03)  1.14 (0.86)  1.49 (0.85)  
Anti-anxiety 
medication 
           
     Yes 183 1.29 (0.98) -2.54b 1.51 (1.09) -5.89d 1.97 (0.98) -4.12d 1.41 (0.84) -3.96d 1.80 (0.79) -5.36d
     No 167 1.03 (0.95)  0.88 (0.92)  1.53 (1.02)  1.05 (0.87)  1.34 (0.82)  
Other psychotropic 
medication 
           
     Yes 113 1.18 (0.96) -0.15 1.33 (1.03) -1.46 1.87 (0.97) -1.36 1.38 (0.86) -2.24a 1.68 (0.78) -1.54 
     No 
 
237 1.16 (0.98)  1.15 (1.07)  1.71 (1.04)  1.16 (0.87)  1.53 (0.86)  
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  Hostility 
 
Phobic Anxiety Paranoia Psychoticism Global Severity Index
 N 
 
Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test 
Child sexual abuse            
     Yes 147 1.29 (0.98) -2.09a 1.45 (1.09) -3.69c 2.02 (1.02) -4.07d 1.38 (0.79) -2.62b 1.79 (0.71) -4.26d
     No 203 1.07 (0.97)  1.04 (0.99)  1.58 (0.98)  1.13 (0.77)  1.42 (0.76)  
Child physical abuse            
     Yes 137 1.31 (1.01) -2.23a 1.46 (1.09) -3.64c 2.03 (1.04) -4.03d 1.44 (0.92) -3.60c 1.80 (0.83) -4.10d
     No 213 1.07 (0.94)  1.05 (1.00)  1.59 (0.98)  1.10 (0.81)  1.43 (0.81)  
Adult sexual assault            
     Yes 116 1.19 (0.93) -0.35 1.63 (1.09) -5.40d 2.06 (1.03) -3.87d 1.44 (0.85) -3.11c 1.84 (0.80) -4.27d
     No 234 1.15 (1.00)  1.00 (0.98)  1.62 (0.99)  1.13 (0.86)  1.45 (0.82)  
Adult physical 
assault 
           
     Yes 138 1.26 (1.00) -1.50 1.50 (1.12) -4.21d 2.05 (1.05) -4.40d 1.38 (0.84) -2.53b 1.80 (0.84) -4.11d
     No 212 1.10 (0.97)   1.14 (0.88)  1.57 (0.96)  1.02 (0.97) 1.43 (0.81)  
 
Note:  a = p ≤ .05; b = p ≤ .01; c = p ≤ .001; d = p ≤ .0001 
 
 
 
Table 159 
 
Symptoms by Social Support  
 
 Partner 
or best 
friend 
support 
 
Family 
Support 
 
Provider 
Support 
 
Friends 
Support 
 
Community 
involvement 
 
Trust 
 
Psychosomatic 
 
-0.11a -0.14b -0.06 -0.11a -0.03 -0.15b
OCD 
 
-0.14b -0.17c -0.09 -0.15b -0.14 -0.24d
Interpersonal 
Sensitivity 
-0.21d -0.20c -0.06 -0.16b -0.16 -0.25d
Depression 
 
-0.27d -0.25d -0.14b -0.24d -0.20 -0.22d
Anxiety 
 
-0.19c -0.19c -0.07 -0.17c -0.13 -0.25d
Hostility 
 
-0.11a -0.13b -0.03 -0.11a -0.08 -0.27d
Phobic 
Anxiety 
-0.15b -0.18c -0.03 -0.14b -0.09 -0.23d
Paranoia 
 
-0.21d -0.21d -0.05 -0.18c -0.09 -0.28d
Psychoticism 
 
-0.19c -0.10 -0.01 -0.14b -0.07 -0.24d
Global 
Severity Index 
-0.22d -0.21d -0.08 -0.19c -0.14b -0.27d
 
Note:  a = p ≤ .05; b = p ≤ .01; c = p ≤ .001; d = p ≤ .0001 
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Table 160 
 
Symptoms by Empowerment  
 
 Self-esteem 
and 
self-
efficacy 
Power and 
powerlessness
 
Community 
activism and 
autonomy 
 
Optimism 
and control 
over the 
future 
 
Righteous 
anger 
 
 
Psychosomatic 
 
-0.28d -0.18c -0.03 -0.24d -0.01 
OCD 
 
-0.41d -0.29d -0.03 -0.24d -0.01 
Interpersonal 
Sensitivity 
-0.42d -0.35d -0.06 -0.26d -0.01 
Depression 
 
-0.51d -0.34d -0.07 -0.30d -0.02 
Anxiety 
 
-0.43d -0.28d -0.05 -0.28d -0.01 
Hostility 
 
-0.23d -0.19c -0.02 -0.12a -0.09 
Phobic 
Anxiety 
-0.40d -0.31d -0.13b -0.28d -0.05 
Paranoia 
 
-0.35d -0.31d -0.09 -0.21 -0.04 
Psychoticism 
 
-0.38d -0.38d -0.07 -0.21 -0.06 
Global 
Severity Index 
-0.46d -0.34d -0.07 -0.29 -0.00 
 
Note:  a = p ≤ .05; b = p ≤ .01; c = p ≤ .001; d = p ≤ .0001 
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Table 161 
 
Symptoms by Stigma  
 
 Alienation Stereotype 
endorsement 
 
Discrimination 
occurrence 
 
Social 
withdrawal 
 
Stigma 
resistance  
 
Psychosomatic 
 
0.27d 0.12a 0.28d 0.27d 0.20c
OCD 
 
0.45d 0.23d 0.37d 0.43d 0.26d
Interpersonal 
Sensitivity 
0.50d 0.28d 0.44d 0.50d 0.30d
Depression 
 
0.51d 0.25d 0.41d 0.49d 0.34d
Anxiety 
 
0.46d 0.24d 0.38d 0.46d 0.34d
Hostility 
 
0.23d 0.17c 0.23d 0.26d 0.17c
Phobic 
Anxiety 
0.45d 0.31d 0.40d 0.48d 0.28d
Paranoia 
 
0.45d 0.23d 0.44d 0.43d 0.27d
Psychoticism 
 
0.43d 0.29d 0.39d 0.46d 0.27d
Global 
Severity Index 
0.50d 0.27d 0.43d 0.50d 0.33d
 
Note:  a = p ≤ .05; b = p ≤ .01; c = p ≤ .001; d = p ≤ .0001 
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Table 162 
 
Symptoms by Service Variables 
 
 Total number  
of services 
 
Total contact 
hours 
 
Average 
satisfaction 
 
Psychosomatic 
 
-0.02 -0.05 -0.19c
OCD 
 
0.07 -0.03 -0.24d
Interpersonal Sensitivity 
 
0.07 0.01 -0.27d
Depression 
 
0.04 -0.01 -0.26d
Anxiety 
 
0.06 -0.01 -0.26d
Hostility 
 
-0.05 -0.03 -0.12a
Phobic Anxiety 
 
0.06 0.02 -0.15b
Paranoia 
 
0.09 -0.01 -0.26d
Psychoticism 
 
0.13b 0.07 -0.21d
Global Severity Index 0.06 
 
-0.00 -0.26d
 
Note:  a = p ≤ .05; b = p ≤ .01; c = p ≤ .001; d = p ≤ .0001 
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Table 163   
 
Continuous Domain 1 Variables Correlation Table  
 
 Age of onset Lifetime 
hospitalizations 
Total years 
employed 
MI:  Nuclear 
family 
Lifetime 
hospitalizations
 
-0.13b    
Total years 
employed 
 
0.15b -0.08   
MI:  Nuclear 
family 
 
-0.11a 0.10 0.18c  
MI: Extended 
family 
 
-0.15b 0.05 0.16b 0.81d
 
Note:  a = p ≤ .05; b = p ≤ .01; c = p ≤ .001; d = p ≤ .0001 
 
 
Table 164 
 
Continuous Domain 1 Variables (Age of onset, hospitalizations, years employed and familial mental illness) by Categorical Domain 1 Variables 
  
  Age of Onset Hospitalizations in 
Lifetime 
 
Total years employed Mental illness: nuclear 
family
Mental illness:  
extended family
Diagnosis 
 
N Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test 
Hospitalized in last 
year 
           
     Yes 120 22.61 (16.3) -0.98 11.1 (15.7) -4.50d 14.41 (10.4) -0.64 2.77 (2.22) -2.76b 0.89 (1.16) -1.19 
     No 230 
ed
20.91 (10.6) 4.43 (6.3)  13.62 (10.8)  2.12 (2.00)  0.75 (1.02)  
Currently Empl  oy            
     Yes 74 19.72 (9.0) 1.70 3.16 (5.26) 4.77d 14.25 (9.9) -0.35 2.40 (1.95) -0.29 0.88 (1.06) -0.74 
     No 276 21.98 (13.7)  7.64 (11.8)  13.75 (10.8)  2.33 (2.14)  0.77 (1.08)  
Co-occurring 
substance diagnosis 
           
     Yes 119 19.57 (10.1) 2.23a 7.40 (11.4) -0.87 15.79 (10.5) -2.46b 2.74 (2.18) -2.56b 0.99 (1.12) -2.45b
     No 231 22.49 (14.0)  6.33 (10.7)  12.86 (10.6)  2.14 (2.03)  0.70 (1.01)  
Anti-psychotic 
medication 
           
     Yes 155 20.39 (14.1) 1.41 9.94 (13.7) -4.78d 13.13 (10.7) 1.15 2.33 (2.05) 0.11 0.83 (1.07) -0.55 
     No 195 22.38 (11.8)  4.12 (7.08)  14.44 (10.6)  2.35 (2.14)  0.77 (1.08)  
Anti-depressant 
medication 
           
     Yes 266 20.97 (11.2) 1.09 7.06 (11.4) -1.25 14.57 (10.6) -2.25a 2.52 (2.14) -3.05c 0.85 (1.11) -1.63 
     No 84 23.16 (17.2)  5.54 (9.15)  11.60 (10.6)  1.79 (1.84)  0.63 (0.93)  
Anti-manic 
medication 
           
     Yes 96  20.98 (11.7) 0.46 9.17 (14.2) -2.17a 14.45 (10.4) -0.64 2.88 (2.18) -2.95b 1.10 (1.21) -3.06b
     No 254 21.69 (13.3)  5.76 (9.2)  13.63 (10.7)  2.14 (2.03)  0.68 (0.99)  
Anti-anxiety 
medication 
           
     Yes 183 21.97 (14.7) -0.72 7.84 (12.8) -2.10a 14.65 (10.0) -1.47 2.65 (2.11) -2.90b 0.83 (1.08) -0.61 
     No 
 
167 20.98 (10.6)  5.44 (8.27)  12.99 (11.3)  2.01 (2.04)  0.76 (1.07)  
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  Age of Onset Hospitalizations in 
Lifetime
Total years employed Mental illness: nuclear 
family 
 
Mental illness:  
extended family
Diagnosis 
 
N Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test 
Other psychotropic 
medication 
           
     Yes 113 21.01 (11.0) 0.53 7.58 (8.8) -1.16 13.51 (10.6) 0.42 2.44 (2.22) -0.61 0.93 (1.15) -1.60 
     No 237 21.73 (13.7)  6.27 (11.8)  14.02 (10.6)  2.30 (2.04)  0.73 (1.03)  
Child sexual abuse            
     Yes 147 20.71 (15.1)     0.93 7.86 (13.4) -1.59 13.90 (10.6) -0.06 2.87 (2.04) -4.10d 0.96 (1.13) -2.42b
     No 203 22.07 (11.0)  5.86 (8.7)  13.83 (10.7)  1.96 (2.06)  0.68 (1.01)  
Child physical abuse            
     Yes 137 19.28 (10.4) 2.78b 8.20 (11.7) -2.08a 14.12 (10.2) -0.37 3.09 (2.07) -5.55d 1.07 (1.20) -3.64c
     No 213 22.93 (14.1)  5.73 (10.3)  13.69 (10.9)  1.86 (1.97)  0.62 (0.94)  
Adult sexual assault            
     Yes 116 18.42 (9.8) 3.57c 8.91 (12.6) -2.47b 14.68 (10.3) -1.01 2.96 (2.16) -3.94d 1.03 (1.16) -2.81b
     No 234 23.02 (13.9)  5.60 (9.9)  13.45 (10.8)  2.04 (2.00)  0.68 (1.00)  
Adult physical 
assault 
           
     Yes 138 20.24 (11.1) 1.55 7.53 (11.5) -1.15 15.21 (10.4) -1.93a 2.88 (2.09) -3.98d 1.03 (1.16) -3.20c
     No 
 
212 12.98 (10.7)  22.32 (13.9)  6.16 (10.5)  1.99 (2.03)  0.65 (0.98)  
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; d p ≤ .0001 
 
 
 
Table 165 
 
Continuous Domain 1 Variables by Social Support  
 
 Age of 0nset Hospitalizations 
in lifetime 
Total years 
employed 
Mental 
illness: 
nuclear 
family 
 
Mental 
illness:  
extended 
family 
Partner or best 
friend support 
-0.06 -0.03 -0.11a -0.06 -0.08 
Family 
Support 
0.03 -0.10a -0.09 -0.23d -0.15c
Provider 
Support 
0.09 0.11a -0.10 -0.11a -0.08 
Friends 
Support 
-0.02 -0.03 -0.09 -0.10 -0.11 
Community 
involvement 
-0.00 -0.02 -0.01 0.01 0.02 
Trust 0.06 
 
0.01 -0.04 -0.03 -0.04 
 
Note:  a = p ≤ .05; b = p ≤ .01; c = p ≤ .001; d = p ≤ .0001 
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Table 166 
 
Continuous Domain 1 Variables by Empowerment  
 
 Age of 0nset Hospitalizations 
in lifetime 
Total years 
employed 
Mental 
illness: 
nuclear 
family 
 
Mental 
illness:  
extended 
family 
Self-esteem/ 
self-efficacy 
 
0.01 -0.11a -0.09 -0.16b -0.14b
Power and 
powerlessness 
 
-0.03 -0.08 0.07 0.14b 0.12a
Community 
activism and 
autonomy 
-0.04 0.03 -0.11a 0.02 0.03 
Optimism and 
control over 
the future 
0.03 -0.16b -0.09 -0.06 0.02 
0.02 Righteous 
anger 
 
0.08 0.01 0.10a 0.08 
 
Note:  a = p ≤ .05; b = p ≤ .01; c = p ≤ .001; d = p ≤ .0001 
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Table 167 
 
Continuous Domain 1 Variables by Stigma  
 
 Age of 0nset Hospitalizations 
in lifetime 
Total years 
employed 
Mental 
illness: 
nuclear 
family 
 
Mental 
illness:  
extended 
family 
Alienation 
 
-0.04 0.14b 0.02 0.15b 0.12a
Stereotype 
endorsement 
0.00 0.03 -0.07 -0.17b -0.14b
Discrimination 
occurrence  
-0.02 0.12a 0.01 0.15b 0.13b
Social 
withdrawal 
-0.07 0.15b -0.01 0.09 0.07 
Stigma 
resistance 
0.10 0.05 0.06 -0.08 -0.07 
 
Note:  a = p ≤ .05; b = p ≤ .01; c = p ≤ .001; d = p ≤ .0001 
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Table 168 
 
Continuous Domain 1 Variables by Service Variables  
 
 Age of 0nset Hospitalizations 
in lifetime 
Total years 
employed 
Mental 
illness: 
nuclear 
family 
 
Mental 
illness:  
extended 
family 
Total number  
of services 
 
-0.06 0.29d -0.12a 0.04 0.04 
Total contact 
hours 
 
-0.06 0.17b -0.18c -0.08 -0.03 
Average 
satisfaction 
 
-0.01 -0.06 -0.03 -0.10a -0.04 
 
Note:  a = p ≤ .05; b = p ≤ .01; c = p ≤ .001; d = p ≤ .0001 
 
 
Table 170 
 
 Categorical Domain 1 Variables  by Social Support  
 
  Partner or best friend support 
 
Family Support 
 
Provider Support 
 
 N Mean (s.d.) 
 
t-test Mean (s.d.) t-test Mean (s.d.) t-test 
Hospitalized in last year        
     Yes 120 4.07 (1.21) 0.82 3.63 (1.52) 0.74 4.06 (0.90) -0.15 
     No 230 4.18 (1.16) 3.76 )1.53)  4.05 (0.84)  
Currently Employed        
     Yes 74 4.18 (1.23) -0.34 3.70 (1.49) 0.09 3.94 (0.85) 1.21 
     No 276 4.13 (1.16)  3.72 (1.54)  4.08 (0.86)  
Substance diagnosis        
     Yes 119 4.18 (1.23) -0.40 3.62 (1.58) 0.80 4.15 (0.80) -1.50 
     No 231 4.12 (1.15)  3.76 (1.50)  4.00 (0.88)  
Anti-psychotic medication        
     Yes 155 4.04 (1.17) 1.49 3.81 (1.49) -1.05 4.19 (0.75) -2.82b
     No 195 4.23 (1.18)  3.64 (1.56)  3.94 (0.92)  
Anti-depressant medication        
     Yes 266 4.13 (1.14) 0.23 3.69 (1.50) 0.56 4.06 (0.85) -0.49 
     No 84 4.17 (1.31  3.80 (1.60)  4.01 (0.89)  
Anti-manic medication        
     Yes 96  4.07 (1.19) 0.75 3.65 (1.51) 0.46 4.01 (0.93) 0.53 
     No 254 4.17 (1.17)  3.74 (1.54)  4.07 (0.83)  
Anti-anxiety medication        
     Yes 183 4.04 (1.21) 1.77 3.51 (1.54) 2.62b 4.05 (0.85) -0.02 
     No 167 4.26 (1.13)  3.94 (1.45)  4.05 (0.87)  
Other psychotropic         
     Yes 113 4.07 (1.21) 0.81 3.54 (1.59) 1.48 4.16 (1.12) -1.59 
     No 237 4.18 (1.16)  3.80 (1.49)  4.00 (0.83)  
Child sexual abuse        
     Yes 147 4.09 (1.21)      0.77 3.38 (1.56) 3.51c 4.05 (0.83) -0.05 
     No 
 
 
203 4.18 (1.15)  3.95 (1.46)  4.05 (0.88)  
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  Friends Support 
 
Community involvement 
 
Trust 
 
 N Mean (s.d.) 
 
t-test Mean (s.d.) t-test Mean (s.d.) t-test 
Child physical abuse        
     Yes 137 4.19 (1.22) -0.60 3.28 (1.56) 4.31d 4.02 (0.81) 0.50 
     No 213 4.11 (1.15)  3.99 (1.45)  4.07 (0.89)  
Adult sexual assault        
     Yes 116 4.05 (1.19) 0.99 3.35 (1.51) 3.16b 4.03 (0.83) 0.24 
     No 234 4.19 (1.17)  3.89 (1.51)  4.06 (0.88)  
Adult physical assault        
     Yes 138 3.97 (1.25) 2.23a 3.28 (1.53) 4.38d 4.01 (0.80) 0.78 
     No 212 4.25 (1.12)  4.00 (1.46)  4.09 (0.90)  
Hospitalized in last year        
     Yes 120 4.10 (1.16) 0.11 3.40 (1.14) 1.04 3.05 (0.96) 0.35 
     No 230 4.12 (1.14) 3.54 (1.18)  3.08 (0.95)  
Currently Employed        
     Yes 74 4.19 (1.09) -0.68 3.41 (1.27) 0.62 3.05 (0.83) 0.17 
     No 276 4.09 (1.16)  3.51 (1.14)  3.08 (0.98)  
Substance diagnosis        
     Yes 119 4.12 (1.20) -0.10 3.35 (1.08) 1.54 3.04 (0.98) 0.49 
     No 231 4.11 (1.12)  3.56 (1.21)  3.09 (0.94)  
Anti-psychotic medication        
     Yes 155 4.12 (1.15) -0.12 3.53 (1.17) -0.65 3.11 (0.95) -0.68 
     No 195 4.10 (1.15)  3.45 (1.17)  3.04 (0.95)  
Anti-depressant medication        
     Yes 266 4.07 (1.13) 1.16 3.53 (1.13) -1.14 3.06 (0.96) 0.24 
     No 84 4.24 (1.20)  3.36 (1.27)  3.09 (0.93)  
Anti-manic medication        
     Yes 96  4.08 (1.16) 0.36 3.42 (1.12) 0.65 3.02 (0.97) 0.60 
     No 254 4.12 (1.15)  3.51 (1.19)  3.09 (0.94)  
Anti-anxiety medication        
     Yes 183 3.99 (1.23) 2.09a 3.38 (1.10) 1.74 3.04 (0.96) 0.67 
     No 
 
167 4.24 (1.03)  3.60 (1.24)  3.11 (0.94)  
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Table 170 (cont.) 
 
  Friends Support 
 
Community involvement 
 
Trust 
 
 N Mean (s.d.) 
 
t-test Mean (s.d.) t-test Mean (s.d.) t-test 
Other psychotropic         
     Yes 113 4.07 (1.12) 0.43 3.52 (1.13) -0.31 3.02 (1.03) 0.69 
     No 237 4.13 (1.16)  3.48 (1.19)  3.09 (0.91)  
Child sexual abuse        
     Yes 147 4.01 (1.21) 1.43 3.36 (1.16) 1.71 2.93 (0.92) 2.28a
     No 203 4.19 (1.09)  3.58 (1.17)  3.17 (0.97)  
Child physical abuse        
     Yes 137 4.14 (1.14) -0.43 3.50 (1.18) -0.21 2.89 (0.89) 2.87b
     No 213 4.09 (1.16)  3.48 (1.17)  3.19 (0.97)  
Adult sexual assault        
     Yes 116 4.05 (1.11) 0.66 3.43 (1.14) 0.65 3.08 (0.88) -0.07 
     No 234 4.14 (1.17)  3.52 (1.19)  3.07 (0.99)  
Adult physical assault        
     Yes 138 4.02 (1.22) 1.20 3.52 (1.19) -0.43 3.02 (0.88) 0.78 
     No 212 4.17 (1.10)  3.47 (1.16)  3.10 (1.00)  
 
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; d p ≤ .0001 
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Table 171 
 
Categorical Domain 1 Variables by Empowerment  
 
  Self-esteem and 
self-efficacy
Power and 
powerlessness 
 
Community activism 
and autonomy 
 
Optimism and control 
over the future 
 
Righteous anger 
 
Diagnosis N Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test 
 
Hospitalized in last 
year 
           
120 2.80 (0.59) 2.02a 2.45 (0.43) 0.88 3.12 (0.42) -0.51 2.79 (0.48) 0.72 2.49 (0.55) -0.63      Yes 
     No 230 2.92 (0.50) 2.49 (0.42)  3.14 (0.40)  2.83 (0.45)  2.45 (0.53)  
Currently Employed            
74 2.97 (0.57) -1.66 2.58 (0.46) -2.40b 3.17 (0.37) -0.39 2.90 (0.42) -1.71 2.53 (0.60) -1.19      Yes 
     No 276 2.86 (0.52)  2.45 (0.41)  3.15 (0.42)  2.79 (0.47)  2.44 (0.52)  
Co-occurring 
substance diagnosis 
           
119 2.89 (0.54) -0.29 2.55 (0.43) -2.21a 3.18 (0.37) -0.83 2.85 (0.41) -1.12 2.50 (0.49) -1.08      Yes 
     No 231 2.87 (0.53)  2.44 (0.42)  3.14 (0.42)  2.80 (0.48)  2.44 (0.56)  
Anti-psychotic 
medication 
           
155 2.81 (0.52) 2.28a 2.45 (0.42) 1.37 3.14 (0.40) 0.66 2.79 (0.46) 0.87 2.44 (0.53) 0.62      Yes 
     No 195 2.94 (0.54)  2.51 (0.43)  3.16 (0.41)  2.83 (0.46)  2.48 (0.54)  
Anti-depressant 
medication 
           
266 2.82 (0.54) 3.94d 2.46 (0.42) 1.84 3.14 (0.39) 1.20 2.77 (0.45) 2.70b 2.47 (0.52) -0.71      Yes 
     No 84 3.08 (0.46)  2.55 (0.44)  3.20 (0.45)  2.93 (0.47)  2.42 (0.58)  
Anti-manic 
medication 
           
     Yes 96  2.79 (0.53) 1.89a 2.50 (0.44) -0.54 3.13 (0.41) 0.69 2.81 (0.44) 0.11 2.48 (0.54) -0.39 
     No 254 2.91 (0.53)  2.47 (0.42)  3.16 (0.40)  2.82 (0.47)  2.45 (0.54)  
Anti-anxiety 
medication 
           
183 2.77 (0.53) 4.03d 2.44 (0.40) 1.87 3.12 (0.40) 1.40 2.74 (0.47) 3.12b 2.45 (0.54) 0.53      Yes 
     No 167 3.00 (0.51)  2.52 (0.45)  3.18 (0.41)  2.89 (0.44)  2.48 (0.54)  
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Table 171 (cont.) 
 
  Self-esteem and 
self-efficacy
Power and 
powerlessness 
 
Community activism 
and autonomy 
 
Optimism and control 
over the future 
 
Righteous anger 
 
N Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test  
Other psychotropic 
medication 
           
113 2.85 (0.46) 0.89 2.42 (0.43) 1.91a 3.11 (0.41) 1.39 2.76 (0.45) 1.50 2.39 (0.50) 1.65      Yes 
     No 237 2.90 (0.57)  2.51 (0.42)  3.17 (0.40)  2.84 (0.46)  2.49 (0.55)  
Child sexual abuse            
147 2.76 (0.49)      3.60c 2.43 (0.43) 2.04a 3.15 (0.40) -0.14 2.75 (0.47) 2.36a 2.52 (0.54) -1.73      Yes 
     No 203 2.97 (0.55)  2.52 (0.42)  3.15 (0.41)  2.86 (0.45)  2.42 (0.53)  
Child physical abuse            
137 2.83 (0.50) 1.28 2.45 (0.43) 1.19 3.18 (0.41) -0.88 2.80 (0.50) 0.47 2.53 (0.58) -2.02a     Yes 
     No 213 2.91 (0.55)  2.50 (0.42)  3.14 (0.40)  2.82 (0.43)  2.41 (0.50)  
Adult sexual assault            
116 2.77 (0.47) 2.87b 2.43 (0.42) 1.40 3.14 (0.36) 0.52 2.75 (0.47) 1.78 2.54 (0.52) -2.02a     Yes 
     No 234 2.93 (0.55)  2.50 (0.43)  3.16 (0.43)  2.85 (0.45)  2.42 (0.54)  
Adult physical 
assault 
           
     Yes 138 2.84 (0.49) 1.02 2.48 (0.43) 0.10 3.18 (0.38) -0.95 2.81 (0.47) -0.03 2.50 (0.56) -1.03 
     No 212 2.90 (0.56)  2.48 (0.43)  3.13 (0.42)  
 
2.81 (0.46)  2.44 (0.52)  
 
Note:  a = p ≤ .05; b = p ≤ .01; c = p ≤ .001; d = p ≤ .0001 
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Table 172 
 
Categorical Domain 1 Variables by Stigma 
 
  Alienation 
 
Stereotype 
endorsement 
 
Discrimination 
occurrence 
 
Social withdrawal 
 
 
Stigma resistance 
 
N Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test  
Hospitalized in last 
year 
           
120 2.61 (0.60) -3.20b 2.00 (0.47) -0.94 2.56 (0.58) -3.34c 2.47 (0.60) -2.53b 2.21 (0.47) -1.45      Yes 
     No 230 2.39 (0.61) 1.95 (0.47)  2.33 (0.63)  2.30 (0.58)  2.13 (0.45)  
Currently Employed            
74 2.06 (0.62) 3.27c 1.85 (0.46) 2.41a 2.23 (0.62) 2.78b 2.17 (0.65) 3.08b 2.12 (0.54) 0.74      Yes 
     No 276 2.52 (0.60)  2.00 (0.47)  2.46 (0.62)  2.41 (0.57)  2.17 (0.43)  
Co-occurring 
substance diagnosis 
           
119 2.52 (0.62) 2.37a 1.88 (0.46) 2.39a 2.29 (0.59) 2.69b 2.27 (0.60) 1.93a 2.06 (0.48) 2.93b     Yes 
     No 231 2.36 (0.60)  2.01 (0.47)  2.47 (0.63)  2.40 (0.59)  2.21 (0.44)  
Anti-psychotic 
medication 
           
     Yes 155 2.57 (0.58) -2.69 2.01 (0.48) -1.32 2.53 (0.60) -3.23c 2.47 (0.55) -3.18b 2.17 (0.46) -0.57 
     No 195 2.39 (0.63)  1.94 (0.47)  2.31 (0.63)  2.27 (0.61)  2.14 (0.45)  
Anti-depressant 
medication 
           
266 2.52 (0.59) -2.98b 1.99 (0.48) -1.38 2.47 (0.61) -3.05b 2.42 (0.58) -3.73c 2.17 (0.45) -0.79      Yes 
     No 84 2.30 (0.65)  1.91 (0.46)  2.23 (0.63)  2.15 (0.58)  2.12 (0.49)  
Anti-manic 
medication 
           
96  2.61 (0.49) -2.71b 2.00 (0.42) -0.77 2.48 (0.53) -1.24 2.44 (0.58) -1.60 2.18 (0.45) -0.63      Yes 
     No 254 2.41 (0.57)  1.96 (0.43)  2.38 (0.58)  2.32 (0.55)  2.15 (0.46)  
Anti-anxiety 
medication 
           
     Yes 183 2.57 (0.60) -3.44c 2.01 (0.46) -1.58 2.52 (0.59) -3.63c 2.45 (0.54) -3.02b 2.19 (0.44) -1.47 
     No 167 2.35 (0.61)  
 
1.93 (0.48)  2.29 (0.64)  2.26 (0.64)  2.12 (0.47)  
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Table 172 (cont.) 
 
  Alienation 
 
Stereotype 
endorsement 
 
Discrimination 
occurrence 
 
Social withdrawal 
 
 
Stigma resistance 
 
 N Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test 
Other psychotropic 
medication 
           
     Yes 113 2.57 (0.56) -2.12a 2.08 (0.47) -3.19b 2.53 (0.60) -2.45b 2.47 (0.53) -2.53b 2.14 (0.43) 0.36 
     No 237 2.42 (0.64)  1.91 (0.46)  2.35 (0.63)  2.30 (0.61)  2.16 (0.47)  
Child sexual abuse            
     Yes 147 2.60 (0.59)     -3.51c 1.98 (0.46) -0.45 2.51 (0.60) -2.69b 2.46 (0.58) -2.82b 2.19 (0.43) -1.06 
     No 203 2.37 (0.61)  1.96 (0.48)  2.33 (0.63)  2.28 (0.59)  2.13 (0.47)  
Child physical abuse            
     Yes 137 2.55 (0.62) -2.11a 1.97 (0.46) -0.15 2.51 (0.62) -2.52b 2.44 (0.61) -2.20a 2.15 (0.44) 0.04 
     No 213 2.41 (0.61)  1.97 (0.48)  2.34 (0.62)  2.30 (0.57)  2.16 (0.47)  
Adult sexual assault            
     Yes 116 2.59 (0.59) -2.63b 1.98 (0.48) -0.20 2.53 (0.58) -2.47b 2.44 (0.59) -1.79 2.18 (0.45) -0.67 
     No 234 2.41 (0.62)  1.96 (0.47)  2.35 (0.64)  2.32 (0.59)  2.14 (0.46)  
           Adult physical 
assault 
     Yes 138 2.51 (0.62) -0.97 1.95 (0.48) 0.54 2.49 (0.62) -1.98a 2.40 (0.62) -1.23 2.14 (0.46) 0.37 
     No 2.16 (0.45) 2.36 (0.62)  2.32 (0.57)   1.98 (0.47) 212 2.44 (0.61)  
 
 
 
Note:  a = p ≤ .05; b = p ≤ .01; c = p ≤ .001; d = p ≤ .0001 
 
 
 
Table 173   
 
Categorical Domain 1 Variables by Service Variables  
 
  Total number 
of services 
 
Total contact hours 
 
Average satisfaction 
 
 N Mean (s.d.) t-test Mean (s.d.) t-test Mean (s.d.) t-test 
Hospitalized in last year        
     Yes 120 2.68 (1.27) -2.87b 8.11 (8.62) -1.69 4.92 (1.00) 2.44a
     No 230 2.29 (1.14) 6.55 (7.15)  5.19 (0.97)  
Currently Employed        
     Yes 74 2.08 (1.17) 2.78b 5.91 (5.03) 1.95a 5.11 (1.15) -0.14 
     No 276 2.51 (1.20)  7.40 (8.26)  5.09 (0.94)  
Co-occurring substance 
diagnosis 
       
     Yes 119 2.44 (1.34) -0.15 6.85 (7.22) 0.41 5.15 (1.01) -0.65 
     No 231 2.42 (1.13)  7.21 (7.95)  5.07 (0.98)  
Anti-psychotic 
medication 
       
     Yes 155 2.94 (1.22) -7.64d 9.30 (9.16) -4.72d 5.11 (0.89) -0.24 
     No 195 2.01 (1.02)  5.32 (5.76)  5.09 (1.06)  
Anti-depressant 
medication 
       
     Yes 266 2.54 (1.20) -3.33c 7.22 (7.89) -0.57 5.04 (0.99) 1.85 
     No 84 2.05 (1.14)  6.67 (7.13)  5.27 (0.98)  
Anti-manic medication        
     Yes 96  2.72 (1.25) -2.86b 6.87 (7.41) 0.33 4.98 (1.09) 1.39 
     No 254 2.31 (1.16)  7.17 (7.83)  5.14 (0.95)  
Anti-anxiety 
medication 
       
     Yes 183 2.63 (1.25) -3.40c 7.35 (7.85) -0.67 5.03 (1.00) 1.33 
     No 167 2.20 (1.11)  6.80 (7.56)  5.17 (0.98)  
Other psychotropic 
medication 
       
     Yes 113 2.78 (1.19) -3.91d 8.10 (8.34) -1.70 5.07 (0.80) 0.35 
     No 237 2.25 (1.17)  6.61 (7.35)  5.11 (1.07)  
Child sexual abuse        
     Yes 147 2.47 (1.16) -0.62 6.92 (6.91) 0.36 5.06 (0.97) 0.54 
     No 203 2.39 (1.23)  7.21 (8.25)  5.12 (1.00)  
Child physical abuse        
     Yes 137 2.61 (1.08) -2.30a 6.46 (6.14) 1.27 4.93 (0.86) 2.55b
     No 213 2.31 (1.08)  7.49 (7.48)  5.20 (0.91)  
Adult sexual assault        
     Yes 116 2.65 (1.24) -2.47b 7.52 (7.20) -0.74 5.04 (0.84) 0.83 
     No 234 2.31 (1.17)  6.87 (7.95)  5.13 (1.06)  
Adult physical assault        
     Yes 138 2.51 (1.23) -1.15 6.60 (6.47) 1.00 5.02 (0.96) 1.13 
     No 212 2.36 (1.18)  7.40 (8.41)  5.15 (1.01)  
 
Note:  a p ≤ .05; b p ≤ .01; c p ≤ .001; d p ≤ .0001 
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Table 174 
 
Social Support Correlation Table  
 
 Partner or 
best friend 
support 
Family 
Support 
 
Provider 
Support 
 
Friends 
Support 
 
Community 
involvement 
 
Family 
Support 
 
0.34d     
Provider 
Support 
 
0.34d 0.26d    
Friends 
Support 
 
0.66d 0.35d 0.39d   
Community 
involvement 
 
0.25d 0.24d 0.37d 0.28d  
Trust 
 0.18
c 0.06 0.21d 0.20d 0.01 
 
Note:  a = p ≤ .05; b = p ≤ .01; c = p ≤ .001; d = p ≤ .0001 
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Table 175 
 
Social Support by Empowerment  
 
 
 
Self-esteem 
and 
Self-
efficacy 
Power and 
powerlessness 
 
Community 
activism and 
autonomy 
 
Optimism 
and control 
over the 
future 
 
Righteous 
anger 
 
Partner or 
best friend 
support 
 
0.38d 0.18c 0.16b 0.24d 0.02 
Family 
Support 
 
0.28d 0.03 0.12a 0.23d -0.07 
Provider 
Support 
 
 
0.15b -0.12 0.06 0.17c -0.01 
Friends 
Support 
 
0.29d 0.14b 0.08 -0.23d 0.03 
Community 
involvement 
 
0.38d 0.12a 0.17c 0.25d -0.01 
Trust 
 
0.08 0.06 -0.02 0.03 -0.04 
 
Note:  a = p ≤ .05; b = p ≤ .01; c = p ≤ .001; d = p ≤ .0001 
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Table 176 
 
Social Support by Stigma  
 
 
 
Alienation 
 
Stereotype 
endorsement 
 
Discrimination 
occurrence 
 
Social 
withdrawal 
 
Stigma 
resistance 
 
Partner or 
best friend 
support 
-0.28d -0.16b -0.19c -0.26d -0.33 
Family 
Support 
 
-0.21d 0.01 -0.17b -0.18c -0.17b
Provider 
Support 
 
-0.13b -0.08 -0.00 -0.12a -0.19c
Friends 
Support 
 
-0.28d -0.17b -0.15b -0.28d -0.27d
Community 
involvement 
 
-0.23d -0.15b -0.07 -0.20d -0.25d
Trust 
 
-0.13b -0.03 -0.17b -0.11a -0.04 
 
Note:  a = p ≤ .05; b = p ≤ .01; c = p ≤ .001; d = p ≤ .0001 
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Table 177 
 
Social Support by Service Variables  
 
 Total number 
of services 
 
Total contact hours 
 
Average satisfaction 
 
Partner or 
best friend 
support 
-0.02 0.00 0.29d
Family 
Support 
 
0.02 0.14b 0.24d
Provider 
Support 
 
0.16b 0.14b 0.35d
Friends 
Support 
 
0.02 0.02 0.23d
Community 
involvement 
 
0.02 -0.10a 0.16b
Trust 
 
0.04 0.12a 0.09 
 
Note:  a = p ≤ .05; b = p ≤ .01; c = p ≤ .001; d = p ≤ .0001 
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Table 178 
 
Empowerment Correlation Table  
 
 Self-esteem and 
Self-efficacy 
Power and 
powerlessness 
 
Community 
activism and 
autonomy 
 
Optimism and 
control over the 
future 
 
Power and 
powerlessness 
 
0.24d    
Community 
activism and 
autonomy 
 
0.38d 0.04   
Optimism and 
control over 
the future 
 
0.58d 0.13a 0.40d  
Righteous 
anger 
 
-0.13a 0.28d -0.03 -0.10a
 
Note:  a = p ≤ .05; b = p ≤ .01; c = p ≤ .001; d = p ≤ .0001 
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Table 179 
 
Empowerment by Stigma  
 
 Alienation 
 
Stereotype 
endorsement 
 
Discrimination 
occurrence 
 
Social 
withdrawal 
 
Stigma 
resistance 
 
Self-esteem and 
self-efficacy 
 
-0.51d -0.25d -0.44d -0.51d -0.48d
Power and 
powerlessness 
-0.37d -0.41d -0.26d -0.36d -0.30d
 
Community 
activism and 
autonomy 
-0.25d -0.32d -0.26d -0.25d -0.30d
Optimism and 
control over the 
future 
-0.39d -0.19c -0.25d -0.34d -0.42d
Righteous anger 
 
-0.03 -0.12a -0.03 -0.04 -0.04 
 
Note:  a = p ≤ .05; b = p ≤ .01; c = p ≤ .001; d = p ≤ .0001 
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Table 180 
 
Empowerment by Service Variables 
 
 Total number 
of services 
 
Total contact hours 
 
Average satisfaction 
 
Self-esteem and 
self-efficacy 
 
-0.03 -0.09 0.32d
Power and 
powerlessness 
 
-0.11a -0.17b 0.09 
Community 
activism and 
autonomy 
0.02 -0.04 0.03 
Optimism and 
control over the 
future 
-0.02 0.00 0.22d
Righteous anger 
 
0.06 -0.02 -0.01 
 
Note:  a = p ≤ .05; b = p ≤ .01; c = p ≤ .001; d = p ≤ .0001 
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Table 181 
 
Stigma Correlation Table 
 
 Alienation 
 
Stereotype 
endorsement 
 
Discrimination 
occurrence 
 
Social 
withdrawal 
 
Stereotype 
endorsement 
 
0.54d    
Discrimination 
occurrence  
 
0.68d 0.54d   
Social 
withdrawal 
 
0.79d 0.63d 0.75d  
Stigma 
resistance 
 
0.51d 0.48d 0.39d 0.54d
 
Note:  a = p ≤ .05; b = p ≤ .01; c = p ≤ .001; d = p ≤ .0001 
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Table 182 
 
Stigma by Service Variables 
 
 Total number 
of services 
 
Total contact hours 
 
Average satisfaction 
 
Alienation 
 
0.03 0.04 -0.31d
Stereotype 
endorsement 
 
-0.02 0.07 -0.13b
Discrimination 
occurrence  
 
0.04 -0.02 -0.23d
Social 
withdrawal 
 
0.04 0.05 -0.30d
Stigma 
resistance 
 
-0.05 0.03 -0.27d
 
Note:  a = p ≤ .05; b = p ≤ .01; c = p ≤ .001; d = p ≤ .0001 
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Table 183 
 
Service Domain Correlation Table  
 
 Number of Services 
 
Contact Hours per Month 
Contact Hours per 
Month 0.59d  
 
Service Satisfaction 
a 0.01 0.12
 
 
Note:  a = p ≤ .05; b = p ≤ .01; c = p ≤ .001; d = p ≤ .0001 
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